data_1eh2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1eh2 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.593 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 15.5 t90 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.254 0.55 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -44.94 -27.74 0.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 110.342 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.593 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 16.3 t -89.84 137.57 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.209 -0.932 . . . . 0.0 110.116 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.529 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 5.4 mttt -92.81 168.29 12.72 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.666 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 38.3 Cg_endo -65.9 -34.56 38.68 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.638 1.336 . . . . 0.0 109.763 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.67 -25.05 60.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.345 -0.847 . . . . 0.0 109.252 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -83.95 -38.36 21.12 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -67.78 -17.45 64.54 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.453 -0.78 . . . . 0.0 109.192 179.071 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.16 -40.43 27.34 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 3.7 ptmt -79.23 -24.1 43.29 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.0 m-30 -75.07 -35.68 61.83 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -76.68 -11.73 59.89 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.261 0.553 . . . . 0.0 110.182 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -94.82 -34.33 12.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.567 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 21.4 mt -75.78 -32.68 24.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -68.15 -37.98 81.63 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.452 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 13.6 t70 -89.75 1.72 55.75 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.546 -0.721 . . . . 0.0 109.966 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -92.81 0.13 57.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 108.65 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.4 OUTLIER -113.85 -2.12 13.72 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER 82.69 89.81 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.8 Cg_endo -75.29 150.85 37.52 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 124.352 1.711 . . . . 0.0 110.721 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 98.8 t -117.59 96.9 4.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.561 -0.712 . . . . 0.0 109.505 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 10.4 t30 56.93 20.49 5.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.923 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.55 32.28 3.98 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 90.7 m-85 -149.98 158.6 44.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.194 -1.18 . . . . 0.0 111.378 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.577 HD13 ' CD2' ' A' ' 21' ' ' PHE . 40.5 mt -135.21 132.51 37.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.572 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 9.2 p -80.66 140.23 35.77 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.445 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.47 -26.38 0.38 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 32' ' ' SER . 8.4 t0 -62.77 -16.37 57.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -1.159 . . . . 0.0 110.378 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 17.5 mttm -107.58 -42.2 4.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.237 -0.914 . . . . 0.0 109.298 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.544 HG13 ' CD1' ' A' ' 65' ' ' LEU . 64.9 t -74.31 -35.66 40.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.835 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.563 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 14.3 tttp -49.4 -54.59 28.64 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 110.229 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.5 Cg_endo -65.09 -30.29 56.0 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.493 1.26 . . . . 0.0 108.997 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.587 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 4.3 t -76.4 -10.32 13.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.361 0.601 . . . . 0.0 109.741 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.505 ' CD2' HG22 ' A' ' 77' ' ' VAL . 68.5 mt -100.86 -16.09 17.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.546 ' CD1' ' HA ' ' A' ' 38' ' ' PRO . 7.7 mt -87.16 -40.69 14.37 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.51 -0.744 . . . . 0.0 109.575 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -52.34 -20.81 2.99 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.068 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.8 OUTLIER -66.95 -6.15 15.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.579 -0.701 . . . . 0.0 110.085 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.3 OUTLIER 72.43 9.5 5.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.865 . . . . 0.0 109.96 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.564 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 14.9 mt -91.58 157.16 42.4 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 110.322 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.563 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.2 Cg_endo -74.47 164.35 34.15 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.138 1.599 . . . . 0.0 110.191 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.83 -8.75 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 110.159 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.84 -40.23 63.45 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.053 -1.029 . . . . 0.0 108.309 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.563 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 10.3 mm -68.34 -47.72 76.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 40' ' ' LEU . 4.4 mt -62.62 -17.38 60.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -88.72 -33.67 9.82 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 87' ' ' PRO . 16.7 ttm-85 -91.77 -55.78 3.34 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.461 -1.023 . . . . 0.0 109.321 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.518 ' O ' ' HB3' ' A' ' 57' ' ' SER . 24.7 t -47.64 -58.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.37 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.576 ' CE3' HD13 ' A' ' 65' ' ' LEU . 7.7 t-105 -47.35 -54.85 10.07 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.686 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 17.8 mm-40 -47.39 -51.9 18.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 110.02 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.606 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 2.6 mt -74.57 -7.65 53.81 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.317 -0.864 . . . . 0.0 109.642 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.553 ' HB2' ' CA ' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -100.53 -36.23 9.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.418 -0.801 . . . . 0.0 110.269 179.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 36.3 t0 -79.31 71.89 5.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.441 -0.787 . . . . 0.0 109.495 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.464 ' O ' ' NE2' ' A' ' 61' ' ' HIS . 36.8 mm -40.16 -33.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.622 -0.674 . . . . 0.0 110.658 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -93.22 -27.59 16.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.946 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.546 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 14.4 m-70 64.67 45.2 3.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.21 -0.931 . . . . 0.0 110.762 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.496 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 2.6 p-10 -113.38 20.88 15.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 110.787 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.53 0.66 89.33 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.572 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 3.3 mtt -130.81 160.26 34.92 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.293 -1.122 . . . . 0.0 110.314 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.576 HD13 ' CE3' ' A' ' 54' ' ' TRP . 21.3 mt -126.97 114.27 17.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 110.542 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 8.9 t70 -69.74 172.96 6.74 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.142 -0.974 . . . . 0.0 109.395 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.598 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 5.2 ptt180 -55.42 -31.72 62.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 110.768 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.426 ' O ' HG22 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -87.78 -32.54 19.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.089 -1.007 . . . . 0.0 109.778 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.479 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 28.0 mt-10 -78.16 -39.3 41.4 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.264 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.569 ' CE1' ' SD ' ' A' ' 74' ' ' MET . 62.6 t80 -65.61 -27.56 68.49 Favored 'General case' 0 C--N 1.303 -1.457 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.865 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.38 -45.44 87.7 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.796 0.808 . . . . 0.0 109.685 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.541 HG11 ' CD2' ' A' ' 94' ' ' LEU . 48.1 t -61.64 -20.29 22.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.333 0.587 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.553 ' CA ' ' HB2' ' A' ' 57' ' ' SER . . . -90.36 -11.12 41.56 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 111.65 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.569 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 5.7 mmm -89.1 -41.52 12.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.699 -1.251 . . . . 0.0 110.385 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.582 ' CE1' HD22 ' A' ' 94' ' ' LEU . 1.8 p90 -78.97 -23.29 44.63 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.046 -1.061 . . . . 0.0 108.55 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.564 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 6.1 mt -74.61 -23.64 58.75 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.58 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 55.6 t -91.03 -59.03 3.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -47.85 -22.73 0.6 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.796 -0.565 . . . . 0.0 111.567 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -83.74 -16.85 43.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.882 -1.136 . . . . 0.0 110.048 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.564 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -86.8 -14.18 42.96 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.325 -0.859 . . . . 0.0 109.484 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.58 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 6.7 mp -86.65 -40.4 15.15 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 . . . . . 0 C--N 1.301 -1.517 0 CA-C-O 121.376 0.608 . . . . 0.0 109.858 179.495 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.515 HG12 ' CG2' ' A' ' 53' ' ' VAL . 76.5 t . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 120.629 0.252 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.489 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 49.8 Cg_endo -83.3 -167.52 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.999 1.526 . . . . 0.0 109.359 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.473 ' HA ' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -117.63 9.95 13.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.109 -0.994 . . . . 0.0 110.405 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.5 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 90.5 p -108.28 107.2 17.69 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.307 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.606 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -55.71 107.1 0.78 Allowed Pre-proline 0 C--N 1.294 -1.808 0 C-N-CA 120.061 -0.655 . . . . 0.0 109.811 178.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.518 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 41.6 Cg_endo -73.67 149.31 43.21 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.744 1.392 . . . . 0.0 110.606 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.477 ' HA ' ' CG1' ' A' ' 95' ' ' VAL . 48.3 Cg_endo -72.5 -3.98 14.44 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.224 1.644 . . . . 0.0 111.85 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -94.66 -23.37 17.62 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.072 -1.018 . . . . 0.0 109.225 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.582 HD22 ' CE1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -98.21 -14.38 20.36 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.786 0.803 . . . . 0.0 109.255 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.477 ' CG1' ' HA ' ' A' ' 92' ' ' PRO . 8.9 p . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.081 -1.012 . . . . 0.0 110.519 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.503 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.3 t90 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.157 0.503 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.538 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -41.66 -29.53 0.19 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.511 -0.743 . . . . 0.0 109.831 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.557 HG23 ' CD2' ' A' ' 75' ' ' PHE . 92.3 t -92.08 158.59 2.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.548 -0.72 . . . . 0.0 109.865 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.518 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 6.0 mttt -126.36 178.09 1.68 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.952 . . . . 0.0 110.13 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 40.0 Cg_endo -66.67 -36.48 24.82 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.913 1.481 . . . . 0.0 110.141 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -69.88 -36.23 75.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 109.101 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -83.54 -33.43 25.47 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 16.4 tptp -78.64 -20.64 49.86 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' PRO . . . -68.05 -41.9 81.34 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.598 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.7 ptpt -72.9 -31.81 64.92 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.598 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -66.59 -38.31 86.75 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 62.8 t0 -68.99 -11.1 60.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.672 -0.643 . . . . 0.0 110.331 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -96.39 -34.45 11.54 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.541 HG21 ' CE2' ' A' ' 70' ' ' PHE . 26.5 mt -78.35 -31.57 16.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.546 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -68.3 -37.98 81.16 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.473 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.1 t70 -90.41 0.99 57.05 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.625 -0.672 . . . . 0.0 109.916 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -92.72 2.71 56.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 108.77 178.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -115.6 -1.67 12.68 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER 79.52 87.0 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -73.87 147.46 39.31 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 124.446 1.761 . . . . 0.0 110.666 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 34.6 t -114.37 105.94 19.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 9.4 t30 55.49 23.71 6.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -0.983 . . . . 0.0 109.284 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.405 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 91.77 37.36 6.11 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.559 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 86.4 m-85 -149.92 158.03 43.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -1.098 . . . . 0.0 111.233 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.493 ' CD2' ' HB2' ' A' ' 24' ' ' LEU . 12.0 mt -136.4 133.15 36.41 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.569 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -79.63 140.74 37.0 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.414 -0.804 . . . . 0.0 110.408 -179.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.52 -25.54 0.85 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 32' ' ' SER . 4.8 t70 -68.37 -9.07 45.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -1.173 . . . . 0.0 110.237 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.481 ' HD2' ' OG ' ' A' ' 32' ' ' SER . 4.6 mtpp -114.05 -43.35 3.25 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.886 0.851 . . . . 0.0 109.348 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.5 HG12 ' CE1' ' A' ' 70' ' ' PHE . 85.8 t -76.94 -46.21 29.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.78 -0.575 . . . . 0.0 110.266 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 39.0 tttt -46.19 -49.23 42.47 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 110.796 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.4 Cg_endo -68.58 -34.93 18.37 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 N-CA-C 108.918 -1.224 . . . . 0.0 108.918 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.524 ' CG2' HD21 ' A' ' 24' ' ' LEU . 2.4 t -62.72 -25.21 37.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 20.0 mt -84.02 -15.84 46.14 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.408 -0.807 . . . . 0.0 109.173 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.526 ' HG ' ' CD1' ' A' ' 50' ' ' LEU . 16.0 mt -76.44 -28.13 56.48 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 31.9 m-80 -63.51 -15.63 58.43 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.472 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.541 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -72.68 -1.54 16.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.504 -0.748 . . . . 0.0 110.155 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 43' ' ' SER . 7.8 ttpt 68.73 18.15 8.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -0.865 . . . . 0.0 109.925 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.575 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 16.8 mt -100.11 162.05 22.24 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.387 -0.821 . . . . 0.0 110.375 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.561 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.9 Cg_endo -74.14 166.18 30.18 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.106 1.582 . . . . 0.0 110.288 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 t -66.65 -7.52 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.404 -0.81 . . . . 0.0 110.22 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -40.93 59.6 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.561 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 21.5 mm -64.91 -44.87 96.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.526 ' CD1' ' HG ' ' A' ' 41' ' ' LEU . 4.8 mt -65.74 -17.88 64.93 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.335 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -87.92 -30.57 17.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.554 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 4.1 ttm180 -92.73 -56.27 3.07 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.403 -1.057 . . . . 0.0 109.45 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.526 ' CG1' HG21 ' A' ' 77' ' ' VAL . 41.0 t -46.6 -39.82 4.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.281 -0.968 . . . . 0.0 109.058 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.546 ' CZ3' HD13 ' A' ' 65' ' ' LEU . 18.5 t-105 -65.51 -60.35 3.03 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.814 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 4.1 mm-40 -44.25 -54.68 5.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 109.826 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.628 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 1.7 mt -69.9 -9.94 56.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.393 -0.817 . . . . 0.0 109.662 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.553 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 3.1 t -100.52 -32.75 10.63 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.442 -0.786 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.583 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 22.7 t0 -80.07 76.43 6.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.305 -0.872 . . . . 0.0 110.21 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.51 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 41.6 mm -45.96 -32.56 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.482 -0.761 . . . . 0.0 109.833 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 22.7 m-20 -95.8 -21.73 17.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.539 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 88.5 m-70 57.38 48.47 14.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 109.563 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.44 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 1.7 p-10 -117.64 6.57 12.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.404 -0.81 . . . . 0.0 110.376 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.83 8.85 59.0 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.569 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 5.9 mtt -141.85 160.63 39.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -1.147 . . . . 0.0 110.89 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.546 HD13 ' CZ3' ' A' ' 54' ' ' TRP . 35.9 mt -130.18 120.66 24.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.379 -0.826 . . . . 0.0 109.986 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.559 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 2.0 p30 -79.45 166.33 22.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.885 -1.135 . . . . 0.0 110.036 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.534 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 9.6 ptt180 -36.97 -46.83 0.67 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.456 -0.778 . . . . 0.0 111.596 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.484 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 63.1 m-20 -79.91 -33.9 39.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.139 -0.976 . . . . 0.0 110.381 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 13.1 tt0 -67.94 -50.75 54.12 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.346 -0.847 . . . . 0.0 109.785 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.572 ' CE2' ' SD ' ' A' ' 74' ' ' MET . 62.5 t80 -56.0 -27.42 52.84 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.11 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.49 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . . . -62.63 -47.33 84.2 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.564 0.697 . . . . 0.0 110.103 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 57' ' ' SER . 96.2 t -59.67 -24.48 29.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.501 -0.75 . . . . 0.0 109.875 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.553 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -88.39 -6.48 57.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.26 -0.9 . . . . 0.0 111.605 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.572 ' SD ' ' CE2' ' A' ' 70' ' ' PHE . 8.7 mmm -90.17 -42.77 10.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.383 -1.448 . . . . 0.0 110.332 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.557 ' CD2' HG23 ' A' ' 9' ' ' VAL . 2.0 p90 -76.44 -22.58 54.46 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.965 -1.094 . . . . 0.0 108.339 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.55 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 14.9 mt -73.7 -28.36 61.69 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.564 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 41.2 t -92.09 -56.4 5.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.732 -0.605 . . . . 0.0 109.551 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 74' ' ' MET . 1.0 OUTLIER -53.31 -18.85 2.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.416 -0.802 . . . . 0.0 110.812 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 75' ' ' PHE . 11.7 m -86.13 -16.94 36.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.933 . . . . 0.0 109.945 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.575 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -85.82 -11.91 52.21 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.191 -0.943 . . . . 0.0 109.564 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.564 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 6.2 mp -87.52 -43.78 11.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.377 -0.827 . . . . 0.0 109.222 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.459 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.23 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.482 HG13 HG21 ' A' ' 53' ' ' VAL . 53.3 t . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 120.636 0.255 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.448 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 49.4 Cg_endo -83.14 176.5 7.41 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.921 1.485 . . . . 0.0 109.724 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.554 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 31.7 mtp -103.21 15.81 28.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.091 -1.006 . . . . 0.0 110.345 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.582 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 75.7 m -114.06 105.33 13.09 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.954 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.628 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -82.25 106.13 5.91 Favored Pre-proline 0 C--N 1.289 -2.046 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 89' ' ' SER . 40.5 Cg_endo -66.36 158.83 53.17 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.906 1.477 . . . . 0.0 110.244 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.19 -15.59 31.81 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.882 1.464 . . . . 0.0 110.312 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -72.47 -7.5 50.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.538 ' CD1' ' CB ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -90.5 -28.36 18.61 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.62 -0.675 . . . . 0.0 110.122 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.481 -0.762 . . . . 0.0 111.098 -179.086 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.576 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 13.9 t90 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.236 0.541 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.582 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -41.43 -33.21 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.596 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.576 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 55.4 t -98.38 122.89 50.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.357 -0.839 . . . . 0.0 110.142 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.536 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.0 mtmt -91.26 -177.28 0.73 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 110.107 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.2 Cg_endo -71.24 -36.26 7.39 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.811 1.427 . . . . 0.0 110.242 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.78 -24.16 58.63 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.314 -0.866 . . . . 0.0 109.302 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -86.5 -37.04 18.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.309 -0.869 . . . . 0.0 108.914 179.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -18.42 59.38 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.31 -39.53 71.36 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -75.19 -19.02 60.03 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 13.0 m-30 -82.83 -30.25 28.86 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -76.6 -11.3 59.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.718 -0.614 . . . . 0.0 110.053 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.47 -33.66 15.12 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.58 HG21 ' CE1' ' A' ' 70' ' ' PHE . 6.9 mt -80.38 -29.03 12.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -75.51 -35.46 60.76 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.002 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.502 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -89.48 -1.92 58.2 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.594 -0.691 . . . . 0.0 109.88 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.44 -6.02 56.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 109.206 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.581 ' O ' ' CB ' ' A' ' 25' ' ' SER . 1.9 mt -108.35 -9.82 15.41 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.5 m 83.16 92.21 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.8 Cg_endo -73.05 148.52 44.98 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.351 1.711 . . . . 0.0 110.577 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.473 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 28.3 t -111.94 113.14 43.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.441 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER 46.04 25.09 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.835 . . . . 0.0 109.719 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.46 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 96.8 34.58 5.67 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.609 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 85.0 m-85 -151.55 153.8 35.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.085 -1.244 . . . . 0.0 111.72 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 64' ' ' MET . 41.7 mt -123.15 127.95 49.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 35' ' ' LYS . 60.1 p -65.84 137.96 57.56 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.862 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.597 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -48.28 -26.97 5.18 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.66 -14.65 58.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -1.124 . . . . 0.0 109.633 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.551 ' CD ' HD21 ' A' ' 31' ' ' LEU . 21.0 ttmm -91.88 -39.55 11.66 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.528 HG12 ' CD1' ' A' ' 65' ' ' LEU . 89.7 t -83.1 -31.05 8.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.437 0.637 . . . . 0.0 110.098 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.62 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -39.86 -51.28 5.55 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.535 -0.728 . . . . 0.0 111.122 -179.282 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 36.7 Cg_endo -63.02 -31.05 76.74 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.425 1.223 . . . . 0.0 109.841 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.541 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 2.9 t -74.46 -14.92 16.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.628 -0.67 . . . . 0.0 109.866 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.487 ' O ' HD23 ' A' ' 50' ' ' LEU . 66.9 mt -97.41 -23.93 15.85 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.295 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.501 HD11 ' HA ' ' A' ' 38' ' ' PRO . 2.5 mt -87.74 -34.2 18.43 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.188 -0.945 . . . . 0.0 110.063 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.541 ' ND2' ' HA ' ' A' ' 39' ' ' VAL . 2.0 p30 -65.6 -9.95 31.39 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.579 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.473 ' OG ' HG12 ' A' ' 77' ' ' VAL . 2.3 m -79.77 7.72 8.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 110.475 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 64.75 16.76 10.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.125 -0.984 . . . . 0.0 110.489 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.535 HD21 ' HD2' ' A' ' 46' ' ' PRO . 14.5 mt -97.0 153.81 38.41 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 109.967 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.567 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.6 Cg_endo -74.79 163.64 35.25 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.998 1.525 . . . . 0.0 110.467 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.6 t -64.77 -8.43 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.718 . . . . 0.0 110.513 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -76.3 -41.18 49.48 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.567 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 23.0 mm -65.03 -44.93 95.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 40' ' ' LEU . 3.9 mt -61.97 -18.42 60.35 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.35 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.67 -31.16 19.27 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.468 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 1.2 mtm180 -94.95 -55.38 3.11 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.43 -1.041 . . . . 0.0 109.455 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.53 HG22 ' CG2' ' A' ' 49' ' ' ILE . 30.0 t -49.08 -42.69 14.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.246 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.597 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 14.6 t-105 -65.55 -58.57 5.46 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.138 -0.976 . . . . 0.0 109.513 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.583 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 5.2 mm-40 -51.43 -33.45 30.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.995 . . . . 0.0 109.142 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.493 ' HB3' ' HG ' ' A' ' 90' ' ' LEU . 6.7 mt -86.01 -15.27 41.94 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.493 -0.754 . . . . 0.0 109.343 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.534 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 50.4 m -100.16 -29.54 12.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.484 -0.76 . . . . 0.0 110.396 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 42.1 t0 -85.45 66.62 9.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.275 -0.891 . . . . 0.0 109.842 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 58' ' ' ASP . 42.0 mm -40.36 -29.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.485 0.659 . . . . 0.0 110.22 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 6.3 t0 -89.33 -28.51 19.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.362 -0.836 . . . . 0.0 110.826 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.583 ' CE1' ' O ' ' A' ' 55' ' ' GLU . 87.7 m-70 56.32 50.59 12.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.084 -1.01 . . . . 0.0 110.083 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 63' ' ' GLY . 5.3 p-10 -118.79 -10.11 10.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 110.409 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.424 ' N ' ' OD1' ' A' ' 62' ' ' ASP . . . 116.61 8.69 12.07 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.556 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 15.4 mtp -142.7 160.87 39.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -1.148 . . . . 0.0 110.228 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.528 ' CD1' HG12 ' A' ' 36' ' ' VAL . 13.0 mt -120.77 105.6 10.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.286 -0.884 . . . . 0.0 109.767 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.609 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 1.8 t70 -72.58 171.66 12.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.879 -1.138 . . . . 0.0 110.258 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.486 ' N ' ' CG ' ' A' ' 66' ' ' ASP . 16.2 ptp180 -45.71 -39.84 8.58 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.771 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.446 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 30.8 t0 -81.77 -31.79 31.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.195 -0.94 . . . . 0.0 110.458 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.486 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 27.5 mt-10 -77.95 -42.06 34.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.215 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.588 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 44.0 t80 -66.72 -28.06 68.12 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.536 -0.727 . . . . 0.0 109.376 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -65.72 -51.98 54.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 110.018 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.501 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 93.2 t -55.65 -21.79 10.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.537 -0.727 . . . . 0.0 110.281 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.534 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -90.49 -14.61 32.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.219 -0.925 . . . . 0.0 111.766 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.628 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 7.0 mmm -80.18 -41.8 24.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.744 -1.223 . . . . 0.0 109.924 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.59 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.7 p90 -77.74 -22.34 50.45 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.59 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 6.6 mt -75.95 -30.76 58.78 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.673 0.749 . . . . 0.0 109.126 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.497 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 44.4 t -90.19 -20.19 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.6 -0.688 . . . . 0.0 109.867 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.4 OUTLIER -90.56 -23.0 21.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.453 -0.779 . . . . 0.0 109.655 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 1.6 m -86.25 -17.98 33.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.446 -0.784 . . . . 0.0 109.731 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.522 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -83.91 -9.36 58.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.434 -0.791 . . . . 0.0 109.177 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.524 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 2.0 mt -89.59 -45.93 9.02 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.714 0.769 . . . . 0.0 109.227 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 C--N 1.3 -1.562 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.645 179.657 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.547 ' CG1' ' HD2' ' A' ' 87' ' ' PRO . 60.0 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.547 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 44.8 Cg_endo -80.19 -165.01 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.61 1.321 . . . . 0.0 110.063 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.07 3.16 17.17 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 111.114 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -177.74 29.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.745 -1.222 . . . . 0.0 111.674 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.5 HD21 ' CB ' ' A' ' 94' ' ' LEU . 9.6 mt 57.65 120.49 0.01 OUTLIER Pre-proline 0 C--N 1.285 -2.226 0 O-C-N 121.96 -0.463 . . . . 0.0 110.509 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.577 ' HG2' ' CD2' ' A' ' 94' ' ' LEU . 40.0 Cg_endo -70.28 176.86 6.59 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 123.641 1.338 . . . . 0.0 109.15 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 40.2 Cg_endo -65.65 -9.72 23.78 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.558 1.294 . . . . 0.0 111.894 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.502 ' O ' ' HB1' ' A' ' 8' ' ' ALA . . . -98.64 4.18 47.94 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.049 -1.032 . . . . 0.0 110.604 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.582 ' CD1' ' CB ' ' A' ' 8' ' ' ALA . 4.2 mm? -117.35 38.57 3.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.011 -1.056 . . . . 0.0 111.295 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.542 ' O ' ' CG1' ' A' ' 95' ' ' VAL . 8.8 p . . . . . 0 C--N 1.3 -1.583 0 O-C-N 120.91 -1.119 . . . . 0.0 110.603 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.488 ' HA ' ' O ' ' A' ' 93' ' ' ALA . 11.1 t90 . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -41.14 -27.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.0 109.787 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.467 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 38.0 t -99.51 149.02 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.438 -0.789 . . . . 0.0 109.69 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.471 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.6 mttt -111.48 173.36 2.91 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 110.02 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.8 Cg_endo -68.94 -34.51 17.29 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.835 1.44 . . . . 0.0 109.404 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 10.5 pt-20 -80.21 -26.7 39.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.47 -0.768 . . . . 0.0 109.646 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 1.6 m-20 -83.34 -41.38 18.29 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.473 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -69.06 -16.99 63.83 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.455 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.11 -42.42 72.69 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.602 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -70.68 -27.63 64.17 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -69.38 -37.48 77.58 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.22 -10.37 57.43 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.426 0.631 . . . . 0.0 109.969 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -92.79 -34.55 13.83 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.579 HG21 ' CE1' ' A' ' 70' ' ' PHE . 15.8 mt -80.97 -28.46 11.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.618 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -75.68 -36.01 60.2 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.485 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.4 t70 -88.65 -2.17 58.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.667 -0.646 . . . . 0.0 109.712 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 29.5 t -91.3 0.91 57.44 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.593 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.5 OUTLIER -113.12 -5.51 13.71 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.593 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 82.63 86.58 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.092 0 CA-C-O 121.131 0.491 . . . . 0.0 109.827 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -73.53 147.4 40.78 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 O-C-N 124.418 1.746 . . . . 0.0 110.903 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -115.89 111.83 37.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.633 -0.667 . . . . 0.0 109.242 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.531 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 54.52 20.52 2.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 109.468 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . 95.58 32.68 6.8 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.593 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 94.5 m-85 -146.32 158.96 43.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.432 -1.04 . . . . 0.0 110.643 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.583 HD13 ' CD2' ' A' ' 21' ' ' PHE . 16.5 mt -136.77 128.7 29.28 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.58 -0.7 . . . . 0.0 109.177 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.541 ' OG ' ' CE ' ' A' ' 64' ' ' MET . 0.7 OUTLIER -74.49 137.41 42.51 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.273 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.34 -32.38 1.16 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.443 ' O ' ' HG3' ' A' ' 38' ' ' PRO . 72.0 m-20 -53.38 -24.44 12.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -1.142 . . . . 0.0 110.027 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 12.1 mttm -103.3 -44.61 5.12 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.019 0.914 . . . . 0.0 109.072 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.529 HG12 ' CD1' ' A' ' 65' ' ' LEU . 40.2 t -76.63 -49.13 24.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 O-C-N 121.81 -0.556 . . . . 0.0 110.467 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 14.7 ttpt -43.17 -50.2 14.95 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.484 -0.887 . . . . 0.0 110.801 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.8 Cg_endo -67.05 -34.49 28.62 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 N-CA-C 109.108 -1.151 . . . . 0.0 109.108 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.513 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 2.3 t -65.15 -23.83 34.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.492 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 16.4 mt -86.33 -15.06 41.73 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.392 -0.817 . . . . 0.0 109.203 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.417 ' HG ' ' CD1' ' A' ' 50' ' ' LEU . 27.8 mt -77.97 -26.85 48.96 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 38.7 m-80 -62.55 -13.9 36.19 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.623 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.532 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -78.63 2.13 20.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.563 -0.711 . . . . 0.0 110.327 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 43' ' ' SER . 1.7 mtpt 63.53 15.6 8.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -0.902 . . . . 0.0 110.362 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.533 ' CD1' HG23 ' A' ' 49' ' ' ILE . 13.6 mt -94.82 162.54 24.99 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.143 -0.973 . . . . 0.0 109.915 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.533 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.1 Cg_endo -73.99 164.91 33.34 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.013 1.533 . . . . 0.0 110.957 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 t -64.96 -9.1 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.502 -0.749 . . . . 0.0 109.776 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -72.48 -41.31 66.17 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.533 HG23 ' CD1' ' A' ' 45' ' ' LEU . 20.3 mm -64.2 -47.49 89.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.492 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 5.3 mt -65.6 -23.11 66.75 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.632 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.501 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -86.03 -30.78 22.12 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.488 ' HG2' HD13 ' A' ' 56' ' ' LEU . 13.7 ttm180 -91.52 -54.95 3.68 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.506 -0.996 . . . . 0.0 109.667 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.556 ' O ' ' CB ' ' A' ' 57' ' ' SER . 26.7 t -49.67 -42.89 18.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.993 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.495 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 16.3 t-105 -61.86 -58.19 8.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.831 . . . . 0.0 111.05 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 17.0 mt-10 -51.6 -36.9 47.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.883 -1.136 . . . . 0.0 109.607 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.53 HD21 ' N ' ' A' ' 90' ' ' LEU . 18.5 mt -90.07 -8.44 51.45 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.516 0.674 . . . . 0.0 109.485 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 4.6 t -100.11 -30.29 12.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.448 -0.783 . . . . 0.0 108.916 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.597 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 13.3 t0 -84.65 68.25 10.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.485 -0.759 . . . . 0.0 109.631 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.558 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 35.5 mm -37.4 -29.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.266 0.555 . . . . 0.0 110.471 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.539 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 76.4 m-20 -90.68 -25.66 19.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 111.31 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 0.3 OUTLIER 59.71 26.46 15.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.883 -1.136 . . . . 0.0 108.913 -179.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.424 ' OD2' ' HG3' ' A' ' 64' ' ' MET . 3.9 p-10 -90.82 -24.25 20.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.524 -0.735 . . . . 0.0 110.665 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.38 4.35 4.48 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.553 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.7 mtp -145.2 161.16 40.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.002 -1.293 . . . . 0.0 110.313 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.529 ' CD1' HG12 ' A' ' 36' ' ' VAL . 33.5 mt -115.82 112.16 21.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -0.844 . . . . 0.0 109.984 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.593 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 4.9 p30 -76.08 165.05 25.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.799 -1.188 . . . . 0.0 110.019 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.618 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -39.41 -40.31 0.8 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.458 -0.776 . . . . 0.0 111.741 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 1.4 t0 -80.28 -36.28 34.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.979 -1.075 . . . . 0.0 110.563 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.512 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 44.0 mt-10 -76.17 -41.62 49.15 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.186 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.579 ' CE1' HG21 ' A' ' 20' ' ' ILE . 35.3 t80 -61.82 -25.46 67.52 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -66.56 -51.09 60.29 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.943 0.877 . . . . 0.0 109.648 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.539 HG11 ' CG ' ' A' ' 94' ' ' LEU . 60.5 t -55.12 -23.88 13.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.358 0.599 . . . . 0.0 110.382 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.535 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -89.86 -10.85 43.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 111.815 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.577 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 7.9 mmm -85.09 -48.06 9.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.639 -1.288 . . . . 0.0 110.121 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -72.65 -21.52 61.07 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.566 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 9.6 mt -73.79 -32.79 63.94 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.532 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 70.5 t -91.42 -25.54 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.535 -0.728 . . . . 0.0 110.504 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.5 OUTLIER -86.81 -27.01 23.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.742 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 60.1 m -80.29 -19.05 47.54 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.421 -0.799 . . . . 0.0 108.857 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.447 ' HB1' HD13 ' A' ' 45' ' ' LEU . . . -82.15 -7.97 59.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.475 -0.766 . . . . 0.0 109.344 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 81' ' ' LEU . 6.4 mt -90.25 -47.6 7.67 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.566 0.698 . . . . 0.0 110.026 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? . . . . . 0 C--N 1.3 -1.544 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.924 -179.048 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.516 ' CG1' ' HD2' ' A' ' 87' ' ' PRO . 41.6 t . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.516 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 44.9 Cg_endo -85.93 -165.94 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.662 1.348 . . . . 0.0 109.791 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.476 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 5.7 mtt -129.68 18.87 5.68 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.623 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.478 ' N ' HD23 ' A' ' 56' ' ' LEU . 33.3 t -161.14 23.74 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.268 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.532 ' CD2' HD13 ' A' ' 94' ' ' LEU . 2.4 mt 61.7 118.48 0.02 OUTLIER Pre-proline 0 C--N 1.283 -2.324 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.54 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.522 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 41.8 Cg_endo -76.08 146.35 28.85 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.792 1.417 . . . . 0.0 110.005 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.04 -1.03 8.03 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.736 1.624 . . . . 0.0 112.09 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -99.9 -20.53 16.1 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.05 -1.031 . . . . 0.0 109.854 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.561 ' CD2' ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -101.82 -13.9 17.5 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.588 0.709 . . . . 0.0 109.497 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.479 HG21 HD11 ' A' ' 94' ' ' LEU . 95.4 t . . . . . 0 N--CA 1.492 1.664 0 O-C-N 120.938 -1.101 . . . . 0.0 110.676 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.588 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 15.5 t90 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 121.061 0.458 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.594 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -41.11 -31.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.405 -0.809 . . . . 0.0 110.413 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.588 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 70.4 t -94.45 131.44 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.401 -0.812 . . . . 0.0 109.976 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.522 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 18.0 mttt -95.12 -179.43 0.95 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.846 . . . . 0.0 110.162 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.1 Cg_endo -69.79 -37.32 9.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.903 1.475 . . . . 0.0 110.187 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.474 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -71.18 -24.64 62.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 109.664 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.582 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -83.0 -41.8 18.28 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 2.4 tppt? -66.48 -20.17 65.97 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.68 -0.637 . . . . 0.0 109.363 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.7 -42.66 60.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.375 -0.828 . . . . 0.0 109.064 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.599 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -79.14 -26.15 42.83 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.599 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.5 m-30 -71.85 -34.47 69.27 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 8.0 m-20 -81.07 -10.6 59.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.717 -0.614 . . . . 0.0 109.88 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -93.58 -35.45 12.89 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.521 HG23 ' CE1' ' A' ' 70' ' ' PHE . 51.3 mt -76.47 -36.9 29.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -64.13 -36.59 84.52 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.485 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -90.24 -0.11 57.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.749 -0.595 . . . . 0.0 109.991 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 22.8 t -91.33 0.51 57.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.215 -0.928 . . . . 0.0 109.046 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 25' ' ' SER . 1.2 mt -109.06 -6.61 15.57 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.578 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER 80.29 83.55 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 42.7 Cg_endo -69.11 149.98 71.63 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 O-C-N 124.65 1.868 . . . . 0.0 110.357 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.3 t -113.16 103.92 16.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.339 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 5.6 t30 59.19 21.9 10.04 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.479 -0.763 . . . . 0.0 109.374 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.493 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 93.01 39.2 5.24 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.493 ' CD2' ' C ' ' A' ' 29' ' ' GLY . 82.3 m-85 -150.12 159.56 44.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.428 -1.042 . . . . 0.0 111.302 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.52 HD21 ' CD ' ' A' ' 35' ' ' LYS . 46.1 mt -133.22 131.4 40.29 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.574 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 18.2 p -79.06 141.48 37.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.548 -0.72 . . . . 0.0 110.929 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.592 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -49.76 -24.44 6.0 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.26 -11.95 59.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.419 -1.048 . . . . 0.0 109.66 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.52 ' CD ' HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -97.73 -46.28 6.04 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.316 1.055 . . . . 0.0 108.778 179.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.546 HG12 ' CD1' ' A' ' 65' ' ' LEU . 98.3 t -78.45 -33.07 16.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.069 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.561 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -40.68 -54.85 4.89 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.443 -0.786 . . . . 0.0 110.952 -178.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.2 Cg_endo -64.24 -31.05 64.19 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.557 1.293 . . . . 0.0 109.332 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.594 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 3.4 t -73.38 -8.41 11.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.721 -0.612 . . . . 0.0 109.363 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.508 ' CD2' HG22 ' A' ' 77' ' ' VAL . 42.3 mt -99.87 -16.42 18.04 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 108.541 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.533 ' CD1' ' HA ' ' A' ' 38' ' ' PRO . 4.7 mt -89.03 -41.56 12.26 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.501 -0.75 . . . . 0.0 109.785 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -49.82 -22.04 1.32 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.226 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.539 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -68.7 -5.31 19.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.362 -0.836 . . . . 0.0 110.085 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 73.68 8.89 4.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.378 -0.826 . . . . 0.0 110.378 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.517 HD21 ' HD2' ' A' ' 46' ' ' PRO . 14.3 mt -84.48 155.48 62.63 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 109.769 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.3 Cg_endo -74.38 162.83 37.57 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.789 1.415 . . . . 0.0 110.753 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.471 ' O ' HG11 ' A' ' 47' ' ' VAL . 52.9 t -62.63 -10.58 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.57 -0.706 . . . . 0.0 110.816 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.41 -41.01 57.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.934 -1.104 . . . . 0.0 108.353 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.562 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 27.8 mm -64.11 -44.87 97.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 40' ' ' LEU . 4.6 mt -60.23 -18.19 46.9 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.49 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -84.57 -31.74 23.77 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.479 ' CD ' ' O ' ' A' ' 87' ' ' PRO . 9.8 mtm180 -94.97 -55.26 3.15 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.494 -1.003 . . . . 0.0 109.844 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.522 ' O ' ' CB ' ' A' ' 57' ' ' SER . 17.2 t -44.83 -39.3 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.642 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.592 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 13.0 t-105 -74.38 -59.02 2.92 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.973 -1.08 . . . . 0.0 110.331 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 65.3 mm-40 -51.38 -30.13 17.96 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.086 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.549 HD21 ' N ' ' A' ' 90' ' ' LEU . 46.8 mt -90.41 -14.78 32.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.57 -0.706 . . . . 0.0 109.496 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.538 ' OG ' ' CA ' ' A' ' 73' ' ' ALA . 12.7 m -98.98 -27.81 13.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.476 -0.765 . . . . 0.0 109.642 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 59' ' ' ILE . 13.8 t0 -81.76 69.1 8.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.289 -0.882 . . . . 0.0 109.565 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 58' ' ' ASP . 39.3 mm -40.48 -30.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.511 0.672 . . . . 0.0 109.877 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 62' ' ' ASP . 0.8 OUTLIER -96.15 -28.73 14.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.61 -0.681 . . . . 0.0 109.999 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ASP . 22.8 m-70 61.71 46.5 7.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.164 -0.96 . . . . 0.0 110.644 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 3.1 p-10 -112.66 16.85 19.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 110.265 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.37 5.0 76.4 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.574 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 5.0 mtt -140.4 157.02 46.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -1.145 . . . . 0.0 110.647 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.546 ' CD1' HG12 ' A' ' 36' ' ' VAL . 74.2 mt -118.63 113.79 21.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.381 -0.824 . . . . 0.0 109.842 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.9 OUTLIER -73.2 155.85 39.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.949 -1.094 . . . . 0.0 109.62 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.586 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -33.83 -44.07 0.15 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.761 -0.587 . . . . 0.0 111.372 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -74.94 -45.26 43.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.36 -0.838 . . . . 0.0 109.897 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.478 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 19.3 mt-10 -62.32 -45.83 91.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.582 -0.698 . . . . 0.0 109.563 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.573 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 52.0 t80 -59.96 -24.07 64.1 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.616 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.92 72.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.549 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.79 -23.91 32.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.535 -0.728 . . . . 0.0 109.963 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.538 ' CA ' ' OG ' ' A' ' 57' ' ' SER . . . -90.96 -1.35 57.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -0.877 . . . . 0.0 110.832 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.597 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 13.1 mmt -89.09 -46.02 9.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.083 -1.011 . . . . 0.0 109.463 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.647 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 1.7 p90 -75.83 -30.0 58.82 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.558 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 5.8 mt -63.74 -30.94 71.98 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 43' ' ' SER . 70.5 t -90.64 -23.84 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.878 -0.514 . . . . 0.0 109.936 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -26.55 20.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.365 -0.834 . . . . 0.0 109.31 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 51.6 m -84.4 -12.28 54.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.437 -0.789 . . . . 0.0 109.211 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.512 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -89.23 -8.87 52.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.465 -0.772 . . . . 0.0 109.065 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.548 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 1.5 mt -90.97 -45.34 8.79 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.614 0.721 . . . . 0.0 109.358 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 . . . . . 0 C--N 1.299 -1.621 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.705 179.821 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.539 ' CG1' ' HD2' ' A' ' 87' ' ' PRO . 59.2 t . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.539 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 46.1 Cg_endo -84.42 -163.42 0.2 Allowed 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.688 1.362 . . . . 0.0 110.092 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 2.4 ttt -122.19 10.0 9.93 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.371 -0.831 . . . . 0.0 111.106 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.511 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -165.89 23.88 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.719 -1.238 . . . . 0.0 111.432 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.549 ' N ' HD21 ' A' ' 56' ' ' LEU . 1.6 mt 62.09 123.17 0.02 OUTLIER Pre-proline 0 C--N 1.284 -2.276 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.849 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.52 ' HG2' HD21 ' A' ' 94' ' ' LEU . 40.2 Cg_endo -68.42 174.5 8.19 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.007 1.53 . . . . 0.0 110.137 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 49.6 Cg_endo -75.29 -22.68 14.07 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.964 1.507 . . . . 0.0 111.97 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.463 ' C ' HD23 ' A' ' 94' ' ' LEU . . . -90.79 7.88 37.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.923 -1.111 . . . . 0.0 110.483 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.647 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 4.1 mm? -114.29 34.9 4.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.081 -1.012 . . . . 0.0 111.495 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.429 HG21 ' C ' ' A' ' 94' ' ' LEU . 2.7 t . . . . . 0 N--CA 1.49 1.565 0 O-C-N 120.766 -1.209 . . . . 0.0 110.617 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.505 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.6 t90 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.166 0.508 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.493 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -41.81 -28.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 0.0 110.138 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.505 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 45.5 t -94.76 156.48 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.826 . . . . 0.0 109.978 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.495 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 28.3 mmtt -111.5 171.55 4.25 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -66.9 -35.93 24.96 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.819 1.431 . . . . 0.0 110.431 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.13 -25.59 60.89 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.135 -0.978 . . . . 0.0 109.11 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.579 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 63.6 m-20 -85.57 -35.87 20.78 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.241 -0.912 . . . . 0.0 108.851 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.488 ' NZ ' ' OD1' ' A' ' 18' ' ' ASP . 2.2 tptp -73.26 -17.77 61.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.29 -41.82 56.19 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.606 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.15 -24.73 51.52 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.606 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.4 m-30 -74.95 -35.98 62.12 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.488 ' OD1' ' NZ ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -71.07 -10.1 59.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.777 -0.577 . . . . 0.0 110.135 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.46 ' O ' ' OG ' ' A' ' 23' ' ' SER . . . -95.0 -38.97 10.41 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.521 ' O ' ' CD2' ' A' ' 24' ' ' LEU 0.257 27.9 mt -72.17 -29.19 31.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.631 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -69.26 -40.34 77.87 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.464 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.5 t70 -86.1 1.36 50.76 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.581 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 37.8 m -93.37 -0.14 56.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.314 -0.866 . . . . 0.0 108.768 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.548 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -116.7 -1.21 12.16 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 80.35 97.59 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.95 0 CA-C-O 121.136 0.493 . . . . 0.0 110.246 -179.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 55.4 Cg_endo -77.26 147.69 26.26 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.502 1.791 . . . . 0.0 110.343 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 60.1 t -119.89 94.07 2.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER 68.94 24.51 6.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.428 -0.795 . . . . 0.0 109.061 -178.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 90.93 28.34 15.95 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 35.3 m-85 -143.41 143.28 31.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.394 -1.062 . . . . 0.0 111.133 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.604 HD13 ' CD2' ' A' ' 21' ' ' PHE . 53.4 mt -117.57 131.87 56.61 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.535 ' OG ' ' CE ' ' A' ' 64' ' ' MET . 0.5 OUTLIER -89.48 147.5 23.96 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.578 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.15 -31.12 0.84 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -54.07 -22.7 11.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -1.097 . . . . 0.0 110.096 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 1.5 mttm -111.15 -43.36 3.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.935 . . . . 0.0 109.342 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.53 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 87.5 t -74.75 -53.73 16.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.029 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.569 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -40.75 -49.94 7.33 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.529 -0.732 . . . . 0.0 110.892 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.6 Cg_endo -69.84 -33.19 16.79 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 N-CA-C 108.961 -1.207 . . . . 0.0 108.961 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.522 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.4 t -67.29 -29.01 44.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 17.7 mt -81.4 -17.12 50.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.407 -0.808 . . . . 0.0 108.911 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 20.3 mt -73.88 -26.16 60.41 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 33.2 m-80 -61.4 -20.58 63.22 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.209 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.547 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 1.3 t -71.36 -3.44 20.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.536 -0.728 . . . . 0.0 109.864 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.529 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER 70.79 4.59 5.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 110.028 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.518 HD12 ' CB ' ' A' ' 80' ' ' ALA . 15.7 mt -83.49 159.29 61.74 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.977 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.3 Cg_endo -73.05 162.35 41.11 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.985 1.519 . . . . 0.0 110.502 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.93 -10.17 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 110.21 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.18 -39.1 68.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.544 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 18.5 mm -67.18 -47.41 81.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 50' ' ' LEU . 5.0 mt -64.64 -20.05 66.06 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.95 -33.2 12.65 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.539 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -90.38 -54.96 3.78 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.51 -0.994 . . . . 0.0 109.224 179.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.504 ' O ' ' HB3' ' A' ' 57' ' ' SER . 29.2 t -49.23 -42.71 15.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.01 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.511 ' O ' ' N ' ' A' ' 57' ' ' SER . 12.3 t-105 -59.09 -59.28 5.72 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.461 -0.774 . . . . 0.0 109.673 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 54' ' ' TRP . 1.6 mm-40 -44.06 -50.03 8.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -0.878 . . . . 0.0 109.833 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.542 HD21 ' CA ' ' A' ' 90' ' ' LEU . 1.6 mt -75.04 -14.31 60.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.375 -0.828 . . . . 0.0 109.54 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.558 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -95.35 -25.84 16.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.484 -0.76 . . . . 0.0 110.384 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.53 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 4.1 t0 -86.31 76.83 9.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.323 -0.861 . . . . 0.0 110.329 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.457 ' CG1' ' HG3' ' A' ' 69' ' ' GLU . 42.5 mm -44.12 -35.29 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.368 -0.832 . . . . 0.0 110.32 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.487 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 2.8 m-20 -95.73 -28.41 14.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 110.427 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 18.7 m-70 62.28 37.44 14.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 109.686 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -97.67 -14.57 20.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.386 -0.821 . . . . 0.0 110.452 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.415 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 125.33 3.67 7.25 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.547 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 1.5 mtp -149.27 161.73 41.44 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.022 -1.281 . . . . 0.0 110.438 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.533 ' HB3' ' CA ' ' A' ' 70' ' ' PHE . 46.8 mt -113.39 118.82 35.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.625 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 0.8 OUTLIER -69.36 154.12 42.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.174 -0.954 . . . . 0.0 109.617 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.631 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 7.4 ptp85 -34.3 -44.86 0.2 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.648 -0.658 . . . . 0.0 111.06 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -81.16 -34.41 32.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 109.499 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 57' ' ' SER . 6.8 tt0 -67.26 -51.71 49.71 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.6 -0.687 . . . . 0.0 109.415 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.57 ' CE2' ' SD ' ' A' ' 74' ' ' MET . 87.8 t80 -52.78 -26.02 13.08 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.485 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -62.15 -45.21 94.45 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.67 0.748 . . . . 0.0 109.837 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.488 ' O ' ' CE2' ' A' ' 75' ' ' PHE . 57.6 t -60.03 -25.72 33.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.59 -0.694 . . . . 0.0 110.071 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.558 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -87.42 -11.48 49.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.876 . . . . 0.0 111.952 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 7.4 mmm -85.78 -37.97 18.7 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.32 -1.487 . . . . 0.0 110.451 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.577 ' CZ ' HD13 ' A' ' 94' ' ' LEU . 3.4 p90 -78.33 -23.43 47.01 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.966 -1.084 . . . . 0.0 108.525 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.563 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 6.7 mt -75.19 -28.38 60.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.477 -0.764 . . . . 0.0 108.98 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.547 ' CG1' ' HB2' ' A' ' 43' ' ' SER . 43.3 t -90.61 -25.83 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.508 -0.745 . . . . 0.0 110.058 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.471 ' HA ' HD11 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -84.12 -25.95 29.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 110.056 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 57.9 m -85.62 -14.06 46.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 109.454 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.518 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -79.86 -15.87 56.52 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.182 -0.948 . . . . 0.0 109.242 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 43' ' ' SER . 2.4 mt -92.1 -47.95 6.98 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.604 -0.685 . . . . 0.0 111.304 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.489 1.491 0 C-N-CA 119.503 -0.879 . . . . 0.0 112.033 -178.031 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 55.5 t . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.601 0.239 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.515 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 51.2 Cg_endo -83.66 160.36 14.4 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.892 1.47 . . . . 0.0 109.663 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.539 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 68.6 mtp -82.79 11.24 6.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.998 -1.064 . . . . 0.0 110.237 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.54 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.6 m -99.92 112.81 25.07 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.873 -1.131 . . . . 0.0 110.66 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -100.72 85.67 0.58 Allowed Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 89' ' ' SER . 38.2 Cg_endo -62.31 173.74 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.427 1.418 . . . . 0.0 111.477 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.474 ' O ' HG21 ' A' ' 95' ' ' VAL . 44.1 Cg_endo -69.18 -10.15 28.23 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.339 1.705 . . . . 0.0 110.77 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' A' ' 8' ' ' ALA . . . -76.84 0.76 19.6 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 109.093 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.577 HD13 ' CZ ' ' A' ' 75' ' ' PHE . 2.5 mm? -108.34 -13.59 14.85 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.412 -0.805 . . . . 0.0 110.116 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 92' ' ' PRO . 26.7 m . . . . . 0 N--CA 1.487 1.397 0 O-C-N 121.351 -0.843 . . . . 0.0 110.554 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.526 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.4 t90 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 121.293 0.568 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.575 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . . . -46.34 -25.81 0.71 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.283 -0.886 . . . . 0.0 110.182 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.526 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 50.6 t -111.49 140.06 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.414 -0.804 . . . . 0.0 110.009 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.488 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 7.4 mttt -106.33 177.7 1.28 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.363 -0.836 . . . . 0.0 110.38 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 40.7 Cg_endo -68.24 -37.32 14.33 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.96 1.505 . . . . 0.0 109.647 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.441 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 16.0 pt-20 -66.52 -35.64 80.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.0 109.08 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.441 ' N ' ' CG ' ' A' ' 12' ' ' GLU . 0.6 OUTLIER -81.59 -38.64 25.76 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 1.3 tmtp? -73.01 -15.47 61.53 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 11' ' ' PRO . . . -74.36 -42.54 59.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.591 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.3 ptpt -74.33 -21.15 59.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.591 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.8 m-30 -79.7 -30.26 40.97 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -75.07 -11.51 60.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.704 -0.622 . . . . 0.0 110.19 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.16 -36.05 12.23 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.528 HG21 ' CE2' ' A' ' 70' ' ' PHE 0.253 18.5 mt -75.59 -29.79 21.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.581 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -72.65 -40.32 66.45 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.436 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 6.1 t70 -85.33 0.02 53.34 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.558 -0.714 . . . . 0.0 109.681 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.2 t -91.8 -4.7 54.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.915 . . . . 0.0 108.599 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.572 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -108.92 -3.95 17.15 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 79.7 93.56 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.918 0 CA-C-O 121.409 0.623 . . . . 0.0 109.726 -179.087 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.2 Cg_endo -74.45 147.32 36.34 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 124.452 1.764 . . . . 0.0 110.789 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 86.7 t -119.31 105.14 16.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.714 -0.617 . . . . 0.0 109.354 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 2.7 t30 57.69 22.94 8.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 109.652 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.83 32.89 7.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 89.3 m-85 -150.78 154.77 37.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.332 -1.099 . . . . 0.0 111.105 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 24' ' ' LEU . 22.0 mt -126.97 131.16 51.12 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.457 ' OG ' ' HE2' ' A' ' 35' ' ' LYS . 0.9 OUTLIER -76.86 140.53 40.63 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.272 -0.892 . . . . 0.0 110.392 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -41.99 -27.94 0.43 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' SER . 34.1 t0 -57.53 -28.84 63.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -1.188 . . . . 0.0 110.303 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.457 ' HE2' ' OG ' ' A' ' 32' ' ' SER . 25.4 mttm -98.91 -39.37 8.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.573 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 93.5 t -74.58 -32.44 29.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.076 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.546 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.2 ttpt -52.06 -56.88 17.78 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.233 -0.917 . . . . 0.0 110.347 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.2 Cg_endo -65.9 -31.45 47.34 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.631 1.332 . . . . 0.0 109.117 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.597 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 13.1 t -73.47 -16.68 17.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.164 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.524 ' CD1' HG11 ' A' ' 36' ' ' VAL . 63.3 mt -93.82 -18.45 22.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 108.67 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.45 HD11 ' HA ' ' A' ' 38' ' ' PRO . 23.6 mt -81.24 -33.84 32.54 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.399 0.619 . . . . 0.0 109.833 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.597 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -43.86 -25.35 0.19 Allowed 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.935 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.545 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -73.29 -4.98 36.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.326 -0.859 . . . . 0.0 110.213 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 72.47 7.88 5.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.522 -0.736 . . . . 0.0 110.153 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.519 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 14.8 mt -80.73 160.31 67.03 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.327 -0.858 . . . . 0.0 110.306 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.567 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.7 Cg_endo -74.33 164.69 33.53 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 124.034 1.544 . . . . 0.0 110.483 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 t -65.17 -8.44 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 110.339 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.92 -40.6 60.75 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.036 -1.04 . . . . 0.0 108.265 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.567 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 14.3 mm -65.15 -45.51 93.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 40' ' ' LEU . 6.1 mt -62.28 -18.42 61.22 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.82 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.36 -33.7 11.41 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.532 ' CD ' ' O ' ' A' ' 87' ' ' PRO . 2.4 ttm180 -90.13 -52.16 5.09 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.47 -1.018 . . . . 0.0 109.644 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 57' ' ' SER . 24.3 t -50.94 -42.25 23.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.166 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.529 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 7.7 t-105 -61.55 -57.01 13.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 110.093 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -47.33 -52.66 15.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.838 . . . . 0.0 110.103 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 1.4 mt -74.94 -7.62 54.11 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.811 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 6.4 m -100.05 -29.07 12.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.43 -0.794 . . . . 0.0 110.676 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.477 ' HA ' HD22 ' A' ' 65' ' ' LEU . 16.8 t0 -87.29 73.77 9.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.962 . . . . 0.0 110.202 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.504 ' HB ' ' HG2' ' A' ' 69' ' ' GLU . 45.4 mm -44.0 -30.59 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.5 -0.75 . . . . 0.0 109.314 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 4.4 t0 -95.19 -22.32 17.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.523 -0.736 . . . . 0.0 109.931 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 34.2 p80 40.15 57.28 2.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.546 -0.721 . . . . 0.0 110.232 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.454 ' HB3' ' CG ' ' A' ' 60' ' ' ASP . 1.3 p-10 -117.12 7.04 12.94 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.581 -0.699 . . . . 0.0 109.732 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 109.56 5.87 29.38 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.1 mtp -150.41 161.0 43.34 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.157 -1.202 . . . . 0.0 110.792 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.488 ' CD1' HG13 ' A' ' 36' ' ' VAL . 11.9 mt -114.15 108.45 16.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.452 -0.78 . . . . 0.0 109.298 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.582 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -69.77 171.84 8.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.929 -1.107 . . . . 0.0 110.152 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.581 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 9.4 ptt180 -52.87 -37.53 60.47 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.695 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.6 OUTLIER -81.77 -35.72 29.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.189 -0.944 . . . . 0.0 109.713 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.504 ' HG2' ' HB ' ' A' ' 59' ' ' ILE . 27.1 mt-10 -74.24 -46.6 40.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.569 ' CE2' ' SD ' ' A' ' 74' ' ' MET . 68.3 t80 -57.73 -33.42 68.43 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.41 76.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.398 -0.814 . . . . 0.0 109.996 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 56' ' ' LEU . 55.6 t -59.29 -21.7 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.611 -0.68 . . . . 0.0 110.443 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.498 ' HA ' ' OG ' ' A' ' 57' ' ' SER . . . -90.53 -9.79 45.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.07 -1.018 . . . . 0.0 111.602 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 7.1 mmm -85.41 -41.08 15.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.792 -1.192 . . . . 0.0 109.886 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.588 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.4 p90 -77.41 -26.17 51.47 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.588 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 7.6 mt -70.14 -30.85 68.12 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.545 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 57.0 t -90.98 -19.12 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.679 -0.638 . . . . 0.0 110.349 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.31 -20.18 23.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.34 -0.85 . . . . 0.0 109.75 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -87.73 -16.37 34.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.517 -0.739 . . . . 0.0 109.705 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.519 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -84.92 -12.3 53.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.518 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 2.9 mt -88.17 -43.06 11.9 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.539 -0.725 . . . . 0.0 109.373 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.298 -1.655 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.29 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.433 HG23 HD21 ' A' ' 76' ' ' LEU . 56.1 t . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 120.597 0.237 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.532 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 46.5 Cg_endo -88.32 -165.3 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.948 1.499 . . . . 0.0 109.233 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.505 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -127.7 10.89 6.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.137 -0.977 . . . . 0.0 110.471 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.508 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 58.0 m -115.75 93.83 4.43 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.494 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.59 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -56.88 107.2 0.83 Allowed Pre-proline 0 C--N 1.291 -1.943 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.568 178.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.57 ' HG2' ' CD1' ' A' ' 94' ' ' LEU . 42.8 Cg_endo -82.07 173.32 11.07 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.703 1.37 . . . . 0.0 110.613 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 44.6 Cg_endo -71.21 -5.41 16.94 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.232 1.648 . . . . 0.0 111.418 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.433 ' O ' ' HG ' ' A' ' 94' ' ' LEU . . . -84.01 0.17 49.2 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 109.731 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.575 ' CD2' ' CB ' ' A' ' 8' ' ' ALA . 1.4 mp -138.29 31.24 2.38 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.19 -0.944 . . . . 0.0 110.994 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.491 1.583 0 O-C-N 120.865 -1.147 . . . . 0.0 110.702 -179.358 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.588 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 13.4 t90 . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 121.389 0.614 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -47.7 -25.83 1.34 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.493 -0.754 . . . . 0.0 109.991 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.588 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 56.0 t -88.96 147.04 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.494 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 28.5 mttt -99.93 167.28 11.3 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.237 -0.915 . . . . 0.0 109.847 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.0 Cg_endo -67.74 -33.96 26.04 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.81 1.426 . . . . 0.0 109.709 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -76.64 -24.17 53.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.524 -0.735 . . . . 0.0 109.513 179.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.576 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -80.83 -38.73 27.79 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.47 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 28.4 tptp -65.23 -19.8 66.13 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.58 -44.52 50.46 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.559 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 4.1 ptpt -77.21 -19.2 57.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.593 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 6.9 m-30 -80.15 -33.32 38.59 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -79.57 -10.16 59.75 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.242 0.544 . . . . 0.0 110.151 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 23' ' ' SER . . . -94.93 -31.77 13.51 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.535 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 61.7 mt -80.46 -32.74 13.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -71.45 -39.0 71.28 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.8 t0 -88.93 1.13 55.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.645 -0.66 . . . . 0.0 109.688 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 1.1 m -93.49 0.26 56.65 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.584 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -110.49 -4.99 15.24 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 p 81.93 87.59 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 49.8 Cg_endo -71.7 147.25 50.49 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.16 1.611 . . . . 0.0 110.854 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 99.9 t -116.94 104.77 17.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 14.9 t30 57.03 24.4 9.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.529 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 90.26 39.1 6.12 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.571 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 87.4 m-85 -150.58 156.54 41.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -1.179 . . . . 0.0 111.601 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.545 HD21 ' CD ' ' A' ' 35' ' ' LYS . 75.3 mt -128.77 135.32 49.02 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.54 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 10.2 p -80.36 142.07 34.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.392 -0.817 . . . . 0.0 111.104 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.592 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -51.22 -22.84 7.4 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -84.58 -9.65 58.11 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.363 -1.081 . . . . 0.0 109.36 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.545 ' CD ' HD21 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -97.19 -43.94 7.15 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.333 1.063 . . . . 0.0 108.336 179.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.524 HG12 ' CD1' ' A' ' 65' ' ' LEU . 96.8 t -78.82 -32.52 15.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.334 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.576 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.99 -54.58 4.29 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.421 -0.799 . . . . 0.0 110.852 -179.362 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.2 Cg_endo -63.68 -28.86 69.07 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.644 1.339 . . . . 0.0 109.825 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.564 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 4.8 t -79.72 -12.77 13.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.444 0.64 . . . . 0.0 110.244 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.485 ' CD1' HG13 ' A' ' 36' ' ' VAL . 66.2 mt -98.69 -17.05 18.76 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.85 -1.156 . . . . 0.0 109.1 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.537 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 1.9 mt -88.74 -32.3 18.0 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.421 -0.799 . . . . 0.0 110.036 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 6.1 p30 -67.23 -8.21 29.97 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.061 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.467 ' O ' HD22 ' A' ' 81' ' ' LEU . 50.3 m -77.53 7.23 5.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.462 -0.774 . . . . 0.0 109.905 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 65.33 16.34 10.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -0.963 . . . . 0.0 109.565 -179.489 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.552 ' CD1' ' HB2' ' A' ' 80' ' ' ALA . 16.2 mt -100.28 151.55 37.57 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.444 -0.785 . . . . 0.0 110.625 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.574 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.1 Cg_endo -75.12 159.45 40.91 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.142 1.601 . . . . 0.0 110.085 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.44 ' O ' HG11 ' A' ' 47' ' ' VAL . 15.1 t -60.72 -10.11 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.809 . . . . 0.0 110.933 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.08 -42.4 60.21 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.931 -1.106 . . . . 0.0 108.311 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.574 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.8 mm -64.61 -45.02 96.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.49 ' CD1' ' HG ' ' A' ' 41' ' ' LEU . 4.2 mt -63.14 -21.53 66.25 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.176 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.29 -30.62 24.6 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.557 ' HD3' ' CG ' ' A' ' 88' ' ' MET . 10.3 ttm180 -94.16 -54.0 3.74 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.495 -1.003 . . . . 0.0 109.547 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 57' ' ' SER . 37.7 t -52.75 -33.06 18.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.071 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.592 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 10.7 t-105 -71.26 -57.06 4.84 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.919 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -47.41 -47.74 26.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.9 . . . . 0.0 109.983 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.621 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 4.5 mt -76.77 -10.3 59.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 0.0 109.523 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.545 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 2.8 t -98.66 -34.2 10.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.447 -0.783 . . . . 0.0 110.257 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.599 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 19.6 t0 -79.79 68.16 5.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.357 -0.84 . . . . 0.0 109.338 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.455 ' C ' ' O ' ' A' ' 58' ' ' ASP . 31.2 mm -34.57 -30.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.116 0.484 . . . . 0.0 111.36 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 58' ' ' ASP . 54.1 m-20 -100.48 -19.59 16.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.088 -1.007 . . . . 0.0 111.601 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.599 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 3.8 m170 63.71 35.13 11.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.859 -1.151 . . . . 0.0 109.448 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -102.19 12.13 37.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.92 . . . . 0.0 110.826 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.11 10.11 81.11 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.54 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 4.7 mtt -139.32 160.19 40.4 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.335 -1.097 . . . . 0.0 110.89 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.57 HD13 ' CZ3' ' A' ' 54' ' ' TRP . 87.9 mt -125.33 112.1 15.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.302 -0.874 . . . . 0.0 110.405 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.571 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 16.5 t0 -68.93 169.86 10.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.838 -1.163 . . . . 0.0 109.48 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.576 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 11.4 ptm180 -48.03 -40.61 23.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.681 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.64 -31.31 36.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.328 -0.857 . . . . 0.0 110.407 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.487 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 31.3 mt-10 -75.69 -38.1 58.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.735 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.549 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 52.6 t80 -68.28 -19.51 64.71 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.367 -0.833 . . . . 0.0 109.439 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.38 -39.84 52.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.444 -0.785 . . . . 0.0 109.395 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.544 HG11 ' CD2' ' A' ' 94' ' ' LEU . 38.3 t -64.0 -23.49 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.555 0.693 . . . . 0.0 109.192 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.545 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -90.57 -8.2 50.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.624 -0.673 . . . . 0.0 110.854 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.593 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 14.8 mmt -83.03 -46.89 12.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.064 -1.022 . . . . 0.0 109.907 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.607 ' CE1' HD22 ' A' ' 94' ' ' LEU . 5.4 p90 -76.27 -25.57 55.06 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.582 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 11.0 mt -69.92 -25.83 63.85 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.585 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 51.9 t -91.39 -62.74 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -47.61 -25.44 1.16 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.614 -0.679 . . . . 0.0 111.131 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 33.6 m -82.71 -12.31 57.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.986 -1.071 . . . . 0.0 109.843 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . . . -90.13 -10.67 43.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.291 -0.881 . . . . 0.0 109.179 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.585 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 7.0 mp -87.91 -43.46 11.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 109.348 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.302 -1.499 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.665 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.466 HG23 HG23 ' A' ' 53' ' ' VAL . 97.2 t . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.613 0.244 . . . . 0.0 110.665 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.483 ' O ' HD12 ' A' ' 56' ' ' LEU . 50.7 Cg_endo -85.24 -169.31 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.979 1.515 . . . . 0.0 109.407 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.557 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 2.7 mtp -116.22 8.05 14.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 0.0 109.983 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 58.5 m -106.08 104.96 14.78 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.812 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.621 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -50.05 106.49 0.64 Allowed Pre-proline 0 C--N 1.292 -1.92 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.494 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 39.4 Cg_endo -68.68 142.99 54.71 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.926 1.487 . . . . 0.0 111.215 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.441 ' HA ' HG22 ' A' ' 95' ' ' VAL . 46.1 Cg_endo -71.99 -7.56 21.29 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.422 1.748 . . . . 0.0 111.311 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.567 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -100.0 21.68 12.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.166 -0.959 . . . . 0.0 108.772 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.607 HD22 ' CE1' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -141.52 -11.34 0.92 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.285 0.564 . . . . 0.0 110.426 -178.179 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.441 HG22 ' HA ' ' A' ' 92' ' ' PRO . 2.0 t . . . . . 0 N--CA 1.492 1.651 0 O-C-N 120.439 -1.413 . . . . 0.0 110.133 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.556 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 9.5 t90 . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 93' ' ' ALA . . . -39.39 -26.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.843 . . . . 0.0 110.43 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.556 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 12.3 t -99.04 127.76 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.586 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.506 ' CD ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -84.6 175.96 4.15 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 110.334 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.506 ' HD2' ' CD ' ' A' ' 10' ' ' LYS . 42.6 Cg_endo -70.4 -34.38 12.54 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.079 1.568 . . . . 0.0 109.515 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -78.72 -24.36 44.93 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.593 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 19.8 m-20 -82.97 -48.79 10.28 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.473 ' HG3' ' CZ3' ' A' ' 7' ' ' TRP . 0.1 OUTLIER -63.95 -19.23 64.98 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.63 -43.76 19.96 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.567 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.35 -28.04 60.95 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 8.1 m-30 -70.65 -36.78 73.57 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 66.5 t0 -72.66 -9.29 58.44 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.446 0.641 . . . . 0.0 109.74 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.19 -35.86 11.69 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.575 HG23 ' CE1' ' A' ' 70' ' ' PHE . 29.3 mt -77.73 -32.49 18.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.587 ' CD2' HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -69.75 -43.82 71.5 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.345 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.507 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 47.5 t0 -83.49 2.62 35.98 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.41 0.624 . . . . 0.0 109.558 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.405 ' HB2' ' HA ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -90.56 -8.41 50.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.331 -0.855 . . . . 0.0 109.208 179.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.565 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.9 mt -104.65 -8.07 19.17 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m 83.14 93.77 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.995 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.5 Cg_endo -74.27 145.41 34.47 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.374 1.723 . . . . 0.0 110.533 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 21.1 t -113.15 102.56 14.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER 62.4 19.95 11.5 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.323 -0.861 . . . . 0.0 109.268 -179.053 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 92.28 34.05 7.31 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.561 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 77.9 m-85 -144.56 149.5 35.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.165 -1.197 . . . . 0.0 111.566 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.587 HD13 ' CD2' ' A' ' 21' ' ' PHE . 52.3 mt -125.7 131.87 52.49 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.565 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -77.42 138.46 39.28 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.443 -0.785 . . . . 0.0 110.029 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -43.01 -25.64 0.38 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 6.0 m-20 -65.52 -20.88 66.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -1.175 . . . . 0.0 110.337 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 9.1 mtpp -97.98 -39.78 8.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.176 -0.952 . . . . 0.0 109.073 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.538 HG13 ' CD1' ' A' ' 65' ' ' LEU . 60.4 t -78.15 -36.6 21.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 121.485 0.659 . . . . 0.0 109.769 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.591 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.5 tttt -48.08 -54.69 22.59 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.859 . . . . 0.0 110.171 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.0 Cg_endo -63.6 -29.24 70.01 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.58 1.305 . . . . 0.0 108.907 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.591 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 4.7 t -80.63 -11.27 12.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 121.659 0.742 . . . . 0.0 109.46 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.534 ' CD1' HG11 ' A' ' 36' ' ' VAL . 42.0 mt -99.94 -14.97 18.48 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.166 -0.959 . . . . 0.0 108.677 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.478 HD11 ' HA ' ' A' ' 38' ' ' PRO . 7.9 mt -89.42 -33.9 16.67 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.642 -0.661 . . . . 0.0 110.089 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 6.6 p30 -64.24 -9.85 19.9 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.735 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 1.4 m -72.35 -1.83 16.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 110.052 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 43' ' ' SER . 17.4 ttmt 69.55 14.62 8.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.307 -0.871 . . . . 0.0 110.455 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.552 ' CD1' ' HB2' ' A' ' 80' ' ' ALA . 14.9 mt -100.46 163.64 17.81 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.217 -0.927 . . . . 0.0 110.317 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.552 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.1 Cg_endo -75.18 160.92 39.03 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.982 1.517 . . . . 0.0 110.047 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.6 t -64.96 -7.17 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.132 -0.98 . . . . 0.0 110.373 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.06 -40.31 62.9 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.552 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 15.3 mm -64.13 -43.62 97.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 50' ' ' LEU . 5.1 mt -66.26 -21.19 66.28 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.735 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.14 -27.97 29.48 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.547 ' CD ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -94.54 -54.73 3.4 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.465 -1.021 . . . . 0.0 109.329 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 57' ' ' SER . 33.2 t -52.36 -41.01 33.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.517 -0.873 . . . . 0.0 108.685 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.539 ' CZ2' ' OD2' ' A' ' 58' ' ' ASP . 9.0 t-105 -62.6 -56.44 17.8 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.449 -0.782 . . . . 0.0 109.795 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.518 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 12.0 mm-40 -45.33 -56.48 4.87 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.389 -0.82 . . . . 0.0 110.104 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 1.4 mt -72.1 -10.94 60.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.687 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 8.0 m -96.8 -23.15 16.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.377 -0.827 . . . . 0.0 110.263 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.579 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 6.7 t0 -93.26 76.06 4.58 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.356 -0.84 . . . . 0.0 109.569 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.466 ' HB ' ' OE1' ' A' ' 69' ' ' GLU . 34.4 mm -41.23 -32.52 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.712 -0.618 . . . . 0.0 110.236 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 35.5 m-20 -93.48 -22.06 19.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.386 -0.821 . . . . 0.0 110.717 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 46.1 m-70 55.47 42.81 29.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 109.716 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -112.45 3.36 16.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.464 -0.773 . . . . 0.0 110.887 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.93 3.84 48.63 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.565 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 4.6 mtt -133.94 159.45 40.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -1.131 . . . . 0.0 110.82 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.538 ' CD1' HG13 ' A' ' 36' ' ' VAL . 10.5 mt -124.38 110.97 15.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.561 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -72.56 172.62 10.23 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.866 -1.146 . . . . 0.0 109.781 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.514 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -49.36 -38.07 26.96 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.603 -0.686 . . . . 0.0 111.313 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.15 -31.21 21.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.007 -1.058 . . . . 0.0 110.221 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.482 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 27.9 mt-10 -75.76 -42.35 50.61 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.285 -0.884 . . . . 0.0 109.593 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.581 ' CE1' ' SD ' ' A' ' 74' ' ' MET . 61.4 t80 -62.66 -31.45 72.33 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.069 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.36 -49.05 79.12 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.79 0.805 . . . . 0.0 109.89 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.526 HG21 ' CD2' ' A' ' 94' ' ' LEU . 85.6 t -57.73 -24.2 22.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 121.333 0.587 . . . . 0.0 110.427 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.509 ' HA ' ' OG ' ' A' ' 57' ' ' SER . . . -90.46 -6.15 55.21 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.183 -0.948 . . . . 0.0 111.852 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.581 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 11.3 mmm -89.97 -43.15 10.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.648 -1.283 . . . . 0.0 110.121 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.576 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.6 p90 -76.84 -27.71 55.22 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.876 -1.13 . . . . 0.0 108.115 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.576 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 9.6 mt -69.47 -27.15 64.98 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.491 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 30.3 t -91.59 -32.79 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.501 -0.75 . . . . 0.0 110.431 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -81.83 -33.01 30.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.13 -0.981 . . . . 0.0 110.043 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 65.1 m -75.45 -20.09 59.04 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . . . -71.64 -16.7 62.28 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.523 ' CD2' HD13 ' A' ' 45' ' ' LEU . 5.6 mt -90.56 -44.4 9.58 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.542 0.687 . . . . 0.0 109.787 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.612 -0.68 . . . . 0.0 111.731 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.478 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 85.5 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.507 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 49.4 Cg_endo -84.44 169.86 10.8 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.87 1.458 . . . . 0.0 109.405 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.547 ' HG2' ' CD ' ' A' ' 52' ' ' ARG . 4.2 mtm -98.85 12.76 34.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.917 -1.114 . . . . 0.0 110.261 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.481 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 72.2 m -108.63 103.83 13.01 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.715 -1.194 . . . . 0.0 112.044 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.594 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 2.2 mt -51.74 106.38 0.65 Allowed Pre-proline 0 C--N 1.292 -1.927 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.233 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.507 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 41.2 Cg_endo -72.07 150.36 54.09 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.759 1.4 . . . . 0.0 110.51 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.438 ' HA ' ' CG2' ' A' ' 95' ' ' VAL . 43.8 Cg_endo -70.16 -5.82 17.36 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.146 1.603 . . . . 0.0 111.068 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 8' ' ' ALA . . . -100.62 24.59 8.83 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.598 ' O ' ' CD1' ' A' ' 94' ' ' LEU 0.25 0.3 OUTLIER -158.19 34.36 0.24 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.338 1.066 . . . . 0.0 109.015 -178.128 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 O-C-N 120.623 -1.298 . . . . 0.0 110.347 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.541 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.515 0.674 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.522 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -46.45 -24.56 0.52 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.447 -0.783 . . . . 0.0 110.652 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.541 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 73.3 t -103.6 130.99 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.793 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.608 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.5 mttt -93.64 174.47 3.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.476 -0.765 . . . . 0.0 109.007 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 38.2 Cg_endo -65.44 -37.48 30.01 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.287 1.151 . . . . 0.0 109.957 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 8.0 pt-20 -64.71 -25.94 68.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.215 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.596 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -84.0 -38.34 21.05 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.508 ' O ' ' CB ' ' A' ' 18' ' ' ASP . 9.9 tptm -72.88 -17.03 61.57 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.576 0.703 . . . . 0.0 109.258 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.55 -37.84 65.43 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 2.3 mtmt -80.82 -39.18 27.05 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.596 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 5.3 m-30 -66.26 -22.69 66.32 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 6.3 t0 -85.81 -15.45 41.93 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.631 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -90.33 -28.14 18.93 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.567 HG21 ' CE1' ' A' ' 70' ' ' PHE . 15.7 mt -82.7 -31.85 9.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -74.31 -40.49 62.19 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 4.2 t0 -84.9 -0.57 54.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.643 -0.66 . . . . 0.0 109.839 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -89.34 -7.18 55.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.844 . . . . 0.0 109.04 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.561 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.5 mt -107.08 -8.66 16.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER 82.17 95.07 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.4 Cg_endo -74.49 150.17 40.41 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.994 1.523 . . . . 0.0 110.838 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 40.8 t -118.81 101.55 11.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER 65.22 26.58 12.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 108.891 -178.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . 85.14 35.72 12.03 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.578 ' CD1' ' HB2' ' A' ' 66' ' ' ASP . 93.8 m-85 -150.04 159.26 44.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.641 -0.917 . . . . 0.0 110.598 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.567 ' CD1' ' CD2' ' A' ' 21' ' ' PHE . 12.7 mt -135.02 128.95 33.34 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.473 ' HB3' ' HE2' ' A' ' 64' ' ' MET . 0.3 OUTLIER -73.09 139.21 46.33 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.452 -0.78 . . . . 0.0 110.541 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -43.07 -32.87 1.64 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.43 -15.83 7.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -1.153 . . . . 0.0 110.016 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 9.6 mtpp -111.77 -35.39 5.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.277 -0.889 . . . . 0.0 108.95 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 84.8 t -91.32 -46.27 14.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.698 -0.626 . . . . 0.0 110.179 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.611 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 ttpt -45.22 -47.83 33.17 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 110.661 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -69.01 -31.63 23.43 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.38 1.2 . . . . 0.0 109.377 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.491 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 1.9 t -65.71 -31.01 51.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.778 -0.576 . . . . 0.0 109.629 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.512 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 18.8 mt -80.59 -14.74 57.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.213 -0.93 . . . . 0.0 109.026 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 33.7 mt -76.25 -26.49 56.06 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 35.8 m-80 -63.32 -17.05 62.14 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.138 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.529 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -76.55 1.97 15.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.265 -0.897 . . . . 0.0 110.327 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 43' ' ' SER . 6.0 tttm 64.71 11.82 7.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 0.0 110.083 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.522 HD13 ' CD2' ' A' ' 81' ' ' LEU . 15.1 mt -86.89 158.41 53.38 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.864 . . . . 0.0 110.087 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.7 Cg_endo -73.61 159.11 46.53 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.068 1.562 . . . . 0.0 110.851 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -58.93 -10.74 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.984 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.27 -42.38 59.71 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.959 -1.088 . . . . 0.0 108.073 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.554 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 21.1 mm -61.84 -42.62 95.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.512 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 12.7 mt -66.77 -22.81 66.03 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -82.65 -24.59 53.06 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.562 ' CD ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -99.01 -59.59 1.7 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.545 -0.974 . . . . 0.0 109.711 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.547 ' O ' ' CB ' ' A' ' 57' ' ' SER . 46.2 t -46.58 -36.44 2.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.012 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.529 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 9.3 t-105 -73.07 -59.33 2.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 110.211 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.478 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 52.5 mm-40 -44.16 -45.5 8.34 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.195 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.564 ' HA ' ' HG ' ' A' ' 90' ' ' LEU . 1.8 mt -81.52 -16.5 51.59 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.339 -0.944 . . . . 0.0 109.586 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.2 t -88.39 -25.9 22.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.455 -0.778 . . . . 0.0 109.457 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.562 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 15.7 t0 -85.0 81.38 8.93 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.505 -0.747 . . . . 0.0 109.745 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.532 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 33.2 mm -47.8 -30.94 2.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 120.134 -0.627 . . . . 0.0 110.504 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 4.4 p-10 -103.92 -16.28 15.4 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.039 -1.064 . . . . 0.0 111.309 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.562 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 34.8 m-70 54.73 41.51 31.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.894 -1.129 . . . . 0.0 109.948 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.478 ' OD2' ' HG3' ' A' ' 64' ' ' MET . 1.1 p-10 -100.96 -10.76 20.29 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.357 -0.839 . . . . 0.0 110.171 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.422 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 117.9 8.93 10.29 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.552 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.0 mtp -145.55 161.36 39.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -1.174 . . . . 0.0 110.116 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.5 HD22 ' HA ' ' A' ' 58' ' ' ASP . 15.6 mt -117.4 106.0 12.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.172 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.578 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -69.59 172.91 6.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.779 -1.201 . . . . 0.0 110.297 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.52 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.5 ptm180 -47.73 -39.57 18.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.614 -0.679 . . . . 0.0 111.032 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.46 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 5.6 m-20 -84.87 -31.97 23.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 0.0 110.338 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.532 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 18.9 mt-10 -77.2 -44.16 31.08 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.392 -0.818 . . . . 0.0 109.091 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.581 ' CE1' ' SD ' ' A' ' 74' ' ' MET . 62.0 t80 -64.46 -29.12 70.17 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.551 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -62.28 -50.4 71.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.42 -0.8 . . . . 0.0 110.226 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.447 HG11 HD13 ' A' ' 76' ' ' LEU . 41.8 t -56.31 -24.11 17.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.51 -0.744 . . . . 0.0 109.8 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -86.69 -9.88 54.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.195 -0.941 . . . . 0.0 111.831 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.581 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 9.1 mmm -87.85 -39.11 15.1 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.602 -1.312 . . . . 0.0 110.574 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.583 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.2 p90 -78.93 -20.23 49.84 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.834 -1.146 . . . . 0.0 108.212 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.583 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 10.5 mt -79.83 -25.47 40.79 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.611 0.719 . . . . 0.0 109.217 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.537 HG21 ' CG1' ' A' ' 53' ' ' VAL . 78.5 t -91.49 -26.99 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.478 -0.764 . . . . 0.0 110.327 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.46 -29.96 21.02 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.267 -0.895 . . . . 0.0 110.039 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 3.0 t -81.19 -14.78 57.22 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.265 -0.897 . . . . 0.0 108.861 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.481 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . . . -85.22 -7.68 58.92 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.4 -0.812 . . . . 0.0 109.12 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.539 HD22 ' N ' ' A' ' 81' ' ' LEU . 2.8 mt -90.46 -50.29 6.03 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.584 -0.698 . . . . 0.0 109.968 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.649 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.425 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.528 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 44.5 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.635 0.255 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.538 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 51.7 Cg_endo -90.45 147.49 4.25 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.933 1.491 . . . . 0.0 109.72 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.562 ' HG2' ' CD ' ' A' ' 52' ' ' ARG . 4.7 mtm -81.96 11.2 5.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.88 -1.138 . . . . 0.0 110.348 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.475 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 68.3 m -106.84 106.4 16.91 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.598 -178.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 56' ' ' LEU . 2.1 mt -54.66 107.81 0.97 Allowed Pre-proline 0 C--N 1.294 -1.841 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.919 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.506 ' HG2' ' CG ' ' A' ' 94' ' ' LEU . 40.1 Cg_endo -67.93 161.03 45.87 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 124.076 1.566 . . . . 0.0 110.14 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.11 -20.59 16.5 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.002 1.527 . . . . 0.0 111.098 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.485 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -88.84 15.29 8.62 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.152 -0.968 . . . . 0.0 109.734 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 3.9 mm? -118.33 -23.03 7.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.205 -0.934 . . . . 0.0 110.611 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.4 t . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.341 -0.849 . . . . 0.0 110.855 -179.208 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.559 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.1 t90 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.2 0.524 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.575 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -42.4 -28.84 0.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 110.277 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.559 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 39.0 t -100.09 146.05 9.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.348 -0.845 . . . . 0.0 109.72 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.507 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.1 mtmt -119.47 178.07 1.2 Allowed Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.192 -0.942 . . . . 0.0 109.693 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 38.3 Cg_endo -64.9 -36.42 39.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.84 1.442 . . . . 0.0 110.252 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.483 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 18.3 pt-20 -65.35 -35.73 81.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.327 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 92.4 m-20 -81.95 -34.41 29.81 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.49 ' NZ ' ' OD1' ' A' ' 68' ' ' ASP . 1.1 tppp? -70.91 -20.6 62.47 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 11' ' ' PRO . . . -69.21 -40.02 78.26 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.622 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.7 ptmm? -79.79 -24.82 41.19 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.622 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.7 m-30 -72.18 -35.86 69.09 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 35.0 t0 -74.47 -8.75 57.32 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.238 0.542 . . . . 0.0 110.455 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.08 -41.22 9.22 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.48 ' O ' ' HG ' ' A' ' 24' ' ' LEU 0.251 15.5 mt -72.51 -29.62 31.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -70.73 -39.72 73.19 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.463 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.2 t70 -88.6 2.99 52.05 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.572 -0.705 . . . . 0.0 109.816 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.5 m -91.01 -4.95 56.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 108.663 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.575 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.9 OUTLIER -110.74 -6.02 14.87 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER 80.88 96.33 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.2 Cg_endo -72.9 147.63 44.27 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 O-C-N 124.611 1.848 . . . . 0.0 110.691 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.7 t -117.61 103.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.518 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 1.1 t30 62.2 21.9 12.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.942 . . . . 0.0 109.223 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.58 34.56 7.33 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CE1' ' CB ' ' A' ' 66' ' ' ASP . 96.9 m-85 -150.43 160.64 43.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -1.113 . . . . 0.0 111.134 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.491 ' CD2' ' HB2' ' A' ' 24' ' ' LEU . 42.8 mt -126.61 132.91 51.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.508 -0.745 . . . . 0.0 109.529 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.579 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.5 OUTLIER -80.54 138.9 36.55 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.358 -0.839 . . . . 0.0 110.458 -179.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -40.62 -25.68 0.11 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 32' ' ' SER . 8.7 m-20 -63.93 -17.94 63.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -1.141 . . . . 0.0 110.969 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -111.6 -36.42 5.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.937 -1.102 . . . . 0.0 109.942 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.516 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 82.2 t -79.09 -54.19 12.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.316 -0.865 . . . . 0.0 109.964 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.597 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -40.43 -49.88 6.74 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.581 -0.699 . . . . 0.0 110.459 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.2 Cg_endo -68.27 -31.97 27.59 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.376 1.198 . . . . 0.0 109.413 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.494 HG22 ' CD2' ' A' ' 24' ' ' LEU . 2.2 t -67.51 -31.65 53.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.576 -0.703 . . . . 0.0 109.572 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.54 ' CB ' ' CD2' ' A' ' 50' ' ' LEU . 11.4 mt -78.72 -15.66 58.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.049 -1.032 . . . . 0.0 108.636 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.506 ' HG ' ' CD1' ' A' ' 50' ' ' LEU . 14.8 mt -75.47 -24.29 56.94 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.423 -0.798 . . . . 0.0 108.901 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 32.6 m-80 -66.98 -19.03 65.65 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.001 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.549 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -74.07 0.08 14.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.273 -0.892 . . . . 0.0 110.252 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.3 OUTLIER 69.49 4.35 4.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.12 -0.987 . . . . 0.0 110.577 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.488 HD21 ' CD ' ' A' ' 46' ' ' PRO . 15.7 mt -79.2 160.37 70.89 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.011 . . . . 0.0 110.224 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.54 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 41.7 Cg_endo -73.43 161.57 42.18 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.04 1.547 . . . . 0.0 110.287 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.78 -11.39 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.41 -0.806 . . . . 0.0 110.527 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.75 -40.07 66.32 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.54 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 28.3 mm -64.0 -44.82 97.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.54 ' CD2' ' CB ' ' A' ' 40' ' ' LEU . 13.5 mt -61.52 -17.78 56.28 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . -88.57 -27.4 24.8 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -96.34 -54.54 3.24 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.665 -0.903 . . . . 0.0 109.332 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.564 ' O ' ' CB ' ' A' ' 57' ' ' SER . 45.0 t -48.16 -33.42 4.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.901 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.514 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 10.4 t-105 -76.96 -59.59 2.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.315 -0.866 . . . . 0.0 110.32 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 64.8 mm-40 -45.65 -41.18 10.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.266 -0.896 . . . . 0.0 109.841 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.531 HD21 ' N ' ' A' ' 90' ' ' LEU . 20.9 mt -83.23 -17.61 42.13 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.557 -0.714 . . . . 0.0 109.454 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 8.3 t -92.33 -23.54 19.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.342 -0.849 . . . . 0.0 109.457 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.589 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 23.5 t0 -84.49 65.88 9.19 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.318 -0.864 . . . . 0.0 110.12 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.523 HG12 ' HG2' ' A' ' 69' ' ' GLU . 40.2 mm -39.28 -30.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.373 0.606 . . . . 0.0 110.013 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 21.8 m-20 -95.71 -25.76 15.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.436 -0.79 . . . . 0.0 110.507 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 75.2 m-70 59.62 48.9 8.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.919 . . . . 0.0 109.829 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -117.38 -10.69 10.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 110.434 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.25 8.87 16.37 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.579 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 2.8 mtt -143.55 160.8 39.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.381 -1.07 . . . . 0.0 110.323 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 58' ' ' ASP . 69.7 mt -123.85 116.87 23.65 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.13 -0.981 . . . . 0.0 110.937 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.532 ' CB ' ' CE1' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -72.23 160.21 32.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.897 -1.127 . . . . 0.0 109.743 178.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.574 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 9.7 ptm180 -41.73 -37.76 1.29 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.345 -0.847 . . . . 0.0 111.479 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.49 ' OD1' ' NZ ' ' A' ' 14' ' ' LYS . 52.8 m-20 -81.1 -30.13 34.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.855 -1.153 . . . . 0.0 109.528 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' HG2' HG12 ' A' ' 59' ' ' ILE . 9.4 mt-10 -74.29 -46.37 41.63 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.609 0.718 . . . . 0.0 109.132 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.515 ' O ' ' HG2' ' A' ' 74' ' ' MET . 42.3 t80 -59.87 -18.01 41.11 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.742 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.464 ' CB ' ' HE2' ' A' ' 14' ' ' LYS . . . -72.33 -49.81 31.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.425 -0.797 . . . . 0.0 109.809 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.528 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 46.8 t -61.01 -22.0 25.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.91 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.541 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -90.12 -5.18 56.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.221 -0.924 . . . . 0.0 111.008 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 70' ' ' PHE . 2.1 mmt -87.84 -45.97 9.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.913 -1.117 . . . . 0.0 110.077 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.622 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 2.2 p90 -75.04 -33.8 61.79 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.588 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 29.4 mt -59.02 -30.19 67.83 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.559 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 98.0 t -91.55 -45.06 14.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.784 -0.572 . . . . 0.0 110.059 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.494 ' HA ' HD11 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -72.92 -25.91 61.22 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.397 -0.814 . . . . 0.0 111.045 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 74.5 m -84.79 -18.37 35.23 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.05 -1.031 . . . . 0.0 109.726 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.454 ' HB2' HD12 ' A' ' 45' ' ' LEU . . . -79.35 -12.65 59.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.889 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.559 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 1.2 mt -90.54 -47.13 7.88 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.742 0.782 . . . . 0.0 110.116 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 . . . . . 0 C--N 1.3 -1.579 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.656 -179.097 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.546 ' CG1' ' HD2' ' A' ' 87' ' ' PRO . 35.4 t . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.546 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 43.6 Cg_endo -86.35 -166.28 0.31 Allowed 'Trans proline' 0 C--N 1.302 -1.911 0 O-C-N 123.586 1.308 . . . . 0.0 109.897 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 73.3 mtp -123.63 11.32 9.15 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.292 -0.88 . . . . 0.0 111.03 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -168.43 23.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.552 -1.259 . . . . 0.0 111.926 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.531 ' N ' HD21 ' A' ' 56' ' ' LEU . 0.6 OUTLIER 53.81 119.35 0.0 OUTLIER Pre-proline 0 C--N 1.283 -2.32 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.788 178.343 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.537 ' HG2' HD21 ' A' ' 94' ' ' LEU . 43.8 Cg_endo -73.56 169.84 21.38 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.725 1.382 . . . . 0.0 109.883 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.37 -16.85 27.63 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.853 1.449 . . . . 0.0 111.919 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.489 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -92.09 12.23 22.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.787 -1.195 . . . . 0.0 110.853 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.622 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 3.4 mm? -113.75 -17.8 12.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.087 -1.008 . . . . 0.0 111.56 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.092 -1.005 . . . . 0.0 110.91 -179.074 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.512 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.4 t90 . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.444 0.64 . . . . 0.0 109.991 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.548 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -46.55 -27.5 1.14 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.42 -0.8 . . . . 0.0 110.151 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.512 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 37.4 t -93.04 129.71 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.395 -0.815 . . . . 0.0 110.332 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.505 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -93.94 179.13 1.31 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.755 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 39.5 Cg_endo -67.65 -35.49 22.11 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.795 1.418 . . . . 0.0 110.224 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -75.15 -26.37 59.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.842 . . . . 0.0 110.058 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.453 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 4.1 m-20 -86.08 -37.43 18.85 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HG3' ' CZ3' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -76.18 -13.55 60.18 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.588 -0.695 . . . . 0.0 109.175 178.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.81 -40.81 63.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 108.901 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.57 -26.46 50.87 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.36 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.5 m-30 -71.83 -27.6 63.02 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.14 -10.71 59.6 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.338 0.589 . . . . 0.0 109.937 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.02 -36.54 11.51 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.485 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 82.3 mt -74.81 -33.98 32.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -65.39 -39.09 91.79 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.474 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.2 t0 -89.31 2.65 54.06 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.694 -0.629 . . . . 0.0 109.706 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.476 ' HB2' ' HA ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -93.83 0.83 56.44 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.847 0.832 . . . . 0.0 108.978 178.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.576 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -116.63 -2.49 11.93 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 80.17 90.53 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.855 0 CA-C-O 121.368 0.604 . . . . 0.0 109.838 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.6 Cg_endo -75.27 148.59 34.48 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 124.558 1.82 . . . . 0.0 110.458 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 44.0 t -117.86 108.51 24.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.663 -0.648 . . . . 0.0 109.422 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 16.7 t30 55.44 21.49 4.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.07 -1.018 . . . . 0.0 109.741 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.446 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 97.03 33.58 5.98 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.59 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 66.2 m-85 -149.76 150.51 32.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -1.104 . . . . 0.0 111.41 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.532 HD12 ' CD1' ' A' ' 24' ' ' LEU . 30.7 mt -118.56 129.94 55.62 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.71 -0.796 . . . . 0.0 108.994 178.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.554 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -78.76 138.47 38.24 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.606 -0.684 . . . . 0.0 110.616 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -44.08 -25.33 0.67 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 32' ' ' SER . 10.3 t70 -62.27 -17.75 59.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.288 -1.125 . . . . 0.0 110.226 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -114.47 -33.98 5.4 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.325 -0.86 . . . . 0.0 109.377 179.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.531 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 98.6 t -79.19 -51.83 16.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 119.516 -0.873 . . . . 0.0 109.765 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.604 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 48.6 tttt -42.68 -49.88 13.04 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 110.338 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.6 Cg_endo -67.39 -31.09 35.49 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 N-CA-C 108.854 -1.248 . . . . 0.0 108.854 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.589 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 2.8 t -76.22 -10.43 13.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.523 0.677 . . . . 0.0 109.507 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.512 ' CD2' HG22 ' A' ' 77' ' ' VAL . 97.2 mt -99.21 -15.09 19.03 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.544 ' CD1' ' HA ' ' A' ' 38' ' ' PRO . 6.9 mt -84.63 -33.32 23.33 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.479 -0.763 . . . . 0.0 109.595 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 7.8 p30 -71.12 -2.97 17.47 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.865 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 9.4 m -80.37 5.5 14.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.31 -0.869 . . . . 0.0 110.033 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 43' ' ' SER . 27.8 tttt 65.54 12.61 8.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.547 HD12 ' CB ' ' A' ' 80' ' ' ALA . 15.5 mt -99.82 156.24 35.56 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 110.036 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 40.4 Cg_endo -73.09 162.44 40.8 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.952 1.501 . . . . 0.0 110.153 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.1 t -63.88 -7.93 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.432 -0.792 . . . . 0.0 110.725 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.23 -40.59 51.67 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.554 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 10.9 mm -65.59 -43.53 94.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.504 HD23 ' O ' ' A' ' 40' ' ' LEU . 3.7 mt -66.03 -21.32 66.38 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.33 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.6 -28.11 22.73 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.471 ' HD3' ' HG3' ' A' ' 88' ' ' MET . 3.8 ttm180 -95.3 -47.42 6.32 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.519 -0.989 . . . . 0.0 109.606 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 76' ' ' LEU . 45.7 t -57.45 -39.11 66.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.277 -0.89 . . . . 0.0 109.201 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.576 ' CZ3' HD13 ' A' ' 65' ' ' LEU . 6.7 t-105 -68.69 -53.22 23.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.502 -0.749 . . . . 0.0 110.172 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.479 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 5.7 mm-40 -47.58 -50.02 25.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.381 -0.824 . . . . 0.0 109.906 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.627 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 3.3 mt -76.38 -8.49 57.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.669 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.545 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 1.3 t -99.76 -27.62 13.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.475 -0.766 . . . . 0.0 110.422 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.487 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 11.8 t0 -83.82 90.01 7.28 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.387 -0.821 . . . . 0.0 109.384 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.466 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 46.1 mm -53.45 -32.71 20.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.496 -0.752 . . . . 0.0 110.549 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 24.8 p-10 -106.42 -13.75 15.27 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.185 -0.947 . . . . 0.0 111.021 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.536 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 78.0 m-70 56.45 43.69 25.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.076 -1.015 . . . . 0.0 110.358 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.461 ' OD1' ' OD2' ' A' ' 60' ' ' ASP . 1.1 p-10 -104.3 18.45 22.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.931 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.61 10.42 83.34 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.554 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 4.2 mtt -139.43 161.82 36.55 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.538 -0.977 . . . . 0.0 110.911 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.576 HD13 ' CZ3' ' A' ' 54' ' ' TRP . 71.1 mt -130.76 119.48 22.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.346 -0.846 . . . . 0.0 110.387 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.59 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -79.59 166.59 21.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.896 -1.127 . . . . 0.0 109.484 179.026 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.476 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -43.26 -30.45 0.5 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.457 -0.777 . . . . 0.0 111.275 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 58.7 m-20 -90.06 -31.15 17.28 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.14 -0.975 . . . . 0.0 109.766 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.466 ' OE1' ' N ' ' A' ' 59' ' ' ILE . 10.0 mt-10 -76.93 -38.56 53.17 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.412 -0.805 . . . . 0.0 109.378 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.544 ' CZ ' HD13 ' A' ' 24' ' ' LEU . 56.9 t80 -70.71 -24.56 62.67 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.705 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.27 -41.22 77.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 109.552 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.481 HG13 HD13 ' A' ' 76' ' ' LEU . 59.3 t -62.94 -29.66 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.639 -0.663 . . . . 0.0 110.043 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.545 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -90.33 -4.46 57.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.154 -0.966 . . . . 0.0 110.9 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.515 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 9.7 mmt -83.37 -46.49 12.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.003 -1.061 . . . . 0.0 109.76 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CZ ' HD12 ' A' ' 94' ' ' LEU . 4.3 p90 -77.2 -24.24 51.37 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.603 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 15.3 mt -72.89 -25.76 61.19 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.512 HG22 ' CD2' ' A' ' 40' ' ' LEU . 42.4 t -91.06 -34.46 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.639 -0.663 . . . . 0.0 109.663 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -80.12 -26.39 39.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -0.779 . . . . 0.0 110.034 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 65.1 m -82.11 -12.78 58.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.203 -0.935 . . . . 0.0 109.127 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.547 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -85.91 -13.73 46.91 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.333 -0.854 . . . . 0.0 108.923 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.544 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.2 mt -89.58 -42.48 11.39 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.904 0.859 . . . . 0.0 109.014 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.298 -1.642 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.423 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.471 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 44.2 t . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 120.692 0.282 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.47 ' O ' HD12 ' A' ' 56' ' ' LEU . 52.1 Cg_endo -84.67 -170.69 0.84 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.958 1.504 . . . . 0.0 109.831 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.471 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 4.8 mtt -115.2 13.89 16.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.069 -1.019 . . . . 0.0 110.634 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.495 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 5.3 m -113.13 103.05 10.97 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 118.729 -1.188 . . . . 0.0 111.688 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.627 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -57.07 108.26 1.18 Allowed Pre-proline 0 C--N 1.291 -1.94 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.824 179.21 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.551 ' HG2' ' CD2' ' A' ' 94' ' ' LEU . 49.6 Cg_endo -80.05 157.72 23.64 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 123.928 1.489 . . . . 0.0 110.328 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.26 -11.04 24.74 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.079 1.568 . . . . 0.0 110.828 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.474 ' O ' ' HB1' ' A' ' 8' ' ' ALA . . . -84.15 -0.76 53.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.627 HD12 ' CZ ' ' A' ' 75' ' ' PHE . 3.9 mm? -117.46 -9.69 10.81 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.313 -0.867 . . . . 0.0 110.164 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.513 ' O ' ' CG1' ' A' ' 95' ' ' VAL . 6.3 p . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.953 . . . . 0.0 110.748 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.455 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.8 t90 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.593 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . . . -40.96 -32.42 0.23 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.298 -0.876 . . . . 0.0 109.931 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.455 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 64.9 t -89.71 153.23 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.481 -0.762 . . . . 0.0 109.565 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.513 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 11.5 mmtt -99.04 167.03 11.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.2 Cg_endo -66.5 -33.67 36.21 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.747 1.393 . . . . 0.0 109.755 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -76.53 -23.81 53.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.506 -0.746 . . . . 0.0 109.367 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.576 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 21.8 m-20 -82.79 -38.75 22.71 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.47 ' HE2' ' HB2' ' A' ' 18' ' ' ASP . 7.2 tptm -65.29 -20.33 66.36 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.39 -43.19 41.65 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.578 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.7 ptpt -79.15 -24.05 43.56 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.578 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 6.9 m-30 -74.96 -34.33 62.03 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.47 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 10.1 t70 -79.96 -8.4 59.31 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.381 0.61 . . . . 0.0 109.939 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.72 -37.23 10.88 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.533 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 28.0 mt -75.43 -26.66 18.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.559 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -75.2 -36.84 61.37 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.486 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.2 t70 -90.27 1.75 56.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.696 -0.627 . . . . 0.0 109.815 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -93.86 -1.38 54.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.35 -0.844 . . . . 0.0 108.821 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.573 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -114.0 -1.77 13.7 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.594 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 81.71 91.1 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.107 0 CA-C-O 121.111 0.481 . . . . 0.0 109.707 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.4 Cg_endo -75.11 148.51 34.98 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.305 1.687 . . . . 0.0 110.746 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 99.2 t -120.03 109.44 25.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.625 -0.672 . . . . 0.0 109.561 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 9.3 t30 55.53 23.33 5.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.063 -1.023 . . . . 0.0 109.556 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 92.87 35.41 6.42 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 91.1 m-85 -151.42 152.55 33.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -1.153 . . . . 0.0 111.118 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 64' ' ' MET . 29.7 mt -122.23 127.87 50.47 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.495 ' CA ' ' HE1' ' A' ' 64' ' ' MET . 0.1 OUTLIER -78.86 138.2 38.03 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.613 -179.069 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -38.53 -34.05 0.23 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 32' ' ' SER . 7.9 t0 -49.75 -21.6 1.14 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -1.212 . . . . 0.0 110.022 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 13.0 mttm -113.08 -39.71 4.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.42 -0.8 . . . . 0.0 109.443 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.497 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 96.1 t -79.35 -37.17 18.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.647 -0.658 . . . . 0.0 110.015 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.1 ttpt -49.34 -50.38 65.11 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.34 -0.85 . . . . 0.0 110.584 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.6 Cg_endo -66.93 -29.23 41.41 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 N-CA-C 108.812 -1.265 . . . . 0.0 108.812 178.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.571 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 3.2 t -73.97 -13.29 15.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.216 0.531 . . . . 0.0 110.303 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.535 ' HB3' HD23 ' A' ' 50' ' ' LEU . 77.9 mt -98.75 -14.0 19.95 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.967 -1.083 . . . . 0.0 108.568 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 20.3 mt -87.89 -41.72 13.01 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.707 -0.621 . . . . 0.0 110.073 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -52.78 -20.46 3.23 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.365 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -64.08 -9.45 16.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.467 -0.771 . . . . 0.0 110.431 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 71.24 7.91 6.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.142 -0.973 . . . . 0.0 109.72 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.531 ' CD1' ' HB2' ' A' ' 80' ' ' ALA . 15.7 mt -88.26 159.88 46.76 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 110.014 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 41.0 Cg_endo -72.41 151.9 54.22 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 123.941 1.495 . . . . 0.0 110.301 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.5 t -54.28 -14.07 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.268 -0.895 . . . . 0.0 110.991 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -39.85 75.08 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.801 -1.187 . . . . 0.0 108.354 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.538 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 4.9 mm -66.89 -47.18 83.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.566 ' N ' HD21 ' A' ' 50' ' ' LEU . 4.5 mt -63.31 -21.14 66.07 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.05 -28.33 25.98 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.514 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 2.1 ttm180 -94.4 -55.71 3.07 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.473 -1.016 . . . . 0.0 109.272 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.555 ' CG1' HG22 ' A' ' 77' ' ' VAL . 55.3 t -47.64 -44.15 9.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.24 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.532 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 6.0 t-105 -64.62 -57.32 9.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.49 -0.756 . . . . 0.0 109.995 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.561 ' CG ' ' N ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER -47.54 -50.85 22.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.684 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.562 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 2.6 mt -70.69 -9.7 57.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.311 -0.868 . . . . 0.0 109.398 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -100.3 -36.24 9.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.607 -0.683 . . . . 0.0 110.258 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.522 ' HA ' HD22 ' A' ' 65' ' ' LEU . 9.4 t0 -78.76 85.36 4.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.451 -0.78 . . . . 0.0 109.295 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.505 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 31.4 mm -52.47 -30.99 14.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.728 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 0.7 OUTLIER -99.52 -18.09 17.57 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.053 -1.029 . . . . 0.0 111.006 -179.341 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 7.5 m-70 56.85 31.78 20.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.975 -1.078 . . . . 0.0 108.895 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -90.99 -9.3 46.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.634 -0.666 . . . . 0.0 110.538 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.422 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 113.24 9.98 16.54 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 9.2 mtp -149.19 158.18 43.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -1.169 . . . . 0.0 110.732 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.522 HD22 ' HA ' ' A' ' 58' ' ' ASP . 41.5 mt -116.35 117.18 29.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.603 -0.685 . . . . 0.0 110.159 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.582 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 3.2 t70 -77.35 172.8 12.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.082 -1.011 . . . . 0.0 110.023 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.559 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.4 ptm180 -48.11 -43.18 30.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.519 -0.738 . . . . 0.0 111.36 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -80.4 -33.57 36.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.142 -0.974 . . . . 0.0 110.58 -179.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.513 ' OE2' ' OD1' ' A' ' 60' ' ' ASP . 66.7 mt-10 -73.74 -50.13 22.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 108.593 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.567 ' CE2' ' SD ' ' A' ' 74' ' ' MET . 55.2 t80 -52.03 -33.24 37.78 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -56.47 -53.81 53.15 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.565 0.698 . . . . 0.0 109.96 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 56' ' ' LEU . 78.3 t -55.45 -25.14 17.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.548 -0.72 . . . . 0.0 110.334 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.504 ' O ' HG22 ' A' ' 77' ' ' VAL . . . -89.28 -5.44 57.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.157 -0.964 . . . . 0.0 111.396 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.568 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 8.0 mmm -90.84 -35.32 14.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.515 -1.366 . . . . 0.0 110.284 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.64 ' CZ ' ' CD2' ' A' ' 94' ' ' LEU . 2.1 p90 -83.1 -24.47 32.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.135 -0.978 . . . . 0.0 108.596 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.562 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 3.8 mt -77.4 -23.72 50.62 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.644 -0.66 . . . . 0.0 109.316 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.555 HG22 ' CG1' ' A' ' 53' ' ' VAL . 48.7 t -89.93 -32.29 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.507 -0.746 . . . . 0.0 109.136 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.499 ' HA ' HD11 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -82.87 -25.46 32.53 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 109.786 179.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 64.4 m -86.15 -12.24 50.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.386 -0.821 . . . . 0.0 109.717 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . . . -80.81 -19.13 45.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.916 -1.115 . . . . 0.0 108.456 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.499 HD11 ' HA ' ' A' ' 78' ' ' TYR . 3.3 mt -91.69 -40.71 11.12 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.149 0.5 . . . . 0.0 110.391 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 82' ' ' GLU . 3.8 tt0 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 112.9 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.476 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 41.4 t . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.741 0.305 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.477 ' O ' HD12 ' A' ' 56' ' ' LEU . 52.4 Cg_endo -81.42 158.41 19.62 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.813 1.428 . . . . 0.0 109.404 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.514 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 2.5 mtt -86.33 16.37 4.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.963 -1.086 . . . . 0.0 110.036 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.603 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 61.6 m -106.58 110.92 23.26 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.221 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.562 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -91.25 98.57 1.77 Allowed Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.18 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.603 ' HD3' ' O ' ' A' ' 89' ' ' SER . 38.3 Cg_endo -63.9 167.61 13.63 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.673 1.354 . . . . 0.0 111.379 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.35 -9.23 24.94 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.208 1.636 . . . . 0.0 111.072 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.24 -7.76 55.59 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.318 -0.864 . . . . 0.0 109.095 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.64 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 2.6 mt -111.4 3.5 18.24 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.422 -0.799 . . . . 0.0 110.32 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.966 . . . . 0.0 110.615 -179.499 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.559 ' CZ2' ' HB ' ' A' ' 9' ' ' VAL . 19.1 t90 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.258 0.552 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.567 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -47.81 -27.69 2.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.486 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.559 ' HB ' ' CZ2' ' A' ' 7' ' ' TRP . 89.4 t -112.73 154.2 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.867 . . . . 0.0 110.453 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -113.65 -176.56 0.38 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.396 -0.815 . . . . 0.0 110.244 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.9 Cg_endo -69.75 -41.21 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.698 1.367 . . . . 0.0 110.305 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.433 ' HG2' ' OD1' ' A' ' 13' ' ' ASP . 15.3 pt-20 -65.15 -28.5 69.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 109.75 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.57 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 4.3 m-20 -84.25 -40.61 17.82 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 18' ' ' ASP . 1.5 tppp? -69.78 -14.14 62.63 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.79 -39.33 44.26 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 8.8 mtmt -81.61 -40.08 23.53 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.57 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 5.0 m-30 -64.04 -22.12 66.8 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 4.4 t70 -89.28 -16.84 30.23 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.799 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.05 -29.75 18.18 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.592 HG23 ' CE1' ' A' ' 70' ' ' PHE . 20.8 mt -80.08 -34.98 15.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.602 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -69.56 -38.02 77.26 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.003 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.508 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.1 t70 -88.11 -0.7 57.38 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.701 -0.624 . . . . 0.0 110.227 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.7 t -90.72 -3.84 57.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 109.206 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.609 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.2 mt -108.95 -8.09 15.3 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m 86.05 89.08 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.5 Cg_endo -73.55 145.03 36.86 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.455 1.766 . . . . 0.0 110.507 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.7 110.15 31.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 52.14 23.44 2.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.086 -1.009 . . . . 0.0 108.474 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 91.1 33.97 7.87 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.571 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 65.0 m-85 -144.52 148.61 34.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -1.124 . . . . 0.0 112.01 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.494 HD11 ' CD2' ' A' ' 70' ' ' PHE . 35.1 mt -122.63 134.26 54.51 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.58 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.3 OUTLIER -77.89 143.19 37.94 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.181 -0.949 . . . . 0.0 111.107 -178.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -50.4 -26.9 10.42 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.241 -1.943 . . . . 0.0 108.241 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -77.52 -9.67 59.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.35 -1.088 . . . . 0.0 109.466 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.564 ' HD2' ' CB ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -100.74 -46.56 5.12 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 39' ' ' VAL . 72.4 t -77.67 -37.34 24.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.924 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.569 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -38.47 -51.88 3.46 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.423 -0.798 . . . . 0.0 111.176 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.6 Cg_endo -65.98 -30.61 47.9 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.311 1.163 . . . . 0.0 109.35 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.581 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 5.4 t -77.51 -10.19 12.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.427 0.632 . . . . 0.0 109.733 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.531 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 58.6 mt -100.31 -14.46 18.4 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.554 ' CD1' ' HA ' ' A' ' 38' ' ' PRO . 10.7 mt -87.0 -42.48 13.08 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.636 -0.665 . . . . 0.0 109.483 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -50.05 -22.87 1.78 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 118.75 -1.18 . . . . 0.0 108.556 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -60.94 -10.96 6.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 110.107 178.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.6 OUTLIER 74.02 18.96 3.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.326 -0.859 . . . . 0.0 109.982 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.531 HD12 ' CB ' ' A' ' 80' ' ' ALA . 14.3 mt -98.9 156.25 35.73 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.569 -0.707 . . . . 0.0 109.823 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.532 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 41.9 Cg_endo -74.65 156.11 44.59 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.973 1.512 . . . . 0.0 110.279 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.0 t -58.66 -12.38 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.483 -0.76 . . . . 0.0 110.714 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.28 -37.63 71.86 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.026 -1.046 . . . . 0.0 108.233 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.532 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 26.0 mm -68.23 -45.95 81.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.531 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 9.8 mt -61.61 -20.39 63.29 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.516 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -84.49 -29.98 28.55 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.048 -2.021 . . . . 0.0 108.048 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.576 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 1.1 ttm180 -94.76 -58.32 2.21 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.58 -0.953 . . . . 0.0 109.629 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 57' ' ' SER . 6.3 t -46.83 -49.95 6.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.209 -0.997 . . . . 0.0 108.756 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.499 ' CZ3' HD13 ' A' ' 65' ' ' LEU . 16.9 t-105 -56.81 -59.44 5.02 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.931 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 10.4 mm-40 -44.05 -58.39 2.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.158 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.611 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 3.3 mt -70.25 -11.63 61.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.854 . . . . 0.0 109.803 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 19.3 m -96.2 -27.54 14.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 0.0 110.379 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 54' ' ' TRP . 19.0 t0 -87.14 81.59 7.96 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.241 -0.912 . . . . 0.0 109.455 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.489 HG12 ' HG3' ' A' ' 69' ' ' GLU . 32.1 mm -44.29 -32.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.616 -0.677 . . . . 0.0 110.449 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 9.5 p-10 -105.39 -14.98 15.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.126 -0.984 . . . . 0.0 111.034 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.536 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 29.7 m-70 56.27 41.71 28.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.046 -1.034 . . . . 0.0 110.113 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.454 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 2.2 p-10 -100.89 15.66 27.8 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 110.135 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.72 15.56 77.5 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.58 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 9.1 mtt -146.81 160.74 41.9 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.558 -0.966 . . . . 0.0 110.467 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.499 HD13 ' CZ3' ' A' ' 54' ' ' TRP . 43.5 mt -128.54 118.16 22.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.329 -0.857 . . . . 0.0 109.436 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.571 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 20.2 t0 -69.77 166.6 18.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.863 -1.148 . . . . 0.0 109.996 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.602 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 10.7 ttm180 -44.0 -46.33 8.28 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 110.142 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.5 m-20 -78.7 -26.72 44.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.383 -0.823 . . . . 0.0 109.66 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.489 ' HG3' HG12 ' A' ' 59' ' ' ILE . 4.7 tt0 -75.71 -39.57 57.16 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.59 0.709 . . . . 0.0 109.53 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.592 ' CE1' HG23 ' A' ' 20' ' ' ILE . 18.2 t80 -66.67 -17.75 65.01 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.691 0.758 . . . . 0.0 109.072 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -74.99 -43.61 52.97 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.469 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.52 HG12 ' CD1' ' A' ' 94' ' ' LEU . 59.2 t -60.57 -26.1 36.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.535 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.499 ' HA ' ' OG ' ' A' ' 57' ' ' SER . . . -90.56 -4.35 56.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.52 -0.737 . . . . 0.0 111.074 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.563 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 11.1 mmt -86.27 -47.05 9.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.925 -1.109 . . . . 0.0 109.971 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.526 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 1.9 p90 -76.91 -24.57 52.47 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.526 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 8.4 mt -71.21 -24.53 62.23 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.593 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 66.0 t -91.66 -61.92 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -48.32 -21.66 0.56 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.721 -0.612 . . . . 0.0 111.597 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 2.1 m -86.21 -14.76 42.96 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.006 -1.059 . . . . 0.0 109.883 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.531 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -89.33 -10.19 47.65 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.282 -0.886 . . . . 0.0 109.302 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.593 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 7.0 mp -87.04 -43.91 11.97 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.477 -0.765 . . . . 0.0 109.026 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 . . . . . 0 C--N 1.301 -1.523 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.777 179.649 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.45 HG23 HD21 ' A' ' 76' ' ' LEU . 77.9 t . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 120.608 0.242 . . . . 0.0 110.514 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.541 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 49.7 Cg_endo -81.27 -165.85 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.842 1.443 . . . . 0.0 110.097 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.576 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 67.0 mtm -120.48 17.11 12.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.267 -0.896 . . . . 0.0 110.609 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.532 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 42.0 m -117.04 95.47 5.01 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.039 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.611 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -57.12 106.71 0.72 Allowed Pre-proline 0 C--N 1.291 -1.962 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.491 178.6 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.546 ' HG2' ' CD2' ' A' ' 94' ' ' LEU . 50.9 Cg_endo -75.16 169.3 22.84 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.668 1.352 . . . . 0.0 109.826 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.64 -12.71 26.97 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.857 1.451 . . . . 0.0 111.012 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 8' ' ' ALA . . . -86.67 8.44 22.41 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.086 -1.009 . . . . 0.0 109.477 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.567 HD23 ' CB ' ' A' ' 8' ' ' ALA . 1.4 mm? -113.75 6.18 16.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 110.597 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.46 ' O ' HG11 ' A' ' 95' ' ' VAL . 9.9 p . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.068 -1.02 . . . . 0.0 110.713 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.575 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 19.0 t90 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.276 0.56 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.557 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -40.97 -34.4 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.401 -0.812 . . . . 0.0 110.839 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.575 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 61.2 t -108.39 141.36 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 110.384 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.558 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -99.42 -177.13 0.55 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.385 -0.822 . . . . 0.0 109.909 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.6 Cg_endo -69.43 -35.99 12.55 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.662 1.349 . . . . 0.0 109.834 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 20.3 pt-20 -68.46 -25.75 65.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 109.825 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.422 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 39.7 m-20 -86.13 -38.86 17.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.308 -0.87 . . . . 0.0 108.912 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -75.48 -17.25 60.18 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 11' ' ' PRO . . . -74.88 -31.12 61.52 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.633 ' HG3' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -86.45 -21.28 27.16 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.633 ' CD1' ' HG3' ' A' ' 16' ' ' LYS . 17.7 m-30 -78.9 -33.39 45.63 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -13.84 62.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.859 -0.526 . . . . 0.0 110.009 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -89.31 -34.06 16.7 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.494 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 22.2 mt -80.72 -35.91 15.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.6 ' CD2' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -68.37 -35.39 77.65 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.491 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.3 t0 -89.1 -1.7 58.21 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.446 -0.784 . . . . 0.0 109.987 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -91.04 -1.51 57.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 0.0 108.648 178.442 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.581 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -109.38 -3.82 16.82 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 81.26 87.52 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 121.454 0.645 . . . . 0.0 109.265 -178.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -72.32 147.65 47.68 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 O-C-N 124.65 1.869 . . . . 0.0 110.896 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 61.3 t -116.26 106.59 20.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.576 -0.703 . . . . 0.0 109.186 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 9.1 t30 57.1 26.55 12.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.265 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 88.24 36.14 8.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.582 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 87.4 m-85 -150.31 160.14 43.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.433 -1.039 . . . . 0.0 111.142 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.6 ' CD1' ' CD2' ' A' ' 21' ' ' PHE . 12.3 mt -136.25 134.04 37.64 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.584 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -83.08 139.89 32.97 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.854 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -38.77 -28.52 0.07 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.6 OUTLIER -53.04 -35.58 59.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.347 -1.09 . . . . 0.0 111.064 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 1.3 mttm -97.41 -42.13 7.89 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.083 -1.01 . . . . 0.0 109.561 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.525 HG12 ' CD1' ' A' ' 65' ' ' LEU . 41.9 t -71.61 -47.45 57.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.62 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.559 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 40.9 tttp -45.99 -52.12 28.04 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 110.819 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.6 Cg_endo -66.48 -34.15 34.77 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.262 1.138 . . . . 0.0 109.164 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.52 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 2.2 t -62.77 -28.02 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.274 0.559 . . . . 0.0 109.606 178.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.532 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 30.3 mt -83.62 -14.76 51.25 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.168 -0.958 . . . . 0.0 109.479 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 21.5 mt -78.8 -29.01 44.65 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 37.0 m-80 -58.13 -28.29 64.54 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.036 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 3.6 p -62.2 -13.01 23.25 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.638 -0.664 . . . . 0.0 109.648 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 75.6 13.63 2.93 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.445 0.64 . . . . 0.0 109.864 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.538 ' CD1' ' HB2' ' A' ' 80' ' ' ALA . 16.4 mt -85.92 158.59 55.92 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.498 -0.751 . . . . 0.0 109.834 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.5 Cg_endo -73.22 157.3 50.39 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 O-C-N 124.088 1.573 . . . . 0.0 110.265 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.0 t -58.28 -10.92 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.42 -0.8 . . . . 0.0 111.109 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -73.85 -41.96 61.49 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.83 -1.169 . . . . 0.0 108.213 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.566 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 12.9 mm -61.95 -44.55 99.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.532 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 11.1 mt -62.17 -20.79 64.51 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.2 -28.51 36.64 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.556 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 0.3 OUTLIER -97.68 -57.21 2.29 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.529 -0.983 . . . . 0.0 109.665 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.563 HG13 ' CG2' ' A' ' 77' ' ' VAL . 3.8 t -47.42 -34.92 3.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.204 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.542 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 7.5 t-105 -75.11 -58.98 2.95 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.979 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.561 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 2.9 pt-20 -47.21 -46.22 23.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.621 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.653 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 7.6 mt -76.52 -12.31 60.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.46 -0.775 . . . . 0.0 109.456 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.6 t -96.55 -35.06 11.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.362 -0.836 . . . . 0.0 110.002 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.581 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 11.4 t0 -77.69 86.09 3.99 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.434 HG21 HD11 ' A' ' 59' ' ' ILE . 36.1 mm -50.35 -32.59 9.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.647 -0.658 . . . . 0.0 111.16 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 53.8 p30 -103.65 -15.1 15.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.933 -1.105 . . . . 0.0 111.256 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 1.4 m80 63.88 43.85 5.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.845 -1.159 . . . . 0.0 109.726 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.468 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 6.2 p-10 -107.17 15.69 24.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 110.588 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.91 8.35 87.74 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.584 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 3.6 mtt -142.07 160.82 39.46 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.362 -1.081 . . . . 0.0 110.478 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.525 ' CD1' HG12 ' A' ' 36' ' ' VAL . 47.4 mt -127.04 120.37 28.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 110.79 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.582 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 8.7 t0 -69.57 164.53 23.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.947 -1.095 . . . . 0.0 109.326 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.52 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 8.9 ptm180 -45.81 -34.46 3.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 110.468 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' OD1' ' HG3' ' A' ' 67' ' ' ARG . 10.2 m-20 -85.81 -32.57 21.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.102 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 16.1 mt-10 -71.13 -42.75 68.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.94 . . . . 0.0 108.819 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.579 ' CE2' ' SD ' ' A' ' 74' ' ' MET . 42.3 t80 -59.22 -32.56 70.07 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.444 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -57.32 -48.37 79.14 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.768 0.794 . . . . 0.0 110.161 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.527 HG12 ' CD1' ' A' ' 94' ' ' LEU . 87.5 t -59.8 -26.61 35.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.645 -0.659 . . . . 0.0 110.739 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.542 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -86.97 -5.62 59.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.159 -0.963 . . . . 0.0 111.723 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.59 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 14.4 mmm -90.45 -41.24 11.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.604 -1.31 . . . . 0.0 110.096 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CE2' HD13 ' A' ' 94' ' ' LEU . 2.3 p90 -79.38 -17.45 54.39 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.868 -1.133 . . . . 0.0 108.477 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.458 ' HB3' HG23 ' A' ' 53' ' ' VAL . 6.8 mt -82.57 -20.88 35.65 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.563 ' CG2' HG13 ' A' ' 53' ' ' VAL . 77.7 t -90.89 -41.83 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.565 -0.709 . . . . 0.0 109.723 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -71.32 -21.0 62.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.385 -0.822 . . . . 0.0 110.126 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 7.6 t -80.82 -15.14 57.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.268 -0.895 . . . . 0.0 109.087 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.538 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . . . -90.17 -13.61 35.26 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.52 -0.737 . . . . 0.0 109.38 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 1.7 mt -90.5 -33.78 15.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.0 109.222 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 . . . . . 0 C--N 1.301 -1.539 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.663 179.664 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.502 HG23 ' CG2' ' A' ' 53' ' ' VAL . 61.5 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.604 0.24 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.492 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 51.4 Cg_endo -86.74 -168.66 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.979 1.515 . . . . 0.0 110.159 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.556 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 10.7 mtp -113.65 6.95 17.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.335 -0.853 . . . . 0.0 110.684 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.506 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.1 m -114.24 104.43 12.08 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.442 -1.303 . . . . 0.0 112.135 -177.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.653 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -60.24 107.94 1.23 Allowed Pre-proline 0 C--N 1.288 -2.071 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.379 178.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.562 ' HG2' ' CD2' ' A' ' 94' ' ' LEU . 41.1 Cg_endo -66.36 167.36 18.79 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.855 1.45 . . . . 0.0 109.946 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.67 -12.46 29.04 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.945 1.497 . . . . 0.0 111.628 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 8' ' ' ALA . . . -87.07 2.53 49.42 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.073 -1.017 . . . . 0.0 110.113 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.562 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 3.0 mm? -107.69 -0.37 21.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.145 -0.972 . . . . 0.0 111.052 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 N--CA 1.493 1.7 0 O-C-N 120.964 -1.085 . . . . 0.0 110.695 -179.436 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.606 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.7 t90 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.079 0.466 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.554 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -47.21 -30.36 2.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.009 . . . . 0.0 110.16 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.606 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 72.5 t -102.3 149.69 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.397 -0.814 . . . . 0.0 109.857 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.525 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -126.74 171.91 7.34 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.422 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 10' ' ' LYS . 36.8 Cg_endo -62.91 -34.18 72.47 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.741 1.39 . . . . 0.0 110.592 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.402 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 9.6 mt-10 -72.98 -35.64 66.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 109.62 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -83.19 -41.29 18.62 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HG3' ' CB ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -70.03 -15.19 62.97 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 12' ' ' GLU . . . -67.18 -40.82 86.63 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.9 ptpt -75.79 -25.87 56.79 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.609 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -72.61 -33.75 66.89 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.7 -10.9 60.16 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.41 0.624 . . . . 0.0 109.7 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.58 -35.91 14.74 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.552 HG23 ' CE1' ' A' ' 70' ' ' PHE . 19.8 mt -76.73 -34.78 23.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -70.81 -33.56 70.82 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.5 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.9 t0 -88.97 -3.11 58.82 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.546 -0.721 . . . . 0.0 109.892 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.1 m -85.65 -13.73 47.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.084 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.607 ' O ' ' CB ' ' A' ' 25' ' ' SER . 4.4 mt -100.11 -11.7 20.27 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.607 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 t 85.6 99.41 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.152 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.3 Cg_endo -74.87 148.79 36.41 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 O-C-N 124.337 1.704 . . . . 0.0 110.807 -178.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 60.2 t -117.95 107.87 23.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 121.746 -0.596 . . . . 0.0 109.617 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 6.0 t30 56.9 17.5 3.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.359 -0.838 . . . . 0.0 109.421 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 96.96 36.0 5.14 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 94.7 m-85 -151.28 160.08 44.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -1.129 . . . . 0.0 110.877 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.593 ' CD1' ' CD2' ' A' ' 70' ' ' PHE . 37.8 mt -130.81 129.45 42.4 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.515 ' CA ' ' HE1' ' A' ' 64' ' ' MET . 12.2 p -78.23 139.97 38.91 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.854 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.04 -28.78 0.52 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 32' ' ' SER . 13.1 t70 -61.54 -11.23 10.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -1.142 . . . . 0.0 110.269 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' A' ' 24' ' ' LEU . 17.9 mtpp -116.27 -34.83 4.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -0.975 . . . . 0.0 109.02 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.501 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 98.0 t -84.34 -36.31 11.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.401 0.619 . . . . 0.0 109.694 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.627 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.3 tttt -48.37 -47.86 67.44 Favored Pre-proline 0 N--CA 1.487 1.384 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.158 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.7 Cg_endo -67.77 -30.74 33.5 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.407 1.214 . . . . 0.0 109.018 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.555 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 2.5 t -73.99 -9.43 12.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.798 -0.564 . . . . 0.0 109.584 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.534 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 82.4 mt -100.18 -15.92 17.96 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.139 -0.976 . . . . 0.0 108.515 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 38' ' ' PRO . 7.0 mt -89.95 -37.31 14.45 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.549 -0.72 . . . . 0.0 110.16 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 6.6 p30 -58.68 -16.45 16.37 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.153 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.487 ' HB3' HG11 ' A' ' 77' ' ' VAL . 0.8 OUTLIER -73.71 -1.83 20.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.374 -0.829 . . . . 0.0 109.871 179.275 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 68.69 14.98 9.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.235 -0.916 . . . . 0.0 110.207 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.54 HD13 ' CD2' ' A' ' 81' ' ' LEU . 15.4 mt -91.79 155.94 43.09 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.07 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.516 ' HG2' HG12 ' A' ' 49' ' ' ILE . 40.8 Cg_endo -73.23 154.24 51.54 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.889 1.468 . . . . 0.0 110.466 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.0 t -58.53 -10.6 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.32 -0.863 . . . . 0.0 110.777 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -39.51 68.58 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.887 -1.133 . . . . 0.0 107.987 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.516 HG12 ' HG2' ' A' ' 46' ' ' PRO . 30.3 mm -64.96 -43.61 96.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 3.7 mt -63.89 -14.47 53.66 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.365 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 55' ' ' GLU . . . -83.37 -36.1 15.48 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 53' ' ' VAL . 5.1 mtm-85 -94.23 -52.34 4.41 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.598 -0.942 . . . . 0.0 109.984 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' A' ' 57' ' ' SER . 24.3 t -44.18 -50.29 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.59 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.547 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 7.2 t-105 -66.32 -57.68 6.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 0.0 110.174 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.494 ' HG2' ' HG ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER -53.84 -38.52 64.73 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.927 -1.108 . . . . 0.0 109.127 -179.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.527 HD21 ' N ' ' A' ' 90' ' ' LEU . 94.4 mt -81.33 -14.88 56.8 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.701 -0.624 . . . . 0.0 109.386 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 10.7 m -97.78 -35.34 10.57 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.365 -0.834 . . . . 0.0 110.159 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.605 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 16.9 t0 -75.32 69.39 2.13 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 58' ' ' ASP . 35.8 mm -35.2 -31.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.056 0.455 . . . . 0.0 111.0 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.541 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 14.7 p-10 -104.73 -16.66 14.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.055 -1.028 . . . . 0.0 111.333 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.605 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER 58.2 30.59 19.64 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.836 -1.165 . . . . 0.0 109.48 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.479 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 2.5 p-10 -84.32 -11.72 55.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.414 -0.804 . . . . 0.0 110.053 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.431 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 116.82 5.34 15.76 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.583 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 3.5 mtp -150.05 160.8 43.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -1.175 . . . . 0.0 110.164 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 58' ' ' ASP . 16.8 mt -115.57 115.24 26.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.077 -1.015 . . . . 0.0 109.53 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.585 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 3.7 t70 -69.15 171.11 8.83 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.011 -1.055 . . . . 0.0 109.809 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 4.4 ptm180 -46.18 -42.43 14.05 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.63 -0.669 . . . . 0.0 110.658 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.468 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -78.71 -33.98 46.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.0 110.345 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.497 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 28.0 mt-10 -74.53 -43.18 57.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.973 . . . . 0.0 109.2 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.593 ' CD2' ' CD1' ' A' ' 31' ' ' LEU . 18.3 t80 -61.0 -21.58 63.71 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.483 -0.761 . . . . 0.0 109.327 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.405 ' CB ' ' HG3' ' A' ' 14' ' ' LYS . . . -73.08 -40.86 64.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.345 -0.847 . . . . 0.0 109.45 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.437 ' O ' ' CG ' ' A' ' 76' ' ' LEU . 60.1 t -63.2 -27.04 42.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.513 0.673 . . . . 0.0 109.348 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.527 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -90.83 -4.84 56.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.528 -0.733 . . . . 0.0 110.862 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.56 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 11.3 mmt -84.59 -50.21 7.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.997 -1.065 . . . . 0.0 109.603 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.583 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 1.9 p90 -72.85 -31.62 64.89 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.567 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 9.9 mt -61.46 -31.22 71.17 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 46.0 t -92.16 -42.09 13.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.825 -0.547 . . . . 0.0 110.574 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.7 OUTLIER -74.36 -40.42 62.12 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.821 -179.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 69.5 m -76.46 -14.78 60.03 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.026 -1.047 . . . . 0.0 109.139 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 76' ' ' LEU . . . -77.66 -11.44 59.87 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 77' ' ' VAL . 4.0 mt -91.12 -50.1 6.03 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.615 0.722 . . . . 0.0 109.949 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 N--CA 1.493 1.722 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.518 -178.225 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.534 HG23 ' CG2' ' A' ' 53' ' ' VAL . 13.4 t . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 86' ' ' VAL . 44.0 Cg_endo -87.52 -162.17 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.877 1.461 . . . . 0.0 109.73 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.6 mtt -129.31 12.4 6.0 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.26 -0.9 . . . . 0.0 110.945 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 90' ' ' LEU . 22.8 t -165.95 23.54 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.931 -1.106 . . . . 0.0 111.279 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.533 ' CD2' ' HB3' ' A' ' 94' ' ' LEU . 2.1 mt 54.89 116.81 0.01 OUTLIER Pre-proline 0 C--N 1.284 -2.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.012 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.581 ' HG2' ' CD2' ' A' ' 94' ' ' LEU . 44.3 Cg_endo -72.77 175.02 10.88 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.597 1.314 . . . . 0.0 109.16 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 50.1 Cg_endo -74.34 -19.9 19.09 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.632 1.332 . . . . 0.0 111.67 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 8' ' ' ALA . . . -90.29 28.44 1.44 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.97 -1.081 . . . . 0.0 109.479 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.583 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -127.06 -25.69 3.25 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.822 -178.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.46 ' O ' HG21 ' A' ' 95' ' ' VAL . 27.3 m . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.051 -1.03 . . . . 0.0 111.036 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.518 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.1 t90 . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.154 0.502 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.556 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -40.62 -27.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 110.525 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.518 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 91.1 t -102.9 138.74 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.87 . . . . 0.0 109.938 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.536 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -97.15 -179.91 0.98 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.314 -0.866 . . . . 0.0 110.434 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.3 Cg_endo -69.23 -35.51 14.06 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.934 1.492 . . . . 0.0 110.049 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -75.54 -28.41 59.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.375 -0.828 . . . . 0.0 109.835 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.569 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -83.29 -37.17 23.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.209 -0.932 . . . . 0.0 108.59 178.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 13.8 tptp -69.73 -20.16 63.52 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.08 -44.07 63.85 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.583 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 6.5 ptpt -74.51 -24.17 58.94 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.583 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.6 m-30 -74.25 -35.61 63.82 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -76.8 -9.73 58.88 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.302 0.572 . . . . 0.0 110.031 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -93.74 -34.97 13.01 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.566 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 37.6 mt -78.04 -30.18 15.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.588 ' CD2' HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -74.44 -39.53 62.51 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.555 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.501 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 32.6 t70 -88.59 4.39 47.09 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.611 -0.681 . . . . 0.0 109.831 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -90.54 -15.63 30.31 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.769 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.575 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -97.75 -8.0 29.5 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 84.48 98.21 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.4 Cg_endo -74.27 146.63 36.17 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.056 1.556 . . . . 0.0 110.762 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 27.3 t -116.33 98.57 6.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.486 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 64.97 22.44 12.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.359 -0.838 . . . . 0.0 109.393 -179.124 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 91.97 32.35 8.53 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.521 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 93.8 m-85 -150.23 152.76 35.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.407 -1.055 . . . . 0.0 111.145 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.588 HD13 ' CD2' ' A' ' 21' ' ' PHE . 32.5 mt -124.7 131.85 53.43 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 33' ' ' GLY . 93.9 p -78.19 137.39 38.13 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.272 -0.893 . . . . 0.0 110.43 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.57 -30.86 0.95 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -60.47 -16.24 34.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -1.082 . . . . 0.0 110.318 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.535 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 21.3 mtpp -108.38 -35.3 6.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 109.121 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.529 HG13 ' CD1' ' A' ' 65' ' ' LEU . 96.8 t -82.77 -31.12 9.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.597 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -50.17 -52.45 53.55 Favored Pre-proline 0 C--N 1.305 -1.363 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.897 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.6 Cg_endo -64.92 -31.44 56.52 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.581 1.306 . . . . 0.0 109.246 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.584 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 4.3 t -74.87 -10.66 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.447 0.642 . . . . 0.0 109.772 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.522 ' CD2' HG22 ' A' ' 77' ' ' VAL . 78.5 mt -100.24 -15.51 18.06 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 37' ' ' LYS . 8.4 mt -88.3 -44.58 10.71 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.569 -0.707 . . . . 0.0 109.486 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.584 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -47.83 -25.33 1.25 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.722 -1.191 . . . . 0.0 108.62 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.57 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 12.5 m -61.67 -12.15 14.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.508 -0.745 . . . . 0.0 110.032 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 43' ' ' SER . 3.5 tptp 74.1 18.84 3.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.231 -0.918 . . . . 0.0 109.956 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.527 HD12 ' CB ' ' A' ' 80' ' ' ALA . 15.4 mt -100.1 158.36 32.16 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 110.087 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.536 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 41.5 Cg_endo -73.08 156.54 51.7 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 123.934 1.491 . . . . 0.0 110.647 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 t -58.3 -10.85 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.662 -0.649 . . . . 0.0 110.88 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.58 -41.32 60.72 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.866 -1.146 . . . . 0.0 108.432 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.536 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 11.8 mm -64.24 -44.9 97.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 40' ' ' LEU . 3.8 mt -66.98 -16.99 64.71 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.711 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.29 -32.84 15.56 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.374 -1.891 . . . . 0.0 108.374 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.481 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -92.5 -53.67 4.11 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.517 -0.99 . . . . 0.0 109.526 179.321 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 57' ' ' SER . 32.5 t -47.83 -32.08 2.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.25 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.529 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 8.2 t-105 -74.11 -59.29 2.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.841 . . . . 0.0 110.084 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.55 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 5.0 pt-20 -47.67 -45.62 28.34 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.501 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.592 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 2.7 mt -75.91 -11.74 60.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.579 -0.7 . . . . 0.0 109.57 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.555 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 2.8 t -99.28 -36.11 9.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.634 -0.666 . . . . 0.0 110.758 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.457 ' HA ' HD22 ' A' ' 65' ' ' LEU . 26.9 t0 -82.61 86.63 6.79 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.483 -0.76 . . . . 0.0 109.454 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.47 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 32.1 mm -51.55 -36.24 17.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.75 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 3.5 m-20 -90.33 -17.05 28.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.538 -0.726 . . . . 0.0 110.566 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 33.1 p80 40.25 39.77 0.71 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.816 0.817 . . . . 0.0 109.23 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -98.17 -9.65 25.39 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.754 -0.591 . . . . 0.0 110.192 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 126.57 4.39 6.29 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 6.0 mtp -149.54 160.72 43.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.093 -1.24 . . . . 0.0 110.491 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.529 ' CD1' HG13 ' A' ' 36' ' ' VAL . 34.1 mt -112.49 112.25 23.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.583 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.528 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 17.3 t0 -69.62 166.93 17.99 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.895 -1.128 . . . . 0.0 110.106 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.552 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -42.16 -44.45 3.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.528 -0.732 . . . . 0.0 111.012 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 8.7 p-10 -78.02 -43.01 30.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.368 -0.832 . . . . 0.0 110.162 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.528 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 33.7 mt-10 -61.64 -48.99 78.34 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.656 -0.653 . . . . 0.0 109.779 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.581 ' CE1' ' SD ' ' A' ' 74' ' ' MET . 43.5 t80 -58.94 -26.22 64.21 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.395 -0.815 . . . . 0.0 109.373 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -67.22 -45.99 75.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.647 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.471 HG11 HD13 ' A' ' 94' ' ' LEU . 88.3 t -60.45 -23.04 27.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.542 -0.723 . . . . 0.0 110.018 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.555 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -89.73 -5.33 57.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.291 -0.88 . . . . 0.0 110.932 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.581 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 1.6 mmm -89.33 -44.86 9.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.999 -1.063 . . . . 0.0 110.038 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.554 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 2.5 p90 -76.24 -25.22 54.8 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 72' ' ' VAL . 4.8 mt -69.99 -28.33 65.44 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.537 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 53.6 t -89.35 -29.59 5.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.549 ' HA ' HD11 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -79.53 -25.08 41.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.428 -0.795 . . . . 0.0 110.524 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -87.08 -10.65 52.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 110.172 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.527 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -85.54 -20.16 30.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.354 -0.841 . . . . 0.0 109.658 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.57 ' CD2' ' O ' ' A' ' 43' ' ' SER . 1.3 mt -92.35 -36.47 13.14 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.556 0.693 . . . . 0.0 110.694 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 . . . . . 0 C--N 1.299 -1.622 0 C-N-CA 119.525 -0.87 . . . . 0.0 108.792 -179.361 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' A' ' 52' ' ' ARG . 24.3 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.705 0.288 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.464 ' O ' HD12 ' A' ' 56' ' ' LEU . 47.0 Cg_endo -89.24 -164.94 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.935 1.492 . . . . 0.0 109.344 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.498 ' CB ' ' OE2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -123.61 6.12 8.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.368 -0.833 . . . . 0.0 110.253 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.488 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 55.1 m -105.65 98.44 8.13 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 119.114 -1.034 . . . . 0.0 111.294 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.592 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -54.96 107.14 0.78 Allowed Pre-proline 0 C--N 1.293 -1.866 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.753 179.256 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.541 ' HG2' ' CD2' ' A' ' 94' ' ' LEU . 42.5 Cg_endo -68.75 162.69 40.17 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.995 1.523 . . . . 0.0 109.984 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.97 -13.35 34.04 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.825 1.434 . . . . 0.0 111.149 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 8' ' ' ALA . . . -89.04 19.92 3.92 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.011 -1.055 . . . . 0.0 109.308 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.556 HD23 ' CB ' ' A' ' 8' ' ' ALA . 1.9 mm? -121.03 -13.61 8.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.469 -0.769 . . . . 0.0 110.451 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 0.0 111.119 -178.927 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.595 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.8 t90 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 121.362 0.601 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -59.24 -25.72 64.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 110.285 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.595 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 18.8 t -95.07 160.35 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.575 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -108.32 171.32 4.63 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.069 -1.019 . . . . 0.0 110.491 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.11 -34.48 10.17 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.231 1.648 . . . . 0.0 109.53 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -78.76 -28.98 44.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.578 -0.702 . . . . 0.0 109.349 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.539 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 1.6 m-20 -81.11 -34.22 32.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.456 -0.777 . . . . 0.0 108.913 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 67' ' ' ARG . 16.2 tptt -72.35 -19.98 61.55 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.604 0.716 . . . . 0.0 109.225 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.87 -41.7 61.81 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.596 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.49 -26.09 60.75 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.596 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.3 m-30 -74.34 -38.34 63.28 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 3.1 t70 -73.17 -12.35 60.85 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.279 0.561 . . . . 0.0 110.207 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.61 -32.77 13.27 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.437 ' O ' ' HG ' ' A' ' 24' ' ' LEU 0.253 42.3 mt -78.34 -28.76 14.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.589 ' CD2' HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.7 -37.77 65.08 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 1.6 t70 -90.29 1.65 56.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.697 -0.627 . . . . 0.0 109.926 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 t -91.89 -2.74 56.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 108.658 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.57 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -112.7 -3.51 14.25 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.47 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.6 t 80.3 96.9 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.9 Cg_endo -71.29 147.31 52.94 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 O-C-N 124.427 1.751 . . . . 0.0 110.548 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 43.0 t -118.05 101.66 12.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 18.3 t30 57.98 30.78 19.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.859 . . . . 0.0 109.624 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.488 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 85.79 34.72 12.69 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.586 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 93.7 m-85 -151.11 153.83 35.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -1.162 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.589 HD13 ' CD2' ' A' ' 21' ' ' PHE . 24.2 mt -124.68 122.95 38.95 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.675 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.541 ' CA ' ' HE1' ' A' ' 64' ' ' MET . 0.7 OUTLIER -72.92 139.99 47.18 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.612 0.72 . . . . 0.0 111.108 -178.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -46.39 -25.3 1.94 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -58.55 -33.67 70.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -1.104 . . . . 0.0 110.281 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.542 ' HD3' ' CA ' ' A' ' 31' ' ' LEU . 5.1 ptmt -99.96 -28.19 13.21 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.874 0.845 . . . . 0.0 109.714 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.54 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 72.1 t -80.73 -48.37 19.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 CA-C-O 121.444 0.64 . . . . 0.0 109.629 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.591 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.25 -51.98 7.74 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.462 -0.774 . . . . 0.0 110.493 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.6 Cg_endo -66.28 -33.06 40.36 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 108.889 -1.235 . . . . 0.0 108.889 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.594 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 2.7 t -72.36 -12.23 15.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.497 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 90.4 mt -97.85 -16.87 19.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 92.5 mt -78.92 -36.41 41.92 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.56 -0.713 . . . . 0.0 109.286 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -46.42 -23.87 0.43 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.552 179.119 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.559 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -73.93 6.34 3.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.566 -0.709 . . . . 0.0 111.091 -179.405 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.26 15.36 1.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.755 -1.215 . . . . 0.0 110.051 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.5 HD21 ' HD2' ' A' ' 46' ' ' PRO . 15.3 mt -93.59 158.76 36.18 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.117 -0.99 . . . . 0.0 109.856 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HD2' HG13 ' A' ' 49' ' ' ILE . 41.4 Cg_endo -72.87 157.39 51.66 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.978 1.515 . . . . 0.0 110.294 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.6 t -59.66 -11.24 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 110.706 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.03 -36.49 69.67 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.915 -1.116 . . . . 0.0 108.18 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.521 HG13 ' HD2' ' A' ' 46' ' ' PRO . 32.6 mm -68.51 -45.2 82.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.497 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 3.6 mt -65.55 -20.39 66.31 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . -85.2 -30.02 26.43 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.511 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 16.0 ttm-85 -93.03 -55.43 3.35 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.467 -1.019 . . . . 0.0 109.562 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.52 HG23 ' HB3' ' A' ' 76' ' ' LEU . 39.4 t -49.76 -38.45 13.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.103 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.493 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 8.6 t-105 -64.93 -56.67 11.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 109.3 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.595 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 68.5 mm-40 -44.52 -55.3 5.23 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.484 -0.76 . . . . 0.0 109.977 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.626 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 4.7 mt -70.75 -10.5 59.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 0.0 109.913 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.534 ' OG ' ' CA ' ' A' ' 73' ' ' ALA . 17.4 m -96.15 -37.43 10.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 110.118 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.575 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 13.5 t0 -77.61 70.48 3.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.358 -0.839 . . . . 0.0 109.27 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.51 HG22 HD11 ' A' ' 59' ' ' ILE . 45.2 mm -39.95 -31.73 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.637 -0.664 . . . . 0.0 110.789 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.49 ' OD2' ' HB3' ' A' ' 62' ' ' ASP . 0.6 OUTLIER -98.79 -23.48 15.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.369 -0.832 . . . . 0.0 110.6 -178.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 55' ' ' GLU . 90.9 m-70 57.41 49.62 12.68 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.189 -0.944 . . . . 0.0 110.545 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.49 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 5.7 p-10 -111.97 0.99 16.22 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.041 -1.037 . . . . 0.0 110.286 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.459 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 112.43 2.43 26.04 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.541 ' HE1' ' CA ' ' A' ' 32' ' ' SER . 5.0 mtp -149.1 160.06 43.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.991 -1.299 . . . . 0.0 110.616 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.467 HD21 ' HA ' ' A' ' 58' ' ' ASP . 70.8 mt -111.69 115.24 28.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.551 -0.718 . . . . 0.0 109.948 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.586 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 7.0 t0 -69.18 164.18 23.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.892 -1.13 . . . . 0.0 109.733 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.532 ' O ' ' NZ ' ' A' ' 14' ' ' LYS . 1.7 ptt180 -37.76 -42.28 0.57 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.677 -0.64 . . . . 0.0 111.512 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.522 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -84.74 -33.02 23.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.211 -0.931 . . . . 0.0 110.888 -179.202 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.5 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 24.3 mt-10 -69.72 -42.65 73.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 109.368 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.577 ' CE1' ' SD ' ' A' ' 74' ' ' MET . 50.5 t80 -64.14 -28.88 70.06 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.559 -0.713 . . . . 0.0 109.178 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -61.73 -48.95 78.41 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.774 0.797 . . . . 0.0 109.964 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.511 ' CG1' HD13 ' A' ' 94' ' ' LEU . 70.7 t -59.25 -24.03 26.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.685 -0.634 . . . . 0.0 110.424 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.534 ' CA ' ' OG ' ' A' ' 57' ' ' SER . . . -86.71 -8.7 57.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.156 -0.965 . . . . 0.0 112.003 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.579 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 12.0 mmm -90.08 -40.5 12.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.639 -1.288 . . . . 0.0 110.489 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.511 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.6 p90 -78.19 -19.02 54.72 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.789 -1.165 . . . . 0.0 108.374 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.52 ' HB3' HG23 ' A' ' 53' ' ' VAL . 9.2 mt -80.91 -23.63 38.82 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.468 0.652 . . . . 0.0 109.48 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.544 ' CG1' ' OG ' ' A' ' 43' ' ' SER . 70.1 t -91.65 -32.16 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.529 -0.732 . . . . 0.0 110.3 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.484 ' HA ' HD11 ' A' ' 81' ' ' LEU . 1.2 m-85 -80.04 -24.18 40.91 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.184 -0.947 . . . . 0.0 110.417 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 79.3 m -86.66 -13.76 44.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.256 -0.903 . . . . 0.0 109.395 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.454 ' HB2' HD12 ' A' ' 45' ' ' LEU . . . -76.69 -18.95 58.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.08 -1.012 . . . . 0.0 108.743 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.559 ' CD2' ' O ' ' A' ' 43' ' ' SER . 1.9 mt -92.41 -48.63 6.55 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.516 0.674 . . . . 0.0 111.471 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' A' ' 82' ' ' GLU . 3.4 tp10 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 112.359 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 72.1 t . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.605 0.24 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.478 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 48.2 Cg_endo -80.43 -173.83 2.01 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.756 1.398 . . . . 0.0 109.617 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.511 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 20.1 mtm -114.68 20.98 14.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 0.0 110.347 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.502 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 69.0 m -111.18 103.89 12.36 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.696 -1.201 . . . . 0.0 111.434 -178.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.626 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 2.1 mt -59.16 108.15 1.24 Allowed Pre-proline 0 C--N 1.293 -1.856 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.734 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 89' ' ' SER . 43.2 Cg_endo -68.77 141.9 50.85 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.948 1.499 . . . . 0.0 110.549 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.64 -4.54 14.83 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.027 1.54 . . . . 0.0 110.72 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -92.9 8.53 39.29 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.397 -0.814 . . . . 0.0 109.357 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.563 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -127.92 -7.8 5.5 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.589 0.709 . . . . 0.0 110.136 -178.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.491 1.58 0 O-C-N 120.888 -1.133 . . . . 0.0 110.721 -179.791 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.502 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.8 t90 . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -40.64 -27.49 0.05 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 0.0 109.889 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.502 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 10.0 t -103.73 128.26 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.424 -0.797 . . . . 0.0 109.534 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.508 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.0 mttt -82.2 178.98 2.11 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.933 . . . . 0.0 110.156 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.6 Cg_endo -71.24 -35.12 9.01 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.01 1.532 . . . . 0.0 109.908 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 2.0 pt-20 -81.07 -19.89 42.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.423 -0.798 . . . . 0.0 109.446 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.505 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 0.3 OUTLIER -81.91 -39.89 23.13 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.202 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.445 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -78.01 -14.85 59.36 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.82 -37.49 55.6 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.604 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -77.24 -22.82 51.63 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.604 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 13.3 m-30 -77.32 -33.71 55.53 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -70.78 -8.82 55.21 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.319 0.58 . . . . 0.0 110.004 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.57 -34.64 14.66 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.505 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 34.0 mt -81.78 -30.11 10.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.575 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -74.14 -34.76 63.97 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.498 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.6 t70 -89.18 -4.5 58.22 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.676 -0.64 . . . . 0.0 110.213 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.59 -2.69 58.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 108.986 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.572 ' O ' ' CB ' ' A' ' 25' ' ' SER . 3.2 mt -107.14 -12.15 15.46 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.2 t 83.89 87.94 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 44.9 Cg_endo -71.21 150.92 60.19 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 O-C-N 124.739 1.915 . . . . 0.0 110.331 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 28.7 t -116.05 107.48 22.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.65 -0.656 . . . . 0.0 109.802 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 14.9 t30 55.81 21.06 4.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.379 -0.825 . . . . 0.0 109.52 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 96.16 37.56 4.84 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 92.5 m-85 -150.89 159.94 44.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -1.141 . . . . 0.0 111.227 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.521 HD13 ' CD2' ' A' ' 21' ' ' PHE . 27.0 mt -137.77 129.68 28.68 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 2.7 p -75.01 137.88 41.83 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.421 -0.8 . . . . 0.0 110.871 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -43.91 -25.03 0.57 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' SER . 80.1 m-20 -65.15 -16.21 63.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.284 -1.127 . . . . 0.0 109.855 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 21.8 mtpp -105.12 -38.92 6.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.128 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.528 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 88.7 t -76.39 -33.18 22.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.544 0.688 . . . . 0.0 109.208 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.57 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.7 tttp -48.79 -56.04 17.05 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.724 -0.61 . . . . 0.0 110.228 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.5 Cg_endo -64.93 -28.4 58.22 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.73 1.384 . . . . 0.0 109.093 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.595 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 3.5 t -78.71 -11.01 13.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.3 0.571 . . . . 0.0 109.932 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.525 ' CD1' HG11 ' A' ' 36' ' ' VAL . 71.7 mt -101.08 -18.22 16.33 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.185 -0.947 . . . . 0.0 108.554 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 38' ' ' PRO . 15.3 mt -85.14 -41.62 15.51 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.615 -0.678 . . . . 0.0 109.717 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -50.19 -22.72 1.82 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.694 -1.202 . . . . 0.0 108.807 179.317 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.541 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 35.1 m -64.15 -7.27 8.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.623 -0.673 . . . . 0.0 110.615 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.4 OUTLIER 72.82 10.07 5.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.219 -0.925 . . . . 0.0 109.932 -179.605 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.539 HD12 ' CG2' ' A' ' 49' ' ' ILE . 13.0 mt -90.41 158.82 42.76 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.401 -0.812 . . . . 0.0 110.14 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.563 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 41.8 Cg_endo -75.72 167.21 26.82 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.992 1.522 . . . . 0.0 109.908 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.432 ' O ' HG11 ' A' ' 47' ' ' VAL . 43.8 t -69.2 -5.81 5.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.419 -0.801 . . . . 0.0 110.508 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.89 -39.79 34.07 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.183 -0.948 . . . . 0.0 108.547 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.563 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 27.8 mm -66.96 -44.08 88.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 40' ' ' LEU . 9.5 mt -66.32 -17.0 64.5 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.072 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.5 -29.75 20.85 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.558 ' HD3' ' CG ' ' A' ' 88' ' ' MET . 0.3 OUTLIER -93.57 -55.61 3.21 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.509 -0.994 . . . . 0.0 109.374 179.493 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.537 ' O ' ' HB3' ' A' ' 57' ' ' SER . 36.5 t -49.94 -55.33 5.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.535 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 6.6 t-105 -50.37 -56.85 9.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.517 -0.74 . . . . 0.0 110.37 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -49.97 -45.96 52.0 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.415 -179.176 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 2.5 mt -76.81 -8.57 57.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.659 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.537 ' HB3' ' O ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -99.34 -39.86 8.2 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.397 -0.814 . . . . 0.0 109.663 179.194 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.531 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 30.4 t0 -75.52 86.02 2.62 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.494 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 30.6 mm -49.36 -34.23 7.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.128 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 35.9 p-10 -103.47 -9.97 18.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.998 -1.064 . . . . 0.0 111.354 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.531 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 51.3 m-70 55.63 41.62 30.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.953 -1.092 . . . . 0.0 109.517 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 3.4 p-10 -101.34 16.24 26.23 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.622 -0.674 . . . . 0.0 110.133 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.93 10.9 84.46 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.567 ' HG2' ' HA ' ' A' ' 32' ' ' SER . 5.0 mtt -142.31 160.3 40.53 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.389 -1.065 . . . . 0.0 110.638 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.514 ' CD1' HG13 ' A' ' 36' ' ' VAL . 44.0 mt -126.19 119.19 26.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.389 -0.82 . . . . 0.0 109.836 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 4.7 t0 -73.9 166.54 23.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.81 -1.181 . . . . 0.0 109.685 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.524 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -42.22 -46.07 4.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.227 -0.92 . . . . 0.0 110.229 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.46 -46.76 46.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.523 -0.736 . . . . 0.0 110.342 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.494 ' OE1' ' N ' ' A' ' 59' ' ' ILE . 14.4 mt-10 -60.56 -41.65 94.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.383 -0.823 . . . . 0.0 109.34 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.575 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 18.8 t80 -60.71 -30.13 69.77 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.1 93.25 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.782 0.801 . . . . 0.0 110.046 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.542 HG11 ' CD1' ' A' ' 94' ' ' LEU . 63.4 t -61.11 -28.58 44.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.591 0.71 . . . . 0.0 110.289 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 57' ' ' SER . . . -84.93 -6.93 59.34 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.478 -0.764 . . . . 0.0 111.559 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.594 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 9.4 mmm -90.23 -43.08 10.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.307 -1.496 . . . . 0.0 110.465 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.527 ' CZ ' HD12 ' A' ' 94' ' ' LEU . 2.9 p90 -76.92 -15.37 59.69 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.985 -1.086 . . . . 0.0 108.683 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.506 ' HB3' HG23 ' A' ' 53' ' ' VAL . 10.0 mt -85.3 -25.62 27.08 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.476 -0.765 . . . . 0.0 108.979 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 73' ' ' ALA . 19.0 t -91.06 -28.51 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.006 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.88 -25.18 37.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.247 -0.908 . . . . 0.0 110.365 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -85.49 -13.04 50.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.956 . . . . 0.0 109.519 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.524 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . . . -88.1 -9.54 52.94 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.384 -0.823 . . . . 0.0 109.119 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 1.5 mt -90.33 -45.26 9.14 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.825 0.822 . . . . 0.0 109.063 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.299 -1.608 0 C-N-CA 120.189 -0.605 . . . . 0.0 109.8 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.473 HG23 HG23 ' A' ' 53' ' ' VAL . 97.3 t . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.749 0.309 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.443 ' C ' ' HD3' ' A' ' 52' ' ' ARG . 45.9 Cg_endo -87.02 -171.89 0.83 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.021 1.537 . . . . 0.0 109.179 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.558 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 18.5 mtm -114.64 7.11 15.92 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.992 -1.067 . . . . 0.0 110.162 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.2 m -111.94 100.64 9.05 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.791 -1.163 . . . . 0.0 111.861 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.583 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -46.54 108.53 0.85 Allowed Pre-proline 0 C--N 1.289 -2.032 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.492 178.576 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.491 ' HD2' HD21 ' A' ' 94' ' ' LEU . 38.3 Cg_endo -64.75 146.58 88.71 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.899 1.473 . . . . 0.0 110.676 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.82 -11.61 27.84 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.161 1.611 . . . . 0.0 111.565 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -93.89 24.25 4.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.03 -1.044 . . . . 0.0 108.651 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.542 ' CD1' HG11 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -141.75 -3.33 1.14 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.797 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.492 1.655 0 O-C-N 120.803 -1.186 . . . . 0.0 110.665 -179.829 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.578 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 17.2 t90 . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -41.98 -26.97 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 110.089 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.578 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 79.1 t -109.99 124.74 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.0 109.913 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -86.15 174.36 5.67 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.322 -0.861 . . . . 0.0 110.36 -179.731 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.0 Cg_endo -66.19 -35.94 30.71 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.009 1.531 . . . . 0.0 109.787 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.39 -24.23 61.22 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.357 -0.84 . . . . 0.0 109.242 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -82.69 -42.08 18.54 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.27 -15.86 61.91 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.154 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' A' ' 11' ' ' PRO . . . -70.82 -33.34 70.59 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -82.33 -43.79 17.01 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.596 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 4.3 m-30 -61.68 -17.77 56.92 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -87.1 -18.1 31.29 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.802 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.455 ' O ' ' OG ' ' A' ' 23' ' ' SER . . . -90.77 -30.61 16.93 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.543 HG21 ' CE1' ' A' ' 70' ' ' PHE . 27.0 mt -79.62 -32.62 14.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.583 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -69.47 -41.33 76.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.51 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.8 t70 -86.75 2.69 47.88 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.332 0.587 . . . . 0.0 109.842 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 2.4 m -93.3 0.13 56.88 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.543 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -113.65 -0.62 14.26 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.468 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 p 77.23 89.9 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 CA-C-O 121.568 0.699 . . . . 0.0 109.119 -178.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 53.4 Cg_endo -74.21 146.99 36.95 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.113 1.586 . . . . 0.0 110.314 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 98.1 t -114.49 103.55 15.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER 61.89 21.52 12.35 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.189 -0.944 . . . . 0.0 108.933 -178.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.552 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 91.78 33.05 8.09 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 37.9 m-85 -142.74 156.94 45.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -1.108 . . . . 0.0 111.606 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.532 ' CD1' ' CD2' ' A' ' 21' ' ' PHE . 37.6 mt -133.35 132.67 41.55 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.564 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.1 OUTLIER -84.49 149.5 25.9 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.342 -0.849 . . . . 0.0 111.22 -178.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -50.68 -21.99 5.32 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.03 -8.63 55.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.236 . . . . 0.0 110.136 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 5.0 mtpp -114.25 -42.1 3.39 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.925 0.869 . . . . 0.0 109.148 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.531 HG13 ' CD1' ' A' ' 65' ' ' LEU . 46.7 t -80.73 -47.44 20.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.528 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.604 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.7 tttp -43.37 -48.37 17.3 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.535 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.9 Cg_endo -68.07 -35.59 19.54 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.335 1.176 . . . . 0.0 109.155 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.492 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 2.3 t -64.06 -31.12 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.386 0.613 . . . . 0.0 109.414 178.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 20.9 mt -79.8 -16.95 54.51 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 109.016 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.482 HD22 HD13 ' A' ' 50' ' ' LEU . 75.9 mt -76.38 -24.69 54.14 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.562 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 33.0 m-80 -67.78 -15.98 63.9 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.452 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.43 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -72.55 -0.25 12.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.544 -0.722 . . . . 0.0 110.422 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.88 18.75 10.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.111 -0.993 . . . . 0.0 109.343 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.542 ' CD1' ' CD2' ' A' ' 81' ' ' LEU . 14.5 mt -96.34 160.58 29.39 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.631 -0.668 . . . . 0.0 110.009 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 41.7 Cg_endo -74.29 161.94 39.46 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.878 1.462 . . . . 0.0 109.461 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 t -63.17 -9.24 4.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.379 -0.825 . . . . 0.0 110.177 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -73.52 -39.12 65.04 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.543 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 20.8 mm -70.41 -47.98 62.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.482 HD13 HD22 ' A' ' 41' ' ' LEU . 5.0 mt -66.07 -22.12 66.4 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.58 -28.34 29.94 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.528 ' HD3' ' N ' ' A' ' 88' ' ' MET . 3.8 ttm180 -95.72 -58.38 2.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.467 -1.02 . . . . 0.0 109.464 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 49' ' ' ILE . 39.0 t -46.8 -29.19 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.785 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.5 ' O ' ' N ' ' A' ' 57' ' ' SER . 18.4 t-105 -74.19 -59.54 2.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.744 -0.598 . . . . 0.0 110.058 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -46.01 -42.18 12.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 109.722 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' A' ' 87' ' ' PRO . 1.5 mt -78.9 -17.23 55.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.385 -0.822 . . . . 0.0 109.276 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.529 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 1.3 t -92.41 -35.71 13.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.543 -0.723 . . . . 0.0 110.076 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.509 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 24.7 t0 -78.71 77.16 5.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.467 -0.771 . . . . 0.0 109.291 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.526 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 35.6 mm -40.72 -31.82 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.362 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 2.9 m-20 -96.24 -27.03 15.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.335 -0.853 . . . . 0.0 110.557 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 28.0 m-70 64.74 45.43 3.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.076 -1.015 . . . . 0.0 109.274 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -114.32 -2.74 13.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 110.582 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.31 -0.94 34.97 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.564 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 2.4 mtt -129.35 155.94 44.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.323 -1.104 . . . . 0.0 110.312 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.531 ' CD1' HG13 ' A' ' 36' ' ' VAL . 11.0 mt -122.56 121.15 35.82 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.312 -0.867 . . . . 0.0 110.969 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 1.1 m-20 -80.47 155.81 26.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.151 -0.968 . . . . 0.0 108.932 178.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.583 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 11.1 ptt180 -40.14 -31.71 0.14 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 0.0 111.491 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.475 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 81.5 m-20 -85.71 -31.53 22.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.038 -1.039 . . . . 0.0 109.839 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.526 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 54.8 mt-10 -77.41 -42.39 36.39 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.569 ' CE1' ' SD ' ' A' ' 74' ' ' MET . 43.5 t80 -57.68 -32.65 67.55 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -60.63 -53.69 54.43 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.584 0.707 . . . . 0.0 110.302 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.53 HG11 ' CD1' ' A' ' 94' ' ' LEU . 80.8 t -53.53 -26.74 13.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.525 -0.734 . . . . 0.0 110.242 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -87.68 -11.16 49.18 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.117 -0.989 . . . . 0.0 112.673 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.569 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 9.0 mmm -86.65 -43.42 12.64 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.342 -1.474 . . . . 0.0 111.036 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.645 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 2.0 p90 -76.83 -23.26 52.76 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.632 -1.227 . . . . 0.0 108.244 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.602 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 5.5 mt -76.0 -21.76 56.55 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.38 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 73' ' ' ALA . 75.5 t -90.93 -26.46 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.373 -0.83 . . . . 0.0 109.766 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -89.49 -23.14 22.15 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.335 -0.853 . . . . 0.0 109.271 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 30.3 m -82.44 -13.31 56.98 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.39 -0.819 . . . . 0.0 108.9 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.459 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -89.31 -11.14 44.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.393 -0.817 . . . . 0.0 108.974 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.571 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 1.6 mt -90.82 -43.51 10.01 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.677 0.751 . . . . 0.0 109.563 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 C--N 1.299 -1.595 0 C-N-CA 119.909 -0.717 . . . . 0.0 109.608 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.505 HG23 ' CG2' ' A' ' 53' ' ' VAL . 69.5 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.623 0.249 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.534 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 49.3 Cg_endo -89.32 145.67 5.07 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.869 1.457 . . . . 0.0 109.394 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.528 ' N ' ' HD3' ' A' ' 52' ' ' ARG . 1.2 ptt? -75.33 5.08 6.08 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.029 -1.044 . . . . 0.0 111.526 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.432 ' C ' ' CD2' ' A' ' 56' ' ' LEU . 58.2 m -98.57 104.56 16.6 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 118.821 -1.152 . . . . 0.0 112.24 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.529 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -44.48 104.99 0.41 Allowed Pre-proline 0 C--N 1.299 -1.617 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.418 178.155 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.491 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 39.4 Cg_endo -67.0 139.9 52.74 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.774 1.407 . . . . 0.0 110.624 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.38 -6.44 19.17 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.066 1.561 . . . . 0.0 111.095 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -97.09 19.06 13.52 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.645 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -151.42 13.03 0.65 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.758 0.79 . . . . 0.0 110.142 -178.657 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.299 -1.63 0 O-C-N 120.645 -1.284 . . . . 0.0 110.038 -179.891 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.483 0.864 0 CA-C-O 121.513 0.547 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.593 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 15.5 t90 -73.96 130.94 40.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.519 -0.738 . . . . 0.0 110.04 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -44.94 -27.74 0.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 110.342 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.593 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 16.3 t -89.84 137.57 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.209 -0.932 . . . . 0.0 110.116 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.529 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 5.4 mttt -92.81 168.29 12.72 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.666 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 38.3 Cg_endo -65.9 -34.56 38.68 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.638 1.336 . . . . 0.0 109.763 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.67 -25.05 60.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.345 -0.847 . . . . 0.0 109.252 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -83.95 -38.36 21.12 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -67.78 -17.45 64.54 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.453 -0.78 . . . . 0.0 109.192 179.071 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.16 -40.43 27.34 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 3.7 ptmt -79.23 -24.1 43.29 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.0 m-30 -75.07 -35.68 61.83 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -76.68 -11.73 59.89 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.261 0.553 . . . . 0.0 110.182 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -94.82 -34.33 12.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.567 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 21.4 mt -75.78 -32.68 24.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -68.15 -37.98 81.63 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.452 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 13.6 t70 -89.75 1.72 55.75 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.546 -0.721 . . . . 0.0 109.966 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -92.81 0.13 57.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 108.65 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.4 OUTLIER -113.85 -2.12 13.72 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER 82.69 89.81 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.8 Cg_endo -75.29 150.85 37.52 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 124.352 1.711 . . . . 0.0 110.721 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 98.8 t -117.59 96.9 4.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.561 -0.712 . . . . 0.0 109.505 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 10.4 t30 56.93 20.49 5.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.923 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.55 32.28 3.98 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 90.7 m-85 -149.98 158.6 44.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.194 -1.18 . . . . 0.0 111.378 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.577 HD13 ' CD2' ' A' ' 21' ' ' PHE . 40.5 mt -135.21 132.51 37.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.572 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 9.2 p -80.66 140.23 35.77 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.445 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.47 -26.38 0.38 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 32' ' ' SER . 8.4 t0 -62.77 -16.37 57.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -1.159 . . . . 0.0 110.378 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 17.5 mttm -107.58 -42.2 4.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.237 -0.914 . . . . 0.0 109.298 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.544 HG13 ' CD1' ' A' ' 65' ' ' LEU . 64.9 t -74.31 -35.66 40.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.835 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.563 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 14.3 tttp -49.4 -54.59 28.64 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 110.229 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.5 Cg_endo -65.09 -30.29 56.0 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.493 1.26 . . . . 0.0 108.997 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.587 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 4.3 t -76.4 -10.32 13.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.361 0.601 . . . . 0.0 109.741 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.505 ' CD2' HG22 ' A' ' 77' ' ' VAL . 68.5 mt -100.86 -16.09 17.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.546 ' CD1' ' HA ' ' A' ' 38' ' ' PRO . 7.7 mt -87.16 -40.69 14.37 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.51 -0.744 . . . . 0.0 109.575 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -52.34 -20.81 2.99 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.068 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.8 OUTLIER -66.95 -6.15 15.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.579 -0.701 . . . . 0.0 110.085 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.3 OUTLIER 72.43 9.5 5.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.865 . . . . 0.0 109.96 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.564 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 14.9 mt -91.58 157.16 42.4 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 110.322 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.563 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.2 Cg_endo -74.47 164.35 34.15 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.138 1.599 . . . . 0.0 110.191 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.83 -8.75 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 110.159 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.84 -40.23 63.45 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.053 -1.029 . . . . 0.0 108.309 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.563 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 10.3 mm -68.34 -47.72 76.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 40' ' ' LEU . 4.4 mt -62.62 -17.38 60.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -88.72 -33.67 9.82 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 87' ' ' PRO . 16.7 ttm-85 -91.77 -55.78 3.34 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.461 -1.023 . . . . 0.0 109.321 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.518 ' O ' ' HB3' ' A' ' 57' ' ' SER . 24.7 t -47.64 -58.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.37 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.576 ' CE3' HD13 ' A' ' 65' ' ' LEU . 7.7 t-105 -47.35 -54.85 10.07 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.686 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 17.8 mm-40 -47.39 -51.9 18.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 110.02 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.606 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 2.6 mt -74.57 -7.65 53.81 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.317 -0.864 . . . . 0.0 109.642 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.553 ' HB2' ' CA ' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -100.53 -36.23 9.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.418 -0.801 . . . . 0.0 110.269 179.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 36.3 t0 -79.31 71.89 5.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.441 -0.787 . . . . 0.0 109.495 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.464 ' O ' ' NE2' ' A' ' 61' ' ' HIS . 36.8 mm -40.16 -33.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.622 -0.674 . . . . 0.0 110.658 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -93.22 -27.59 16.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.946 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.546 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 14.4 m-70 64.67 45.2 3.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.21 -0.931 . . . . 0.0 110.762 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.496 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 2.6 p-10 -113.38 20.88 15.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 110.787 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.53 0.66 89.33 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.572 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 3.3 mtt -130.81 160.26 34.92 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.293 -1.122 . . . . 0.0 110.314 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.576 HD13 ' CE3' ' A' ' 54' ' ' TRP . 21.3 mt -126.97 114.27 17.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 110.542 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 8.9 t70 -69.74 172.96 6.74 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.142 -0.974 . . . . 0.0 109.395 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.598 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 5.2 ptt180 -55.42 -31.72 62.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 110.768 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.426 ' O ' HG22 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -87.78 -32.54 19.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.089 -1.007 . . . . 0.0 109.778 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.479 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 28.0 mt-10 -78.16 -39.3 41.4 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.264 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.569 ' CE1' ' SD ' ' A' ' 74' ' ' MET . 62.6 t80 -65.61 -27.56 68.49 Favored 'General case' 0 C--N 1.303 -1.457 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.865 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.38 -45.44 87.7 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.796 0.808 . . . . 0.0 109.685 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.541 HG11 ' CD2' ' A' ' 94' ' ' LEU . 48.1 t -61.64 -20.29 22.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.333 0.587 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.553 ' CA ' ' HB2' ' A' ' 57' ' ' SER . . . -90.36 -11.12 41.56 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 111.65 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.569 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 5.7 mmm -89.1 -41.52 12.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.699 -1.251 . . . . 0.0 110.385 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.582 ' CE1' HD22 ' A' ' 94' ' ' LEU . 1.8 p90 -78.97 -23.29 44.63 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.046 -1.061 . . . . 0.0 108.55 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.564 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 6.1 mt -74.61 -23.64 58.75 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.58 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 55.6 t -91.03 -59.03 3.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -47.85 -22.73 0.6 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.796 -0.565 . . . . 0.0 111.567 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -83.74 -16.85 43.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.882 -1.136 . . . . 0.0 110.048 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.564 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -86.8 -14.18 42.96 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.325 -0.859 . . . . 0.0 109.484 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.58 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 6.7 mp -86.65 -40.4 15.15 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 7.6 tt0 -72.93 -54.51 8.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.376 0.608 . . . . 0.0 109.858 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 13.2 tttt 177.95 -23.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.342 -0.849 . . . . 0.0 111.598 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -78.69 113.79 37.94 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 120.977 -1.077 . . . . 0.0 111.318 -178.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.413 ' O ' HG21 ' A' ' 86' ' ' VAL . 44.3 Cg_endo -72.31 -170.6 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.794 1.418 . . . . 0.0 109.597 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.515 HG12 ' CG2' ' A' ' 53' ' ' VAL . 76.5 t -136.98 127.83 16.31 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.972 -1.08 . . . . 0.0 110.699 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.489 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 49.8 Cg_endo -83.3 -167.52 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.999 1.526 . . . . 0.0 109.359 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.473 ' HA ' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -117.63 9.95 13.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.109 -0.994 . . . . 0.0 110.405 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.5 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 90.5 p -108.28 107.2 17.69 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.307 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.606 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -55.71 107.1 0.78 Allowed Pre-proline 0 C--N 1.294 -1.808 0 C-N-CA 120.061 -0.655 . . . . 0.0 109.811 178.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.518 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 41.6 Cg_endo -73.67 149.31 43.21 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.744 1.392 . . . . 0.0 110.606 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.477 ' HA ' ' CG1' ' A' ' 95' ' ' VAL . 48.3 Cg_endo -72.5 -3.98 14.44 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.224 1.644 . . . . 0.0 111.85 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -94.66 -23.37 17.62 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.072 -1.018 . . . . 0.0 109.225 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.582 HD22 ' CE1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -98.21 -14.38 20.36 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.786 0.803 . . . . 0.0 109.255 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.516 ' CG2' ' HB3' ' A' ' 99' ' ' LYS . 8.9 p -87.95 136.51 32.28 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.081 -1.012 . . . . 0.0 110.519 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.436 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 44.3 Cg_endo -72.47 173.28 13.45 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.016 1.535 . . . . 0.0 110.133 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.532 ' HA ' ' CD ' ' A' ' 100' ' ' ARG . 47.4 Cg_endo -72.62 -2.64 12.13 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.972 1.512 . . . . 0.0 110.575 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.58 -18.23 36.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.197 -0.939 . . . . 0.0 109.834 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.516 ' HB3' ' CG2' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -89.71 -0.81 57.77 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.3 -0.875 . . . . 0.0 109.498 179.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.532 ' CD ' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.355 -0.841 . . . . 0.0 109.909 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 N--CA 1.483 0.876 0 N-CA-C 110.293 -0.695 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.503 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.3 t90 -87.1 119.04 26.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 110.103 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.538 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -41.66 -29.53 0.19 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.511 -0.743 . . . . 0.0 109.831 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.557 HG23 ' CD2' ' A' ' 75' ' ' PHE . 92.3 t -92.08 158.59 2.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.548 -0.72 . . . . 0.0 109.865 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.518 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 6.0 mttt -126.36 178.09 1.68 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.952 . . . . 0.0 110.13 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 40.0 Cg_endo -66.67 -36.48 24.82 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.913 1.481 . . . . 0.0 110.141 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -69.88 -36.23 75.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 109.101 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -83.54 -33.43 25.47 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 16.4 tptp -78.64 -20.64 49.86 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' PRO . . . -68.05 -41.9 81.34 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.598 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.7 ptpt -72.9 -31.81 64.92 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.598 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -66.59 -38.31 86.75 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 62.8 t0 -68.99 -11.1 60.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.672 -0.643 . . . . 0.0 110.331 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -96.39 -34.45 11.54 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.541 HG21 ' CE2' ' A' ' 70' ' ' PHE . 26.5 mt -78.35 -31.57 16.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.546 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -68.3 -37.98 81.16 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.473 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.1 t70 -90.41 0.99 57.05 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.625 -0.672 . . . . 0.0 109.916 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -92.72 2.71 56.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 108.77 178.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -115.6 -1.67 12.68 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER 79.52 87.0 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -73.87 147.46 39.31 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 124.446 1.761 . . . . 0.0 110.666 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 34.6 t -114.37 105.94 19.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 9.4 t30 55.49 23.71 6.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -0.983 . . . . 0.0 109.284 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 91.77 37.36 6.11 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.559 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 86.4 m-85 -149.92 158.03 43.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -1.098 . . . . 0.0 111.233 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.493 ' CD2' ' HB2' ' A' ' 24' ' ' LEU . 12.0 mt -136.4 133.15 36.41 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.569 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -79.63 140.74 37.0 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.414 -0.804 . . . . 0.0 110.408 -179.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.52 -25.54 0.85 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 32' ' ' SER . 4.8 t70 -68.37 -9.07 45.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -1.173 . . . . 0.0 110.237 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.481 ' HD2' ' OG ' ' A' ' 32' ' ' SER . 4.6 mtpp -114.05 -43.35 3.25 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.886 0.851 . . . . 0.0 109.348 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.5 HG12 ' CE1' ' A' ' 70' ' ' PHE . 85.8 t -76.94 -46.21 29.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.78 -0.575 . . . . 0.0 110.266 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 39.0 tttt -46.19 -49.23 42.47 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 110.796 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.4 Cg_endo -68.58 -34.93 18.37 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 N-CA-C 108.918 -1.224 . . . . 0.0 108.918 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.524 ' CG2' HD21 ' A' ' 24' ' ' LEU . 2.4 t -62.72 -25.21 37.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 20.0 mt -84.02 -15.84 46.14 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.408 -0.807 . . . . 0.0 109.173 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.526 ' HG ' ' CD1' ' A' ' 50' ' ' LEU . 16.0 mt -76.44 -28.13 56.48 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 31.9 m-80 -63.51 -15.63 58.43 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.472 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.541 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -72.68 -1.54 16.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.504 -0.748 . . . . 0.0 110.155 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 43' ' ' SER . 7.8 ttpt 68.73 18.15 8.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -0.865 . . . . 0.0 109.925 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.575 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 16.8 mt -100.11 162.05 22.24 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.387 -0.821 . . . . 0.0 110.375 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.561 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.9 Cg_endo -74.14 166.18 30.18 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.106 1.582 . . . . 0.0 110.288 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 t -66.65 -7.52 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.404 -0.81 . . . . 0.0 110.22 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -40.93 59.6 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.561 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 21.5 mm -64.91 -44.87 96.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.526 ' CD1' ' HG ' ' A' ' 41' ' ' LEU . 4.8 mt -65.74 -17.88 64.93 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.335 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -87.92 -30.57 17.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.554 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 4.1 ttm180 -92.73 -56.27 3.07 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.403 -1.057 . . . . 0.0 109.45 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.526 ' CG1' HG21 ' A' ' 77' ' ' VAL . 41.0 t -46.6 -39.82 4.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.281 -0.968 . . . . 0.0 109.058 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.546 ' CZ3' HD13 ' A' ' 65' ' ' LEU . 18.5 t-105 -65.51 -60.35 3.03 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.814 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 4.1 mm-40 -44.25 -54.68 5.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 109.826 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.628 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 1.7 mt -69.9 -9.94 56.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.393 -0.817 . . . . 0.0 109.662 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.553 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 3.1 t -100.52 -32.75 10.63 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.442 -0.786 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.583 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 22.7 t0 -80.07 76.43 6.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.305 -0.872 . . . . 0.0 110.21 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.51 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 41.6 mm -45.96 -32.56 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.482 -0.761 . . . . 0.0 109.833 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 22.7 m-20 -95.8 -21.73 17.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.539 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 88.5 m-70 57.38 48.47 14.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 109.563 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.44 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 1.7 p-10 -117.64 6.57 12.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.404 -0.81 . . . . 0.0 110.376 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.83 8.85 59.0 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.569 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 5.9 mtt -141.85 160.63 39.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -1.147 . . . . 0.0 110.89 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.546 HD13 ' CZ3' ' A' ' 54' ' ' TRP . 35.9 mt -130.18 120.66 24.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.379 -0.826 . . . . 0.0 109.986 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.559 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 2.0 p30 -79.45 166.33 22.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.885 -1.135 . . . . 0.0 110.036 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.534 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 9.6 ptt180 -36.97 -46.83 0.67 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.456 -0.778 . . . . 0.0 111.596 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.484 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 63.1 m-20 -79.91 -33.9 39.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.139 -0.976 . . . . 0.0 110.381 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 13.1 tt0 -67.94 -50.75 54.12 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.346 -0.847 . . . . 0.0 109.785 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.572 ' CE2' ' SD ' ' A' ' 74' ' ' MET . 62.5 t80 -56.0 -27.42 52.84 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.11 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.49 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . . . -62.63 -47.33 84.2 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.564 0.697 . . . . 0.0 110.103 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 57' ' ' SER . 96.2 t -59.67 -24.48 29.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.501 -0.75 . . . . 0.0 109.875 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.553 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -88.39 -6.48 57.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.26 -0.9 . . . . 0.0 111.605 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.572 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 8.7 mmm -90.17 -42.77 10.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.383 -1.448 . . . . 0.0 110.332 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.557 ' CD2' HG23 ' A' ' 9' ' ' VAL . 2.0 p90 -76.44 -22.58 54.46 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.965 -1.094 . . . . 0.0 108.339 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.55 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 14.9 mt -73.7 -28.36 61.69 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.564 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 41.2 t -92.09 -56.4 5.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.732 -0.605 . . . . 0.0 109.551 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 74' ' ' MET . 1.0 OUTLIER -53.31 -18.85 2.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.416 -0.802 . . . . 0.0 110.812 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 84' ' ' GLU . 11.7 m -86.13 -16.94 36.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.933 . . . . 0.0 109.945 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.575 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -85.82 -11.91 52.21 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.191 -0.943 . . . . 0.0 109.564 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.564 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 6.2 mp -87.52 -43.78 11.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.377 -0.827 . . . . 0.0 109.222 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.6 OUTLIER -69.78 -51.63 32.2 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.23 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 3.9 tttm 177.41 -25.53 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.018 . . . . 0.0 111.613 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 2.4 mm-40 -76.89 112.3 21.69 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.045 -1.034 . . . . 0.0 111.124 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 42.6 Cg_endo -69.59 -171.69 0.48 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.854 1.449 . . . . 0.0 110.191 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.482 HG13 HG21 ' A' ' 53' ' ' VAL . 53.3 t -126.81 119.41 22.6 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.114 -0.991 . . . . 0.0 110.981 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.448 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 49.4 Cg_endo -83.14 176.5 7.41 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.921 1.485 . . . . 0.0 109.724 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.554 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 31.7 mtp -103.21 15.81 28.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.091 -1.006 . . . . 0.0 110.345 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.582 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 75.7 m -114.06 105.33 13.09 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.954 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.628 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -82.25 106.13 5.91 Favored Pre-proline 0 C--N 1.289 -2.046 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 89' ' ' SER . 40.5 Cg_endo -66.36 158.83 53.17 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.906 1.477 . . . . 0.0 110.244 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.19 -15.59 31.81 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.882 1.464 . . . . 0.0 110.312 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -72.47 -7.5 50.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.538 ' CD1' ' CB ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -90.5 -28.36 18.61 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.62 -0.675 . . . . 0.0 110.122 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.533 ' CG1' ' HB2' ' A' ' 99' ' ' LYS . 46.3 t -68.83 136.53 89.99 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.481 -0.762 . . . . 0.0 111.098 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.466 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 45.3 Cg_endo -72.09 174.77 10.82 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.112 1.585 . . . . 0.0 110.152 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 44.4 Cg_endo -72.4 -9.87 24.76 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.817 1.43 . . . . 0.0 110.762 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.7 p -74.61 -26.0 59.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.114 -0.991 . . . . 0.0 109.912 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.533 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -89.42 7.53 35.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.418 -0.801 . . . . 0.0 109.539 179.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.458 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.274 -0.891 . . . . 0.0 110.45 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.483 0.858 0 N-CA-C 110.54 -0.6 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.576 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 13.9 t90 -90.76 131.43 36.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 0.0 109.843 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.582 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -41.43 -33.21 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.596 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.576 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 55.4 t -98.38 122.89 50.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.357 -0.839 . . . . 0.0 110.142 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.536 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.0 mtmt -91.26 -177.28 0.73 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 110.107 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.2 Cg_endo -71.24 -36.26 7.39 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.811 1.427 . . . . 0.0 110.242 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.78 -24.16 58.63 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.314 -0.866 . . . . 0.0 109.302 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -86.5 -37.04 18.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.309 -0.869 . . . . 0.0 108.914 179.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -18.42 59.38 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.31 -39.53 71.36 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -75.19 -19.02 60.03 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 13.0 m-30 -82.83 -30.25 28.86 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -76.6 -11.3 59.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.718 -0.614 . . . . 0.0 110.053 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.47 -33.66 15.12 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.58 HG21 ' CE1' ' A' ' 70' ' ' PHE . 6.9 mt -80.38 -29.03 12.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -75.51 -35.46 60.76 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.002 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.502 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -89.48 -1.92 58.2 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.594 -0.691 . . . . 0.0 109.88 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.44 -6.02 56.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 109.206 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.581 ' O ' ' CB ' ' A' ' 25' ' ' SER . 1.9 mt -108.35 -9.82 15.41 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.5 m 83.16 92.21 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.8 Cg_endo -73.05 148.52 44.98 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.351 1.711 . . . . 0.0 110.577 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.473 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 28.3 t -111.94 113.14 43.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.441 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.511 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.4 OUTLIER 46.04 25.09 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.835 . . . . 0.0 109.719 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.46 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 96.8 34.58 5.67 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.609 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 85.0 m-85 -151.55 153.8 35.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.085 -1.244 . . . . 0.0 111.72 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 64' ' ' MET . 41.7 mt -123.15 127.95 49.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 35' ' ' LYS . 60.1 p -65.84 137.96 57.56 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.862 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.597 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -48.28 -26.97 5.18 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.66 -14.65 58.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -1.124 . . . . 0.0 109.633 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.551 ' CD ' HD21 ' A' ' 31' ' ' LEU . 21.0 ttmm -91.88 -39.55 11.66 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.528 HG12 ' CD1' ' A' ' 65' ' ' LEU . 89.7 t -83.1 -31.05 8.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.437 0.637 . . . . 0.0 110.098 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.62 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -39.86 -51.28 5.55 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.535 -0.728 . . . . 0.0 111.122 -179.282 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 36.7 Cg_endo -63.02 -31.05 76.74 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.425 1.223 . . . . 0.0 109.841 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.541 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 2.9 t -74.46 -14.92 16.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.628 -0.67 . . . . 0.0 109.866 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.487 ' O ' HD23 ' A' ' 50' ' ' LEU . 66.9 mt -97.41 -23.93 15.85 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.295 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.501 HD11 ' HA ' ' A' ' 38' ' ' PRO . 2.5 mt -87.74 -34.2 18.43 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.188 -0.945 . . . . 0.0 110.063 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.541 ' ND2' ' HA ' ' A' ' 39' ' ' VAL . 2.0 p30 -65.6 -9.95 31.39 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.579 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.473 ' OG ' HG12 ' A' ' 77' ' ' VAL . 2.3 m -79.77 7.72 8.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 110.475 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 64.75 16.76 10.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.125 -0.984 . . . . 0.0 110.489 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.535 HD21 ' HD2' ' A' ' 46' ' ' PRO . 14.5 mt -97.0 153.81 38.41 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 109.967 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.567 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.6 Cg_endo -74.79 163.64 35.25 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.998 1.525 . . . . 0.0 110.467 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.6 t -64.77 -8.43 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.718 . . . . 0.0 110.513 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -76.3 -41.18 49.48 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.567 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 23.0 mm -65.03 -44.93 95.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 40' ' ' LEU . 3.9 mt -61.97 -18.42 60.35 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.35 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.67 -31.16 19.27 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.468 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 1.2 mtm180 -94.95 -55.38 3.11 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.43 -1.041 . . . . 0.0 109.455 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.53 HG22 ' CG2' ' A' ' 49' ' ' ILE . 30.0 t -49.08 -42.69 14.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.246 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.597 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 14.6 t-105 -65.55 -58.57 5.46 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.138 -0.976 . . . . 0.0 109.513 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.583 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 5.2 mm-40 -51.43 -33.45 30.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.995 . . . . 0.0 109.142 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.493 ' HB3' ' HG ' ' A' ' 90' ' ' LEU . 6.7 mt -86.01 -15.27 41.94 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.493 -0.754 . . . . 0.0 109.343 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.534 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 50.4 m -100.16 -29.54 12.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.484 -0.76 . . . . 0.0 110.396 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 42.1 t0 -85.45 66.62 9.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.275 -0.891 . . . . 0.0 109.842 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 58' ' ' ASP . 42.0 mm -40.36 -29.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.485 0.659 . . . . 0.0 110.22 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 6.3 t0 -89.33 -28.51 19.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.362 -0.836 . . . . 0.0 110.826 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.583 ' CE1' ' O ' ' A' ' 55' ' ' GLU . 87.7 m-70 56.32 50.59 12.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.084 -1.01 . . . . 0.0 110.083 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 63' ' ' GLY . 5.3 p-10 -118.79 -10.11 10.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 110.409 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' N ' ' OD1' ' A' ' 62' ' ' ASP . . . 116.61 8.69 12.07 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.556 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 15.4 mtp -142.7 160.87 39.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -1.148 . . . . 0.0 110.228 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.528 ' CD1' HG12 ' A' ' 36' ' ' VAL . 13.0 mt -120.77 105.6 10.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.286 -0.884 . . . . 0.0 109.767 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.609 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 1.8 t70 -72.58 171.66 12.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.879 -1.138 . . . . 0.0 110.258 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.486 ' N ' ' CG ' ' A' ' 66' ' ' ASP . 16.2 ptp180 -45.71 -39.84 8.58 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.771 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.446 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 30.8 t0 -81.77 -31.79 31.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.195 -0.94 . . . . 0.0 110.458 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.486 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 27.5 mt-10 -77.95 -42.06 34.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.215 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.588 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 44.0 t80 -66.72 -28.06 68.12 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.536 -0.727 . . . . 0.0 109.376 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -65.72 -51.98 54.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 110.018 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.501 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 93.2 t -55.65 -21.79 10.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.537 -0.727 . . . . 0.0 110.281 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.534 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -90.49 -14.61 32.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.219 -0.925 . . . . 0.0 111.766 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.628 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 7.0 mmm -80.18 -41.8 24.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.744 -1.223 . . . . 0.0 109.924 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.59 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.7 p90 -77.74 -22.34 50.45 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.59 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 6.6 mt -75.95 -30.76 58.78 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.673 0.749 . . . . 0.0 109.126 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.497 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 44.4 t -90.19 -20.19 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.6 -0.688 . . . . 0.0 109.867 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.4 OUTLIER -90.56 -23.0 21.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.453 -0.779 . . . . 0.0 109.655 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.479 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.6 m -86.25 -17.98 33.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.446 -0.784 . . . . 0.0 109.731 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.522 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -83.91 -9.36 58.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.434 -0.791 . . . . 0.0 109.177 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 81' ' ' LEU . 2.0 mt -89.59 -45.93 9.02 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.714 0.769 . . . . 0.0 109.227 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.5 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 46.8 mt-10 -70.02 -52.91 20.27 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.645 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 1.2 tttt 178.44 -28.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.809 -0.756 . . . . 0.0 111.115 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 79' ' ' CYS . 14.0 mt-10 -68.59 111.84 9.39 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.168 -0.958 . . . . 0.0 111.106 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 46.7 Cg_endo -75.38 -165.47 0.29 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.895 1.471 . . . . 0.0 110.224 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.547 ' CG1' ' HD2' ' A' ' 87' ' ' PRO . 60.0 t -114.65 149.85 42.99 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.359 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.547 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 44.8 Cg_endo -80.19 -165.01 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.61 1.321 . . . . 0.0 110.063 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.07 3.16 17.17 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 111.114 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -177.74 29.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.745 -1.222 . . . . 0.0 111.674 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.5 HD21 ' CB ' ' A' ' 94' ' ' LEU . 9.6 mt 57.65 120.49 0.01 OUTLIER Pre-proline 0 C--N 1.285 -2.226 0 O-C-N 121.96 -0.463 . . . . 0.0 110.509 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.577 ' HG2' ' CD2' ' A' ' 94' ' ' LEU . 40.0 Cg_endo -70.28 176.86 6.59 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 123.641 1.338 . . . . 0.0 109.15 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 40.2 Cg_endo -65.65 -9.72 23.78 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.558 1.294 . . . . 0.0 111.894 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.502 ' O ' ' HB1' ' A' ' 8' ' ' ALA . . . -98.64 4.18 47.94 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.049 -1.032 . . . . 0.0 110.604 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.582 ' CD1' ' CB ' ' A' ' 8' ' ' ALA . 4.2 mm? -117.35 38.57 3.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.011 -1.056 . . . . 0.0 111.295 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 95' ' ' VAL . 8.8 p -146.85 115.74 4.43 Favored Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 120.91 -1.119 . . . . 0.0 110.603 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.439 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 44.7 Cg_endo -72.48 174.18 12.02 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.827 1.435 . . . . 0.0 110.038 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.577 ' O ' ' CB ' ' A' ' 98' ' ' SER . 44.3 Cg_endo -71.88 173.47 12.71 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.952 1.501 . . . . 0.0 110.33 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.577 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 1.3 m 80.7 -32.45 0.12 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.951 -0.468 . . . . 0.0 110.123 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 99' ' ' LYS . 48.2 tptt -89.0 -0.0 57.04 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.073 -1.017 . . . . 0.0 108.537 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 100' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.411 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.483 0.875 0 N-CA-C 110.039 -0.793 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.488 ' HA ' ' O ' ' A' ' 93' ' ' ALA . 11.1 t90 -71.21 115.68 10.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.001 -1.062 . . . . 0.0 109.486 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -41.14 -27.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.0 109.787 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.467 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 38.0 t -99.51 149.02 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.438 -0.789 . . . . 0.0 109.69 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.471 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.6 mttt -111.48 173.36 2.91 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 110.02 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.8 Cg_endo -68.94 -34.51 17.29 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.835 1.44 . . . . 0.0 109.404 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 10.5 pt-20 -80.21 -26.7 39.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.47 -0.768 . . . . 0.0 109.646 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 1.6 m-20 -83.34 -41.38 18.29 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.473 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -69.06 -16.99 63.83 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.455 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.11 -42.42 72.69 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.602 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -70.68 -27.63 64.17 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -69.38 -37.48 77.58 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.22 -10.37 57.43 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.426 0.631 . . . . 0.0 109.969 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -92.79 -34.55 13.83 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.579 HG21 ' CE1' ' A' ' 70' ' ' PHE . 15.8 mt -80.97 -28.46 11.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.618 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -75.68 -36.01 60.2 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.485 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.4 t70 -88.65 -2.17 58.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.667 -0.646 . . . . 0.0 109.712 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 29.5 t -91.3 0.91 57.44 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.593 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.5 OUTLIER -113.12 -5.51 13.71 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.593 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 82.63 86.58 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.092 0 CA-C-O 121.131 0.491 . . . . 0.0 109.827 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -73.53 147.4 40.78 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 O-C-N 124.418 1.746 . . . . 0.0 110.903 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -115.89 111.83 37.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.633 -0.667 . . . . 0.0 109.242 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.531 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 54.52 20.52 2.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 109.468 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . 95.58 32.68 6.8 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.593 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 94.5 m-85 -146.32 158.96 43.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.432 -1.04 . . . . 0.0 110.643 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.583 HD13 ' CD2' ' A' ' 21' ' ' PHE . 16.5 mt -136.77 128.7 29.28 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.58 -0.7 . . . . 0.0 109.177 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.541 ' OG ' ' CE ' ' A' ' 64' ' ' MET . 0.7 OUTLIER -74.49 137.41 42.51 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.273 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.34 -32.38 1.16 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.443 ' O ' ' HG3' ' A' ' 38' ' ' PRO . 72.0 m-20 -53.38 -24.44 12.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -1.142 . . . . 0.0 110.027 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 12.1 mttm -103.3 -44.61 5.12 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.019 0.914 . . . . 0.0 109.072 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.529 HG12 ' CD1' ' A' ' 65' ' ' LEU . 40.2 t -76.63 -49.13 24.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 O-C-N 121.81 -0.556 . . . . 0.0 110.467 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 14.7 ttpt -43.17 -50.2 14.95 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.484 -0.887 . . . . 0.0 110.801 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.8 Cg_endo -67.05 -34.49 28.62 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 N-CA-C 109.108 -1.151 . . . . 0.0 109.108 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.513 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 2.3 t -65.15 -23.83 34.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.492 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 16.4 mt -86.33 -15.06 41.73 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.392 -0.817 . . . . 0.0 109.203 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.417 ' HG ' ' CD1' ' A' ' 50' ' ' LEU . 27.8 mt -77.97 -26.85 48.96 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 38.7 m-80 -62.55 -13.9 36.19 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.623 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.532 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -78.63 2.13 20.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.563 -0.711 . . . . 0.0 110.327 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 43' ' ' SER . 1.7 mtpt 63.53 15.6 8.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -0.902 . . . . 0.0 110.362 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.533 ' CD1' HG23 ' A' ' 49' ' ' ILE . 13.6 mt -94.82 162.54 24.99 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.143 -0.973 . . . . 0.0 109.915 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.533 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.1 Cg_endo -73.99 164.91 33.34 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.013 1.533 . . . . 0.0 110.957 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 t -64.96 -9.1 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.502 -0.749 . . . . 0.0 109.776 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -72.48 -41.31 66.17 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.533 HG23 ' CD1' ' A' ' 45' ' ' LEU . 20.3 mm -64.2 -47.49 89.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.492 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 5.3 mt -65.6 -23.11 66.75 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.632 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.501 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -86.03 -30.78 22.12 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.488 ' HG2' HD13 ' A' ' 56' ' ' LEU . 13.7 ttm180 -91.52 -54.95 3.68 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.506 -0.996 . . . . 0.0 109.667 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.556 ' O ' ' CB ' ' A' ' 57' ' ' SER . 26.7 t -49.67 -42.89 18.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.993 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.495 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 16.3 t-105 -61.86 -58.19 8.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.831 . . . . 0.0 111.05 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 17.0 mt-10 -51.6 -36.9 47.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.883 -1.136 . . . . 0.0 109.607 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.53 HD21 ' N ' ' A' ' 90' ' ' LEU . 18.5 mt -90.07 -8.44 51.45 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.516 0.674 . . . . 0.0 109.485 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 4.6 t -100.11 -30.29 12.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.448 -0.783 . . . . 0.0 108.916 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.597 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 13.3 t0 -84.65 68.25 10.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.485 -0.759 . . . . 0.0 109.631 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.558 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 35.5 mm -37.4 -29.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.266 0.555 . . . . 0.0 110.471 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.539 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 76.4 m-20 -90.68 -25.66 19.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 111.31 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 0.3 OUTLIER 59.71 26.46 15.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.883 -1.136 . . . . 0.0 108.913 -179.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' OD2' ' HG3' ' A' ' 64' ' ' MET . 3.9 p-10 -90.82 -24.25 20.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.524 -0.735 . . . . 0.0 110.665 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.38 4.35 4.48 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.553 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.7 mtp -145.2 161.16 40.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.002 -1.293 . . . . 0.0 110.313 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.529 ' CD1' HG12 ' A' ' 36' ' ' VAL . 33.5 mt -115.82 112.16 21.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -0.844 . . . . 0.0 109.984 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.593 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 4.9 p30 -76.08 165.05 25.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.799 -1.188 . . . . 0.0 110.019 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.618 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -39.41 -40.31 0.8 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.458 -0.776 . . . . 0.0 111.741 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 1.4 t0 -80.28 -36.28 34.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.979 -1.075 . . . . 0.0 110.563 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.512 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 44.0 mt-10 -76.17 -41.62 49.15 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.186 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.579 ' CE1' HG21 ' A' ' 20' ' ' ILE . 35.3 t80 -61.82 -25.46 67.52 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -66.56 -51.09 60.29 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.943 0.877 . . . . 0.0 109.648 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.539 HG11 ' CG ' ' A' ' 94' ' ' LEU . 60.5 t -55.12 -23.88 13.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.358 0.599 . . . . 0.0 110.382 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.535 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -89.86 -10.85 43.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 111.815 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.577 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 7.9 mmm -85.09 -48.06 9.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.639 -1.288 . . . . 0.0 110.121 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -72.65 -21.52 61.07 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.566 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 9.6 mt -73.79 -32.79 63.94 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.532 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 70.5 t -91.42 -25.54 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.535 -0.728 . . . . 0.0 110.504 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.5 OUTLIER -86.81 -27.01 23.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.742 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 84' ' ' GLU . 60.1 m -80.29 -19.05 47.54 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.421 -0.799 . . . . 0.0 108.857 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 84' ' ' GLU . . . -82.15 -7.97 59.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.475 -0.766 . . . . 0.0 109.344 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 81' ' ' LEU . 6.4 mt -90.25 -47.6 7.67 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.566 0.698 . . . . 0.0 110.026 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 2.7 pp20? -77.44 -40.44 43.31 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.924 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.49 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 0.2 OUTLIER 177.94 -37.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.594 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 79' ' ' CYS . 0.2 OUTLIER -72.79 111.15 10.16 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 120.98 -1.075 . . . . 0.0 111.333 -178.305 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 48.8 Cg_endo -74.77 -169.64 0.65 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.76 1.4 . . . . 0.0 110.101 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.516 ' CG1' ' HD2' ' A' ' 87' ' ' PRO . 41.6 t -112.87 152.15 44.62 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.264 -0.898 . . . . 0.0 109.017 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.516 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 44.9 Cg_endo -85.93 -165.94 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.662 1.348 . . . . 0.0 109.791 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.476 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 5.7 mtt -129.68 18.87 5.68 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.623 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.478 ' N ' HD23 ' A' ' 56' ' ' LEU . 33.3 t -161.14 23.74 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.268 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.532 ' CD2' HD13 ' A' ' 94' ' ' LEU . 2.4 mt 61.7 118.48 0.02 OUTLIER Pre-proline 0 C--N 1.283 -2.324 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.54 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.522 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 41.8 Cg_endo -76.08 146.35 28.85 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.792 1.417 . . . . 0.0 110.005 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.04 -1.03 8.03 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.736 1.624 . . . . 0.0 112.09 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -99.9 -20.53 16.1 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.05 -1.031 . . . . 0.0 109.854 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.561 ' CD2' ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -101.82 -13.9 17.5 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.588 0.709 . . . . 0.0 109.497 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.479 HG21 HD11 ' A' ' 94' ' ' LEU . 95.4 t -86.22 124.14 70.6 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.938 -1.101 . . . . 0.0 110.676 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.99 172.14 16.51 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.892 1.469 . . . . 0.0 110.449 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.43 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 46.1 Cg_endo -73.23 -11.35 24.95 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.068 1.562 . . . . 0.0 110.381 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -25.49 67.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.917 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.402 ' HE2' HG12 ' A' ' 95' ' ' VAL . 3.0 ttpp -90.4 9.32 29.51 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.347 -0.846 . . . . 0.0 109.591 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.478 ' NH2' HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.42 -0.8 . . . . 0.0 110.133 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 N--CA 1.482 0.802 0 N-CA-C 110.339 -0.677 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.588 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 15.5 t90 -65.79 133.7 51.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.878 . . . . 0.0 109.811 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.594 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -41.11 -31.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.405 -0.809 . . . . 0.0 110.413 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.588 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 70.4 t -94.45 131.44 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.401 -0.812 . . . . 0.0 109.976 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.522 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 18.0 mttt -95.12 -179.43 0.95 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.846 . . . . 0.0 110.162 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.1 Cg_endo -69.79 -37.32 9.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.903 1.475 . . . . 0.0 110.187 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.474 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -71.18 -24.64 62.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 109.664 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.582 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -83.0 -41.8 18.28 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 2.4 tppt? -66.48 -20.17 65.97 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.68 -0.637 . . . . 0.0 109.363 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.7 -42.66 60.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.375 -0.828 . . . . 0.0 109.064 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.599 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -79.14 -26.15 42.83 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.599 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.5 m-30 -71.85 -34.47 69.27 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 8.0 m-20 -81.07 -10.6 59.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.717 -0.614 . . . . 0.0 109.88 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -93.58 -35.45 12.89 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.521 HG23 ' CE1' ' A' ' 70' ' ' PHE . 51.3 mt -76.47 -36.9 29.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -64.13 -36.59 84.52 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.485 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -90.24 -0.11 57.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.749 -0.595 . . . . 0.0 109.991 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 22.8 t -91.33 0.51 57.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.215 -0.928 . . . . 0.0 109.046 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 25' ' ' SER . 1.2 mt -109.06 -6.61 15.57 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.578 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER 80.29 83.55 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 42.7 Cg_endo -69.11 149.98 71.63 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 O-C-N 124.65 1.868 . . . . 0.0 110.357 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.3 t -113.16 103.92 16.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.339 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 5.6 t30 59.19 21.9 10.04 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.479 -0.763 . . . . 0.0 109.374 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.493 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 93.01 39.2 5.24 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.493 ' CD2' ' C ' ' A' ' 29' ' ' GLY . 82.3 m-85 -150.12 159.56 44.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.428 -1.042 . . . . 0.0 111.302 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.52 HD21 ' CD ' ' A' ' 35' ' ' LYS . 46.1 mt -133.22 131.4 40.29 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.574 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 18.2 p -79.06 141.48 37.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.548 -0.72 . . . . 0.0 110.929 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.592 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -49.76 -24.44 6.0 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.26 -11.95 59.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.419 -1.048 . . . . 0.0 109.66 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.52 ' CD ' HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -97.73 -46.28 6.04 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.316 1.055 . . . . 0.0 108.778 179.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.546 HG12 ' CD1' ' A' ' 65' ' ' LEU . 98.3 t -78.45 -33.07 16.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.069 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.561 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -40.68 -54.85 4.89 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.443 -0.786 . . . . 0.0 110.952 -178.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.2 Cg_endo -64.24 -31.05 64.19 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.557 1.293 . . . . 0.0 109.332 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.594 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 3.4 t -73.38 -8.41 11.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.721 -0.612 . . . . 0.0 109.363 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.508 ' CD2' HG22 ' A' ' 77' ' ' VAL . 42.3 mt -99.87 -16.42 18.04 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 108.541 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.533 ' CD1' ' HA ' ' A' ' 38' ' ' PRO . 4.7 mt -89.03 -41.56 12.26 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.501 -0.75 . . . . 0.0 109.785 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -49.82 -22.04 1.32 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.226 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.539 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -68.7 -5.31 19.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.362 -0.836 . . . . 0.0 110.085 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 73.68 8.89 4.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.378 -0.826 . . . . 0.0 110.378 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.517 HD21 ' HD2' ' A' ' 46' ' ' PRO . 14.3 mt -84.48 155.48 62.63 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 109.769 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.3 Cg_endo -74.38 162.83 37.57 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.789 1.415 . . . . 0.0 110.753 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.471 ' O ' HG11 ' A' ' 47' ' ' VAL . 52.9 t -62.63 -10.58 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.57 -0.706 . . . . 0.0 110.816 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.41 -41.01 57.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.934 -1.104 . . . . 0.0 108.353 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.562 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 27.8 mm -64.11 -44.87 97.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 40' ' ' LEU . 4.6 mt -60.23 -18.19 46.9 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.49 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -84.57 -31.74 23.77 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.479 ' CD ' ' O ' ' A' ' 87' ' ' PRO . 9.8 mtm180 -94.97 -55.26 3.15 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.494 -1.003 . . . . 0.0 109.844 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.522 ' O ' ' CB ' ' A' ' 57' ' ' SER . 17.2 t -44.83 -39.3 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.642 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.592 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 13.0 t-105 -74.38 -59.02 2.92 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.973 -1.08 . . . . 0.0 110.331 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 65.3 mm-40 -51.38 -30.13 17.96 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.086 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.549 HD21 ' N ' ' A' ' 90' ' ' LEU . 46.8 mt -90.41 -14.78 32.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.57 -0.706 . . . . 0.0 109.496 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.538 ' OG ' ' CA ' ' A' ' 73' ' ' ALA . 12.7 m -98.98 -27.81 13.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.476 -0.765 . . . . 0.0 109.642 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 59' ' ' ILE . 13.8 t0 -81.76 69.1 8.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.289 -0.882 . . . . 0.0 109.565 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.473 ' CG2' ' HG3' ' A' ' 99' ' ' LYS . 39.3 mm -40.48 -30.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.511 0.672 . . . . 0.0 109.877 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 62' ' ' ASP . 0.8 OUTLIER -96.15 -28.73 14.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.61 -0.681 . . . . 0.0 109.999 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ASP . 22.8 m-70 61.71 46.5 7.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.164 -0.96 . . . . 0.0 110.644 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 3.1 p-10 -112.66 16.85 19.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 110.265 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.37 5.0 76.4 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.574 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 5.0 mtt -140.4 157.02 46.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -1.145 . . . . 0.0 110.647 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.546 ' CD1' HG12 ' A' ' 36' ' ' VAL . 74.2 mt -118.63 113.79 21.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.381 -0.824 . . . . 0.0 109.842 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 0.9 OUTLIER -73.2 155.85 39.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.949 -1.094 . . . . 0.0 109.62 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.586 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -33.83 -44.07 0.15 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.761 -0.587 . . . . 0.0 111.372 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -74.94 -45.26 43.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.36 -0.838 . . . . 0.0 109.897 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.478 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 19.3 mt-10 -62.32 -45.83 91.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.582 -0.698 . . . . 0.0 109.563 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.573 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 52.0 t80 -59.96 -24.07 64.1 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.616 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.92 72.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.549 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.79 -23.91 32.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.535 -0.728 . . . . 0.0 109.963 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.538 ' CA ' ' OG ' ' A' ' 57' ' ' SER . . . -90.96 -1.35 57.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -0.877 . . . . 0.0 110.832 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.597 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 13.1 mmt -89.09 -46.02 9.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.083 -1.011 . . . . 0.0 109.463 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.647 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 1.7 p90 -75.83 -30.0 58.82 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.558 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 5.8 mt -63.74 -30.94 71.98 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 43' ' ' SER . 70.5 t -90.64 -23.84 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.878 -0.514 . . . . 0.0 109.936 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -26.55 20.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.365 -0.834 . . . . 0.0 109.31 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 51.6 m -84.4 -12.28 54.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.437 -0.789 . . . . 0.0 109.211 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.512 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -89.23 -8.87 52.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.465 -0.772 . . . . 0.0 109.065 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 81' ' ' LEU . 1.5 mt -90.97 -45.34 8.79 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.614 0.721 . . . . 0.0 109.358 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 40.2 mm-40 -69.45 -52.98 21.62 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.705 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 3.5 ttpt 178.9 -28.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.466 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.3 OUTLIER -63.76 111.84 6.08 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.986 -1.071 . . . . 0.0 111.291 -178.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 48.3 Cg_endo -74.86 -177.65 3.58 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.94 1.495 . . . . 0.0 110.098 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.539 ' CG1' ' HD2' ' A' ' 87' ' ' PRO . 59.2 t -112.34 149.61 41.29 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.142 -0.974 . . . . 0.0 109.191 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.539 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 46.1 Cg_endo -84.42 -163.42 0.2 Allowed 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.688 1.362 . . . . 0.0 110.092 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 2.4 ttt -122.19 10.0 9.93 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.371 -0.831 . . . . 0.0 111.106 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.511 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -165.89 23.88 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.719 -1.238 . . . . 0.0 111.432 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.549 ' N ' HD21 ' A' ' 56' ' ' LEU . 1.6 mt 62.09 123.17 0.02 OUTLIER Pre-proline 0 C--N 1.284 -2.276 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.849 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.52 ' HG2' HD21 ' A' ' 94' ' ' LEU . 40.2 Cg_endo -68.42 174.5 8.19 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.007 1.53 . . . . 0.0 110.137 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 49.6 Cg_endo -75.29 -22.68 14.07 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.964 1.507 . . . . 0.0 111.97 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.463 ' C ' HD23 ' A' ' 94' ' ' LEU . . . -90.79 7.88 37.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.923 -1.111 . . . . 0.0 110.483 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.647 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 4.1 mm? -114.29 34.9 4.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.081 -1.012 . . . . 0.0 111.495 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.429 HG21 ' C ' ' A' ' 94' ' ' LEU . 2.7 t -125.58 129.31 24.42 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.766 -1.209 . . . . 0.0 110.617 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.464 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 47.1 Cg_endo -72.77 175.19 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.993 1.523 . . . . 0.0 109.964 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.54 ' O ' ' CB ' ' A' ' 98' ' ' SER . 45.7 Cg_endo -71.44 163.31 39.48 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.877 1.462 . . . . 0.0 110.215 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER 76.47 -45.2 0.5 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.626 -0.672 . . . . 0.0 110.344 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.487 ' O ' ' CE ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -88.1 6.73 34.93 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.09 -1.006 . . . . 0.0 108.562 178.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' A' ' 96' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.02 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.482 0.803 0 N-CA-C 110.167 -0.744 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.505 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.6 t90 -78.6 126.99 31.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 110.053 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.493 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -41.81 -28.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 0.0 110.138 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.505 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 45.5 t -94.76 156.48 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.826 . . . . 0.0 109.978 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.495 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 28.3 mmtt -111.5 171.55 4.25 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -66.9 -35.93 24.96 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.819 1.431 . . . . 0.0 110.431 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.13 -25.59 60.89 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.135 -0.978 . . . . 0.0 109.11 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.579 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 63.6 m-20 -85.57 -35.87 20.78 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.241 -0.912 . . . . 0.0 108.851 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' NZ ' ' OD1' ' A' ' 18' ' ' ASP . 2.2 tptp -73.26 -17.77 61.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.29 -41.82 56.19 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.606 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.15 -24.73 51.52 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.606 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.4 m-30 -74.95 -35.98 62.12 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.488 ' OD1' ' NZ ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -71.07 -10.1 59.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.777 -0.577 . . . . 0.0 110.135 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.46 ' O ' ' OG ' ' A' ' 23' ' ' SER . . . -95.0 -38.97 10.41 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.521 ' O ' ' CD2' ' A' ' 24' ' ' LEU 0.257 27.9 mt -72.17 -29.19 31.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.631 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -69.26 -40.34 77.87 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.464 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.5 t70 -86.1 1.36 50.76 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.581 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 37.8 m -93.37 -0.14 56.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.314 -0.866 . . . . 0.0 108.768 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.548 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -116.7 -1.21 12.16 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 80.35 97.59 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.95 0 CA-C-O 121.136 0.493 . . . . 0.0 110.246 -179.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 55.4 Cg_endo -77.26 147.69 26.26 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.502 1.791 . . . . 0.0 110.343 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 60.1 t -119.89 94.07 2.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER 68.94 24.51 6.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.428 -0.795 . . . . 0.0 109.061 -178.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 90.93 28.34 15.95 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 35.3 m-85 -143.41 143.28 31.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.394 -1.062 . . . . 0.0 111.133 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.604 HD13 ' CD2' ' A' ' 21' ' ' PHE . 53.4 mt -117.57 131.87 56.61 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.535 ' OG ' ' CE ' ' A' ' 64' ' ' MET . 0.5 OUTLIER -89.48 147.5 23.96 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.578 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.15 -31.12 0.84 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -54.07 -22.7 11.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -1.097 . . . . 0.0 110.096 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 1.5 mttm -111.15 -43.36 3.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.935 . . . . 0.0 109.342 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.53 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 87.5 t -74.75 -53.73 16.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.029 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.569 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -40.75 -49.94 7.33 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.529 -0.732 . . . . 0.0 110.892 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.6 Cg_endo -69.84 -33.19 16.79 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 N-CA-C 108.961 -1.207 . . . . 0.0 108.961 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.522 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.4 t -67.29 -29.01 44.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 17.7 mt -81.4 -17.12 50.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.407 -0.808 . . . . 0.0 108.911 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 20.3 mt -73.88 -26.16 60.41 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 33.2 m-80 -61.4 -20.58 63.22 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.209 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.547 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 1.3 t -71.36 -3.44 20.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.536 -0.728 . . . . 0.0 109.864 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.529 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER 70.79 4.59 5.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 110.028 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.518 HD12 ' CB ' ' A' ' 80' ' ' ALA . 15.7 mt -83.49 159.29 61.74 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.977 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.3 Cg_endo -73.05 162.35 41.11 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.985 1.519 . . . . 0.0 110.502 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.93 -10.17 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 110.21 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.18 -39.1 68.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.544 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 18.5 mm -67.18 -47.41 81.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 50' ' ' LEU . 5.0 mt -64.64 -20.05 66.06 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.95 -33.2 12.65 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.539 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -90.38 -54.96 3.78 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.51 -0.994 . . . . 0.0 109.224 179.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.504 ' O ' ' HB3' ' A' ' 57' ' ' SER . 29.2 t -49.23 -42.71 15.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.01 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.511 ' O ' ' N ' ' A' ' 57' ' ' SER . 12.3 t-105 -59.09 -59.28 5.72 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.461 -0.774 . . . . 0.0 109.673 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 54' ' ' TRP . 1.6 mm-40 -44.06 -50.03 8.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -0.878 . . . . 0.0 109.833 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.542 HD21 ' CA ' ' A' ' 90' ' ' LEU . 1.6 mt -75.04 -14.31 60.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.375 -0.828 . . . . 0.0 109.54 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.558 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -95.35 -25.84 16.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.484 -0.76 . . . . 0.0 110.384 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.53 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 4.1 t0 -86.31 76.83 9.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.323 -0.861 . . . . 0.0 110.329 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.457 ' CG1' ' HG3' ' A' ' 69' ' ' GLU . 42.5 mm -44.12 -35.29 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.368 -0.832 . . . . 0.0 110.32 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.487 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 2.8 m-20 -95.73 -28.41 14.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 110.427 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 18.7 m-70 62.28 37.44 14.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 109.686 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -97.67 -14.57 20.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.386 -0.821 . . . . 0.0 110.452 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.415 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 125.33 3.67 7.25 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.547 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 1.5 mtp -149.27 161.73 41.44 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.022 -1.281 . . . . 0.0 110.438 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.533 ' HB3' ' CA ' ' A' ' 70' ' ' PHE . 46.8 mt -113.39 118.82 35.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.625 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 0.8 OUTLIER -69.36 154.12 42.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.174 -0.954 . . . . 0.0 109.617 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.631 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 7.4 ptp85 -34.3 -44.86 0.2 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.648 -0.658 . . . . 0.0 111.06 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -81.16 -34.41 32.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 109.499 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 57' ' ' SER . 6.8 tt0 -67.26 -51.71 49.71 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.6 -0.687 . . . . 0.0 109.415 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.57 ' CE2' ' SD ' ' A' ' 74' ' ' MET . 87.8 t80 -52.78 -26.02 13.08 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.485 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -62.15 -45.21 94.45 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.67 0.748 . . . . 0.0 109.837 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.488 ' O ' ' CE2' ' A' ' 75' ' ' PHE . 57.6 t -60.03 -25.72 33.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.59 -0.694 . . . . 0.0 110.071 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.558 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -87.42 -11.48 49.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.876 . . . . 0.0 111.952 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 7.4 mmm -85.78 -37.97 18.7 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.32 -1.487 . . . . 0.0 110.451 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.577 ' CZ ' HD13 ' A' ' 94' ' ' LEU . 3.4 p90 -78.33 -23.43 47.01 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.966 -1.084 . . . . 0.0 108.525 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.563 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 6.7 mt -75.19 -28.38 60.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.477 -0.764 . . . . 0.0 108.98 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.547 ' CG1' ' HB2' ' A' ' 43' ' ' SER . 43.3 t -90.61 -25.83 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.508 -0.745 . . . . 0.0 110.058 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.471 ' HA ' HD11 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -84.12 -25.95 29.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 110.056 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.512 ' CA ' ' HB3' ' A' ' 83' ' ' LYS . 57.9 m -85.62 -14.06 46.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 109.454 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 84' ' ' GLU . . . -79.86 -15.87 56.52 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.182 -0.948 . . . . 0.0 109.242 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 43' ' ' SER . 2.4 mt -92.1 -47.95 6.98 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.604 -0.685 . . . . 0.0 111.304 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -116.68 -23.65 8.08 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.503 -0.879 . . . . 0.0 112.033 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.512 ' HB3' ' CA ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -88.04 -89.38 0.13 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.612 -1.305 . . . . 0.0 110.903 -179.066 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -149.18 176.21 2.37 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.971 -1.08 . . . . 0.0 110.177 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.529 ' HD2' ' CG ' ' A' ' 84' ' ' GLU . 40.8 Cg_endo -66.81 -179.19 1.54 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.934 1.492 . . . . 0.0 110.582 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 55.5 t -122.41 122.16 27.48 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.864 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.515 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 51.2 Cg_endo -83.66 160.36 14.4 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.892 1.47 . . . . 0.0 109.663 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.539 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 68.6 mtp -82.79 11.24 6.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.998 -1.064 . . . . 0.0 110.237 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.54 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.6 m -99.92 112.81 25.07 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.873 -1.131 . . . . 0.0 110.66 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -100.72 85.67 0.58 Allowed Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 89' ' ' SER . 38.2 Cg_endo -62.31 173.74 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.427 1.418 . . . . 0.0 111.477 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.474 ' O ' HG21 ' A' ' 95' ' ' VAL . 44.1 Cg_endo -69.18 -10.15 28.23 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.339 1.705 . . . . 0.0 110.77 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' A' ' 8' ' ' ALA . . . -76.84 0.76 19.6 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 109.093 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.577 HD13 ' CZ ' ' A' ' 75' ' ' PHE . 2.5 mm? -108.34 -13.59 14.85 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.412 -0.805 . . . . 0.0 110.116 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 92' ' ' PRO . 26.7 m -85.13 126.93 66.24 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.351 -0.843 . . . . 0.0 110.554 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.531 ' CG ' ' HD3' ' A' ' 99' ' ' LYS . 43.6 Cg_endo -71.23 175.17 9.65 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.886 1.466 . . . . 0.0 109.86 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 44.0 Cg_endo -71.39 -16.17 31.1 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.742 1.391 . . . . 0.0 110.611 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.1 t -85.83 -36.13 20.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.113 -0.992 . . . . 0.0 109.588 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.531 ' HD3' ' CG ' ' A' ' 96' ' ' PRO . 4.0 mttp -90.02 9.19 28.96 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.383 -0.823 . . . . 0.0 109.083 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.7 ttm-85 . . . . . 0 N--CA 1.487 1.404 0 O-C-N 121.281 -0.887 . . . . 0.0 109.404 179.889 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.485 0.99 0 N-CA-C 110.742 -0.522 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.526 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.4 t90 -55.94 131.99 48.64 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.474 -0.766 . . . . 0.0 109.957 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.575 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . . . -46.34 -25.81 0.71 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.283 -0.886 . . . . 0.0 110.182 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.526 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 50.6 t -111.49 140.06 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.414 -0.804 . . . . 0.0 110.009 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.488 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 7.4 mttt -106.33 177.7 1.28 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.363 -0.836 . . . . 0.0 110.38 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 40.7 Cg_endo -68.24 -37.32 14.33 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.96 1.505 . . . . 0.0 109.647 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.441 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 16.0 pt-20 -66.52 -35.64 80.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.0 109.08 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.441 ' N ' ' CG ' ' A' ' 12' ' ' GLU . 0.6 OUTLIER -81.59 -38.64 25.76 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 1.3 tmtp? -73.01 -15.47 61.53 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 11' ' ' PRO . . . -74.36 -42.54 59.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.591 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.3 ptpt -74.33 -21.15 59.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.591 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.8 m-30 -79.7 -30.26 40.97 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -75.07 -11.51 60.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.704 -0.622 . . . . 0.0 110.19 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.16 -36.05 12.23 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.528 HG21 ' CE2' ' A' ' 70' ' ' PHE 0.253 18.5 mt -75.59 -29.79 21.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.581 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -72.65 -40.32 66.45 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 6.1 t70 -85.33 0.02 53.34 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.558 -0.714 . . . . 0.0 109.681 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.2 t -91.8 -4.7 54.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.915 . . . . 0.0 108.599 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.572 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -108.92 -3.95 17.15 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 79.7 93.56 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.918 0 CA-C-O 121.409 0.623 . . . . 0.0 109.726 -179.087 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.2 Cg_endo -74.45 147.32 36.34 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 124.452 1.764 . . . . 0.0 110.789 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 86.7 t -119.31 105.14 16.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.714 -0.617 . . . . 0.0 109.354 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 2.7 t30 57.69 22.94 8.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 109.652 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.83 32.89 7.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 89.3 m-85 -150.78 154.77 37.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.332 -1.099 . . . . 0.0 111.105 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 24' ' ' LEU . 22.0 mt -126.97 131.16 51.12 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.457 ' OG ' ' HE2' ' A' ' 35' ' ' LYS . 0.9 OUTLIER -76.86 140.53 40.63 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.272 -0.892 . . . . 0.0 110.392 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -41.99 -27.94 0.43 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' SER . 34.1 t0 -57.53 -28.84 63.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -1.188 . . . . 0.0 110.303 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.457 ' HE2' ' OG ' ' A' ' 32' ' ' SER . 25.4 mttm -98.91 -39.37 8.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.573 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 93.5 t -74.58 -32.44 29.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.076 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.546 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.2 ttpt -52.06 -56.88 17.78 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.233 -0.917 . . . . 0.0 110.347 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.2 Cg_endo -65.9 -31.45 47.34 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.631 1.332 . . . . 0.0 109.117 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.597 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 13.1 t -73.47 -16.68 17.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.164 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.524 ' CD1' HG11 ' A' ' 36' ' ' VAL . 63.3 mt -93.82 -18.45 22.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 108.67 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.45 HD11 ' HA ' ' A' ' 38' ' ' PRO . 23.6 mt -81.24 -33.84 32.54 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.399 0.619 . . . . 0.0 109.833 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.597 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -43.86 -25.35 0.19 Allowed 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.935 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.545 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -73.29 -4.98 36.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.326 -0.859 . . . . 0.0 110.213 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 72.47 7.88 5.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.522 -0.736 . . . . 0.0 110.153 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.519 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 14.8 mt -80.73 160.31 67.03 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.327 -0.858 . . . . 0.0 110.306 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.567 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.7 Cg_endo -74.33 164.69 33.53 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 124.034 1.544 . . . . 0.0 110.483 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 t -65.17 -8.44 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 110.339 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.92 -40.6 60.75 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.036 -1.04 . . . . 0.0 108.265 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.567 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 14.3 mm -65.15 -45.51 93.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 40' ' ' LEU . 6.1 mt -62.28 -18.42 61.22 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.82 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.36 -33.7 11.41 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.532 ' CD ' ' O ' ' A' ' 87' ' ' PRO . 2.4 ttm180 -90.13 -52.16 5.09 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.47 -1.018 . . . . 0.0 109.644 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 57' ' ' SER . 24.3 t -50.94 -42.25 23.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.166 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.529 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 7.7 t-105 -61.55 -57.01 13.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 110.093 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -47.33 -52.66 15.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.838 . . . . 0.0 110.103 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 1.4 mt -74.94 -7.62 54.11 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.811 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 6.4 m -100.05 -29.07 12.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.43 -0.794 . . . . 0.0 110.676 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.477 ' HA ' HD22 ' A' ' 65' ' ' LEU . 16.8 t0 -87.29 73.77 9.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.962 . . . . 0.0 110.202 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.504 ' HB ' ' HG2' ' A' ' 69' ' ' GLU . 45.4 mm -44.0 -30.59 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.5 -0.75 . . . . 0.0 109.314 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 4.4 t0 -95.19 -22.32 17.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.523 -0.736 . . . . 0.0 109.931 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 34.2 p80 40.15 57.28 2.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.546 -0.721 . . . . 0.0 110.232 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.454 ' HB3' ' CG ' ' A' ' 60' ' ' ASP . 1.3 p-10 -117.12 7.04 12.94 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.581 -0.699 . . . . 0.0 109.732 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 109.56 5.87 29.38 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.1 mtp -150.41 161.0 43.34 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.157 -1.202 . . . . 0.0 110.792 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.488 ' CD1' HG13 ' A' ' 36' ' ' VAL . 11.9 mt -114.15 108.45 16.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.452 -0.78 . . . . 0.0 109.298 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.582 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -69.77 171.84 8.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.929 -1.107 . . . . 0.0 110.152 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.581 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 9.4 ptt180 -52.87 -37.53 60.47 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.695 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.6 OUTLIER -81.77 -35.72 29.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.189 -0.944 . . . . 0.0 109.713 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.504 ' HG2' ' HB ' ' A' ' 59' ' ' ILE . 27.1 mt-10 -74.24 -46.6 40.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.569 ' CE2' ' SD ' ' A' ' 74' ' ' MET . 68.3 t80 -57.73 -33.42 68.43 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.41 76.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.398 -0.814 . . . . 0.0 109.996 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 56' ' ' LEU . 55.6 t -59.29 -21.7 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.611 -0.68 . . . . 0.0 110.443 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.498 ' HA ' ' OG ' ' A' ' 57' ' ' SER . . . -90.53 -9.79 45.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.07 -1.018 . . . . 0.0 111.602 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 7.1 mmm -85.41 -41.08 15.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.792 -1.192 . . . . 0.0 109.886 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.588 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.4 p90 -77.41 -26.17 51.47 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.588 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 7.6 mt -70.14 -30.85 68.12 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.545 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 57.0 t -90.98 -19.12 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.679 -0.638 . . . . 0.0 110.349 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.31 -20.18 23.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.34 -0.85 . . . . 0.0 109.75 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -87.73 -16.37 34.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.517 -0.739 . . . . 0.0 109.705 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.519 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -84.92 -12.3 53.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.518 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 2.9 mt -88.17 -43.06 11.9 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.539 -0.725 . . . . 0.0 109.373 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.4 OUTLIER -69.41 -52.25 28.7 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.29 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.47 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 2.2 tttp 177.69 -26.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.568 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 79' ' ' CYS . 10.4 mm-40 -77.91 111.37 17.59 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.039 -1.038 . . . . 0.0 111.243 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 43.8 Cg_endo -71.32 -167.44 0.29 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.974 1.513 . . . . 0.0 110.126 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.433 HG23 HD21 ' A' ' 76' ' ' LEU . 56.1 t -130.08 135.07 26.89 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.325 -0.859 . . . . 0.0 110.53 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.532 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 46.5 Cg_endo -88.32 -165.3 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.948 1.499 . . . . 0.0 109.233 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.505 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -127.7 10.89 6.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.137 -0.977 . . . . 0.0 110.471 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.508 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 58.0 m -115.75 93.83 4.43 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.494 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.59 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -56.88 107.2 0.83 Allowed Pre-proline 0 C--N 1.291 -1.943 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.568 178.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.57 ' HG2' ' CD1' ' A' ' 94' ' ' LEU . 42.8 Cg_endo -82.07 173.32 11.07 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.703 1.37 . . . . 0.0 110.613 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 44.6 Cg_endo -71.21 -5.41 16.94 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.232 1.648 . . . . 0.0 111.418 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.433 ' O ' ' HG ' ' A' ' 94' ' ' LEU . . . -84.01 0.17 49.2 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 109.731 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.575 ' CD2' ' CB ' ' A' ' 8' ' ' ALA . 1.4 mp -138.29 31.24 2.38 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.19 -0.944 . . . . 0.0 110.994 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 99' ' ' LYS . 3.7 t -109.05 114.92 57.68 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.865 -1.147 . . . . 0.0 110.702 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.49 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 43.6 Cg_endo -69.71 175.5 7.98 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.988 1.52 . . . . 0.0 110.059 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 45.3 Cg_endo -71.81 -2.44 11.45 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.903 1.475 . . . . 0.0 110.852 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.4 t -79.33 -24.4 42.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 109.704 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.46 ' HB3' HG13 ' A' ' 95' ' ' VAL . 5.8 tptt -89.86 5.23 47.15 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.433 -0.792 . . . . 0.0 109.557 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.465 ' CG ' ' HA ' ' A' ' 97' ' ' PRO . 2.9 mmp_? . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.267 -0.896 . . . . 0.0 110.24 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 N--CA 1.483 0.905 0 N-CA-C 110.514 -0.61 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.588 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 13.4 t90 -73.17 126.44 30.05 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.33 -0.856 . . . . 0.0 109.979 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -47.7 -25.83 1.34 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.493 -0.754 . . . . 0.0 109.991 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.588 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 56.0 t -88.96 147.04 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.494 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 28.5 mttt -99.93 167.28 11.3 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.237 -0.915 . . . . 0.0 109.847 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.0 Cg_endo -67.74 -33.96 26.04 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.81 1.426 . . . . 0.0 109.709 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -76.64 -24.17 53.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.524 -0.735 . . . . 0.0 109.513 179.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.576 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -80.83 -38.73 27.79 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.47 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 28.4 tptp -65.23 -19.8 66.13 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.58 -44.52 50.46 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.559 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 4.1 ptpt -77.21 -19.2 57.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.593 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 6.9 m-30 -80.15 -33.32 38.59 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -79.57 -10.16 59.75 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.242 0.544 . . . . 0.0 110.151 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 23' ' ' SER . . . -94.93 -31.77 13.51 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.535 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 61.7 mt -80.46 -32.74 13.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -71.45 -39.0 71.28 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.8 t0 -88.93 1.13 55.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.645 -0.66 . . . . 0.0 109.688 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 1.1 m -93.49 0.26 56.65 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.584 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -110.49 -4.99 15.24 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 p 81.93 87.59 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 49.8 Cg_endo -71.7 147.25 50.49 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.16 1.611 . . . . 0.0 110.854 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 99.9 t -116.94 104.77 17.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 14.9 t30 57.03 24.4 9.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.529 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 90.26 39.1 6.12 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.571 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 87.4 m-85 -150.58 156.54 41.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -1.179 . . . . 0.0 111.601 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.545 HD21 ' CD ' ' A' ' 35' ' ' LYS . 75.3 mt -128.77 135.32 49.02 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.54 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 10.2 p -80.36 142.07 34.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.392 -0.817 . . . . 0.0 111.104 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.592 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -51.22 -22.84 7.4 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -84.58 -9.65 58.11 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.363 -1.081 . . . . 0.0 109.36 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.545 ' CD ' HD21 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -97.19 -43.94 7.15 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.333 1.063 . . . . 0.0 108.336 179.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.524 HG12 ' CD1' ' A' ' 65' ' ' LEU . 96.8 t -78.82 -32.52 15.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.334 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.576 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.99 -54.58 4.29 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.421 -0.799 . . . . 0.0 110.852 -179.362 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.2 Cg_endo -63.68 -28.86 69.07 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.644 1.339 . . . . 0.0 109.825 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.564 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 4.8 t -79.72 -12.77 13.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.444 0.64 . . . . 0.0 110.244 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.485 ' CD1' HG13 ' A' ' 36' ' ' VAL . 66.2 mt -98.69 -17.05 18.76 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.85 -1.156 . . . . 0.0 109.1 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.537 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 1.9 mt -88.74 -32.3 18.0 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.421 -0.799 . . . . 0.0 110.036 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 6.1 p30 -67.23 -8.21 29.97 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.061 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.467 ' O ' HD22 ' A' ' 81' ' ' LEU . 50.3 m -77.53 7.23 5.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.462 -0.774 . . . . 0.0 109.905 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 65.33 16.34 10.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -0.963 . . . . 0.0 109.565 -179.489 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.552 ' CD1' ' HB2' ' A' ' 80' ' ' ALA . 16.2 mt -100.28 151.55 37.57 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.444 -0.785 . . . . 0.0 110.625 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.574 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.1 Cg_endo -75.12 159.45 40.91 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.142 1.601 . . . . 0.0 110.085 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.44 ' O ' HG11 ' A' ' 47' ' ' VAL . 15.1 t -60.72 -10.11 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.809 . . . . 0.0 110.933 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.08 -42.4 60.21 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.931 -1.106 . . . . 0.0 108.311 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.574 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.8 mm -64.61 -45.02 96.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.49 ' CD1' ' HG ' ' A' ' 41' ' ' LEU . 4.2 mt -63.14 -21.53 66.25 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.176 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.29 -30.62 24.6 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.557 ' HD3' ' CG ' ' A' ' 88' ' ' MET . 10.3 ttm180 -94.16 -54.0 3.74 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.495 -1.003 . . . . 0.0 109.547 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 57' ' ' SER . 37.7 t -52.75 -33.06 18.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.071 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.592 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 10.7 t-105 -71.26 -57.06 4.84 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.919 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -47.41 -47.74 26.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.9 . . . . 0.0 109.983 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.621 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 4.5 mt -76.77 -10.3 59.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 0.0 109.523 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.545 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 2.8 t -98.66 -34.2 10.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.447 -0.783 . . . . 0.0 110.257 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.599 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 19.6 t0 -79.79 68.16 5.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.357 -0.84 . . . . 0.0 109.338 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.455 ' C ' ' O ' ' A' ' 58' ' ' ASP . 31.2 mm -34.57 -30.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.116 0.484 . . . . 0.0 111.36 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 58' ' ' ASP . 54.1 m-20 -100.48 -19.59 16.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.088 -1.007 . . . . 0.0 111.601 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.599 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 3.8 m170 63.71 35.13 11.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.859 -1.151 . . . . 0.0 109.448 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -102.19 12.13 37.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.92 . . . . 0.0 110.826 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.11 10.11 81.11 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.54 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 4.7 mtt -139.32 160.19 40.4 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.335 -1.097 . . . . 0.0 110.89 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.57 HD13 ' CZ3' ' A' ' 54' ' ' TRP . 87.9 mt -125.33 112.1 15.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.302 -0.874 . . . . 0.0 110.405 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.571 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 16.5 t0 -68.93 169.86 10.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.838 -1.163 . . . . 0.0 109.48 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.576 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 11.4 ptm180 -48.03 -40.61 23.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.681 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.64 -31.31 36.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.328 -0.857 . . . . 0.0 110.407 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.487 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 31.3 mt-10 -75.69 -38.1 58.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.735 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.549 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 52.6 t80 -68.28 -19.51 64.71 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.367 -0.833 . . . . 0.0 109.439 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.38 -39.84 52.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.444 -0.785 . . . . 0.0 109.395 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.544 HG11 ' CD2' ' A' ' 94' ' ' LEU . 38.3 t -64.0 -23.49 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.555 0.693 . . . . 0.0 109.192 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.545 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -90.57 -8.2 50.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.624 -0.673 . . . . 0.0 110.854 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.593 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 14.8 mmt -83.03 -46.89 12.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.064 -1.022 . . . . 0.0 109.907 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.607 ' CE1' HD22 ' A' ' 94' ' ' LEU . 5.4 p90 -76.27 -25.57 55.06 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.582 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 11.0 mt -69.92 -25.83 63.85 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.585 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 51.9 t -91.39 -62.74 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -47.61 -25.44 1.16 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.614 -0.679 . . . . 0.0 111.131 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 84' ' ' GLU . 33.6 m -82.71 -12.31 57.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.986 -1.071 . . . . 0.0 109.843 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . . . -90.13 -10.67 43.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.291 -0.881 . . . . 0.0 109.179 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.585 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 7.0 mp -87.91 -43.46 11.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 109.348 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.7 OUTLIER -69.88 -55.88 8.56 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.665 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 14.7 ttmt 177.92 -23.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 111.229 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 79' ' ' CYS . 11.1 mm-40 -67.82 112.05 9.4 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.963 -1.086 . . . . 0.0 111.198 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 45.3 Cg_endo -73.14 172.1 16.23 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.829 1.436 . . . . 0.0 109.758 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.466 HG23 HG23 ' A' ' 53' ' ' VAL . 97.2 t -121.02 125.77 26.88 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.028 -1.045 . . . . 0.0 110.665 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.483 ' O ' HD12 ' A' ' 56' ' ' LEU . 50.7 Cg_endo -85.24 -169.31 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.979 1.515 . . . . 0.0 109.407 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.557 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 2.7 mtp -116.22 8.05 14.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 0.0 109.983 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 58.5 m -106.08 104.96 14.78 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.812 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.621 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -50.05 106.49 0.64 Allowed Pre-proline 0 C--N 1.292 -1.92 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.494 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 39.4 Cg_endo -68.68 142.99 54.71 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.926 1.487 . . . . 0.0 111.215 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.441 ' HA ' HG22 ' A' ' 95' ' ' VAL . 46.1 Cg_endo -71.99 -7.56 21.29 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.422 1.748 . . . . 0.0 111.311 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.567 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -100.0 21.68 12.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.166 -0.959 . . . . 0.0 108.772 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.607 HD22 ' CE1' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -141.52 -11.34 0.92 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.285 0.564 . . . . 0.0 110.426 -178.179 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.467 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 2.0 t -78.69 143.73 63.51 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.439 -1.413 . . . . 0.0 110.133 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.467 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 43.8 Cg_endo -71.32 162.93 40.81 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.872 1.459 . . . . 0.0 109.274 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.601 ' HA ' ' NE ' ' A' ' 100' ' ' ARG . 44.4 Cg_endo -71.5 57.1 2.3 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.636 1.335 . . . . 0.0 110.711 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.8 t -143.18 -38.68 0.33 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.549 ' O ' ' C ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -92.48 11.49 26.11 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.592 178.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.601 ' NE ' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.225 0 O-C-N 121.923 -0.486 . . . . 0.0 111.629 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 7' ' ' TRP . 49.3 Cg_endo . . . . . 0 N--CA 1.485 0.978 0 N-CA-C 110.567 -0.59 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.556 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 9.5 t90 -41.58 128.13 3.16 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.555 -0.715 . . . . 0.0 109.461 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 93' ' ' ALA . . . -39.39 -26.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.843 . . . . 0.0 110.43 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.556 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 12.3 t -99.04 127.76 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.586 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.506 ' CD ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -84.6 175.96 4.15 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 110.334 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.506 ' HD2' ' CD ' ' A' ' 10' ' ' LYS . 42.6 Cg_endo -70.4 -34.38 12.54 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.079 1.568 . . . . 0.0 109.515 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -78.72 -24.36 44.93 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.593 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 19.8 m-20 -82.97 -48.79 10.28 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.473 ' HG3' ' CZ3' ' A' ' 7' ' ' TRP . 0.1 OUTLIER -63.95 -19.23 64.98 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.63 -43.76 19.96 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.567 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.35 -28.04 60.95 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 8.1 m-30 -70.65 -36.78 73.57 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 66.5 t0 -72.66 -9.29 58.44 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.446 0.641 . . . . 0.0 109.74 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.19 -35.86 11.69 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.575 HG23 ' CE1' ' A' ' 70' ' ' PHE . 29.3 mt -77.73 -32.49 18.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.587 ' CD2' HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -69.75 -43.82 71.5 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.345 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.507 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 47.5 t0 -83.49 2.62 35.98 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.41 0.624 . . . . 0.0 109.558 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.405 ' HB2' ' HA ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -90.56 -8.41 50.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.331 -0.855 . . . . 0.0 109.208 179.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.565 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.9 mt -104.65 -8.07 19.17 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m 83.14 93.77 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.995 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.5 Cg_endo -74.27 145.41 34.47 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.374 1.723 . . . . 0.0 110.533 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 21.1 t -113.15 102.56 14.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.516 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.7 OUTLIER 62.4 19.95 11.5 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.323 -0.861 . . . . 0.0 109.268 -179.053 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 92.28 34.05 7.31 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.561 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 77.9 m-85 -144.56 149.5 35.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.165 -1.197 . . . . 0.0 111.566 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.587 HD13 ' CD2' ' A' ' 21' ' ' PHE . 52.3 mt -125.7 131.87 52.49 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.565 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -77.42 138.46 39.28 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.443 -0.785 . . . . 0.0 110.029 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -43.01 -25.64 0.38 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 6.0 m-20 -65.52 -20.88 66.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -1.175 . . . . 0.0 110.337 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 9.1 mtpp -97.98 -39.78 8.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.176 -0.952 . . . . 0.0 109.073 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.538 HG13 ' CD1' ' A' ' 65' ' ' LEU . 60.4 t -78.15 -36.6 21.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 121.485 0.659 . . . . 0.0 109.769 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.591 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.5 tttt -48.08 -54.69 22.59 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.859 . . . . 0.0 110.171 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.0 Cg_endo -63.6 -29.24 70.01 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.58 1.305 . . . . 0.0 108.907 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.591 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 4.7 t -80.63 -11.27 12.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 121.659 0.742 . . . . 0.0 109.46 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.534 ' CD1' HG11 ' A' ' 36' ' ' VAL . 42.0 mt -99.94 -14.97 18.48 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.166 -0.959 . . . . 0.0 108.677 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.478 HD11 ' HA ' ' A' ' 38' ' ' PRO . 7.9 mt -89.42 -33.9 16.67 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.642 -0.661 . . . . 0.0 110.089 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 6.6 p30 -64.24 -9.85 19.9 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.735 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 1.4 m -72.35 -1.83 16.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 110.052 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 43' ' ' SER . 17.4 ttmt 69.55 14.62 8.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.307 -0.871 . . . . 0.0 110.455 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.552 ' CD1' ' HB2' ' A' ' 80' ' ' ALA . 14.9 mt -100.46 163.64 17.81 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.217 -0.927 . . . . 0.0 110.317 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.552 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.1 Cg_endo -75.18 160.92 39.03 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.982 1.517 . . . . 0.0 110.047 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.6 t -64.96 -7.17 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.132 -0.98 . . . . 0.0 110.373 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.06 -40.31 62.9 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.552 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 15.3 mm -64.13 -43.62 97.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 50' ' ' LEU . 5.1 mt -66.26 -21.19 66.28 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.735 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.14 -27.97 29.48 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.547 ' CD ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -94.54 -54.73 3.4 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.465 -1.021 . . . . 0.0 109.329 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 57' ' ' SER . 33.2 t -52.36 -41.01 33.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.517 -0.873 . . . . 0.0 108.685 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.539 ' CZ2' ' OD2' ' A' ' 58' ' ' ASP . 9.0 t-105 -62.6 -56.44 17.8 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.449 -0.782 . . . . 0.0 109.795 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.518 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 12.0 mm-40 -45.33 -56.48 4.87 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.389 -0.82 . . . . 0.0 110.104 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 1.4 mt -72.1 -10.94 60.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.687 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 8.0 m -96.8 -23.15 16.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.377 -0.827 . . . . 0.0 110.263 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.579 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 6.7 t0 -93.26 76.06 4.58 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.356 -0.84 . . . . 0.0 109.569 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.466 ' HB ' ' OE1' ' A' ' 69' ' ' GLU . 34.4 mm -41.23 -32.52 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.712 -0.618 . . . . 0.0 110.236 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 35.5 m-20 -93.48 -22.06 19.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.386 -0.821 . . . . 0.0 110.717 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 46.1 m-70 55.47 42.81 29.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 109.716 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -112.45 3.36 16.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.464 -0.773 . . . . 0.0 110.887 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.93 3.84 48.63 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.565 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 4.6 mtt -133.94 159.45 40.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -1.131 . . . . 0.0 110.82 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.538 ' CD1' HG13 ' A' ' 36' ' ' VAL . 10.5 mt -124.38 110.97 15.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.561 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -72.56 172.62 10.23 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.866 -1.146 . . . . 0.0 109.781 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.514 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -49.36 -38.07 26.96 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.603 -0.686 . . . . 0.0 111.313 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.15 -31.21 21.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.007 -1.058 . . . . 0.0 110.221 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.482 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 27.9 mt-10 -75.76 -42.35 50.61 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.285 -0.884 . . . . 0.0 109.593 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.581 ' CE1' ' SD ' ' A' ' 74' ' ' MET . 61.4 t80 -62.66 -31.45 72.33 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.069 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.36 -49.05 79.12 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.79 0.805 . . . . 0.0 109.89 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.526 HG21 ' CD2' ' A' ' 94' ' ' LEU . 85.6 t -57.73 -24.2 22.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 121.333 0.587 . . . . 0.0 110.427 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.509 ' HA ' ' OG ' ' A' ' 57' ' ' SER . . . -90.46 -6.15 55.21 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.183 -0.948 . . . . 0.0 111.852 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.581 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 11.3 mmm -89.97 -43.15 10.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.648 -1.283 . . . . 0.0 110.121 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.576 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.6 p90 -76.84 -27.71 55.22 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.876 -1.13 . . . . 0.0 108.115 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.576 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 9.6 mt -69.47 -27.15 64.98 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.491 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 30.3 t -91.59 -32.79 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.501 -0.75 . . . . 0.0 110.431 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -81.83 -33.01 30.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.13 -0.981 . . . . 0.0 110.043 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 65.1 m -75.45 -20.09 59.04 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . . . -71.64 -16.7 62.28 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.523 ' CD2' HD13 ' A' ' 45' ' ' LEU . 5.6 mt -90.56 -44.4 9.58 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.542 0.687 . . . . 0.0 109.787 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.54 35.91 4.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.612 -0.68 . . . . 0.0 111.731 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 79' ' ' CYS . 0.9 OUTLIER -146.24 -69.46 0.26 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.655 -1.278 . . . . 0.0 110.822 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -176.54 177.68 0.48 Allowed Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 110.212 -179.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 42.9 Cg_endo -70.12 170.92 15.86 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.875 1.461 . . . . 0.0 109.575 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.478 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 85.5 t -112.47 131.06 22.8 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 110.2 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.507 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 49.4 Cg_endo -84.44 169.86 10.8 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.87 1.458 . . . . 0.0 109.405 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.547 ' HG2' ' CD ' ' A' ' 52' ' ' ARG . 4.2 mtm -98.85 12.76 34.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.917 -1.114 . . . . 0.0 110.261 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.481 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 72.2 m -108.63 103.83 13.01 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.715 -1.194 . . . . 0.0 112.044 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.594 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 2.2 mt -51.74 106.38 0.65 Allowed Pre-proline 0 C--N 1.292 -1.927 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.233 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.507 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 41.2 Cg_endo -72.07 150.36 54.09 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.759 1.4 . . . . 0.0 110.51 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.438 ' HA ' ' CG2' ' A' ' 95' ' ' VAL . 43.8 Cg_endo -70.16 -5.82 17.36 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.146 1.603 . . . . 0.0 111.068 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 8' ' ' ALA . . . -100.62 24.59 8.83 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.598 ' O ' ' CD1' ' A' ' 94' ' ' LEU 0.25 0.3 OUTLIER -158.19 34.36 0.24 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.338 1.066 . . . . 0.0 109.015 -178.128 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.456 HG11 ' HE2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -132.07 130.97 22.26 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.623 -1.298 . . . . 0.0 110.347 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.503 ' O ' ' NZ ' ' A' ' 99' ' ' LYS . 40.2 Cg_endo -68.04 174.66 7.56 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.784 1.413 . . . . 0.0 109.053 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 98' ' ' SER . 45.7 Cg_endo -72.34 179.27 5.2 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.54 1.284 . . . . 0.0 111.351 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.1 OUTLIER 75.09 -52.01 0.67 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.776 -0.578 . . . . 0.0 110.99 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.561 ' NZ ' ' HB3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -88.27 8.97 24.76 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.031 -1.043 . . . . 0.0 108.578 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.525 -0.734 . . . . 0.0 109.265 179.263 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 N--CA 1.482 0.816 0 N-CA-C 110.628 -0.566 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.541 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 -76.69 124.03 27.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.875 . . . . 0.0 110.113 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.522 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -46.45 -24.56 0.52 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.447 -0.783 . . . . 0.0 110.652 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.541 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 73.3 t -103.6 130.99 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.793 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.608 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.5 mttt -93.64 174.47 3.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.476 -0.765 . . . . 0.0 109.007 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 38.2 Cg_endo -65.44 -37.48 30.01 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.287 1.151 . . . . 0.0 109.957 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 8.0 pt-20 -64.71 -25.94 68.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.215 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.596 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -84.0 -38.34 21.05 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.508 ' O ' ' CB ' ' A' ' 18' ' ' ASP . 9.9 tptm -72.88 -17.03 61.57 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.576 0.703 . . . . 0.0 109.258 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.55 -37.84 65.43 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 2.3 mtmt -80.82 -39.18 27.05 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.596 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 5.3 m-30 -66.26 -22.69 66.32 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 6.3 t0 -85.81 -15.45 41.93 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.631 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -90.33 -28.14 18.93 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.567 HG21 ' CE1' ' A' ' 70' ' ' PHE . 15.7 mt -82.7 -31.85 9.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -74.31 -40.49 62.19 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 4.2 t0 -84.9 -0.57 54.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.643 -0.66 . . . . 0.0 109.839 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -89.34 -7.18 55.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.844 . . . . 0.0 109.04 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.561 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.5 mt -107.08 -8.66 16.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER 82.17 95.07 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.4 Cg_endo -74.49 150.17 40.41 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.994 1.523 . . . . 0.0 110.838 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 40.8 t -118.81 101.55 11.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER 65.22 26.58 12.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 108.891 -178.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . 85.14 35.72 12.03 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.578 ' CD1' ' HB2' ' A' ' 66' ' ' ASP . 93.8 m-85 -150.04 159.26 44.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.641 -0.917 . . . . 0.0 110.598 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.567 ' CD1' ' CD2' ' A' ' 21' ' ' PHE . 12.7 mt -135.02 128.95 33.34 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.473 ' HB3' ' HE2' ' A' ' 64' ' ' MET . 0.3 OUTLIER -73.09 139.21 46.33 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.452 -0.78 . . . . 0.0 110.541 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -43.07 -32.87 1.64 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.43 -15.83 7.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -1.153 . . . . 0.0 110.016 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 9.6 mtpp -111.77 -35.39 5.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.277 -0.889 . . . . 0.0 108.95 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 84.8 t -91.32 -46.27 14.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.698 -0.626 . . . . 0.0 110.179 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.611 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 ttpt -45.22 -47.83 33.17 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 110.661 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -69.01 -31.63 23.43 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.38 1.2 . . . . 0.0 109.377 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.491 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 1.9 t -65.71 -31.01 51.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.778 -0.576 . . . . 0.0 109.629 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.512 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 18.8 mt -80.59 -14.74 57.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.213 -0.93 . . . . 0.0 109.026 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 33.7 mt -76.25 -26.49 56.06 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 35.8 m-80 -63.32 -17.05 62.14 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.138 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.529 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -76.55 1.97 15.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.265 -0.897 . . . . 0.0 110.327 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 43' ' ' SER . 6.0 tttm 64.71 11.82 7.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 0.0 110.083 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.522 HD13 ' CD2' ' A' ' 81' ' ' LEU . 15.1 mt -86.89 158.41 53.38 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.864 . . . . 0.0 110.087 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.7 Cg_endo -73.61 159.11 46.53 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.068 1.562 . . . . 0.0 110.851 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -58.93 -10.74 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.984 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.27 -42.38 59.71 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.959 -1.088 . . . . 0.0 108.073 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.554 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 21.1 mm -61.84 -42.62 95.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.512 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 12.7 mt -66.77 -22.81 66.03 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -82.65 -24.59 53.06 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.562 ' CD ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -99.01 -59.59 1.7 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.545 -0.974 . . . . 0.0 109.711 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.547 ' O ' ' CB ' ' A' ' 57' ' ' SER . 46.2 t -46.58 -36.44 2.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.012 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.529 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 9.3 t-105 -73.07 -59.33 2.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 110.211 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.478 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 52.5 mm-40 -44.16 -45.5 8.34 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.195 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.564 ' HA ' ' HG ' ' A' ' 90' ' ' LEU . 1.8 mt -81.52 -16.5 51.59 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.339 -0.944 . . . . 0.0 109.586 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.2 t -88.39 -25.9 22.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.455 -0.778 . . . . 0.0 109.457 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.562 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 15.7 t0 -85.0 81.38 8.93 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.505 -0.747 . . . . 0.0 109.745 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.599 ' CG2' ' HG2' ' A' ' 99' ' ' LYS . 33.2 mm -47.8 -30.94 2.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 120.134 -0.627 . . . . 0.0 110.504 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 4.4 p-10 -103.92 -16.28 15.4 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.039 -1.064 . . . . 0.0 111.309 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.562 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 34.8 m-70 54.73 41.51 31.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.894 -1.129 . . . . 0.0 109.948 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' OD2' ' HG3' ' A' ' 64' ' ' MET . 1.1 p-10 -100.96 -10.76 20.29 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.357 -0.839 . . . . 0.0 110.171 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.422 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 117.9 8.93 10.29 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.552 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.0 mtp -145.55 161.36 39.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -1.174 . . . . 0.0 110.116 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.5 HD22 ' HA ' ' A' ' 58' ' ' ASP . 15.6 mt -117.4 106.0 12.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.172 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.578 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -69.59 172.91 6.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.779 -1.201 . . . . 0.0 110.297 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.52 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.5 ptm180 -47.73 -39.57 18.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.614 -0.679 . . . . 0.0 111.032 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.46 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 5.6 m-20 -84.87 -31.97 23.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 0.0 110.338 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.532 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 18.9 mt-10 -77.2 -44.16 31.08 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.392 -0.818 . . . . 0.0 109.091 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.581 ' CE1' ' SD ' ' A' ' 74' ' ' MET . 62.0 t80 -64.46 -29.12 70.17 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.551 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -62.28 -50.4 71.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.42 -0.8 . . . . 0.0 110.226 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.447 HG11 HD13 ' A' ' 76' ' ' LEU . 41.8 t -56.31 -24.11 17.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.51 -0.744 . . . . 0.0 109.8 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -86.69 -9.88 54.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.195 -0.941 . . . . 0.0 111.831 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.581 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 9.1 mmm -87.85 -39.11 15.1 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.602 -1.312 . . . . 0.0 110.574 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.583 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.2 p90 -78.93 -20.23 49.84 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.834 -1.146 . . . . 0.0 108.212 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.583 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 10.5 mt -79.83 -25.47 40.79 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.611 0.719 . . . . 0.0 109.217 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.537 HG21 ' CG1' ' A' ' 53' ' ' VAL . 78.5 t -91.49 -26.99 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.478 -0.764 . . . . 0.0 110.327 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.46 -29.96 21.02 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.267 -0.895 . . . . 0.0 110.039 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 3.0 t -81.19 -14.78 57.22 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.265 -0.897 . . . . 0.0 108.861 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.481 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . . . -85.22 -7.68 58.92 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.4 -0.812 . . . . 0.0 109.12 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.539 HD22 ' N ' ' A' ' 81' ' ' LEU . 2.8 mt -90.46 -50.29 6.03 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.584 -0.698 . . . . 0.0 109.968 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -71.08 -51.26 26.19 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.425 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 2.8 tptt 176.89 79.51 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.98 -1.075 . . . . 0.0 111.376 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.537 ' CB ' ' O ' ' A' ' 79' ' ' CYS . 5.3 tp10 -166.71 116.36 0.74 Allowed Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.61 -1.306 . . . . 0.0 111.439 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.57 160.97 40.64 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.878 1.462 . . . . 0.0 109.662 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.528 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 44.5 t -118.25 126.92 26.91 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.855 -1.153 . . . . 0.0 110.833 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.538 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 51.7 Cg_endo -90.45 147.49 4.25 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.933 1.491 . . . . 0.0 109.72 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.562 ' HG2' ' CD ' ' A' ' 52' ' ' ARG . 4.7 mtm -81.96 11.2 5.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.88 -1.138 . . . . 0.0 110.348 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.475 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 68.3 m -106.84 106.4 16.91 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.598 -178.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 56' ' ' LEU . 2.1 mt -54.66 107.81 0.97 Allowed Pre-proline 0 C--N 1.294 -1.841 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.919 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.506 ' HG2' ' CG ' ' A' ' 94' ' ' LEU . 40.1 Cg_endo -67.93 161.03 45.87 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 124.076 1.566 . . . . 0.0 110.14 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.11 -20.59 16.5 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.002 1.527 . . . . 0.0 111.098 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.485 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -88.84 15.29 8.62 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.152 -0.968 . . . . 0.0 109.734 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 3.9 mm? -118.33 -23.03 7.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.205 -0.934 . . . . 0.0 110.611 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.4 t -76.56 132.02 73.15 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.341 -0.849 . . . . 0.0 110.855 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.414 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 41.0 Cg_endo -69.28 173.05 11.1 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.992 1.522 . . . . 0.0 109.479 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 98' ' ' SER . 44.6 Cg_endo -72.07 166.03 30.84 Favored 'Trans proline' 0 C--N 1.301 -1.961 0 O-C-N 123.823 1.433 . . . . 0.0 111.093 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 1.0 OUTLIER 73.99 -52.74 0.69 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.459 -0.775 . . . . 0.0 110.606 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.599 ' HG2' ' CG2' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -88.07 9.91 20.94 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.113 -0.992 . . . . 0.0 108.498 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 110.156 179.779 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 N--CA 1.483 0.9 0 N-CA-C 110.592 -0.58 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.559 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.1 t90 -83.05 122.06 27.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.339 -0.85 . . . . 0.0 109.887 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.575 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -42.4 -28.84 0.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 110.277 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.559 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 39.0 t -100.09 146.05 9.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.348 -0.845 . . . . 0.0 109.72 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.507 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.1 mtmt -119.47 178.07 1.2 Allowed Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.192 -0.942 . . . . 0.0 109.693 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 38.3 Cg_endo -64.9 -36.42 39.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.84 1.442 . . . . 0.0 110.252 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.483 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 18.3 pt-20 -65.35 -35.73 81.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.327 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 92.4 m-20 -81.95 -34.41 29.81 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.49 ' NZ ' ' OD1' ' A' ' 68' ' ' ASP . 1.1 tppp? -70.91 -20.6 62.47 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 11' ' ' PRO . . . -69.21 -40.02 78.26 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.622 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.7 ptmm? -79.79 -24.82 41.19 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.622 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.7 m-30 -72.18 -35.86 69.09 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 35.0 t0 -74.47 -8.75 57.32 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.238 0.542 . . . . 0.0 110.455 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.08 -41.22 9.22 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.48 ' O ' ' HG ' ' A' ' 24' ' ' LEU 0.251 15.5 mt -72.51 -29.62 31.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -70.73 -39.72 73.19 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.463 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.2 t70 -88.6 2.99 52.05 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.572 -0.705 . . . . 0.0 109.816 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.5 m -91.01 -4.95 56.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 108.663 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.575 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.9 OUTLIER -110.74 -6.02 14.87 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER 80.88 96.33 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.2 Cg_endo -72.9 147.63 44.27 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 O-C-N 124.611 1.848 . . . . 0.0 110.691 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.7 t -117.61 103.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.518 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 1.1 t30 62.2 21.9 12.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.942 . . . . 0.0 109.223 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.58 34.56 7.33 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CE1' ' CB ' ' A' ' 66' ' ' ASP . 96.9 m-85 -150.43 160.64 43.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -1.113 . . . . 0.0 111.134 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.491 ' CD2' ' HB2' ' A' ' 24' ' ' LEU . 42.8 mt -126.61 132.91 51.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.508 -0.745 . . . . 0.0 109.529 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.579 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.5 OUTLIER -80.54 138.9 36.55 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.358 -0.839 . . . . 0.0 110.458 -179.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -40.62 -25.68 0.11 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 32' ' ' SER . 8.7 m-20 -63.93 -17.94 63.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -1.141 . . . . 0.0 110.969 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -111.6 -36.42 5.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.937 -1.102 . . . . 0.0 109.942 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.516 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 82.2 t -79.09 -54.19 12.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.316 -0.865 . . . . 0.0 109.964 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.597 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -40.43 -49.88 6.74 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.581 -0.699 . . . . 0.0 110.459 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.2 Cg_endo -68.27 -31.97 27.59 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.376 1.198 . . . . 0.0 109.413 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.494 HG22 ' CD2' ' A' ' 24' ' ' LEU . 2.2 t -67.51 -31.65 53.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.576 -0.703 . . . . 0.0 109.572 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.54 ' CB ' ' CD2' ' A' ' 50' ' ' LEU . 11.4 mt -78.72 -15.66 58.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.049 -1.032 . . . . 0.0 108.636 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.506 ' HG ' ' CD1' ' A' ' 50' ' ' LEU . 14.8 mt -75.47 -24.29 56.94 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.423 -0.798 . . . . 0.0 108.901 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 32.6 m-80 -66.98 -19.03 65.65 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.001 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.549 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -74.07 0.08 14.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.273 -0.892 . . . . 0.0 110.252 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.3 OUTLIER 69.49 4.35 4.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.12 -0.987 . . . . 0.0 110.577 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.488 HD21 ' CD ' ' A' ' 46' ' ' PRO . 15.7 mt -79.2 160.37 70.89 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.011 . . . . 0.0 110.224 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.54 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 41.7 Cg_endo -73.43 161.57 42.18 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.04 1.547 . . . . 0.0 110.287 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.78 -11.39 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.41 -0.806 . . . . 0.0 110.527 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.75 -40.07 66.32 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.54 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 28.3 mm -64.0 -44.82 97.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.54 ' CD2' ' CB ' ' A' ' 40' ' ' LEU . 13.5 mt -61.52 -17.78 56.28 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . -88.57 -27.4 24.8 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -96.34 -54.54 3.24 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.665 -0.903 . . . . 0.0 109.332 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.564 ' O ' ' CB ' ' A' ' 57' ' ' SER . 45.0 t -48.16 -33.42 4.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.901 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.514 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 10.4 t-105 -76.96 -59.59 2.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.315 -0.866 . . . . 0.0 110.32 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 64.8 mm-40 -45.65 -41.18 10.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.266 -0.896 . . . . 0.0 109.841 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.531 HD21 ' N ' ' A' ' 90' ' ' LEU . 20.9 mt -83.23 -17.61 42.13 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.557 -0.714 . . . . 0.0 109.454 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 8.3 t -92.33 -23.54 19.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.342 -0.849 . . . . 0.0 109.457 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.589 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 23.5 t0 -84.49 65.88 9.19 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.318 -0.864 . . . . 0.0 110.12 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.523 HG12 ' HG2' ' A' ' 69' ' ' GLU . 40.2 mm -39.28 -30.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.373 0.606 . . . . 0.0 110.013 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 21.8 m-20 -95.71 -25.76 15.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.436 -0.79 . . . . 0.0 110.507 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 75.2 m-70 59.62 48.9 8.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.919 . . . . 0.0 109.829 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -117.38 -10.69 10.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 110.434 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.25 8.87 16.37 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.579 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 2.8 mtt -143.55 160.8 39.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.381 -1.07 . . . . 0.0 110.323 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 58' ' ' ASP . 69.7 mt -123.85 116.87 23.65 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.13 -0.981 . . . . 0.0 110.937 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.532 ' CB ' ' CE1' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -72.23 160.21 32.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.897 -1.127 . . . . 0.0 109.743 178.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.574 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 9.7 ptm180 -41.73 -37.76 1.29 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.345 -0.847 . . . . 0.0 111.479 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.49 ' OD1' ' NZ ' ' A' ' 14' ' ' LYS . 52.8 m-20 -81.1 -30.13 34.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.855 -1.153 . . . . 0.0 109.528 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' HG2' HG12 ' A' ' 59' ' ' ILE . 9.4 mt-10 -74.29 -46.37 41.63 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.609 0.718 . . . . 0.0 109.132 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.515 ' O ' ' HG2' ' A' ' 74' ' ' MET . 42.3 t80 -59.87 -18.01 41.11 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.742 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.464 ' CB ' ' HE2' ' A' ' 14' ' ' LYS . . . -72.33 -49.81 31.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.425 -0.797 . . . . 0.0 109.809 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.528 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 46.8 t -61.01 -22.0 25.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.91 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.541 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -90.12 -5.18 56.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.221 -0.924 . . . . 0.0 111.008 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 70' ' ' PHE . 2.1 mmt -87.84 -45.97 9.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.913 -1.117 . . . . 0.0 110.077 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.622 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 2.2 p90 -75.04 -33.8 61.79 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.588 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 29.4 mt -59.02 -30.19 67.83 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.559 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 98.0 t -91.55 -45.06 14.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.784 -0.572 . . . . 0.0 110.059 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.494 ' HA ' HD11 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -72.92 -25.91 61.22 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.397 -0.814 . . . . 0.0 111.045 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 74.5 m -84.79 -18.37 35.23 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.05 -1.031 . . . . 0.0 109.726 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 84' ' ' GLU . . . -79.35 -12.65 59.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.889 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.559 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 1.2 mt -90.54 -47.13 7.88 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.742 0.782 . . . . 0.0 110.116 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 26.4 pt-20 -68.3 -43.73 77.0 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.656 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.51 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 0.0 OUTLIER 177.71 -34.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.633 -1.227 . . . . 0.0 112.64 179.236 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 14.0 mt-10 -84.19 108.56 14.67 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.866 -1.146 . . . . 0.0 111.729 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 46.2 Cg_endo -71.66 -162.01 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.905 1.476 . . . . 0.0 110.68 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.546 ' CG1' ' HD2' ' A' ' 87' ' ' PRO . 35.4 t -106.87 153.24 40.95 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.546 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 43.6 Cg_endo -86.35 -166.28 0.31 Allowed 'Trans proline' 0 C--N 1.302 -1.911 0 O-C-N 123.586 1.308 . . . . 0.0 109.897 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 73.3 mtp -123.63 11.32 9.15 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.292 -0.88 . . . . 0.0 111.03 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -168.43 23.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.552 -1.259 . . . . 0.0 111.926 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.531 ' N ' HD21 ' A' ' 56' ' ' LEU . 0.6 OUTLIER 53.81 119.35 0.0 OUTLIER Pre-proline 0 C--N 1.283 -2.32 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.788 178.343 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.537 ' HG2' HD21 ' A' ' 94' ' ' LEU . 43.8 Cg_endo -73.56 169.84 21.38 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.725 1.382 . . . . 0.0 109.883 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.37 -16.85 27.63 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.853 1.449 . . . . 0.0 111.919 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.489 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -92.09 12.23 22.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.787 -1.195 . . . . 0.0 110.853 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.622 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 3.4 mm? -113.75 -17.8 12.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.087 -1.008 . . . . 0.0 111.56 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 t -80.15 127.23 77.39 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.092 -1.005 . . . . 0.0 110.91 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.508 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 43.1 Cg_endo -71.21 177.27 6.76 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.101 1.579 . . . . 0.0 109.628 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.517 ' O ' ' CB ' ' A' ' 98' ' ' SER . 41.2 Cg_endo -66.89 169.19 15.28 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.549 1.289 . . . . 0.0 110.643 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.1 OUTLIER 72.43 -55.18 0.68 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.674 -179.211 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.3 mmtm -88.93 15.53 8.38 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.534 -0.729 . . . . 0.0 110.389 -179.689 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.485 0.997 0 N-CA-C 110.121 -0.761 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.512 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.4 t90 -86.98 120.59 28.41 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.105 -0.997 . . . . 0.0 109.991 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.548 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -46.55 -27.5 1.14 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.42 -0.8 . . . . 0.0 110.151 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.512 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 37.4 t -93.04 129.71 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.395 -0.815 . . . . 0.0 110.332 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.505 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -93.94 179.13 1.31 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.755 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 39.5 Cg_endo -67.65 -35.49 22.11 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.795 1.418 . . . . 0.0 110.224 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -75.15 -26.37 59.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.842 . . . . 0.0 110.058 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.453 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 4.1 m-20 -86.08 -37.43 18.85 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HG3' ' CZ3' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -76.18 -13.55 60.18 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.588 -0.695 . . . . 0.0 109.175 178.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.81 -40.81 63.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 108.901 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.57 -26.46 50.87 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.36 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.5 m-30 -71.83 -27.6 63.02 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.14 -10.71 59.6 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.338 0.589 . . . . 0.0 109.937 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.02 -36.54 11.51 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.485 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 82.3 mt -74.81 -33.98 32.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -65.39 -39.09 91.79 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.474 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.2 t0 -89.31 2.65 54.06 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.694 -0.629 . . . . 0.0 109.706 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.476 ' HB2' ' HA ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -93.83 0.83 56.44 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.847 0.832 . . . . 0.0 108.978 178.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.576 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -116.63 -2.49 11.93 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 80.17 90.53 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.855 0 CA-C-O 121.368 0.604 . . . . 0.0 109.838 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.6 Cg_endo -75.27 148.59 34.48 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 124.558 1.82 . . . . 0.0 110.458 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 44.0 t -117.86 108.51 24.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.663 -0.648 . . . . 0.0 109.422 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 16.7 t30 55.44 21.49 4.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.07 -1.018 . . . . 0.0 109.741 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.446 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 97.03 33.58 5.98 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.59 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 66.2 m-85 -149.76 150.51 32.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -1.104 . . . . 0.0 111.41 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.532 HD12 ' CD1' ' A' ' 24' ' ' LEU . 30.7 mt -118.56 129.94 55.62 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.71 -0.796 . . . . 0.0 108.994 178.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.554 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -78.76 138.47 38.24 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.606 -0.684 . . . . 0.0 110.616 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -44.08 -25.33 0.67 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 32' ' ' SER . 10.3 t70 -62.27 -17.75 59.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.288 -1.125 . . . . 0.0 110.226 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -114.47 -33.98 5.4 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.325 -0.86 . . . . 0.0 109.377 179.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.531 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 98.6 t -79.19 -51.83 16.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 119.516 -0.873 . . . . 0.0 109.765 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.604 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 48.6 tttt -42.68 -49.88 13.04 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 110.338 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.6 Cg_endo -67.39 -31.09 35.49 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 N-CA-C 108.854 -1.248 . . . . 0.0 108.854 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.589 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 2.8 t -76.22 -10.43 13.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.523 0.677 . . . . 0.0 109.507 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.512 ' CD2' HG22 ' A' ' 77' ' ' VAL . 97.2 mt -99.21 -15.09 19.03 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.544 ' CD1' ' HA ' ' A' ' 38' ' ' PRO . 6.9 mt -84.63 -33.32 23.33 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.479 -0.763 . . . . 0.0 109.595 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 7.8 p30 -71.12 -2.97 17.47 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.865 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 9.4 m -80.37 5.5 14.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.31 -0.869 . . . . 0.0 110.033 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 43' ' ' SER . 27.8 tttt 65.54 12.61 8.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.547 HD12 ' CB ' ' A' ' 80' ' ' ALA . 15.5 mt -99.82 156.24 35.56 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 110.036 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 40.4 Cg_endo -73.09 162.44 40.8 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.952 1.501 . . . . 0.0 110.153 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.1 t -63.88 -7.93 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.432 -0.792 . . . . 0.0 110.725 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.23 -40.59 51.67 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.554 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 10.9 mm -65.59 -43.53 94.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.504 HD23 ' O ' ' A' ' 40' ' ' LEU . 3.7 mt -66.03 -21.32 66.38 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.33 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.6 -28.11 22.73 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 86' ' ' VAL . 3.8 ttm180 -95.3 -47.42 6.32 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.519 -0.989 . . . . 0.0 109.606 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 76' ' ' LEU . 45.7 t -57.45 -39.11 66.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.277 -0.89 . . . . 0.0 109.201 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.576 ' CZ3' HD13 ' A' ' 65' ' ' LEU . 6.7 t-105 -68.69 -53.22 23.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.502 -0.749 . . . . 0.0 110.172 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.479 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 5.7 mm-40 -47.58 -50.02 25.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.381 -0.824 . . . . 0.0 109.906 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.627 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 3.3 mt -76.38 -8.49 57.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.669 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.545 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 1.3 t -99.76 -27.62 13.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.475 -0.766 . . . . 0.0 110.422 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.487 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 11.8 t0 -83.82 90.01 7.28 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.387 -0.821 . . . . 0.0 109.384 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.493 ' CG2' ' HD3' ' A' ' 99' ' ' LYS . 46.1 mm -53.45 -32.71 20.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.496 -0.752 . . . . 0.0 110.549 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 24.8 p-10 -106.42 -13.75 15.27 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.185 -0.947 . . . . 0.0 111.021 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.536 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 78.0 m-70 56.45 43.69 25.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.076 -1.015 . . . . 0.0 110.358 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.461 ' OD1' ' OD2' ' A' ' 60' ' ' ASP . 1.1 p-10 -104.3 18.45 22.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.931 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.61 10.42 83.34 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.554 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 4.2 mtt -139.43 161.82 36.55 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.538 -0.977 . . . . 0.0 110.911 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.576 HD13 ' CZ3' ' A' ' 54' ' ' TRP . 71.1 mt -130.76 119.48 22.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.346 -0.846 . . . . 0.0 110.387 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.59 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -79.59 166.59 21.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.896 -1.127 . . . . 0.0 109.484 179.026 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.476 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -43.26 -30.45 0.5 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.457 -0.777 . . . . 0.0 111.275 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 58.7 m-20 -90.06 -31.15 17.28 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.14 -0.975 . . . . 0.0 109.766 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.466 ' OE1' ' N ' ' A' ' 59' ' ' ILE . 10.0 mt-10 -76.93 -38.56 53.17 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.412 -0.805 . . . . 0.0 109.378 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.544 ' CZ ' HD13 ' A' ' 24' ' ' LEU . 56.9 t80 -70.71 -24.56 62.67 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.705 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.27 -41.22 77.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 109.552 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.481 HG13 HD13 ' A' ' 76' ' ' LEU . 59.3 t -62.94 -29.66 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.639 -0.663 . . . . 0.0 110.043 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.545 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -90.33 -4.46 57.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.154 -0.966 . . . . 0.0 110.9 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.515 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 9.7 mmt -83.37 -46.49 12.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.003 -1.061 . . . . 0.0 109.76 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CZ ' HD12 ' A' ' 94' ' ' LEU . 4.3 p90 -77.2 -24.24 51.37 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.603 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 15.3 mt -72.89 -25.76 61.19 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.512 HG22 ' CD2' ' A' ' 40' ' ' LEU . 42.4 t -91.06 -34.46 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.639 -0.663 . . . . 0.0 109.663 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -80.12 -26.39 39.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -0.779 . . . . 0.0 110.034 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.518 ' HB3' ' CB ' ' A' ' 84' ' ' GLU . 65.1 m -82.11 -12.78 58.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.203 -0.935 . . . . 0.0 109.127 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.547 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -85.91 -13.73 46.91 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.333 -0.854 . . . . 0.0 108.923 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.544 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.2 mt -89.58 -42.48 11.39 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.904 0.859 . . . . 0.0 109.014 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -68.86 -54.83 13.42 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.423 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 23.1 tttt 177.87 -24.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.617 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.518 ' CB ' ' HB3' ' A' ' 79' ' ' CYS . 0.2 OUTLIER -72.65 112.95 17.08 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.959 -1.088 . . . . 0.0 111.406 -178.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 48.4 Cg_endo -75.67 -174.57 2.07 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.987 1.519 . . . . 0.0 109.789 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.471 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 44.2 t -132.49 128.14 20.93 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.941 -1.1 . . . . 0.0 110.702 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.47 ' O ' HD12 ' A' ' 56' ' ' LEU . 52.1 Cg_endo -84.67 -170.69 0.84 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.958 1.504 . . . . 0.0 109.831 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.471 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 4.8 mtt -115.2 13.89 16.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.069 -1.019 . . . . 0.0 110.634 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.495 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 5.3 m -113.13 103.05 10.97 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 118.729 -1.188 . . . . 0.0 111.688 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.627 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -57.07 108.26 1.18 Allowed Pre-proline 0 C--N 1.291 -1.94 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.824 179.21 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.551 ' HG2' ' CD2' ' A' ' 94' ' ' LEU . 49.6 Cg_endo -80.05 157.72 23.64 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 123.928 1.489 . . . . 0.0 110.328 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.26 -11.04 24.74 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.079 1.568 . . . . 0.0 110.828 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.474 ' O ' ' HB1' ' A' ' 8' ' ' ALA . . . -84.15 -0.76 53.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.627 HD12 ' CZ ' ' A' ' 75' ' ' PHE . 3.9 mm? -117.46 -9.69 10.81 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.313 -0.867 . . . . 0.0 110.164 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.513 ' CG1' ' O ' ' A' ' 95' ' ' VAL . 6.3 p -103.29 124.49 38.08 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.953 . . . . 0.0 110.748 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.482 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 43.6 Cg_endo -71.49 151.56 59.21 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.78 1.411 . . . . 0.0 109.801 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.487 ' HA ' ' HG3' ' A' ' 100' ' ' ARG . 45.7 Cg_endo -72.04 -20.34 25.43 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.945 1.497 . . . . 0.0 111.244 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.1 -11.41 60.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.963 -1.086 . . . . 0.0 110.135 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HD3' ' CG2' ' A' ' 59' ' ' ILE . 9.6 mttm -102.58 8.58 39.77 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.372 -0.83 . . . . 0.0 109.62 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.487 ' HG3' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.094 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.483 0.868 0 N-CA-C 110.632 -0.565 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.455 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.8 t90 -83.75 129.49 34.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.389 -0.82 . . . . 0.0 109.875 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.593 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . . . -40.96 -32.42 0.23 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.298 -0.876 . . . . 0.0 109.931 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.455 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 64.9 t -89.71 153.23 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.481 -0.762 . . . . 0.0 109.565 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.513 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 11.5 mmtt -99.04 167.03 11.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.2 Cg_endo -66.5 -33.67 36.21 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.747 1.393 . . . . 0.0 109.755 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -76.53 -23.81 53.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.506 -0.746 . . . . 0.0 109.367 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.576 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 21.8 m-20 -82.79 -38.75 22.71 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.47 ' HE2' ' HB2' ' A' ' 18' ' ' ASP . 7.2 tptm -65.29 -20.33 66.36 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.39 -43.19 41.65 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.578 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.7 ptpt -79.15 -24.05 43.56 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.578 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 6.9 m-30 -74.96 -34.33 62.03 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.47 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 10.1 t70 -79.96 -8.4 59.31 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.381 0.61 . . . . 0.0 109.939 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.72 -37.23 10.88 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.533 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 28.0 mt -75.43 -26.66 18.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.559 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -75.2 -36.84 61.37 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.486 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.2 t70 -90.27 1.75 56.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.696 -0.627 . . . . 0.0 109.815 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -93.86 -1.38 54.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.35 -0.844 . . . . 0.0 108.821 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.573 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -114.0 -1.77 13.7 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.594 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 81.71 91.1 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.107 0 CA-C-O 121.111 0.481 . . . . 0.0 109.707 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.4 Cg_endo -75.11 148.51 34.98 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.305 1.687 . . . . 0.0 110.746 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 99.2 t -120.03 109.44 25.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.625 -0.672 . . . . 0.0 109.561 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.521 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 9.3 t30 55.53 23.33 5.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.063 -1.023 . . . . 0.0 109.556 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 92.87 35.41 6.42 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 91.1 m-85 -151.42 152.55 33.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -1.153 . . . . 0.0 111.118 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 64' ' ' MET . 29.7 mt -122.23 127.87 50.47 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.495 ' CA ' ' HE1' ' A' ' 64' ' ' MET . 0.1 OUTLIER -78.86 138.2 38.03 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.613 -179.069 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -38.53 -34.05 0.23 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 32' ' ' SER . 7.9 t0 -49.75 -21.6 1.14 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -1.212 . . . . 0.0 110.022 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 13.0 mttm -113.08 -39.71 4.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.42 -0.8 . . . . 0.0 109.443 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.497 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 96.1 t -79.35 -37.17 18.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.647 -0.658 . . . . 0.0 110.015 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.1 ttpt -49.34 -50.38 65.11 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.34 -0.85 . . . . 0.0 110.584 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.6 Cg_endo -66.93 -29.23 41.41 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 N-CA-C 108.812 -1.265 . . . . 0.0 108.812 178.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.571 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 3.2 t -73.97 -13.29 15.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.216 0.531 . . . . 0.0 110.303 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.535 ' HB3' HD23 ' A' ' 50' ' ' LEU . 77.9 mt -98.75 -14.0 19.95 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.967 -1.083 . . . . 0.0 108.568 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 20.3 mt -87.89 -41.72 13.01 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.707 -0.621 . . . . 0.0 110.073 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -52.78 -20.46 3.23 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.365 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -64.08 -9.45 16.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.467 -0.771 . . . . 0.0 110.431 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 71.24 7.91 6.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.142 -0.973 . . . . 0.0 109.72 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.531 ' CD1' ' HB2' ' A' ' 80' ' ' ALA . 15.7 mt -88.26 159.88 46.76 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 110.014 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 41.0 Cg_endo -72.41 151.9 54.22 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 123.941 1.495 . . . . 0.0 110.301 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.5 t -54.28 -14.07 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.268 -0.895 . . . . 0.0 110.991 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -39.85 75.08 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.801 -1.187 . . . . 0.0 108.354 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.538 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 4.9 mm -66.89 -47.18 83.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.566 HD21 ' N ' ' A' ' 50' ' ' LEU . 4.5 mt -63.31 -21.14 66.07 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.05 -28.33 25.98 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.514 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 2.1 ttm180 -94.4 -55.71 3.07 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.473 -1.016 . . . . 0.0 109.272 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.555 ' CG1' HG22 ' A' ' 77' ' ' VAL . 55.3 t -47.64 -44.15 9.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.24 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.532 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 6.0 t-105 -64.62 -57.32 9.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.49 -0.756 . . . . 0.0 109.995 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.561 ' CG ' ' N ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER -47.54 -50.85 22.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.684 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.562 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 2.6 mt -70.69 -9.7 57.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.311 -0.868 . . . . 0.0 109.398 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -100.3 -36.24 9.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.607 -0.683 . . . . 0.0 110.258 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.522 ' HA ' HD22 ' A' ' 65' ' ' LEU . 9.4 t0 -78.76 85.36 4.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.451 -0.78 . . . . 0.0 109.295 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.505 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 31.4 mm -52.47 -30.99 14.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.728 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 0.7 OUTLIER -99.52 -18.09 17.57 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.053 -1.029 . . . . 0.0 111.006 -179.341 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 7.5 m-70 56.85 31.78 20.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.975 -1.078 . . . . 0.0 108.895 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -90.99 -9.3 46.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.634 -0.666 . . . . 0.0 110.538 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.422 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 113.24 9.98 16.54 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 9.2 mtp -149.19 158.18 43.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -1.169 . . . . 0.0 110.732 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.522 HD22 ' HA ' ' A' ' 58' ' ' ASP . 41.5 mt -116.35 117.18 29.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.603 -0.685 . . . . 0.0 110.159 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.582 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 3.2 t70 -77.35 172.8 12.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.082 -1.011 . . . . 0.0 110.023 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.559 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.4 ptm180 -48.11 -43.18 30.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.519 -0.738 . . . . 0.0 111.36 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -80.4 -33.57 36.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.142 -0.974 . . . . 0.0 110.58 -179.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.513 ' OE2' ' OD1' ' A' ' 60' ' ' ASP . 66.7 mt-10 -73.74 -50.13 22.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 108.593 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.567 ' CE2' ' SD ' ' A' ' 74' ' ' MET . 55.2 t80 -52.03 -33.24 37.78 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -56.47 -53.81 53.15 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.565 0.698 . . . . 0.0 109.96 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 56' ' ' LEU . 78.3 t -55.45 -25.14 17.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.548 -0.72 . . . . 0.0 110.334 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' O ' HG22 ' A' ' 77' ' ' VAL . . . -89.28 -5.44 57.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.157 -0.964 . . . . 0.0 111.396 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.568 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 8.0 mmm -90.84 -35.32 14.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.515 -1.366 . . . . 0.0 110.284 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.64 ' CZ ' ' CD2' ' A' ' 94' ' ' LEU . 2.1 p90 -83.1 -24.47 32.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.135 -0.978 . . . . 0.0 108.596 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.562 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 3.8 mt -77.4 -23.72 50.62 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.644 -0.66 . . . . 0.0 109.316 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.555 HG22 ' CG1' ' A' ' 53' ' ' VAL . 48.7 t -89.93 -32.29 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.507 -0.746 . . . . 0.0 109.136 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.499 ' HA ' HD11 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -82.87 -25.46 32.53 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 109.786 179.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.497 ' HA ' ' HB2' ' A' ' 83' ' ' LYS . 64.4 m -86.15 -12.24 50.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.386 -0.821 . . . . 0.0 109.717 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . . . -80.81 -19.13 45.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.916 -1.115 . . . . 0.0 108.456 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.499 HD11 ' HA ' ' A' ' 78' ' ' TYR . 3.3 mt -91.69 -40.71 11.12 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.149 0.5 . . . . 0.0 110.391 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 82' ' ' GLU . 3.8 tt0 -123.38 -11.49 7.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 112.9 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.497 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -96.07 -73.33 0.6 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.31 -1.494 . . . . 0.0 111.477 -179.098 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.547 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . 2.0 mt-10 -171.3 -175.97 0.34 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.917 -1.115 . . . . 0.0 110.123 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 39.7 Cg_endo -67.72 163.94 33.28 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.544 1.286 . . . . 0.0 110.233 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.476 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 41.4 t -112.81 121.28 38.91 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 110.942 -179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.477 ' O ' HD12 ' A' ' 56' ' ' LEU . 52.4 Cg_endo -81.42 158.41 19.62 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.813 1.428 . . . . 0.0 109.404 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.514 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 2.5 mtt -86.33 16.37 4.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.963 -1.086 . . . . 0.0 110.036 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.603 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 61.6 m -106.58 110.92 23.26 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.221 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.562 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -91.25 98.57 1.77 Allowed Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.18 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.603 ' HD3' ' O ' ' A' ' 89' ' ' SER . 38.3 Cg_endo -63.9 167.61 13.63 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.673 1.354 . . . . 0.0 111.379 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.35 -9.23 24.94 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.208 1.636 . . . . 0.0 111.072 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.24 -7.76 55.59 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.318 -0.864 . . . . 0.0 109.095 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.64 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 2.6 mt -111.4 3.5 18.24 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.422 -0.799 . . . . 0.0 110.32 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.2 t -89.06 110.7 40.05 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.966 . . . . 0.0 110.615 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.468 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 43.8 Cg_endo -71.88 175.63 9.45 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.08 1.569 . . . . 0.0 109.519 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 44.1 Cg_endo -70.98 56.51 1.92 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.707 1.372 . . . . 0.0 110.536 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.9 m -134.49 -39.76 0.81 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -89.21 6.06 41.89 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.327 -0.858 . . . . 0.0 110.429 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.483 0.858 0 N-CA-C 110.344 -0.675 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.559 ' CZ2' ' HB ' ' A' ' 9' ' ' VAL . 19.1 t90 -66.99 140.5 57.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.821 . . . . 0.0 110.159 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.567 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -47.81 -27.69 2.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.486 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.559 ' HB ' ' CZ2' ' A' ' 7' ' ' TRP . 89.4 t -112.73 154.2 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.867 . . . . 0.0 110.453 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -113.65 -176.56 0.38 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.396 -0.815 . . . . 0.0 110.244 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.9 Cg_endo -69.75 -41.21 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.698 1.367 . . . . 0.0 110.305 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.433 ' HG2' ' OD1' ' A' ' 13' ' ' ASP . 15.3 pt-20 -65.15 -28.5 69.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 109.75 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.57 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 4.3 m-20 -84.25 -40.61 17.82 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 18' ' ' ASP . 1.5 tppp? -69.78 -14.14 62.63 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.79 -39.33 44.26 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 8.8 mtmt -81.61 -40.08 23.53 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.57 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 5.0 m-30 -64.04 -22.12 66.8 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 4.4 t70 -89.28 -16.84 30.23 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.799 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.05 -29.75 18.18 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.592 HG23 ' CE1' ' A' ' 70' ' ' PHE . 20.8 mt -80.08 -34.98 15.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.602 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -69.56 -38.02 77.26 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.003 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.508 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.1 t70 -88.11 -0.7 57.38 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.701 -0.624 . . . . 0.0 110.227 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.7 t -90.72 -3.84 57.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 109.206 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.609 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.2 mt -108.95 -8.09 15.3 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m 86.05 89.08 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.5 Cg_endo -73.55 145.03 36.86 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.455 1.766 . . . . 0.0 110.507 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.7 110.15 31.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 52.14 23.44 2.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.086 -1.009 . . . . 0.0 108.474 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 91.1 33.97 7.87 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.571 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 65.0 m-85 -144.52 148.61 34.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -1.124 . . . . 0.0 112.01 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.494 HD11 ' CD2' ' A' ' 70' ' ' PHE . 35.1 mt -122.63 134.26 54.51 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.58 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.3 OUTLIER -77.89 143.19 37.94 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.181 -0.949 . . . . 0.0 111.107 -178.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -50.4 -26.9 10.42 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.241 -1.943 . . . . 0.0 108.241 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -77.52 -9.67 59.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.35 -1.088 . . . . 0.0 109.466 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.564 ' HD2' ' CB ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -100.74 -46.56 5.12 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 39' ' ' VAL . 72.4 t -77.67 -37.34 24.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.924 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.569 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -38.47 -51.88 3.46 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.423 -0.798 . . . . 0.0 111.176 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.6 Cg_endo -65.98 -30.61 47.9 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.311 1.163 . . . . 0.0 109.35 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.581 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 5.4 t -77.51 -10.19 12.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.427 0.632 . . . . 0.0 109.733 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.531 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 58.6 mt -100.31 -14.46 18.4 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.554 ' CD1' ' HA ' ' A' ' 38' ' ' PRO . 10.7 mt -87.0 -42.48 13.08 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.636 -0.665 . . . . 0.0 109.483 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -50.05 -22.87 1.78 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 118.75 -1.18 . . . . 0.0 108.556 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -60.94 -10.96 6.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 110.107 178.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.6 OUTLIER 74.02 18.96 3.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.326 -0.859 . . . . 0.0 109.982 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.531 HD12 ' CB ' ' A' ' 80' ' ' ALA . 14.3 mt -98.9 156.25 35.73 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.569 -0.707 . . . . 0.0 109.823 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.532 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 41.9 Cg_endo -74.65 156.11 44.59 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.973 1.512 . . . . 0.0 110.279 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.0 t -58.66 -12.38 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.483 -0.76 . . . . 0.0 110.714 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.28 -37.63 71.86 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.026 -1.046 . . . . 0.0 108.233 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.532 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 26.0 mm -68.23 -45.95 81.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.531 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 9.8 mt -61.61 -20.39 63.29 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.516 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -84.49 -29.98 28.55 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.048 -2.021 . . . . 0.0 108.048 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.576 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 1.1 ttm180 -94.76 -58.32 2.21 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.58 -0.953 . . . . 0.0 109.629 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 57' ' ' SER . 6.3 t -46.83 -49.95 6.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.209 -0.997 . . . . 0.0 108.756 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.499 ' CZ3' HD13 ' A' ' 65' ' ' LEU . 16.9 t-105 -56.81 -59.44 5.02 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.931 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 10.4 mm-40 -44.05 -58.39 2.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.158 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.611 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 3.3 mt -70.25 -11.63 61.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.854 . . . . 0.0 109.803 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 19.3 m -96.2 -27.54 14.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 0.0 110.379 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 54' ' ' TRP . 19.0 t0 -87.14 81.59 7.96 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.241 -0.912 . . . . 0.0 109.455 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.489 HG12 ' HG3' ' A' ' 69' ' ' GLU . 32.1 mm -44.29 -32.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.616 -0.677 . . . . 0.0 110.449 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 9.5 p-10 -105.39 -14.98 15.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.126 -0.984 . . . . 0.0 111.034 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.536 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 29.7 m-70 56.27 41.71 28.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.046 -1.034 . . . . 0.0 110.113 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.454 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 2.2 p-10 -100.89 15.66 27.8 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 110.135 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.72 15.56 77.5 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.58 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 9.1 mtt -146.81 160.74 41.9 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.558 -0.966 . . . . 0.0 110.467 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.499 HD13 ' CZ3' ' A' ' 54' ' ' TRP . 43.5 mt -128.54 118.16 22.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.329 -0.857 . . . . 0.0 109.436 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.571 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 20.2 t0 -69.77 166.6 18.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.863 -1.148 . . . . 0.0 109.996 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.602 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 10.7 ttm180 -44.0 -46.33 8.28 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 110.142 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.5 m-20 -78.7 -26.72 44.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.383 -0.823 . . . . 0.0 109.66 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.489 ' HG3' HG12 ' A' ' 59' ' ' ILE . 4.7 tt0 -75.71 -39.57 57.16 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.59 0.709 . . . . 0.0 109.53 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.592 ' CE1' HG23 ' A' ' 20' ' ' ILE . 18.2 t80 -66.67 -17.75 65.01 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.691 0.758 . . . . 0.0 109.072 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -74.99 -43.61 52.97 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.469 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.52 HG12 ' CD1' ' A' ' 94' ' ' LEU . 59.2 t -60.57 -26.1 36.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.535 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.499 ' HA ' ' OG ' ' A' ' 57' ' ' SER . . . -90.56 -4.35 56.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.52 -0.737 . . . . 0.0 111.074 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.563 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 11.1 mmt -86.27 -47.05 9.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.925 -1.109 . . . . 0.0 109.971 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.526 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 1.9 p90 -76.91 -24.57 52.47 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.526 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 8.4 mt -71.21 -24.53 62.23 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.593 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 66.0 t -91.66 -61.92 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -48.32 -21.66 0.56 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.721 -0.612 . . . . 0.0 111.597 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.526 ' HB3' ' CB ' ' A' ' 84' ' ' GLU . 2.1 m -86.21 -14.76 42.96 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.006 -1.059 . . . . 0.0 109.883 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.531 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -89.33 -10.19 47.65 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.282 -0.886 . . . . 0.0 109.302 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.593 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 7.0 mp -87.04 -43.91 11.97 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.477 -0.765 . . . . 0.0 109.026 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 74.4 mt-10 -72.17 -54.01 10.96 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.777 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 179.11 -26.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.479 -0.763 . . . . 0.0 111.422 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.526 ' CB ' ' HB3' ' A' ' 79' ' ' CYS . 1.8 mp0 -67.35 113.22 12.77 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.099 -1.001 . . . . 0.0 111.32 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 50.4 Cg_endo -75.46 -175.17 2.29 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.953 1.502 . . . . 0.0 110.312 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.45 HG23 HD21 ' A' ' 76' ' ' LEU . 77.9 t -131.84 122.53 18.6 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.186 -0.946 . . . . 0.0 110.514 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.541 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 49.7 Cg_endo -81.27 -165.85 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.842 1.443 . . . . 0.0 110.097 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.576 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 67.0 mtm -120.48 17.11 12.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.267 -0.896 . . . . 0.0 110.609 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.532 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 42.0 m -117.04 95.47 5.01 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.039 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.611 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -57.12 106.71 0.72 Allowed Pre-proline 0 C--N 1.291 -1.962 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.491 178.6 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' HG2' ' CD2' ' A' ' 94' ' ' LEU . 50.9 Cg_endo -75.16 169.3 22.84 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.668 1.352 . . . . 0.0 109.826 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.64 -12.71 26.97 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.857 1.451 . . . . 0.0 111.012 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 8' ' ' ALA . . . -86.67 8.44 22.41 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.086 -1.009 . . . . 0.0 109.477 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.567 HD23 ' CB ' ' A' ' 8' ' ' ALA . 1.4 mm? -113.75 6.18 16.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 110.597 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.46 ' O ' HG11 ' A' ' 95' ' ' VAL . 9.9 p -120.48 124.27 27.73 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.068 -1.02 . . . . 0.0 110.713 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.08 159.81 51.16 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.077 1.567 . . . . 0.0 110.115 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.78 1.09 7.39 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.007 1.53 . . . . 0.0 110.644 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 p -76.79 -28.86 55.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.123 -0.986 . . . . 0.0 110.15 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -89.23 8.05 32.3 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.362 -0.836 . . . . 0.0 109.31 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.464 -0.772 . . . . 0.0 110.167 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.481 0.778 0 N-CA-C 110.435 -0.641 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.575 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 19.0 t90 -98.05 132.84 43.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.395 -0.816 . . . . 0.0 110.055 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.557 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -40.97 -34.4 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.401 -0.812 . . . . 0.0 110.839 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.575 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 61.2 t -108.39 141.36 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 110.384 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.558 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -99.42 -177.13 0.55 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.385 -0.822 . . . . 0.0 109.909 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.6 Cg_endo -69.43 -35.99 12.55 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.662 1.349 . . . . 0.0 109.834 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 20.3 pt-20 -68.46 -25.75 65.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 109.825 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.422 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 39.7 m-20 -86.13 -38.86 17.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.308 -0.87 . . . . 0.0 108.912 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -75.48 -17.25 60.18 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 11' ' ' PRO . . . -74.88 -31.12 61.52 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.633 ' HG3' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -86.45 -21.28 27.16 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.633 ' CD1' ' HG3' ' A' ' 16' ' ' LYS . 17.7 m-30 -78.9 -33.39 45.63 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -13.84 62.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.859 -0.526 . . . . 0.0 110.009 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -89.31 -34.06 16.7 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.494 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 22.2 mt -80.72 -35.91 15.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.6 ' CD2' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -68.37 -35.39 77.65 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.491 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.3 t0 -89.1 -1.7 58.21 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.446 -0.784 . . . . 0.0 109.987 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -91.04 -1.51 57.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 0.0 108.648 178.442 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.581 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -109.38 -3.82 16.82 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 81.26 87.52 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 121.454 0.645 . . . . 0.0 109.265 -178.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -72.32 147.65 47.68 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 O-C-N 124.65 1.869 . . . . 0.0 110.896 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 61.3 t -116.26 106.59 20.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.576 -0.703 . . . . 0.0 109.186 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 9.1 t30 57.1 26.55 12.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.265 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 88.24 36.14 8.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.582 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 87.4 m-85 -150.31 160.14 43.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.433 -1.039 . . . . 0.0 111.142 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.6 ' CD1' ' CD2' ' A' ' 21' ' ' PHE . 12.3 mt -136.25 134.04 37.64 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.584 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -83.08 139.89 32.97 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.854 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -38.77 -28.52 0.07 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.6 OUTLIER -53.04 -35.58 59.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.347 -1.09 . . . . 0.0 111.064 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 1.3 mttm -97.41 -42.13 7.89 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.083 -1.01 . . . . 0.0 109.561 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.525 HG12 ' CD1' ' A' ' 65' ' ' LEU . 41.9 t -71.61 -47.45 57.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.62 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.559 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 40.9 tttp -45.99 -52.12 28.04 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 110.819 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.6 Cg_endo -66.48 -34.15 34.77 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.262 1.138 . . . . 0.0 109.164 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.52 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 2.2 t -62.77 -28.02 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.274 0.559 . . . . 0.0 109.606 178.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.532 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 30.3 mt -83.62 -14.76 51.25 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.168 -0.958 . . . . 0.0 109.479 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 21.5 mt -78.8 -29.01 44.65 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 37.0 m-80 -58.13 -28.29 64.54 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.036 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 3.6 p -62.2 -13.01 23.25 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.638 -0.664 . . . . 0.0 109.648 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 75.6 13.63 2.93 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.445 0.64 . . . . 0.0 109.864 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.538 ' CD1' ' HB2' ' A' ' 80' ' ' ALA . 16.4 mt -85.92 158.59 55.92 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.498 -0.751 . . . . 0.0 109.834 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.5 Cg_endo -73.22 157.3 50.39 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 O-C-N 124.088 1.573 . . . . 0.0 110.265 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.0 t -58.28 -10.92 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.42 -0.8 . . . . 0.0 111.109 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -73.85 -41.96 61.49 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.83 -1.169 . . . . 0.0 108.213 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.566 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 12.9 mm -61.95 -44.55 99.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.532 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 11.1 mt -62.17 -20.79 64.51 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.2 -28.51 36.64 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.556 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 0.3 OUTLIER -97.68 -57.21 2.29 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.529 -0.983 . . . . 0.0 109.665 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.563 HG13 ' CG2' ' A' ' 77' ' ' VAL . 3.8 t -47.42 -34.92 3.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.204 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.542 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 7.5 t-105 -75.11 -58.98 2.95 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.979 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.561 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 2.9 pt-20 -47.21 -46.22 23.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.621 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.653 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 7.6 mt -76.52 -12.31 60.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.46 -0.775 . . . . 0.0 109.456 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.6 t -96.55 -35.06 11.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.362 -0.836 . . . . 0.0 110.002 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.581 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 11.4 t0 -77.69 86.09 3.99 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.434 HG21 HD11 ' A' ' 59' ' ' ILE . 36.1 mm -50.35 -32.59 9.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.647 -0.658 . . . . 0.0 111.16 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 53.8 p30 -103.65 -15.1 15.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.933 -1.105 . . . . 0.0 111.256 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 1.4 m80 63.88 43.85 5.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.845 -1.159 . . . . 0.0 109.726 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.468 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 6.2 p-10 -107.17 15.69 24.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 110.588 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.91 8.35 87.74 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.584 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 3.6 mtt -142.07 160.82 39.46 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.362 -1.081 . . . . 0.0 110.478 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.525 ' CD1' HG12 ' A' ' 36' ' ' VAL . 47.4 mt -127.04 120.37 28.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 110.79 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.582 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 8.7 t0 -69.57 164.53 23.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.947 -1.095 . . . . 0.0 109.326 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.52 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 8.9 ptm180 -45.81 -34.46 3.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 110.468 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' OD1' ' HG3' ' A' ' 67' ' ' ARG . 10.2 m-20 -85.81 -32.57 21.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.102 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 16.1 mt-10 -71.13 -42.75 68.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.94 . . . . 0.0 108.819 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.579 ' CE2' ' SD ' ' A' ' 74' ' ' MET . 42.3 t80 -59.22 -32.56 70.07 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.444 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -57.32 -48.37 79.14 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.768 0.794 . . . . 0.0 110.161 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.527 HG12 ' CD1' ' A' ' 94' ' ' LEU . 87.5 t -59.8 -26.61 35.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.645 -0.659 . . . . 0.0 110.739 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.542 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -86.97 -5.62 59.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.159 -0.963 . . . . 0.0 111.723 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.59 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 14.4 mmm -90.45 -41.24 11.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.604 -1.31 . . . . 0.0 110.096 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CE2' HD13 ' A' ' 94' ' ' LEU . 2.3 p90 -79.38 -17.45 54.39 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.868 -1.133 . . . . 0.0 108.477 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.458 ' HB3' HG23 ' A' ' 53' ' ' VAL . 6.8 mt -82.57 -20.88 35.65 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.563 ' CG2' HG13 ' A' ' 53' ' ' VAL . 77.7 t -90.89 -41.83 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.565 -0.709 . . . . 0.0 109.723 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -71.32 -21.0 62.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.385 -0.822 . . . . 0.0 110.126 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 7.6 t -80.82 -15.14 57.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.268 -0.895 . . . . 0.0 109.087 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.538 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . . . -90.17 -13.61 35.26 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.52 -0.737 . . . . 0.0 109.38 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 1.7 mt -90.5 -33.78 15.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.0 109.222 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 42.8 tp10 -70.06 -53.64 16.6 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.663 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER 176.41 -18.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.126 -1.03 . . . . 0.0 112.723 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 67.5 mm-40 -98.56 122.45 53.36 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 120.543 -1.348 . . . . 0.0 111.465 -178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.17 -167.27 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.981 1.516 . . . . 0.0 110.249 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.502 HG23 ' CG2' ' A' ' 53' ' ' VAL . 61.5 t -130.4 140.38 38.47 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.0 110.435 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.492 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 51.4 Cg_endo -86.74 -168.66 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.979 1.515 . . . . 0.0 110.159 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.556 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 10.7 mtp -113.65 6.95 17.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.335 -0.853 . . . . 0.0 110.684 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.506 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.1 m -114.24 104.43 12.08 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.442 -1.303 . . . . 0.0 112.135 -177.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.653 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -60.24 107.94 1.23 Allowed Pre-proline 0 C--N 1.288 -2.071 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.379 178.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.562 ' HG2' ' CD2' ' A' ' 94' ' ' LEU . 41.1 Cg_endo -66.36 167.36 18.79 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.855 1.45 . . . . 0.0 109.946 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.67 -12.46 29.04 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.945 1.497 . . . . 0.0 111.628 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 8' ' ' ALA . . . -87.07 2.53 49.42 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.073 -1.017 . . . . 0.0 110.113 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.562 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 3.0 mm? -107.69 -0.37 21.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.145 -0.972 . . . . 0.0 111.052 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.2 t -103.42 117.34 60.34 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.964 -1.085 . . . . 0.0 110.695 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.422 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 42.4 Cg_endo -69.45 173.24 10.99 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.987 1.519 . . . . 0.0 110.142 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.5 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 46.0 Cg_endo -73.13 -19.33 22.88 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.913 1.481 . . . . 0.0 110.93 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -20.85 63.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.976 -1.077 . . . . 0.0 109.886 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.46 11.9 31.26 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.864 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.5 ' CG ' ' HA ' ' A' ' 97' ' ' PRO . 5.5 mmt180 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.327 -0.858 . . . . 0.0 110.467 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.481 0.76 0 N-CA-C 110.632 -0.565 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.606 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.7 t90 -94.17 132.02 39.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.494 -0.754 . . . . 0.0 109.81 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.554 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -47.21 -30.36 2.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.009 . . . . 0.0 110.16 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.606 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 72.5 t -102.3 149.69 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.397 -0.814 . . . . 0.0 109.857 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.525 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -126.74 171.91 7.34 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.422 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 10' ' ' LYS . 36.8 Cg_endo -62.91 -34.18 72.47 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.741 1.39 . . . . 0.0 110.592 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.402 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 9.6 mt-10 -72.98 -35.64 66.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 109.62 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -83.19 -41.29 18.62 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HG3' ' CB ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -70.03 -15.19 62.97 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 12' ' ' GLU . . . -67.18 -40.82 86.63 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.9 ptpt -75.79 -25.87 56.79 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.609 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -72.61 -33.75 66.89 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.7 -10.9 60.16 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.41 0.624 . . . . 0.0 109.7 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.58 -35.91 14.74 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.552 HG23 ' CE1' ' A' ' 70' ' ' PHE . 19.8 mt -76.73 -34.78 23.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -70.81 -33.56 70.82 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.5 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.9 t0 -88.97 -3.11 58.82 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.546 -0.721 . . . . 0.0 109.892 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.1 m -85.65 -13.73 47.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.084 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.607 ' O ' ' CB ' ' A' ' 25' ' ' SER . 4.4 mt -100.11 -11.7 20.27 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.607 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 t 85.6 99.41 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.152 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.3 Cg_endo -74.87 148.79 36.41 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 O-C-N 124.337 1.704 . . . . 0.0 110.807 -178.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 60.2 t -117.95 107.87 23.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 121.746 -0.596 . . . . 0.0 109.617 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 6.0 t30 56.9 17.5 3.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.359 -0.838 . . . . 0.0 109.421 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 96.96 36.0 5.14 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 94.7 m-85 -151.28 160.08 44.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -1.129 . . . . 0.0 110.877 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.593 ' CD1' ' CD2' ' A' ' 70' ' ' PHE . 37.8 mt -130.81 129.45 42.4 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.515 ' CA ' ' HE1' ' A' ' 64' ' ' MET . 12.2 p -78.23 139.97 38.91 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.854 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.04 -28.78 0.52 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 32' ' ' SER . 13.1 t70 -61.54 -11.23 10.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -1.142 . . . . 0.0 110.269 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' A' ' 24' ' ' LEU . 17.9 mtpp -116.27 -34.83 4.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -0.975 . . . . 0.0 109.02 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.501 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 98.0 t -84.34 -36.31 11.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.401 0.619 . . . . 0.0 109.694 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.627 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.3 tttt -48.37 -47.86 67.44 Favored Pre-proline 0 N--CA 1.487 1.384 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.158 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.7 Cg_endo -67.77 -30.74 33.5 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.407 1.214 . . . . 0.0 109.018 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.555 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 2.5 t -73.99 -9.43 12.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.798 -0.564 . . . . 0.0 109.584 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.534 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 82.4 mt -100.18 -15.92 17.96 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.139 -0.976 . . . . 0.0 108.515 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 38' ' ' PRO . 7.0 mt -89.95 -37.31 14.45 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.549 -0.72 . . . . 0.0 110.16 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 6.6 p30 -58.68 -16.45 16.37 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.153 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.487 ' HB3' HG11 ' A' ' 77' ' ' VAL . 0.8 OUTLIER -73.71 -1.83 20.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.374 -0.829 . . . . 0.0 109.871 179.275 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 68.69 14.98 9.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.235 -0.916 . . . . 0.0 110.207 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.54 HD13 ' CD2' ' A' ' 81' ' ' LEU . 15.4 mt -91.79 155.94 43.09 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.07 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.516 ' HG2' HG12 ' A' ' 49' ' ' ILE . 40.8 Cg_endo -73.23 154.24 51.54 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.889 1.468 . . . . 0.0 110.466 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.0 t -58.53 -10.6 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.32 -0.863 . . . . 0.0 110.777 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -39.51 68.58 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.887 -1.133 . . . . 0.0 107.987 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.516 HG12 ' HG2' ' A' ' 46' ' ' PRO . 30.3 mm -64.96 -43.61 96.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 3.7 mt -63.89 -14.47 53.66 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.365 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 55' ' ' GLU . . . -83.37 -36.1 15.48 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 53' ' ' VAL . 5.1 mtm-85 -94.23 -52.34 4.41 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.598 -0.942 . . . . 0.0 109.984 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' A' ' 57' ' ' SER . 24.3 t -44.18 -50.29 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.59 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.547 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 7.2 t-105 -66.32 -57.68 6.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 0.0 110.174 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' HG2' ' HG ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER -53.84 -38.52 64.73 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.927 -1.108 . . . . 0.0 109.127 -179.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.527 HD21 ' N ' ' A' ' 90' ' ' LEU . 94.4 mt -81.33 -14.88 56.8 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.701 -0.624 . . . . 0.0 109.386 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 10.7 m -97.78 -35.34 10.57 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.365 -0.834 . . . . 0.0 110.159 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.605 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 16.9 t0 -75.32 69.39 2.13 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.491 ' CG2' ' HD2' ' A' ' 99' ' ' LYS . 35.8 mm -35.2 -31.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.056 0.455 . . . . 0.0 111.0 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.541 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 14.7 p-10 -104.73 -16.66 14.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.055 -1.028 . . . . 0.0 111.333 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.605 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER 58.2 30.59 19.64 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.836 -1.165 . . . . 0.0 109.48 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.479 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 2.5 p-10 -84.32 -11.72 55.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.414 -0.804 . . . . 0.0 110.053 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.431 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 116.82 5.34 15.76 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.583 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 3.5 mtp -150.05 160.8 43.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -1.175 . . . . 0.0 110.164 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 58' ' ' ASP . 16.8 mt -115.57 115.24 26.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.077 -1.015 . . . . 0.0 109.53 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.585 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 3.7 t70 -69.15 171.11 8.83 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.011 -1.055 . . . . 0.0 109.809 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 4.4 ptm180 -46.18 -42.43 14.05 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.63 -0.669 . . . . 0.0 110.658 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.468 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -78.71 -33.98 46.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.0 110.345 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.497 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 28.0 mt-10 -74.53 -43.18 57.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.973 . . . . 0.0 109.2 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.593 ' CD2' ' CD1' ' A' ' 31' ' ' LEU . 18.3 t80 -61.0 -21.58 63.71 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.483 -0.761 . . . . 0.0 109.327 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.405 ' CB ' ' HG3' ' A' ' 14' ' ' LYS . . . -73.08 -40.86 64.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.345 -0.847 . . . . 0.0 109.45 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.437 ' O ' ' CG ' ' A' ' 76' ' ' LEU . 60.1 t -63.2 -27.04 42.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.513 0.673 . . . . 0.0 109.348 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.527 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -90.83 -4.84 56.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.528 -0.733 . . . . 0.0 110.862 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.56 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 11.3 mmt -84.59 -50.21 7.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.997 -1.065 . . . . 0.0 109.603 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.583 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 1.9 p90 -72.85 -31.62 64.89 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.567 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 9.9 mt -61.46 -31.22 71.17 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 46.0 t -92.16 -42.09 13.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.825 -0.547 . . . . 0.0 110.574 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.7 OUTLIER -74.36 -40.42 62.12 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.821 -179.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.545 ' CA ' ' HB3' ' A' ' 83' ' ' LYS . 69.5 m -76.46 -14.78 60.03 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.026 -1.047 . . . . 0.0 109.139 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 76' ' ' LEU . . . -77.66 -11.44 59.87 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 77' ' ' VAL . 4.0 mt -91.12 -50.1 6.03 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.615 0.722 . . . . 0.0 109.949 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -134.13 38.94 3.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.518 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.545 ' HB3' ' CA ' ' A' ' 79' ' ' CYS . 7.7 ttmt -160.05 -91.61 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.303 -1.498 . . . . 0.0 112.342 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.7 OUTLIER -117.63 148.63 43.42 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.104 -0.998 . . . . 0.0 111.146 -178.355 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -75.98 -162.39 0.16 Allowed 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 124.4 1.737 . . . . 0.0 110.316 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.534 HG23 ' CG2' ' A' ' 53' ' ' VAL . 13.4 t -115.62 145.04 33.67 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.517 -0.739 . . . . 0.0 109.583 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 86' ' ' VAL . 44.0 Cg_endo -87.52 -162.17 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.877 1.461 . . . . 0.0 109.73 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.6 mtt -129.31 12.4 6.0 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.26 -0.9 . . . . 0.0 110.945 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 90' ' ' LEU . 22.8 t -165.95 23.54 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.931 -1.106 . . . . 0.0 111.279 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.533 ' CD2' ' HB3' ' A' ' 94' ' ' LEU . 2.1 mt 54.89 116.81 0.01 OUTLIER Pre-proline 0 C--N 1.284 -2.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.012 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.581 ' HG2' ' CD2' ' A' ' 94' ' ' LEU . 44.3 Cg_endo -72.77 175.02 10.88 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.597 1.314 . . . . 0.0 109.16 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 50.1 Cg_endo -74.34 -19.9 19.09 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.632 1.332 . . . . 0.0 111.67 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 8' ' ' ALA . . . -90.29 28.44 1.44 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.97 -1.081 . . . . 0.0 109.479 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.583 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -127.06 -25.69 3.25 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.822 -178.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.46 ' O ' HG21 ' A' ' 95' ' ' VAL . 27.3 m -91.3 136.32 27.19 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.051 -1.03 . . . . 0.0 111.036 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.51 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 42.9 Cg_endo -70.91 161.69 45.22 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.955 1.503 . . . . 0.0 109.261 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.461 ' HA ' ' CD ' ' A' ' 100' ' ' ARG . 46.7 Cg_endo -71.35 -24.29 23.0 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 123.954 1.502 . . . . 0.0 111.537 -178.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.3 t -84.47 -0.01 51.34 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.804 -1.185 . . . . 0.0 110.195 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.491 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 8.6 mmtt -106.64 -1.1 23.18 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.389 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.532 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 O-C-N 121.111 -0.993 . . . . 0.0 110.812 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.483 0.906 0 N-CA-C 110.336 -0.679 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.518 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.1 t90 -48.69 130.92 17.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.648 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.556 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -40.62 -27.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 110.525 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.518 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 91.1 t -102.9 138.74 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.87 . . . . 0.0 109.938 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.536 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -97.15 -179.91 0.98 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.314 -0.866 . . . . 0.0 110.434 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.3 Cg_endo -69.23 -35.51 14.06 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.934 1.492 . . . . 0.0 110.049 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -75.54 -28.41 59.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.375 -0.828 . . . . 0.0 109.835 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.569 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -83.29 -37.17 23.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.209 -0.932 . . . . 0.0 108.59 178.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 13.8 tptp -69.73 -20.16 63.52 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.08 -44.07 63.85 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.583 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 6.5 ptpt -74.51 -24.17 58.94 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.583 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.6 m-30 -74.25 -35.61 63.82 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -76.8 -9.73 58.88 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.302 0.572 . . . . 0.0 110.031 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -93.74 -34.97 13.01 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.566 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 37.6 mt -78.04 -30.18 15.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.588 ' CD2' HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -74.44 -39.53 62.51 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.555 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.501 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 32.6 t70 -88.59 4.39 47.09 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.611 -0.681 . . . . 0.0 109.831 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -90.54 -15.63 30.31 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.769 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.575 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -97.75 -8.0 29.5 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 84.48 98.21 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.4 Cg_endo -74.27 146.63 36.17 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.056 1.556 . . . . 0.0 110.762 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 27.3 t -116.33 98.57 6.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.486 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 64.97 22.44 12.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.359 -0.838 . . . . 0.0 109.393 -179.124 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 91.97 32.35 8.53 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.521 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 93.8 m-85 -150.23 152.76 35.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.407 -1.055 . . . . 0.0 111.145 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.588 HD13 ' CD2' ' A' ' 21' ' ' PHE . 32.5 mt -124.7 131.85 53.43 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 33' ' ' GLY . 93.9 p -78.19 137.39 38.13 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.272 -0.893 . . . . 0.0 110.43 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.57 -30.86 0.95 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -60.47 -16.24 34.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -1.082 . . . . 0.0 110.318 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 21.3 mtpp -108.38 -35.3 6.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 109.121 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.529 HG13 ' CD1' ' A' ' 65' ' ' LEU . 96.8 t -82.77 -31.12 9.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.597 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -50.17 -52.45 53.55 Favored Pre-proline 0 C--N 1.305 -1.363 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.897 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.6 Cg_endo -64.92 -31.44 56.52 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.581 1.306 . . . . 0.0 109.246 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.584 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 4.3 t -74.87 -10.66 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.447 0.642 . . . . 0.0 109.772 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.522 ' CD2' HG22 ' A' ' 77' ' ' VAL . 78.5 mt -100.24 -15.51 18.06 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 37' ' ' LYS . 8.4 mt -88.3 -44.58 10.71 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.569 -0.707 . . . . 0.0 109.486 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.584 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -47.83 -25.33 1.25 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.722 -1.191 . . . . 0.0 108.62 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.57 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 12.5 m -61.67 -12.15 14.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.508 -0.745 . . . . 0.0 110.032 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 43' ' ' SER . 3.5 tptp 74.1 18.84 3.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.231 -0.918 . . . . 0.0 109.956 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.527 HD12 ' CB ' ' A' ' 80' ' ' ALA . 15.4 mt -100.1 158.36 32.16 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 110.087 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.536 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 41.5 Cg_endo -73.08 156.54 51.7 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 123.934 1.491 . . . . 0.0 110.647 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 t -58.3 -10.85 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.662 -0.649 . . . . 0.0 110.88 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.58 -41.32 60.72 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.866 -1.146 . . . . 0.0 108.432 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.536 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 11.8 mm -64.24 -44.9 97.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 40' ' ' LEU . 3.8 mt -66.98 -16.99 64.71 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.711 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.29 -32.84 15.56 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.374 -1.891 . . . . 0.0 108.374 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.481 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -92.5 -53.67 4.11 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.517 -0.99 . . . . 0.0 109.526 179.321 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 57' ' ' SER . 32.5 t -47.83 -32.08 2.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.25 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.529 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 8.2 t-105 -74.11 -59.29 2.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.841 . . . . 0.0 110.084 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.55 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 5.0 pt-20 -47.67 -45.62 28.34 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.501 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.592 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 2.7 mt -75.91 -11.74 60.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.579 -0.7 . . . . 0.0 109.57 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.555 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 2.8 t -99.28 -36.11 9.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.634 -0.666 . . . . 0.0 110.758 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.457 ' HA ' HD22 ' A' ' 65' ' ' LEU . 26.9 t0 -82.61 86.63 6.79 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.483 -0.76 . . . . 0.0 109.454 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.47 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 32.1 mm -51.55 -36.24 17.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.75 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 3.5 m-20 -90.33 -17.05 28.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.538 -0.726 . . . . 0.0 110.566 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 33.1 p80 40.25 39.77 0.71 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.816 0.817 . . . . 0.0 109.23 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -98.17 -9.65 25.39 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.754 -0.591 . . . . 0.0 110.192 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 126.57 4.39 6.29 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 6.0 mtp -149.54 160.72 43.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.093 -1.24 . . . . 0.0 110.491 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.529 ' CD1' HG13 ' A' ' 36' ' ' VAL . 34.1 mt -112.49 112.25 23.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.583 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.528 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 17.3 t0 -69.62 166.93 17.99 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.895 -1.128 . . . . 0.0 110.106 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.552 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -42.16 -44.45 3.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.528 -0.732 . . . . 0.0 111.012 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 8.7 p-10 -78.02 -43.01 30.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.368 -0.832 . . . . 0.0 110.162 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 33.7 mt-10 -61.64 -48.99 78.34 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.656 -0.653 . . . . 0.0 109.779 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.581 ' CE1' ' SD ' ' A' ' 74' ' ' MET . 43.5 t80 -58.94 -26.22 64.21 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.395 -0.815 . . . . 0.0 109.373 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -67.22 -45.99 75.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.647 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.471 HG11 HD13 ' A' ' 94' ' ' LEU . 88.3 t -60.45 -23.04 27.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.542 -0.723 . . . . 0.0 110.018 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.555 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -89.73 -5.33 57.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.291 -0.88 . . . . 0.0 110.932 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.581 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 1.6 mmm -89.33 -44.86 9.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.999 -1.063 . . . . 0.0 110.038 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.554 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 2.5 p90 -76.24 -25.22 54.8 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 72' ' ' VAL . 4.8 mt -69.99 -28.33 65.44 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.537 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 53.6 t -89.35 -29.59 5.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.549 ' HA ' HD11 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -79.53 -25.08 41.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.428 -0.795 . . . . 0.0 110.524 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -87.08 -10.65 52.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 110.172 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 84' ' ' GLU . . . -85.54 -20.16 30.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.354 -0.841 . . . . 0.0 109.658 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.57 ' CD2' ' O ' ' A' ' 43' ' ' SER . 1.3 mt -92.35 -36.47 13.14 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.556 0.693 . . . . 0.0 110.694 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.54 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 10.2 mt-10 -66.47 -50.51 63.05 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.525 -0.87 . . . . 0.0 108.792 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.54 ' CG ' ' O ' ' A' ' 82' ' ' GLU . 3.6 mttt 174.49 -20.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 118.852 -1.139 . . . . 0.0 112.638 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 57.3 mm-40 -85.1 124.24 72.46 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 120.705 -1.247 . . . . 0.0 111.426 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.98 -179.38 3.41 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.845 1.445 . . . . 0.0 109.862 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' A' ' 52' ' ' ARG . 24.3 t -128.62 127.97 23.55 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.036 -1.04 . . . . 0.0 110.757 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.464 ' O ' HD12 ' A' ' 56' ' ' LEU . 47.0 Cg_endo -89.24 -164.94 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.935 1.492 . . . . 0.0 109.344 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.498 ' CB ' ' OE2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -123.61 6.12 8.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.368 -0.833 . . . . 0.0 110.253 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.488 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 55.1 m -105.65 98.44 8.13 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 119.114 -1.034 . . . . 0.0 111.294 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.592 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -54.96 107.14 0.78 Allowed Pre-proline 0 C--N 1.293 -1.866 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.753 179.256 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.541 ' HG2' ' CD2' ' A' ' 94' ' ' LEU . 42.5 Cg_endo -68.75 162.69 40.17 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.995 1.523 . . . . 0.0 109.984 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.97 -13.35 34.04 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.825 1.434 . . . . 0.0 111.149 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 8' ' ' ALA . . . -89.04 19.92 3.92 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.011 -1.055 . . . . 0.0 109.308 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.556 HD23 ' CB ' ' A' ' 8' ' ' ALA . 1.9 mm? -121.03 -13.61 8.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.469 -0.769 . . . . 0.0 110.451 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.6 m -86.88 120.76 71.81 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 0.0 111.119 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.498 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 45.9 Cg_endo -74.36 176.7 9.3 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 124.039 1.547 . . . . 0.0 109.26 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.51 ' HA ' ' HG3' ' A' ' 100' ' ' ARG . 42.3 Cg_endo -69.04 62.84 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.52 1.274 . . . . 0.0 110.771 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.56 -56.58 0.52 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.415 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 5.2 tptt -89.59 11.9 18.31 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.51 ' HG3' ' HA ' ' A' ' 97' ' ' PRO . 44.4 mmm-85 . . . . . 0 N--CA 1.494 1.75 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.154 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 N--CA 1.484 0.921 0 CA-C-O 121.481 0.534 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.595 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.8 t90 -96.11 138.59 33.51 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.449 -0.782 . . . . 0.0 110.114 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -59.24 -25.72 64.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 110.285 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.595 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 18.8 t -95.07 160.35 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.575 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -108.32 171.32 4.63 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.069 -1.019 . . . . 0.0 110.491 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.11 -34.48 10.17 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.231 1.648 . . . . 0.0 109.53 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -78.76 -28.98 44.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.578 -0.702 . . . . 0.0 109.349 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.539 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 1.6 m-20 -81.11 -34.22 32.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.456 -0.777 . . . . 0.0 108.913 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 67' ' ' ARG . 16.2 tptt -72.35 -19.98 61.55 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.604 0.716 . . . . 0.0 109.225 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.87 -41.7 61.81 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.596 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.49 -26.09 60.75 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.596 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.3 m-30 -74.34 -38.34 63.28 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 3.1 t70 -73.17 -12.35 60.85 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.279 0.561 . . . . 0.0 110.207 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.61 -32.77 13.27 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.437 ' O ' ' HG ' ' A' ' 24' ' ' LEU 0.253 42.3 mt -78.34 -28.76 14.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.589 ' CD2' HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.7 -37.77 65.08 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 1.6 t70 -90.29 1.65 56.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.697 -0.627 . . . . 0.0 109.926 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 t -91.89 -2.74 56.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 108.658 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.57 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -112.7 -3.51 14.25 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.47 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.6 t 80.3 96.9 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.9 Cg_endo -71.29 147.31 52.94 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 O-C-N 124.427 1.751 . . . . 0.0 110.548 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 43.0 t -118.05 101.66 12.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 18.3 t30 57.98 30.78 19.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.859 . . . . 0.0 109.624 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.488 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 85.79 34.72 12.69 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.586 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 93.7 m-85 -151.11 153.83 35.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -1.162 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.589 HD13 ' CD2' ' A' ' 21' ' ' PHE . 24.2 mt -124.68 122.95 38.95 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.675 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.541 ' CA ' ' HE1' ' A' ' 64' ' ' MET . 0.7 OUTLIER -72.92 139.99 47.18 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.612 0.72 . . . . 0.0 111.108 -178.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -46.39 -25.3 1.94 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -58.55 -33.67 70.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -1.104 . . . . 0.0 110.281 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.542 ' HD3' ' CA ' ' A' ' 31' ' ' LEU . 5.1 ptmt -99.96 -28.19 13.21 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.874 0.845 . . . . 0.0 109.714 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.54 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 72.1 t -80.73 -48.37 19.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 CA-C-O 121.444 0.64 . . . . 0.0 109.629 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.591 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.25 -51.98 7.74 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.462 -0.774 . . . . 0.0 110.493 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.6 Cg_endo -66.28 -33.06 40.36 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 108.889 -1.235 . . . . 0.0 108.889 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.594 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 2.7 t -72.36 -12.23 15.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.497 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 90.4 mt -97.85 -16.87 19.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 92.5 mt -78.92 -36.41 41.92 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.56 -0.713 . . . . 0.0 109.286 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -46.42 -23.87 0.43 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.552 179.119 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.559 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -73.93 6.34 3.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.566 -0.709 . . . . 0.0 111.091 -179.405 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.26 15.36 1.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.755 -1.215 . . . . 0.0 110.051 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.5 HD21 ' HD2' ' A' ' 46' ' ' PRO . 15.3 mt -93.59 158.76 36.18 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.117 -0.99 . . . . 0.0 109.856 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HD2' HG13 ' A' ' 49' ' ' ILE . 41.4 Cg_endo -72.87 157.39 51.66 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.978 1.515 . . . . 0.0 110.294 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.6 t -59.66 -11.24 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 110.706 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.03 -36.49 69.67 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.915 -1.116 . . . . 0.0 108.18 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.521 HG13 ' HD2' ' A' ' 46' ' ' PRO . 32.6 mm -68.51 -45.2 82.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.497 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 3.6 mt -65.55 -20.39 66.31 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . -85.2 -30.02 26.43 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.511 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 16.0 ttm-85 -93.03 -55.43 3.35 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.467 -1.019 . . . . 0.0 109.562 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.52 HG23 ' HB3' ' A' ' 76' ' ' LEU . 39.4 t -49.76 -38.45 13.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.103 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.493 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 8.6 t-105 -64.93 -56.67 11.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 109.3 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.595 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 68.5 mm-40 -44.52 -55.3 5.23 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.484 -0.76 . . . . 0.0 109.977 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.626 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 4.7 mt -70.75 -10.5 59.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 0.0 109.913 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.534 ' OG ' ' CA ' ' A' ' 73' ' ' ALA . 17.4 m -96.15 -37.43 10.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 110.118 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.575 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 13.5 t0 -77.61 70.48 3.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.358 -0.839 . . . . 0.0 109.27 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.51 HG22 HD11 ' A' ' 59' ' ' ILE . 45.2 mm -39.95 -31.73 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.637 -0.664 . . . . 0.0 110.789 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.49 ' OD2' ' HB3' ' A' ' 62' ' ' ASP . 0.6 OUTLIER -98.79 -23.48 15.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.369 -0.832 . . . . 0.0 110.6 -178.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 55' ' ' GLU . 90.9 m-70 57.41 49.62 12.68 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.189 -0.944 . . . . 0.0 110.545 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.49 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 5.7 p-10 -111.97 0.99 16.22 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.041 -1.037 . . . . 0.0 110.286 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.459 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 112.43 2.43 26.04 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.541 ' HE1' ' CA ' ' A' ' 32' ' ' SER . 5.0 mtp -149.1 160.06 43.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.991 -1.299 . . . . 0.0 110.616 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.467 HD21 ' HA ' ' A' ' 58' ' ' ASP . 70.8 mt -111.69 115.24 28.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.551 -0.718 . . . . 0.0 109.948 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.586 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 7.0 t0 -69.18 164.18 23.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.892 -1.13 . . . . 0.0 109.733 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.532 ' O ' ' NZ ' ' A' ' 14' ' ' LYS . 1.7 ptt180 -37.76 -42.28 0.57 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.677 -0.64 . . . . 0.0 111.512 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.522 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -84.74 -33.02 23.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.211 -0.931 . . . . 0.0 110.888 -179.202 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.5 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 24.3 mt-10 -69.72 -42.65 73.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 109.368 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.577 ' CE1' ' SD ' ' A' ' 74' ' ' MET . 50.5 t80 -64.14 -28.88 70.06 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.559 -0.713 . . . . 0.0 109.178 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -61.73 -48.95 78.41 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.774 0.797 . . . . 0.0 109.964 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.511 ' CG1' HD13 ' A' ' 94' ' ' LEU . 70.7 t -59.25 -24.03 26.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.685 -0.634 . . . . 0.0 110.424 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.534 ' CA ' ' OG ' ' A' ' 57' ' ' SER . . . -86.71 -8.7 57.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.156 -0.965 . . . . 0.0 112.003 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.579 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 12.0 mmm -90.08 -40.5 12.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.639 -1.288 . . . . 0.0 110.489 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.511 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.6 p90 -78.19 -19.02 54.72 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.789 -1.165 . . . . 0.0 108.374 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.52 ' HB3' HG23 ' A' ' 53' ' ' VAL . 9.2 mt -80.91 -23.63 38.82 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.468 0.652 . . . . 0.0 109.48 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.544 ' CG1' ' OG ' ' A' ' 43' ' ' SER . 70.1 t -91.65 -32.16 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.529 -0.732 . . . . 0.0 110.3 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.484 ' HA ' HD11 ' A' ' 81' ' ' LEU . 1.2 m-85 -80.04 -24.18 40.91 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.184 -0.947 . . . . 0.0 110.417 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 79.3 m -86.66 -13.76 44.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.256 -0.903 . . . . 0.0 109.395 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 84' ' ' GLU . . . -76.69 -18.95 58.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.08 -1.012 . . . . 0.0 108.743 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.559 ' CD2' ' O ' ' A' ' 43' ' ' SER . 1.9 mt -92.41 -48.63 6.55 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.516 0.674 . . . . 0.0 111.471 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' A' ' 82' ' ' GLU . 3.4 tp10 -108.03 -28.0 9.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 112.359 -177.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 79' ' ' CYS . 5.8 mttt -88.86 -87.68 0.16 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.727 -1.233 . . . . 0.0 111.19 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -155.31 177.92 1.85 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.081 -1.012 . . . . 0.0 110.306 -179.552 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 40.4 Cg_endo -65.99 171.9 9.32 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.819 1.431 . . . . 0.0 110.501 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 72.1 t -116.68 127.77 26.5 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.234 -0.916 . . . . 0.0 110.477 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.478 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 48.2 Cg_endo -80.43 -173.83 2.01 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.756 1.398 . . . . 0.0 109.617 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.511 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 20.1 mtm -114.68 20.98 14.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 0.0 110.347 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.502 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 69.0 m -111.18 103.89 12.36 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.696 -1.201 . . . . 0.0 111.434 -178.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.626 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 2.1 mt -59.16 108.15 1.24 Allowed Pre-proline 0 C--N 1.293 -1.856 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.734 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 89' ' ' SER . 43.2 Cg_endo -68.77 141.9 50.85 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.948 1.499 . . . . 0.0 110.549 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.64 -4.54 14.83 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.027 1.54 . . . . 0.0 110.72 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -92.9 8.53 39.29 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.397 -0.814 . . . . 0.0 109.357 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.563 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -127.92 -7.8 5.5 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.589 0.709 . . . . 0.0 110.136 -178.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.8 t -82.45 113.28 43.19 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 120.888 -1.133 . . . . 0.0 110.721 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.479 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 42.4 Cg_endo -69.63 175.19 8.32 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.05 1.552 . . . . 0.0 110.093 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 98' ' ' SER . 41.7 Cg_endo -68.56 -172.98 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.858 1.451 . . . . 0.0 110.51 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.9 OUTLIER 75.24 -49.86 0.65 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.53 -0.731 . . . . 0.0 110.073 -179.098 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.461 ' HD2' HG22 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -88.27 13.13 12.19 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.131 -0.981 . . . . 0.0 108.552 178.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.412 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 7' ' ' TRP . 45.4 Cg_endo . . . . . 0 N--CA 1.484 0.953 0 N-CA-C 110.265 -0.706 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.502 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.8 t90 -44.62 128.95 6.84 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.215 -0.928 . . . . 0.0 109.255 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -40.64 -27.49 0.05 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 0.0 109.889 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.502 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 10.0 t -103.73 128.26 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.424 -0.797 . . . . 0.0 109.534 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.508 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.0 mttt -82.2 178.98 2.11 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.933 . . . . 0.0 110.156 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.6 Cg_endo -71.24 -35.12 9.01 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.01 1.532 . . . . 0.0 109.908 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 2.0 pt-20 -81.07 -19.89 42.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.423 -0.798 . . . . 0.0 109.446 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.505 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 0.3 OUTLIER -81.91 -39.89 23.13 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.202 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.445 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -78.01 -14.85 59.36 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.82 -37.49 55.6 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.604 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -77.24 -22.82 51.63 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.604 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 13.3 m-30 -77.32 -33.71 55.53 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -70.78 -8.82 55.21 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.319 0.58 . . . . 0.0 110.004 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.57 -34.64 14.66 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.505 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 34.0 mt -81.78 -30.11 10.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.575 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -74.14 -34.76 63.97 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.498 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.6 t70 -89.18 -4.5 58.22 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.676 -0.64 . . . . 0.0 110.213 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.59 -2.69 58.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 108.986 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.572 ' O ' ' CB ' ' A' ' 25' ' ' SER . 3.2 mt -107.14 -12.15 15.46 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.2 t 83.89 87.94 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 44.9 Cg_endo -71.21 150.92 60.19 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 O-C-N 124.739 1.915 . . . . 0.0 110.331 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 28.7 t -116.05 107.48 22.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.65 -0.656 . . . . 0.0 109.802 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 14.9 t30 55.81 21.06 4.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.379 -0.825 . . . . 0.0 109.52 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 96.16 37.56 4.84 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 92.5 m-85 -150.89 159.94 44.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -1.141 . . . . 0.0 111.227 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.521 HD13 ' CD2' ' A' ' 21' ' ' PHE . 27.0 mt -137.77 129.68 28.68 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 2.7 p -75.01 137.88 41.83 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.421 -0.8 . . . . 0.0 110.871 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -43.91 -25.03 0.57 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' SER . 80.1 m-20 -65.15 -16.21 63.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.284 -1.127 . . . . 0.0 109.855 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 21.8 mtpp -105.12 -38.92 6.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.128 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.528 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 88.7 t -76.39 -33.18 22.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.544 0.688 . . . . 0.0 109.208 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.57 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.7 tttp -48.79 -56.04 17.05 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.724 -0.61 . . . . 0.0 110.228 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.5 Cg_endo -64.93 -28.4 58.22 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.73 1.384 . . . . 0.0 109.093 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.595 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 3.5 t -78.71 -11.01 13.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.3 0.571 . . . . 0.0 109.932 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.525 ' CD1' HG11 ' A' ' 36' ' ' VAL . 71.7 mt -101.08 -18.22 16.33 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.185 -0.947 . . . . 0.0 108.554 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 38' ' ' PRO . 15.3 mt -85.14 -41.62 15.51 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.615 -0.678 . . . . 0.0 109.717 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -50.19 -22.72 1.82 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.694 -1.202 . . . . 0.0 108.807 179.317 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.541 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 35.1 m -64.15 -7.27 8.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.623 -0.673 . . . . 0.0 110.615 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.4 OUTLIER 72.82 10.07 5.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.219 -0.925 . . . . 0.0 109.932 -179.605 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.539 HD12 ' CG2' ' A' ' 49' ' ' ILE . 13.0 mt -90.41 158.82 42.76 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.401 -0.812 . . . . 0.0 110.14 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.563 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 41.8 Cg_endo -75.72 167.21 26.82 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.992 1.522 . . . . 0.0 109.908 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.432 ' O ' HG11 ' A' ' 47' ' ' VAL . 43.8 t -69.2 -5.81 5.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.419 -0.801 . . . . 0.0 110.508 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.89 -39.79 34.07 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.183 -0.948 . . . . 0.0 108.547 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.563 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 27.8 mm -66.96 -44.08 88.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 40' ' ' LEU . 9.5 mt -66.32 -17.0 64.5 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.072 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.5 -29.75 20.85 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.558 ' HD3' ' CG ' ' A' ' 88' ' ' MET . 0.3 OUTLIER -93.57 -55.61 3.21 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.509 -0.994 . . . . 0.0 109.374 179.493 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.537 ' O ' ' HB3' ' A' ' 57' ' ' SER . 36.5 t -49.94 -55.33 5.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.535 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 6.6 t-105 -50.37 -56.85 9.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.517 -0.74 . . . . 0.0 110.37 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -49.97 -45.96 52.0 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.415 -179.176 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 2.5 mt -76.81 -8.57 57.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.659 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.537 ' HB3' ' O ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -99.34 -39.86 8.2 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.397 -0.814 . . . . 0.0 109.663 179.194 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.531 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 30.4 t0 -75.52 86.02 2.62 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.494 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 30.6 mm -49.36 -34.23 7.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.128 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 35.9 p-10 -103.47 -9.97 18.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.998 -1.064 . . . . 0.0 111.354 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.531 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 51.3 m-70 55.63 41.62 30.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.953 -1.092 . . . . 0.0 109.517 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 3.4 p-10 -101.34 16.24 26.23 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.622 -0.674 . . . . 0.0 110.133 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.93 10.9 84.46 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.567 ' HG2' ' HA ' ' A' ' 32' ' ' SER . 5.0 mtt -142.31 160.3 40.53 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.389 -1.065 . . . . 0.0 110.638 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.514 ' CD1' HG13 ' A' ' 36' ' ' VAL . 44.0 mt -126.19 119.19 26.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.389 -0.82 . . . . 0.0 109.836 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 4.7 t0 -73.9 166.54 23.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.81 -1.181 . . . . 0.0 109.685 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.524 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -42.22 -46.07 4.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.227 -0.92 . . . . 0.0 110.229 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.46 -46.76 46.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.523 -0.736 . . . . 0.0 110.342 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.494 ' OE1' ' N ' ' A' ' 59' ' ' ILE . 14.4 mt-10 -60.56 -41.65 94.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.383 -0.823 . . . . 0.0 109.34 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.575 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 18.8 t80 -60.71 -30.13 69.77 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.1 93.25 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.782 0.801 . . . . 0.0 110.046 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.542 HG11 ' CD1' ' A' ' 94' ' ' LEU . 63.4 t -61.11 -28.58 44.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.591 0.71 . . . . 0.0 110.289 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 57' ' ' SER . . . -84.93 -6.93 59.34 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.478 -0.764 . . . . 0.0 111.559 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.594 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 9.4 mmm -90.23 -43.08 10.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.307 -1.496 . . . . 0.0 110.465 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.527 ' CZ ' HD12 ' A' ' 94' ' ' LEU . 2.9 p90 -76.92 -15.37 59.69 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.985 -1.086 . . . . 0.0 108.683 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.506 ' HB3' HG23 ' A' ' 53' ' ' VAL . 10.0 mt -85.3 -25.62 27.08 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.476 -0.765 . . . . 0.0 108.979 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 73' ' ' ALA . 19.0 t -91.06 -28.51 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.006 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.88 -25.18 37.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.247 -0.908 . . . . 0.0 110.365 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -85.49 -13.04 50.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.956 . . . . 0.0 109.519 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.524 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . . . -88.1 -9.54 52.94 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.384 -0.823 . . . . 0.0 109.119 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 1.5 mt -90.33 -45.26 9.14 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.825 0.822 . . . . 0.0 109.063 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.5 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.8 OUTLIER -70.01 -53.08 19.23 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 120.189 -0.605 . . . . 0.0 109.8 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 179.13 -28.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.464 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 20.6 mt-10 -66.4 110.74 5.24 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.177 -0.952 . . . . 0.0 111.203 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 47.9 Cg_endo -74.05 178.5 6.82 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.978 1.515 . . . . 0.0 110.157 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.473 HG23 HG23 ' A' ' 53' ' ' VAL . 97.3 t -125.45 132.89 24.43 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.007 . . . . 0.0 110.63 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.443 ' C ' ' HD3' ' A' ' 52' ' ' ARG . 45.9 Cg_endo -87.02 -171.89 0.83 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.021 1.537 . . . . 0.0 109.179 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.558 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 18.5 mtm -114.64 7.11 15.92 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.992 -1.067 . . . . 0.0 110.162 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.2 m -111.94 100.64 9.05 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.791 -1.163 . . . . 0.0 111.861 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.583 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -46.54 108.53 0.85 Allowed Pre-proline 0 C--N 1.289 -2.032 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.492 178.576 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.491 ' HD2' HD21 ' A' ' 94' ' ' LEU . 38.3 Cg_endo -64.75 146.58 88.71 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.899 1.473 . . . . 0.0 110.676 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.82 -11.61 27.84 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.161 1.611 . . . . 0.0 111.565 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -93.89 24.25 4.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.03 -1.044 . . . . 0.0 108.651 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.542 ' CD1' HG11 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -141.75 -3.33 1.14 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.797 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.8 t -88.96 125.73 61.52 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.803 -1.186 . . . . 0.0 110.665 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.408 ' HG2' ' HB3' ' A' ' 99' ' ' LYS . 49.6 Cg_endo -75.16 152.98 40.69 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.917 1.483 . . . . 0.0 110.539 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 98' ' ' SER . 47.6 Cg_endo -76.42 154.4 35.9 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.877 1.461 . . . . 0.0 110.328 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.7 OUTLIER 73.18 -2.52 2.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.519 -0.738 . . . . 0.0 109.759 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.471 ' HG2' HG22 ' A' ' 59' ' ' ILE . 2.0 tppt? -117.77 -0.7 11.71 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.631 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 N--CA 1.483 0.86 0 N-CA-C 110.121 -0.761 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.578 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 17.2 t90 -68.16 122.2 17.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.213 -0.93 . . . . 0.0 109.766 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -41.98 -26.97 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 110.089 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.578 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 79.1 t -109.99 124.74 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.0 109.913 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -86.15 174.36 5.67 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.322 -0.861 . . . . 0.0 110.36 -179.731 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.0 Cg_endo -66.19 -35.94 30.71 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.009 1.531 . . . . 0.0 109.787 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.39 -24.23 61.22 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.357 -0.84 . . . . 0.0 109.242 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -82.69 -42.08 18.54 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.27 -15.86 61.91 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.154 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' A' ' 11' ' ' PRO . . . -70.82 -33.34 70.59 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -82.33 -43.79 17.01 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.596 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 4.3 m-30 -61.68 -17.77 56.92 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -87.1 -18.1 31.29 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.802 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.455 ' O ' ' OG ' ' A' ' 23' ' ' SER . . . -90.77 -30.61 16.93 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.543 HG21 ' CE1' ' A' ' 70' ' ' PHE . 27.0 mt -79.62 -32.62 14.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.583 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -69.47 -41.33 76.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.51 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.8 t70 -86.75 2.69 47.88 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.332 0.587 . . . . 0.0 109.842 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 2.4 m -93.3 0.13 56.88 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.543 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -113.65 -0.62 14.26 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.468 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 p 77.23 89.9 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 CA-C-O 121.568 0.699 . . . . 0.0 109.119 -178.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 53.4 Cg_endo -74.21 146.99 36.95 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.113 1.586 . . . . 0.0 110.314 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 98.1 t -114.49 103.55 15.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER 61.89 21.52 12.35 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.189 -0.944 . . . . 0.0 108.933 -178.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.552 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 91.78 33.05 8.09 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 37.9 m-85 -142.74 156.94 45.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -1.108 . . . . 0.0 111.606 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.532 ' CD1' ' CD2' ' A' ' 21' ' ' PHE . 37.6 mt -133.35 132.67 41.55 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.564 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.1 OUTLIER -84.49 149.5 25.9 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.342 -0.849 . . . . 0.0 111.22 -178.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -50.68 -21.99 5.32 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.03 -8.63 55.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.236 . . . . 0.0 110.136 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 5.0 mtpp -114.25 -42.1 3.39 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.925 0.869 . . . . 0.0 109.148 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.531 HG13 ' CD1' ' A' ' 65' ' ' LEU . 46.7 t -80.73 -47.44 20.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.528 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.604 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.7 tttp -43.37 -48.37 17.3 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.535 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.9 Cg_endo -68.07 -35.59 19.54 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.335 1.176 . . . . 0.0 109.155 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.492 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 2.3 t -64.06 -31.12 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.386 0.613 . . . . 0.0 109.414 178.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 20.9 mt -79.8 -16.95 54.51 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 109.016 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.482 HD22 HD13 ' A' ' 50' ' ' LEU . 75.9 mt -76.38 -24.69 54.14 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.562 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 33.0 m-80 -67.78 -15.98 63.9 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.452 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.43 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -72.55 -0.25 12.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.544 -0.722 . . . . 0.0 110.422 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.88 18.75 10.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.111 -0.993 . . . . 0.0 109.343 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.542 ' CD1' ' CD2' ' A' ' 81' ' ' LEU . 14.5 mt -96.34 160.58 29.39 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.631 -0.668 . . . . 0.0 110.009 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 41.7 Cg_endo -74.29 161.94 39.46 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.878 1.462 . . . . 0.0 109.461 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 t -63.17 -9.24 4.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.379 -0.825 . . . . 0.0 110.177 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -73.52 -39.12 65.04 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.543 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 20.8 mm -70.41 -47.98 62.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.482 HD13 HD22 ' A' ' 41' ' ' LEU . 5.0 mt -66.07 -22.12 66.4 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.58 -28.34 29.94 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.528 ' HD3' ' N ' ' A' ' 88' ' ' MET . 3.8 ttm180 -95.72 -58.38 2.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.467 -1.02 . . . . 0.0 109.464 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 49' ' ' ILE . 39.0 t -46.8 -29.19 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.785 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.5 ' O ' ' N ' ' A' ' 57' ' ' SER . 18.4 t-105 -74.19 -59.54 2.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.744 -0.598 . . . . 0.0 110.058 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -46.01 -42.18 12.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 109.722 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' A' ' 87' ' ' PRO . 1.5 mt -78.9 -17.23 55.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.385 -0.822 . . . . 0.0 109.276 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.529 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 1.3 t -92.41 -35.71 13.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.543 -0.723 . . . . 0.0 110.076 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.509 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 24.7 t0 -78.71 77.16 5.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.467 -0.771 . . . . 0.0 109.291 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.526 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 35.6 mm -40.72 -31.82 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.362 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 2.9 m-20 -96.24 -27.03 15.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.335 -0.853 . . . . 0.0 110.557 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 28.0 m-70 64.74 45.43 3.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.076 -1.015 . . . . 0.0 109.274 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -114.32 -2.74 13.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 110.582 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.31 -0.94 34.97 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.564 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 2.4 mtt -129.35 155.94 44.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.323 -1.104 . . . . 0.0 110.312 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.531 ' CD1' HG13 ' A' ' 36' ' ' VAL . 11.0 mt -122.56 121.15 35.82 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.312 -0.867 . . . . 0.0 110.969 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 1.1 m-20 -80.47 155.81 26.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.151 -0.968 . . . . 0.0 108.932 178.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.583 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 11.1 ptt180 -40.14 -31.71 0.14 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 0.0 111.491 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.475 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 81.5 m-20 -85.71 -31.53 22.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.038 -1.039 . . . . 0.0 109.839 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.526 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 54.8 mt-10 -77.41 -42.39 36.39 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.569 ' CE1' ' SD ' ' A' ' 74' ' ' MET . 43.5 t80 -57.68 -32.65 67.55 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -60.63 -53.69 54.43 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.584 0.707 . . . . 0.0 110.302 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.53 HG11 ' CD1' ' A' ' 94' ' ' LEU . 80.8 t -53.53 -26.74 13.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.525 -0.734 . . . . 0.0 110.242 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -87.68 -11.16 49.18 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.117 -0.989 . . . . 0.0 112.673 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.569 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 9.0 mmm -86.65 -43.42 12.64 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.342 -1.474 . . . . 0.0 111.036 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.645 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 2.0 p90 -76.83 -23.26 52.76 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.632 -1.227 . . . . 0.0 108.244 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.602 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 5.5 mt -76.0 -21.76 56.55 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.38 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 73' ' ' ALA . 75.5 t -90.93 -26.46 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.373 -0.83 . . . . 0.0 109.766 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -89.49 -23.14 22.15 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.335 -0.853 . . . . 0.0 109.271 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 30.3 m -82.44 -13.31 56.98 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.39 -0.819 . . . . 0.0 108.9 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 84' ' ' GLU . . . -89.31 -11.14 44.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.393 -0.817 . . . . 0.0 108.974 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.571 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 1.6 mt -90.82 -43.51 10.01 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.677 0.751 . . . . 0.0 109.563 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 6.2 tp10 -69.22 -53.31 20.6 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.909 -0.717 . . . . 0.0 109.608 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 9.9 tttm 178.1 -26.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.286 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -63.29 113.1 8.43 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.001 -1.062 . . . . 0.0 111.08 -178.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.68 155.42 58.79 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.987 1.52 . . . . 0.0 110.019 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.505 HG23 ' CG2' ' A' ' 53' ' ' VAL . 69.5 t -109.83 119.76 46.7 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.998 -1.064 . . . . 0.0 110.717 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.534 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 49.3 Cg_endo -89.32 145.67 5.07 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.869 1.457 . . . . 0.0 109.394 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.528 ' N ' ' HD3' ' A' ' 52' ' ' ARG . 1.2 ptt? -75.33 5.08 6.08 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.029 -1.044 . . . . 0.0 111.526 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.432 ' C ' ' CD2' ' A' ' 56' ' ' LEU . 58.2 m -98.57 104.56 16.6 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 118.821 -1.152 . . . . 0.0 112.24 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.529 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -44.48 104.99 0.41 Allowed Pre-proline 0 C--N 1.299 -1.617 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.418 178.155 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.491 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 39.4 Cg_endo -67.0 139.9 52.74 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.774 1.407 . . . . 0.0 110.624 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.38 -6.44 19.17 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.066 1.561 . . . . 0.0 111.095 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -97.09 19.06 13.52 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.645 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -151.42 13.03 0.65 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.758 0.79 . . . . 0.0 110.142 -178.657 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 p -104.02 136.27 19.22 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 120.645 -1.284 . . . . 0.0 110.038 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.08 146.16 90.48 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.964 1.508 . . . . 0.0 109.803 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.478 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 42.0 Cg_endo -68.87 -3.4 11.31 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.899 1.473 . . . . 0.0 111.376 -178.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t -86.38 -21.93 26.91 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.004 -1.06 . . . . 0.0 109.403 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.453 ' HE3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -89.99 2.86 54.65 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.391 -0.818 . . . . 0.0 109.687 179.242 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 10.9 ptp180 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 110.327 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.861 ' HE1' HD22 ' A' ' 94' ' ' LEU . 15.5 t90 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.254 0.55 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -44.94 -27.74 0.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 110.342 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.605 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 16.3 t -89.84 137.57 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.209 -0.932 . . . . 0.0 110.116 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 5.4 mttt -92.81 168.29 12.72 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.666 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 38.3 Cg_endo -65.9 -34.56 38.68 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.638 1.336 . . . . 0.0 109.763 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.67 -25.05 60.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.345 -0.847 . . . . 0.0 109.252 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -83.95 -38.36 21.12 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.769 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -67.78 -17.45 64.54 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.453 -0.78 . . . . 0.0 109.192 179.071 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.16 -40.43 27.34 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.64 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 3.7 ptmt -79.23 -24.1 43.29 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.64 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.0 m-30 -75.07 -35.68 61.83 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -76.68 -11.73 59.89 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.261 0.553 . . . . 0.0 110.182 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -94.82 -34.33 12.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.66 HG22 ' CE1' ' A' ' 70' ' ' PHE . 21.4 mt -75.78 -32.68 24.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.718 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -68.15 -37.98 81.63 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.833 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.498 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 13.6 t70 -89.75 1.72 55.75 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.546 -0.721 . . . . 0.0 109.966 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -92.81 0.13 57.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 108.65 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.056 HD22 HG21 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -113.85 -2.12 13.72 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER 82.69 89.81 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.8 Cg_endo -75.29 150.85 37.52 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 124.352 1.711 . . . . 0.0 110.721 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 98.8 t -117.59 96.9 4.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.561 -0.712 . . . . 0.0 109.505 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 25.9 t-20 56.93 20.49 5.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.923 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.55 32.28 3.98 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 90.7 m-85 -149.98 158.6 44.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.194 -1.18 . . . . 0.0 111.378 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.988 HD13 HD12 ' A' ' 24' ' ' LEU . 40.5 mt -135.21 132.51 37.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.555 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 9.2 p -80.66 140.23 35.77 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.445 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.47 -26.38 0.38 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 32' ' ' SER . 8.4 t0 -62.77 -16.37 57.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -1.159 . . . . 0.0 110.378 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 17.5 mttm -107.58 -42.2 4.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.237 -0.914 . . . . 0.0 109.298 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.931 HG11 HD12 ' A' ' 65' ' ' LEU . 64.9 t -74.31 -35.66 40.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.835 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.581 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 14.3 tttp -49.4 -54.59 28.64 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 110.229 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 1.051 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.5 Cg_endo -65.09 -30.29 56.0 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.493 1.26 . . . . 0.0 108.997 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.056 HG21 HD22 ' A' ' 24' ' ' LEU . 4.3 t -76.4 -10.32 13.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.361 0.601 . . . . 0.0 109.741 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.783 ' HB3' HD22 ' A' ' 50' ' ' LEU . 68.5 mt -100.86 -16.09 17.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.051 HD12 ' HA ' ' A' ' 38' ' ' PRO . 7.7 mt -87.16 -40.69 14.37 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.51 -0.744 . . . . 0.0 109.575 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 7.4 p-10 -52.34 -20.81 2.99 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.068 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.544 ' CA ' HD21 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -66.95 -6.15 15.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.579 -0.701 . . . . 0.0 110.085 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.3 OUTLIER 72.43 9.5 5.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.865 . . . . 0.0 109.96 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.026 HD13 HG21 ' A' ' 49' ' ' ILE . 14.9 mt -91.58 157.16 42.4 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 110.322 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.2 Cg_endo -74.47 164.35 34.15 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.138 1.599 . . . . 0.0 110.191 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.83 -8.75 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 110.159 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.84 -40.23 63.45 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.053 -1.029 . . . . 0.0 108.309 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.026 HG21 HD13 ' A' ' 45' ' ' LEU . 10.3 mm -68.34 -47.72 76.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.783 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.4 mt -62.62 -17.38 60.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -88.72 -33.67 9.82 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.504 ' HD2' ' O ' ' A' ' 87' ' ' PRO . 16.7 ttm-85 -91.77 -55.78 3.34 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.461 -1.023 . . . . 0.0 109.321 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.858 HG11 HG23 ' A' ' 77' ' ' VAL . 24.7 t -47.64 -58.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.37 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.489 ' HB3' ' O ' ' A' ' 50' ' ' LEU . 7.7 t-105 -47.35 -54.85 10.07 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.686 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 17.8 mm-40 -47.39 -51.9 18.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 110.02 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.687 HD21 ' C ' ' A' ' 88' ' ' MET . 2.6 mt -74.57 -7.65 53.81 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.317 -0.864 . . . . 0.0 109.642 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.893 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -100.53 -36.23 9.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.418 -0.801 . . . . 0.0 110.269 179.481 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.543 ' HA ' HD23 ' A' ' 65' ' ' LEU . 36.3 t0 -79.31 71.89 5.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.441 -0.787 . . . . 0.0 109.495 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.466 ' HB ' ' HG2' ' A' ' 69' ' ' GLU . 36.8 mm -40.16 -33.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.622 -0.674 . . . . 0.0 110.658 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -93.22 -27.59 16.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.946 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.546 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 14.4 m-70 64.67 45.2 3.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.21 -0.931 . . . . 0.0 110.762 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.495 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 2.6 p-10 -113.38 20.88 15.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 110.787 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.53 0.66 89.33 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.555 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 3.3 mtt -130.81 160.26 34.92 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.293 -1.122 . . . . 0.0 110.314 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.931 HD12 HG11 ' A' ' 36' ' ' VAL . 21.3 mt -126.97 114.27 17.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 110.542 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 8.9 t70 -69.74 172.96 6.74 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.142 -0.974 . . . . 0.0 109.395 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.573 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 5.2 ptt180 -55.42 -31.72 62.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 110.768 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.78 -32.54 19.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.089 -1.007 . . . . 0.0 109.778 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 28.0 mt-10 -78.16 -39.3 41.4 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.264 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.804 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 62.6 t80 -65.61 -27.56 68.49 Favored 'General case' 0 C--N 1.303 -1.457 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.865 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.38 -45.44 87.7 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.796 0.808 . . . . 0.0 109.685 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.893 HG13 HD21 ' A' ' 94' ' ' LEU . 48.1 t -61.64 -20.29 22.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.333 0.587 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.893 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.36 -11.12 41.56 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 111.65 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.569 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 5.7 mmm -89.1 -41.52 12.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.699 -1.251 . . . . 0.0 110.385 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.584 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 1.8 p90 -78.97 -23.29 44.63 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.046 -1.061 . . . . 0.0 108.55 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.799 ' HB3' HG13 ' A' ' 53' ' ' VAL . 6.1 mt -74.61 -23.64 58.75 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.858 HG23 HG11 ' A' ' 53' ' ' VAL . 55.6 t -91.03 -59.03 3.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.485 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.5 m-85 -47.85 -22.73 0.6 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.796 -0.565 . . . . 0.0 111.567 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -83.74 -16.85 43.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.882 -1.136 . . . . 0.0 110.048 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.953 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -86.8 -14.18 42.96 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.325 -0.859 . . . . 0.0 109.484 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.754 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.7 mp -86.65 -40.4 15.15 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 . . . . . 0 C--N 1.301 -1.517 0 CA-C-O 121.376 0.608 . . . . 0.0 109.858 179.495 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.757 HG13 HD22 ' A' ' 76' ' ' LEU . 76.5 t . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 120.629 0.252 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.618 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.8 Cg_endo -83.3 -167.52 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.999 1.526 . . . . 0.0 109.359 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.687 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -117.63 9.95 13.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.109 -0.994 . . . . 0.0 110.405 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.492 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 90.5 p -108.28 107.2 17.69 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.307 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.606 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -55.71 107.1 0.78 Allowed Pre-proline 0 C--N 1.294 -1.808 0 C-N-CA 120.061 -0.655 . . . . 0.0 109.811 178.634 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.547 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 41.6 Cg_endo -73.67 149.31 43.21 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.744 1.392 . . . . 0.0 110.606 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.537 ' HA ' ' CG1' ' A' ' 95' ' ' VAL . 48.3 Cg_endo -72.5 -3.98 14.44 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.224 1.644 . . . . 0.0 111.85 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -94.66 -23.37 17.62 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.072 -1.018 . . . . 0.0 109.225 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.969 HD22 ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -98.21 -14.38 20.36 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.786 0.803 . . . . 0.0 109.255 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.537 ' CG1' ' HA ' ' A' ' 92' ' ' PRO . 8.9 p . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.081 -1.012 . . . . 0.0 110.519 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.511 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.3 t90 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.157 0.503 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.907 ' HB3' HD12 ' A' ' 94' ' ' LEU . . . -41.66 -29.53 0.19 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.511 -0.743 . . . . 0.0 109.831 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.552 HG22 ' CD2' ' A' ' 75' ' ' PHE . 92.3 t -92.08 158.59 2.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.548 -0.72 . . . . 0.0 109.865 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.527 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 6.0 mttt -126.36 178.09 1.68 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.952 . . . . 0.0 110.13 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.657 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 40.0 Cg_endo -66.67 -36.48 24.82 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.913 1.481 . . . . 0.0 110.141 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -69.88 -36.23 75.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 109.101 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -83.54 -33.43 25.47 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 10' ' ' LYS . 16.4 tptp -78.64 -20.64 49.86 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -68.05 -41.9 81.34 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.626 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.7 ptpt -72.9 -31.81 64.92 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.626 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -66.59 -38.31 86.75 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 62.8 t0 -68.99 -11.1 60.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.672 -0.643 . . . . 0.0 110.331 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -96.39 -34.45 11.54 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.674 HG22 ' CE2' ' A' ' 70' ' ' PHE . 26.5 mt -78.35 -31.57 16.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.546 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -68.3 -37.98 81.16 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.605 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.529 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.1 t70 -90.41 0.99 57.05 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.625 -0.672 . . . . 0.0 109.916 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -92.72 2.71 56.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 108.77 178.792 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.055 HD22 HG21 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -115.6 -1.67 12.68 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER 79.52 87.0 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.416 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -73.87 147.46 39.31 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 124.446 1.761 . . . . 0.0 110.666 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 34.6 t -114.37 105.94 19.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 14.1 t-20 55.49 23.71 6.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -0.983 . . . . 0.0 109.284 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.405 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 91.77 37.36 6.11 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 86.4 m-85 -149.92 158.03 43.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -1.098 . . . . 0.0 111.233 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.77 HD22 ' HB2' ' A' ' 24' ' ' LEU . 12.0 mt -136.4 133.15 36.41 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.555 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -79.63 140.74 37.0 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.414 -0.804 . . . . 0.0 110.408 -179.427 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.52 -25.54 0.85 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 32' ' ' SER . 4.8 t70 -68.37 -9.07 45.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -1.173 . . . . 0.0 110.237 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HD2' ' OG ' ' A' ' 32' ' ' SER . 4.6 mtpp -114.05 -43.35 3.25 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.886 0.851 . . . . 0.0 109.348 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.972 HG11 ' CD1' ' A' ' 65' ' ' LEU . 85.8 t -76.94 -46.21 29.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.78 -0.575 . . . . 0.0 110.266 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.6 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 39.0 tttt -46.19 -49.23 42.47 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 110.796 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.913 ' HA ' HD12 ' A' ' 41' ' ' LEU . 41.4 Cg_endo -68.58 -34.93 18.37 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 N-CA-C 108.918 -1.224 . . . . 0.0 108.918 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.055 HG21 HD22 ' A' ' 24' ' ' LEU . 2.4 t -62.72 -25.21 37.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.93 ' HB3' HD22 ' A' ' 50' ' ' LEU . 20.0 mt -84.02 -15.84 46.14 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.408 -0.807 . . . . 0.0 109.173 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.913 HD12 ' HA ' ' A' ' 38' ' ' PRO . 16.0 mt -76.44 -28.13 56.48 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -63.51 -15.63 58.43 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.472 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.559 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -72.68 -1.54 16.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.504 -0.748 . . . . 0.0 110.155 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 43' ' ' SER . 7.8 ttpt 68.73 18.15 8.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -0.865 . . . . 0.0 109.925 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.024 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.8 mt -100.11 162.05 22.24 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.387 -0.821 . . . . 0.0 110.375 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.9 Cg_endo -74.14 166.18 30.18 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.106 1.582 . . . . 0.0 110.288 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 t -66.65 -7.52 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.404 -0.81 . . . . 0.0 110.22 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -40.93 59.6 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.958 HG21 HD13 ' A' ' 45' ' ' LEU . 21.5 mm -64.91 -44.87 96.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.93 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.8 mt -65.74 -17.88 64.93 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.335 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -87.92 -30.57 17.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.598 ' O ' HD12 ' A' ' 56' ' ' LEU . 4.1 ttm180 -92.73 -56.27 3.07 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.403 -1.057 . . . . 0.0 109.45 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.049 HG11 HG23 ' A' ' 77' ' ' VAL . 41.0 t -46.6 -39.82 4.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.281 -0.968 . . . . 0.0 109.058 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.517 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 18.5 t-105 -65.51 -60.35 3.03 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.814 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 4.1 mm-40 -44.25 -54.68 5.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 109.826 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 90' ' ' LEU . 1.7 mt -69.9 -9.94 56.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.393 -0.817 . . . . 0.0 109.662 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 1.097 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 3.1 t -100.52 -32.75 10.63 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.442 -0.786 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.483 ' OD2' ' HA ' ' A' ' 61' ' ' HIS . 22.7 t0 -80.07 76.43 6.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.305 -0.872 . . . . 0.0 110.21 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.51 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 41.6 mm -45.96 -32.56 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.482 -0.761 . . . . 0.0 109.833 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 22.7 m-20 -95.8 -21.73 17.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.539 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.483 ' HA ' ' OD2' ' A' ' 58' ' ' ASP . 75.7 m80 57.38 48.47 14.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 109.563 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.455 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 1.7 p-10 -117.64 6.57 12.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.404 -0.81 . . . . 0.0 110.376 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.83 8.85 59.0 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.555 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 5.9 mtt -141.85 160.63 39.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -1.147 . . . . 0.0 110.89 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.972 ' CD1' HG11 ' A' ' 36' ' ' VAL . 35.9 mt -130.18 120.66 24.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.379 -0.826 . . . . 0.0 109.986 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.583 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 2.0 p30 -79.45 166.33 22.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.885 -1.135 . . . . 0.0 110.036 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.523 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 9.6 ptt180 -36.97 -46.83 0.67 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.456 -0.778 . . . . 0.0 111.596 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 63.1 m-20 -79.91 -33.9 39.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.139 -0.976 . . . . 0.0 110.381 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.567 ' HG2' HD23 ' A' ' 65' ' ' LEU . 13.1 tt0 -67.94 -50.75 54.12 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.346 -0.847 . . . . 0.0 109.785 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.71 ' CE1' HG13 ' A' ' 36' ' ' VAL . 62.5 t80 -56.0 -27.42 52.84 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.11 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -62.63 -47.33 84.2 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.564 0.697 . . . . 0.0 110.103 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.717 HG13 ' HG ' ' A' ' 94' ' ' LEU . 96.2 t -59.67 -24.48 29.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.501 -0.75 . . . . 0.0 109.875 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.097 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -88.39 -6.48 57.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.26 -0.9 . . . . 0.0 111.605 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.572 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 8.7 mmm -90.17 -42.77 10.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.383 -1.448 . . . . 0.0 110.332 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.7 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.0 p90 -76.44 -22.58 54.46 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.965 -1.094 . . . . 0.0 108.339 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 72' ' ' VAL . 14.9 mt -73.7 -28.36 61.69 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.049 HG23 HG11 ' A' ' 53' ' ' VAL . 41.2 t -92.09 -56.4 5.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.732 -0.605 . . . . 0.0 109.551 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.603 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -53.31 -18.85 2.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.416 -0.802 . . . . 0.0 110.812 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 75' ' ' PHE . 11.7 m -86.13 -16.94 36.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.933 . . . . 0.0 109.945 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.024 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.82 -11.91 52.21 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.191 -0.943 . . . . 0.0 109.564 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.624 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.2 mp -87.52 -43.78 11.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.377 -0.827 . . . . 0.0 109.222 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.459 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.23 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.621 HG21 ' CG2' ' A' ' 53' ' ' VAL . 53.3 t . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 120.636 0.255 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.575 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.4 Cg_endo -83.14 176.5 7.41 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.921 1.485 . . . . 0.0 109.724 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.653 ' C ' HD21 ' A' ' 56' ' ' LEU . 31.7 mtp -103.21 15.81 28.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.091 -1.006 . . . . 0.0 110.345 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.591 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 75.7 m -114.06 105.33 13.09 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.954 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.709 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -82.25 106.13 5.91 Favored Pre-proline 0 C--N 1.289 -2.046 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.592 ' HD2' HD22 ' A' ' 94' ' ' LEU . 40.5 Cg_endo -66.36 158.83 53.17 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.906 1.477 . . . . 0.0 110.244 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.19 -15.59 31.81 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.882 1.464 . . . . 0.0 110.312 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -72.47 -7.5 50.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.907 HD12 ' HB3' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -90.5 -28.36 18.61 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.62 -0.675 . . . . 0.0 110.122 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.481 -0.762 . . . . 0.0 111.098 -179.086 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.584 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 13.9 t90 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.236 0.541 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.885 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -41.43 -33.21 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.596 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.584 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 55.4 t -98.38 122.89 50.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.357 -0.839 . . . . 0.0 110.142 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.557 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 2.0 mtmt -91.26 -177.28 0.73 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 110.107 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.557 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 43.2 Cg_endo -71.24 -36.26 7.39 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.811 1.427 . . . . 0.0 110.242 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.78 -24.16 58.63 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.314 -0.866 . . . . 0.0 109.302 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -86.5 -37.04 18.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.309 -0.869 . . . . 0.0 108.914 179.029 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -18.42 59.38 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.31 -39.53 71.36 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.732 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -75.19 -19.02 60.03 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.781 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 13.0 m-30 -82.83 -30.25 28.86 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -76.6 -11.3 59.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.718 -0.614 . . . . 0.0 110.053 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.47 -33.66 15.12 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.732 HD12 ' O ' ' A' ' 16' ' ' LYS . 6.9 mt -80.38 -29.03 12.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.628 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -75.51 -35.46 60.76 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.002 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.56 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -89.48 -1.92 58.2 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.594 -0.691 . . . . 0.0 109.88 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.44 -6.02 56.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 109.206 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.646 ' HB2' HD22 ' A' ' 31' ' ' LEU . 1.9 mt -108.35 -9.82 15.41 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.5 m 83.16 92.21 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.8 Cg_endo -73.05 148.52 44.98 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.351 1.711 . . . . 0.0 110.577 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.473 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 28.3 t -111.94 113.14 43.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.441 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER 46.04 25.09 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.835 . . . . 0.0 109.719 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.46 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 96.8 34.58 5.67 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.634 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 85.0 m-85 -151.55 153.8 35.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.085 -1.244 . . . . 0.0 111.72 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.666 HD23 ' HD2' ' A' ' 35' ' ' LYS . 41.7 mt -123.15 127.95 49.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 35' ' ' LYS . 60.1 p -65.84 137.96 57.56 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.862 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.619 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -48.28 -26.97 5.18 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.66 -14.65 58.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -1.124 . . . . 0.0 109.633 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.666 ' HD2' HD23 ' A' ' 31' ' ' LEU . 21.0 ttmm -91.88 -39.55 11.66 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.944 HG11 HD12 ' A' ' 65' ' ' LEU . 89.7 t -83.1 -31.05 8.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.437 0.637 . . . . 0.0 110.098 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.639 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -39.86 -51.28 5.55 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.535 -0.728 . . . . 0.0 111.122 -179.282 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 36.7 Cg_endo -63.02 -31.05 76.74 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.425 1.223 . . . . 0.0 109.841 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 36' ' ' VAL . 2.9 t -74.46 -14.92 16.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.628 -0.67 . . . . 0.0 109.866 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.938 ' HB3' HD22 ' A' ' 50' ' ' LEU . 66.9 mt -97.41 -23.93 15.85 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.295 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 38' ' ' PRO . 2.5 mt -87.74 -34.2 18.43 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.188 -0.945 . . . . 0.0 110.063 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 39' ' ' VAL . 3.8 p-10 -65.6 -9.95 31.39 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.579 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.468 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 2.3 m -79.77 7.72 8.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 110.475 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 64.75 16.76 10.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.125 -0.984 . . . . 0.0 110.489 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.997 HD13 HG21 ' A' ' 49' ' ' ILE . 14.5 mt -97.0 153.81 38.41 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 109.967 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.6 Cg_endo -74.79 163.64 35.25 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.998 1.525 . . . . 0.0 110.467 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.6 t -64.77 -8.43 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.718 . . . . 0.0 110.513 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -76.3 -41.18 49.48 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.997 HG21 HD13 ' A' ' 45' ' ' LEU . 23.0 mm -65.03 -44.93 95.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.938 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.9 mt -61.97 -18.42 60.35 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.35 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.67 -31.16 19.27 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.782 ' C ' HD12 ' A' ' 56' ' ' LEU . 1.2 mtm180 -94.95 -55.38 3.11 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.43 -1.041 . . . . 0.0 109.455 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.798 HG23 HG21 ' A' ' 86' ' ' VAL . 30.0 t -49.08 -42.69 14.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.246 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.619 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 14.6 t-105 -65.55 -58.57 5.46 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.138 -0.976 . . . . 0.0 109.513 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.583 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 5.2 mm-40 -51.43 -33.45 30.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.995 . . . . 0.0 109.142 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.917 ' O ' HD11 ' A' ' 90' ' ' LEU . 6.7 mt -86.01 -15.27 41.94 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.493 -0.754 . . . . 0.0 109.343 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.989 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 50.4 m -100.16 -29.54 12.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.484 -0.76 . . . . 0.0 110.396 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 42.1 t0 -85.45 66.62 9.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.275 -0.891 . . . . 0.0 109.842 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 58' ' ' ASP . 42.0 mm -40.36 -29.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.485 0.659 . . . . 0.0 110.22 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 6.3 t0 -89.33 -28.51 19.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.362 -0.836 . . . . 0.0 110.826 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.583 ' CE1' ' O ' ' A' ' 55' ' ' GLU . 87.7 m-70 56.32 50.59 12.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.084 -1.01 . . . . 0.0 110.083 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 63' ' ' GLY . 5.3 p-10 -118.79 -10.11 10.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 110.409 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.424 ' N ' ' OD1' ' A' ' 62' ' ' ASP . . . 116.61 8.69 12.07 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.586 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 15.4 mtp -142.7 160.87 39.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -1.148 . . . . 0.0 110.228 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.944 HD12 HG11 ' A' ' 36' ' ' VAL . 13.0 mt -120.77 105.6 10.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.286 -0.884 . . . . 0.0 109.767 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.634 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 1.8 t70 -72.58 171.66 12.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.879 -1.138 . . . . 0.0 110.258 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.486 ' N ' ' CG ' ' A' ' 66' ' ' ASP . 16.2 ptp180 -45.71 -39.84 8.58 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.771 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.446 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 30.8 t0 -81.77 -31.79 31.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.195 -0.94 . . . . 0.0 110.458 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.478 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 27.5 mt-10 -77.95 -42.06 34.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.215 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.72 ' CE1' HG22 ' A' ' 20' ' ' ILE . 44.0 t80 -66.72 -28.06 68.12 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.536 -0.727 . . . . 0.0 109.376 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.473 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -65.72 -51.98 54.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 110.018 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.894 ' O ' HD12 ' A' ' 76' ' ' LEU . 93.2 t -55.65 -21.79 10.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.537 -0.727 . . . . 0.0 110.281 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.989 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.49 -14.61 32.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.219 -0.925 . . . . 0.0 111.766 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.628 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 7.0 mmm -80.18 -41.8 24.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.744 -1.223 . . . . 0.0 109.924 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.6 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.7 p90 -77.74 -22.34 50.45 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.894 HD12 ' O ' ' A' ' 72' ' ' VAL . 6.6 mt -75.95 -30.76 58.78 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.673 0.749 . . . . 0.0 109.126 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.629 HG23 HG11 ' A' ' 53' ' ' VAL . 44.4 t -90.19 -20.19 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.6 -0.688 . . . . 0.0 109.867 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.4 OUTLIER -90.56 -23.0 21.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.453 -0.779 . . . . 0.0 109.655 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 1.6 m -86.25 -17.98 33.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.446 -0.784 . . . . 0.0 109.731 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.973 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -83.91 -9.36 58.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.434 -0.791 . . . . 0.0 109.177 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.791 HD23 ' N ' ' A' ' 81' ' ' LEU . 2.0 mt -89.59 -45.93 9.02 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.714 0.769 . . . . 0.0 109.227 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 C--N 1.3 -1.562 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.645 179.657 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.798 HG21 HG23 ' A' ' 53' ' ' VAL . 60.0 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.558 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 44.8 Cg_endo -80.19 -165.01 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.61 1.321 . . . . 0.0 110.063 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.07 3.16 17.17 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 111.114 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -177.74 29.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.745 -1.222 . . . . 0.0 111.674 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.917 HD11 ' O ' ' A' ' 56' ' ' LEU . 9.6 mt 57.65 120.49 0.01 OUTLIER Pre-proline 0 C--N 1.285 -2.226 0 O-C-N 121.96 -0.463 . . . . 0.0 110.509 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.07 ' HG2' HD23 ' A' ' 94' ' ' LEU . 40.0 Cg_endo -70.28 176.86 6.59 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 123.641 1.338 . . . . 0.0 109.15 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 40.2 Cg_endo -65.65 -9.72 23.78 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.558 1.294 . . . . 0.0 111.894 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.658 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -98.64 4.18 47.94 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.049 -1.032 . . . . 0.0 110.604 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.07 HD23 ' HG2' ' A' ' 91' ' ' PRO . 4.2 mm? -117.35 38.57 3.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.011 -1.056 . . . . 0.0 111.295 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.694 ' O ' HG13 ' A' ' 95' ' ' VAL . 8.8 p . . . . . 0 C--N 1.3 -1.583 0 O-C-N 120.91 -1.119 . . . . 0.0 110.603 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.787 ' HE1' HD22 ' A' ' 94' ' ' LEU . 11.1 t90 . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -41.14 -27.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.0 109.787 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.475 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 38.0 t -99.51 149.02 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.438 -0.789 . . . . 0.0 109.69 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.6 mttt -111.48 173.36 2.91 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 110.02 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.8 Cg_endo -68.94 -34.51 17.29 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.835 1.44 . . . . 0.0 109.404 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 10.5 pt-20 -80.21 -26.7 39.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.47 -0.768 . . . . 0.0 109.646 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 1.6 m-20 -83.34 -41.38 18.29 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -69.06 -16.99 63.83 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.455 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.11 -42.42 72.69 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.629 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -70.68 -27.63 64.17 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.856 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -69.38 -37.48 77.58 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.22 -10.37 57.43 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.426 0.631 . . . . 0.0 109.969 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -92.79 -34.55 13.83 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.726 HG22 ' CE1' ' A' ' 70' ' ' PHE . 15.8 mt -80.97 -28.46 11.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.85 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.68 -36.01 60.2 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.585 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.541 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.4 t70 -88.65 -2.17 58.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.667 -0.646 . . . . 0.0 109.712 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 29.5 t -91.3 0.91 57.44 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.053 HD22 HG21 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -113.12 -5.51 13.71 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.593 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 82.63 86.58 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.092 0 CA-C-O 121.131 0.491 . . . . 0.0 109.827 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.541 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -73.53 147.4 40.78 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 O-C-N 124.418 1.746 . . . . 0.0 110.903 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -115.89 111.83 37.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.633 -0.667 . . . . 0.0 109.242 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 54.52 20.52 2.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 109.468 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . 95.58 32.68 6.8 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.613 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 94.5 m-85 -146.32 158.96 43.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.432 -1.04 . . . . 0.0 110.643 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.95 HD22 ' HB2' ' A' ' 24' ' ' LEU . 16.5 mt -136.77 128.7 29.28 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.58 -0.7 . . . . 0.0 109.177 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.541 ' OG ' ' CE ' ' A' ' 64' ' ' MET . 0.7 OUTLIER -74.49 137.41 42.51 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.273 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.34 -32.38 1.16 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 38' ' ' PRO . 72.0 m-20 -53.38 -24.44 12.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -1.142 . . . . 0.0 110.027 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 12.1 mttm -103.3 -44.61 5.12 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.019 0.914 . . . . 0.0 109.072 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.086 HG11 HD12 ' A' ' 65' ' ' LEU . 40.2 t -76.63 -49.13 24.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 O-C-N 121.81 -0.556 . . . . 0.0 110.467 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.594 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 14.7 ttpt -43.17 -50.2 14.95 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.484 -0.887 . . . . 0.0 110.801 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.884 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.8 Cg_endo -67.05 -34.49 28.62 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 N-CA-C 109.108 -1.151 . . . . 0.0 109.108 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.053 HG21 HD22 ' A' ' 24' ' ' LEU . 2.3 t -65.15 -23.83 34.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.016 ' HB3' HD22 ' A' ' 50' ' ' LEU . 16.4 mt -86.33 -15.06 41.73 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.392 -0.817 . . . . 0.0 109.203 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.884 HD12 ' HA ' ' A' ' 38' ' ' PRO . 27.8 mt -77.97 -26.85 48.96 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -62.55 -13.9 36.19 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.623 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.532 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -78.63 2.13 20.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.563 -0.711 . . . . 0.0 110.327 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 43' ' ' SER . 1.7 mtpt 63.53 15.6 8.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -0.902 . . . . 0.0 110.362 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.036 HD13 HG21 ' A' ' 49' ' ' ILE . 13.6 mt -94.82 162.54 24.99 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.143 -0.973 . . . . 0.0 109.915 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.519 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.1 Cg_endo -73.99 164.91 33.34 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.013 1.533 . . . . 0.0 110.957 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 t -64.96 -9.1 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.502 -0.749 . . . . 0.0 109.776 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -72.48 -41.31 66.17 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.036 HG21 HD13 ' A' ' 45' ' ' LEU . 20.3 mm -64.2 -47.49 89.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.016 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.3 mt -65.6 -23.11 66.75 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.632 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.498 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -86.03 -30.78 22.12 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HD3' ' HG2' ' A' ' 88' ' ' MET . 13.7 ttm180 -91.52 -54.95 3.68 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.506 -0.996 . . . . 0.0 109.667 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.851 ' CG2' HG21 ' A' ' 86' ' ' VAL . 26.7 t -49.67 -42.89 18.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.993 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.556 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 16.3 t-105 -61.86 -58.19 8.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.831 . . . . 0.0 111.05 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 17.0 mt-10 -51.6 -36.9 47.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.883 -1.136 . . . . 0.0 109.607 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.018 HD22 ' N ' ' A' ' 90' ' ' LEU . 18.5 mt -90.07 -8.44 51.45 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.516 0.674 . . . . 0.0 109.485 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 1.042 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 4.6 t -100.11 -30.29 12.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.448 -0.783 . . . . 0.0 108.916 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.539 ' HA ' HD23 ' A' ' 65' ' ' LEU . 13.3 t0 -84.65 68.25 10.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.485 -0.759 . . . . 0.0 109.631 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.612 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 35.5 mm -37.4 -29.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.266 0.555 . . . . 0.0 110.471 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.539 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 76.4 m-20 -90.68 -25.66 19.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 111.31 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.612 ' CE1' ' O ' ' A' ' 59' ' ' ILE . 1.6 m-70 59.71 26.46 15.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.883 -1.136 . . . . 0.0 108.913 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.428 ' OD2' ' HG3' ' A' ' 64' ' ' MET . 3.9 p-10 -90.82 -24.25 20.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.524 -0.735 . . . . 0.0 110.665 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.38 4.35 4.48 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.7 mtp -145.2 161.16 40.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.002 -1.293 . . . . 0.0 110.313 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.086 HD12 HG11 ' A' ' 36' ' ' VAL . 33.5 mt -115.82 112.16 21.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -0.844 . . . . 0.0 109.984 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.613 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 4.9 p30 -76.08 165.05 25.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.799 -1.188 . . . . 0.0 110.019 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.618 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -39.41 -40.31 0.8 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.458 -0.776 . . . . 0.0 111.741 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 1.4 t0 -80.28 -36.28 34.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.979 -1.075 . . . . 0.0 110.563 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.519 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 44.0 mt-10 -76.17 -41.62 49.15 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.186 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.813 ' CE2' HG13 ' A' ' 36' ' ' VAL . 35.3 t80 -61.82 -25.46 67.52 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -66.56 -51.09 60.29 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.943 0.877 . . . . 0.0 109.648 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.926 HG22 HD21 ' A' ' 94' ' ' LEU . 60.5 t -55.12 -23.88 13.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.358 0.599 . . . . 0.0 110.382 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.042 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -89.86 -10.85 43.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 111.815 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.577 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 7.9 mmm -85.09 -48.06 9.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.639 -1.288 . . . . 0.0 110.121 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.574 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -72.65 -21.52 61.07 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 72' ' ' VAL . 9.6 mt -73.79 -32.79 63.94 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.723 HG21 HD22 ' A' ' 40' ' ' LEU . 70.5 t -91.42 -25.54 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.535 -0.728 . . . . 0.0 110.504 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.5 OUTLIER -86.81 -27.01 23.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.742 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 60.1 m -80.29 -19.05 47.54 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.421 -0.799 . . . . 0.0 108.857 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.843 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -82.15 -7.97 59.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.475 -0.766 . . . . 0.0 109.344 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.54 ' N ' HD23 ' A' ' 81' ' ' LEU . 6.4 mt -90.25 -47.6 7.67 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.566 0.698 . . . . 0.0 110.026 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? . . . . . 0 C--N 1.3 -1.544 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.924 -179.048 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.851 HG21 ' CG2' ' A' ' 53' ' ' VAL . 41.6 t . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.744 ' HD2' HG13 ' A' ' 86' ' ' VAL . 44.9 Cg_endo -85.93 -165.94 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.662 1.348 . . . . 0.0 109.791 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.48 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 5.7 mtt -129.68 18.87 5.68 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.623 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 33.3 t -161.14 23.74 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.268 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 1.018 ' N ' HD22 ' A' ' 56' ' ' LEU . 2.4 mt 61.7 118.48 0.02 OUTLIER Pre-proline 0 C--N 1.283 -2.324 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.54 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.624 ' O ' HG23 ' A' ' 95' ' ' VAL . 41.8 Cg_endo -76.08 146.35 28.85 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.792 1.417 . . . . 0.0 110.005 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.04 -1.03 8.03 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.736 1.624 . . . . 0.0 112.09 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -99.9 -20.53 16.1 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.05 -1.031 . . . . 0.0 109.854 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.975 HD22 ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -101.82 -13.9 17.5 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.588 0.709 . . . . 0.0 109.497 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.856 HG22 HD22 ' A' ' 90' ' ' LEU . 95.4 t . . . . . 0 N--CA 1.492 1.664 0 O-C-N 120.938 -1.101 . . . . 0.0 110.676 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.599 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 15.5 t90 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 121.061 0.458 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.733 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -41.11 -31.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.405 -0.809 . . . . 0.0 110.413 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.599 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 70.4 t -94.45 131.44 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.401 -0.812 . . . . 0.0 109.976 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.532 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 18.0 mttt -95.12 -179.43 0.95 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.846 . . . . 0.0 110.162 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.1 Cg_endo -69.79 -37.32 9.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.903 1.475 . . . . 0.0 110.187 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -71.18 -24.64 62.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 109.664 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.582 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -83.0 -41.8 18.28 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 2.4 tppt? -66.48 -20.17 65.97 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.68 -0.637 . . . . 0.0 109.363 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.7 -42.66 60.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.375 -0.828 . . . . 0.0 109.064 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.625 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -79.14 -26.15 42.83 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.436 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.5 m-30 -71.85 -34.47 69.27 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 8.0 m-20 -81.07 -10.6 59.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.717 -0.614 . . . . 0.0 109.88 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -93.58 -35.45 12.89 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.558 HG21 ' SD ' ' A' ' 74' ' ' MET . 51.3 mt -76.47 -36.9 29.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.582 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -64.13 -36.59 84.52 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.773 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.549 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -90.24 -0.11 57.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.749 -0.595 . . . . 0.0 109.991 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 22.8 t -91.33 0.51 57.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.215 -0.928 . . . . 0.0 109.046 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.968 HD22 HG21 ' A' ' 39' ' ' VAL . 1.2 mt -109.06 -6.61 15.57 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.578 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER 80.29 83.55 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.549 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 42.7 Cg_endo -69.11 149.98 71.63 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 O-C-N 124.65 1.868 . . . . 0.0 110.357 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.3 t -113.16 103.92 16.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.339 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 24.7 t-20 59.19 21.9 10.04 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.479 -0.763 . . . . 0.0 109.374 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.493 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 93.01 39.2 5.24 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.493 ' CD2' ' C ' ' A' ' 29' ' ' GLY . 82.3 m-85 -150.12 159.56 44.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.428 -1.042 . . . . 0.0 111.302 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.679 HD13 HD12 ' A' ' 24' ' ' LEU . 46.1 mt -133.22 131.4 40.29 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.561 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 18.2 p -79.06 141.48 37.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.548 -0.72 . . . . 0.0 110.929 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.612 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -49.76 -24.44 6.0 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.26 -11.95 59.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.419 -1.048 . . . . 0.0 109.66 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.65 ' HD2' HD23 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -97.73 -46.28 6.04 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.316 1.055 . . . . 0.0 108.778 179.305 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.633 HG11 HD12 ' A' ' 65' ' ' LEU . 98.3 t -78.45 -33.07 16.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.069 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.575 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -40.68 -54.85 4.89 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.443 -0.786 . . . . 0.0 110.952 -178.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.995 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.2 Cg_endo -64.24 -31.05 64.19 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.557 1.293 . . . . 0.0 109.332 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.968 HG21 HD22 ' A' ' 24' ' ' LEU . 3.4 t -73.38 -8.41 11.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.721 -0.612 . . . . 0.0 109.363 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.871 ' HB3' HD22 ' A' ' 50' ' ' LEU . 42.3 mt -99.87 -16.42 18.04 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 108.541 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.995 HD12 ' HA ' ' A' ' 38' ' ' PRO . 4.7 mt -89.03 -41.56 12.26 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.501 -0.75 . . . . 0.0 109.785 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 8.0 p-10 -49.82 -22.04 1.32 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.226 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.561 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -68.7 -5.31 19.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.362 -0.836 . . . . 0.0 110.085 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 73.68 8.89 4.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.378 -0.826 . . . . 0.0 110.378 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.054 HD13 HG21 ' A' ' 49' ' ' ILE . 14.3 mt -84.48 155.48 62.63 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 109.769 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.551 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.3 Cg_endo -74.38 162.83 37.57 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.789 1.415 . . . . 0.0 110.753 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.9 t -62.63 -10.58 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.57 -0.706 . . . . 0.0 110.816 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.41 -41.01 57.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.934 -1.104 . . . . 0.0 108.353 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.054 HG21 HD13 ' A' ' 45' ' ' LEU . 27.8 mm -64.11 -44.87 97.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.871 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.6 mt -60.23 -18.19 46.9 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.49 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -84.57 -31.74 23.77 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.479 ' CD ' ' O ' ' A' ' 87' ' ' PRO . 9.8 mtm180 -94.97 -55.26 3.15 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.494 -1.003 . . . . 0.0 109.844 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.646 HG23 HG21 ' A' ' 86' ' ' VAL . 17.2 t -44.83 -39.3 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.642 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.612 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 13.0 t-105 -74.38 -59.02 2.92 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.973 -1.08 . . . . 0.0 110.331 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 65.3 mm-40 -51.38 -30.13 17.96 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.086 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.844 HD22 ' N ' ' A' ' 90' ' ' LEU . 46.8 mt -90.41 -14.78 32.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.57 -0.706 . . . . 0.0 109.496 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.991 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 12.7 m -98.98 -27.81 13.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.476 -0.765 . . . . 0.0 109.642 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 59' ' ' ILE . 13.8 t0 -81.76 69.1 8.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.289 -0.882 . . . . 0.0 109.565 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 58' ' ' ASP . 39.3 mm -40.48 -30.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.511 0.672 . . . . 0.0 109.877 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.451 ' OD2' ' HB3' ' A' ' 62' ' ' ASP . 0.8 OUTLIER -96.15 -28.73 14.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.61 -0.681 . . . . 0.0 109.999 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ASP . 15.6 m80 61.71 46.5 7.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.164 -0.96 . . . . 0.0 110.644 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.451 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 3.1 p-10 -112.66 16.85 19.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 110.265 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.37 5.0 76.4 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.561 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 5.0 mtt -140.4 157.02 46.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -1.145 . . . . 0.0 110.647 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.633 HD12 HG11 ' A' ' 36' ' ' VAL . 74.2 mt -118.63 113.79 21.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.381 -0.824 . . . . 0.0 109.842 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.9 OUTLIER -73.2 155.85 39.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.949 -1.094 . . . . 0.0 109.62 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.575 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -33.83 -44.07 0.15 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.761 -0.587 . . . . 0.0 111.372 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 3.2 p-10 -74.94 -45.26 43.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.36 -0.838 . . . . 0.0 109.897 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.482 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 19.3 mt-10 -62.32 -45.83 91.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.582 -0.698 . . . . 0.0 109.563 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.582 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 52.0 t80 -59.96 -24.07 64.1 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.616 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -68.15 -45.92 72.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.549 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.722 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.3 t -61.79 -23.91 32.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.535 -0.728 . . . . 0.0 109.963 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.991 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.96 -1.35 57.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -0.877 . . . . 0.0 110.832 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.621 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 13.1 mmt -89.09 -46.02 9.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.083 -1.011 . . . . 0.0 109.463 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.668 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 1.7 p90 -75.83 -30.0 58.82 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.722 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.8 mt -63.74 -30.94 71.98 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.616 ' O ' HD21 ' A' ' 81' ' ' LEU . 70.5 t -90.64 -23.84 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.878 -0.514 . . . . 0.0 109.936 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -26.55 20.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.365 -0.834 . . . . 0.0 109.31 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 51.6 m -84.4 -12.28 54.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.437 -0.789 . . . . 0.0 109.211 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.038 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -89.23 -8.87 52.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.465 -0.772 . . . . 0.0 109.065 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.814 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.5 mt -90.97 -45.34 8.79 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.614 0.721 . . . . 0.0 109.358 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 . . . . . 0 C--N 1.299 -1.621 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.705 179.821 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.646 HG21 HG23 ' A' ' 53' ' ' VAL . 59.2 t . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 46.1 Cg_endo -84.42 -163.42 0.2 Allowed 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.688 1.362 . . . . 0.0 110.092 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 2.4 ttt -122.19 10.0 9.93 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.371 -0.831 . . . . 0.0 111.106 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.89 23.88 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.719 -1.238 . . . . 0.0 111.432 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.868 HD23 ' HD2' ' A' ' 91' ' ' PRO . 1.6 mt 62.09 123.17 0.02 OUTLIER Pre-proline 0 C--N 1.284 -2.276 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.849 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.868 ' HD2' HD23 ' A' ' 90' ' ' LEU . 40.2 Cg_endo -68.42 174.5 8.19 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.007 1.53 . . . . 0.0 110.137 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 49.6 Cg_endo -75.29 -22.68 14.07 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.964 1.507 . . . . 0.0 111.97 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.746 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -90.79 7.88 37.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.923 -1.111 . . . . 0.0 110.483 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.746 HD22 ' C ' ' A' ' 93' ' ' ALA . 4.1 mm? -114.29 34.9 4.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.081 -1.012 . . . . 0.0 111.495 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.49 1.565 0 O-C-N 120.766 -1.209 . . . . 0.0 110.617 -179.849 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.515 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.6 t90 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.166 0.508 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -41.81 -28.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 0.0 110.138 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.515 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 45.5 t -94.76 156.48 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.826 . . . . 0.0 109.978 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.507 ' HD3' ' HD2' ' A' ' 11' ' ' PRO . 28.3 mmtt -111.5 171.55 4.25 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.507 ' HD2' ' HD3' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -66.9 -35.93 24.96 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.819 1.431 . . . . 0.0 110.431 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.13 -25.59 60.89 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.135 -0.978 . . . . 0.0 109.11 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.579 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 63.6 m-20 -85.57 -35.87 20.78 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.241 -0.912 . . . . 0.0 108.851 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.508 ' CD ' ' HB2' ' A' ' 71' ' ' ALA . 2.2 tptp -73.26 -17.77 61.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.29 -41.82 56.19 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.637 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.15 -24.73 51.52 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.56 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.637 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.4 m-30 -74.95 -35.98 62.12 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.469 ' OD1' ' NZ ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -71.07 -10.1 59.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.777 -0.577 . . . . 0.0 110.135 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.0 -38.97 10.41 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.827 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.257 27.9 mt -72.17 -29.19 31.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.783 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.987 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -69.26 -40.34 77.87 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.464 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.5 t70 -86.1 1.36 50.76 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.581 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.695 ' C ' HD23 ' A' ' 24' ' ' LEU . 37.8 m -93.37 -0.14 56.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.314 -0.866 . . . . 0.0 108.768 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.085 HD22 HG21 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -116.7 -1.21 12.16 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 80.35 97.59 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.95 0 CA-C-O 121.136 0.493 . . . . 0.0 110.246 -179.334 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 55.4 Cg_endo -77.26 147.69 26.26 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.502 1.791 . . . . 0.0 110.343 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.508 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 60.1 t -119.89 94.07 2.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.508 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER 68.94 24.51 6.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.428 -0.795 . . . . 0.0 109.061 -178.527 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 90.93 28.34 15.95 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 35.3 m-85 -143.41 143.28 31.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.394 -1.062 . . . . 0.0 111.133 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.987 HD11 ' O ' ' A' ' 21' ' ' PHE . 53.4 mt -117.57 131.87 56.61 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.572 ' OG ' ' HE2' ' A' ' 64' ' ' MET . 0.5 OUTLIER -89.48 147.5 23.96 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.578 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.15 -31.12 0.84 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -54.07 -22.7 11.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -1.097 . . . . 0.0 110.096 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 1.5 mttm -111.15 -43.36 3.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.935 . . . . 0.0 109.342 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.935 HG11 HD12 ' A' ' 65' ' ' LEU . 87.5 t -74.75 -53.73 16.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.029 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.588 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -40.75 -49.94 7.33 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.529 -0.732 . . . . 0.0 110.892 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.891 ' HA ' HD12 ' A' ' 41' ' ' LEU . 40.6 Cg_endo -69.84 -33.19 16.79 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 N-CA-C 108.961 -1.207 . . . . 0.0 108.961 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.085 HG21 HD22 ' A' ' 24' ' ' LEU . 2.4 t -67.29 -29.01 44.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.885 ' HB3' HD22 ' A' ' 50' ' ' LEU . 17.7 mt -81.4 -17.12 50.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.407 -0.808 . . . . 0.0 108.911 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.891 HD12 ' HA ' ' A' ' 38' ' ' PRO . 20.3 mt -73.88 -26.16 60.41 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.401 ' OD1' ' HA ' ' A' ' 39' ' ' VAL . 16.4 m120 -61.4 -20.58 63.22 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.209 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 1.004 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.3 t -71.36 -3.44 20.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.536 -0.728 . . . . 0.0 109.864 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.538 ' CE ' ' HA ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER 70.79 4.59 5.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 110.028 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.028 HD13 HG21 ' A' ' 49' ' ' ILE . 15.7 mt -83.49 159.29 61.74 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.977 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.531 ' HG2' HG12 ' A' ' 49' ' ' ILE . 43.3 Cg_endo -73.05 162.35 41.11 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.985 1.519 . . . . 0.0 110.502 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.93 -10.17 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 110.21 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.18 -39.1 68.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.028 HG21 HD13 ' A' ' 45' ' ' LEU . 18.5 mm -67.18 -47.41 81.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.885 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.0 mt -64.64 -20.05 66.06 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.95 -33.2 12.65 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.577 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -90.38 -54.96 3.78 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.51 -0.994 . . . . 0.0 109.224 179.311 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.901 HG11 HG23 ' A' ' 77' ' ' VAL . 29.2 t -49.23 -42.71 15.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.01 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.522 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 12.3 t-105 -59.09 -59.28 5.72 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.461 -0.774 . . . . 0.0 109.673 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 54' ' ' TRP . 1.6 mm-40 -44.06 -50.03 8.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -0.878 . . . . 0.0 109.833 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.913 HD21 ' C ' ' A' ' 88' ' ' MET . 1.6 mt -75.04 -14.31 60.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.375 -0.828 . . . . 0.0 109.54 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 1.093 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -95.35 -25.84 16.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.484 -0.76 . . . . 0.0 110.384 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.557 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 4.1 t0 -86.31 76.83 9.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.323 -0.861 . . . . 0.0 110.329 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.479 ' CG1' ' HG3' ' A' ' 69' ' ' GLU . 42.5 mm -44.12 -35.29 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.368 -0.832 . . . . 0.0 110.32 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 2.8 m-20 -95.73 -28.41 14.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 110.427 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.557 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 13.0 m80 62.28 37.44 14.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 109.686 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -97.67 -14.57 20.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.386 -0.821 . . . . 0.0 110.452 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.443 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 125.33 3.67 7.25 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.572 ' HE2' ' OG ' ' A' ' 32' ' ' SER . 1.5 mtp -149.27 161.73 41.44 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.022 -1.281 . . . . 0.0 110.438 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.935 HD12 HG11 ' A' ' 36' ' ' VAL . 46.8 mt -113.39 118.82 35.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.625 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.8 OUTLIER -69.36 154.12 42.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.174 -0.954 . . . . 0.0 109.617 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.623 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 7.4 ptp85 -34.3 -44.86 0.2 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.648 -0.658 . . . . 0.0 111.06 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.678 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -81.16 -34.41 32.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 109.499 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 57' ' ' SER . 6.8 tt0 -67.26 -51.71 49.71 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.6 -0.687 . . . . 0.0 109.415 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.827 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 87.8 t80 -52.78 -26.02 13.08 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -62.15 -45.21 94.45 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.67 0.748 . . . . 0.0 109.837 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 1.022 HG13 HD12 ' A' ' 94' ' ' LEU . 57.6 t -60.03 -25.72 33.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.59 -0.694 . . . . 0.0 110.071 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.093 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -87.42 -11.48 49.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.876 . . . . 0.0 111.952 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.763 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 7.4 mmm -85.78 -37.97 18.7 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.32 -1.487 . . . . 0.0 110.451 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.034 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 3.4 p90 -78.33 -23.43 47.01 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.966 -1.084 . . . . 0.0 108.525 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.847 ' HB3' HG13 ' A' ' 53' ' ' VAL . 6.7 mt -75.19 -28.38 60.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.477 -0.764 . . . . 0.0 108.98 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.901 HG23 HG11 ' A' ' 53' ' ' VAL . 43.3 t -90.61 -25.83 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.508 -0.745 . . . . 0.0 110.058 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.489 ' HA ' HD12 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -84.12 -25.95 29.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 110.056 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 57.9 m -85.62 -14.06 46.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 109.454 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.852 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -79.86 -15.87 56.52 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.182 -0.948 . . . . 0.0 109.242 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.004 HD21 ' O ' ' A' ' 43' ' ' SER . 2.4 mt -92.1 -47.95 6.98 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.604 -0.685 . . . . 0.0 111.304 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.489 1.491 0 C-N-CA 119.503 -0.879 . . . . 0.0 112.033 -178.031 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.512 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 55.5 t . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.601 0.239 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.53 ' O ' HD11 ' A' ' 56' ' ' LEU . 51.2 Cg_endo -83.66 160.36 14.4 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.892 1.47 . . . . 0.0 109.663 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.913 ' C ' HD21 ' A' ' 56' ' ' LEU . 68.6 mtp -82.79 11.24 6.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.998 -1.064 . . . . 0.0 110.237 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.585 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.6 m -99.92 112.81 25.07 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.873 -1.131 . . . . 0.0 110.66 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.743 HD12 ' C ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -100.72 85.67 0.58 Allowed Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 89' ' ' SER . 38.2 Cg_endo -62.31 173.74 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.427 1.418 . . . . 0.0 111.477 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.892 ' O ' HG22 ' A' ' 95' ' ' VAL . 44.1 Cg_endo -69.18 -10.15 28.23 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.339 1.705 . . . . 0.0 110.77 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.626 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -76.84 0.76 19.6 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 109.093 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.034 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 2.5 mm? -108.34 -13.59 14.85 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.412 -0.805 . . . . 0.0 110.116 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 92' ' ' PRO . 26.7 m . . . . . 0 N--CA 1.487 1.397 0 O-C-N 121.351 -0.843 . . . . 0.0 110.554 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.536 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.4 t90 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 121.293 0.568 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.645 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . . . -46.34 -25.81 0.71 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.283 -0.886 . . . . 0.0 110.182 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.536 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 50.6 t -111.49 140.06 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.414 -0.804 . . . . 0.0 110.009 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.498 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 7.4 mttt -106.33 177.7 1.28 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.363 -0.836 . . . . 0.0 110.38 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.547 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 40.7 Cg_endo -68.24 -37.32 14.33 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.96 1.505 . . . . 0.0 109.647 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.441 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 16.0 pt-20 -66.52 -35.64 80.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.0 109.08 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.441 ' N ' ' CG ' ' A' ' 12' ' ' GLU . 0.6 OUTLIER -81.59 -38.64 25.76 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.612 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 1.3 tmtp? -73.01 -15.47 61.53 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -74.36 -42.54 59.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.616 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.3 ptpt -74.33 -21.15 59.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.616 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.8 m-30 -79.7 -30.26 40.97 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -75.07 -11.51 60.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.704 -0.622 . . . . 0.0 110.19 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.16 -36.05 12.23 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.67 HG22 ' CE2' ' A' ' 70' ' ' PHE 0.253 18.5 mt -75.59 -29.79 21.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.646 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -72.65 -40.32 66.45 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.073 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.474 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.1 t70 -85.33 0.02 53.34 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.558 -0.714 . . . . 0.0 109.681 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.569 ' C ' HD23 ' A' ' 24' ' ' LEU . 13.2 t -91.8 -4.7 54.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.915 . . . . 0.0 108.599 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.947 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -108.92 -3.95 17.15 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 79.7 93.56 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.918 0 CA-C-O 121.409 0.623 . . . . 0.0 109.726 -179.087 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.2 Cg_endo -74.45 147.32 36.34 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 124.452 1.764 . . . . 0.0 110.789 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 86.7 t -119.31 105.14 16.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.714 -0.617 . . . . 0.0 109.354 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 2.7 t30 57.69 22.94 8.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 109.652 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.83 32.89 7.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.614 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 89.3 m-85 -150.78 154.77 37.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.332 -1.099 . . . . 0.0 111.105 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.947 HD22 ' HB2' ' A' ' 24' ' ' LEU . 22.0 mt -126.97 131.16 51.12 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.484 ' OG ' ' HE2' ' A' ' 35' ' ' LYS . 0.9 OUTLIER -76.86 140.53 40.63 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.272 -0.892 . . . . 0.0 110.392 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -41.99 -27.94 0.43 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' SER . 34.1 t0 -57.53 -28.84 63.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -1.188 . . . . 0.0 110.303 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.484 ' HE2' ' OG ' ' A' ' 32' ' ' SER . 25.4 mttm -98.91 -39.37 8.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.089 HG11 HD12 ' A' ' 65' ' ' LEU . 93.5 t -74.58 -32.44 29.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.076 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.56 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.2 ttpt -52.06 -56.88 17.78 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.233 -0.917 . . . . 0.0 110.347 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.89 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.2 Cg_endo -65.9 -31.45 47.34 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.631 1.332 . . . . 0.0 109.117 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.761 HG21 HD22 ' A' ' 24' ' ' LEU . 13.1 t -73.47 -16.68 17.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.164 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.986 ' HB3' HD22 ' A' ' 50' ' ' LEU . 63.3 mt -93.82 -18.45 22.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 108.67 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' A' ' 38' ' ' PRO . 23.6 mt -81.24 -33.84 32.54 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.399 0.619 . . . . 0.0 109.833 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 9.2 p-10 -43.86 -25.35 0.19 Allowed 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.935 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.715 ' HB2' HD11 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -73.29 -4.98 36.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.326 -0.859 . . . . 0.0 110.213 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 72.47 7.88 5.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.522 -0.736 . . . . 0.0 110.153 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.045 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.8 mt -80.73 160.31 67.03 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.327 -0.858 . . . . 0.0 110.306 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.556 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.7 Cg_endo -74.33 164.69 33.53 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 124.034 1.544 . . . . 0.0 110.483 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 t -65.17 -8.44 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 110.339 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.92 -40.6 60.75 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.036 -1.04 . . . . 0.0 108.265 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.031 HG21 HD13 ' A' ' 45' ' ' LEU . 14.3 mm -65.15 -45.51 93.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.986 HD22 ' HB3' ' A' ' 40' ' ' LEU . 6.1 mt -62.28 -18.42 61.22 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.82 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.36 -33.7 11.41 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.628 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.4 ttm180 -90.13 -52.16 5.09 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.47 -1.018 . . . . 0.0 109.644 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.702 HG11 HG23 ' A' ' 77' ' ' VAL . 24.3 t -50.94 -42.25 23.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.166 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 57' ' ' SER . 7.7 t-105 -61.55 -57.01 13.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 110.093 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -47.33 -52.66 15.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.838 . . . . 0.0 110.103 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.822 HD11 ' HA ' ' A' ' 88' ' ' MET . 1.4 mt -74.94 -7.62 54.11 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.811 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.92 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 6.4 m -100.05 -29.07 12.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.43 -0.794 . . . . 0.0 110.676 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.466 ' OD2' ' HA ' ' A' ' 61' ' ' HIS . 16.8 t0 -87.29 73.77 9.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.962 . . . . 0.0 110.202 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.519 ' HB ' ' HG2' ' A' ' 69' ' ' GLU . 45.4 mm -44.0 -30.59 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.5 -0.75 . . . . 0.0 109.314 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 4.4 t0 -95.19 -22.32 17.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.523 -0.736 . . . . 0.0 109.931 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 34.2 p80 40.15 57.28 2.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.546 -0.721 . . . . 0.0 110.232 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' HB3' ' CG ' ' A' ' 60' ' ' ASP . 1.3 p-10 -117.12 7.04 12.94 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.581 -0.699 . . . . 0.0 109.732 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 109.56 5.87 29.38 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.1 mtp -150.41 161.0 43.34 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.157 -1.202 . . . . 0.0 110.792 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.089 HD12 HG11 ' A' ' 36' ' ' VAL . 11.9 mt -114.15 108.45 16.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.452 -0.78 . . . . 0.0 109.298 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.614 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -69.77 171.84 8.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.929 -1.107 . . . . 0.0 110.152 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 9.4 ptt180 -52.87 -37.53 60.47 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.695 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.6 OUTLIER -81.77 -35.72 29.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.189 -0.944 . . . . 0.0 109.713 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.519 ' HG2' ' HB ' ' A' ' 59' ' ' ILE . 27.1 mt-10 -74.24 -46.6 40.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 20' ' ' ILE . 68.3 t80 -57.73 -33.42 68.43 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.404 ' HA ' ' HG2' ' A' ' 74' ' ' MET . . . -57.18 -49.41 76.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.398 -0.814 . . . . 0.0 109.996 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.48 ' O ' HD12 ' A' ' 76' ' ' LEU . 55.6 t -59.29 -21.7 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.611 -0.68 . . . . 0.0 110.443 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.92 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -90.53 -9.79 45.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.07 -1.018 . . . . 0.0 111.602 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.669 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 7.1 mmm -85.41 -41.08 15.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.792 -1.192 . . . . 0.0 109.886 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.599 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.4 p90 -77.41 -26.17 51.47 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.599 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 7.6 mt -70.14 -30.85 68.12 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.702 HG23 HG11 ' A' ' 53' ' ' VAL . 57.0 t -90.98 -19.12 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.679 -0.638 . . . . 0.0 110.349 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.31 -20.18 23.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.34 -0.85 . . . . 0.0 109.75 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -87.73 -16.37 34.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.517 -0.739 . . . . 0.0 109.705 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.045 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -84.92 -12.3 53.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.518 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.779 ' N ' HD23 ' A' ' 81' ' ' LEU . 2.9 mt -88.17 -43.06 11.9 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.539 -0.725 . . . . 0.0 109.373 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.298 -1.655 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.29 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.666 HG21 ' CG2' ' A' ' 53' ' ' VAL . 56.1 t . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 120.597 0.237 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.62 ' O ' HD11 ' A' ' 56' ' ' LEU . 46.5 Cg_endo -88.32 -165.3 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.948 1.499 . . . . 0.0 109.233 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.822 ' HA ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -127.7 10.89 6.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.137 -0.977 . . . . 0.0 110.471 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.605 ' N ' HD21 ' A' ' 56' ' ' LEU . 58.0 m -115.75 93.83 4.43 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.494 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.732 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -56.88 107.2 0.83 Allowed Pre-proline 0 C--N 1.291 -1.943 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.568 178.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.617 ' HG2' HD12 ' A' ' 94' ' ' LEU . 42.8 Cg_endo -82.07 173.32 11.07 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.703 1.37 . . . . 0.0 110.613 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 44.6 Cg_endo -71.21 -5.41 16.94 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.232 1.648 . . . . 0.0 111.418 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.44 ' O ' ' HG ' ' A' ' 94' ' ' LEU . . . -84.01 0.17 49.2 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 109.731 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.645 ' HG ' ' HB2' ' A' ' 8' ' ' ALA . 1.4 mp -138.29 31.24 2.38 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.19 -0.944 . . . . 0.0 110.994 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 92' ' ' PRO . 3.7 t . . . . . 0 N--CA 1.491 1.583 0 O-C-N 120.865 -1.147 . . . . 0.0 110.702 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.851 ' HE1' HD22 ' A' ' 94' ' ' LEU . 13.4 t90 . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 121.389 0.614 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -47.7 -25.83 1.34 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.493 -0.754 . . . . 0.0 109.991 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.6 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 56.0 t -88.96 147.04 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.496 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 28.5 mttt -99.93 167.28 11.3 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.237 -0.915 . . . . 0.0 109.847 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.0 Cg_endo -67.74 -33.96 26.04 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.81 1.426 . . . . 0.0 109.709 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -76.64 -24.17 53.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.524 -0.735 . . . . 0.0 109.513 179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.576 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -80.83 -38.73 27.79 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.527 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 28.4 tptp -65.23 -19.8 66.13 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.58 -44.52 50.46 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.58 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 4.1 ptpt -77.21 -19.2 57.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.619 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 6.9 m-30 -80.15 -33.32 38.59 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -79.57 -10.16 59.75 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.242 0.544 . . . . 0.0 110.151 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 23' ' ' SER . . . -94.93 -31.77 13.51 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.639 ' O ' HD21 ' A' ' 24' ' ' LEU . 61.7 mt -80.46 -32.74 13.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.559 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -71.45 -39.0 71.28 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.528 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.8 t0 -88.93 1.13 55.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.645 -0.66 . . . . 0.0 109.688 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 1.1 m -93.49 0.26 56.65 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.061 HD22 HG21 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -110.49 -4.99 15.24 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 p 81.93 87.59 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.528 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 49.8 Cg_endo -71.7 147.25 50.49 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.16 1.611 . . . . 0.0 110.854 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 99.9 t -116.94 104.77 17.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 14.9 t30 57.03 24.4 9.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.529 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 90.26 39.1 6.12 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.571 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 87.4 m-85 -150.58 156.54 41.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -1.179 . . . . 0.0 111.601 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.913 HD13 HD12 ' A' ' 24' ' ' LEU . 75.3 mt -128.77 135.32 49.02 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.542 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 10.2 p -80.36 142.07 34.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.392 -0.817 . . . . 0.0 111.104 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.612 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -51.22 -22.84 7.4 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -84.58 -9.65 58.11 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.363 -1.081 . . . . 0.0 109.36 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.647 ' HD2' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -97.19 -43.94 7.15 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.333 1.063 . . . . 0.0 108.336 179.164 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.602 HG21 HD12 ' A' ' 65' ' ' LEU . 96.8 t -78.82 -32.52 15.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.334 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.932 ' O ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -39.99 -54.58 4.29 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.421 -0.799 . . . . 0.0 110.852 -179.362 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.2 Cg_endo -63.68 -28.86 69.07 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.644 1.339 . . . . 0.0 109.825 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.061 HG21 HD22 ' A' ' 24' ' ' LEU . 4.8 t -79.72 -12.77 13.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.444 0.64 . . . . 0.0 110.244 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.768 ' HB3' HD22 ' A' ' 50' ' ' LEU . 66.2 mt -98.69 -17.05 18.76 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.85 -1.156 . . . . 0.0 109.1 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.932 HD12 ' O ' ' A' ' 37' ' ' LYS . 1.9 mt -88.74 -32.3 18.0 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.421 -0.799 . . . . 0.0 110.036 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.438 ' OD1' ' HA ' ' A' ' 39' ' ' VAL . 3.3 p-10 -67.23 -8.21 29.97 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.061 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 50.3 m -77.53 7.23 5.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.462 -0.774 . . . . 0.0 109.905 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 65.33 16.34 10.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -0.963 . . . . 0.0 109.565 -179.489 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.996 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.2 mt -100.28 151.55 37.57 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.444 -0.785 . . . . 0.0 110.625 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.565 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.1 Cg_endo -75.12 159.45 40.91 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.142 1.601 . . . . 0.0 110.085 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.1 t -60.72 -10.11 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.809 . . . . 0.0 110.933 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.08 -42.4 60.21 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.931 -1.106 . . . . 0.0 108.311 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.917 HG13 HD22 ' A' ' 45' ' ' LEU . 8.8 mm -64.61 -45.02 96.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.768 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.2 mt -63.14 -21.53 66.25 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.176 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.29 -30.62 24.6 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.537 ' HD3' ' CG ' ' A' ' 88' ' ' MET . 10.3 ttm180 -94.16 -54.0 3.74 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.495 -1.003 . . . . 0.0 109.547 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.811 HG11 HG23 ' A' ' 77' ' ' VAL . 37.7 t -52.75 -33.06 18.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.071 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.612 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 10.7 t-105 -71.26 -57.06 4.84 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.919 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -47.41 -47.74 26.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.9 . . . . 0.0 109.983 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.909 HD11 ' HA ' ' A' ' 88' ' ' MET . 4.5 mt -76.77 -10.3 59.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 0.0 109.523 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 1.029 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 2.8 t -98.66 -34.2 10.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.447 -0.783 . . . . 0.0 110.257 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 60' ' ' ASP . 19.6 t0 -79.79 68.16 5.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.357 -0.84 . . . . 0.0 109.338 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.455 ' C ' ' O ' ' A' ' 58' ' ' ASP . 31.2 mm -34.57 -30.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.116 0.484 . . . . 0.0 111.36 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 58' ' ' ASP . 54.1 m-20 -100.48 -19.59 16.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.088 -1.007 . . . . 0.0 111.601 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.472 ' N ' ' O ' ' A' ' 58' ' ' ASP . 5.5 m-70 63.71 35.13 11.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.859 -1.151 . . . . 0.0 109.448 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -102.19 12.13 37.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.92 . . . . 0.0 110.826 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.11 10.11 81.11 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.543 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.7 mtt -139.32 160.19 40.4 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.335 -1.097 . . . . 0.0 110.89 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.602 HD12 HG21 ' A' ' 36' ' ' VAL . 87.9 mt -125.33 112.1 15.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.302 -0.874 . . . . 0.0 110.405 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.571 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 16.5 t0 -68.93 169.86 10.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.838 -1.163 . . . . 0.0 109.48 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.559 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 11.4 ptm180 -48.03 -40.61 23.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.681 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.466 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -80.64 -31.31 36.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.328 -0.857 . . . . 0.0 110.407 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.512 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 31.3 mt-10 -75.69 -38.1 58.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.735 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.661 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 52.6 t80 -68.28 -19.51 64.71 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.367 -0.833 . . . . 0.0 109.439 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.38 -39.84 52.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.444 -0.785 . . . . 0.0 109.395 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.886 HG13 HD21 ' A' ' 94' ' ' LEU . 38.3 t -64.0 -23.49 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.555 0.693 . . . . 0.0 109.192 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.029 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.57 -8.2 50.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.624 -0.673 . . . . 0.0 110.854 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.619 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 14.8 mmt -83.03 -46.89 12.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.064 -1.022 . . . . 0.0 109.907 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.59 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 5.4 p90 -76.27 -25.57 55.06 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.738 ' HB3' HG13 ' A' ' 53' ' ' VAL . 11.0 mt -69.92 -25.83 63.85 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.863 HG13 HD12 ' A' ' 45' ' ' LEU . 51.9 t -91.39 -62.74 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.548 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.2 m-85 -47.61 -25.44 1.16 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.614 -0.679 . . . . 0.0 111.131 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 33.6 m -82.71 -12.31 57.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.986 -1.071 . . . . 0.0 109.843 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.996 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.13 -10.67 43.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.291 -0.881 . . . . 0.0 109.179 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.784 ' N ' HD12 ' A' ' 81' ' ' LEU . 7.0 mp -87.91 -43.46 11.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 109.348 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.302 -1.499 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.665 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.69 HG11 ' CG2' ' A' ' 53' ' ' VAL . 97.2 t . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.613 0.244 . . . . 0.0 110.665 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.5 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.7 Cg_endo -85.24 -169.31 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.979 1.515 . . . . 0.0 109.407 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.909 ' HA ' HD11 ' A' ' 56' ' ' LEU . 2.7 mtp -116.22 8.05 14.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 0.0 109.983 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.416 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 58.5 m -106.08 104.96 14.78 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.812 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.621 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -50.05 106.49 0.64 Allowed Pre-proline 0 C--N 1.292 -1.92 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.629 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.514 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 39.4 Cg_endo -68.68 142.99 54.71 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.926 1.487 . . . . 0.0 111.215 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.99 -7.56 21.29 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.422 1.748 . . . . 0.0 111.311 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.598 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -100.0 21.68 12.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.166 -0.959 . . . . 0.0 108.772 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.952 ' O ' HD22 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -141.52 -11.34 0.92 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.285 0.564 . . . . 0.0 110.426 -178.179 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.427 ' H ' HG23 ' A' ' 95' ' ' VAL . 2.0 t . . . . . 0 N--CA 1.492 1.651 0 O-C-N 120.439 -1.413 . . . . 0.0 110.133 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.564 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 9.5 t90 . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -39.39 -26.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.843 . . . . 0.0 110.43 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.564 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 12.3 t -99.04 127.76 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.586 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.522 ' CD ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -84.6 175.96 4.15 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 110.334 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' CD ' ' A' ' 10' ' ' LYS . 42.6 Cg_endo -70.4 -34.38 12.54 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.079 1.568 . . . . 0.0 109.515 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -78.72 -24.36 44.93 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.593 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 19.8 m-20 -82.97 -48.79 10.28 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.514 ' HE2' ' HB2' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -63.95 -19.23 64.98 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -80.63 -43.76 19.96 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.587 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.35 -28.04 60.95 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 8.1 m-30 -70.65 -36.78 73.57 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 66.5 t0 -72.66 -9.29 58.44 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.446 0.641 . . . . 0.0 109.74 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.19 -35.86 11.69 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.503 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 29.3 mt -77.73 -32.49 18.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.587 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -69.75 -43.82 71.5 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.345 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.554 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 47.5 t0 -83.49 2.62 35.98 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.41 0.624 . . . . 0.0 109.558 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.451 ' HB2' ' HA ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -90.56 -8.41 50.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.331 -0.855 . . . . 0.0 109.208 179.013 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.688 HD12 HD13 ' A' ' 31' ' ' LEU . 2.9 mt -104.65 -8.07 19.17 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m 83.14 93.77 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.995 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.5 Cg_endo -74.27 145.41 34.47 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.374 1.723 . . . . 0.0 110.533 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 21.1 t -113.15 102.56 14.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER 62.4 19.95 11.5 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.323 -0.861 . . . . 0.0 109.268 -179.053 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 92.28 34.05 7.31 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 77.9 m-85 -144.56 149.5 35.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.165 -1.197 . . . . 0.0 111.566 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.688 HD13 HD12 ' A' ' 24' ' ' LEU . 52.3 mt -125.7 131.87 52.49 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.549 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -77.42 138.46 39.28 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.443 -0.785 . . . . 0.0 110.029 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -43.01 -25.64 0.38 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 6.0 m-20 -65.52 -20.88 66.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -1.175 . . . . 0.0 110.337 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 9.1 mtpp -97.98 -39.78 8.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.176 -0.952 . . . . 0.0 109.073 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.955 HG11 HD12 ' A' ' 65' ' ' LEU . 60.4 t -78.15 -36.6 21.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 121.485 0.659 . . . . 0.0 109.769 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.5 tttt -48.08 -54.69 22.59 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.859 . . . . 0.0 110.171 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.923 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.0 Cg_endo -63.6 -29.24 70.01 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.58 1.305 . . . . 0.0 108.907 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.582 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 4.7 t -80.63 -11.27 12.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 121.659 0.742 . . . . 0.0 109.46 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.685 ' HB3' HD22 ' A' ' 50' ' ' LEU . 42.0 mt -99.94 -14.97 18.48 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.166 -0.959 . . . . 0.0 108.677 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.923 HD12 ' HA ' ' A' ' 38' ' ' PRO . 7.9 mt -89.42 -33.9 16.67 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.642 -0.661 . . . . 0.0 110.089 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 3.8 p-10 -64.24 -9.85 19.9 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.735 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 1.4 m -72.35 -1.83 16.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 110.052 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 43' ' ' SER . 17.4 ttmt 69.55 14.62 8.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.307 -0.871 . . . . 0.0 110.455 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.044 HD13 HG21 ' A' ' 49' ' ' ILE . 14.9 mt -100.46 163.64 17.81 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.217 -0.927 . . . . 0.0 110.317 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HG2' HG12 ' A' ' 49' ' ' ILE . 44.1 Cg_endo -75.18 160.92 39.03 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.982 1.517 . . . . 0.0 110.047 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.6 t -64.96 -7.17 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.132 -0.98 . . . . 0.0 110.373 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.06 -40.31 62.9 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.044 HG21 HD13 ' A' ' 45' ' ' LEU . 15.3 mm -64.13 -43.62 97.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.685 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.1 mt -66.26 -21.19 66.28 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.735 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.14 -27.97 29.48 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.565 ' CD ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -94.54 -54.73 3.4 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.465 -1.021 . . . . 0.0 109.329 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.954 HG11 HG23 ' A' ' 77' ' ' VAL . 33.2 t -52.36 -41.01 33.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.517 -0.873 . . . . 0.0 108.685 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.539 ' CZ2' ' OD2' ' A' ' 58' ' ' ASP . 9.0 t-105 -62.6 -56.44 17.8 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.449 -0.782 . . . . 0.0 109.795 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.518 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 12.0 mm-40 -45.33 -56.48 4.87 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.389 -0.82 . . . . 0.0 110.104 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.724 HD21 ' C ' ' A' ' 88' ' ' MET . 1.4 mt -72.1 -10.94 60.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.687 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.971 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 8.0 m -96.8 -23.15 16.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.377 -0.827 . . . . 0.0 110.263 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.579 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 6.7 t0 -93.26 76.06 4.58 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.356 -0.84 . . . . 0.0 109.569 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.473 ' HB ' ' OE1' ' A' ' 69' ' ' GLU . 34.4 mm -41.23 -32.52 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.712 -0.618 . . . . 0.0 110.236 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 35.5 m-20 -93.48 -22.06 19.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.386 -0.821 . . . . 0.0 110.717 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 46.1 m-70 55.47 42.81 29.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 109.716 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -112.45 3.36 16.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.464 -0.773 . . . . 0.0 110.887 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.93 3.84 48.63 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.549 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 4.6 mtt -133.94 159.45 40.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -1.131 . . . . 0.0 110.82 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.955 HD12 HG11 ' A' ' 36' ' ' VAL . 10.5 mt -124.38 110.97 15.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.576 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -72.56 172.62 10.23 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.866 -1.146 . . . . 0.0 109.781 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.498 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -49.36 -38.07 26.96 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.603 -0.686 . . . . 0.0 111.313 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.15 -31.21 21.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.007 -1.058 . . . . 0.0 110.221 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.487 ' OE2' ' HB3' ' A' ' 66' ' ' ASP . 27.9 mt-10 -75.76 -42.35 50.61 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.285 -0.884 . . . . 0.0 109.593 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.656 ' HA ' HD13 ' A' ' 65' ' ' LEU . 61.4 t80 -62.66 -31.45 72.33 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.069 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.514 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . . . -60.36 -49.05 79.12 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.79 0.805 . . . . 0.0 109.89 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 1.057 HG13 HD21 ' A' ' 94' ' ' LEU . 85.6 t -57.73 -24.2 22.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 121.333 0.587 . . . . 0.0 110.427 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.971 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -90.46 -6.15 55.21 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.183 -0.948 . . . . 0.0 111.852 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.581 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 11.3 mmm -89.97 -43.15 10.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.648 -1.283 . . . . 0.0 110.121 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.586 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.6 p90 -76.84 -27.71 55.22 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.876 -1.13 . . . . 0.0 108.115 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.711 ' HB3' HG13 ' A' ' 53' ' ' VAL . 9.6 mt -69.47 -27.15 64.98 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.954 HG23 HG11 ' A' ' 53' ' ' VAL . 30.3 t -91.59 -32.79 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.501 -0.75 . . . . 0.0 110.431 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -81.83 -33.01 30.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.13 -0.981 . . . . 0.0 110.043 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 65.1 m -75.45 -20.09 59.04 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.698 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -71.64 -16.7 62.28 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 81' ' ' LEU . 5.6 mt -90.56 -44.4 9.58 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.542 0.687 . . . . 0.0 109.787 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.612 -0.68 . . . . 0.0 111.731 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.576 HG21 ' CG2' ' A' ' 53' ' ' VAL . 85.5 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.59 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.4 Cg_endo -84.44 169.86 10.8 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.87 1.458 . . . . 0.0 109.405 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.724 ' C ' HD21 ' A' ' 56' ' ' LEU . 4.2 mtm -98.85 12.76 34.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.917 -1.114 . . . . 0.0 110.261 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.468 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 72.2 m -108.63 103.83 13.01 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.715 -1.194 . . . . 0.0 112.044 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.594 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 2.2 mt -51.74 106.38 0.65 Allowed Pre-proline 0 C--N 1.292 -1.927 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.233 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.663 ' HD2' HD12 ' A' ' 94' ' ' LEU . 41.2 Cg_endo -72.07 150.36 54.09 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.759 1.4 . . . . 0.0 110.51 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.508 ' HA ' ' CG2' ' A' ' 95' ' ' VAL . 43.8 Cg_endo -70.16 -5.82 17.36 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.146 1.603 . . . . 0.0 111.068 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -100.62 24.59 8.83 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.057 HD21 HG13 ' A' ' 72' ' ' VAL 0.25 0.3 OUTLIER -158.19 34.36 0.24 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.338 1.066 . . . . 0.0 109.015 -178.128 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.508 ' CG2' ' HA ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 O-C-N 120.623 -1.298 . . . . 0.0 110.347 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.549 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.515 0.674 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.447 ' HB2' HD22 ' A' ' 94' ' ' LEU . . . -46.45 -24.56 0.52 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.447 -0.783 . . . . 0.0 110.652 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.549 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 73.3 t -103.6 130.99 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.793 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.639 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.5 mttt -93.64 174.47 3.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.476 -0.765 . . . . 0.0 109.007 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.639 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 38.2 Cg_endo -65.44 -37.48 30.01 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.287 1.151 . . . . 0.0 109.957 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 8.0 pt-20 -64.71 -25.94 68.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.215 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.596 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -84.0 -38.34 21.05 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 9.9 tptm -72.88 -17.03 61.57 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.576 0.703 . . . . 0.0 109.258 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.55 -37.84 65.43 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 2.3 mtmt -80.82 -39.18 27.05 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.596 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 5.3 m-30 -66.26 -22.69 66.32 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 6.3 t0 -85.81 -15.45 41.93 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.631 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -90.33 -28.14 18.93 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.739 HG22 ' CE1' ' A' ' 70' ' ' PHE . 15.7 mt -82.7 -31.85 9.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.605 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -74.31 -40.49 62.19 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.523 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.2 t0 -84.9 -0.57 54.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.643 -0.66 . . . . 0.0 109.839 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -89.34 -7.18 55.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.844 . . . . 0.0 109.04 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.856 ' HB2' HD22 ' A' ' 31' ' ' LEU . 2.5 mt -107.08 -8.66 16.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER 82.17 95.07 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.4 Cg_endo -74.49 150.17 40.41 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.994 1.523 . . . . 0.0 110.838 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 40.8 t -118.81 101.55 11.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER 65.22 26.58 12.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 108.891 -178.506 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . 85.14 35.72 12.03 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.604 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 93.8 m-85 -150.04 159.26 44.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.641 -0.917 . . . . 0.0 110.598 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.856 HD22 ' HB2' ' A' ' 24' ' ' LEU . 12.7 mt -135.02 128.95 33.34 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.471 ' OG ' ' CD ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -73.09 139.21 46.33 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.452 -0.78 . . . . 0.0 110.541 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -43.07 -32.87 1.64 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.43 -15.83 7.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -1.153 . . . . 0.0 110.016 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 9.6 mtpp -111.77 -35.39 5.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.277 -0.889 . . . . 0.0 108.95 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.999 HG11 HD12 ' A' ' 65' ' ' LEU . 84.8 t -91.32 -46.27 14.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.698 -0.626 . . . . 0.0 110.179 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.635 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 ttpt -45.22 -47.83 33.17 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 110.661 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.869 ' HA ' HD12 ' A' ' 41' ' ' LEU . 40.0 Cg_endo -69.01 -31.63 23.43 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.38 1.2 . . . . 0.0 109.377 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.532 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 1.9 t -65.71 -31.01 51.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.778 -0.576 . . . . 0.0 109.629 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.843 ' HB3' HD22 ' A' ' 50' ' ' LEU . 18.8 mt -80.59 -14.74 57.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.213 -0.93 . . . . 0.0 109.026 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.869 HD12 ' HA ' ' A' ' 38' ' ' PRO . 33.7 mt -76.25 -26.49 56.06 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -63.32 -17.05 62.14 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.138 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.529 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -76.55 1.97 15.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.265 -0.897 . . . . 0.0 110.327 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 43' ' ' SER . 6.0 tttm 64.71 11.82 7.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 0.0 110.083 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.955 HD13 HG21 ' A' ' 49' ' ' ILE . 15.1 mt -86.89 158.41 53.38 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.864 . . . . 0.0 110.087 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.7 Cg_endo -73.61 159.11 46.53 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.068 1.562 . . . . 0.0 110.851 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -58.93 -10.74 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.984 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.27 -42.38 59.71 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.959 -1.088 . . . . 0.0 108.073 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.955 HG21 HD13 ' A' ' 45' ' ' LEU . 21.1 mm -61.84 -42.62 95.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.843 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.7 mt -66.77 -22.81 66.03 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.484 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . -82.65 -24.59 53.06 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.578 ' CD ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -99.01 -59.59 1.7 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.545 -0.974 . . . . 0.0 109.711 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.856 HG11 HG23 ' A' ' 77' ' ' VAL . 46.2 t -46.58 -36.44 2.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.012 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.554 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 9.3 t-105 -73.07 -59.33 2.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 110.211 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 52.5 mm-40 -44.16 -45.5 8.34 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.195 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.75 HD21 ' C ' ' A' ' 88' ' ' MET . 1.8 mt -81.52 -16.5 51.59 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.339 -0.944 . . . . 0.0 109.586 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.933 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 3.2 t -88.39 -25.9 22.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.455 -0.778 . . . . 0.0 109.457 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.476 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 15.7 t0 -85.0 81.38 8.93 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.505 -0.747 . . . . 0.0 109.745 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.531 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 33.2 mm -47.8 -30.94 2.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 120.134 -0.627 . . . . 0.0 110.504 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 4.4 p-10 -103.92 -16.28 15.4 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.039 -1.064 . . . . 0.0 111.309 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.534 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 30.9 m80 54.73 41.51 31.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.894 -1.129 . . . . 0.0 109.948 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 64' ' ' MET . 1.1 p-10 -100.96 -10.76 20.29 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.357 -0.839 . . . . 0.0 110.171 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.433 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 117.9 8.93 10.29 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.572 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.0 mtp -145.55 161.36 39.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -1.174 . . . . 0.0 110.116 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.999 HD12 HG11 ' A' ' 36' ' ' VAL . 15.6 mt -117.4 106.0 12.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.172 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.604 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -69.59 172.91 6.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.779 -1.201 . . . . 0.0 110.297 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.494 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.5 ptm180 -47.73 -39.57 18.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.614 -0.679 . . . . 0.0 111.032 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.46 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 5.6 m-20 -84.87 -31.97 23.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 0.0 110.338 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.531 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 18.9 mt-10 -77.2 -44.16 31.08 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.392 -0.818 . . . . 0.0 109.091 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.788 ' CE2' HG13 ' A' ' 36' ' ' VAL . 62.0 t80 -64.46 -29.12 70.17 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -62.28 -50.4 71.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.42 -0.8 . . . . 0.0 110.226 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.992 HG13 HD12 ' A' ' 94' ' ' LEU . 41.8 t -56.31 -24.11 17.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.51 -0.744 . . . . 0.0 109.8 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.933 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -86.69 -9.88 54.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.195 -0.941 . . . . 0.0 111.831 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.59 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 9.1 mmm -87.85 -39.11 15.1 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.602 -1.312 . . . . 0.0 110.574 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.997 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 3.2 p90 -78.93 -20.23 49.84 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.834 -1.146 . . . . 0.0 108.212 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.748 HD12 ' O ' ' A' ' 72' ' ' VAL . 10.5 mt -79.83 -25.47 40.79 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.611 0.719 . . . . 0.0 109.217 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.856 HG23 HG11 ' A' ' 53' ' ' VAL . 78.5 t -91.49 -26.99 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.478 -0.764 . . . . 0.0 110.327 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.46 -29.96 21.02 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.267 -0.895 . . . . 0.0 110.039 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 3.0 t -81.19 -14.78 57.22 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.265 -0.897 . . . . 0.0 108.861 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.71 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.22 -7.68 58.92 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.4 -0.812 . . . . 0.0 109.12 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.749 HD23 ' N ' ' A' ' 81' ' ' LEU . 2.8 mt -90.46 -50.29 6.03 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.584 -0.698 . . . . 0.0 109.968 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.649 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.425 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.528 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 44.5 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.635 0.255 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.594 ' O ' HD11 ' A' ' 56' ' ' LEU . 51.7 Cg_endo -90.45 147.49 4.25 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.933 1.491 . . . . 0.0 109.72 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.75 ' C ' HD21 ' A' ' 56' ' ' LEU . 4.7 mtm -81.96 11.2 5.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.88 -1.138 . . . . 0.0 110.348 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.467 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 68.3 m -106.84 106.4 16.91 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.598 -178.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.604 ' HG ' ' HA ' ' A' ' 56' ' ' LEU . 2.1 mt -54.66 107.81 0.97 Allowed Pre-proline 0 C--N 1.294 -1.841 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.919 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.645 ' HG2' HD23 ' A' ' 94' ' ' LEU . 40.1 Cg_endo -67.93 161.03 45.87 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 124.076 1.566 . . . . 0.0 110.14 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.11 -20.59 16.5 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.002 1.527 . . . . 0.0 111.098 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.623 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -88.84 15.29 8.62 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.152 -0.968 . . . . 0.0 109.734 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.997 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 3.9 mm? -118.33 -23.03 7.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.205 -0.934 . . . . 0.0 110.611 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.4 t . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.341 -0.849 . . . . 0.0 110.855 -179.208 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.569 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.1 t90 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.2 0.524 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.721 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -42.4 -28.84 0.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 110.277 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.569 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 39.0 t -100.09 146.05 9.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.348 -0.845 . . . . 0.0 109.72 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.516 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.1 mtmt -119.47 178.07 1.2 Allowed Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.192 -0.942 . . . . 0.0 109.693 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 38.3 Cg_endo -64.9 -36.42 39.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.84 1.442 . . . . 0.0 110.252 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 18.3 pt-20 -65.35 -35.73 81.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.327 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 92.4 m-20 -81.95 -34.41 29.81 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.883 ' HE2' ' HB2' ' A' ' 71' ' ' ALA . 1.1 tppp? -70.91 -20.6 62.47 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.21 -40.02 78.26 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.655 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.7 ptmm? -79.79 -24.82 41.19 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.655 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.7 m-30 -72.18 -35.86 69.09 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 35.0 t0 -74.47 -8.75 57.32 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.238 0.542 . . . . 0.0 110.455 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.08 -41.22 9.22 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.644 HG22 ' CE2' ' A' ' 70' ' ' PHE 0.251 15.5 mt -72.51 -29.62 31.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.684 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -70.73 -39.72 73.19 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.517 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.2 t70 -88.6 2.99 52.05 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.572 -0.705 . . . . 0.0 109.816 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.5 m -91.01 -4.95 56.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 108.663 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.892 HD12 HD13 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -110.74 -6.02 14.87 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER 80.88 96.33 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.2 Cg_endo -72.9 147.63 44.27 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 O-C-N 124.611 1.848 . . . . 0.0 110.691 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.7 t -117.61 103.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 1.1 t30 62.2 21.9 12.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.942 . . . . 0.0 109.223 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.58 34.56 7.33 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CE1' ' CB ' ' A' ' 66' ' ' ASP . 96.9 m-85 -150.43 160.64 43.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -1.113 . . . . 0.0 111.134 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.892 HD13 HD12 ' A' ' 24' ' ' LEU . 42.8 mt -126.61 132.91 51.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.508 -0.745 . . . . 0.0 109.529 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.561 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.5 OUTLIER -80.54 138.9 36.55 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.358 -0.839 . . . . 0.0 110.458 -179.707 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -40.62 -25.68 0.11 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 32' ' ' SER . 8.7 m-20 -63.93 -17.94 63.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -1.141 . . . . 0.0 110.969 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -111.6 -36.42 5.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.937 -1.102 . . . . 0.0 109.942 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.015 HG11 HD12 ' A' ' 65' ' ' LEU . 82.2 t -79.09 -54.19 12.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.316 -0.865 . . . . 0.0 109.964 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.618 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -40.43 -49.88 6.74 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.581 -0.699 . . . . 0.0 110.459 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.858 ' HA ' HD12 ' A' ' 41' ' ' LEU . 41.2 Cg_endo -68.27 -31.97 27.59 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.376 1.198 . . . . 0.0 109.413 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.688 HG21 ' CD2' ' A' ' 24' ' ' LEU . 2.2 t -67.51 -31.65 53.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.576 -0.703 . . . . 0.0 109.572 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.959 ' CB ' HD22 ' A' ' 50' ' ' LEU . 11.4 mt -78.72 -15.66 58.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.049 -1.032 . . . . 0.0 108.636 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.858 HD12 ' HA ' ' A' ' 38' ' ' PRO . 14.8 mt -75.47 -24.29 56.94 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.423 -0.798 . . . . 0.0 108.901 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -66.98 -19.03 65.65 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.001 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 1.039 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -74.07 0.08 14.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.273 -0.892 . . . . 0.0 110.252 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.3 OUTLIER 69.49 4.35 4.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.12 -0.987 . . . . 0.0 110.577 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.003 HD13 HG21 ' A' ' 49' ' ' ILE . 15.7 mt -79.2 160.37 70.89 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.011 . . . . 0.0 110.224 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HD2' HG13 ' A' ' 49' ' ' ILE . 41.7 Cg_endo -73.43 161.57 42.18 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.04 1.547 . . . . 0.0 110.287 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.78 -11.39 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.41 -0.806 . . . . 0.0 110.527 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.75 -40.07 66.32 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.003 HG21 HD13 ' A' ' 45' ' ' LEU . 28.3 mm -64.0 -44.82 97.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.959 HD22 ' CB ' ' A' ' 40' ' ' LEU . 13.5 mt -61.52 -17.78 56.28 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . -88.57 -27.4 24.8 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -96.34 -54.54 3.24 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.665 -0.903 . . . . 0.0 109.332 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.869 HG23 HG21 ' A' ' 86' ' ' VAL . 45.0 t -48.16 -33.42 4.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.901 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 10.4 t-105 -76.96 -59.59 2.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.315 -0.866 . . . . 0.0 110.32 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 64.8 mm-40 -45.65 -41.18 10.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.266 -0.896 . . . . 0.0 109.841 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.81 HD22 ' N ' ' A' ' 90' ' ' LEU . 20.9 mt -83.23 -17.61 42.13 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.557 -0.714 . . . . 0.0 109.454 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 1.032 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 8.3 t -92.33 -23.54 19.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.342 -0.849 . . . . 0.0 109.457 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 54' ' ' TRP . 23.5 t0 -84.49 65.88 9.19 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.318 -0.864 . . . . 0.0 110.12 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.567 HG12 ' HG2' ' A' ' 69' ' ' GLU . 40.2 mm -39.28 -30.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.373 0.606 . . . . 0.0 110.013 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 21.8 m-20 -95.71 -25.76 15.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.436 -0.79 . . . . 0.0 110.507 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.475 ' N ' ' O ' ' A' ' 58' ' ' ASP . 69.3 m80 59.62 48.9 8.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.919 . . . . 0.0 109.829 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -117.38 -10.69 10.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 110.434 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.25 8.87 16.37 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.561 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 2.8 mtt -143.55 160.8 39.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.381 -1.07 . . . . 0.0 110.323 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.015 HD12 HG11 ' A' ' 36' ' ' VAL . 69.7 mt -123.85 116.87 23.65 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.13 -0.981 . . . . 0.0 110.937 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.547 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -72.23 160.21 32.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.897 -1.127 . . . . 0.0 109.743 178.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.543 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 9.7 ptm180 -41.73 -37.76 1.29 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.345 -0.847 . . . . 0.0 111.479 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.474 ' OD1' ' NZ ' ' A' ' 14' ' ' LYS . 52.8 m-20 -81.1 -30.13 34.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.855 -1.153 . . . . 0.0 109.528 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.567 ' HG2' HG12 ' A' ' 59' ' ' ILE . 9.4 mt-10 -74.29 -46.37 41.63 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.609 0.718 . . . . 0.0 109.132 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.765 ' CE1' HG22 ' A' ' 36' ' ' VAL . 42.3 t80 -59.87 -18.01 41.11 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.742 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.883 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . . . -72.33 -49.81 31.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.425 -0.797 . . . . 0.0 109.809 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.645 ' O ' HD12 ' A' ' 76' ' ' LEU . 46.8 t -61.01 -22.0 25.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.91 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.032 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.12 -5.18 56.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.221 -0.924 . . . . 0.0 111.008 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.551 ' HG2' ' O ' ' A' ' 70' ' ' PHE . 2.1 mmt -87.84 -45.97 9.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.913 -1.117 . . . . 0.0 110.077 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.764 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.2 p90 -75.04 -33.8 61.79 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 72' ' ' VAL . 29.4 mt -59.02 -30.19 67.83 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.806 ' O ' HD12 ' A' ' 81' ' ' LEU . 98.0 t -91.55 -45.06 14.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.784 -0.572 . . . . 0.0 110.059 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.451 ' HA ' HD12 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -72.92 -25.91 61.22 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.397 -0.814 . . . . 0.0 111.045 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 74.5 m -84.79 -18.37 35.23 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.05 -1.031 . . . . 0.0 109.726 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.842 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -79.35 -12.65 59.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.889 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.039 HD21 ' O ' ' A' ' 43' ' ' SER . 1.2 mt -90.54 -47.13 7.88 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.742 0.782 . . . . 0.0 110.116 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 . . . . . 0 C--N 1.3 -1.579 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.656 -179.097 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.869 HG21 HG23 ' A' ' 53' ' ' VAL . 35.4 t . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.568 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 43.6 Cg_endo -86.35 -166.28 0.31 Allowed 'Trans proline' 0 C--N 1.302 -1.911 0 O-C-N 123.586 1.308 . . . . 0.0 109.897 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 73.3 mtp -123.63 11.32 9.15 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.292 -0.88 . . . . 0.0 111.03 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -168.43 23.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.552 -1.259 . . . . 0.0 111.926 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.81 ' N ' HD22 ' A' ' 56' ' ' LEU . 0.6 OUTLIER 53.81 119.35 0.0 OUTLIER Pre-proline 0 C--N 1.283 -2.32 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.788 178.343 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.735 ' HG2' HD23 ' A' ' 94' ' ' LEU . 43.8 Cg_endo -73.56 169.84 21.38 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.725 1.382 . . . . 0.0 109.883 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.37 -16.85 27.63 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.853 1.449 . . . . 0.0 111.919 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.633 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -92.09 12.23 22.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.787 -1.195 . . . . 0.0 110.853 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.764 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 3.4 mm? -113.75 -17.8 12.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.087 -1.008 . . . . 0.0 111.56 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.092 -1.005 . . . . 0.0 110.91 -179.074 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.521 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.4 t90 . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.444 0.64 . . . . 0.0 109.991 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.02 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -46.55 -27.5 1.14 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.42 -0.8 . . . . 0.0 110.151 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.521 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 37.4 t -93.04 129.71 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.395 -0.815 . . . . 0.0 110.332 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.516 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -93.94 179.13 1.31 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.755 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 39.5 Cg_endo -67.65 -35.49 22.11 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.795 1.418 . . . . 0.0 110.224 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -75.15 -26.37 59.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.842 . . . . 0.0 110.058 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.453 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 4.1 m-20 -86.08 -37.43 18.85 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HG3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -76.18 -13.55 60.18 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.588 -0.695 . . . . 0.0 109.175 178.863 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -73.81 -40.81 63.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 108.901 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.635 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.57 -26.46 50.87 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.36 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.635 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.5 m-30 -71.83 -27.6 63.02 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.14 -10.71 59.6 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.338 0.589 . . . . 0.0 109.937 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.02 -36.54 11.51 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.527 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 82.3 mt -74.81 -33.98 32.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.792 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -65.39 -39.09 91.79 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.649 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.529 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.2 t0 -89.31 2.65 54.06 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.694 -0.629 . . . . 0.0 109.706 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.527 ' HB2' ' HA ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -93.83 0.83 56.44 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.847 0.832 . . . . 0.0 108.978 178.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.079 HD22 HG21 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -116.63 -2.49 11.93 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 80.17 90.53 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.855 0 CA-C-O 121.368 0.604 . . . . 0.0 109.838 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.6 Cg_endo -75.27 148.59 34.48 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 124.558 1.82 . . . . 0.0 110.458 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 44.0 t -117.86 108.51 24.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.663 -0.648 . . . . 0.0 109.422 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 16.7 t30 55.44 21.49 4.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.07 -1.018 . . . . 0.0 109.741 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 97.03 33.58 5.98 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.624 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 66.2 m-85 -149.76 150.51 32.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -1.104 . . . . 0.0 111.41 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.911 HD13 HD12 ' A' ' 24' ' ' LEU . 30.7 mt -118.56 129.94 55.62 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.71 -0.796 . . . . 0.0 108.994 178.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.54 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -78.76 138.47 38.24 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.606 -0.684 . . . . 0.0 110.616 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -44.08 -25.33 0.67 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 32' ' ' SER . 10.3 t70 -62.27 -17.75 59.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.288 -1.125 . . . . 0.0 110.226 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -114.47 -33.98 5.4 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.325 -0.86 . . . . 0.0 109.377 179.732 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.918 HG11 HD12 ' A' ' 65' ' ' LEU . 98.6 t -79.19 -51.83 16.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 119.516 -0.873 . . . . 0.0 109.765 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 48.6 tttt -42.68 -49.88 13.04 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 110.338 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 1.027 ' HA ' HD12 ' A' ' 41' ' ' LEU . 39.6 Cg_endo -67.39 -31.09 35.49 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 N-CA-C 108.854 -1.248 . . . . 0.0 108.854 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.079 HG21 HD22 ' A' ' 24' ' ' LEU . 2.8 t -76.22 -10.43 13.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.523 0.677 . . . . 0.0 109.507 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.838 ' HB3' HD22 ' A' ' 50' ' ' LEU . 97.2 mt -99.21 -15.09 19.03 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.027 HD12 ' HA ' ' A' ' 38' ' ' PRO . 6.9 mt -84.63 -33.32 23.33 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.479 -0.763 . . . . 0.0 109.595 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.455 ' OD1' ' HA ' ' A' ' 39' ' ' VAL . 2.7 p-10 -71.12 -2.97 17.47 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.865 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 9.4 m -80.37 5.5 14.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.31 -0.869 . . . . 0.0 110.033 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 43' ' ' SER . 27.8 tttt 65.54 12.61 8.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.09 HD13 HG21 ' A' ' 49' ' ' ILE . 15.5 mt -99.82 156.24 35.56 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 110.036 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.547 ' HG2' HG12 ' A' ' 49' ' ' ILE . 40.4 Cg_endo -73.09 162.44 40.8 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.952 1.501 . . . . 0.0 110.153 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.1 t -63.88 -7.93 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.432 -0.792 . . . . 0.0 110.725 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.23 -40.59 51.67 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.09 HG21 HD13 ' A' ' 45' ' ' LEU . 10.9 mm -65.59 -43.53 94.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.838 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.7 mt -66.03 -21.32 66.38 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.33 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.6 -28.11 22.73 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.56 ' O ' HD12 ' A' ' 56' ' ' LEU . 3.8 ttm180 -95.3 -47.42 6.32 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.519 -0.989 . . . . 0.0 109.606 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.939 HG11 HG23 ' A' ' 77' ' ' VAL . 45.7 t -57.45 -39.11 66.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.277 -0.89 . . . . 0.0 109.201 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.553 ' CE3' HD11 ' A' ' 65' ' ' LEU . 6.7 t-105 -68.69 -53.22 23.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.502 -0.749 . . . . 0.0 110.172 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.462 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 5.7 mm-40 -47.58 -50.02 25.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.381 -0.824 . . . . 0.0 109.906 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.688 HD11 ' O ' ' A' ' 87' ' ' PRO . 3.3 mt -76.38 -8.49 57.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.669 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 1.044 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.3 t -99.76 -27.62 13.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.475 -0.766 . . . . 0.0 110.422 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.471 ' OD2' ' CZ2' ' A' ' 54' ' ' TRP . 11.8 t0 -83.82 90.01 7.28 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.387 -0.821 . . . . 0.0 109.384 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.466 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 46.1 mm -53.45 -32.71 20.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.496 -0.752 . . . . 0.0 110.549 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 24.8 p-10 -106.42 -13.75 15.27 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.185 -0.947 . . . . 0.0 111.021 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.536 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 57.2 m80 56.45 43.69 25.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.076 -1.015 . . . . 0.0 110.358 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.461 ' OD1' ' OD2' ' A' ' 60' ' ' ASP . 1.1 p-10 -104.3 18.45 22.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.931 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.61 10.42 83.34 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.54 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 4.2 mtt -139.43 161.82 36.55 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.538 -0.977 . . . . 0.0 110.911 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.918 HD12 HG11 ' A' ' 36' ' ' VAL . 71.1 mt -130.76 119.48 22.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.346 -0.846 . . . . 0.0 110.387 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.624 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -79.59 166.59 21.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.896 -1.127 . . . . 0.0 109.484 179.026 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.447 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -43.26 -30.45 0.5 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.457 -0.777 . . . . 0.0 111.275 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.456 ' HB2' ' OD1' ' A' ' 66' ' ' ASP . 58.7 m-20 -90.06 -31.15 17.28 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.14 -0.975 . . . . 0.0 109.766 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.466 ' OE1' ' N ' ' A' ' 59' ' ' ILE . 10.0 mt-10 -76.93 -38.56 53.17 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.412 -0.805 . . . . 0.0 109.378 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.735 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 56.9 t80 -70.71 -24.56 62.67 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.705 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.27 -41.22 77.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 109.552 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.456 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.3 t -62.94 -29.66 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.639 -0.663 . . . . 0.0 110.043 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.044 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.33 -4.46 57.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.154 -0.966 . . . . 0.0 110.9 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.535 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 9.7 mmt -83.37 -46.49 12.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.003 -1.061 . . . . 0.0 109.76 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.687 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 4.3 p90 -77.2 -24.24 51.37 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.667 ' CB ' HG13 ' A' ' 53' ' ' VAL . 15.3 mt -72.89 -25.76 61.19 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.939 HG23 HG11 ' A' ' 53' ' ' VAL . 42.4 t -91.06 -34.46 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.639 -0.663 . . . . 0.0 109.663 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -80.12 -26.39 39.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -0.779 . . . . 0.0 110.034 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 65.1 m -82.11 -12.78 58.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.203 -0.935 . . . . 0.0 109.127 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.023 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.91 -13.73 46.91 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.333 -0.854 . . . . 0.0 108.923 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.681 HD23 ' N ' ' A' ' 81' ' ' LEU . 3.2 mt -89.58 -42.48 11.39 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.904 0.859 . . . . 0.0 109.014 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.298 -1.642 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.423 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.562 HG21 ' CG2' ' A' ' 53' ' ' VAL . 44.2 t . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 120.692 0.282 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.688 ' O ' HD11 ' A' ' 56' ' ' LEU . 52.1 Cg_endo -84.67 -170.69 0.84 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.958 1.504 . . . . 0.0 109.831 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.517 ' C ' HD21 ' A' ' 56' ' ' LEU . 4.8 mtt -115.2 13.89 16.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.069 -1.019 . . . . 0.0 110.634 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.485 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 5.3 m -113.13 103.05 10.97 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 118.729 -1.188 . . . . 0.0 111.688 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.627 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -57.07 108.26 1.18 Allowed Pre-proline 0 C--N 1.291 -1.94 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.824 179.21 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.051 ' HG2' HD23 ' A' ' 94' ' ' LEU . 49.6 Cg_endo -80.05 157.72 23.64 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 123.928 1.489 . . . . 0.0 110.328 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.26 -11.04 24.74 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.079 1.568 . . . . 0.0 110.828 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.597 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -84.15 -0.76 53.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.051 HD23 ' HG2' ' A' ' 91' ' ' PRO . 3.9 mm? -117.46 -9.69 10.81 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.313 -0.867 . . . . 0.0 110.164 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 95' ' ' VAL . 6.3 p . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.953 . . . . 0.0 110.748 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.462 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 12.8 t90 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.729 ' HB3' HD23 ' A' ' 94' ' ' LEU . . . -40.96 -32.42 0.23 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.298 -0.876 . . . . 0.0 109.931 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.462 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 64.9 t -89.71 153.23 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.481 -0.762 . . . . 0.0 109.565 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 11.5 mmtt -99.04 167.03 11.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.2 Cg_endo -66.5 -33.67 36.21 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.747 1.393 . . . . 0.0 109.755 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -76.53 -23.81 53.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.506 -0.746 . . . . 0.0 109.367 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.576 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 21.8 m-20 -82.79 -38.75 22.71 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 7.2 tptm -65.29 -20.33 66.36 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.39 -43.19 41.65 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.602 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.7 ptpt -79.15 -24.05 43.56 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 6.9 m-30 -74.96 -34.33 62.03 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.476 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 10.1 t70 -79.96 -8.4 59.31 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.381 0.61 . . . . 0.0 109.939 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.72 -37.23 10.88 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.681 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 28.0 mt -75.43 -26.66 18.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 1.014 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.2 -36.84 61.37 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.534 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.2 t70 -90.27 1.75 56.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.696 -0.627 . . . . 0.0 109.815 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.511 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.7 m -93.86 -1.38 54.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.35 -0.844 . . . . 0.0 108.821 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.018 HD12 HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -114.0 -1.77 13.7 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.594 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 81.71 91.1 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.107 0 CA-C-O 121.111 0.481 . . . . 0.0 109.707 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.4 Cg_endo -75.11 148.51 34.98 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.305 1.687 . . . . 0.0 110.746 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 99.2 t -120.03 109.44 25.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.625 -0.672 . . . . 0.0 109.561 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 9.3 t30 55.53 23.33 5.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.063 -1.023 . . . . 0.0 109.556 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 92.87 35.41 6.42 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.604 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 91.1 m-85 -151.42 152.55 33.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -1.153 . . . . 0.0 111.118 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.018 HD13 HD12 ' A' ' 24' ' ' LEU . 29.7 mt -122.23 127.87 50.47 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.485 ' OG ' ' HE2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -78.86 138.2 38.03 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.613 -179.069 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -38.53 -34.05 0.23 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 32' ' ' SER . 7.9 t0 -49.75 -21.6 1.14 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -1.212 . . . . 0.0 110.022 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 13.0 mttm -113.08 -39.71 4.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.42 -0.8 . . . . 0.0 109.443 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.019 HG11 HD12 ' A' ' 65' ' ' LEU . 96.1 t -79.35 -37.17 18.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.647 -0.658 . . . . 0.0 110.015 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.619 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.1 ttpt -49.34 -50.38 65.11 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.34 -0.85 . . . . 0.0 110.584 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.933 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.6 Cg_endo -66.93 -29.23 41.41 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 N-CA-C 108.812 -1.265 . . . . 0.0 108.812 178.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.561 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 3.2 t -73.97 -13.29 15.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.216 0.531 . . . . 0.0 110.303 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.651 ' HB3' HD22 ' A' ' 50' ' ' LEU . 77.9 mt -98.75 -14.0 19.95 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.967 -1.083 . . . . 0.0 108.568 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.933 HD12 ' HA ' ' A' ' 38' ' ' PRO . 20.3 mt -87.89 -41.72 13.01 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.707 -0.621 . . . . 0.0 110.073 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 7.6 p-10 -52.78 -20.46 3.23 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.365 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -64.08 -9.45 16.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.467 -0.771 . . . . 0.0 110.431 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 71.24 7.91 6.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.142 -0.973 . . . . 0.0 109.72 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.937 HD13 HG21 ' A' ' 49' ' ' ILE . 15.7 mt -88.26 159.88 46.76 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 110.014 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.536 ' HG2' HG12 ' A' ' 49' ' ' ILE . 41.0 Cg_endo -72.41 151.9 54.22 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 123.941 1.495 . . . . 0.0 110.301 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.5 t -54.28 -14.07 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.268 -0.895 . . . . 0.0 110.991 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -39.85 75.08 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.801 -1.187 . . . . 0.0 108.354 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.937 HG21 HD13 ' A' ' 45' ' ' LEU . 4.9 mm -66.89 -47.18 83.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.5 mt -63.31 -21.14 66.07 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.05 -28.33 25.98 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.611 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.1 ttm180 -94.4 -55.71 3.07 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.473 -1.016 . . . . 0.0 109.272 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.978 HG11 HG23 ' A' ' 77' ' ' VAL . 55.3 t -47.64 -44.15 9.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.24 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.532 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 6.0 t-105 -64.62 -57.32 9.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.49 -0.756 . . . . 0.0 109.995 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.561 ' CG ' ' N ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER -47.54 -50.85 22.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.684 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.719 HD23 ' CB ' ' A' ' 90' ' ' LEU . 2.6 mt -70.69 -9.7 57.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.311 -0.868 . . . . 0.0 109.398 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.948 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -100.3 -36.24 9.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.607 -0.683 . . . . 0.0 110.258 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD2' ' CZ2' ' A' ' 54' ' ' TRP . 9.4 t0 -78.76 85.36 4.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.451 -0.78 . . . . 0.0 109.295 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.512 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 31.4 mm -52.47 -30.99 14.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.728 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 0.7 OUTLIER -99.52 -18.09 17.57 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.053 -1.029 . . . . 0.0 111.006 -179.341 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.475 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 14.6 m80 56.85 31.78 20.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.975 -1.078 . . . . 0.0 108.895 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -90.99 -9.3 46.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.634 -0.666 . . . . 0.0 110.538 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 113.24 9.98 16.54 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.579 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 9.2 mtp -149.19 158.18 43.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -1.169 . . . . 0.0 110.732 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.019 HD12 HG11 ' A' ' 36' ' ' VAL . 41.5 mt -116.35 117.18 29.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.603 -0.685 . . . . 0.0 110.159 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.604 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 3.2 t70 -77.35 172.8 12.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.082 -1.011 . . . . 0.0 110.023 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.559 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.4 ptm180 -48.11 -43.18 30.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.519 -0.738 . . . . 0.0 111.36 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -80.4 -33.57 36.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.142 -0.974 . . . . 0.0 110.58 -179.333 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.516 ' CD ' ' HB3' ' A' ' 66' ' ' ASP . 66.7 mt-10 -73.74 -50.13 22.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 108.593 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.681 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 55.2 t80 -52.03 -33.24 37.78 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -56.47 -53.81 53.15 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.565 0.698 . . . . 0.0 109.96 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.613 HG11 ' O ' ' A' ' 56' ' ' LEU . 78.3 t -55.45 -25.14 17.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.548 -0.72 . . . . 0.0 110.334 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.948 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.28 -5.44 57.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.157 -0.964 . . . . 0.0 111.396 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.582 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 8.0 mmm -90.84 -35.32 14.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.515 -1.366 . . . . 0.0 110.284 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.64 ' CZ ' ' CD2' ' A' ' 94' ' ' LEU . 2.1 p90 -83.1 -24.47 32.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.135 -0.978 . . . . 0.0 108.596 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.77 ' HB3' HG13 ' A' ' 53' ' ' VAL . 3.8 mt -77.4 -23.72 50.62 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.644 -0.66 . . . . 0.0 109.316 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.978 HG23 HG11 ' A' ' 53' ' ' VAL . 48.7 t -89.93 -32.29 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.507 -0.746 . . . . 0.0 109.136 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.737 ' HA ' HD12 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -82.87 -25.46 32.53 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 109.786 179.2 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 64.4 m -86.15 -12.24 50.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.386 -0.821 . . . . 0.0 109.717 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.925 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -80.81 -19.13 45.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.916 -1.115 . . . . 0.0 108.456 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.737 HD12 ' HA ' ' A' ' 78' ' ' TYR . 3.3 mt -91.69 -40.71 11.12 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.149 0.5 . . . . 0.0 110.391 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 3.8 tt0 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 112.9 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.509 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 41.4 t . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.741 0.305 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.504 ' O ' HD11 ' A' ' 56' ' ' LEU . 52.4 Cg_endo -81.42 158.41 19.62 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.813 1.428 . . . . 0.0 109.404 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.706 ' C ' HD21 ' A' ' 56' ' ' LEU . 2.5 mtt -86.33 16.37 4.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.963 -1.086 . . . . 0.0 110.036 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.634 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 61.6 m -106.58 110.92 23.26 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.221 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.726 ' C ' HD12 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -91.25 98.57 1.77 Allowed Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.18 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.847 ' HG2' HD12 ' A' ' 94' ' ' LEU . 38.3 Cg_endo -63.9 167.61 13.63 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.673 1.354 . . . . 0.0 111.379 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.35 -9.23 24.94 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.208 1.636 . . . . 0.0 111.072 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.24 -7.76 55.59 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.318 -0.864 . . . . 0.0 109.095 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.847 HD12 ' HG2' ' A' ' 91' ' ' PRO . 2.6 mt -111.4 3.5 18.24 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.422 -0.799 . . . . 0.0 110.32 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.966 . . . . 0.0 110.615 -179.499 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.569 ' CZ2' ' HB ' ' A' ' 9' ' ' VAL . 19.1 t90 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.258 0.552 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.696 ' HB2' HD22 ' A' ' 94' ' ' LEU . . . -47.81 -27.69 2.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.486 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.569 ' HB ' ' CZ2' ' A' ' 7' ' ' TRP . 89.4 t -112.73 154.2 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.867 . . . . 0.0 110.453 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.558 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -113.65 -176.56 0.38 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.396 -0.815 . . . . 0.0 110.244 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.9 Cg_endo -69.75 -41.21 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.698 1.367 . . . . 0.0 110.305 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.455 ' HG2' ' OD1' ' A' ' 13' ' ' ASP . 15.3 pt-20 -65.15 -28.5 69.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 109.75 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.57 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 4.3 m-20 -84.25 -40.61 17.82 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 18' ' ' ASP . 1.5 tppp? -69.78 -14.14 62.63 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.79 -39.33 44.26 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 8.8 mtmt -81.61 -40.08 23.53 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CD1' ' HB3' ' A' ' 74' ' ' MET . 5.0 m-30 -64.04 -22.12 66.8 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 4.4 t70 -89.28 -16.84 30.23 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.799 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.05 -29.75 18.18 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.517 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 20.8 mt -80.08 -34.98 15.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -69.56 -38.02 77.26 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.003 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.566 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.1 t70 -88.11 -0.7 57.38 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.701 -0.624 . . . . 0.0 110.227 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.7 t -90.72 -3.84 57.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 109.206 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.02 HD22 HG21 ' A' ' 39' ' ' VAL . 2.2 mt -108.95 -8.09 15.3 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m 86.05 89.08 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.5 Cg_endo -73.55 145.03 36.86 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.455 1.766 . . . . 0.0 110.507 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.7 110.15 31.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.8 m120 52.14 23.44 2.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.086 -1.009 . . . . 0.0 108.474 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 91.1 33.97 7.87 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.571 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 65.0 m-85 -144.52 148.61 34.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -1.124 . . . . 0.0 112.01 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.804 HD13 HD12 ' A' ' 24' ' ' LEU . 35.1 mt -122.63 134.26 54.51 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.572 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.3 OUTLIER -77.89 143.19 37.94 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.181 -0.949 . . . . 0.0 111.107 -178.503 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -50.4 -26.9 10.42 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.241 -1.943 . . . . 0.0 108.241 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -77.52 -9.67 59.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.35 -1.088 . . . . 0.0 109.466 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.582 ' HD2' ' CB ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -100.74 -46.56 5.12 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.593 HG22 ' HE2' ' A' ' 70' ' ' PHE . 72.4 t -77.67 -37.34 24.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.924 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.589 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -38.47 -51.88 3.46 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.423 -0.798 . . . . 0.0 111.176 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 1.095 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.6 Cg_endo -65.98 -30.61 47.9 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.311 1.163 . . . . 0.0 109.35 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.02 HG21 HD22 ' A' ' 24' ' ' LEU . 5.4 t -77.51 -10.19 12.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.427 0.632 . . . . 0.0 109.733 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.968 ' HB3' HD22 ' A' ' 50' ' ' LEU . 58.6 mt -100.31 -14.46 18.4 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.095 HD12 ' HA ' ' A' ' 38' ' ' PRO . 10.7 mt -87.0 -42.48 13.08 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.636 -0.665 . . . . 0.0 109.483 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 7.7 p-10 -50.05 -22.87 1.78 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 118.75 -1.18 . . . . 0.0 108.556 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -60.94 -10.96 6.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 110.107 178.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.6 OUTLIER 74.02 18.96 3.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.326 -0.859 . . . . 0.0 109.982 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.022 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.3 mt -98.9 156.25 35.73 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.569 -0.707 . . . . 0.0 109.823 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.536 ' HG2' HG12 ' A' ' 49' ' ' ILE . 41.9 Cg_endo -74.65 156.11 44.59 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.973 1.512 . . . . 0.0 110.279 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.0 t -58.66 -12.38 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.483 -0.76 . . . . 0.0 110.714 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.28 -37.63 71.86 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.026 -1.046 . . . . 0.0 108.233 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.913 HG21 HD13 ' A' ' 45' ' ' LEU . 26.0 mm -68.23 -45.95 81.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.968 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.8 mt -61.61 -20.39 63.29 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.516 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -84.49 -29.98 28.55 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.048 -2.021 . . . . 0.0 108.048 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.6 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 1.1 ttm180 -94.76 -58.32 2.21 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.58 -0.953 . . . . 0.0 109.629 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.644 ' CG2' HG21 ' A' ' 86' ' ' VAL . 6.3 t -46.83 -49.95 6.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.209 -0.997 . . . . 0.0 108.756 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.553 ' HA ' ' HB2' ' A' ' 57' ' ' SER . 16.9 t-105 -56.81 -59.44 5.02 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.931 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 10.4 mm-40 -44.05 -58.39 2.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.158 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.77 HD11 ' HA ' ' A' ' 88' ' ' MET . 3.3 mt -70.25 -11.63 61.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.854 . . . . 0.0 109.803 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 1.008 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 19.3 m -96.2 -27.54 14.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 0.0 110.379 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 54' ' ' TRP . 19.0 t0 -87.14 81.59 7.96 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.241 -0.912 . . . . 0.0 109.455 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.532 HG12 ' HG3' ' A' ' 69' ' ' GLU . 32.1 mm -44.29 -32.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.616 -0.677 . . . . 0.0 110.449 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 9.5 p-10 -105.39 -14.98 15.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.126 -0.984 . . . . 0.0 111.034 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.536 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 18.4 m80 56.27 41.71 28.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.046 -1.034 . . . . 0.0 110.113 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.473 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 2.2 p-10 -100.89 15.66 27.8 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 110.135 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.72 15.56 77.5 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.572 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 9.1 mtt -146.81 160.74 41.9 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.558 -0.966 . . . . 0.0 110.467 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 58' ' ' ASP . 43.5 mt -128.54 118.16 22.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.329 -0.857 . . . . 0.0 109.436 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.571 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 20.2 t0 -69.77 166.6 18.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.863 -1.148 . . . . 0.0 109.996 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.584 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 10.7 ttm180 -44.0 -46.33 8.28 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 110.142 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.5 m-20 -78.7 -26.72 44.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.383 -0.823 . . . . 0.0 109.66 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.532 ' HG3' HG12 ' A' ' 59' ' ' ILE . 4.7 tt0 -75.71 -39.57 57.16 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.59 0.709 . . . . 0.0 109.53 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.593 ' HE2' HG22 ' A' ' 36' ' ' VAL . 18.2 t80 -66.67 -17.75 65.01 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.691 0.758 . . . . 0.0 109.072 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.469 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -74.99 -43.61 52.97 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.469 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.935 HG13 HD12 ' A' ' 94' ' ' LEU . 59.2 t -60.57 -26.1 36.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.535 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.008 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -90.56 -4.35 56.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.52 -0.737 . . . . 0.0 111.074 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.579 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 11.1 mmt -86.27 -47.05 9.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.925 -1.109 . . . . 0.0 109.971 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.046 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 1.9 p90 -76.91 -24.57 52.47 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.533 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 8.4 mt -71.21 -24.53 62.23 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 73' ' ' ALA . 66.0 t -91.66 -61.92 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.557 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.2 m-85 -48.32 -21.66 0.56 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.721 -0.612 . . . . 0.0 111.597 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 2.1 m -86.21 -14.76 42.96 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.006 -1.059 . . . . 0.0 109.883 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.022 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -89.33 -10.19 47.65 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.282 -0.886 . . . . 0.0 109.302 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.702 ' N ' HD12 ' A' ' 81' ' ' LEU . 7.0 mp -87.04 -43.91 11.97 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.477 -0.765 . . . . 0.0 109.026 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 . . . . . 0 C--N 1.301 -1.523 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.777 179.649 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.644 HG21 ' CG2' ' A' ' 53' ' ' VAL . 77.9 t . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 120.608 0.242 . . . . 0.0 110.514 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.607 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.7 Cg_endo -81.27 -165.85 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.842 1.443 . . . . 0.0 110.097 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.77 ' HA ' HD11 ' A' ' 56' ' ' LEU . 67.0 mtm -120.48 17.11 12.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.267 -0.896 . . . . 0.0 110.609 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.523 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 42.0 m -117.04 95.47 5.01 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.039 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.611 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -57.12 106.71 0.72 Allowed Pre-proline 0 C--N 1.291 -1.962 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.491 178.6 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.048 ' HG2' HD23 ' A' ' 94' ' ' LEU . 50.9 Cg_endo -75.16 169.3 22.84 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.668 1.352 . . . . 0.0 109.826 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.64 -12.71 26.97 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.857 1.451 . . . . 0.0 111.012 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -86.67 8.44 22.41 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.086 -1.009 . . . . 0.0 109.477 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.048 HD23 ' HG2' ' A' ' 91' ' ' PRO . 1.4 mm? -113.75 6.18 16.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 110.597 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 95' ' ' VAL . 9.9 p . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.068 -1.02 . . . . 0.0 110.713 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.585 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 19.0 t90 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.276 0.56 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -40.97 -34.4 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.401 -0.812 . . . . 0.0 110.839 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.585 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 61.2 t -108.39 141.36 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 110.384 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.573 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -99.42 -177.13 0.55 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.385 -0.822 . . . . 0.0 109.909 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.573 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.6 Cg_endo -69.43 -35.99 12.55 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.662 1.349 . . . . 0.0 109.834 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 10' ' ' LYS . 20.3 pt-20 -68.46 -25.75 65.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 109.825 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.433 ' HB2' HG13 ' A' ' 9' ' ' VAL . 39.7 m-20 -86.13 -38.86 17.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.308 -0.87 . . . . 0.0 108.912 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.424 ' NZ ' ' OD1' ' A' ' 68' ' ' ASP . 3.8 ttmt -75.48 -17.25 60.18 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -74.88 -31.12 61.52 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.657 ' HG3' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -86.45 -21.28 27.16 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.657 ' CD1' ' HG3' ' A' ' 16' ' ' LYS . 17.7 m-30 -78.9 -33.39 45.63 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -13.84 62.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.859 -0.526 . . . . 0.0 110.009 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -89.31 -34.06 16.7 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.558 HG22 ' CE2' ' A' ' 70' ' ' PHE . 22.2 mt -80.72 -35.91 15.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.604 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -68.37 -35.39 77.65 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.747 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.55 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.3 t0 -89.1 -1.7 58.21 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.446 -0.784 . . . . 0.0 109.987 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -91.04 -1.51 57.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 0.0 108.648 178.442 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.864 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -109.38 -3.82 16.82 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 81.26 87.52 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 121.454 0.645 . . . . 0.0 109.265 -178.842 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -72.32 147.65 47.68 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 O-C-N 124.65 1.869 . . . . 0.0 110.896 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 61.3 t -116.26 106.59 20.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.576 -0.703 . . . . 0.0 109.186 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 9.1 t30 57.1 26.55 12.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.265 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 88.24 36.14 8.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.582 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 87.4 m-85 -150.31 160.14 43.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.433 -1.039 . . . . 0.0 111.142 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.864 HD22 ' HB2' ' A' ' 24' ' ' LEU . 12.3 mt -136.25 134.04 37.64 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.568 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -83.08 139.89 32.97 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.854 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -38.77 -28.52 0.07 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.6 OUTLIER -53.04 -35.58 59.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.347 -1.09 . . . . 0.0 111.064 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 1.3 mttm -97.41 -42.13 7.89 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.083 -1.01 . . . . 0.0 109.561 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.956 HG11 HD12 ' A' ' 65' ' ' LEU . 41.9 t -71.61 -47.45 57.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.62 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.572 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 40.9 tttp -45.99 -52.12 28.04 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 110.819 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.935 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.6 Cg_endo -66.48 -34.15 34.77 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.262 1.138 . . . . 0.0 109.164 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.846 HG21 HD22 ' A' ' 24' ' ' LEU . 2.2 t -62.77 -28.02 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.274 0.559 . . . . 0.0 109.606 178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.9 ' HB3' HD22 ' A' ' 50' ' ' LEU . 30.3 mt -83.62 -14.76 51.25 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.168 -0.958 . . . . 0.0 109.479 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.935 HD12 ' HA ' ' A' ' 38' ' ' PRO . 21.5 mt -78.8 -29.01 44.65 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.408 ' OD1' ' HA ' ' A' ' 39' ' ' VAL . 17.9 m120 -58.13 -28.29 64.54 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.036 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.601 ' HB2' HD11 ' A' ' 81' ' ' LEU . 3.6 p -62.2 -13.01 23.25 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.638 -0.664 . . . . 0.0 109.648 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 75.6 13.63 2.93 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.445 0.64 . . . . 0.0 109.864 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.031 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.4 mt -85.92 158.59 55.92 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.498 -0.751 . . . . 0.0 109.834 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.558 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.5 Cg_endo -73.22 157.3 50.39 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 O-C-N 124.088 1.573 . . . . 0.0 110.265 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.0 t -58.28 -10.92 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.42 -0.8 . . . . 0.0 111.109 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -73.85 -41.96 61.49 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.83 -1.169 . . . . 0.0 108.213 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.983 HG21 HD13 ' A' ' 45' ' ' LEU . 12.9 mm -61.95 -44.55 99.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.9 HD22 ' HB3' ' A' ' 40' ' ' LEU . 11.1 mt -62.17 -20.79 64.51 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.2 -28.51 36.64 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.582 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 0.3 OUTLIER -97.68 -57.21 2.29 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.529 -0.983 . . . . 0.0 109.665 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.701 HG11 ' CG2' ' A' ' 77' ' ' VAL . 3.8 t -47.42 -34.92 3.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.204 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 7.5 t-105 -75.11 -58.98 2.95 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.979 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.572 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 2.9 pt-20 -47.21 -46.22 23.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.621 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.782 HD11 ' O ' ' A' ' 87' ' ' PRO . 7.6 mt -76.52 -12.31 60.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.46 -0.775 . . . . 0.0 109.456 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 1.075 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 2.6 t -96.55 -35.06 11.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.362 -0.836 . . . . 0.0 110.002 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.498 ' HA ' HD23 ' A' ' 65' ' ' LEU . 11.4 t0 -77.69 86.09 3.99 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.427 ' HB ' ' CD ' ' A' ' 69' ' ' GLU . 36.1 mm -50.35 -32.59 9.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.647 -0.658 . . . . 0.0 111.16 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 53.8 p30 -103.65 -15.1 15.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.933 -1.105 . . . . 0.0 111.256 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.543 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 3.0 m-70 63.88 43.85 5.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.845 -1.159 . . . . 0.0 109.726 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 6.2 p-10 -107.17 15.69 24.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 110.588 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.91 8.35 87.74 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.568 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 3.6 mtt -142.07 160.82 39.46 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.362 -1.081 . . . . 0.0 110.478 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.956 HD12 HG11 ' A' ' 36' ' ' VAL . 47.4 mt -127.04 120.37 28.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 110.79 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.582 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 8.7 t0 -69.57 164.53 23.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.947 -1.095 . . . . 0.0 109.326 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.508 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 8.9 ptm180 -45.81 -34.46 3.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 110.468 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 10.2 m-20 -85.81 -32.57 21.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.102 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 16.1 mt-10 -71.13 -42.75 68.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.94 . . . . 0.0 108.819 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.682 ' CE1' HG13 ' A' ' 36' ' ' VAL . 42.3 t80 -59.22 -32.56 70.07 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -57.32 -48.37 79.14 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.768 0.794 . . . . 0.0 110.161 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 1.039 HG13 HD12 ' A' ' 94' ' ' LEU . 87.5 t -59.8 -26.61 35.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.645 -0.659 . . . . 0.0 110.739 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.075 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -86.97 -5.62 59.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.159 -0.963 . . . . 0.0 111.723 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.612 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 14.4 mmm -90.45 -41.24 11.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.604 -1.31 . . . . 0.0 110.096 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.978 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.3 p90 -79.38 -17.45 54.39 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.868 -1.133 . . . . 0.0 108.477 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 76' ' ' LEU . 6.8 mt -82.57 -20.88 35.65 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.772 HG21 HD22 ' A' ' 40' ' ' LEU . 77.7 t -90.89 -41.83 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.565 -0.709 . . . . 0.0 109.723 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -71.32 -21.0 62.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.385 -0.822 . . . . 0.0 110.126 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 7.6 t -80.82 -15.14 57.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.268 -0.895 . . . . 0.0 109.087 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.031 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.17 -13.61 35.26 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.52 -0.737 . . . . 0.0 109.38 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.83 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.7 mt -90.5 -33.78 15.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.0 109.222 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 . . . . . 0 C--N 1.301 -1.539 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.663 179.664 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.54 HG21 ' CG2' ' A' ' 53' ' ' VAL . 61.5 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.604 0.24 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.782 ' O ' HD11 ' A' ' 56' ' ' LEU . 51.4 Cg_endo -86.74 -168.66 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.979 1.515 . . . . 0.0 110.159 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.582 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 10.7 mtp -113.65 6.95 17.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.335 -0.853 . . . . 0.0 110.684 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.502 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.1 m -114.24 104.43 12.08 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.442 -1.303 . . . . 0.0 112.135 -177.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.653 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -60.24 107.94 1.23 Allowed Pre-proline 0 C--N 1.288 -2.071 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.379 178.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.032 ' HG2' HD23 ' A' ' 94' ' ' LEU . 41.1 Cg_endo -66.36 167.36 18.79 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.855 1.45 . . . . 0.0 109.946 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.67 -12.46 29.04 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.945 1.497 . . . . 0.0 111.628 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.632 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -87.07 2.53 49.42 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.073 -1.017 . . . . 0.0 110.113 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.039 HD12 HG13 ' A' ' 72' ' ' VAL . 3.0 mm? -107.69 -0.37 21.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.145 -0.972 . . . . 0.0 111.052 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 N--CA 1.493 1.7 0 O-C-N 120.964 -1.085 . . . . 0.0 110.695 -179.436 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.617 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.7 t90 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.079 0.466 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -47.21 -30.36 2.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.009 . . . . 0.0 110.16 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.617 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 72.5 t -102.3 149.69 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.397 -0.814 . . . . 0.0 109.857 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.531 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -126.74 171.91 7.34 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.422 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.684 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.8 Cg_endo -62.91 -34.18 72.47 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.741 1.39 . . . . 0.0 110.592 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -72.98 -35.64 66.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 109.62 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -83.19 -41.29 18.62 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.432 ' HG3' ' CB ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -70.03 -15.19 62.97 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.237 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -67.18 -40.82 86.63 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.638 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.9 ptpt -75.79 -25.87 56.79 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.638 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -72.61 -33.75 66.89 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.7 -10.9 60.16 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.41 0.624 . . . . 0.0 109.7 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.58 -35.91 14.74 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.647 HD13 ' SD ' ' A' ' 74' ' ' MET . 19.8 mt -76.73 -34.78 23.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.618 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -70.81 -33.56 70.82 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.554 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.9 t0 -88.97 -3.11 58.82 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.546 -0.721 . . . . 0.0 109.892 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.1 m -85.65 -13.73 47.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.084 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.617 HD12 HD13 ' A' ' 31' ' ' LEU . 4.4 mt -100.11 -11.7 20.27 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.607 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 t 85.6 99.41 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.152 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.3 Cg_endo -74.87 148.79 36.41 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 O-C-N 124.337 1.704 . . . . 0.0 110.807 -178.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 60.2 t -117.95 107.87 23.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 121.746 -0.596 . . . . 0.0 109.617 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 6.0 t30 56.9 17.5 3.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.359 -0.838 . . . . 0.0 109.421 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 96.96 36.0 5.14 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.605 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 94.7 m-85 -151.28 160.08 44.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -1.129 . . . . 0.0 110.877 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.627 HD12 ' CD2' ' A' ' 70' ' ' PHE . 37.8 mt -130.81 129.45 42.4 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.558 ' CA ' ' HE3' ' A' ' 64' ' ' MET . 12.2 p -78.23 139.97 38.91 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.854 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.04 -28.78 0.52 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 32' ' ' SER . 13.1 t70 -61.54 -11.23 10.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -1.142 . . . . 0.0 110.269 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' A' ' 24' ' ' LEU . 17.9 mtpp -116.27 -34.83 4.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -0.975 . . . . 0.0 109.02 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.872 HG22 ' HE2' ' A' ' 70' ' ' PHE . 98.0 t -84.34 -36.31 11.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.401 0.619 . . . . 0.0 109.694 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.65 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.3 tttt -48.37 -47.86 67.44 Favored Pre-proline 0 N--CA 1.487 1.384 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.158 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.995 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.7 Cg_endo -67.77 -30.74 33.5 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.407 1.214 . . . . 0.0 109.018 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.5 t -73.99 -9.43 12.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.798 -0.564 . . . . 0.0 109.584 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.001 ' HB3' HD22 ' A' ' 50' ' ' LEU . 82.4 mt -100.18 -15.92 17.96 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.139 -0.976 . . . . 0.0 108.515 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.995 HD12 ' HA ' ' A' ' 38' ' ' PRO . 7.0 mt -89.95 -37.31 14.45 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.549 -0.72 . . . . 0.0 110.16 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 4.0 p-10 -58.68 -16.45 16.37 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.153 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.487 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.8 OUTLIER -73.71 -1.83 20.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.374 -0.829 . . . . 0.0 109.871 179.275 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 68.69 14.98 9.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.235 -0.916 . . . . 0.0 110.207 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.922 HD13 HG21 ' A' ' 49' ' ' ILE . 15.4 mt -91.79 155.94 43.09 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.07 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' HG13 ' A' ' 49' ' ' ILE . 40.8 Cg_endo -73.23 154.24 51.54 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.889 1.468 . . . . 0.0 110.466 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.0 t -58.53 -10.6 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.32 -0.863 . . . . 0.0 110.777 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -39.51 68.58 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.887 -1.133 . . . . 0.0 107.987 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.964 HG23 HG21 ' A' ' 86' ' ' VAL . 30.3 mm -64.96 -43.61 96.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.001 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.7 mt -63.89 -14.47 53.66 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.365 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 55' ' ' GLU . . . -83.37 -36.1 15.48 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.455 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 5.1 mtm-85 -94.23 -52.34 4.41 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.598 -0.942 . . . . 0.0 109.984 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.653 HG21 HG22 ' A' ' 49' ' ' ILE . 24.3 t -44.18 -50.29 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.59 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.547 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 7.2 t-105 -66.32 -57.68 6.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 0.0 110.174 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.533 ' HG2' ' HG ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER -53.84 -38.52 64.73 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.927 -1.108 . . . . 0.0 109.127 -179.433 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.868 HD22 ' N ' ' A' ' 90' ' ' LEU . 94.4 mt -81.33 -14.88 56.8 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.701 -0.624 . . . . 0.0 109.386 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.948 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 10.7 m -97.78 -35.34 10.57 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.365 -0.834 . . . . 0.0 110.159 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.592 ' HA ' HD23 ' A' ' 65' ' ' LEU . 16.9 t0 -75.32 69.39 2.13 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 58' ' ' ASP . 35.8 mm -35.2 -31.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.056 0.455 . . . . 0.0 111.0 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.541 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 14.7 p-10 -104.73 -16.66 14.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.055 -1.028 . . . . 0.0 111.333 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.541 ' CG ' ' C ' ' A' ' 60' ' ' ASP . 1.7 m-70 58.2 30.59 19.64 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.836 -1.165 . . . . 0.0 109.48 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.475 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 2.5 p-10 -84.32 -11.72 55.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.414 -0.804 . . . . 0.0 110.053 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 116.82 5.34 15.76 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.596 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 3.5 mtp -150.05 160.8 43.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -1.175 . . . . 0.0 110.164 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.833 ' CD1' HG11 ' A' ' 36' ' ' VAL . 16.8 mt -115.57 115.24 26.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.077 -1.015 . . . . 0.0 109.53 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.605 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 3.7 t70 -69.15 171.11 8.83 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.011 -1.055 . . . . 0.0 109.809 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 4.4 ptm180 -46.18 -42.43 14.05 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.63 -0.669 . . . . 0.0 110.658 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.468 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -78.71 -33.98 46.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.0 110.345 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.503 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 28.0 mt-10 -74.53 -43.18 57.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.973 . . . . 0.0 109.2 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.872 ' HE2' HG22 ' A' ' 36' ' ' VAL . 18.3 t80 -61.0 -21.58 63.71 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.483 -0.761 . . . . 0.0 109.327 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.432 ' CB ' ' HG3' ' A' ' 14' ' ' LYS . . . -73.08 -40.86 64.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.345 -0.847 . . . . 0.0 109.45 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.883 HG13 HD12 ' A' ' 94' ' ' LEU . 60.1 t -63.2 -27.04 42.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.513 0.673 . . . . 0.0 109.348 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.948 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.83 -4.84 56.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.528 -0.733 . . . . 0.0 110.862 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.647 ' SD ' HD13 ' A' ' 20' ' ' ILE . 11.3 mmt -84.59 -50.21 7.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.997 -1.065 . . . . 0.0 109.603 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.132 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 1.9 p90 -72.85 -31.62 64.89 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.577 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 9.9 mt -61.46 -31.22 71.17 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.716 HG21 ' CD2' ' A' ' 40' ' ' LEU . 46.0 t -92.16 -42.09 13.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.825 -0.547 . . . . 0.0 110.574 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.36 -40.42 62.12 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.821 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 69.5 m -76.46 -14.78 60.03 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.026 -1.047 . . . . 0.0 109.139 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.826 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -77.66 -11.44 59.87 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.635 HD23 ' N ' ' A' ' 81' ' ' LEU . 4.0 mt -91.12 -50.1 6.03 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.615 0.722 . . . . 0.0 109.949 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 N--CA 1.493 1.722 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.518 -178.225 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.964 HG21 HG23 ' A' ' 49' ' ' ILE . 13.4 t . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 86' ' ' VAL . 44.0 Cg_endo -87.52 -162.17 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.877 1.461 . . . . 0.0 109.73 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.6 mtt -129.31 12.4 6.0 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.26 -0.9 . . . . 0.0 110.945 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 90' ' ' LEU . 22.8 t -165.95 23.54 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.931 -1.106 . . . . 0.0 111.279 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.868 ' N ' HD22 ' A' ' 56' ' ' LEU . 2.1 mt 54.89 116.81 0.01 OUTLIER Pre-proline 0 C--N 1.284 -2.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.012 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.014 ' HG2' HD23 ' A' ' 94' ' ' LEU . 44.3 Cg_endo -72.77 175.02 10.88 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.597 1.314 . . . . 0.0 109.16 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 50.1 Cg_endo -74.34 -19.9 19.09 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.632 1.332 . . . . 0.0 111.67 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.604 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -90.29 28.44 1.44 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.97 -1.081 . . . . 0.0 109.479 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.132 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -127.06 -25.69 3.25 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.822 -178.747 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 95' ' ' VAL . 27.3 m . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.051 -1.03 . . . . 0.0 111.036 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.526 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.1 t90 . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.154 0.502 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -40.62 -27.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 110.525 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.526 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 91.1 t -102.9 138.74 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.87 . . . . 0.0 109.938 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -97.15 -179.91 0.98 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.314 -0.866 . . . . 0.0 110.434 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.3 Cg_endo -69.23 -35.51 14.06 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.934 1.492 . . . . 0.0 110.049 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -75.54 -28.41 59.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.375 -0.828 . . . . 0.0 109.835 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.569 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -83.29 -37.17 23.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.209 -0.932 . . . . 0.0 108.59 178.861 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 13.8 tptp -69.73 -20.16 63.52 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.08 -44.07 63.85 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.606 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 6.5 ptpt -74.51 -24.17 58.94 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.606 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.6 m-30 -74.25 -35.61 63.82 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -76.8 -9.73 58.88 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.302 0.572 . . . . 0.0 110.031 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.74 -34.97 13.01 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.734 HG22 ' CE1' ' A' ' 70' ' ' PHE . 37.6 mt -78.04 -30.18 15.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.823 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -74.44 -39.53 62.51 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.555 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.551 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 32.6 t70 -88.59 4.39 47.09 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.611 -0.681 . . . . 0.0 109.831 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.46 ' C ' HD23 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -90.54 -15.63 30.31 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.769 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.847 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -97.75 -8.0 29.5 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.846 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 84.48 98.21 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.4 Cg_endo -74.27 146.63 36.17 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.056 1.556 . . . . 0.0 110.762 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 27.3 t -116.33 98.57 6.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.505 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 64.97 22.44 12.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.359 -0.838 . . . . 0.0 109.393 -179.124 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 91.97 32.35 8.53 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.521 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 93.8 m-85 -150.23 152.76 35.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.407 -1.055 . . . . 0.0 111.145 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.847 HD22 ' HB2' ' A' ' 24' ' ' LEU . 32.5 mt -124.7 131.85 53.43 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 33' ' ' GLY . 93.9 p -78.19 137.39 38.13 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.272 -0.893 . . . . 0.0 110.43 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.57 -30.86 0.95 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -60.47 -16.24 34.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -1.082 . . . . 0.0 110.318 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.535 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 21.3 mtpp -108.38 -35.3 6.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 109.121 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.899 HG11 HD12 ' A' ' 65' ' ' LEU . 96.8 t -82.77 -31.12 9.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.618 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -50.17 -52.45 53.55 Favored Pre-proline 0 C--N 1.305 -1.363 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.897 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.942 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.6 Cg_endo -64.92 -31.44 56.52 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.581 1.306 . . . . 0.0 109.246 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 4.3 t -74.87 -10.66 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.447 0.642 . . . . 0.0 109.772 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.801 ' HB3' HD22 ' A' ' 50' ' ' LEU . 78.5 mt -100.24 -15.51 18.06 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 38' ' ' PRO . 8.4 mt -88.3 -44.58 10.71 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.569 -0.707 . . . . 0.0 109.486 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 8.2 p-10 -47.83 -25.33 1.25 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.722 -1.191 . . . . 0.0 108.62 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.57 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 12.5 m -61.67 -12.15 14.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.508 -0.745 . . . . 0.0 110.032 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 43' ' ' SER . 3.5 tptp 74.1 18.84 3.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.231 -0.918 . . . . 0.0 109.956 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.835 HD13 HG21 ' A' ' 49' ' ' ILE . 15.4 mt -100.1 158.36 32.16 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 110.087 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.524 ' HG2' HG12 ' A' ' 49' ' ' ILE . 41.5 Cg_endo -73.08 156.54 51.7 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 123.934 1.491 . . . . 0.0 110.647 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 t -58.3 -10.85 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.662 -0.649 . . . . 0.0 110.88 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.58 -41.32 60.72 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.866 -1.146 . . . . 0.0 108.432 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.835 HG21 HD13 ' A' ' 45' ' ' LEU . 11.8 mm -64.24 -44.9 97.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.801 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.8 mt -66.98 -16.99 64.71 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.711 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.29 -32.84 15.56 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.374 -1.891 . . . . 0.0 108.374 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.623 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -92.5 -53.67 4.11 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.517 -0.99 . . . . 0.0 109.526 179.321 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.755 HG11 HG23 ' A' ' 77' ' ' VAL . 32.5 t -47.83 -32.08 2.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.25 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.529 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 8.2 t-105 -74.11 -59.29 2.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.841 . . . . 0.0 110.084 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.561 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 5.0 pt-20 -47.67 -45.62 28.34 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.501 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.926 HD21 ' C ' ' A' ' 88' ' ' MET . 2.7 mt -75.91 -11.74 60.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.579 -0.7 . . . . 0.0 109.57 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . 1.025 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 2.8 t -99.28 -36.11 9.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.634 -0.666 . . . . 0.0 110.758 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.469 ' HA ' HD23 ' A' ' 65' ' ' LEU . 26.9 t0 -82.61 86.63 6.79 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.483 -0.76 . . . . 0.0 109.454 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.474 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 32.1 mm -51.55 -36.24 17.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.75 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 3.5 m-20 -90.33 -17.05 28.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.538 -0.726 . . . . 0.0 110.566 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 33.1 p80 40.25 39.77 0.71 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.816 0.817 . . . . 0.0 109.23 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -98.17 -9.65 25.39 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.754 -0.591 . . . . 0.0 110.192 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.479 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 126.57 4.39 6.29 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 6.0 mtp -149.54 160.72 43.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.093 -1.24 . . . . 0.0 110.491 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.899 HD12 HG11 ' A' ' 36' ' ' VAL . 34.1 mt -112.49 112.25 23.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.583 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.536 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 17.3 t0 -69.62 166.93 17.99 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.895 -1.128 . . . . 0.0 110.106 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.541 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -42.16 -44.45 3.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.528 -0.732 . . . . 0.0 111.012 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 8.7 p-10 -78.02 -43.01 30.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.368 -0.832 . . . . 0.0 110.162 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.536 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 33.7 mt-10 -61.64 -48.99 78.34 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.656 -0.653 . . . . 0.0 109.779 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.777 ' HE2' HG22 ' A' ' 36' ' ' VAL . 43.5 t80 -58.94 -26.22 64.21 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.395 -0.815 . . . . 0.0 109.373 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -67.22 -45.99 75.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.647 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 1.022 HG13 HD12 ' A' ' 94' ' ' LEU . 88.3 t -60.45 -23.04 27.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.542 -0.723 . . . . 0.0 110.018 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.025 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -89.73 -5.33 57.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.291 -0.88 . . . . 0.0 110.932 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.581 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 1.6 mmm -89.33 -44.86 9.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.999 -1.063 . . . . 0.0 110.038 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.091 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.5 p90 -76.24 -25.22 54.8 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.746 ' HB3' HG13 ' A' ' 53' ' ' VAL . 4.8 mt -69.99 -28.33 65.44 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.755 HG23 HG11 ' A' ' 53' ' ' VAL . 53.6 t -89.35 -29.59 5.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.658 ' HA ' HD12 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -79.53 -25.08 41.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.428 -0.795 . . . . 0.0 110.524 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -87.08 -10.65 52.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 110.172 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.767 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.54 -20.16 30.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.354 -0.841 . . . . 0.0 109.658 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.658 HD12 ' HA ' ' A' ' 78' ' ' TYR . 1.3 mt -92.35 -36.47 13.14 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.556 0.693 . . . . 0.0 110.694 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 . . . . . 0 C--N 1.299 -1.622 0 C-N-CA 119.525 -0.87 . . . . 0.0 108.792 -179.361 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.58 HG11 HG23 ' A' ' 53' ' ' VAL . 24.3 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.705 0.288 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.644 ' O ' HD11 ' A' ' 56' ' ' LEU . 47.0 Cg_endo -89.24 -164.94 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.935 1.492 . . . . 0.0 109.344 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.926 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -123.61 6.12 8.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.368 -0.833 . . . . 0.0 110.253 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.599 ' N ' HD21 ' A' ' 56' ' ' LEU . 55.1 m -105.65 98.44 8.13 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 119.114 -1.034 . . . . 0.0 111.294 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.731 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -54.96 107.14 0.78 Allowed Pre-proline 0 C--N 1.293 -1.866 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.753 179.256 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.057 ' HG2' HD23 ' A' ' 94' ' ' LEU . 42.5 Cg_endo -68.75 162.69 40.17 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.995 1.523 . . . . 0.0 109.984 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.435 ' O ' HG22 ' A' ' 95' ' ' VAL . 43.2 Cg_endo -69.97 -13.35 34.04 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.825 1.434 . . . . 0.0 111.149 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -89.04 19.92 3.92 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.011 -1.055 . . . . 0.0 109.308 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.091 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 1.9 mm? -121.03 -13.61 8.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.469 -0.769 . . . . 0.0 110.451 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 95' ' ' VAL . 30.6 m . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 0.0 111.119 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.605 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.8 t90 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 121.362 0.601 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -59.24 -25.72 64.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 110.285 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.605 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 18.8 t -95.07 160.35 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.575 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -108.32 171.32 4.63 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.069 -1.019 . . . . 0.0 110.491 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.11 -34.48 10.17 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.231 1.648 . . . . 0.0 109.53 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -78.76 -28.98 44.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.578 -0.702 . . . . 0.0 109.349 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.539 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 1.6 m-20 -81.11 -34.22 32.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.456 -0.777 . . . . 0.0 108.913 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 67' ' ' ARG . 16.2 tptt -72.35 -19.98 61.55 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.604 0.716 . . . . 0.0 109.225 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.87 -41.7 61.81 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.622 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.49 -26.09 60.75 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.577 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.622 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.3 m-30 -74.34 -38.34 63.28 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 3.1 t70 -73.17 -12.35 60.85 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.279 0.561 . . . . 0.0 110.207 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.61 -32.77 13.27 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.702 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.253 42.3 mt -78.34 -28.76 14.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.895 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.972 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.7 -37.77 65.08 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.6 t70 -90.29 1.65 56.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.697 -0.627 . . . . 0.0 109.926 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.427 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.4 t -91.89 -2.74 56.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 108.658 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.975 HD12 HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -112.7 -3.51 14.25 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.47 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.6 t 80.3 96.9 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.9 Cg_endo -71.29 147.31 52.94 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 O-C-N 124.427 1.751 . . . . 0.0 110.548 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 43.0 t -118.05 101.66 12.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 22.0 t-20 57.98 30.78 19.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.859 . . . . 0.0 109.624 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.488 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 85.79 34.72 12.69 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.586 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 93.7 m-85 -151.11 153.83 35.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -1.162 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.975 HD13 HD12 ' A' ' 24' ' ' LEU . 24.2 mt -124.68 122.95 38.95 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.675 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.551 ' CA ' ' HE3' ' A' ' 64' ' ' MET . 0.7 OUTLIER -72.92 139.99 47.18 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.612 0.72 . . . . 0.0 111.108 -178.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -46.39 -25.3 1.94 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -58.55 -33.67 70.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -1.104 . . . . 0.0 110.281 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.562 ' HD3' ' CA ' ' A' ' 31' ' ' LEU . 5.1 ptmt -99.96 -28.19 13.21 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.874 0.845 . . . . 0.0 109.714 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.69 HG11 HD12 ' A' ' 65' ' ' LEU . 72.1 t -80.73 -48.37 19.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 CA-C-O 121.444 0.64 . . . . 0.0 109.629 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.61 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.25 -51.98 7.74 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.462 -0.774 . . . . 0.0 110.493 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.809 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.6 Cg_endo -66.28 -33.06 40.36 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 108.889 -1.235 . . . . 0.0 108.889 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.893 HG21 HD22 ' A' ' 24' ' ' LEU . 2.7 t -72.36 -12.23 15.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.949 ' HB3' HD22 ' A' ' 50' ' ' LEU . 90.4 mt -97.85 -16.87 19.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 38' ' ' PRO . 92.5 mt -78.92 -36.41 41.92 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.56 -0.713 . . . . 0.0 109.286 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 8.2 p-10 -46.42 -23.87 0.43 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.552 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 1.034 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -73.93 6.34 3.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.566 -0.709 . . . . 0.0 111.091 -179.405 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.26 15.36 1.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.755 -1.215 . . . . 0.0 110.051 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.028 HD13 HG21 ' A' ' 49' ' ' ILE . 15.3 mt -93.59 158.76 36.18 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.117 -0.99 . . . . 0.0 109.856 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.556 ' HD2' HG13 ' A' ' 49' ' ' ILE . 41.4 Cg_endo -72.87 157.39 51.66 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.978 1.515 . . . . 0.0 110.294 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.6 t -59.66 -11.24 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 110.706 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.03 -36.49 69.67 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.915 -1.116 . . . . 0.0 108.18 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.028 HG21 HD13 ' A' ' 45' ' ' LEU . 32.6 mm -68.51 -45.2 82.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.949 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.6 mt -65.55 -20.39 66.31 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.486 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . -85.2 -30.02 26.43 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.527 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 16.0 ttm-85 -93.03 -55.43 3.35 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.467 -1.019 . . . . 0.0 109.562 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.826 HG11 HG23 ' A' ' 77' ' ' VAL . 39.4 t -49.76 -38.45 13.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.103 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.532 ' HA ' ' HB2' ' A' ' 57' ' ' SER . 8.6 t-105 -64.93 -56.67 11.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 109.3 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 68.5 mm-40 -44.52 -55.3 5.23 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.484 -0.76 . . . . 0.0 109.977 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.886 HD11 ' HA ' ' A' ' 88' ' ' MET . 4.7 mt -70.75 -10.5 59.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 0.0 109.913 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.856 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 17.4 m -96.15 -37.43 10.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 110.118 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.659 ' HA ' HD23 ' A' ' 65' ' ' LEU . 13.5 t0 -77.61 70.48 3.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.358 -0.839 . . . . 0.0 109.27 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 58' ' ' ASP . 45.2 mm -39.95 -31.73 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.637 -0.664 . . . . 0.0 110.789 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 62' ' ' ASP . 0.6 OUTLIER -98.79 -23.48 15.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.369 -0.832 . . . . 0.0 110.6 -178.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 78.2 m80 57.41 49.62 12.68 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.189 -0.944 . . . . 0.0 110.545 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.487 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 5.7 p-10 -111.97 0.99 16.22 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.041 -1.037 . . . . 0.0 110.286 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 112.43 2.43 26.04 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.551 ' HE3' ' CA ' ' A' ' 32' ' ' SER . 5.0 mtp -149.1 160.06 43.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.991 -1.299 . . . . 0.0 110.616 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.69 HD12 HG11 ' A' ' 36' ' ' VAL . 70.8 mt -111.69 115.24 28.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.551 -0.718 . . . . 0.0 109.948 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.586 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 7.0 t0 -69.18 164.18 23.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.892 -1.13 . . . . 0.0 109.733 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.54 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 1.7 ptt180 -37.76 -42.28 0.57 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.677 -0.64 . . . . 0.0 111.512 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.54 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -84.74 -33.02 23.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.211 -0.931 . . . . 0.0 110.888 -179.202 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 24.3 mt-10 -69.72 -42.65 73.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 109.368 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.702 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 50.5 t80 -64.14 -28.88 70.06 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.559 -0.713 . . . . 0.0 109.178 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -61.73 -48.95 78.41 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.774 0.797 . . . . 0.0 109.964 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 1.014 ' CG1' HD11 ' A' ' 94' ' ' LEU . 70.7 t -59.25 -24.03 26.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.685 -0.634 . . . . 0.0 110.424 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.856 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -86.71 -8.7 57.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.156 -0.965 . . . . 0.0 112.003 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.602 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 12.0 mmm -90.08 -40.5 12.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.639 -1.288 . . . . 0.0 110.489 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.519 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.6 p90 -78.19 -19.02 54.72 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.789 -1.165 . . . . 0.0 108.374 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.675 HD22 HG13 ' A' ' 86' ' ' VAL . 9.2 mt -80.91 -23.63 38.82 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.468 0.652 . . . . 0.0 109.48 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.826 HG23 HG11 ' A' ' 53' ' ' VAL . 70.1 t -91.65 -32.16 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.529 -0.732 . . . . 0.0 110.3 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.539 ' HA ' HD12 ' A' ' 81' ' ' LEU . 1.2 m-85 -80.04 -24.18 40.91 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.184 -0.947 . . . . 0.0 110.417 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 79.3 m -86.66 -13.76 44.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.256 -0.903 . . . . 0.0 109.395 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.841 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -76.69 -18.95 58.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.08 -1.012 . . . . 0.0 108.743 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.034 HD21 ' O ' ' A' ' 43' ' ' SER . 1.9 mt -92.41 -48.63 6.55 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.516 0.674 . . . . 0.0 111.471 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 82' ' ' GLU . 3.4 tp10 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 112.359 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.675 HG13 HD22 ' A' ' 76' ' ' LEU . 72.1 t . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.605 0.24 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.585 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.2 Cg_endo -80.43 -173.83 2.01 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.756 1.398 . . . . 0.0 109.617 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.886 ' HA ' HD11 ' A' ' 56' ' ' LEU . 20.1 mtm -114.68 20.98 14.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 0.0 110.347 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.496 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 69.0 m -111.18 103.89 12.36 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.696 -1.201 . . . . 0.0 111.434 -178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.8 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.1 mt -59.16 108.15 1.24 Allowed Pre-proline 0 C--N 1.293 -1.856 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.734 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 89' ' ' SER . 43.2 Cg_endo -68.77 141.9 50.85 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.948 1.499 . . . . 0.0 110.549 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.64 -4.54 14.83 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.027 1.54 . . . . 0.0 110.72 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -92.9 8.53 39.29 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.397 -0.814 . . . . 0.0 109.357 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.014 HD11 ' CG1' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -127.92 -7.8 5.5 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.589 0.709 . . . . 0.0 110.136 -178.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.491 1.58 0 O-C-N 120.888 -1.133 . . . . 0.0 110.721 -179.791 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.511 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.8 t90 . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.666 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -40.64 -27.49 0.05 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 0.0 109.889 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.511 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 10.0 t -103.73 128.26 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.424 -0.797 . . . . 0.0 109.534 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.517 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.0 mttt -82.2 178.98 2.11 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.933 . . . . 0.0 110.156 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.6 Cg_endo -71.24 -35.12 9.01 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.01 1.532 . . . . 0.0 109.908 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 2.0 pt-20 -81.07 -19.89 42.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.423 -0.798 . . . . 0.0 109.446 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.515 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 0.3 OUTLIER -81.91 -39.89 23.13 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.202 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.01 -14.85 59.36 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.82 -37.49 55.6 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.634 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -77.24 -22.82 51.63 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.628 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 13.3 m-30 -77.32 -33.71 55.53 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -70.78 -8.82 55.21 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.319 0.58 . . . . 0.0 110.004 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.57 -34.64 14.66 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.509 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 34.0 mt -81.78 -30.11 10.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.59 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -74.14 -34.76 63.97 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.759 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.56 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.6 t70 -89.18 -4.5 58.22 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.676 -0.64 . . . . 0.0 110.213 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.59 -2.69 58.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 108.986 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.668 ' HB2' HD22 ' A' ' 31' ' ' LEU . 3.2 mt -107.14 -12.15 15.46 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.2 t 83.89 87.94 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 44.9 Cg_endo -71.21 150.92 60.19 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 O-C-N 124.739 1.915 . . . . 0.0 110.331 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 28.7 t -116.05 107.48 22.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.65 -0.656 . . . . 0.0 109.802 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 14.5 t-20 55.81 21.06 4.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.379 -0.825 . . . . 0.0 109.52 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 96.16 37.56 4.84 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 92.5 m-85 -150.89 159.94 44.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -1.141 . . . . 0.0 111.227 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.668 HD22 ' HB2' ' A' ' 24' ' ' LEU . 27.0 mt -137.77 129.68 28.68 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.591 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 2.7 p -75.01 137.88 41.83 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.421 -0.8 . . . . 0.0 110.871 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -43.91 -25.03 0.57 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' SER . 80.1 m-20 -65.15 -16.21 63.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.284 -1.127 . . . . 0.0 109.855 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 21.8 mtpp -105.12 -38.92 6.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.128 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.707 HG11 HD12 ' A' ' 65' ' ' LEU . 88.7 t -76.39 -33.18 22.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.544 0.688 . . . . 0.0 109.208 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.7 tttp -48.79 -56.04 17.05 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.724 -0.61 . . . . 0.0 110.228 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.711 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.5 Cg_endo -64.93 -28.4 58.22 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.73 1.384 . . . . 0.0 109.093 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.664 HG21 ' CD2' ' A' ' 24' ' ' LEU . 3.5 t -78.71 -11.01 13.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.3 0.571 . . . . 0.0 109.932 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.938 ' HB3' HD22 ' A' ' 50' ' ' LEU . 71.7 mt -101.08 -18.22 16.33 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.185 -0.947 . . . . 0.0 108.554 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.711 HD12 ' HA ' ' A' ' 38' ' ' PRO . 15.3 mt -85.14 -41.62 15.51 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.615 -0.678 . . . . 0.0 109.717 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 8.5 p-10 -50.19 -22.72 1.82 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.694 -1.202 . . . . 0.0 108.807 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.541 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 35.1 m -64.15 -7.27 8.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.623 -0.673 . . . . 0.0 110.615 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.4 OUTLIER 72.82 10.07 5.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.219 -0.925 . . . . 0.0 109.932 -179.605 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.091 HD13 HG21 ' A' ' 49' ' ' ILE . 13.0 mt -90.41 158.82 42.76 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.401 -0.812 . . . . 0.0 110.14 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.558 ' HD2' HG13 ' A' ' 49' ' ' ILE . 41.8 Cg_endo -75.72 167.21 26.82 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.992 1.522 . . . . 0.0 109.908 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.416 ' O ' HG12 ' A' ' 47' ' ' VAL . 43.8 t -69.2 -5.81 5.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.419 -0.801 . . . . 0.0 110.508 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.89 -39.79 34.07 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.183 -0.948 . . . . 0.0 108.547 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.091 HG21 HD13 ' A' ' 45' ' ' LEU . 27.8 mm -66.96 -44.08 88.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.938 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.5 mt -66.32 -17.0 64.5 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.072 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 55' ' ' GLU . . . -87.5 -29.75 20.85 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.667 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -93.57 -55.61 3.21 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.509 -0.994 . . . . 0.0 109.374 179.493 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.755 HG11 HG23 ' A' ' 77' ' ' VAL . 36.5 t -49.94 -55.33 5.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.535 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 6.6 t-105 -50.37 -56.85 9.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.517 -0.74 . . . . 0.0 110.37 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.501 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -49.97 -45.96 52.0 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.415 -179.176 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.736 HD21 ' C ' ' A' ' 88' ' ' MET . 2.5 mt -76.81 -8.57 57.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.659 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.891 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -99.34 -39.86 8.2 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.397 -0.814 . . . . 0.0 109.663 179.194 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.571 ' HA ' HD23 ' A' ' 65' ' ' LEU . 30.4 t0 -75.52 86.02 2.62 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.494 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 30.6 mm -49.36 -34.23 7.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.128 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 35.9 p-10 -103.47 -9.97 18.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.998 -1.064 . . . . 0.0 111.354 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.477 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 68.1 m80 55.63 41.62 30.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.953 -1.092 . . . . 0.0 109.517 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.46 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 3.4 p-10 -101.34 16.24 26.23 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.622 -0.674 . . . . 0.0 110.133 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.93 10.9 84.46 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.591 ' HG2' ' HA ' ' A' ' 32' ' ' SER . 5.0 mtt -142.31 160.3 40.53 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.389 -1.065 . . . . 0.0 110.638 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.707 HD12 HG11 ' A' ' 36' ' ' VAL . 44.0 mt -126.19 119.19 26.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.389 -0.82 . . . . 0.0 109.836 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 4.7 t0 -73.9 166.54 23.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.81 -1.181 . . . . 0.0 109.685 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.491 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -42.22 -46.07 4.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.227 -0.92 . . . . 0.0 110.229 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -73.46 -46.76 46.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.523 -0.736 . . . . 0.0 110.342 -179.441 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.516 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 14.4 mt-10 -60.56 -41.65 94.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.383 -0.823 . . . . 0.0 109.34 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.59 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 18.8 t80 -60.71 -30.13 69.77 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -64.12 -44.1 93.25 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.782 0.801 . . . . 0.0 110.046 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.999 HG13 HD11 ' A' ' 94' ' ' LEU . 63.4 t -61.11 -28.58 44.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.591 0.71 . . . . 0.0 110.289 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' A' ' 57' ' ' SER . . . -84.93 -6.93 59.34 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.478 -0.764 . . . . 0.0 111.559 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.594 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 9.4 mmm -90.23 -43.08 10.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.307 -1.496 . . . . 0.0 110.465 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.601 ' CZ ' HD13 ' A' ' 94' ' ' LEU . 2.9 p90 -76.92 -15.37 59.69 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.985 -1.086 . . . . 0.0 108.683 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.569 ' HB3' HG13 ' A' ' 53' ' ' VAL . 10.0 mt -85.3 -25.62 27.08 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.476 -0.765 . . . . 0.0 108.979 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.755 HG23 HG11 ' A' ' 53' ' ' VAL . 19.0 t -91.06 -28.51 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.006 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.88 -25.18 37.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.247 -0.908 . . . . 0.0 110.365 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -85.49 -13.04 50.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.956 . . . . 0.0 109.519 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.892 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.1 -9.54 52.94 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.384 -0.823 . . . . 0.0 109.119 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.803 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.5 mt -90.33 -45.26 9.14 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.825 0.822 . . . . 0.0 109.063 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.299 -1.608 0 C-N-CA 120.189 -0.605 . . . . 0.0 109.8 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.604 HG21 ' CG2' ' A' ' 53' ' ' VAL . 97.3 t . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.749 0.309 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.635 ' O ' HD11 ' A' ' 56' ' ' LEU . 45.9 Cg_endo -87.02 -171.89 0.83 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.021 1.537 . . . . 0.0 109.179 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.736 ' C ' HD21 ' A' ' 56' ' ' LEU . 18.5 mtm -114.64 7.11 15.92 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.992 -1.067 . . . . 0.0 110.162 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.2 m -111.94 100.64 9.05 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.791 -1.163 . . . . 0.0 111.861 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.756 HD23 HD23 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -46.54 108.53 0.85 Allowed Pre-proline 0 C--N 1.289 -2.032 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.492 178.576 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.455 ' HD2' ' CD2' ' A' ' 94' ' ' LEU . 38.3 Cg_endo -64.75 146.58 88.71 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.899 1.473 . . . . 0.0 110.676 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.82 -11.61 27.84 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.161 1.611 . . . . 0.0 111.565 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.666 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -93.89 24.25 4.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.03 -1.044 . . . . 0.0 108.651 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.999 HD11 HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -141.75 -3.33 1.14 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.797 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.492 1.655 0 O-C-N 120.803 -1.186 . . . . 0.0 110.665 -179.829 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.589 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 17.2 t90 . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.536 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -41.98 -26.97 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 110.089 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.589 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 79.1 t -109.99 124.74 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.0 109.913 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.467 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -86.15 174.36 5.67 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.322 -0.861 . . . . 0.0 110.36 -179.731 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.0 Cg_endo -66.19 -35.94 30.71 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.009 1.531 . . . . 0.0 109.787 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.39 -24.23 61.22 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.357 -0.84 . . . . 0.0 109.242 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -82.69 -42.08 18.54 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -72.27 -15.86 61.91 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.154 178.921 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.82 -33.34 70.59 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -82.33 -43.79 17.01 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.3 m-30 -61.68 -17.77 56.92 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -87.1 -18.1 31.29 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.802 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.404 ' O ' ' OG ' ' A' ' 23' ' ' SER . . . -90.77 -30.61 16.93 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.708 HG22 ' CE1' ' A' ' 70' ' ' PHE . 27.0 mt -79.62 -32.62 14.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.546 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -69.47 -41.33 76.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.51 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.526 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.8 t70 -86.75 2.69 47.88 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.332 0.587 . . . . 0.0 109.842 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.485 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.4 m -93.3 0.13 56.88 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.834 HD12 HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -113.65 -0.62 14.26 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.468 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 p 77.23 89.9 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 CA-C-O 121.568 0.699 . . . . 0.0 109.119 -178.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.526 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 53.4 Cg_endo -74.21 146.99 36.95 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.113 1.586 . . . . 0.0 110.314 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 98.1 t -114.49 103.55 15.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER 61.89 21.52 12.35 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.189 -0.944 . . . . 0.0 108.933 -178.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.552 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 91.78 33.05 8.09 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 37.9 m-85 -142.74 156.94 45.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -1.108 . . . . 0.0 111.606 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.834 HD13 HD12 ' A' ' 24' ' ' LEU . 37.6 mt -133.35 132.67 41.55 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.546 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.1 OUTLIER -84.49 149.5 25.9 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.342 -0.849 . . . . 0.0 111.22 -178.871 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -50.68 -21.99 5.32 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.03 -8.63 55.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.236 . . . . 0.0 110.136 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 5.0 mtpp -114.25 -42.1 3.39 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.925 0.869 . . . . 0.0 109.148 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.991 HG11 HD12 ' A' ' 65' ' ' LEU . 46.7 t -80.73 -47.44 20.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.528 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.626 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.7 tttp -43.37 -48.37 17.3 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.535 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.896 ' HA ' HD12 ' A' ' 41' ' ' LEU . 39.9 Cg_endo -68.07 -35.59 19.54 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.335 1.176 . . . . 0.0 109.155 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.649 HG21 HD22 ' A' ' 24' ' ' LEU . 2.3 t -64.06 -31.12 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.386 0.613 . . . . 0.0 109.414 178.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.897 ' HB3' HD22 ' A' ' 50' ' ' LEU . 20.9 mt -79.8 -16.95 54.51 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 109.016 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.896 HD12 ' HA ' ' A' ' 38' ' ' PRO . 75.9 mt -76.38 -24.69 54.14 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.41 ' OD1' ' O ' ' A' ' 38' ' ' PRO . 16.6 m120 -67.78 -15.98 63.9 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.452 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.43 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -72.55 -0.25 12.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.544 -0.722 . . . . 0.0 110.422 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.88 18.75 10.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.111 -0.993 . . . . 0.0 109.343 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.049 HD13 HG21 ' A' ' 49' ' ' ILE . 14.5 mt -96.34 160.58 29.39 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.631 -0.668 . . . . 0.0 110.009 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HG2' HG12 ' A' ' 49' ' ' ILE . 41.7 Cg_endo -74.29 161.94 39.46 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.878 1.462 . . . . 0.0 109.461 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 t -63.17 -9.24 4.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.379 -0.825 . . . . 0.0 110.177 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 3.0 t70 -73.52 -39.12 65.04 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.049 HG21 HD13 ' A' ' 45' ' ' LEU . 20.8 mm -70.41 -47.98 62.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.897 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.0 mt -66.07 -22.12 66.4 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.58 -28.34 29.94 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.538 ' HD3' ' N ' ' A' ' 88' ' ' MET . 3.8 ttm180 -95.72 -58.38 2.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.467 -1.02 . . . . 0.0 109.464 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.808 HG11 HG23 ' A' ' 77' ' ' VAL . 39.0 t -46.8 -29.19 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.785 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.5 ' O ' ' N ' ' A' ' 57' ' ' SER . 18.4 t-105 -74.19 -59.54 2.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.744 -0.598 . . . . 0.0 110.058 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -46.01 -42.18 12.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 109.722 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.905 HD21 ' C ' ' A' ' 88' ' ' MET . 1.5 mt -78.9 -17.23 55.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.385 -0.822 . . . . 0.0 109.276 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.965 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.3 t -92.41 -35.71 13.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.543 -0.723 . . . . 0.0 110.076 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.469 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 24.7 t0 -78.71 77.16 5.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.467 -0.771 . . . . 0.0 109.291 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.528 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 35.6 mm -40.72 -31.82 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.362 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 2.9 m-20 -96.24 -27.03 15.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.335 -0.853 . . . . 0.0 110.557 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.444 ' CB ' ' O ' ' A' ' 60' ' ' ASP . 28.0 m-70 64.74 45.43 3.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.076 -1.015 . . . . 0.0 109.274 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -114.32 -2.74 13.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 110.582 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.31 -0.94 34.97 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.546 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 2.4 mtt -129.35 155.94 44.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.323 -1.104 . . . . 0.0 110.312 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.991 HD12 HG11 ' A' ' 36' ' ' VAL . 11.0 mt -122.56 121.15 35.82 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.312 -0.867 . . . . 0.0 110.969 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 1.1 m-20 -80.47 155.81 26.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.151 -0.968 . . . . 0.0 108.932 178.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.546 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 11.1 ptt180 -40.14 -31.71 0.14 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 0.0 111.491 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.483 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 81.5 m-20 -85.71 -31.53 22.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.038 -1.039 . . . . 0.0 109.839 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.528 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 54.8 mt-10 -77.41 -42.39 36.39 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.767 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 43.5 t80 -57.68 -32.65 67.55 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.504 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -60.63 -53.69 54.43 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.584 0.707 . . . . 0.0 110.302 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.945 HG13 HD11 ' A' ' 94' ' ' LEU . 80.8 t -53.53 -26.74 13.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.525 -0.734 . . . . 0.0 110.242 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.965 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -87.68 -11.16 49.18 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.117 -0.989 . . . . 0.0 112.673 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.58 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 9.0 mmm -86.65 -43.42 12.64 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.342 -1.474 . . . . 0.0 111.036 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.645 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 2.0 p90 -76.83 -23.26 52.76 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.632 -1.227 . . . . 0.0 108.244 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.774 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.5 mt -76.0 -21.76 56.55 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.38 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.808 HG23 HG11 ' A' ' 53' ' ' VAL . 75.5 t -90.93 -26.46 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.373 -0.83 . . . . 0.0 109.766 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -89.49 -23.14 22.15 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.335 -0.853 . . . . 0.0 109.271 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 30.3 m -82.44 -13.31 56.98 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.39 -0.819 . . . . 0.0 108.9 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.622 ' C ' HD23 ' A' ' 81' ' ' LEU . . . -89.31 -11.14 44.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.393 -0.817 . . . . 0.0 108.974 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.814 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.6 mt -90.82 -43.51 10.01 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.677 0.751 . . . . 0.0 109.563 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 C--N 1.299 -1.595 0 C-N-CA 119.909 -0.717 . . . . 0.0 109.608 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.642 HG11 ' CG2' ' A' ' 53' ' ' VAL . 69.5 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.623 0.249 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.593 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.3 Cg_endo -89.32 145.67 5.07 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.869 1.457 . . . . 0.0 109.394 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.905 ' C ' HD21 ' A' ' 56' ' ' LEU . 1.2 ptt? -75.33 5.08 6.08 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.029 -1.044 . . . . 0.0 111.526 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.56 ' N ' HD21 ' A' ' 56' ' ' LEU . 58.2 m -98.57 104.56 16.6 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 118.821 -1.152 . . . . 0.0 112.24 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.668 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -44.48 104.99 0.41 Allowed Pre-proline 0 C--N 1.299 -1.617 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.418 178.155 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.517 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 39.4 Cg_endo -67.0 139.9 52.74 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.774 1.407 . . . . 0.0 110.624 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.38 -6.44 19.17 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.066 1.561 . . . . 0.0 111.095 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -97.09 19.06 13.52 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.945 HD11 HG13 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -151.42 13.03 0.65 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.758 0.79 . . . . 0.0 110.142 -178.657 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.5 p . . . . . 0 C--N 1.299 -1.63 0 O-C-N 120.645 -1.284 . . . . 0.0 110.038 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.483 0.864 0 CA-C-O 121.513 0.547 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.861 ' HE1' HD22 ' A' ' 94' ' ' LEU . 15.5 t90 -73.96 130.94 40.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.519 -0.738 . . . . 0.0 110.04 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -44.94 -27.74 0.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 110.342 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.605 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 16.3 t -89.84 137.57 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.209 -0.932 . . . . 0.0 110.116 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 5.4 mttt -92.81 168.29 12.72 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.666 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 38.3 Cg_endo -65.9 -34.56 38.68 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.638 1.336 . . . . 0.0 109.763 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.67 -25.05 60.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.345 -0.847 . . . . 0.0 109.252 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -83.95 -38.36 21.12 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.769 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -67.78 -17.45 64.54 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.453 -0.78 . . . . 0.0 109.192 179.071 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.16 -40.43 27.34 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.64 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 3.7 ptmt -79.23 -24.1 43.29 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.64 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.0 m-30 -75.07 -35.68 61.83 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -76.68 -11.73 59.89 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.261 0.553 . . . . 0.0 110.182 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -94.82 -34.33 12.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.66 HG22 ' CE1' ' A' ' 70' ' ' PHE . 21.4 mt -75.78 -32.68 24.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.718 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -68.15 -37.98 81.63 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.498 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 13.6 t70 -89.75 1.72 55.75 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.546 -0.721 . . . . 0.0 109.966 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -92.81 0.13 57.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 108.65 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.056 HD22 HG21 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -113.85 -2.12 13.72 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER 82.69 89.81 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.8 Cg_endo -75.29 150.85 37.52 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 124.352 1.711 . . . . 0.0 110.721 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 98.8 t -117.59 96.9 4.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.561 -0.712 . . . . 0.0 109.505 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 25.9 t-20 56.93 20.49 5.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.923 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.55 32.28 3.98 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 90.7 m-85 -149.98 158.6 44.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.194 -1.18 . . . . 0.0 111.378 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.988 HD13 HD12 ' A' ' 24' ' ' LEU . 40.5 mt -135.21 132.51 37.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.555 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 9.2 p -80.66 140.23 35.77 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.445 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.47 -26.38 0.38 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 32' ' ' SER . 8.4 t0 -62.77 -16.37 57.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -1.159 . . . . 0.0 110.378 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 17.5 mttm -107.58 -42.2 4.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.237 -0.914 . . . . 0.0 109.298 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.931 HG11 HD12 ' A' ' 65' ' ' LEU . 64.9 t -74.31 -35.66 40.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.835 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.581 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 14.3 tttp -49.4 -54.59 28.64 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 110.229 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 1.051 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.5 Cg_endo -65.09 -30.29 56.0 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.493 1.26 . . . . 0.0 108.997 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.056 HG21 HD22 ' A' ' 24' ' ' LEU . 4.3 t -76.4 -10.32 13.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.361 0.601 . . . . 0.0 109.741 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.783 ' HB3' HD22 ' A' ' 50' ' ' LEU . 68.5 mt -100.86 -16.09 17.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.051 HD12 ' HA ' ' A' ' 38' ' ' PRO . 7.7 mt -87.16 -40.69 14.37 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.51 -0.744 . . . . 0.0 109.575 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 7.4 p-10 -52.34 -20.81 2.99 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.068 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.544 ' CA ' HD21 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -66.95 -6.15 15.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.579 -0.701 . . . . 0.0 110.085 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.3 OUTLIER 72.43 9.5 5.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.865 . . . . 0.0 109.96 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.026 HD13 HG21 ' A' ' 49' ' ' ILE . 14.9 mt -91.58 157.16 42.4 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 110.322 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.2 Cg_endo -74.47 164.35 34.15 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.138 1.599 . . . . 0.0 110.191 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.83 -8.75 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 110.159 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.84 -40.23 63.45 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.053 -1.029 . . . . 0.0 108.309 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.026 HG21 HD13 ' A' ' 45' ' ' LEU . 10.3 mm -68.34 -47.72 76.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.783 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.4 mt -62.62 -17.38 60.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -88.72 -33.67 9.82 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.504 ' HD2' ' O ' ' A' ' 87' ' ' PRO . 16.7 ttm-85 -91.77 -55.78 3.34 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.461 -1.023 . . . . 0.0 109.321 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.858 HG11 HG23 ' A' ' 77' ' ' VAL . 24.7 t -47.64 -58.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.37 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.489 ' HB3' ' O ' ' A' ' 50' ' ' LEU . 7.7 t-105 -47.35 -54.85 10.07 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.686 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 17.8 mm-40 -47.39 -51.9 18.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 110.02 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.687 HD21 ' C ' ' A' ' 88' ' ' MET . 2.6 mt -74.57 -7.65 53.81 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.317 -0.864 . . . . 0.0 109.642 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.893 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -100.53 -36.23 9.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.418 -0.801 . . . . 0.0 110.269 179.481 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.543 ' HA ' HD23 ' A' ' 65' ' ' LEU . 36.3 t0 -79.31 71.89 5.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.441 -0.787 . . . . 0.0 109.495 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.689 HG23 ' HD3' ' A' ' 99' ' ' LYS . 36.8 mm -40.16 -33.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.622 -0.674 . . . . 0.0 110.658 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -93.22 -27.59 16.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.946 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.546 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 14.4 m-70 64.67 45.2 3.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.21 -0.931 . . . . 0.0 110.762 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.495 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 2.6 p-10 -113.38 20.88 15.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 110.787 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.53 0.66 89.33 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.555 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 3.3 mtt -130.81 160.26 34.92 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.293 -1.122 . . . . 0.0 110.314 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.931 HD12 HG11 ' A' ' 36' ' ' VAL . 21.3 mt -126.97 114.27 17.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 110.542 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 8.9 t70 -69.74 172.96 6.74 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.142 -0.974 . . . . 0.0 109.395 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.573 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 5.2 ptt180 -55.42 -31.72 62.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 110.768 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.78 -32.54 19.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.089 -1.007 . . . . 0.0 109.778 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 28.0 mt-10 -78.16 -39.3 41.4 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.264 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.804 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 62.6 t80 -65.61 -27.56 68.49 Favored 'General case' 0 C--N 1.303 -1.457 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.865 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.38 -45.44 87.7 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.796 0.808 . . . . 0.0 109.685 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.893 HG13 HD21 ' A' ' 94' ' ' LEU . 48.1 t -61.64 -20.29 22.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.333 0.587 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.893 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.36 -11.12 41.56 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 111.65 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.569 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 5.7 mmm -89.1 -41.52 12.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.699 -1.251 . . . . 0.0 110.385 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.584 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 1.8 p90 -78.97 -23.29 44.63 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.046 -1.061 . . . . 0.0 108.55 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.799 ' HB3' HG13 ' A' ' 53' ' ' VAL . 6.1 mt -74.61 -23.64 58.75 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.858 HG23 HG11 ' A' ' 53' ' ' VAL . 55.6 t -91.03 -59.03 3.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.485 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.5 m-85 -47.85 -22.73 0.6 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.796 -0.565 . . . . 0.0 111.567 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -83.74 -16.85 43.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.882 -1.136 . . . . 0.0 110.048 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.953 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -86.8 -14.18 42.96 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.325 -0.859 . . . . 0.0 109.484 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.754 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.7 mp -86.65 -40.4 15.15 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 7.6 tt0 -72.93 -54.51 8.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.376 0.608 . . . . 0.0 109.858 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 13.2 tttt 177.95 -23.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.342 -0.849 . . . . 0.0 111.598 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -78.69 113.79 37.94 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 120.977 -1.077 . . . . 0.0 111.318 -178.661 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.31 -170.6 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.794 1.418 . . . . 0.0 109.597 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.757 HG13 HD22 ' A' ' 76' ' ' LEU . 76.5 t -136.98 127.83 16.31 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.972 -1.08 . . . . 0.0 110.699 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.618 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.8 Cg_endo -83.3 -167.52 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.999 1.526 . . . . 0.0 109.359 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.687 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -117.63 9.95 13.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.109 -0.994 . . . . 0.0 110.405 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.492 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 90.5 p -108.28 107.2 17.69 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.307 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.606 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -55.71 107.1 0.78 Allowed Pre-proline 0 C--N 1.294 -1.808 0 C-N-CA 120.061 -0.655 . . . . 0.0 109.811 178.634 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.547 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 41.6 Cg_endo -73.67 149.31 43.21 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.744 1.392 . . . . 0.0 110.606 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.537 ' HA ' ' CG1' ' A' ' 95' ' ' VAL . 48.3 Cg_endo -72.5 -3.98 14.44 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.224 1.644 . . . . 0.0 111.85 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -94.66 -23.37 17.62 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.072 -1.018 . . . . 0.0 109.225 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.969 HD22 ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -98.21 -14.38 20.36 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.786 0.803 . . . . 0.0 109.255 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.539 ' CG2' ' HB3' ' A' ' 99' ' ' LYS . 8.9 p -87.95 136.51 32.28 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.081 -1.012 . . . . 0.0 110.519 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.446 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 44.3 Cg_endo -72.47 173.28 13.45 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.016 1.535 . . . . 0.0 110.133 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.572 ' HA ' ' CD ' ' A' ' 100' ' ' ARG . 47.4 Cg_endo -72.62 -2.64 12.13 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.972 1.512 . . . . 0.0 110.575 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.58 -18.23 36.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.197 -0.939 . . . . 0.0 109.834 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.689 ' HD3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -89.71 -0.81 57.77 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.3 -0.875 . . . . 0.0 109.498 179.127 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.572 ' CD ' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.355 -0.841 . . . . 0.0 109.909 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 N--CA 1.483 0.876 0 N-CA-C 110.293 -0.695 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.511 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.3 t90 -87.1 119.04 26.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 110.103 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.907 ' HB3' HD12 ' A' ' 94' ' ' LEU . . . -41.66 -29.53 0.19 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.511 -0.743 . . . . 0.0 109.831 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.552 HG22 ' CD2' ' A' ' 75' ' ' PHE . 92.3 t -92.08 158.59 2.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.548 -0.72 . . . . 0.0 109.865 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.527 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 6.0 mttt -126.36 178.09 1.68 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.952 . . . . 0.0 110.13 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.657 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 40.0 Cg_endo -66.67 -36.48 24.82 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.913 1.481 . . . . 0.0 110.141 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -69.88 -36.23 75.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 109.101 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -83.54 -33.43 25.47 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 10' ' ' LYS . 16.4 tptp -78.64 -20.64 49.86 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -68.05 -41.9 81.34 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.626 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.7 ptpt -72.9 -31.81 64.92 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.626 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -66.59 -38.31 86.75 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 62.8 t0 -68.99 -11.1 60.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.672 -0.643 . . . . 0.0 110.331 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -96.39 -34.45 11.54 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.674 HG22 ' CE2' ' A' ' 70' ' ' PHE . 26.5 mt -78.35 -31.57 16.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.546 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -68.3 -37.98 81.16 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.605 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.529 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.1 t70 -90.41 0.99 57.05 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.625 -0.672 . . . . 0.0 109.916 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -92.72 2.71 56.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 108.77 178.792 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.055 HD22 HG21 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -115.6 -1.67 12.68 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER 79.52 87.0 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.416 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -73.87 147.46 39.31 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 124.446 1.761 . . . . 0.0 110.666 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 34.6 t -114.37 105.94 19.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 14.1 t-20 55.49 23.71 6.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -0.983 . . . . 0.0 109.284 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 91.77 37.36 6.11 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 86.4 m-85 -149.92 158.03 43.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -1.098 . . . . 0.0 111.233 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.77 HD22 ' HB2' ' A' ' 24' ' ' LEU . 12.0 mt -136.4 133.15 36.41 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.555 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -79.63 140.74 37.0 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.414 -0.804 . . . . 0.0 110.408 -179.427 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.52 -25.54 0.85 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 32' ' ' SER . 4.8 t70 -68.37 -9.07 45.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -1.173 . . . . 0.0 110.237 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HD2' ' OG ' ' A' ' 32' ' ' SER . 4.6 mtpp -114.05 -43.35 3.25 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.886 0.851 . . . . 0.0 109.348 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.972 HG11 ' CD1' ' A' ' 65' ' ' LEU . 85.8 t -76.94 -46.21 29.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.78 -0.575 . . . . 0.0 110.266 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.6 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 39.0 tttt -46.19 -49.23 42.47 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 110.796 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.913 ' HA ' HD12 ' A' ' 41' ' ' LEU . 41.4 Cg_endo -68.58 -34.93 18.37 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 N-CA-C 108.918 -1.224 . . . . 0.0 108.918 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.055 HG21 HD22 ' A' ' 24' ' ' LEU . 2.4 t -62.72 -25.21 37.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.93 ' HB3' HD22 ' A' ' 50' ' ' LEU . 20.0 mt -84.02 -15.84 46.14 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.408 -0.807 . . . . 0.0 109.173 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.913 HD12 ' HA ' ' A' ' 38' ' ' PRO . 16.0 mt -76.44 -28.13 56.48 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -63.51 -15.63 58.43 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.472 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.559 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -72.68 -1.54 16.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.504 -0.748 . . . . 0.0 110.155 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 43' ' ' SER . 7.8 ttpt 68.73 18.15 8.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -0.865 . . . . 0.0 109.925 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.024 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.8 mt -100.11 162.05 22.24 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.387 -0.821 . . . . 0.0 110.375 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.9 Cg_endo -74.14 166.18 30.18 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.106 1.582 . . . . 0.0 110.288 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 t -66.65 -7.52 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.404 -0.81 . . . . 0.0 110.22 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -40.93 59.6 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.958 HG21 HD13 ' A' ' 45' ' ' LEU . 21.5 mm -64.91 -44.87 96.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.93 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.8 mt -65.74 -17.88 64.93 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.335 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -87.92 -30.57 17.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.598 ' O ' HD12 ' A' ' 56' ' ' LEU . 4.1 ttm180 -92.73 -56.27 3.07 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.403 -1.057 . . . . 0.0 109.45 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.049 HG11 HG23 ' A' ' 77' ' ' VAL . 41.0 t -46.6 -39.82 4.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.281 -0.968 . . . . 0.0 109.058 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.517 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 18.5 t-105 -65.51 -60.35 3.03 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.814 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 4.1 mm-40 -44.25 -54.68 5.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 109.826 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 90' ' ' LEU . 1.7 mt -69.9 -9.94 56.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.393 -0.817 . . . . 0.0 109.662 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 1.097 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 3.1 t -100.52 -32.75 10.63 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.442 -0.786 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.483 ' OD2' ' HA ' ' A' ' 61' ' ' HIS . 22.7 t0 -80.07 76.43 6.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.305 -0.872 . . . . 0.0 110.21 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.51 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 41.6 mm -45.96 -32.56 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.482 -0.761 . . . . 0.0 109.833 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 22.7 m-20 -95.8 -21.73 17.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.539 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.483 ' HA ' ' OD2' ' A' ' 58' ' ' ASP . 75.7 m80 57.38 48.47 14.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 109.563 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.455 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 1.7 p-10 -117.64 6.57 12.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.404 -0.81 . . . . 0.0 110.376 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.83 8.85 59.0 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.555 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 5.9 mtt -141.85 160.63 39.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -1.147 . . . . 0.0 110.89 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.972 ' CD1' HG11 ' A' ' 36' ' ' VAL . 35.9 mt -130.18 120.66 24.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.379 -0.826 . . . . 0.0 109.986 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 2.0 p30 -79.45 166.33 22.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.885 -1.135 . . . . 0.0 110.036 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.523 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 9.6 ptt180 -36.97 -46.83 0.67 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.456 -0.778 . . . . 0.0 111.596 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 63.1 m-20 -79.91 -33.9 39.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.139 -0.976 . . . . 0.0 110.381 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.567 ' HG2' HD23 ' A' ' 65' ' ' LEU . 13.1 tt0 -67.94 -50.75 54.12 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.346 -0.847 . . . . 0.0 109.785 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.71 ' CE1' HG13 ' A' ' 36' ' ' VAL . 62.5 t80 -56.0 -27.42 52.84 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.11 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -62.63 -47.33 84.2 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.564 0.697 . . . . 0.0 110.103 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.717 HG13 ' HG ' ' A' ' 94' ' ' LEU . 96.2 t -59.67 -24.48 29.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.501 -0.75 . . . . 0.0 109.875 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.097 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -88.39 -6.48 57.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.26 -0.9 . . . . 0.0 111.605 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.572 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 8.7 mmm -90.17 -42.77 10.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.383 -1.448 . . . . 0.0 110.332 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.7 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.0 p90 -76.44 -22.58 54.46 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.965 -1.094 . . . . 0.0 108.339 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 72' ' ' VAL . 14.9 mt -73.7 -28.36 61.69 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.049 HG23 HG11 ' A' ' 53' ' ' VAL . 41.2 t -92.09 -56.4 5.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.732 -0.605 . . . . 0.0 109.551 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.603 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -53.31 -18.85 2.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.416 -0.802 . . . . 0.0 110.812 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 84' ' ' GLU . 11.7 m -86.13 -16.94 36.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.933 . . . . 0.0 109.945 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.024 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.82 -11.91 52.21 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.191 -0.943 . . . . 0.0 109.564 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.624 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.2 mp -87.52 -43.78 11.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.377 -0.827 . . . . 0.0 109.222 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.6 OUTLIER -69.78 -51.63 32.2 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.23 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 3.9 tttm 177.41 -25.53 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.018 . . . . 0.0 111.613 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 79' ' ' CYS . 2.4 mm-40 -76.89 112.3 21.69 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.045 -1.034 . . . . 0.0 111.124 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 84' ' ' GLU . 42.6 Cg_endo -69.59 -171.69 0.48 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.854 1.449 . . . . 0.0 110.191 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.621 HG21 ' CG2' ' A' ' 53' ' ' VAL . 53.3 t -126.81 119.41 22.6 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.114 -0.991 . . . . 0.0 110.981 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.575 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.4 Cg_endo -83.14 176.5 7.41 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.921 1.485 . . . . 0.0 109.724 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.653 ' C ' HD21 ' A' ' 56' ' ' LEU . 31.7 mtp -103.21 15.81 28.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.091 -1.006 . . . . 0.0 110.345 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.591 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 75.7 m -114.06 105.33 13.09 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.954 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.709 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -82.25 106.13 5.91 Favored Pre-proline 0 C--N 1.289 -2.046 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.592 ' HD2' HD22 ' A' ' 94' ' ' LEU . 40.5 Cg_endo -66.36 158.83 53.17 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.906 1.477 . . . . 0.0 110.244 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.19 -15.59 31.81 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.882 1.464 . . . . 0.0 110.312 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -72.47 -7.5 50.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.907 HD12 ' HB3' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -90.5 -28.36 18.61 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.62 -0.675 . . . . 0.0 110.122 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.557 ' CG1' ' HB2' ' A' ' 99' ' ' LYS . 46.3 t -68.83 136.53 89.99 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.481 -0.762 . . . . 0.0 111.098 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.477 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 45.3 Cg_endo -72.09 174.77 10.82 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.112 1.585 . . . . 0.0 110.152 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.564 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 44.4 Cg_endo -72.4 -9.87 24.76 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.817 1.43 . . . . 0.0 110.762 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.7 p -74.61 -26.0 59.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.114 -0.991 . . . . 0.0 109.912 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.557 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -89.42 7.53 35.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.418 -0.801 . . . . 0.0 109.539 179.414 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.274 -0.891 . . . . 0.0 110.45 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.483 0.858 0 N-CA-C 110.54 -0.6 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.584 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 13.9 t90 -90.76 131.43 36.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 0.0 109.843 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.885 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -41.43 -33.21 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.596 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.584 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 55.4 t -98.38 122.89 50.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.357 -0.839 . . . . 0.0 110.142 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.557 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 2.0 mtmt -91.26 -177.28 0.73 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 110.107 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.557 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 43.2 Cg_endo -71.24 -36.26 7.39 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.811 1.427 . . . . 0.0 110.242 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.78 -24.16 58.63 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.314 -0.866 . . . . 0.0 109.302 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -86.5 -37.04 18.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.309 -0.869 . . . . 0.0 108.914 179.029 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -18.42 59.38 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.31 -39.53 71.36 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.732 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -75.19 -19.02 60.03 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.781 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 13.0 m-30 -82.83 -30.25 28.86 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -76.6 -11.3 59.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.718 -0.614 . . . . 0.0 110.053 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.47 -33.66 15.12 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.732 HD12 ' O ' ' A' ' 16' ' ' LYS . 6.9 mt -80.38 -29.03 12.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.628 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -75.51 -35.46 60.76 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.002 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.56 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -89.48 -1.92 58.2 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.594 -0.691 . . . . 0.0 109.88 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.44 -6.02 56.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 109.206 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.646 ' HB2' HD22 ' A' ' 31' ' ' LEU . 1.9 mt -108.35 -9.82 15.41 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.5 m 83.16 92.21 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.8 Cg_endo -73.05 148.52 44.98 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.351 1.711 . . . . 0.0 110.577 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.473 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 28.3 t -111.94 113.14 43.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.441 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER 46.04 25.09 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.835 . . . . 0.0 109.719 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.46 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 96.8 34.58 5.67 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.634 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 85.0 m-85 -151.55 153.8 35.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.085 -1.244 . . . . 0.0 111.72 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.666 HD23 ' HD2' ' A' ' 35' ' ' LYS . 41.7 mt -123.15 127.95 49.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 35' ' ' LYS . 60.1 p -65.84 137.96 57.56 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.862 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.619 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -48.28 -26.97 5.18 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.66 -14.65 58.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -1.124 . . . . 0.0 109.633 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.666 ' HD2' HD23 ' A' ' 31' ' ' LEU . 21.0 ttmm -91.88 -39.55 11.66 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.944 HG11 HD12 ' A' ' 65' ' ' LEU . 89.7 t -83.1 -31.05 8.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.437 0.637 . . . . 0.0 110.098 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.639 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -39.86 -51.28 5.55 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.535 -0.728 . . . . 0.0 111.122 -179.282 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 36.7 Cg_endo -63.02 -31.05 76.74 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.425 1.223 . . . . 0.0 109.841 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 36' ' ' VAL . 2.9 t -74.46 -14.92 16.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.628 -0.67 . . . . 0.0 109.866 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.938 ' HB3' HD22 ' A' ' 50' ' ' LEU . 66.9 mt -97.41 -23.93 15.85 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.295 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 38' ' ' PRO . 2.5 mt -87.74 -34.2 18.43 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.188 -0.945 . . . . 0.0 110.063 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 39' ' ' VAL . 3.8 p-10 -65.6 -9.95 31.39 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.579 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.468 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 2.3 m -79.77 7.72 8.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 110.475 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 64.75 16.76 10.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.125 -0.984 . . . . 0.0 110.489 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.997 HD13 HG21 ' A' ' 49' ' ' ILE . 14.5 mt -97.0 153.81 38.41 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 109.967 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.6 Cg_endo -74.79 163.64 35.25 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.998 1.525 . . . . 0.0 110.467 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.6 t -64.77 -8.43 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.718 . . . . 0.0 110.513 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -76.3 -41.18 49.48 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.997 HG21 HD13 ' A' ' 45' ' ' LEU . 23.0 mm -65.03 -44.93 95.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.938 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.9 mt -61.97 -18.42 60.35 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.35 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.67 -31.16 19.27 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.782 ' C ' HD12 ' A' ' 56' ' ' LEU . 1.2 mtm180 -94.95 -55.38 3.11 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.43 -1.041 . . . . 0.0 109.455 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.798 HG23 HG21 ' A' ' 86' ' ' VAL . 30.0 t -49.08 -42.69 14.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.246 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.619 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 14.6 t-105 -65.55 -58.57 5.46 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.138 -0.976 . . . . 0.0 109.513 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.583 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 5.2 mm-40 -51.43 -33.45 30.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.995 . . . . 0.0 109.142 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.917 ' O ' HD11 ' A' ' 90' ' ' LEU . 6.7 mt -86.01 -15.27 41.94 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.493 -0.754 . . . . 0.0 109.343 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.989 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 50.4 m -100.16 -29.54 12.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.484 -0.76 . . . . 0.0 110.396 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 42.1 t0 -85.45 66.62 9.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.275 -0.891 . . . . 0.0 109.842 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 58' ' ' ASP . 42.0 mm -40.36 -29.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.485 0.659 . . . . 0.0 110.22 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 6.3 t0 -89.33 -28.51 19.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.362 -0.836 . . . . 0.0 110.826 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.583 ' CE1' ' O ' ' A' ' 55' ' ' GLU . 87.7 m-70 56.32 50.59 12.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.084 -1.01 . . . . 0.0 110.083 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 63' ' ' GLY . 5.3 p-10 -118.79 -10.11 10.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 110.409 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' N ' ' OD1' ' A' ' 62' ' ' ASP . . . 116.61 8.69 12.07 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.586 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 15.4 mtp -142.7 160.87 39.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -1.148 . . . . 0.0 110.228 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.944 HD12 HG11 ' A' ' 36' ' ' VAL . 13.0 mt -120.77 105.6 10.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.286 -0.884 . . . . 0.0 109.767 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.634 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 1.8 t70 -72.58 171.66 12.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.879 -1.138 . . . . 0.0 110.258 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.486 ' N ' ' CG ' ' A' ' 66' ' ' ASP . 16.2 ptp180 -45.71 -39.84 8.58 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.771 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.446 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 30.8 t0 -81.77 -31.79 31.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.195 -0.94 . . . . 0.0 110.458 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.478 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 27.5 mt-10 -77.95 -42.06 34.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.215 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.72 ' CE1' HG22 ' A' ' 20' ' ' ILE . 44.0 t80 -66.72 -28.06 68.12 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.536 -0.727 . . . . 0.0 109.376 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.473 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -65.72 -51.98 54.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 110.018 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.894 ' O ' HD12 ' A' ' 76' ' ' LEU . 93.2 t -55.65 -21.79 10.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.537 -0.727 . . . . 0.0 110.281 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.989 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.49 -14.61 32.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.219 -0.925 . . . . 0.0 111.766 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.628 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 7.0 mmm -80.18 -41.8 24.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.744 -1.223 . . . . 0.0 109.924 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.6 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.7 p90 -77.74 -22.34 50.45 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.894 HD12 ' O ' ' A' ' 72' ' ' VAL . 6.6 mt -75.95 -30.76 58.78 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.673 0.749 . . . . 0.0 109.126 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.629 HG23 HG11 ' A' ' 53' ' ' VAL . 44.4 t -90.19 -20.19 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.6 -0.688 . . . . 0.0 109.867 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.4 OUTLIER -90.56 -23.0 21.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.453 -0.779 . . . . 0.0 109.655 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.479 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.6 m -86.25 -17.98 33.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.446 -0.784 . . . . 0.0 109.731 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.973 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -83.91 -9.36 58.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.434 -0.791 . . . . 0.0 109.177 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.791 ' N ' HD23 ' A' ' 81' ' ' LEU . 2.0 mt -89.59 -45.93 9.02 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.714 0.769 . . . . 0.0 109.227 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 46.8 mt-10 -70.02 -52.91 20.27 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.645 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 1.2 tttt 178.44 -28.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.809 -0.756 . . . . 0.0 111.115 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 79' ' ' CYS . 14.0 mt-10 -68.59 111.84 9.39 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.168 -0.958 . . . . 0.0 111.106 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 46.7 Cg_endo -75.38 -165.47 0.29 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.895 1.471 . . . . 0.0 110.224 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.798 HG21 HG23 ' A' ' 53' ' ' VAL . 60.0 t -114.65 149.85 42.99 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.359 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.558 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 44.8 Cg_endo -80.19 -165.01 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.61 1.321 . . . . 0.0 110.063 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.07 3.16 17.17 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 111.114 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -177.74 29.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.745 -1.222 . . . . 0.0 111.674 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.917 HD11 ' O ' ' A' ' 56' ' ' LEU . 9.6 mt 57.65 120.49 0.01 OUTLIER Pre-proline 0 C--N 1.285 -2.226 0 O-C-N 121.96 -0.463 . . . . 0.0 110.509 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.07 ' HG2' HD23 ' A' ' 94' ' ' LEU . 40.0 Cg_endo -70.28 176.86 6.59 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 123.641 1.338 . . . . 0.0 109.15 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 40.2 Cg_endo -65.65 -9.72 23.78 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.558 1.294 . . . . 0.0 111.894 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.658 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -98.64 4.18 47.94 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.049 -1.032 . . . . 0.0 110.604 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.07 HD23 ' HG2' ' A' ' 91' ' ' PRO . 4.2 mm? -117.35 38.57 3.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.011 -1.056 . . . . 0.0 111.295 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.694 ' O ' HG13 ' A' ' 95' ' ' VAL . 8.8 p -146.85 115.74 4.43 Favored Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 120.91 -1.119 . . . . 0.0 110.603 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.451 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 44.7 Cg_endo -72.48 174.18 12.02 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.827 1.435 . . . . 0.0 110.038 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.577 ' O ' ' CB ' ' A' ' 98' ' ' SER . 44.3 Cg_endo -71.88 173.47 12.71 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.952 1.501 . . . . 0.0 110.33 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.577 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 1.3 m 80.7 -32.45 0.12 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.951 -0.468 . . . . 0.0 110.123 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 48.2 tptt -89.0 -0.0 57.04 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.073 -1.017 . . . . 0.0 108.537 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.411 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.483 0.875 0 N-CA-C 110.039 -0.793 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.787 ' HE1' HD22 ' A' ' 94' ' ' LEU . 11.1 t90 -71.21 115.68 10.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.001 -1.062 . . . . 0.0 109.486 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -41.14 -27.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.0 109.787 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.475 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 38.0 t -99.51 149.02 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.438 -0.789 . . . . 0.0 109.69 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.6 mttt -111.48 173.36 2.91 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 110.02 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.8 Cg_endo -68.94 -34.51 17.29 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.835 1.44 . . . . 0.0 109.404 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 10.5 pt-20 -80.21 -26.7 39.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.47 -0.768 . . . . 0.0 109.646 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 1.6 m-20 -83.34 -41.38 18.29 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -69.06 -16.99 63.83 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.455 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.11 -42.42 72.69 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.629 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -70.68 -27.63 64.17 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -69.38 -37.48 77.58 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.22 -10.37 57.43 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.426 0.631 . . . . 0.0 109.969 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -92.79 -34.55 13.83 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.726 HG22 ' CE1' ' A' ' 70' ' ' PHE . 15.8 mt -80.97 -28.46 11.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.85 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.68 -36.01 60.2 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.585 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.541 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.4 t70 -88.65 -2.17 58.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.667 -0.646 . . . . 0.0 109.712 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 29.5 t -91.3 0.91 57.44 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.053 HD22 HG21 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -113.12 -5.51 13.71 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.593 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 82.63 86.58 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.092 0 CA-C-O 121.131 0.491 . . . . 0.0 109.827 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.541 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -73.53 147.4 40.78 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 O-C-N 124.418 1.746 . . . . 0.0 110.903 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -115.89 111.83 37.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.633 -0.667 . . . . 0.0 109.242 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 54.52 20.52 2.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 109.468 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . 95.58 32.68 6.8 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.613 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 94.5 m-85 -146.32 158.96 43.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.432 -1.04 . . . . 0.0 110.643 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.95 HD22 ' HB2' ' A' ' 24' ' ' LEU . 16.5 mt -136.77 128.7 29.28 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.58 -0.7 . . . . 0.0 109.177 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.541 ' OG ' ' CE ' ' A' ' 64' ' ' MET . 0.7 OUTLIER -74.49 137.41 42.51 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.273 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.34 -32.38 1.16 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 38' ' ' PRO . 72.0 m-20 -53.38 -24.44 12.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -1.142 . . . . 0.0 110.027 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 12.1 mttm -103.3 -44.61 5.12 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.019 0.914 . . . . 0.0 109.072 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.086 HG11 HD12 ' A' ' 65' ' ' LEU . 40.2 t -76.63 -49.13 24.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 O-C-N 121.81 -0.556 . . . . 0.0 110.467 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.594 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 14.7 ttpt -43.17 -50.2 14.95 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.484 -0.887 . . . . 0.0 110.801 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.884 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.8 Cg_endo -67.05 -34.49 28.62 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 N-CA-C 109.108 -1.151 . . . . 0.0 109.108 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.053 HG21 HD22 ' A' ' 24' ' ' LEU . 2.3 t -65.15 -23.83 34.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.016 ' HB3' HD22 ' A' ' 50' ' ' LEU . 16.4 mt -86.33 -15.06 41.73 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.392 -0.817 . . . . 0.0 109.203 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.884 HD12 ' HA ' ' A' ' 38' ' ' PRO . 27.8 mt -77.97 -26.85 48.96 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -62.55 -13.9 36.19 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.623 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.532 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -78.63 2.13 20.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.563 -0.711 . . . . 0.0 110.327 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 43' ' ' SER . 1.7 mtpt 63.53 15.6 8.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -0.902 . . . . 0.0 110.362 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.036 HD13 HG21 ' A' ' 49' ' ' ILE . 13.6 mt -94.82 162.54 24.99 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.143 -0.973 . . . . 0.0 109.915 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.519 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.1 Cg_endo -73.99 164.91 33.34 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.013 1.533 . . . . 0.0 110.957 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 t -64.96 -9.1 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.502 -0.749 . . . . 0.0 109.776 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -72.48 -41.31 66.17 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.036 HG21 HD13 ' A' ' 45' ' ' LEU . 20.3 mm -64.2 -47.49 89.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.016 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.3 mt -65.6 -23.11 66.75 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.632 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.498 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -86.03 -30.78 22.12 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HD3' ' HG2' ' A' ' 88' ' ' MET . 13.7 ttm180 -91.52 -54.95 3.68 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.506 -0.996 . . . . 0.0 109.667 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.851 ' CG2' HG21 ' A' ' 86' ' ' VAL . 26.7 t -49.67 -42.89 18.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.993 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.556 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 16.3 t-105 -61.86 -58.19 8.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.831 . . . . 0.0 111.05 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 17.0 mt-10 -51.6 -36.9 47.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.883 -1.136 . . . . 0.0 109.607 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.018 HD22 ' N ' ' A' ' 90' ' ' LEU . 18.5 mt -90.07 -8.44 51.45 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.516 0.674 . . . . 0.0 109.485 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 1.042 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 4.6 t -100.11 -30.29 12.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.448 -0.783 . . . . 0.0 108.916 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.539 ' HA ' HD23 ' A' ' 65' ' ' LEU . 13.3 t0 -84.65 68.25 10.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.485 -0.759 . . . . 0.0 109.631 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.612 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 35.5 mm -37.4 -29.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.266 0.555 . . . . 0.0 110.471 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.539 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 76.4 m-20 -90.68 -25.66 19.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 111.31 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.612 ' CE1' ' O ' ' A' ' 59' ' ' ILE . 1.6 m-70 59.71 26.46 15.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.883 -1.136 . . . . 0.0 108.913 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.428 ' OD2' ' HG3' ' A' ' 64' ' ' MET . 3.9 p-10 -90.82 -24.25 20.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.524 -0.735 . . . . 0.0 110.665 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.38 4.35 4.48 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.7 mtp -145.2 161.16 40.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.002 -1.293 . . . . 0.0 110.313 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.086 HD12 HG11 ' A' ' 36' ' ' VAL . 33.5 mt -115.82 112.16 21.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -0.844 . . . . 0.0 109.984 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.613 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 4.9 p30 -76.08 165.05 25.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.799 -1.188 . . . . 0.0 110.019 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.618 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -39.41 -40.31 0.8 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.458 -0.776 . . . . 0.0 111.741 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 1.4 t0 -80.28 -36.28 34.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.979 -1.075 . . . . 0.0 110.563 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.519 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 44.0 mt-10 -76.17 -41.62 49.15 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.186 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.813 ' CE2' HG13 ' A' ' 36' ' ' VAL . 35.3 t80 -61.82 -25.46 67.52 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -66.56 -51.09 60.29 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.943 0.877 . . . . 0.0 109.648 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.926 HG22 HD21 ' A' ' 94' ' ' LEU . 60.5 t -55.12 -23.88 13.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.358 0.599 . . . . 0.0 110.382 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.042 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -89.86 -10.85 43.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 111.815 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.577 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 7.9 mmm -85.09 -48.06 9.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.639 -1.288 . . . . 0.0 110.121 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.574 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -72.65 -21.52 61.07 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 72' ' ' VAL . 9.6 mt -73.79 -32.79 63.94 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.723 HG21 HD22 ' A' ' 40' ' ' LEU . 70.5 t -91.42 -25.54 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.535 -0.728 . . . . 0.0 110.504 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.5 OUTLIER -86.81 -27.01 23.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.742 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 60.1 m -80.29 -19.05 47.54 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.421 -0.799 . . . . 0.0 108.857 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.843 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -82.15 -7.97 59.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.475 -0.766 . . . . 0.0 109.344 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.54 ' N ' HD23 ' A' ' 81' ' ' LEU . 6.4 mt -90.25 -47.6 7.67 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.566 0.698 . . . . 0.0 110.026 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 2.7 pp20? -77.44 -40.44 43.31 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.924 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.488 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 0.2 OUTLIER 177.94 -37.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.594 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.2 OUTLIER -72.79 111.15 10.16 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 120.98 -1.075 . . . . 0.0 111.333 -178.305 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 48.8 Cg_endo -74.77 -169.64 0.65 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.76 1.4 . . . . 0.0 110.101 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.851 HG21 ' CG2' ' A' ' 53' ' ' VAL . 41.6 t -112.87 152.15 44.62 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.264 -0.898 . . . . 0.0 109.017 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.744 ' HD2' HG13 ' A' ' 86' ' ' VAL . 44.9 Cg_endo -85.93 -165.94 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.662 1.348 . . . . 0.0 109.791 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.48 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 5.7 mtt -129.68 18.87 5.68 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.623 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 33.3 t -161.14 23.74 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.268 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 1.018 ' N ' HD22 ' A' ' 56' ' ' LEU . 2.4 mt 61.7 118.48 0.02 OUTLIER Pre-proline 0 C--N 1.283 -2.324 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.54 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.624 ' O ' HG23 ' A' ' 95' ' ' VAL . 41.8 Cg_endo -76.08 146.35 28.85 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.792 1.417 . . . . 0.0 110.005 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.04 -1.03 8.03 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.736 1.624 . . . . 0.0 112.09 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -99.9 -20.53 16.1 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.05 -1.031 . . . . 0.0 109.854 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.975 HD22 ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -101.82 -13.9 17.5 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.588 0.709 . . . . 0.0 109.497 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.856 HG22 HD22 ' A' ' 90' ' ' LEU . 95.4 t -86.22 124.14 70.6 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.938 -1.101 . . . . 0.0 110.676 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 46.3 Cg_endo -73.99 172.14 16.51 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.892 1.469 . . . . 0.0 110.449 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.42 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 46.1 Cg_endo -73.23 -11.35 24.95 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.068 1.562 . . . . 0.0 110.381 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -25.49 67.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.917 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -90.4 9.32 29.51 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.347 -0.846 . . . . 0.0 109.591 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.42 -0.8 . . . . 0.0 110.133 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 N--CA 1.482 0.802 0 N-CA-C 110.339 -0.677 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.599 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 15.5 t90 -65.79 133.7 51.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.878 . . . . 0.0 109.811 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.733 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -41.11 -31.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.405 -0.809 . . . . 0.0 110.413 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.599 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 70.4 t -94.45 131.44 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.401 -0.812 . . . . 0.0 109.976 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.532 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 18.0 mttt -95.12 -179.43 0.95 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.846 . . . . 0.0 110.162 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.1 Cg_endo -69.79 -37.32 9.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.903 1.475 . . . . 0.0 110.187 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -71.18 -24.64 62.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 109.664 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.582 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -83.0 -41.8 18.28 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 2.4 tppt? -66.48 -20.17 65.97 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.68 -0.637 . . . . 0.0 109.363 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.7 -42.66 60.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.375 -0.828 . . . . 0.0 109.064 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.625 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -79.14 -26.15 42.83 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.436 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.5 m-30 -71.85 -34.47 69.27 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 8.0 m-20 -81.07 -10.6 59.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.717 -0.614 . . . . 0.0 109.88 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -93.58 -35.45 12.89 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.558 HG21 ' SD ' ' A' ' 74' ' ' MET . 51.3 mt -76.47 -36.9 29.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.582 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -64.13 -36.59 84.52 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.773 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.549 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -90.24 -0.11 57.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.749 -0.595 . . . . 0.0 109.991 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 22.8 t -91.33 0.51 57.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.215 -0.928 . . . . 0.0 109.046 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.968 HD22 HG21 ' A' ' 39' ' ' VAL . 1.2 mt -109.06 -6.61 15.57 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.578 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER 80.29 83.55 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.549 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 42.7 Cg_endo -69.11 149.98 71.63 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 O-C-N 124.65 1.868 . . . . 0.0 110.357 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.3 t -113.16 103.92 16.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.339 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 24.7 t-20 59.19 21.9 10.04 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.479 -0.763 . . . . 0.0 109.374 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.493 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 93.01 39.2 5.24 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.493 ' CD2' ' C ' ' A' ' 29' ' ' GLY . 82.3 m-85 -150.12 159.56 44.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.428 -1.042 . . . . 0.0 111.302 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.679 HD13 HD12 ' A' ' 24' ' ' LEU . 46.1 mt -133.22 131.4 40.29 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.561 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 18.2 p -79.06 141.48 37.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.548 -0.72 . . . . 0.0 110.929 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.612 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -49.76 -24.44 6.0 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.26 -11.95 59.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.419 -1.048 . . . . 0.0 109.66 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.65 ' HD2' HD23 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -97.73 -46.28 6.04 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.316 1.055 . . . . 0.0 108.778 179.305 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.633 HG11 HD12 ' A' ' 65' ' ' LEU . 98.3 t -78.45 -33.07 16.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.069 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.575 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -40.68 -54.85 4.89 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.443 -0.786 . . . . 0.0 110.952 -178.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.995 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.2 Cg_endo -64.24 -31.05 64.19 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.557 1.293 . . . . 0.0 109.332 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.968 HG21 HD22 ' A' ' 24' ' ' LEU . 3.4 t -73.38 -8.41 11.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.721 -0.612 . . . . 0.0 109.363 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.871 ' HB3' HD22 ' A' ' 50' ' ' LEU . 42.3 mt -99.87 -16.42 18.04 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 108.541 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.995 HD12 ' HA ' ' A' ' 38' ' ' PRO . 4.7 mt -89.03 -41.56 12.26 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.501 -0.75 . . . . 0.0 109.785 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 8.0 p-10 -49.82 -22.04 1.32 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.226 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.561 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -68.7 -5.31 19.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.362 -0.836 . . . . 0.0 110.085 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 73.68 8.89 4.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.378 -0.826 . . . . 0.0 110.378 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.054 HD13 HG21 ' A' ' 49' ' ' ILE . 14.3 mt -84.48 155.48 62.63 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 109.769 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.551 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.3 Cg_endo -74.38 162.83 37.57 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.789 1.415 . . . . 0.0 110.753 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.9 t -62.63 -10.58 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.57 -0.706 . . . . 0.0 110.816 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.41 -41.01 57.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.934 -1.104 . . . . 0.0 108.353 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.054 HG21 HD13 ' A' ' 45' ' ' LEU . 27.8 mm -64.11 -44.87 97.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.871 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.6 mt -60.23 -18.19 46.9 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.49 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -84.57 -31.74 23.77 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.479 ' CD ' ' O ' ' A' ' 87' ' ' PRO . 9.8 mtm180 -94.97 -55.26 3.15 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.494 -1.003 . . . . 0.0 109.844 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.646 HG23 HG21 ' A' ' 86' ' ' VAL . 17.2 t -44.83 -39.3 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.642 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.612 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 13.0 t-105 -74.38 -59.02 2.92 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.973 -1.08 . . . . 0.0 110.331 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 65.3 mm-40 -51.38 -30.13 17.96 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.086 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.844 HD22 ' N ' ' A' ' 90' ' ' LEU . 46.8 mt -90.41 -14.78 32.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.57 -0.706 . . . . 0.0 109.496 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.991 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 12.7 m -98.98 -27.81 13.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.476 -0.765 . . . . 0.0 109.642 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 59' ' ' ILE . 13.8 t0 -81.76 69.1 8.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.289 -0.882 . . . . 0.0 109.565 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.689 HG23 ' HD2' ' A' ' 99' ' ' LYS . 39.3 mm -40.48 -30.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.511 0.672 . . . . 0.0 109.877 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.451 ' OD2' ' HB3' ' A' ' 62' ' ' ASP . 0.8 OUTLIER -96.15 -28.73 14.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.61 -0.681 . . . . 0.0 109.999 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ASP . 15.6 m80 61.71 46.5 7.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.164 -0.96 . . . . 0.0 110.644 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.451 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 3.1 p-10 -112.66 16.85 19.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 110.265 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.37 5.0 76.4 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.561 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 5.0 mtt -140.4 157.02 46.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -1.145 . . . . 0.0 110.647 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.633 HD12 HG11 ' A' ' 36' ' ' VAL . 74.2 mt -118.63 113.79 21.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.381 -0.824 . . . . 0.0 109.842 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.9 OUTLIER -73.2 155.85 39.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.949 -1.094 . . . . 0.0 109.62 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.575 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -33.83 -44.07 0.15 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.761 -0.587 . . . . 0.0 111.372 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 3.2 p-10 -74.94 -45.26 43.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.36 -0.838 . . . . 0.0 109.897 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.482 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 19.3 mt-10 -62.32 -45.83 91.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.582 -0.698 . . . . 0.0 109.563 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.582 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 52.0 t80 -59.96 -24.07 64.1 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.616 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -68.15 -45.92 72.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.549 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.722 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.3 t -61.79 -23.91 32.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.535 -0.728 . . . . 0.0 109.963 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.991 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.96 -1.35 57.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -0.877 . . . . 0.0 110.832 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.621 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 13.1 mmt -89.09 -46.02 9.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.083 -1.011 . . . . 0.0 109.463 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.668 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 1.7 p90 -75.83 -30.0 58.82 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.722 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.8 mt -63.74 -30.94 71.98 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.616 ' O ' HD21 ' A' ' 81' ' ' LEU . 70.5 t -90.64 -23.84 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.878 -0.514 . . . . 0.0 109.936 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -26.55 20.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.365 -0.834 . . . . 0.0 109.31 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 51.6 m -84.4 -12.28 54.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.437 -0.789 . . . . 0.0 109.211 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.038 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -89.23 -8.87 52.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.465 -0.772 . . . . 0.0 109.065 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.814 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.5 mt -90.97 -45.34 8.79 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.614 0.721 . . . . 0.0 109.358 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 40.2 mm-40 -69.45 -52.98 21.62 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.705 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 3.5 ttpt 178.9 -28.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.466 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.3 OUTLIER -63.76 111.84 6.08 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.986 -1.071 . . . . 0.0 111.291 -178.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 48.3 Cg_endo -74.86 -177.65 3.58 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.94 1.495 . . . . 0.0 110.098 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.646 HG21 HG23 ' A' ' 53' ' ' VAL . 59.2 t -112.34 149.61 41.29 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.142 -0.974 . . . . 0.0 109.191 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 46.1 Cg_endo -84.42 -163.42 0.2 Allowed 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.688 1.362 . . . . 0.0 110.092 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 2.4 ttt -122.19 10.0 9.93 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.371 -0.831 . . . . 0.0 111.106 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.89 23.88 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.719 -1.238 . . . . 0.0 111.432 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.868 HD23 ' HD2' ' A' ' 91' ' ' PRO . 1.6 mt 62.09 123.17 0.02 OUTLIER Pre-proline 0 C--N 1.284 -2.276 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.849 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.868 ' HD2' HD23 ' A' ' 90' ' ' LEU . 40.2 Cg_endo -68.42 174.5 8.19 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.007 1.53 . . . . 0.0 110.137 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 49.6 Cg_endo -75.29 -22.68 14.07 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.964 1.507 . . . . 0.0 111.97 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.746 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -90.79 7.88 37.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.923 -1.111 . . . . 0.0 110.483 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.746 HD22 ' C ' ' A' ' 93' ' ' ALA . 4.1 mm? -114.29 34.9 4.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.081 -1.012 . . . . 0.0 111.495 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -125.58 129.31 24.42 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.766 -1.209 . . . . 0.0 110.617 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.473 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 47.1 Cg_endo -72.77 175.19 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.993 1.523 . . . . 0.0 109.964 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.54 ' O ' ' CB ' ' A' ' 98' ' ' SER . 45.7 Cg_endo -71.44 163.31 39.48 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.877 1.462 . . . . 0.0 110.215 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER 76.47 -45.2 0.5 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.626 -0.672 . . . . 0.0 110.344 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.689 ' HD2' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -88.1 6.73 34.93 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.09 -1.006 . . . . 0.0 108.562 178.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.452 ' HD3' ' O ' ' A' ' 96' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.02 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.482 0.803 0 N-CA-C 110.167 -0.744 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.515 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.6 t90 -78.6 126.99 31.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 110.053 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -41.81 -28.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 0.0 110.138 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.515 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 45.5 t -94.76 156.48 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.826 . . . . 0.0 109.978 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.507 ' HD3' ' HD2' ' A' ' 11' ' ' PRO . 28.3 mmtt -111.5 171.55 4.25 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.507 ' HD2' ' HD3' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -66.9 -35.93 24.96 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.819 1.431 . . . . 0.0 110.431 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.13 -25.59 60.89 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.135 -0.978 . . . . 0.0 109.11 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.579 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 63.6 m-20 -85.57 -35.87 20.78 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.241 -0.912 . . . . 0.0 108.851 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.508 ' CD ' ' HB2' ' A' ' 71' ' ' ALA . 2.2 tptp -73.26 -17.77 61.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.29 -41.82 56.19 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.637 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.15 -24.73 51.52 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.56 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.637 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.4 m-30 -74.95 -35.98 62.12 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.469 ' OD1' ' NZ ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -71.07 -10.1 59.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.777 -0.577 . . . . 0.0 110.135 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.0 -38.97 10.41 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.827 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.257 27.9 mt -72.17 -29.19 31.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.987 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -69.26 -40.34 77.87 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.464 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.5 t70 -86.1 1.36 50.76 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.581 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.695 ' C ' HD23 ' A' ' 24' ' ' LEU . 37.8 m -93.37 -0.14 56.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.314 -0.866 . . . . 0.0 108.768 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.085 HD22 HG21 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -116.7 -1.21 12.16 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 80.35 97.59 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.95 0 CA-C-O 121.136 0.493 . . . . 0.0 110.246 -179.334 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 55.4 Cg_endo -77.26 147.69 26.26 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.502 1.791 . . . . 0.0 110.343 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.508 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 60.1 t -119.89 94.07 2.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.508 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER 68.94 24.51 6.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.428 -0.795 . . . . 0.0 109.061 -178.527 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 90.93 28.34 15.95 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 35.3 m-85 -143.41 143.28 31.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.394 -1.062 . . . . 0.0 111.133 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.987 HD11 ' O ' ' A' ' 21' ' ' PHE . 53.4 mt -117.57 131.87 56.61 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.572 ' OG ' ' HE2' ' A' ' 64' ' ' MET . 0.5 OUTLIER -89.48 147.5 23.96 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.578 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.15 -31.12 0.84 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -54.07 -22.7 11.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -1.097 . . . . 0.0 110.096 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 1.5 mttm -111.15 -43.36 3.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.935 . . . . 0.0 109.342 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.935 HG11 HD12 ' A' ' 65' ' ' LEU . 87.5 t -74.75 -53.73 16.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.029 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.588 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -40.75 -49.94 7.33 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.529 -0.732 . . . . 0.0 110.892 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.891 ' HA ' HD12 ' A' ' 41' ' ' LEU . 40.6 Cg_endo -69.84 -33.19 16.79 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 N-CA-C 108.961 -1.207 . . . . 0.0 108.961 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.085 HG21 HD22 ' A' ' 24' ' ' LEU . 2.4 t -67.29 -29.01 44.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.885 ' HB3' HD22 ' A' ' 50' ' ' LEU . 17.7 mt -81.4 -17.12 50.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.407 -0.808 . . . . 0.0 108.911 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.891 HD12 ' HA ' ' A' ' 38' ' ' PRO . 20.3 mt -73.88 -26.16 60.41 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.401 ' OD1' ' HA ' ' A' ' 39' ' ' VAL . 16.4 m120 -61.4 -20.58 63.22 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.209 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 1.004 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.3 t -71.36 -3.44 20.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.536 -0.728 . . . . 0.0 109.864 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.538 ' CE ' ' HA ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER 70.79 4.59 5.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 110.028 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.028 HD13 HG21 ' A' ' 49' ' ' ILE . 15.7 mt -83.49 159.29 61.74 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.977 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.531 ' HG2' HG12 ' A' ' 49' ' ' ILE . 43.3 Cg_endo -73.05 162.35 41.11 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.985 1.519 . . . . 0.0 110.502 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.93 -10.17 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 110.21 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.18 -39.1 68.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.028 HG21 HD13 ' A' ' 45' ' ' LEU . 18.5 mm -67.18 -47.41 81.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.885 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.0 mt -64.64 -20.05 66.06 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.95 -33.2 12.65 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.577 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -90.38 -54.96 3.78 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.51 -0.994 . . . . 0.0 109.224 179.311 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.901 HG11 HG23 ' A' ' 77' ' ' VAL . 29.2 t -49.23 -42.71 15.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.01 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.522 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 12.3 t-105 -59.09 -59.28 5.72 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.461 -0.774 . . . . 0.0 109.673 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 54' ' ' TRP . 1.6 mm-40 -44.06 -50.03 8.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -0.878 . . . . 0.0 109.833 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.913 HD21 ' C ' ' A' ' 88' ' ' MET . 1.6 mt -75.04 -14.31 60.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.375 -0.828 . . . . 0.0 109.54 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 1.093 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -95.35 -25.84 16.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.484 -0.76 . . . . 0.0 110.384 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.557 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 4.1 t0 -86.31 76.83 9.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.323 -0.861 . . . . 0.0 110.329 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.479 ' CG1' ' HG3' ' A' ' 69' ' ' GLU . 42.5 mm -44.12 -35.29 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.368 -0.832 . . . . 0.0 110.32 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 2.8 m-20 -95.73 -28.41 14.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 110.427 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.557 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 13.0 m80 62.28 37.44 14.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 109.686 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -97.67 -14.57 20.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.386 -0.821 . . . . 0.0 110.452 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.443 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 125.33 3.67 7.25 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.572 ' HE2' ' OG ' ' A' ' 32' ' ' SER . 1.5 mtp -149.27 161.73 41.44 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.022 -1.281 . . . . 0.0 110.438 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.935 HD12 HG11 ' A' ' 36' ' ' VAL . 46.8 mt -113.39 118.82 35.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.625 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.8 OUTLIER -69.36 154.12 42.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.174 -0.954 . . . . 0.0 109.617 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.623 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 7.4 ptp85 -34.3 -44.86 0.2 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.648 -0.658 . . . . 0.0 111.06 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.678 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -81.16 -34.41 32.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 109.499 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 57' ' ' SER . 6.8 tt0 -67.26 -51.71 49.71 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.6 -0.687 . . . . 0.0 109.415 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.827 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 87.8 t80 -52.78 -26.02 13.08 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -62.15 -45.21 94.45 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.67 0.748 . . . . 0.0 109.837 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.022 HG13 HD12 ' A' ' 94' ' ' LEU . 57.6 t -60.03 -25.72 33.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.59 -0.694 . . . . 0.0 110.071 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.093 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -87.42 -11.48 49.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.876 . . . . 0.0 111.952 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.763 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 7.4 mmm -85.78 -37.97 18.7 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.32 -1.487 . . . . 0.0 110.451 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.034 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 3.4 p90 -78.33 -23.43 47.01 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.966 -1.084 . . . . 0.0 108.525 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.847 ' HB3' HG13 ' A' ' 53' ' ' VAL . 6.7 mt -75.19 -28.38 60.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.477 -0.764 . . . . 0.0 108.98 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.901 HG23 HG11 ' A' ' 53' ' ' VAL . 43.3 t -90.61 -25.83 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.508 -0.745 . . . . 0.0 110.058 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.489 ' HA ' HD12 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -84.12 -25.95 29.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 110.056 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.534 ' CA ' ' HB3' ' A' ' 83' ' ' LYS . 57.9 m -85.62 -14.06 46.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 109.454 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.852 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -79.86 -15.87 56.52 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.182 -0.948 . . . . 0.0 109.242 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.004 HD21 ' O ' ' A' ' 43' ' ' SER . 2.4 mt -92.1 -47.95 6.98 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.604 -0.685 . . . . 0.0 111.304 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -116.68 -23.65 8.08 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.503 -0.879 . . . . 0.0 112.033 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.534 ' HB3' ' CA ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -88.04 -89.38 0.13 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.612 -1.305 . . . . 0.0 110.903 -179.066 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.551 ' CG ' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -149.18 176.21 2.37 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.971 -1.08 . . . . 0.0 110.177 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.551 ' HD2' ' CG ' ' A' ' 84' ' ' GLU . 40.8 Cg_endo -66.81 -179.19 1.54 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.934 1.492 . . . . 0.0 110.582 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.512 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 55.5 t -122.41 122.16 27.48 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.864 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.53 ' O ' HD11 ' A' ' 56' ' ' LEU . 51.2 Cg_endo -83.66 160.36 14.4 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.892 1.47 . . . . 0.0 109.663 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.913 ' C ' HD21 ' A' ' 56' ' ' LEU . 68.6 mtp -82.79 11.24 6.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.998 -1.064 . . . . 0.0 110.237 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.585 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.6 m -99.92 112.81 25.07 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.873 -1.131 . . . . 0.0 110.66 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.743 HD12 ' C ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -100.72 85.67 0.58 Allowed Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 89' ' ' SER . 38.2 Cg_endo -62.31 173.74 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.427 1.418 . . . . 0.0 111.477 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.892 ' O ' HG22 ' A' ' 95' ' ' VAL . 44.1 Cg_endo -69.18 -10.15 28.23 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.339 1.705 . . . . 0.0 110.77 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.626 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -76.84 0.76 19.6 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 109.093 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.034 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 2.5 mm? -108.34 -13.59 14.85 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.412 -0.805 . . . . 0.0 110.116 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 92' ' ' PRO . 26.7 m -85.13 126.93 66.24 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.351 -0.843 . . . . 0.0 110.554 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.557 ' CG ' ' HD3' ' A' ' 99' ' ' LYS . 43.6 Cg_endo -71.23 175.17 9.65 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.886 1.466 . . . . 0.0 109.86 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 44.0 Cg_endo -71.39 -16.17 31.1 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.742 1.391 . . . . 0.0 110.611 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.1 t -85.83 -36.13 20.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.113 -0.992 . . . . 0.0 109.588 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.557 ' HD3' ' CG ' ' A' ' 96' ' ' PRO . 4.0 mttp -90.02 9.19 28.96 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.383 -0.823 . . . . 0.0 109.083 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.7 ttm-85 . . . . . 0 N--CA 1.487 1.404 0 O-C-N 121.281 -0.887 . . . . 0.0 109.404 179.889 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.485 0.99 0 N-CA-C 110.742 -0.522 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.536 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.4 t90 -55.94 131.99 48.64 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.474 -0.766 . . . . 0.0 109.957 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.645 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . . . -46.34 -25.81 0.71 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.283 -0.886 . . . . 0.0 110.182 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.536 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 50.6 t -111.49 140.06 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.414 -0.804 . . . . 0.0 110.009 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.498 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 7.4 mttt -106.33 177.7 1.28 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.363 -0.836 . . . . 0.0 110.38 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.547 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 40.7 Cg_endo -68.24 -37.32 14.33 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.96 1.505 . . . . 0.0 109.647 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.441 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 16.0 pt-20 -66.52 -35.64 80.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.0 109.08 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.441 ' N ' ' CG ' ' A' ' 12' ' ' GLU . 0.6 OUTLIER -81.59 -38.64 25.76 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.612 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 1.3 tmtp? -73.01 -15.47 61.53 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -74.36 -42.54 59.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.616 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.3 ptpt -74.33 -21.15 59.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.616 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.8 m-30 -79.7 -30.26 40.97 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -75.07 -11.51 60.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.704 -0.622 . . . . 0.0 110.19 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.16 -36.05 12.23 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.67 HG22 ' CE2' ' A' ' 70' ' ' PHE 0.253 18.5 mt -75.59 -29.79 21.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.646 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -72.65 -40.32 66.45 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.073 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.474 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.1 t70 -85.33 0.02 53.34 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.558 -0.714 . . . . 0.0 109.681 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.569 ' C ' HD23 ' A' ' 24' ' ' LEU . 13.2 t -91.8 -4.7 54.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.915 . . . . 0.0 108.599 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.947 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -108.92 -3.95 17.15 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 79.7 93.56 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.918 0 CA-C-O 121.409 0.623 . . . . 0.0 109.726 -179.087 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.2 Cg_endo -74.45 147.32 36.34 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 124.452 1.764 . . . . 0.0 110.789 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 86.7 t -119.31 105.14 16.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.714 -0.617 . . . . 0.0 109.354 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 2.7 t30 57.69 22.94 8.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 109.652 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.83 32.89 7.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.614 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 89.3 m-85 -150.78 154.77 37.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.332 -1.099 . . . . 0.0 111.105 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.947 HD22 ' HB2' ' A' ' 24' ' ' LEU . 22.0 mt -126.97 131.16 51.12 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.484 ' OG ' ' HE2' ' A' ' 35' ' ' LYS . 0.9 OUTLIER -76.86 140.53 40.63 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.272 -0.892 . . . . 0.0 110.392 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -41.99 -27.94 0.43 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' SER . 34.1 t0 -57.53 -28.84 63.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -1.188 . . . . 0.0 110.303 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.484 ' HE2' ' OG ' ' A' ' 32' ' ' SER . 25.4 mttm -98.91 -39.37 8.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.089 HG11 HD12 ' A' ' 65' ' ' LEU . 93.5 t -74.58 -32.44 29.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.076 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.56 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.2 ttpt -52.06 -56.88 17.78 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.233 -0.917 . . . . 0.0 110.347 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.89 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.2 Cg_endo -65.9 -31.45 47.34 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.631 1.332 . . . . 0.0 109.117 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.761 HG21 HD22 ' A' ' 24' ' ' LEU . 13.1 t -73.47 -16.68 17.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.164 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.986 ' HB3' HD22 ' A' ' 50' ' ' LEU . 63.3 mt -93.82 -18.45 22.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 108.67 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' A' ' 38' ' ' PRO . 23.6 mt -81.24 -33.84 32.54 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.399 0.619 . . . . 0.0 109.833 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 9.2 p-10 -43.86 -25.35 0.19 Allowed 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.935 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.715 ' HB2' HD11 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -73.29 -4.98 36.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.326 -0.859 . . . . 0.0 110.213 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 72.47 7.88 5.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.522 -0.736 . . . . 0.0 110.153 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.045 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.8 mt -80.73 160.31 67.03 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.327 -0.858 . . . . 0.0 110.306 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.556 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.7 Cg_endo -74.33 164.69 33.53 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 124.034 1.544 . . . . 0.0 110.483 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 t -65.17 -8.44 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 110.339 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.92 -40.6 60.75 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.036 -1.04 . . . . 0.0 108.265 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.031 HG21 HD13 ' A' ' 45' ' ' LEU . 14.3 mm -65.15 -45.51 93.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.986 HD22 ' HB3' ' A' ' 40' ' ' LEU . 6.1 mt -62.28 -18.42 61.22 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.82 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.36 -33.7 11.41 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.628 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.4 ttm180 -90.13 -52.16 5.09 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.47 -1.018 . . . . 0.0 109.644 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.702 HG11 HG23 ' A' ' 77' ' ' VAL . 24.3 t -50.94 -42.25 23.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.166 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 57' ' ' SER . 7.7 t-105 -61.55 -57.01 13.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 110.093 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -47.33 -52.66 15.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.838 . . . . 0.0 110.103 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.822 HD11 ' HA ' ' A' ' 88' ' ' MET . 1.4 mt -74.94 -7.62 54.11 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.811 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.92 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 6.4 m -100.05 -29.07 12.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.43 -0.794 . . . . 0.0 110.676 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.466 ' OD2' ' HA ' ' A' ' 61' ' ' HIS . 16.8 t0 -87.29 73.77 9.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.962 . . . . 0.0 110.202 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.526 HG21 ' HG2' ' A' ' 96' ' ' PRO . 45.4 mm -44.0 -30.59 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.5 -0.75 . . . . 0.0 109.314 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 4.4 t0 -95.19 -22.32 17.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.523 -0.736 . . . . 0.0 109.931 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 34.2 p80 40.15 57.28 2.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.546 -0.721 . . . . 0.0 110.232 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' HB3' ' CG ' ' A' ' 60' ' ' ASP . 1.3 p-10 -117.12 7.04 12.94 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.581 -0.699 . . . . 0.0 109.732 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 109.56 5.87 29.38 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.1 mtp -150.41 161.0 43.34 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.157 -1.202 . . . . 0.0 110.792 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.089 HD12 HG11 ' A' ' 36' ' ' VAL . 11.9 mt -114.15 108.45 16.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.452 -0.78 . . . . 0.0 109.298 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.614 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -69.77 171.84 8.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.929 -1.107 . . . . 0.0 110.152 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 9.4 ptt180 -52.87 -37.53 60.47 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.695 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.6 OUTLIER -81.77 -35.72 29.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.189 -0.944 . . . . 0.0 109.713 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.519 ' HG2' ' HB ' ' A' ' 59' ' ' ILE . 27.1 mt-10 -74.24 -46.6 40.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 20' ' ' ILE . 68.3 t80 -57.73 -33.42 68.43 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.404 ' HA ' ' HG2' ' A' ' 74' ' ' MET . . . -57.18 -49.41 76.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.398 -0.814 . . . . 0.0 109.996 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.48 ' O ' HD12 ' A' ' 76' ' ' LEU . 55.6 t -59.29 -21.7 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.611 -0.68 . . . . 0.0 110.443 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.92 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -90.53 -9.79 45.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.07 -1.018 . . . . 0.0 111.602 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.669 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 7.1 mmm -85.41 -41.08 15.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.792 -1.192 . . . . 0.0 109.886 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.599 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.4 p90 -77.41 -26.17 51.47 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.599 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 7.6 mt -70.14 -30.85 68.12 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.702 HG23 HG11 ' A' ' 53' ' ' VAL . 57.0 t -90.98 -19.12 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.679 -0.638 . . . . 0.0 110.349 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.31 -20.18 23.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.34 -0.85 . . . . 0.0 109.75 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -87.73 -16.37 34.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.517 -0.739 . . . . 0.0 109.705 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.045 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -84.92 -12.3 53.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.518 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.779 ' N ' HD23 ' A' ' 81' ' ' LEU . 2.9 mt -88.17 -43.06 11.9 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.539 -0.725 . . . . 0.0 109.373 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.4 OUTLIER -69.41 -52.25 28.7 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.29 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.477 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 2.2 tttp 177.69 -26.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.568 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 79' ' ' CYS . 10.4 mm-40 -77.91 111.37 17.59 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.039 -1.038 . . . . 0.0 111.243 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 43.8 Cg_endo -71.32 -167.44 0.29 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.974 1.513 . . . . 0.0 110.126 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.666 HG21 ' CG2' ' A' ' 53' ' ' VAL . 56.1 t -130.08 135.07 26.89 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.325 -0.859 . . . . 0.0 110.53 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.62 ' O ' HD11 ' A' ' 56' ' ' LEU . 46.5 Cg_endo -88.32 -165.3 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.948 1.499 . . . . 0.0 109.233 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.822 ' HA ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -127.7 10.89 6.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.137 -0.977 . . . . 0.0 110.471 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.605 ' N ' HD21 ' A' ' 56' ' ' LEU . 58.0 m -115.75 93.83 4.43 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.494 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.732 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -56.88 107.2 0.83 Allowed Pre-proline 0 C--N 1.291 -1.943 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.568 178.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.617 ' HG2' HD12 ' A' ' 94' ' ' LEU . 42.8 Cg_endo -82.07 173.32 11.07 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.703 1.37 . . . . 0.0 110.613 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 44.6 Cg_endo -71.21 -5.41 16.94 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.232 1.648 . . . . 0.0 111.418 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.44 ' O ' ' HG ' ' A' ' 94' ' ' LEU . . . -84.01 0.17 49.2 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 109.731 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.645 ' HG ' ' HB2' ' A' ' 8' ' ' ALA . 1.4 mp -138.29 31.24 2.38 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.19 -0.944 . . . . 0.0 110.994 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.489 HG12 ' HB3' ' A' ' 99' ' ' LYS . 3.7 t -109.05 114.92 57.68 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.865 -1.147 . . . . 0.0 110.702 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.526 ' HG2' HG21 ' A' ' 59' ' ' ILE . 43.6 Cg_endo -69.71 175.5 7.98 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.988 1.52 . . . . 0.0 110.059 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.528 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 45.3 Cg_endo -71.81 -2.44 11.45 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.903 1.475 . . . . 0.0 110.852 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.4 t -79.33 -24.4 42.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 109.704 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.489 ' HB3' HG12 ' A' ' 95' ' ' VAL . 5.8 tptt -89.86 5.23 47.15 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.433 -0.792 . . . . 0.0 109.557 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.528 ' CG ' ' HA ' ' A' ' 97' ' ' PRO . 2.9 mmp_? . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.267 -0.896 . . . . 0.0 110.24 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 N--CA 1.483 0.905 0 N-CA-C 110.514 -0.61 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.851 ' HE1' HD22 ' A' ' 94' ' ' LEU . 13.4 t90 -73.17 126.44 30.05 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.33 -0.856 . . . . 0.0 109.979 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -47.7 -25.83 1.34 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.493 -0.754 . . . . 0.0 109.991 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.6 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 56.0 t -88.96 147.04 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.496 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 28.5 mttt -99.93 167.28 11.3 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.237 -0.915 . . . . 0.0 109.847 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.0 Cg_endo -67.74 -33.96 26.04 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.81 1.426 . . . . 0.0 109.709 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -76.64 -24.17 53.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.524 -0.735 . . . . 0.0 109.513 179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.576 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -80.83 -38.73 27.79 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.527 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 28.4 tptp -65.23 -19.8 66.13 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.58 -44.52 50.46 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.58 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 4.1 ptpt -77.21 -19.2 57.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.619 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 6.9 m-30 -80.15 -33.32 38.59 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -79.57 -10.16 59.75 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.242 0.544 . . . . 0.0 110.151 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 23' ' ' SER . . . -94.93 -31.77 13.51 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.639 ' O ' HD21 ' A' ' 24' ' ' LEU . 61.7 mt -80.46 -32.74 13.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.559 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -71.45 -39.0 71.28 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.528 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.8 t0 -88.93 1.13 55.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.645 -0.66 . . . . 0.0 109.688 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 1.1 m -93.49 0.26 56.65 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.061 HD22 HG21 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -110.49 -4.99 15.24 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 p 81.93 87.59 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.528 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 49.8 Cg_endo -71.7 147.25 50.49 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.16 1.611 . . . . 0.0 110.854 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 99.9 t -116.94 104.77 17.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 14.9 t30 57.03 24.4 9.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.529 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 90.26 39.1 6.12 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.571 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 87.4 m-85 -150.58 156.54 41.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -1.179 . . . . 0.0 111.601 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.913 HD13 HD12 ' A' ' 24' ' ' LEU . 75.3 mt -128.77 135.32 49.02 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.542 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 10.2 p -80.36 142.07 34.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.392 -0.817 . . . . 0.0 111.104 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.612 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -51.22 -22.84 7.4 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -84.58 -9.65 58.11 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.363 -1.081 . . . . 0.0 109.36 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.647 ' HD2' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -97.19 -43.94 7.15 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.333 1.063 . . . . 0.0 108.336 179.164 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.602 HG21 HD12 ' A' ' 65' ' ' LEU . 96.8 t -78.82 -32.52 15.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.334 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.932 ' O ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -39.99 -54.58 4.29 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.421 -0.799 . . . . 0.0 110.852 -179.362 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.2 Cg_endo -63.68 -28.86 69.07 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.644 1.339 . . . . 0.0 109.825 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.061 HG21 HD22 ' A' ' 24' ' ' LEU . 4.8 t -79.72 -12.77 13.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.444 0.64 . . . . 0.0 110.244 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.768 ' HB3' HD22 ' A' ' 50' ' ' LEU . 66.2 mt -98.69 -17.05 18.76 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.85 -1.156 . . . . 0.0 109.1 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.932 HD12 ' O ' ' A' ' 37' ' ' LYS . 1.9 mt -88.74 -32.3 18.0 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.421 -0.799 . . . . 0.0 110.036 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.438 ' OD1' ' HA ' ' A' ' 39' ' ' VAL . 3.3 p-10 -67.23 -8.21 29.97 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.061 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 50.3 m -77.53 7.23 5.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.462 -0.774 . . . . 0.0 109.905 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 65.33 16.34 10.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -0.963 . . . . 0.0 109.565 -179.489 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.996 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.2 mt -100.28 151.55 37.57 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.444 -0.785 . . . . 0.0 110.625 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.565 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.1 Cg_endo -75.12 159.45 40.91 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.142 1.601 . . . . 0.0 110.085 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.1 t -60.72 -10.11 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.809 . . . . 0.0 110.933 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.08 -42.4 60.21 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.931 -1.106 . . . . 0.0 108.311 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.917 HG13 HD22 ' A' ' 45' ' ' LEU . 8.8 mm -64.61 -45.02 96.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.768 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.2 mt -63.14 -21.53 66.25 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.176 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.29 -30.62 24.6 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.537 ' HD3' ' CG ' ' A' ' 88' ' ' MET . 10.3 ttm180 -94.16 -54.0 3.74 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.495 -1.003 . . . . 0.0 109.547 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.811 HG11 HG23 ' A' ' 77' ' ' VAL . 37.7 t -52.75 -33.06 18.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.071 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.612 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 10.7 t-105 -71.26 -57.06 4.84 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.919 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -47.41 -47.74 26.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.9 . . . . 0.0 109.983 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.909 HD11 ' HA ' ' A' ' 88' ' ' MET . 4.5 mt -76.77 -10.3 59.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 0.0 109.523 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 1.029 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 2.8 t -98.66 -34.2 10.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.447 -0.783 . . . . 0.0 110.257 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 60' ' ' ASP . 19.6 t0 -79.79 68.16 5.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.357 -0.84 . . . . 0.0 109.338 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.455 ' C ' ' O ' ' A' ' 58' ' ' ASP . 31.2 mm -34.57 -30.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.116 0.484 . . . . 0.0 111.36 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 58' ' ' ASP . 54.1 m-20 -100.48 -19.59 16.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.088 -1.007 . . . . 0.0 111.601 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.472 ' N ' ' O ' ' A' ' 58' ' ' ASP . 5.5 m-70 63.71 35.13 11.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.859 -1.151 . . . . 0.0 109.448 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -102.19 12.13 37.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.92 . . . . 0.0 110.826 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.11 10.11 81.11 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.543 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.7 mtt -139.32 160.19 40.4 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.335 -1.097 . . . . 0.0 110.89 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.602 HD12 HG21 ' A' ' 36' ' ' VAL . 87.9 mt -125.33 112.1 15.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.302 -0.874 . . . . 0.0 110.405 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.571 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 16.5 t0 -68.93 169.86 10.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.838 -1.163 . . . . 0.0 109.48 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.559 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 11.4 ptm180 -48.03 -40.61 23.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.681 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.466 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -80.64 -31.31 36.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.328 -0.857 . . . . 0.0 110.407 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.512 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 31.3 mt-10 -75.69 -38.1 58.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.735 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.661 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 52.6 t80 -68.28 -19.51 64.71 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.367 -0.833 . . . . 0.0 109.439 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.38 -39.84 52.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.444 -0.785 . . . . 0.0 109.395 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.886 HG13 HD21 ' A' ' 94' ' ' LEU . 38.3 t -64.0 -23.49 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.555 0.693 . . . . 0.0 109.192 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.029 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.57 -8.2 50.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.624 -0.673 . . . . 0.0 110.854 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.619 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 14.8 mmt -83.03 -46.89 12.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.064 -1.022 . . . . 0.0 109.907 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.59 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 5.4 p90 -76.27 -25.57 55.06 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.738 ' HB3' HG13 ' A' ' 53' ' ' VAL . 11.0 mt -69.92 -25.83 63.85 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.863 HG13 HD12 ' A' ' 45' ' ' LEU . 51.9 t -91.39 -62.74 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.548 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.2 m-85 -47.61 -25.44 1.16 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.614 -0.679 . . . . 0.0 111.131 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 84' ' ' GLU . 33.6 m -82.71 -12.31 57.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.986 -1.071 . . . . 0.0 109.843 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.996 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.13 -10.67 43.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.291 -0.881 . . . . 0.0 109.179 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.784 HD12 ' N ' ' A' ' 81' ' ' LEU . 7.0 mp -87.91 -43.46 11.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 109.348 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.7 OUTLIER -69.88 -55.88 8.56 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.665 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 14.7 ttmt 177.92 -23.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 111.229 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 79' ' ' CYS . 11.1 mm-40 -67.82 112.05 9.4 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.963 -1.086 . . . . 0.0 111.198 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 45.3 Cg_endo -73.14 172.1 16.23 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.829 1.436 . . . . 0.0 109.758 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.69 HG11 ' CG2' ' A' ' 53' ' ' VAL . 97.2 t -121.02 125.77 26.88 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.028 -1.045 . . . . 0.0 110.665 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.5 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.7 Cg_endo -85.24 -169.31 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.979 1.515 . . . . 0.0 109.407 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.909 ' HA ' HD11 ' A' ' 56' ' ' LEU . 2.7 mtp -116.22 8.05 14.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 0.0 109.983 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.416 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 58.5 m -106.08 104.96 14.78 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.812 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.621 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -50.05 106.49 0.64 Allowed Pre-proline 0 C--N 1.292 -1.92 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.629 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.514 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 39.4 Cg_endo -68.68 142.99 54.71 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.926 1.487 . . . . 0.0 111.215 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.99 -7.56 21.29 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.422 1.748 . . . . 0.0 111.311 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.598 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -100.0 21.68 12.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.166 -0.959 . . . . 0.0 108.772 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.952 HD22 ' O ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -141.52 -11.34 0.92 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.285 0.564 . . . . 0.0 110.426 -178.179 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.525 HG11 ' HB3' ' A' ' 99' ' ' LYS . 2.0 t -78.69 143.73 63.51 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.439 -1.413 . . . . 0.0 110.133 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.509 ' HD2' HG12 ' A' ' 95' ' ' VAL . 43.8 Cg_endo -71.32 162.93 40.81 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.872 1.459 . . . . 0.0 109.274 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.669 ' HA ' ' NE ' ' A' ' 100' ' ' ARG . 44.4 Cg_endo -71.5 57.1 2.3 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.636 1.335 . . . . 0.0 110.711 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.8 t -143.18 -38.68 0.33 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.549 ' O ' ' C ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -92.48 11.49 26.11 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.592 178.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.669 ' NE ' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.225 0 O-C-N 121.923 -0.486 . . . . 0.0 111.629 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 7' ' ' TRP . 49.3 Cg_endo . . . . . 0 N--CA 1.485 0.978 0 N-CA-C 110.567 -0.59 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.564 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 9.5 t90 -41.58 128.13 3.16 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.555 -0.715 . . . . 0.0 109.461 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -39.39 -26.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.843 . . . . 0.0 110.43 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.564 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 12.3 t -99.04 127.76 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.586 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.522 ' CD ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -84.6 175.96 4.15 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 110.334 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' CD ' ' A' ' 10' ' ' LYS . 42.6 Cg_endo -70.4 -34.38 12.54 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.079 1.568 . . . . 0.0 109.515 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -78.72 -24.36 44.93 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.593 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 19.8 m-20 -82.97 -48.79 10.28 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.514 ' HE2' ' HB2' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -63.95 -19.23 64.98 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -80.63 -43.76 19.96 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.587 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.35 -28.04 60.95 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 8.1 m-30 -70.65 -36.78 73.57 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 66.5 t0 -72.66 -9.29 58.44 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.446 0.641 . . . . 0.0 109.74 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.19 -35.86 11.69 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.503 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 29.3 mt -77.73 -32.49 18.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.587 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -69.75 -43.82 71.5 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.345 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.554 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 47.5 t0 -83.49 2.62 35.98 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.41 0.624 . . . . 0.0 109.558 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.451 ' HB2' ' HA ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -90.56 -8.41 50.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.331 -0.855 . . . . 0.0 109.208 179.013 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.688 HD12 HD13 ' A' ' 31' ' ' LEU . 2.9 mt -104.65 -8.07 19.17 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m 83.14 93.77 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.995 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.5 Cg_endo -74.27 145.41 34.47 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.374 1.723 . . . . 0.0 110.533 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 21.1 t -113.15 102.56 14.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER 62.4 19.95 11.5 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.323 -0.861 . . . . 0.0 109.268 -179.053 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 92.28 34.05 7.31 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 77.9 m-85 -144.56 149.5 35.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.165 -1.197 . . . . 0.0 111.566 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.688 HD13 HD12 ' A' ' 24' ' ' LEU . 52.3 mt -125.7 131.87 52.49 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.549 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -77.42 138.46 39.28 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.443 -0.785 . . . . 0.0 110.029 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -43.01 -25.64 0.38 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 6.0 m-20 -65.52 -20.88 66.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -1.175 . . . . 0.0 110.337 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 9.1 mtpp -97.98 -39.78 8.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.176 -0.952 . . . . 0.0 109.073 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.955 HG11 HD12 ' A' ' 65' ' ' LEU . 60.4 t -78.15 -36.6 21.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 121.485 0.659 . . . . 0.0 109.769 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.5 tttt -48.08 -54.69 22.59 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.859 . . . . 0.0 110.171 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.923 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.0 Cg_endo -63.6 -29.24 70.01 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.58 1.305 . . . . 0.0 108.907 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.582 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 4.7 t -80.63 -11.27 12.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 121.659 0.742 . . . . 0.0 109.46 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.685 ' HB3' HD22 ' A' ' 50' ' ' LEU . 42.0 mt -99.94 -14.97 18.48 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.166 -0.959 . . . . 0.0 108.677 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.923 HD12 ' HA ' ' A' ' 38' ' ' PRO . 7.9 mt -89.42 -33.9 16.67 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.642 -0.661 . . . . 0.0 110.089 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 3.8 p-10 -64.24 -9.85 19.9 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.735 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 1.4 m -72.35 -1.83 16.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 110.052 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 43' ' ' SER . 17.4 ttmt 69.55 14.62 8.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.307 -0.871 . . . . 0.0 110.455 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.044 HD13 HG21 ' A' ' 49' ' ' ILE . 14.9 mt -100.46 163.64 17.81 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.217 -0.927 . . . . 0.0 110.317 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HG2' HG12 ' A' ' 49' ' ' ILE . 44.1 Cg_endo -75.18 160.92 39.03 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.982 1.517 . . . . 0.0 110.047 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.6 t -64.96 -7.17 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.132 -0.98 . . . . 0.0 110.373 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.06 -40.31 62.9 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.044 HG21 HD13 ' A' ' 45' ' ' LEU . 15.3 mm -64.13 -43.62 97.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.685 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.1 mt -66.26 -21.19 66.28 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.735 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.14 -27.97 29.48 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.565 ' CD ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -94.54 -54.73 3.4 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.465 -1.021 . . . . 0.0 109.329 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.954 HG11 HG23 ' A' ' 77' ' ' VAL . 33.2 t -52.36 -41.01 33.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.517 -0.873 . . . . 0.0 108.685 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.539 ' CZ2' ' OD2' ' A' ' 58' ' ' ASP . 9.0 t-105 -62.6 -56.44 17.8 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.449 -0.782 . . . . 0.0 109.795 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.518 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 12.0 mm-40 -45.33 -56.48 4.87 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.389 -0.82 . . . . 0.0 110.104 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.724 HD21 ' C ' ' A' ' 88' ' ' MET . 1.4 mt -72.1 -10.94 60.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.687 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.971 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 8.0 m -96.8 -23.15 16.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.377 -0.827 . . . . 0.0 110.263 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.579 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 6.7 t0 -93.26 76.06 4.58 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.356 -0.84 . . . . 0.0 109.569 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.512 HG23 ' HE3' ' A' ' 99' ' ' LYS . 34.4 mm -41.23 -32.52 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.712 -0.618 . . . . 0.0 110.236 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 35.5 m-20 -93.48 -22.06 19.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.386 -0.821 . . . . 0.0 110.717 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 46.1 m-70 55.47 42.81 29.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 109.716 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -112.45 3.36 16.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.464 -0.773 . . . . 0.0 110.887 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.93 3.84 48.63 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.549 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 4.6 mtt -133.94 159.45 40.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -1.131 . . . . 0.0 110.82 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.955 HD12 HG11 ' A' ' 36' ' ' VAL . 10.5 mt -124.38 110.97 15.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.576 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -72.56 172.62 10.23 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.866 -1.146 . . . . 0.0 109.781 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.498 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -49.36 -38.07 26.96 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.603 -0.686 . . . . 0.0 111.313 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.15 -31.21 21.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.007 -1.058 . . . . 0.0 110.221 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.487 ' OE2' ' HB3' ' A' ' 66' ' ' ASP . 27.9 mt-10 -75.76 -42.35 50.61 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.285 -0.884 . . . . 0.0 109.593 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.656 ' HA ' HD13 ' A' ' 65' ' ' LEU . 61.4 t80 -62.66 -31.45 72.33 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.069 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.514 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . . . -60.36 -49.05 79.12 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.79 0.805 . . . . 0.0 109.89 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.057 HG13 HD21 ' A' ' 94' ' ' LEU . 85.6 t -57.73 -24.2 22.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 121.333 0.587 . . . . 0.0 110.427 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.971 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -90.46 -6.15 55.21 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.183 -0.948 . . . . 0.0 111.852 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.581 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 11.3 mmm -89.97 -43.15 10.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.648 -1.283 . . . . 0.0 110.121 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.586 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.6 p90 -76.84 -27.71 55.22 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.876 -1.13 . . . . 0.0 108.115 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.711 ' HB3' HG13 ' A' ' 53' ' ' VAL . 9.6 mt -69.47 -27.15 64.98 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.954 HG23 HG11 ' A' ' 53' ' ' VAL . 30.3 t -91.59 -32.79 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.501 -0.75 . . . . 0.0 110.431 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -81.83 -33.01 30.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.13 -0.981 . . . . 0.0 110.043 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 65.1 m -75.45 -20.09 59.04 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.698 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -71.64 -16.7 62.28 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.561 ' N ' HD23 ' A' ' 81' ' ' LEU . 5.6 mt -90.56 -44.4 9.58 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.542 0.687 . . . . 0.0 109.787 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.54 35.91 4.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.612 -0.68 . . . . 0.0 111.731 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 79' ' ' CYS . 0.9 OUTLIER -146.24 -69.46 0.26 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.655 -1.278 . . . . 0.0 110.822 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -176.54 177.68 0.48 Allowed Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 110.212 -179.606 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 42.9 Cg_endo -70.12 170.92 15.86 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.875 1.461 . . . . 0.0 109.575 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.576 HG21 ' CG2' ' A' ' 53' ' ' VAL . 85.5 t -112.47 131.06 22.8 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 110.2 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.59 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.4 Cg_endo -84.44 169.86 10.8 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.87 1.458 . . . . 0.0 109.405 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.724 ' C ' HD21 ' A' ' 56' ' ' LEU . 4.2 mtm -98.85 12.76 34.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.917 -1.114 . . . . 0.0 110.261 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.468 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 72.2 m -108.63 103.83 13.01 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.715 -1.194 . . . . 0.0 112.044 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.594 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 2.2 mt -51.74 106.38 0.65 Allowed Pre-proline 0 C--N 1.292 -1.927 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.233 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.663 ' HD2' HD12 ' A' ' 94' ' ' LEU . 41.2 Cg_endo -72.07 150.36 54.09 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.759 1.4 . . . . 0.0 110.51 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.508 ' HA ' ' CG2' ' A' ' 95' ' ' VAL . 43.8 Cg_endo -70.16 -5.82 17.36 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.146 1.603 . . . . 0.0 111.068 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -100.62 24.59 8.83 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.057 HD21 HG13 ' A' ' 72' ' ' VAL 0.25 0.3 OUTLIER -158.19 34.36 0.24 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.338 1.066 . . . . 0.0 109.015 -178.128 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.751 HG12 ' HE2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -132.07 130.97 22.26 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.623 -1.298 . . . . 0.0 110.347 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.503 ' O ' ' NZ ' ' A' ' 99' ' ' LYS . 40.2 Cg_endo -68.04 174.66 7.56 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.784 1.413 . . . . 0.0 109.053 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 98' ' ' SER . 45.7 Cg_endo -72.34 179.27 5.2 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.54 1.284 . . . . 0.0 111.351 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.1 OUTLIER 75.09 -52.01 0.67 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.776 -0.578 . . . . 0.0 110.99 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.751 ' HE2' HG12 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -88.27 8.97 24.76 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.031 -1.043 . . . . 0.0 108.578 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.525 -0.734 . . . . 0.0 109.265 179.263 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 N--CA 1.482 0.816 0 N-CA-C 110.628 -0.566 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.549 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 -76.69 124.03 27.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.875 . . . . 0.0 110.113 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.447 ' HB2' HD22 ' A' ' 94' ' ' LEU . . . -46.45 -24.56 0.52 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.447 -0.783 . . . . 0.0 110.652 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.549 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 73.3 t -103.6 130.99 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.793 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.639 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.5 mttt -93.64 174.47 3.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.476 -0.765 . . . . 0.0 109.007 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.639 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 38.2 Cg_endo -65.44 -37.48 30.01 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.287 1.151 . . . . 0.0 109.957 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 8.0 pt-20 -64.71 -25.94 68.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.215 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.596 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -84.0 -38.34 21.05 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 9.9 tptm -72.88 -17.03 61.57 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.576 0.703 . . . . 0.0 109.258 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.55 -37.84 65.43 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 2.3 mtmt -80.82 -39.18 27.05 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.596 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 5.3 m-30 -66.26 -22.69 66.32 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 6.3 t0 -85.81 -15.45 41.93 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.631 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -90.33 -28.14 18.93 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.739 HG22 ' CE1' ' A' ' 70' ' ' PHE . 15.7 mt -82.7 -31.85 9.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.605 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -74.31 -40.49 62.19 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.523 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.2 t0 -84.9 -0.57 54.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.643 -0.66 . . . . 0.0 109.839 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -89.34 -7.18 55.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.844 . . . . 0.0 109.04 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.856 ' HB2' HD22 ' A' ' 31' ' ' LEU . 2.5 mt -107.08 -8.66 16.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER 82.17 95.07 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.4 Cg_endo -74.49 150.17 40.41 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.994 1.523 . . . . 0.0 110.838 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 40.8 t -118.81 101.55 11.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER 65.22 26.58 12.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 108.891 -178.506 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . 85.14 35.72 12.03 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.604 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 93.8 m-85 -150.04 159.26 44.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.641 -0.917 . . . . 0.0 110.598 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.856 HD22 ' HB2' ' A' ' 24' ' ' LEU . 12.7 mt -135.02 128.95 33.34 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.471 ' OG ' ' CD ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -73.09 139.21 46.33 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.452 -0.78 . . . . 0.0 110.541 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -43.07 -32.87 1.64 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.43 -15.83 7.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -1.153 . . . . 0.0 110.016 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 9.6 mtpp -111.77 -35.39 5.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.277 -0.889 . . . . 0.0 108.95 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.999 HG11 HD12 ' A' ' 65' ' ' LEU . 84.8 t -91.32 -46.27 14.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.698 -0.626 . . . . 0.0 110.179 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.635 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 ttpt -45.22 -47.83 33.17 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 110.661 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.869 ' HA ' HD12 ' A' ' 41' ' ' LEU . 40.0 Cg_endo -69.01 -31.63 23.43 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.38 1.2 . . . . 0.0 109.377 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.532 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 1.9 t -65.71 -31.01 51.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.778 -0.576 . . . . 0.0 109.629 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.843 ' HB3' HD22 ' A' ' 50' ' ' LEU . 18.8 mt -80.59 -14.74 57.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.213 -0.93 . . . . 0.0 109.026 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.869 HD12 ' HA ' ' A' ' 38' ' ' PRO . 33.7 mt -76.25 -26.49 56.06 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -63.32 -17.05 62.14 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.138 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.529 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -76.55 1.97 15.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.265 -0.897 . . . . 0.0 110.327 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 43' ' ' SER . 6.0 tttm 64.71 11.82 7.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 0.0 110.083 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.955 HD13 HG21 ' A' ' 49' ' ' ILE . 15.1 mt -86.89 158.41 53.38 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.864 . . . . 0.0 110.087 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.7 Cg_endo -73.61 159.11 46.53 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.068 1.562 . . . . 0.0 110.851 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -58.93 -10.74 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.984 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.27 -42.38 59.71 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.959 -1.088 . . . . 0.0 108.073 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.955 HG21 HD13 ' A' ' 45' ' ' LEU . 21.1 mm -61.84 -42.62 95.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.843 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.7 mt -66.77 -22.81 66.03 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.484 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . -82.65 -24.59 53.06 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.578 ' CD ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -99.01 -59.59 1.7 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.545 -0.974 . . . . 0.0 109.711 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.856 HG11 HG23 ' A' ' 77' ' ' VAL . 46.2 t -46.58 -36.44 2.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.012 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.554 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 9.3 t-105 -73.07 -59.33 2.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 110.211 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 52.5 mm-40 -44.16 -45.5 8.34 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.195 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.75 HD21 ' C ' ' A' ' 88' ' ' MET . 1.8 mt -81.52 -16.5 51.59 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.339 -0.944 . . . . 0.0 109.586 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.933 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 3.2 t -88.39 -25.9 22.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.455 -0.778 . . . . 0.0 109.457 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.476 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 15.7 t0 -85.0 81.38 8.93 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.505 -0.747 . . . . 0.0 109.745 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.622 ' CG2' ' HG2' ' A' ' 99' ' ' LYS . 33.2 mm -47.8 -30.94 2.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 120.134 -0.627 . . . . 0.0 110.504 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 4.4 p-10 -103.92 -16.28 15.4 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.039 -1.064 . . . . 0.0 111.309 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.534 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 30.9 m80 54.73 41.51 31.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.894 -1.129 . . . . 0.0 109.948 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 64' ' ' MET . 1.1 p-10 -100.96 -10.76 20.29 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.357 -0.839 . . . . 0.0 110.171 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.433 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 117.9 8.93 10.29 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.572 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.0 mtp -145.55 161.36 39.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -1.174 . . . . 0.0 110.116 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.999 HD12 HG11 ' A' ' 36' ' ' VAL . 15.6 mt -117.4 106.0 12.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.172 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.604 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -69.59 172.91 6.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.779 -1.201 . . . . 0.0 110.297 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.494 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.5 ptm180 -47.73 -39.57 18.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.614 -0.679 . . . . 0.0 111.032 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.46 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 5.6 m-20 -84.87 -31.97 23.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 0.0 110.338 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.531 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 18.9 mt-10 -77.2 -44.16 31.08 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.392 -0.818 . . . . 0.0 109.091 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.788 ' CE2' HG13 ' A' ' 36' ' ' VAL . 62.0 t80 -64.46 -29.12 70.17 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -62.28 -50.4 71.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.42 -0.8 . . . . 0.0 110.226 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.992 HG13 HD12 ' A' ' 94' ' ' LEU . 41.8 t -56.31 -24.11 17.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.51 -0.744 . . . . 0.0 109.8 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.933 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -86.69 -9.88 54.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.195 -0.941 . . . . 0.0 111.831 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.59 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 9.1 mmm -87.85 -39.11 15.1 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.602 -1.312 . . . . 0.0 110.574 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.997 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 3.2 p90 -78.93 -20.23 49.84 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.834 -1.146 . . . . 0.0 108.212 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.748 HD12 ' O ' ' A' ' 72' ' ' VAL . 10.5 mt -79.83 -25.47 40.79 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.611 0.719 . . . . 0.0 109.217 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.856 HG23 HG11 ' A' ' 53' ' ' VAL . 78.5 t -91.49 -26.99 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.478 -0.764 . . . . 0.0 110.327 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.46 -29.96 21.02 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.267 -0.895 . . . . 0.0 110.039 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 3.0 t -81.19 -14.78 57.22 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.265 -0.897 . . . . 0.0 108.861 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.71 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.22 -7.68 58.92 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.4 -0.812 . . . . 0.0 109.12 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.749 HD23 ' N ' ' A' ' 81' ' ' LEU . 2.8 mt -90.46 -50.29 6.03 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.584 -0.698 . . . . 0.0 109.968 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -71.08 -51.26 26.19 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.425 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 2.8 tptt 176.89 79.51 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.98 -1.075 . . . . 0.0 111.376 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.537 ' CB ' ' O ' ' A' ' 79' ' ' CYS . 5.3 tp10 -166.71 116.36 0.74 Allowed Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.61 -1.306 . . . . 0.0 111.439 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.57 160.97 40.64 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.878 1.462 . . . . 0.0 109.662 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.528 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 44.5 t -118.25 126.92 26.91 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.855 -1.153 . . . . 0.0 110.833 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.594 ' O ' HD11 ' A' ' 56' ' ' LEU . 51.7 Cg_endo -90.45 147.49 4.25 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.933 1.491 . . . . 0.0 109.72 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.75 ' C ' HD21 ' A' ' 56' ' ' LEU . 4.7 mtm -81.96 11.2 5.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.88 -1.138 . . . . 0.0 110.348 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.467 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 68.3 m -106.84 106.4 16.91 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.598 -178.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.604 ' HG ' ' HA ' ' A' ' 56' ' ' LEU . 2.1 mt -54.66 107.81 0.97 Allowed Pre-proline 0 C--N 1.294 -1.841 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.919 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.645 ' HG2' HD23 ' A' ' 94' ' ' LEU . 40.1 Cg_endo -67.93 161.03 45.87 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 124.076 1.566 . . . . 0.0 110.14 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.11 -20.59 16.5 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.002 1.527 . . . . 0.0 111.098 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.623 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -88.84 15.29 8.62 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.152 -0.968 . . . . 0.0 109.734 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.997 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 3.9 mm? -118.33 -23.03 7.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.205 -0.934 . . . . 0.0 110.611 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.414 HG11 ' HA ' ' A' ' 100' ' ' ARG . 53.4 t -76.56 132.02 73.15 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.341 -0.849 . . . . 0.0 110.855 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.424 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 41.0 Cg_endo -69.28 173.05 11.1 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.992 1.522 . . . . 0.0 109.479 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 98' ' ' SER . 44.6 Cg_endo -72.07 166.03 30.84 Favored 'Trans proline' 0 C--N 1.301 -1.961 0 O-C-N 123.823 1.433 . . . . 0.0 111.093 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 1.0 OUTLIER 73.99 -52.74 0.69 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.459 -0.775 . . . . 0.0 110.606 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.622 ' HG2' ' CG2' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -88.07 9.91 20.94 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.113 -0.992 . . . . 0.0 108.498 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.414 ' HA ' HG11 ' A' ' 95' ' ' VAL . 3.8 ptm180 . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 110.156 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 N--CA 1.483 0.9 0 N-CA-C 110.592 -0.58 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.569 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.1 t90 -83.05 122.06 27.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.339 -0.85 . . . . 0.0 109.887 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.721 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -42.4 -28.84 0.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 110.277 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.569 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 39.0 t -100.09 146.05 9.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.348 -0.845 . . . . 0.0 109.72 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.516 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.1 mtmt -119.47 178.07 1.2 Allowed Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.192 -0.942 . . . . 0.0 109.693 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 38.3 Cg_endo -64.9 -36.42 39.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.84 1.442 . . . . 0.0 110.252 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 18.3 pt-20 -65.35 -35.73 81.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.327 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 92.4 m-20 -81.95 -34.41 29.81 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.883 ' HE2' ' HB2' ' A' ' 71' ' ' ALA . 1.1 tppp? -70.91 -20.6 62.47 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.21 -40.02 78.26 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.655 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.7 ptmm? -79.79 -24.82 41.19 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.655 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.7 m-30 -72.18 -35.86 69.09 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 35.0 t0 -74.47 -8.75 57.32 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.238 0.542 . . . . 0.0 110.455 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.08 -41.22 9.22 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.644 HG22 ' CE2' ' A' ' 70' ' ' PHE 0.251 15.5 mt -72.51 -29.62 31.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.684 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -70.73 -39.72 73.19 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.517 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.2 t70 -88.6 2.99 52.05 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.572 -0.705 . . . . 0.0 109.816 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.5 m -91.01 -4.95 56.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 108.663 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.892 HD12 HD13 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -110.74 -6.02 14.87 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER 80.88 96.33 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.2 Cg_endo -72.9 147.63 44.27 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 O-C-N 124.611 1.848 . . . . 0.0 110.691 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.7 t -117.61 103.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 1.1 t30 62.2 21.9 12.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.942 . . . . 0.0 109.223 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.58 34.56 7.33 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CE1' ' CB ' ' A' ' 66' ' ' ASP . 96.9 m-85 -150.43 160.64 43.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -1.113 . . . . 0.0 111.134 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.892 HD13 HD12 ' A' ' 24' ' ' LEU . 42.8 mt -126.61 132.91 51.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.508 -0.745 . . . . 0.0 109.529 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.561 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.5 OUTLIER -80.54 138.9 36.55 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.358 -0.839 . . . . 0.0 110.458 -179.707 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -40.62 -25.68 0.11 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 32' ' ' SER . 8.7 m-20 -63.93 -17.94 63.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -1.141 . . . . 0.0 110.969 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -111.6 -36.42 5.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.937 -1.102 . . . . 0.0 109.942 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.015 HG11 HD12 ' A' ' 65' ' ' LEU . 82.2 t -79.09 -54.19 12.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.316 -0.865 . . . . 0.0 109.964 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.618 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -40.43 -49.88 6.74 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.581 -0.699 . . . . 0.0 110.459 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.858 ' HA ' HD12 ' A' ' 41' ' ' LEU . 41.2 Cg_endo -68.27 -31.97 27.59 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.376 1.198 . . . . 0.0 109.413 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.688 HG21 ' CD2' ' A' ' 24' ' ' LEU . 2.2 t -67.51 -31.65 53.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.576 -0.703 . . . . 0.0 109.572 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.959 ' CB ' HD22 ' A' ' 50' ' ' LEU . 11.4 mt -78.72 -15.66 58.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.049 -1.032 . . . . 0.0 108.636 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.858 HD12 ' HA ' ' A' ' 38' ' ' PRO . 14.8 mt -75.47 -24.29 56.94 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.423 -0.798 . . . . 0.0 108.901 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -66.98 -19.03 65.65 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.001 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 1.039 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -74.07 0.08 14.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.273 -0.892 . . . . 0.0 110.252 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.3 OUTLIER 69.49 4.35 4.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.12 -0.987 . . . . 0.0 110.577 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.003 HD13 HG21 ' A' ' 49' ' ' ILE . 15.7 mt -79.2 160.37 70.89 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.011 . . . . 0.0 110.224 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HD2' HG13 ' A' ' 49' ' ' ILE . 41.7 Cg_endo -73.43 161.57 42.18 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.04 1.547 . . . . 0.0 110.287 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.78 -11.39 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.41 -0.806 . . . . 0.0 110.527 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.75 -40.07 66.32 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.003 HG21 HD13 ' A' ' 45' ' ' LEU . 28.3 mm -64.0 -44.82 97.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.959 HD22 ' CB ' ' A' ' 40' ' ' LEU . 13.5 mt -61.52 -17.78 56.28 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . -88.57 -27.4 24.8 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -96.34 -54.54 3.24 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.665 -0.903 . . . . 0.0 109.332 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.869 HG23 HG21 ' A' ' 86' ' ' VAL . 45.0 t -48.16 -33.42 4.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.901 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 10.4 t-105 -76.96 -59.59 2.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.315 -0.866 . . . . 0.0 110.32 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 64.8 mm-40 -45.65 -41.18 10.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.266 -0.896 . . . . 0.0 109.841 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.81 HD22 ' N ' ' A' ' 90' ' ' LEU . 20.9 mt -83.23 -17.61 42.13 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.557 -0.714 . . . . 0.0 109.454 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 1.032 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 8.3 t -92.33 -23.54 19.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.342 -0.849 . . . . 0.0 109.457 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 54' ' ' TRP . 23.5 t0 -84.49 65.88 9.19 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.318 -0.864 . . . . 0.0 110.12 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.567 HG12 ' HG2' ' A' ' 69' ' ' GLU . 40.2 mm -39.28 -30.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.373 0.606 . . . . 0.0 110.013 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 21.8 m-20 -95.71 -25.76 15.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.436 -0.79 . . . . 0.0 110.507 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.475 ' N ' ' O ' ' A' ' 58' ' ' ASP . 69.3 m80 59.62 48.9 8.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.919 . . . . 0.0 109.829 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -117.38 -10.69 10.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 110.434 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.25 8.87 16.37 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.561 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 2.8 mtt -143.55 160.8 39.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.381 -1.07 . . . . 0.0 110.323 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.015 HD12 HG11 ' A' ' 36' ' ' VAL . 69.7 mt -123.85 116.87 23.65 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.13 -0.981 . . . . 0.0 110.937 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.547 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -72.23 160.21 32.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.897 -1.127 . . . . 0.0 109.743 178.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.543 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 9.7 ptm180 -41.73 -37.76 1.29 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.345 -0.847 . . . . 0.0 111.479 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.474 ' OD1' ' NZ ' ' A' ' 14' ' ' LYS . 52.8 m-20 -81.1 -30.13 34.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.855 -1.153 . . . . 0.0 109.528 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.567 ' HG2' HG12 ' A' ' 59' ' ' ILE . 9.4 mt-10 -74.29 -46.37 41.63 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.609 0.718 . . . . 0.0 109.132 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.765 ' CE1' HG22 ' A' ' 36' ' ' VAL . 42.3 t80 -59.87 -18.01 41.11 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.742 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.883 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . . . -72.33 -49.81 31.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.425 -0.797 . . . . 0.0 109.809 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.645 ' O ' HD12 ' A' ' 76' ' ' LEU . 46.8 t -61.01 -22.0 25.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.91 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.032 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.12 -5.18 56.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.221 -0.924 . . . . 0.0 111.008 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.551 ' HG2' ' O ' ' A' ' 70' ' ' PHE . 2.1 mmt -87.84 -45.97 9.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.913 -1.117 . . . . 0.0 110.077 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.764 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.2 p90 -75.04 -33.8 61.79 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 72' ' ' VAL . 29.4 mt -59.02 -30.19 67.83 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.806 ' O ' HD12 ' A' ' 81' ' ' LEU . 98.0 t -91.55 -45.06 14.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.784 -0.572 . . . . 0.0 110.059 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.451 ' HA ' HD12 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -72.92 -25.91 61.22 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.397 -0.814 . . . . 0.0 111.045 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' GLU . 74.5 m -84.79 -18.37 35.23 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.05 -1.031 . . . . 0.0 109.726 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.842 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -79.35 -12.65 59.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.889 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.039 HD21 ' O ' ' A' ' 43' ' ' SER . 1.2 mt -90.54 -47.13 7.88 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.742 0.782 . . . . 0.0 110.116 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.507 ' HG3' ' N ' ' A' ' 83' ' ' LYS . 26.4 pt-20 -68.3 -43.73 77.0 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.656 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.523 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 0.0 OUTLIER 177.71 -34.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.633 -1.227 . . . . 0.0 112.64 179.236 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 79' ' ' CYS . 14.0 mt-10 -84.19 108.56 14.67 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.866 -1.146 . . . . 0.0 111.729 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 46.2 Cg_endo -71.66 -162.01 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.905 1.476 . . . . 0.0 110.68 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.869 HG21 HG23 ' A' ' 53' ' ' VAL . 35.4 t -106.87 153.24 40.95 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.568 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 43.6 Cg_endo -86.35 -166.28 0.31 Allowed 'Trans proline' 0 C--N 1.302 -1.911 0 O-C-N 123.586 1.308 . . . . 0.0 109.897 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 73.3 mtp -123.63 11.32 9.15 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.292 -0.88 . . . . 0.0 111.03 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -168.43 23.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.552 -1.259 . . . . 0.0 111.926 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.81 ' N ' HD22 ' A' ' 56' ' ' LEU . 0.6 OUTLIER 53.81 119.35 0.0 OUTLIER Pre-proline 0 C--N 1.283 -2.32 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.788 178.343 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.735 ' HG2' HD23 ' A' ' 94' ' ' LEU . 43.8 Cg_endo -73.56 169.84 21.38 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.725 1.382 . . . . 0.0 109.883 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.37 -16.85 27.63 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.853 1.449 . . . . 0.0 111.919 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.633 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -92.09 12.23 22.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.787 -1.195 . . . . 0.0 110.853 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.764 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 3.4 mm? -113.75 -17.8 12.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.087 -1.008 . . . . 0.0 111.56 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 t -80.15 127.23 77.39 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.092 -1.005 . . . . 0.0 110.91 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.528 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 43.1 Cg_endo -71.21 177.27 6.76 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.101 1.579 . . . . 0.0 109.628 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 41.2 Cg_endo -66.89 169.19 15.28 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.549 1.289 . . . . 0.0 110.643 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.1 OUTLIER 72.43 -55.18 0.68 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.674 -179.211 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.3 mmtm -88.93 15.53 8.38 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.534 -0.729 . . . . 0.0 110.389 -179.689 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.485 0.997 0 N-CA-C 110.121 -0.761 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.521 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.4 t90 -86.98 120.59 28.41 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.105 -0.997 . . . . 0.0 109.991 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.02 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -46.55 -27.5 1.14 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.42 -0.8 . . . . 0.0 110.151 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.521 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 37.4 t -93.04 129.71 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.395 -0.815 . . . . 0.0 110.332 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.516 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -93.94 179.13 1.31 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.755 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 39.5 Cg_endo -67.65 -35.49 22.11 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.795 1.418 . . . . 0.0 110.224 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -75.15 -26.37 59.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.842 . . . . 0.0 110.058 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.453 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 4.1 m-20 -86.08 -37.43 18.85 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HG3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -76.18 -13.55 60.18 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.588 -0.695 . . . . 0.0 109.175 178.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -73.81 -40.81 63.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 108.901 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.635 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.57 -26.46 50.87 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.36 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.635 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.5 m-30 -71.83 -27.6 63.02 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.14 -10.71 59.6 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.338 0.589 . . . . 0.0 109.937 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.02 -36.54 11.51 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.527 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 82.3 mt -74.81 -33.98 32.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.792 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -65.39 -39.09 91.79 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.649 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.529 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.2 t0 -89.31 2.65 54.06 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.694 -0.629 . . . . 0.0 109.706 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.527 ' HB2' ' HA ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -93.83 0.83 56.44 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.847 0.832 . . . . 0.0 108.978 178.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.079 HD22 HG21 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -116.63 -2.49 11.93 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 80.17 90.53 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.855 0 CA-C-O 121.368 0.604 . . . . 0.0 109.838 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.6 Cg_endo -75.27 148.59 34.48 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 124.558 1.82 . . . . 0.0 110.458 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 44.0 t -117.86 108.51 24.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.663 -0.648 . . . . 0.0 109.422 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 16.7 t30 55.44 21.49 4.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.07 -1.018 . . . . 0.0 109.741 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 97.03 33.58 5.98 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.624 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 66.2 m-85 -149.76 150.51 32.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -1.104 . . . . 0.0 111.41 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.911 HD13 HD12 ' A' ' 24' ' ' LEU . 30.7 mt -118.56 129.94 55.62 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.71 -0.796 . . . . 0.0 108.994 178.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.54 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -78.76 138.47 38.24 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.606 -0.684 . . . . 0.0 110.616 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -44.08 -25.33 0.67 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 32' ' ' SER . 10.3 t70 -62.27 -17.75 59.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.288 -1.125 . . . . 0.0 110.226 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -114.47 -33.98 5.4 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.325 -0.86 . . . . 0.0 109.377 179.732 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.918 HG11 HD12 ' A' ' 65' ' ' LEU . 98.6 t -79.19 -51.83 16.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 119.516 -0.873 . . . . 0.0 109.765 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 48.6 tttt -42.68 -49.88 13.04 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 110.338 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 1.027 ' HA ' HD12 ' A' ' 41' ' ' LEU . 39.6 Cg_endo -67.39 -31.09 35.49 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 N-CA-C 108.854 -1.248 . . . . 0.0 108.854 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.079 HG21 HD22 ' A' ' 24' ' ' LEU . 2.8 t -76.22 -10.43 13.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.523 0.677 . . . . 0.0 109.507 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.838 ' HB3' HD22 ' A' ' 50' ' ' LEU . 97.2 mt -99.21 -15.09 19.03 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.027 HD12 ' HA ' ' A' ' 38' ' ' PRO . 6.9 mt -84.63 -33.32 23.33 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.479 -0.763 . . . . 0.0 109.595 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.455 ' OD1' ' HA ' ' A' ' 39' ' ' VAL . 2.7 p-10 -71.12 -2.97 17.47 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.865 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 9.4 m -80.37 5.5 14.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.31 -0.869 . . . . 0.0 110.033 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 43' ' ' SER . 27.8 tttt 65.54 12.61 8.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.09 HD13 HG21 ' A' ' 49' ' ' ILE . 15.5 mt -99.82 156.24 35.56 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 110.036 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.547 ' HG2' HG12 ' A' ' 49' ' ' ILE . 40.4 Cg_endo -73.09 162.44 40.8 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.952 1.501 . . . . 0.0 110.153 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.1 t -63.88 -7.93 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.432 -0.792 . . . . 0.0 110.725 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.23 -40.59 51.67 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.09 HG21 HD13 ' A' ' 45' ' ' LEU . 10.9 mm -65.59 -43.53 94.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.838 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.7 mt -66.03 -21.32 66.38 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.33 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.6 -28.11 22.73 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.56 ' O ' HD12 ' A' ' 56' ' ' LEU . 3.8 ttm180 -95.3 -47.42 6.32 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.519 -0.989 . . . . 0.0 109.606 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.939 HG11 HG23 ' A' ' 77' ' ' VAL . 45.7 t -57.45 -39.11 66.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.277 -0.89 . . . . 0.0 109.201 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.553 ' CE3' HD11 ' A' ' 65' ' ' LEU . 6.7 t-105 -68.69 -53.22 23.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.502 -0.749 . . . . 0.0 110.172 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.462 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 5.7 mm-40 -47.58 -50.02 25.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.381 -0.824 . . . . 0.0 109.906 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.688 HD11 ' O ' ' A' ' 87' ' ' PRO . 3.3 mt -76.38 -8.49 57.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.669 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 1.044 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.3 t -99.76 -27.62 13.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.475 -0.766 . . . . 0.0 110.422 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.471 ' OD2' ' CZ2' ' A' ' 54' ' ' TRP . 11.8 t0 -83.82 90.01 7.28 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.387 -0.821 . . . . 0.0 109.384 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.896 HG21 ' HD3' ' A' ' 99' ' ' LYS . 46.1 mm -53.45 -32.71 20.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.496 -0.752 . . . . 0.0 110.549 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 24.8 p-10 -106.42 -13.75 15.27 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.185 -0.947 . . . . 0.0 111.021 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.536 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 57.2 m80 56.45 43.69 25.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.076 -1.015 . . . . 0.0 110.358 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.461 ' OD1' ' OD2' ' A' ' 60' ' ' ASP . 1.1 p-10 -104.3 18.45 22.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.931 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.61 10.42 83.34 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.54 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 4.2 mtt -139.43 161.82 36.55 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.538 -0.977 . . . . 0.0 110.911 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.918 HD12 HG11 ' A' ' 36' ' ' VAL . 71.1 mt -130.76 119.48 22.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.346 -0.846 . . . . 0.0 110.387 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.624 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -79.59 166.59 21.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.896 -1.127 . . . . 0.0 109.484 179.026 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.447 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -43.26 -30.45 0.5 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.457 -0.777 . . . . 0.0 111.275 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.456 ' HB2' ' OD1' ' A' ' 66' ' ' ASP . 58.7 m-20 -90.06 -31.15 17.28 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.14 -0.975 . . . . 0.0 109.766 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.466 ' OE1' ' N ' ' A' ' 59' ' ' ILE . 10.0 mt-10 -76.93 -38.56 53.17 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.412 -0.805 . . . . 0.0 109.378 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.735 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 56.9 t80 -70.71 -24.56 62.67 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.705 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.27 -41.22 77.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 109.552 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.456 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.3 t -62.94 -29.66 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.639 -0.663 . . . . 0.0 110.043 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.044 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.33 -4.46 57.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.154 -0.966 . . . . 0.0 110.9 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.535 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 9.7 mmt -83.37 -46.49 12.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.003 -1.061 . . . . 0.0 109.76 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.687 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 4.3 p90 -77.2 -24.24 51.37 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.667 ' CB ' HG13 ' A' ' 53' ' ' VAL . 15.3 mt -72.89 -25.76 61.19 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.939 HG23 HG11 ' A' ' 53' ' ' VAL . 42.4 t -91.06 -34.46 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.639 -0.663 . . . . 0.0 109.663 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -80.12 -26.39 39.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -0.779 . . . . 0.0 110.034 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.525 ' HB3' ' CB ' ' A' ' 84' ' ' GLU . 65.1 m -82.11 -12.78 58.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.203 -0.935 . . . . 0.0 109.127 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.023 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.91 -13.73 46.91 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.333 -0.854 . . . . 0.0 108.923 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.681 HD23 ' N ' ' A' ' 81' ' ' LEU . 3.2 mt -89.58 -42.48 11.39 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.904 0.859 . . . . 0.0 109.014 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -68.86 -54.83 13.42 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.423 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 23.1 tttt 177.87 -24.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.617 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.525 ' CB ' ' HB3' ' A' ' 79' ' ' CYS . 0.2 OUTLIER -72.65 112.95 17.08 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.959 -1.088 . . . . 0.0 111.406 -178.597 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 48.4 Cg_endo -75.67 -174.57 2.07 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.987 1.519 . . . . 0.0 109.789 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.562 HG21 ' CG2' ' A' ' 53' ' ' VAL . 44.2 t -132.49 128.14 20.93 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.941 -1.1 . . . . 0.0 110.702 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.688 ' O ' HD11 ' A' ' 56' ' ' LEU . 52.1 Cg_endo -84.67 -170.69 0.84 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.958 1.504 . . . . 0.0 109.831 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.517 ' C ' HD21 ' A' ' 56' ' ' LEU . 4.8 mtt -115.2 13.89 16.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.069 -1.019 . . . . 0.0 110.634 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.485 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 5.3 m -113.13 103.05 10.97 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 118.729 -1.188 . . . . 0.0 111.688 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.627 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -57.07 108.26 1.18 Allowed Pre-proline 0 C--N 1.291 -1.94 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.824 179.21 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.051 ' HG2' HD23 ' A' ' 94' ' ' LEU . 49.6 Cg_endo -80.05 157.72 23.64 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 123.928 1.489 . . . . 0.0 110.328 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.26 -11.04 24.74 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.079 1.568 . . . . 0.0 110.828 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.597 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -84.15 -0.76 53.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.051 HD23 ' HG2' ' A' ' 91' ' ' PRO . 3.9 mm? -117.46 -9.69 10.81 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.313 -0.867 . . . . 0.0 110.164 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 95' ' ' VAL . 6.3 p -103.29 124.49 38.08 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.953 . . . . 0.0 110.748 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.484 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 43.6 Cg_endo -71.49 151.56 59.21 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.78 1.411 . . . . 0.0 109.801 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.565 ' HA ' ' HG3' ' A' ' 100' ' ' ARG . 45.7 Cg_endo -72.04 -20.34 25.43 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.945 1.497 . . . . 0.0 111.244 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.1 -11.41 60.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.963 -1.086 . . . . 0.0 110.135 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.896 ' HD3' HG21 ' A' ' 59' ' ' ILE . 9.6 mttm -102.58 8.58 39.77 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.372 -0.83 . . . . 0.0 109.62 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.565 ' HG3' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.094 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.483 0.868 0 N-CA-C 110.632 -0.565 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.462 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 12.8 t90 -83.75 129.49 34.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.389 -0.82 . . . . 0.0 109.875 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.729 ' HB3' HD23 ' A' ' 94' ' ' LEU . . . -40.96 -32.42 0.23 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.298 -0.876 . . . . 0.0 109.931 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.462 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 64.9 t -89.71 153.23 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.481 -0.762 . . . . 0.0 109.565 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 11.5 mmtt -99.04 167.03 11.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.2 Cg_endo -66.5 -33.67 36.21 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.747 1.393 . . . . 0.0 109.755 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -76.53 -23.81 53.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.506 -0.746 . . . . 0.0 109.367 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.576 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 21.8 m-20 -82.79 -38.75 22.71 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 7.2 tptm -65.29 -20.33 66.36 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.39 -43.19 41.65 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.602 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.7 ptpt -79.15 -24.05 43.56 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 6.9 m-30 -74.96 -34.33 62.03 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.476 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 10.1 t70 -79.96 -8.4 59.31 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.381 0.61 . . . . 0.0 109.939 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.72 -37.23 10.88 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.681 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 28.0 mt -75.43 -26.66 18.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 1.014 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.2 -36.84 61.37 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.534 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.2 t70 -90.27 1.75 56.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.696 -0.627 . . . . 0.0 109.815 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.511 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.7 m -93.86 -1.38 54.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.35 -0.844 . . . . 0.0 108.821 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.018 HD12 HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -114.0 -1.77 13.7 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.594 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 81.71 91.1 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.107 0 CA-C-O 121.111 0.481 . . . . 0.0 109.707 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.4 Cg_endo -75.11 148.51 34.98 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.305 1.687 . . . . 0.0 110.746 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 99.2 t -120.03 109.44 25.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.625 -0.672 . . . . 0.0 109.561 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 9.3 t30 55.53 23.33 5.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.063 -1.023 . . . . 0.0 109.556 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 92.87 35.41 6.42 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.604 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 91.1 m-85 -151.42 152.55 33.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -1.153 . . . . 0.0 111.118 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.018 HD13 HD12 ' A' ' 24' ' ' LEU . 29.7 mt -122.23 127.87 50.47 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.485 ' OG ' ' HE2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -78.86 138.2 38.03 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.613 -179.069 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -38.53 -34.05 0.23 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 32' ' ' SER . 7.9 t0 -49.75 -21.6 1.14 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -1.212 . . . . 0.0 110.022 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 13.0 mttm -113.08 -39.71 4.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.42 -0.8 . . . . 0.0 109.443 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.019 HG11 HD12 ' A' ' 65' ' ' LEU . 96.1 t -79.35 -37.17 18.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.647 -0.658 . . . . 0.0 110.015 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.619 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.1 ttpt -49.34 -50.38 65.11 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.34 -0.85 . . . . 0.0 110.584 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.933 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.6 Cg_endo -66.93 -29.23 41.41 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 N-CA-C 108.812 -1.265 . . . . 0.0 108.812 178.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.561 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 3.2 t -73.97 -13.29 15.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.216 0.531 . . . . 0.0 110.303 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.651 ' HB3' HD22 ' A' ' 50' ' ' LEU . 77.9 mt -98.75 -14.0 19.95 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.967 -1.083 . . . . 0.0 108.568 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.933 HD12 ' HA ' ' A' ' 38' ' ' PRO . 20.3 mt -87.89 -41.72 13.01 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.707 -0.621 . . . . 0.0 110.073 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 7.6 p-10 -52.78 -20.46 3.23 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.365 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -64.08 -9.45 16.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.467 -0.771 . . . . 0.0 110.431 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 71.24 7.91 6.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.142 -0.973 . . . . 0.0 109.72 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.937 HD13 HG21 ' A' ' 49' ' ' ILE . 15.7 mt -88.26 159.88 46.76 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 110.014 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.536 ' HG2' HG12 ' A' ' 49' ' ' ILE . 41.0 Cg_endo -72.41 151.9 54.22 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 123.941 1.495 . . . . 0.0 110.301 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.5 t -54.28 -14.07 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.268 -0.895 . . . . 0.0 110.991 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -39.85 75.08 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.801 -1.187 . . . . 0.0 108.354 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.937 HG21 HD13 ' A' ' 45' ' ' LEU . 4.9 mm -66.89 -47.18 83.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.5 mt -63.31 -21.14 66.07 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.05 -28.33 25.98 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.611 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.1 ttm180 -94.4 -55.71 3.07 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.473 -1.016 . . . . 0.0 109.272 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.978 HG11 HG23 ' A' ' 77' ' ' VAL . 55.3 t -47.64 -44.15 9.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.24 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.532 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 6.0 t-105 -64.62 -57.32 9.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.49 -0.756 . . . . 0.0 109.995 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.561 ' CG ' ' N ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER -47.54 -50.85 22.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.684 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.719 HD23 ' CB ' ' A' ' 90' ' ' LEU . 2.6 mt -70.69 -9.7 57.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.311 -0.868 . . . . 0.0 109.398 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.948 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -100.3 -36.24 9.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.607 -0.683 . . . . 0.0 110.258 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD2' ' CZ2' ' A' ' 54' ' ' TRP . 9.4 t0 -78.76 85.36 4.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.451 -0.78 . . . . 0.0 109.295 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.512 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 31.4 mm -52.47 -30.99 14.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.728 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 0.7 OUTLIER -99.52 -18.09 17.57 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.053 -1.029 . . . . 0.0 111.006 -179.341 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.475 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 14.6 m80 56.85 31.78 20.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.975 -1.078 . . . . 0.0 108.895 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -90.99 -9.3 46.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.634 -0.666 . . . . 0.0 110.538 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 113.24 9.98 16.54 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.579 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 9.2 mtp -149.19 158.18 43.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -1.169 . . . . 0.0 110.732 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.019 HD12 HG11 ' A' ' 36' ' ' VAL . 41.5 mt -116.35 117.18 29.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.603 -0.685 . . . . 0.0 110.159 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.604 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 3.2 t70 -77.35 172.8 12.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.082 -1.011 . . . . 0.0 110.023 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.559 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.4 ptm180 -48.11 -43.18 30.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.519 -0.738 . . . . 0.0 111.36 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -80.4 -33.57 36.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.142 -0.974 . . . . 0.0 110.58 -179.333 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.516 ' CD ' ' HB3' ' A' ' 66' ' ' ASP . 66.7 mt-10 -73.74 -50.13 22.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 108.593 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.681 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 55.2 t80 -52.03 -33.24 37.78 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -56.47 -53.81 53.15 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.565 0.698 . . . . 0.0 109.96 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.613 HG11 ' O ' ' A' ' 56' ' ' LEU . 78.3 t -55.45 -25.14 17.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.548 -0.72 . . . . 0.0 110.334 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.948 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.28 -5.44 57.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.157 -0.964 . . . . 0.0 111.396 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.582 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 8.0 mmm -90.84 -35.32 14.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.515 -1.366 . . . . 0.0 110.284 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.64 ' CZ ' ' CD2' ' A' ' 94' ' ' LEU . 2.1 p90 -83.1 -24.47 32.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.135 -0.978 . . . . 0.0 108.596 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.77 ' HB3' HG13 ' A' ' 53' ' ' VAL . 3.8 mt -77.4 -23.72 50.62 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.644 -0.66 . . . . 0.0 109.316 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.978 HG23 HG11 ' A' ' 53' ' ' VAL . 48.7 t -89.93 -32.29 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.507 -0.746 . . . . 0.0 109.136 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.737 ' HA ' HD12 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -82.87 -25.46 32.53 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 109.786 179.2 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 83' ' ' LYS . 64.4 m -86.15 -12.24 50.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.386 -0.821 . . . . 0.0 109.717 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.925 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -80.81 -19.13 45.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.916 -1.115 . . . . 0.0 108.456 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.737 HD12 ' HA ' ' A' ' 78' ' ' TYR . 3.3 mt -91.69 -40.71 11.12 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.149 0.5 . . . . 0.0 110.391 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 3.8 tt0 -123.38 -11.49 7.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 112.9 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -96.07 -73.33 0.6 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.31 -1.494 . . . . 0.0 111.477 -179.098 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.565 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . 2.0 mt-10 -171.3 -175.97 0.34 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.917 -1.115 . . . . 0.0 110.123 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 39.7 Cg_endo -67.72 163.94 33.28 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.544 1.286 . . . . 0.0 110.233 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.509 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 41.4 t -112.81 121.28 38.91 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 110.942 -179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.504 ' O ' HD11 ' A' ' 56' ' ' LEU . 52.4 Cg_endo -81.42 158.41 19.62 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.813 1.428 . . . . 0.0 109.404 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.706 ' C ' HD21 ' A' ' 56' ' ' LEU . 2.5 mtt -86.33 16.37 4.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.963 -1.086 . . . . 0.0 110.036 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.634 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 61.6 m -106.58 110.92 23.26 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.221 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.726 HD12 ' C ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -91.25 98.57 1.77 Allowed Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.18 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.847 ' HG2' HD12 ' A' ' 94' ' ' LEU . 38.3 Cg_endo -63.9 167.61 13.63 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.673 1.354 . . . . 0.0 111.379 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.35 -9.23 24.94 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.208 1.636 . . . . 0.0 111.072 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.24 -7.76 55.59 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.318 -0.864 . . . . 0.0 109.095 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.847 HD12 ' HG2' ' A' ' 91' ' ' PRO . 2.6 mt -111.4 3.5 18.24 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.422 -0.799 . . . . 0.0 110.32 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.452 HG12 ' CZ ' ' A' ' 100' ' ' ARG . 34.2 t -89.06 110.7 40.05 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.966 . . . . 0.0 110.615 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.471 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 43.8 Cg_endo -71.88 175.63 9.45 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.08 1.569 . . . . 0.0 109.519 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 44.1 Cg_endo -70.98 56.51 1.92 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.707 1.372 . . . . 0.0 110.536 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.9 m -134.49 -39.76 0.81 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.441 ' HE3' HG22 ' A' ' 95' ' ' VAL . 1.3 ttmm -89.21 6.06 41.89 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.454 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.327 -0.858 . . . . 0.0 110.429 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.483 0.858 0 N-CA-C 110.344 -0.675 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.569 ' CZ2' ' HB ' ' A' ' 9' ' ' VAL . 19.1 t90 -66.99 140.5 57.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.821 . . . . 0.0 110.159 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.696 ' HB2' HD22 ' A' ' 94' ' ' LEU . . . -47.81 -27.69 2.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.486 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.569 ' HB ' ' CZ2' ' A' ' 7' ' ' TRP . 89.4 t -112.73 154.2 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.867 . . . . 0.0 110.453 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.558 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -113.65 -176.56 0.38 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.396 -0.815 . . . . 0.0 110.244 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.9 Cg_endo -69.75 -41.21 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.698 1.367 . . . . 0.0 110.305 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.455 ' HG2' ' OD1' ' A' ' 13' ' ' ASP . 15.3 pt-20 -65.15 -28.5 69.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 109.75 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.57 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 4.3 m-20 -84.25 -40.61 17.82 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 18' ' ' ASP . 1.5 tppp? -69.78 -14.14 62.63 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.79 -39.33 44.26 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 8.8 mtmt -81.61 -40.08 23.53 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CD1' ' HB3' ' A' ' 74' ' ' MET . 5.0 m-30 -64.04 -22.12 66.8 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 4.4 t70 -89.28 -16.84 30.23 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.799 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.05 -29.75 18.18 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.517 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 20.8 mt -80.08 -34.98 15.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -69.56 -38.02 77.26 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.003 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.566 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.1 t70 -88.11 -0.7 57.38 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.701 -0.624 . . . . 0.0 110.227 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.7 t -90.72 -3.84 57.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 109.206 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.02 HD22 HG21 ' A' ' 39' ' ' VAL . 2.2 mt -108.95 -8.09 15.3 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m 86.05 89.08 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.5 Cg_endo -73.55 145.03 36.86 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.455 1.766 . . . . 0.0 110.507 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.7 110.15 31.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.8 m120 52.14 23.44 2.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.086 -1.009 . . . . 0.0 108.474 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 91.1 33.97 7.87 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.571 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 65.0 m-85 -144.52 148.61 34.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -1.124 . . . . 0.0 112.01 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.804 HD13 HD12 ' A' ' 24' ' ' LEU . 35.1 mt -122.63 134.26 54.51 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.572 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.3 OUTLIER -77.89 143.19 37.94 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.181 -0.949 . . . . 0.0 111.107 -178.503 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -50.4 -26.9 10.42 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.241 -1.943 . . . . 0.0 108.241 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -77.52 -9.67 59.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.35 -1.088 . . . . 0.0 109.466 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.582 ' HD2' ' CB ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -100.74 -46.56 5.12 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.593 HG22 ' HE2' ' A' ' 70' ' ' PHE . 72.4 t -77.67 -37.34 24.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.924 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.589 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -38.47 -51.88 3.46 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.423 -0.798 . . . . 0.0 111.176 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 1.095 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.6 Cg_endo -65.98 -30.61 47.9 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.311 1.163 . . . . 0.0 109.35 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.02 HG21 HD22 ' A' ' 24' ' ' LEU . 5.4 t -77.51 -10.19 12.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.427 0.632 . . . . 0.0 109.733 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.968 ' HB3' HD22 ' A' ' 50' ' ' LEU . 58.6 mt -100.31 -14.46 18.4 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.095 HD12 ' HA ' ' A' ' 38' ' ' PRO . 10.7 mt -87.0 -42.48 13.08 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.636 -0.665 . . . . 0.0 109.483 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 7.7 p-10 -50.05 -22.87 1.78 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 118.75 -1.18 . . . . 0.0 108.556 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -60.94 -10.96 6.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 110.107 178.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.6 OUTLIER 74.02 18.96 3.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.326 -0.859 . . . . 0.0 109.982 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.022 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.3 mt -98.9 156.25 35.73 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.569 -0.707 . . . . 0.0 109.823 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.536 ' HG2' HG12 ' A' ' 49' ' ' ILE . 41.9 Cg_endo -74.65 156.11 44.59 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.973 1.512 . . . . 0.0 110.279 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.0 t -58.66 -12.38 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.483 -0.76 . . . . 0.0 110.714 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.28 -37.63 71.86 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.026 -1.046 . . . . 0.0 108.233 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.913 HG21 HD13 ' A' ' 45' ' ' LEU . 26.0 mm -68.23 -45.95 81.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.968 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.8 mt -61.61 -20.39 63.29 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.516 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -84.49 -29.98 28.55 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.048 -2.021 . . . . 0.0 108.048 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.6 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 1.1 ttm180 -94.76 -58.32 2.21 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.58 -0.953 . . . . 0.0 109.629 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.644 ' CG2' HG21 ' A' ' 86' ' ' VAL . 6.3 t -46.83 -49.95 6.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.209 -0.997 . . . . 0.0 108.756 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.553 ' HA ' ' HB2' ' A' ' 57' ' ' SER . 16.9 t-105 -56.81 -59.44 5.02 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.931 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 10.4 mm-40 -44.05 -58.39 2.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.158 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.77 HD11 ' HA ' ' A' ' 88' ' ' MET . 3.3 mt -70.25 -11.63 61.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.854 . . . . 0.0 109.803 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 1.008 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 19.3 m -96.2 -27.54 14.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 0.0 110.379 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 54' ' ' TRP . 19.0 t0 -87.14 81.59 7.96 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.241 -0.912 . . . . 0.0 109.455 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.532 HG12 ' HG3' ' A' ' 69' ' ' GLU . 32.1 mm -44.29 -32.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.616 -0.677 . . . . 0.0 110.449 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 9.5 p-10 -105.39 -14.98 15.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.126 -0.984 . . . . 0.0 111.034 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.536 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 18.4 m80 56.27 41.71 28.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.046 -1.034 . . . . 0.0 110.113 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.473 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 2.2 p-10 -100.89 15.66 27.8 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 110.135 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.72 15.56 77.5 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.572 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 9.1 mtt -146.81 160.74 41.9 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.558 -0.966 . . . . 0.0 110.467 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 58' ' ' ASP . 43.5 mt -128.54 118.16 22.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.329 -0.857 . . . . 0.0 109.436 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.571 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 20.2 t0 -69.77 166.6 18.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.863 -1.148 . . . . 0.0 109.996 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.584 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 10.7 ttm180 -44.0 -46.33 8.28 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 110.142 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.5 m-20 -78.7 -26.72 44.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.383 -0.823 . . . . 0.0 109.66 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.532 ' HG3' HG12 ' A' ' 59' ' ' ILE . 4.7 tt0 -75.71 -39.57 57.16 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.59 0.709 . . . . 0.0 109.53 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.593 ' HE2' HG22 ' A' ' 36' ' ' VAL . 18.2 t80 -66.67 -17.75 65.01 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.691 0.758 . . . . 0.0 109.072 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.469 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -74.99 -43.61 52.97 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.469 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.935 HG13 HD12 ' A' ' 94' ' ' LEU . 59.2 t -60.57 -26.1 36.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.535 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.008 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -90.56 -4.35 56.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.52 -0.737 . . . . 0.0 111.074 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.579 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 11.1 mmt -86.27 -47.05 9.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.925 -1.109 . . . . 0.0 109.971 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.046 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 1.9 p90 -76.91 -24.57 52.47 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.533 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 8.4 mt -71.21 -24.53 62.23 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 73' ' ' ALA . 66.0 t -91.66 -61.92 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.557 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.2 m-85 -48.32 -21.66 0.56 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.721 -0.612 . . . . 0.0 111.597 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.521 ' HB3' ' CB ' ' A' ' 84' ' ' GLU . 2.1 m -86.21 -14.76 42.96 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.006 -1.059 . . . . 0.0 109.883 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.022 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -89.33 -10.19 47.65 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.282 -0.886 . . . . 0.0 109.302 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.702 ' N ' HD12 ' A' ' 81' ' ' LEU . 7.0 mp -87.04 -43.91 11.97 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.477 -0.765 . . . . 0.0 109.026 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 74.4 mt-10 -72.17 -54.01 10.96 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.777 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 179.11 -26.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.479 -0.763 . . . . 0.0 111.422 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.521 ' CB ' ' HB3' ' A' ' 79' ' ' CYS . 1.8 mp0 -67.35 113.22 12.77 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.099 -1.001 . . . . 0.0 111.32 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 50.4 Cg_endo -75.46 -175.17 2.29 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.953 1.502 . . . . 0.0 110.312 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.644 HG21 ' CG2' ' A' ' 53' ' ' VAL . 77.9 t -131.84 122.53 18.6 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.186 -0.946 . . . . 0.0 110.514 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.607 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.7 Cg_endo -81.27 -165.85 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.842 1.443 . . . . 0.0 110.097 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.77 ' HA ' HD11 ' A' ' 56' ' ' LEU . 67.0 mtm -120.48 17.11 12.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.267 -0.896 . . . . 0.0 110.609 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.523 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 42.0 m -117.04 95.47 5.01 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.039 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.611 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -57.12 106.71 0.72 Allowed Pre-proline 0 C--N 1.291 -1.962 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.491 178.6 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.048 ' HG2' HD23 ' A' ' 94' ' ' LEU . 50.9 Cg_endo -75.16 169.3 22.84 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.668 1.352 . . . . 0.0 109.826 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.64 -12.71 26.97 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.857 1.451 . . . . 0.0 111.012 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -86.67 8.44 22.41 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.086 -1.009 . . . . 0.0 109.477 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.048 HD23 ' HG2' ' A' ' 91' ' ' PRO . 1.4 mm? -113.75 6.18 16.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 110.597 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 95' ' ' VAL . 9.9 p -120.48 124.27 27.73 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.068 -1.02 . . . . 0.0 110.713 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.08 159.81 51.16 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.077 1.567 . . . . 0.0 110.115 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.78 1.09 7.39 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.007 1.53 . . . . 0.0 110.644 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 p -76.79 -28.86 55.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.123 -0.986 . . . . 0.0 110.15 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -89.23 8.05 32.3 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.362 -0.836 . . . . 0.0 109.31 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.464 -0.772 . . . . 0.0 110.167 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.481 0.778 0 N-CA-C 110.435 -0.641 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.585 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 19.0 t90 -98.05 132.84 43.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.395 -0.816 . . . . 0.0 110.055 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -40.97 -34.4 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.401 -0.812 . . . . 0.0 110.839 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.585 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 61.2 t -108.39 141.36 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 110.384 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.573 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -99.42 -177.13 0.55 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.385 -0.822 . . . . 0.0 109.909 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.573 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.6 Cg_endo -69.43 -35.99 12.55 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.662 1.349 . . . . 0.0 109.834 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 10' ' ' LYS . 20.3 pt-20 -68.46 -25.75 65.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 109.825 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.433 ' HB2' HG13 ' A' ' 9' ' ' VAL . 39.7 m-20 -86.13 -38.86 17.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.308 -0.87 . . . . 0.0 108.912 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.424 ' NZ ' ' OD1' ' A' ' 68' ' ' ASP . 3.8 ttmt -75.48 -17.25 60.18 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -74.88 -31.12 61.52 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.657 ' HG3' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -86.45 -21.28 27.16 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.657 ' CD1' ' HG3' ' A' ' 16' ' ' LYS . 17.7 m-30 -78.9 -33.39 45.63 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -13.84 62.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.859 -0.526 . . . . 0.0 110.009 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -89.31 -34.06 16.7 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.558 HG22 ' CE2' ' A' ' 70' ' ' PHE . 22.2 mt -80.72 -35.91 15.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.604 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -68.37 -35.39 77.65 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.55 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.3 t0 -89.1 -1.7 58.21 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.446 -0.784 . . . . 0.0 109.987 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -91.04 -1.51 57.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 0.0 108.648 178.442 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.864 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -109.38 -3.82 16.82 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 81.26 87.52 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 121.454 0.645 . . . . 0.0 109.265 -178.842 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -72.32 147.65 47.68 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 O-C-N 124.65 1.869 . . . . 0.0 110.896 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 61.3 t -116.26 106.59 20.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.576 -0.703 . . . . 0.0 109.186 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 9.1 t30 57.1 26.55 12.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.265 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 88.24 36.14 8.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.582 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 87.4 m-85 -150.31 160.14 43.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.433 -1.039 . . . . 0.0 111.142 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.864 HD22 ' HB2' ' A' ' 24' ' ' LEU . 12.3 mt -136.25 134.04 37.64 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.568 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -83.08 139.89 32.97 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.854 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -38.77 -28.52 0.07 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.6 OUTLIER -53.04 -35.58 59.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.347 -1.09 . . . . 0.0 111.064 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 1.3 mttm -97.41 -42.13 7.89 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.083 -1.01 . . . . 0.0 109.561 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.956 HG11 HD12 ' A' ' 65' ' ' LEU . 41.9 t -71.61 -47.45 57.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.62 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.572 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 40.9 tttp -45.99 -52.12 28.04 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 110.819 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.935 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.6 Cg_endo -66.48 -34.15 34.77 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.262 1.138 . . . . 0.0 109.164 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.846 HG21 HD22 ' A' ' 24' ' ' LEU . 2.2 t -62.77 -28.02 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.274 0.559 . . . . 0.0 109.606 178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.9 ' HB3' HD22 ' A' ' 50' ' ' LEU . 30.3 mt -83.62 -14.76 51.25 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.168 -0.958 . . . . 0.0 109.479 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.935 HD12 ' HA ' ' A' ' 38' ' ' PRO . 21.5 mt -78.8 -29.01 44.65 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.408 ' OD1' ' HA ' ' A' ' 39' ' ' VAL . 17.9 m120 -58.13 -28.29 64.54 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.036 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.601 ' HB2' HD11 ' A' ' 81' ' ' LEU . 3.6 p -62.2 -13.01 23.25 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.638 -0.664 . . . . 0.0 109.648 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 75.6 13.63 2.93 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.445 0.64 . . . . 0.0 109.864 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.031 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.4 mt -85.92 158.59 55.92 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.498 -0.751 . . . . 0.0 109.834 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.558 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.5 Cg_endo -73.22 157.3 50.39 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 O-C-N 124.088 1.573 . . . . 0.0 110.265 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.0 t -58.28 -10.92 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.42 -0.8 . . . . 0.0 111.109 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -73.85 -41.96 61.49 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.83 -1.169 . . . . 0.0 108.213 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.983 HG21 HD13 ' A' ' 45' ' ' LEU . 12.9 mm -61.95 -44.55 99.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.9 HD22 ' HB3' ' A' ' 40' ' ' LEU . 11.1 mt -62.17 -20.79 64.51 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.2 -28.51 36.64 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.582 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 0.3 OUTLIER -97.68 -57.21 2.29 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.529 -0.983 . . . . 0.0 109.665 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.701 HG11 ' CG2' ' A' ' 77' ' ' VAL . 3.8 t -47.42 -34.92 3.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.204 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 7.5 t-105 -75.11 -58.98 2.95 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.979 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.572 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 2.9 pt-20 -47.21 -46.22 23.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.621 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.782 HD11 ' O ' ' A' ' 87' ' ' PRO . 7.6 mt -76.52 -12.31 60.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.46 -0.775 . . . . 0.0 109.456 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 1.075 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 2.6 t -96.55 -35.06 11.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.362 -0.836 . . . . 0.0 110.002 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.498 ' HA ' HD23 ' A' ' 65' ' ' LEU . 11.4 t0 -77.69 86.09 3.99 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.456 HG22 ' HE2' ' A' ' 99' ' ' LYS . 36.1 mm -50.35 -32.59 9.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.647 -0.658 . . . . 0.0 111.16 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 53.8 p30 -103.65 -15.1 15.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.933 -1.105 . . . . 0.0 111.256 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.543 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 3.0 m-70 63.88 43.85 5.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.845 -1.159 . . . . 0.0 109.726 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 6.2 p-10 -107.17 15.69 24.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 110.588 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.91 8.35 87.74 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.568 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 3.6 mtt -142.07 160.82 39.46 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.362 -1.081 . . . . 0.0 110.478 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.956 HD12 HG11 ' A' ' 36' ' ' VAL . 47.4 mt -127.04 120.37 28.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 110.79 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.582 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 8.7 t0 -69.57 164.53 23.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.947 -1.095 . . . . 0.0 109.326 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.508 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 8.9 ptm180 -45.81 -34.46 3.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 110.468 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 10.2 m-20 -85.81 -32.57 21.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.102 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 16.1 mt-10 -71.13 -42.75 68.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.94 . . . . 0.0 108.819 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.682 ' CE1' HG13 ' A' ' 36' ' ' VAL . 42.3 t80 -59.22 -32.56 70.07 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -57.32 -48.37 79.14 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.768 0.794 . . . . 0.0 110.161 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.039 HG13 HD12 ' A' ' 94' ' ' LEU . 87.5 t -59.8 -26.61 35.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.645 -0.659 . . . . 0.0 110.739 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.075 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -86.97 -5.62 59.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.159 -0.963 . . . . 0.0 111.723 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.612 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 14.4 mmm -90.45 -41.24 11.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.604 -1.31 . . . . 0.0 110.096 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.978 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.3 p90 -79.38 -17.45 54.39 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.868 -1.133 . . . . 0.0 108.477 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 76' ' ' LEU . 6.8 mt -82.57 -20.88 35.65 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.772 HG21 HD22 ' A' ' 40' ' ' LEU . 77.7 t -90.89 -41.83 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.565 -0.709 . . . . 0.0 109.723 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -71.32 -21.0 62.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.385 -0.822 . . . . 0.0 110.126 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 7.6 t -80.82 -15.14 57.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.268 -0.895 . . . . 0.0 109.087 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.031 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.17 -13.61 35.26 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.52 -0.737 . . . . 0.0 109.38 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.83 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.7 mt -90.5 -33.78 15.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.0 109.222 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 42.8 tp10 -70.06 -53.64 16.6 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.663 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER 176.41 -18.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.126 -1.03 . . . . 0.0 112.723 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 67.5 mm-40 -98.56 122.45 53.36 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 120.543 -1.348 . . . . 0.0 111.465 -178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.17 -167.27 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.981 1.516 . . . . 0.0 110.249 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.54 HG21 ' CG2' ' A' ' 53' ' ' VAL . 61.5 t -130.4 140.38 38.47 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.0 110.435 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.782 ' O ' HD11 ' A' ' 56' ' ' LEU . 51.4 Cg_endo -86.74 -168.66 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.979 1.515 . . . . 0.0 110.159 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.582 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 10.7 mtp -113.65 6.95 17.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.335 -0.853 . . . . 0.0 110.684 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.502 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.1 m -114.24 104.43 12.08 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.442 -1.303 . . . . 0.0 112.135 -177.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.653 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -60.24 107.94 1.23 Allowed Pre-proline 0 C--N 1.288 -2.071 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.379 178.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.032 ' HG2' HD23 ' A' ' 94' ' ' LEU . 41.1 Cg_endo -66.36 167.36 18.79 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.855 1.45 . . . . 0.0 109.946 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.67 -12.46 29.04 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.945 1.497 . . . . 0.0 111.628 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.632 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -87.07 2.53 49.42 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.073 -1.017 . . . . 0.0 110.113 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.039 HD12 HG13 ' A' ' 72' ' ' VAL . 3.0 mm? -107.69 -0.37 21.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.145 -0.972 . . . . 0.0 111.052 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.2 t -103.42 117.34 60.34 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.964 -1.085 . . . . 0.0 110.695 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 42.4 Cg_endo -69.45 173.24 10.99 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.987 1.519 . . . . 0.0 110.142 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.554 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 46.0 Cg_endo -73.13 -19.33 22.88 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.913 1.481 . . . . 0.0 110.93 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -20.85 63.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.976 -1.077 . . . . 0.0 109.886 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.456 ' HE2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -95.46 11.9 31.26 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.864 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.554 ' CG ' ' HA ' ' A' ' 97' ' ' PRO . 5.5 mmt180 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.327 -0.858 . . . . 0.0 110.467 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.481 0.76 0 N-CA-C 110.632 -0.565 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.617 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.7 t90 -94.17 132.02 39.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.494 -0.754 . . . . 0.0 109.81 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -47.21 -30.36 2.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.009 . . . . 0.0 110.16 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.617 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 72.5 t -102.3 149.69 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.397 -0.814 . . . . 0.0 109.857 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.531 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -126.74 171.91 7.34 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.422 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.684 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.8 Cg_endo -62.91 -34.18 72.47 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.741 1.39 . . . . 0.0 110.592 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -72.98 -35.64 66.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 109.62 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -83.19 -41.29 18.62 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' HG3' ' CB ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -70.03 -15.19 62.97 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.237 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -67.18 -40.82 86.63 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.638 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.9 ptpt -75.79 -25.87 56.79 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.638 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -72.61 -33.75 66.89 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.7 -10.9 60.16 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.41 0.624 . . . . 0.0 109.7 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.58 -35.91 14.74 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.647 HD13 ' SD ' ' A' ' 74' ' ' MET . 19.8 mt -76.73 -34.78 23.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.618 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -70.81 -33.56 70.82 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.554 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.9 t0 -88.97 -3.11 58.82 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.546 -0.721 . . . . 0.0 109.892 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.1 m -85.65 -13.73 47.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.084 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.617 HD12 HD13 ' A' ' 31' ' ' LEU . 4.4 mt -100.11 -11.7 20.27 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.607 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 t 85.6 99.41 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.152 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.3 Cg_endo -74.87 148.79 36.41 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 O-C-N 124.337 1.704 . . . . 0.0 110.807 -178.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 60.2 t -117.95 107.87 23.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 121.746 -0.596 . . . . 0.0 109.617 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 6.0 t30 56.9 17.5 3.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.359 -0.838 . . . . 0.0 109.421 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 96.96 36.0 5.14 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.605 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 94.7 m-85 -151.28 160.08 44.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -1.129 . . . . 0.0 110.877 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.627 HD12 ' CD2' ' A' ' 70' ' ' PHE . 37.8 mt -130.81 129.45 42.4 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.558 ' CA ' ' HE3' ' A' ' 64' ' ' MET . 12.2 p -78.23 139.97 38.91 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.854 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.04 -28.78 0.52 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 32' ' ' SER . 13.1 t70 -61.54 -11.23 10.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -1.142 . . . . 0.0 110.269 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' A' ' 24' ' ' LEU . 17.9 mtpp -116.27 -34.83 4.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -0.975 . . . . 0.0 109.02 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.872 HG22 ' HE2' ' A' ' 70' ' ' PHE . 98.0 t -84.34 -36.31 11.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.401 0.619 . . . . 0.0 109.694 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.65 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.3 tttt -48.37 -47.86 67.44 Favored Pre-proline 0 N--CA 1.487 1.384 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.158 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.995 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.7 Cg_endo -67.77 -30.74 33.5 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.407 1.214 . . . . 0.0 109.018 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.5 t -73.99 -9.43 12.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.798 -0.564 . . . . 0.0 109.584 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.001 ' HB3' HD22 ' A' ' 50' ' ' LEU . 82.4 mt -100.18 -15.92 17.96 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.139 -0.976 . . . . 0.0 108.515 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.995 HD12 ' HA ' ' A' ' 38' ' ' PRO . 7.0 mt -89.95 -37.31 14.45 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.549 -0.72 . . . . 0.0 110.16 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 4.0 p-10 -58.68 -16.45 16.37 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.153 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.487 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.8 OUTLIER -73.71 -1.83 20.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.374 -0.829 . . . . 0.0 109.871 179.275 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 68.69 14.98 9.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.235 -0.916 . . . . 0.0 110.207 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.922 HD13 HG21 ' A' ' 49' ' ' ILE . 15.4 mt -91.79 155.94 43.09 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.07 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' HG13 ' A' ' 49' ' ' ILE . 40.8 Cg_endo -73.23 154.24 51.54 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.889 1.468 . . . . 0.0 110.466 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.0 t -58.53 -10.6 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.32 -0.863 . . . . 0.0 110.777 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -39.51 68.58 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.887 -1.133 . . . . 0.0 107.987 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.964 HG23 HG21 ' A' ' 86' ' ' VAL . 30.3 mm -64.96 -43.61 96.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.001 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.7 mt -63.89 -14.47 53.66 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.365 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 55' ' ' GLU . . . -83.37 -36.1 15.48 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.455 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 5.1 mtm-85 -94.23 -52.34 4.41 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.598 -0.942 . . . . 0.0 109.984 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.653 HG21 HG22 ' A' ' 49' ' ' ILE . 24.3 t -44.18 -50.29 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.59 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.547 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 7.2 t-105 -66.32 -57.68 6.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 0.0 110.174 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.533 ' HG2' ' HG ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER -53.84 -38.52 64.73 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.927 -1.108 . . . . 0.0 109.127 -179.433 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.868 HD22 ' N ' ' A' ' 90' ' ' LEU . 94.4 mt -81.33 -14.88 56.8 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.701 -0.624 . . . . 0.0 109.386 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.948 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 10.7 m -97.78 -35.34 10.57 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.365 -0.834 . . . . 0.0 110.159 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.592 ' HA ' HD23 ' A' ' 65' ' ' LEU . 16.9 t0 -75.32 69.39 2.13 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.63 HG21 ' CD ' ' A' ' 99' ' ' LYS . 35.8 mm -35.2 -31.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.056 0.455 . . . . 0.0 111.0 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.541 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 14.7 p-10 -104.73 -16.66 14.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.055 -1.028 . . . . 0.0 111.333 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.541 ' CG ' ' C ' ' A' ' 60' ' ' ASP . 1.7 m-70 58.2 30.59 19.64 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.836 -1.165 . . . . 0.0 109.48 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.475 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 2.5 p-10 -84.32 -11.72 55.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.414 -0.804 . . . . 0.0 110.053 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 116.82 5.34 15.76 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.596 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 3.5 mtp -150.05 160.8 43.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -1.175 . . . . 0.0 110.164 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.833 ' CD1' HG11 ' A' ' 36' ' ' VAL . 16.8 mt -115.57 115.24 26.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.077 -1.015 . . . . 0.0 109.53 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.605 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 3.7 t70 -69.15 171.11 8.83 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.011 -1.055 . . . . 0.0 109.809 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 4.4 ptm180 -46.18 -42.43 14.05 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.63 -0.669 . . . . 0.0 110.658 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.468 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -78.71 -33.98 46.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.0 110.345 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.503 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 28.0 mt-10 -74.53 -43.18 57.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.973 . . . . 0.0 109.2 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.872 ' HE2' HG22 ' A' ' 36' ' ' VAL . 18.3 t80 -61.0 -21.58 63.71 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.483 -0.761 . . . . 0.0 109.327 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.432 ' CB ' ' HG3' ' A' ' 14' ' ' LYS . . . -73.08 -40.86 64.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.345 -0.847 . . . . 0.0 109.45 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.883 HG13 HD12 ' A' ' 94' ' ' LEU . 60.1 t -63.2 -27.04 42.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.513 0.673 . . . . 0.0 109.348 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.948 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.83 -4.84 56.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.528 -0.733 . . . . 0.0 110.862 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.647 ' SD ' HD13 ' A' ' 20' ' ' ILE . 11.3 mmt -84.59 -50.21 7.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.997 -1.065 . . . . 0.0 109.603 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.132 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 1.9 p90 -72.85 -31.62 64.89 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.577 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 9.9 mt -61.46 -31.22 71.17 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.716 HG21 ' CD2' ' A' ' 40' ' ' LEU . 46.0 t -92.16 -42.09 13.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.825 -0.547 . . . . 0.0 110.574 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.36 -40.42 62.12 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.821 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.566 ' CA ' ' HB3' ' A' ' 83' ' ' LYS . 69.5 m -76.46 -14.78 60.03 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.026 -1.047 . . . . 0.0 109.139 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.826 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -77.66 -11.44 59.87 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.635 HD23 ' N ' ' A' ' 81' ' ' LEU . 4.0 mt -91.12 -50.1 6.03 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.615 0.722 . . . . 0.0 109.949 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -134.13 38.94 3.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.518 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.566 ' HB3' ' CA ' ' A' ' 79' ' ' CYS . 7.7 ttmt -160.05 -91.61 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.303 -1.498 . . . . 0.0 112.342 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.414 ' N ' ' HG2' ' A' ' 83' ' ' LYS . 0.7 OUTLIER -117.63 148.63 43.42 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.104 -0.998 . . . . 0.0 111.146 -178.355 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -75.98 -162.39 0.16 Allowed 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 124.4 1.737 . . . . 0.0 110.316 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.964 HG21 HG23 ' A' ' 49' ' ' ILE . 13.4 t -115.62 145.04 33.67 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.517 -0.739 . . . . 0.0 109.583 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 86' ' ' VAL . 44.0 Cg_endo -87.52 -162.17 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.877 1.461 . . . . 0.0 109.73 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.6 mtt -129.31 12.4 6.0 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.26 -0.9 . . . . 0.0 110.945 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 90' ' ' LEU . 22.8 t -165.95 23.54 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.931 -1.106 . . . . 0.0 111.279 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.868 ' N ' HD22 ' A' ' 56' ' ' LEU . 2.1 mt 54.89 116.81 0.01 OUTLIER Pre-proline 0 C--N 1.284 -2.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.012 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.014 ' HG2' HD23 ' A' ' 94' ' ' LEU . 44.3 Cg_endo -72.77 175.02 10.88 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.597 1.314 . . . . 0.0 109.16 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 50.1 Cg_endo -74.34 -19.9 19.09 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.632 1.332 . . . . 0.0 111.67 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.604 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -90.29 28.44 1.44 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.97 -1.081 . . . . 0.0 109.479 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.132 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -127.06 -25.69 3.25 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.822 -178.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 95' ' ' VAL . 27.3 m -91.3 136.32 27.19 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.051 -1.03 . . . . 0.0 111.036 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.523 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 42.9 Cg_endo -70.91 161.69 45.22 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.955 1.503 . . . . 0.0 109.261 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.512 ' HA ' ' CD ' ' A' ' 100' ' ' ARG . 46.7 Cg_endo -71.35 -24.29 23.0 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 123.954 1.502 . . . . 0.0 111.537 -178.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.3 t -84.47 -0.01 51.34 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.804 -1.185 . . . . 0.0 110.195 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.63 ' CD ' HG21 ' A' ' 59' ' ' ILE . 8.6 mmtt -106.64 -1.1 23.18 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.389 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.539 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 O-C-N 121.111 -0.993 . . . . 0.0 110.812 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.483 0.906 0 N-CA-C 110.336 -0.679 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.526 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.1 t90 -48.69 130.92 17.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.648 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -40.62 -27.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 110.525 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.526 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 91.1 t -102.9 138.74 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.87 . . . . 0.0 109.938 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -97.15 -179.91 0.98 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.314 -0.866 . . . . 0.0 110.434 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.3 Cg_endo -69.23 -35.51 14.06 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.934 1.492 . . . . 0.0 110.049 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -75.54 -28.41 59.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.375 -0.828 . . . . 0.0 109.835 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.569 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -83.29 -37.17 23.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.209 -0.932 . . . . 0.0 108.59 178.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 13.8 tptp -69.73 -20.16 63.52 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.08 -44.07 63.85 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.606 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 6.5 ptpt -74.51 -24.17 58.94 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.606 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.6 m-30 -74.25 -35.61 63.82 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -76.8 -9.73 58.88 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.302 0.572 . . . . 0.0 110.031 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.74 -34.97 13.01 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.734 HG22 ' CE1' ' A' ' 70' ' ' PHE . 37.6 mt -78.04 -30.18 15.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.823 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -74.44 -39.53 62.51 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.555 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.551 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 32.6 t70 -88.59 4.39 47.09 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.611 -0.681 . . . . 0.0 109.831 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.46 ' C ' HD23 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -90.54 -15.63 30.31 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.769 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.847 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -97.75 -8.0 29.5 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.846 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 84.48 98.21 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.4 Cg_endo -74.27 146.63 36.17 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.056 1.556 . . . . 0.0 110.762 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 27.3 t -116.33 98.57 6.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.505 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 64.97 22.44 12.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.359 -0.838 . . . . 0.0 109.393 -179.124 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 91.97 32.35 8.53 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.521 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 93.8 m-85 -150.23 152.76 35.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.407 -1.055 . . . . 0.0 111.145 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.847 HD22 ' HB2' ' A' ' 24' ' ' LEU . 32.5 mt -124.7 131.85 53.43 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 33' ' ' GLY . 93.9 p -78.19 137.39 38.13 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.272 -0.893 . . . . 0.0 110.43 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.57 -30.86 0.95 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -60.47 -16.24 34.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -1.082 . . . . 0.0 110.318 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 21.3 mtpp -108.38 -35.3 6.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 109.121 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.899 HG11 HD12 ' A' ' 65' ' ' LEU . 96.8 t -82.77 -31.12 9.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.618 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -50.17 -52.45 53.55 Favored Pre-proline 0 C--N 1.305 -1.363 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.897 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.942 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.6 Cg_endo -64.92 -31.44 56.52 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.581 1.306 . . . . 0.0 109.246 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 4.3 t -74.87 -10.66 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.447 0.642 . . . . 0.0 109.772 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.801 ' HB3' HD22 ' A' ' 50' ' ' LEU . 78.5 mt -100.24 -15.51 18.06 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 38' ' ' PRO . 8.4 mt -88.3 -44.58 10.71 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.569 -0.707 . . . . 0.0 109.486 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 8.2 p-10 -47.83 -25.33 1.25 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.722 -1.191 . . . . 0.0 108.62 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.57 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 12.5 m -61.67 -12.15 14.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.508 -0.745 . . . . 0.0 110.032 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 43' ' ' SER . 3.5 tptp 74.1 18.84 3.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.231 -0.918 . . . . 0.0 109.956 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.835 HD13 HG21 ' A' ' 49' ' ' ILE . 15.4 mt -100.1 158.36 32.16 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 110.087 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.524 ' HG2' HG12 ' A' ' 49' ' ' ILE . 41.5 Cg_endo -73.08 156.54 51.7 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 123.934 1.491 . . . . 0.0 110.647 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 t -58.3 -10.85 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.662 -0.649 . . . . 0.0 110.88 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.58 -41.32 60.72 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.866 -1.146 . . . . 0.0 108.432 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.835 HG21 HD13 ' A' ' 45' ' ' LEU . 11.8 mm -64.24 -44.9 97.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.801 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.8 mt -66.98 -16.99 64.71 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.711 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.29 -32.84 15.56 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.374 -1.891 . . . . 0.0 108.374 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.623 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -92.5 -53.67 4.11 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.517 -0.99 . . . . 0.0 109.526 179.321 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.755 HG11 HG23 ' A' ' 77' ' ' VAL . 32.5 t -47.83 -32.08 2.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.25 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.529 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 8.2 t-105 -74.11 -59.29 2.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.841 . . . . 0.0 110.084 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.561 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 5.0 pt-20 -47.67 -45.62 28.34 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.501 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.926 HD21 ' C ' ' A' ' 88' ' ' MET . 2.7 mt -75.91 -11.74 60.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.579 -0.7 . . . . 0.0 109.57 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 1.025 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 2.8 t -99.28 -36.11 9.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.634 -0.666 . . . . 0.0 110.758 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.469 ' HA ' HD23 ' A' ' 65' ' ' LEU . 26.9 t0 -82.61 86.63 6.79 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.483 -0.76 . . . . 0.0 109.454 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.474 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 32.1 mm -51.55 -36.24 17.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.75 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 3.5 m-20 -90.33 -17.05 28.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.538 -0.726 . . . . 0.0 110.566 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 33.1 p80 40.25 39.77 0.71 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.816 0.817 . . . . 0.0 109.23 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -98.17 -9.65 25.39 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.754 -0.591 . . . . 0.0 110.192 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.479 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 126.57 4.39 6.29 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 6.0 mtp -149.54 160.72 43.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.093 -1.24 . . . . 0.0 110.491 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.899 HD12 HG11 ' A' ' 36' ' ' VAL . 34.1 mt -112.49 112.25 23.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.583 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.536 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 17.3 t0 -69.62 166.93 17.99 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.895 -1.128 . . . . 0.0 110.106 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.541 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -42.16 -44.45 3.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.528 -0.732 . . . . 0.0 111.012 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 8.7 p-10 -78.02 -43.01 30.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.368 -0.832 . . . . 0.0 110.162 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.536 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 33.7 mt-10 -61.64 -48.99 78.34 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.656 -0.653 . . . . 0.0 109.779 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.777 ' HE2' HG22 ' A' ' 36' ' ' VAL . 43.5 t80 -58.94 -26.22 64.21 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.395 -0.815 . . . . 0.0 109.373 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -67.22 -45.99 75.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.647 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.022 HG13 HD12 ' A' ' 94' ' ' LEU . 88.3 t -60.45 -23.04 27.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.542 -0.723 . . . . 0.0 110.018 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.025 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -89.73 -5.33 57.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.291 -0.88 . . . . 0.0 110.932 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.581 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 1.6 mmm -89.33 -44.86 9.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.999 -1.063 . . . . 0.0 110.038 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.091 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.5 p90 -76.24 -25.22 54.8 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.746 ' HB3' HG13 ' A' ' 53' ' ' VAL . 4.8 mt -69.99 -28.33 65.44 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.755 HG23 HG11 ' A' ' 53' ' ' VAL . 53.6 t -89.35 -29.59 5.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.658 ' HA ' HD12 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -79.53 -25.08 41.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.428 -0.795 . . . . 0.0 110.524 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -87.08 -10.65 52.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 110.172 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.767 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.54 -20.16 30.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.354 -0.841 . . . . 0.0 109.658 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.658 HD12 ' HA ' ' A' ' 78' ' ' TYR . 1.3 mt -92.35 -36.47 13.14 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.556 0.693 . . . . 0.0 110.694 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.54 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 10.2 mt-10 -66.47 -50.51 63.05 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.525 -0.87 . . . . 0.0 108.792 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.54 ' CG ' ' O ' ' A' ' 82' ' ' GLU . 3.6 mttt 174.49 -20.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 118.852 -1.139 . . . . 0.0 112.638 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 57.3 mm-40 -85.1 124.24 72.46 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 120.705 -1.247 . . . . 0.0 111.426 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.98 -179.38 3.41 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.845 1.445 . . . . 0.0 109.862 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.58 HG11 HG23 ' A' ' 53' ' ' VAL . 24.3 t -128.62 127.97 23.55 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.036 -1.04 . . . . 0.0 110.757 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.644 ' O ' HD11 ' A' ' 56' ' ' LEU . 47.0 Cg_endo -89.24 -164.94 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.935 1.492 . . . . 0.0 109.344 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.926 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -123.61 6.12 8.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.368 -0.833 . . . . 0.0 110.253 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.599 ' N ' HD21 ' A' ' 56' ' ' LEU . 55.1 m -105.65 98.44 8.13 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 119.114 -1.034 . . . . 0.0 111.294 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.731 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -54.96 107.14 0.78 Allowed Pre-proline 0 C--N 1.293 -1.866 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.753 179.256 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.057 ' HG2' HD23 ' A' ' 94' ' ' LEU . 42.5 Cg_endo -68.75 162.69 40.17 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.995 1.523 . . . . 0.0 109.984 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.435 ' O ' HG22 ' A' ' 95' ' ' VAL . 43.2 Cg_endo -69.97 -13.35 34.04 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.825 1.434 . . . . 0.0 111.149 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -89.04 19.92 3.92 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.011 -1.055 . . . . 0.0 109.308 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.091 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 1.9 mm? -121.03 -13.61 8.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.469 -0.769 . . . . 0.0 110.451 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 95' ' ' VAL . 30.6 m -86.88 120.76 71.81 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 0.0 111.119 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.512 ' HG3' ' HB2' ' A' ' 68' ' ' ASP . 45.9 Cg_endo -74.36 176.7 9.3 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 124.039 1.547 . . . . 0.0 109.26 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.525 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 42.3 Cg_endo -69.04 62.84 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.52 1.274 . . . . 0.0 110.771 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.56 -56.58 0.52 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 5.2 tptt -89.59 11.9 18.31 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.525 ' CG ' ' HA ' ' A' ' 97' ' ' PRO . 44.4 mmm-85 . . . . . 0 N--CA 1.494 1.75 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.154 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 N--CA 1.484 0.921 0 CA-C-O 121.481 0.534 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.605 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.8 t90 -96.11 138.59 33.51 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.449 -0.782 . . . . 0.0 110.114 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -59.24 -25.72 64.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 110.285 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.605 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 18.8 t -95.07 160.35 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.575 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -108.32 171.32 4.63 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.069 -1.019 . . . . 0.0 110.491 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.11 -34.48 10.17 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.231 1.648 . . . . 0.0 109.53 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -78.76 -28.98 44.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.578 -0.702 . . . . 0.0 109.349 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.539 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 1.6 m-20 -81.11 -34.22 32.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.456 -0.777 . . . . 0.0 108.913 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 67' ' ' ARG . 16.2 tptt -72.35 -19.98 61.55 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.604 0.716 . . . . 0.0 109.225 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.87 -41.7 61.81 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.622 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.49 -26.09 60.75 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.577 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.622 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.3 m-30 -74.34 -38.34 63.28 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 3.1 t70 -73.17 -12.35 60.85 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.279 0.561 . . . . 0.0 110.207 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.61 -32.77 13.27 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.702 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.253 42.3 mt -78.34 -28.76 14.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.895 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.972 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.7 -37.77 65.08 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.6 t70 -90.29 1.65 56.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.697 -0.627 . . . . 0.0 109.926 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.427 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.4 t -91.89 -2.74 56.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 108.658 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.975 HD12 HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -112.7 -3.51 14.25 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.47 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.6 t 80.3 96.9 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.9 Cg_endo -71.29 147.31 52.94 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 O-C-N 124.427 1.751 . . . . 0.0 110.548 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 43.0 t -118.05 101.66 12.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 22.0 t-20 57.98 30.78 19.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.859 . . . . 0.0 109.624 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.488 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 85.79 34.72 12.69 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.586 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 93.7 m-85 -151.11 153.83 35.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -1.162 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.975 HD13 HD12 ' A' ' 24' ' ' LEU . 24.2 mt -124.68 122.95 38.95 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.675 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.551 ' CA ' ' HE3' ' A' ' 64' ' ' MET . 0.7 OUTLIER -72.92 139.99 47.18 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.612 0.72 . . . . 0.0 111.108 -178.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -46.39 -25.3 1.94 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -58.55 -33.67 70.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -1.104 . . . . 0.0 110.281 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.562 ' HD3' ' CA ' ' A' ' 31' ' ' LEU . 5.1 ptmt -99.96 -28.19 13.21 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.874 0.845 . . . . 0.0 109.714 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.69 HG11 HD12 ' A' ' 65' ' ' LEU . 72.1 t -80.73 -48.37 19.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 CA-C-O 121.444 0.64 . . . . 0.0 109.629 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.61 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.25 -51.98 7.74 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.462 -0.774 . . . . 0.0 110.493 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.809 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.6 Cg_endo -66.28 -33.06 40.36 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 108.889 -1.235 . . . . 0.0 108.889 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.893 HG21 HD22 ' A' ' 24' ' ' LEU . 2.7 t -72.36 -12.23 15.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.949 ' HB3' HD22 ' A' ' 50' ' ' LEU . 90.4 mt -97.85 -16.87 19.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 38' ' ' PRO . 92.5 mt -78.92 -36.41 41.92 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.56 -0.713 . . . . 0.0 109.286 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 8.2 p-10 -46.42 -23.87 0.43 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.552 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 1.034 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -73.93 6.34 3.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.566 -0.709 . . . . 0.0 111.091 -179.405 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.26 15.36 1.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.755 -1.215 . . . . 0.0 110.051 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.028 HD13 HG21 ' A' ' 49' ' ' ILE . 15.3 mt -93.59 158.76 36.18 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.117 -0.99 . . . . 0.0 109.856 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.556 ' HD2' HG13 ' A' ' 49' ' ' ILE . 41.4 Cg_endo -72.87 157.39 51.66 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.978 1.515 . . . . 0.0 110.294 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.6 t -59.66 -11.24 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 110.706 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.03 -36.49 69.67 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.915 -1.116 . . . . 0.0 108.18 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.028 HG21 HD13 ' A' ' 45' ' ' LEU . 32.6 mm -68.51 -45.2 82.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.949 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.6 mt -65.55 -20.39 66.31 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.486 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . -85.2 -30.02 26.43 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.527 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 16.0 ttm-85 -93.03 -55.43 3.35 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.467 -1.019 . . . . 0.0 109.562 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.826 HG11 HG23 ' A' ' 77' ' ' VAL . 39.4 t -49.76 -38.45 13.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.103 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.532 ' HA ' ' HB2' ' A' ' 57' ' ' SER . 8.6 t-105 -64.93 -56.67 11.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 109.3 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 68.5 mm-40 -44.52 -55.3 5.23 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.484 -0.76 . . . . 0.0 109.977 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.886 HD11 ' HA ' ' A' ' 88' ' ' MET . 4.7 mt -70.75 -10.5 59.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 0.0 109.913 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.856 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 17.4 m -96.15 -37.43 10.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 110.118 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.659 ' HA ' HD23 ' A' ' 65' ' ' LEU . 13.5 t0 -77.61 70.48 3.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.358 -0.839 . . . . 0.0 109.27 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.428 HG23 ' HD2' ' A' ' 99' ' ' LYS . 45.2 mm -39.95 -31.73 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.637 -0.664 . . . . 0.0 110.789 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 62' ' ' ASP . 0.6 OUTLIER -98.79 -23.48 15.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.369 -0.832 . . . . 0.0 110.6 -178.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 78.2 m80 57.41 49.62 12.68 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.189 -0.944 . . . . 0.0 110.545 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.487 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 5.7 p-10 -111.97 0.99 16.22 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.041 -1.037 . . . . 0.0 110.286 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 112.43 2.43 26.04 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.551 ' HE3' ' CA ' ' A' ' 32' ' ' SER . 5.0 mtp -149.1 160.06 43.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.991 -1.299 . . . . 0.0 110.616 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.69 HD12 HG11 ' A' ' 36' ' ' VAL . 70.8 mt -111.69 115.24 28.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.551 -0.718 . . . . 0.0 109.948 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.586 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 7.0 t0 -69.18 164.18 23.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.892 -1.13 . . . . 0.0 109.733 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.54 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 1.7 ptt180 -37.76 -42.28 0.57 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.677 -0.64 . . . . 0.0 111.512 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.54 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -84.74 -33.02 23.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.211 -0.931 . . . . 0.0 110.888 -179.202 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 24.3 mt-10 -69.72 -42.65 73.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 109.368 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.702 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 50.5 t80 -64.14 -28.88 70.06 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.559 -0.713 . . . . 0.0 109.178 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -61.73 -48.95 78.41 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.774 0.797 . . . . 0.0 109.964 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.014 ' CG1' HD11 ' A' ' 94' ' ' LEU . 70.7 t -59.25 -24.03 26.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.685 -0.634 . . . . 0.0 110.424 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.856 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -86.71 -8.7 57.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.156 -0.965 . . . . 0.0 112.003 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.602 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 12.0 mmm -90.08 -40.5 12.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.639 -1.288 . . . . 0.0 110.489 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.519 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.6 p90 -78.19 -19.02 54.72 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.789 -1.165 . . . . 0.0 108.374 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.675 HD22 HG13 ' A' ' 86' ' ' VAL . 9.2 mt -80.91 -23.63 38.82 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.468 0.652 . . . . 0.0 109.48 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.826 HG23 HG11 ' A' ' 53' ' ' VAL . 70.1 t -91.65 -32.16 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.529 -0.732 . . . . 0.0 110.3 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.539 ' HA ' HD12 ' A' ' 81' ' ' LEU . 1.2 m-85 -80.04 -24.18 40.91 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.184 -0.947 . . . . 0.0 110.417 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 79.3 m -86.66 -13.76 44.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.256 -0.903 . . . . 0.0 109.395 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.841 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -76.69 -18.95 58.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.08 -1.012 . . . . 0.0 108.743 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.034 HD21 ' O ' ' A' ' 43' ' ' SER . 1.9 mt -92.41 -48.63 6.55 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.516 0.674 . . . . 0.0 111.471 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 82' ' ' GLU . 3.4 tp10 -108.03 -28.0 9.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 112.359 -177.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 79' ' ' CYS . 5.8 mttt -88.86 -87.68 0.16 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.727 -1.233 . . . . 0.0 111.19 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.546 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -155.31 177.92 1.85 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.081 -1.012 . . . . 0.0 110.306 -179.552 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 40.4 Cg_endo -65.99 171.9 9.32 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.819 1.431 . . . . 0.0 110.501 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.675 HG13 HD22 ' A' ' 76' ' ' LEU . 72.1 t -116.68 127.77 26.5 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.234 -0.916 . . . . 0.0 110.477 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.585 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.2 Cg_endo -80.43 -173.83 2.01 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.756 1.398 . . . . 0.0 109.617 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.886 ' HA ' HD11 ' A' ' 56' ' ' LEU . 20.1 mtm -114.68 20.98 14.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 0.0 110.347 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.496 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 69.0 m -111.18 103.89 12.36 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.696 -1.201 . . . . 0.0 111.434 -178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.8 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.1 mt -59.16 108.15 1.24 Allowed Pre-proline 0 C--N 1.293 -1.856 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.734 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 89' ' ' SER . 43.2 Cg_endo -68.77 141.9 50.85 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.948 1.499 . . . . 0.0 110.549 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.64 -4.54 14.83 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.027 1.54 . . . . 0.0 110.72 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -92.9 8.53 39.29 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.397 -0.814 . . . . 0.0 109.357 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.014 HD11 ' CG1' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -127.92 -7.8 5.5 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.589 0.709 . . . . 0.0 110.136 -178.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.428 ' HA ' ' HD2' ' A' ' 96' ' ' PRO . 46.8 t -82.45 113.28 43.19 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 120.888 -1.133 . . . . 0.0 110.721 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.487 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 42.4 Cg_endo -69.63 175.19 8.32 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.05 1.552 . . . . 0.0 110.093 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 98' ' ' SER . 41.7 Cg_endo -68.56 -172.98 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.858 1.451 . . . . 0.0 110.51 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.9 OUTLIER 75.24 -49.86 0.65 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.53 -0.731 . . . . 0.0 110.073 -179.098 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.428 ' HD2' HG23 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -88.27 13.13 12.19 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.131 -0.981 . . . . 0.0 108.552 178.597 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.431 ' O ' ' CG ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.412 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 7' ' ' TRP . 45.4 Cg_endo . . . . . 0 N--CA 1.484 0.953 0 N-CA-C 110.265 -0.706 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.511 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.8 t90 -44.62 128.95 6.84 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.215 -0.928 . . . . 0.0 109.255 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.666 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -40.64 -27.49 0.05 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 0.0 109.889 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.511 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 10.0 t -103.73 128.26 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.424 -0.797 . . . . 0.0 109.534 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.517 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.0 mttt -82.2 178.98 2.11 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.933 . . . . 0.0 110.156 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.6 Cg_endo -71.24 -35.12 9.01 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.01 1.532 . . . . 0.0 109.908 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 2.0 pt-20 -81.07 -19.89 42.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.423 -0.798 . . . . 0.0 109.446 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.515 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 0.3 OUTLIER -81.91 -39.89 23.13 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.202 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.01 -14.85 59.36 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.82 -37.49 55.6 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.634 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -77.24 -22.82 51.63 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.628 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 13.3 m-30 -77.32 -33.71 55.53 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -70.78 -8.82 55.21 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.319 0.58 . . . . 0.0 110.004 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.57 -34.64 14.66 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.509 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 34.0 mt -81.78 -30.11 10.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.59 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -74.14 -34.76 63.97 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.56 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.6 t70 -89.18 -4.5 58.22 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.676 -0.64 . . . . 0.0 110.213 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.59 -2.69 58.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 108.986 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.668 ' HB2' HD22 ' A' ' 31' ' ' LEU . 3.2 mt -107.14 -12.15 15.46 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.2 t 83.89 87.94 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 44.9 Cg_endo -71.21 150.92 60.19 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 O-C-N 124.739 1.915 . . . . 0.0 110.331 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 28.7 t -116.05 107.48 22.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.65 -0.656 . . . . 0.0 109.802 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 14.5 t-20 55.81 21.06 4.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.379 -0.825 . . . . 0.0 109.52 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 96.16 37.56 4.84 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 92.5 m-85 -150.89 159.94 44.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -1.141 . . . . 0.0 111.227 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.668 HD22 ' HB2' ' A' ' 24' ' ' LEU . 27.0 mt -137.77 129.68 28.68 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.591 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 2.7 p -75.01 137.88 41.83 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.421 -0.8 . . . . 0.0 110.871 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -43.91 -25.03 0.57 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' SER . 80.1 m-20 -65.15 -16.21 63.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.284 -1.127 . . . . 0.0 109.855 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 21.8 mtpp -105.12 -38.92 6.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.128 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.707 HG11 HD12 ' A' ' 65' ' ' LEU . 88.7 t -76.39 -33.18 22.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.544 0.688 . . . . 0.0 109.208 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.7 tttp -48.79 -56.04 17.05 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.724 -0.61 . . . . 0.0 110.228 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.711 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.5 Cg_endo -64.93 -28.4 58.22 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.73 1.384 . . . . 0.0 109.093 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.664 HG21 ' CD2' ' A' ' 24' ' ' LEU . 3.5 t -78.71 -11.01 13.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.3 0.571 . . . . 0.0 109.932 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.938 ' HB3' HD22 ' A' ' 50' ' ' LEU . 71.7 mt -101.08 -18.22 16.33 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.185 -0.947 . . . . 0.0 108.554 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.711 HD12 ' HA ' ' A' ' 38' ' ' PRO . 15.3 mt -85.14 -41.62 15.51 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.615 -0.678 . . . . 0.0 109.717 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 8.5 p-10 -50.19 -22.72 1.82 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.694 -1.202 . . . . 0.0 108.807 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.541 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 35.1 m -64.15 -7.27 8.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.623 -0.673 . . . . 0.0 110.615 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.4 OUTLIER 72.82 10.07 5.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.219 -0.925 . . . . 0.0 109.932 -179.605 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.091 HD13 HG21 ' A' ' 49' ' ' ILE . 13.0 mt -90.41 158.82 42.76 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.401 -0.812 . . . . 0.0 110.14 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.558 ' HD2' HG13 ' A' ' 49' ' ' ILE . 41.8 Cg_endo -75.72 167.21 26.82 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.992 1.522 . . . . 0.0 109.908 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 47' ' ' VAL . 43.8 t -69.2 -5.81 5.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.419 -0.801 . . . . 0.0 110.508 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.89 -39.79 34.07 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.183 -0.948 . . . . 0.0 108.547 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.091 HG21 HD13 ' A' ' 45' ' ' LEU . 27.8 mm -66.96 -44.08 88.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.938 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.5 mt -66.32 -17.0 64.5 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.072 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 55' ' ' GLU . . . -87.5 -29.75 20.85 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.667 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -93.57 -55.61 3.21 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.509 -0.994 . . . . 0.0 109.374 179.493 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.755 HG11 HG23 ' A' ' 77' ' ' VAL . 36.5 t -49.94 -55.33 5.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.535 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 6.6 t-105 -50.37 -56.85 9.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.517 -0.74 . . . . 0.0 110.37 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.501 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -49.97 -45.96 52.0 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.415 -179.176 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.736 HD21 ' C ' ' A' ' 88' ' ' MET . 2.5 mt -76.81 -8.57 57.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.659 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.891 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -99.34 -39.86 8.2 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.397 -0.814 . . . . 0.0 109.663 179.194 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.571 ' HA ' HD23 ' A' ' 65' ' ' LEU . 30.4 t0 -75.52 86.02 2.62 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.914 HG21 ' CG ' ' A' ' 99' ' ' LYS . 30.6 mm -49.36 -34.23 7.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.128 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 35.9 p-10 -103.47 -9.97 18.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.998 -1.064 . . . . 0.0 111.354 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.477 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 68.1 m80 55.63 41.62 30.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.953 -1.092 . . . . 0.0 109.517 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.46 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 3.4 p-10 -101.34 16.24 26.23 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.622 -0.674 . . . . 0.0 110.133 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.93 10.9 84.46 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.591 ' HG2' ' HA ' ' A' ' 32' ' ' SER . 5.0 mtt -142.31 160.3 40.53 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.389 -1.065 . . . . 0.0 110.638 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.707 HD12 HG11 ' A' ' 36' ' ' VAL . 44.0 mt -126.19 119.19 26.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.389 -0.82 . . . . 0.0 109.836 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 4.7 t0 -73.9 166.54 23.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.81 -1.181 . . . . 0.0 109.685 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.491 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -42.22 -46.07 4.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.227 -0.92 . . . . 0.0 110.229 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -73.46 -46.76 46.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.523 -0.736 . . . . 0.0 110.342 -179.441 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.516 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 14.4 mt-10 -60.56 -41.65 94.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.383 -0.823 . . . . 0.0 109.34 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.59 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 18.8 t80 -60.71 -30.13 69.77 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -64.12 -44.1 93.25 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.782 0.801 . . . . 0.0 110.046 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.999 HG13 HD11 ' A' ' 94' ' ' LEU . 63.4 t -61.11 -28.58 44.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.591 0.71 . . . . 0.0 110.289 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' A' ' 57' ' ' SER . . . -84.93 -6.93 59.34 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.478 -0.764 . . . . 0.0 111.559 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.594 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 9.4 mmm -90.23 -43.08 10.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.307 -1.496 . . . . 0.0 110.465 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.601 ' CZ ' HD13 ' A' ' 94' ' ' LEU . 2.9 p90 -76.92 -15.37 59.69 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.985 -1.086 . . . . 0.0 108.683 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.569 ' HB3' HG13 ' A' ' 53' ' ' VAL . 10.0 mt -85.3 -25.62 27.08 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.476 -0.765 . . . . 0.0 108.979 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.755 HG23 HG11 ' A' ' 53' ' ' VAL . 19.0 t -91.06 -28.51 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.006 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.88 -25.18 37.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.247 -0.908 . . . . 0.0 110.365 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -85.49 -13.04 50.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.956 . . . . 0.0 109.519 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.892 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.1 -9.54 52.94 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.384 -0.823 . . . . 0.0 109.119 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.803 ' N ' HD23 ' A' ' 81' ' ' LEU . 1.5 mt -90.33 -45.26 9.14 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.825 0.822 . . . . 0.0 109.063 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.8 OUTLIER -70.01 -53.08 19.23 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 120.189 -0.605 . . . . 0.0 109.8 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 179.13 -28.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.464 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 79' ' ' CYS . 20.6 mt-10 -66.4 110.74 5.24 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.177 -0.952 . . . . 0.0 111.203 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 47.9 Cg_endo -74.05 178.5 6.82 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.978 1.515 . . . . 0.0 110.157 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.604 HG21 ' CG2' ' A' ' 53' ' ' VAL . 97.3 t -125.45 132.89 24.43 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.007 . . . . 0.0 110.63 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.635 ' O ' HD11 ' A' ' 56' ' ' LEU . 45.9 Cg_endo -87.02 -171.89 0.83 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.021 1.537 . . . . 0.0 109.179 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.736 ' C ' HD21 ' A' ' 56' ' ' LEU . 18.5 mtm -114.64 7.11 15.92 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.992 -1.067 . . . . 0.0 110.162 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.2 m -111.94 100.64 9.05 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.791 -1.163 . . . . 0.0 111.861 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.756 HD23 HD23 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -46.54 108.53 0.85 Allowed Pre-proline 0 C--N 1.289 -2.032 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.492 178.576 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.455 ' HD2' ' CD2' ' A' ' 94' ' ' LEU . 38.3 Cg_endo -64.75 146.58 88.71 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.899 1.473 . . . . 0.0 110.676 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.82 -11.61 27.84 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.161 1.611 . . . . 0.0 111.565 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.666 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -93.89 24.25 4.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.03 -1.044 . . . . 0.0 108.651 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.999 HD11 HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -141.75 -3.33 1.14 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.797 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.8 t -88.96 125.73 61.52 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.803 -1.186 . . . . 0.0 110.665 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.419 ' HG2' ' HB3' ' A' ' 99' ' ' LYS . 49.6 Cg_endo -75.16 152.98 40.69 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.917 1.483 . . . . 0.0 110.539 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 98' ' ' SER . 47.6 Cg_endo -76.42 154.4 35.9 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.877 1.461 . . . . 0.0 110.328 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.7 OUTLIER 73.18 -2.52 2.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.519 -0.738 . . . . 0.0 109.759 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.914 ' CG ' HG21 ' A' ' 59' ' ' ILE . 2.0 tppt? -117.77 -0.7 11.71 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.631 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 N--CA 1.483 0.86 0 N-CA-C 110.121 -0.761 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.589 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 17.2 t90 -68.16 122.2 17.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.213 -0.93 . . . . 0.0 109.766 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.536 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -41.98 -26.97 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 110.089 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.589 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 79.1 t -109.99 124.74 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.0 109.913 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.467 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -86.15 174.36 5.67 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.322 -0.861 . . . . 0.0 110.36 -179.731 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.0 Cg_endo -66.19 -35.94 30.71 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.009 1.531 . . . . 0.0 109.787 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.39 -24.23 61.22 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.357 -0.84 . . . . 0.0 109.242 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -82.69 -42.08 18.54 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -72.27 -15.86 61.91 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.154 178.921 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.82 -33.34 70.59 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -82.33 -43.79 17.01 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.3 m-30 -61.68 -17.77 56.92 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -87.1 -18.1 31.29 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.802 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.404 ' O ' ' OG ' ' A' ' 23' ' ' SER . . . -90.77 -30.61 16.93 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.708 HG22 ' CE1' ' A' ' 70' ' ' PHE . 27.0 mt -79.62 -32.62 14.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.546 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -69.47 -41.33 76.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.51 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.526 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.8 t70 -86.75 2.69 47.88 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.332 0.587 . . . . 0.0 109.842 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.485 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.4 m -93.3 0.13 56.88 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.834 HD12 HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -113.65 -0.62 14.26 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.468 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 p 77.23 89.9 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 CA-C-O 121.568 0.699 . . . . 0.0 109.119 -178.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.526 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 53.4 Cg_endo -74.21 146.99 36.95 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.113 1.586 . . . . 0.0 110.314 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 98.1 t -114.49 103.55 15.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER 61.89 21.52 12.35 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.189 -0.944 . . . . 0.0 108.933 -178.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.552 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 91.78 33.05 8.09 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 37.9 m-85 -142.74 156.94 45.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -1.108 . . . . 0.0 111.606 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.834 HD13 HD12 ' A' ' 24' ' ' LEU . 37.6 mt -133.35 132.67 41.55 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.546 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.1 OUTLIER -84.49 149.5 25.9 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.342 -0.849 . . . . 0.0 111.22 -178.871 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -50.68 -21.99 5.32 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.03 -8.63 55.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.236 . . . . 0.0 110.136 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 5.0 mtpp -114.25 -42.1 3.39 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.925 0.869 . . . . 0.0 109.148 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.991 HG11 HD12 ' A' ' 65' ' ' LEU . 46.7 t -80.73 -47.44 20.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.528 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.626 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.7 tttp -43.37 -48.37 17.3 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.535 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.896 ' HA ' HD12 ' A' ' 41' ' ' LEU . 39.9 Cg_endo -68.07 -35.59 19.54 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.335 1.176 . . . . 0.0 109.155 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.649 HG21 HD22 ' A' ' 24' ' ' LEU . 2.3 t -64.06 -31.12 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.386 0.613 . . . . 0.0 109.414 178.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.897 ' HB3' HD22 ' A' ' 50' ' ' LEU . 20.9 mt -79.8 -16.95 54.51 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 109.016 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.896 HD12 ' HA ' ' A' ' 38' ' ' PRO . 75.9 mt -76.38 -24.69 54.14 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.41 ' OD1' ' O ' ' A' ' 38' ' ' PRO . 16.6 m120 -67.78 -15.98 63.9 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.452 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.43 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -72.55 -0.25 12.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.544 -0.722 . . . . 0.0 110.422 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.88 18.75 10.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.111 -0.993 . . . . 0.0 109.343 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.049 HD13 HG21 ' A' ' 49' ' ' ILE . 14.5 mt -96.34 160.58 29.39 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.631 -0.668 . . . . 0.0 110.009 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HG2' HG12 ' A' ' 49' ' ' ILE . 41.7 Cg_endo -74.29 161.94 39.46 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.878 1.462 . . . . 0.0 109.461 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 t -63.17 -9.24 4.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.379 -0.825 . . . . 0.0 110.177 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 3.0 t70 -73.52 -39.12 65.04 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.049 HG21 HD13 ' A' ' 45' ' ' LEU . 20.8 mm -70.41 -47.98 62.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.897 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.0 mt -66.07 -22.12 66.4 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.58 -28.34 29.94 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.538 ' HD3' ' N ' ' A' ' 88' ' ' MET . 3.8 ttm180 -95.72 -58.38 2.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.467 -1.02 . . . . 0.0 109.464 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.808 HG11 HG23 ' A' ' 77' ' ' VAL . 39.0 t -46.8 -29.19 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.785 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.5 ' O ' ' N ' ' A' ' 57' ' ' SER . 18.4 t-105 -74.19 -59.54 2.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.744 -0.598 . . . . 0.0 110.058 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -46.01 -42.18 12.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 109.722 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.905 HD21 ' C ' ' A' ' 88' ' ' MET . 1.5 mt -78.9 -17.23 55.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.385 -0.822 . . . . 0.0 109.276 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.965 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.3 t -92.41 -35.71 13.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.543 -0.723 . . . . 0.0 110.076 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.469 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 24.7 t0 -78.71 77.16 5.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.467 -0.771 . . . . 0.0 109.291 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.528 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 35.6 mm -40.72 -31.82 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.362 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 2.9 m-20 -96.24 -27.03 15.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.335 -0.853 . . . . 0.0 110.557 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.444 ' CB ' ' O ' ' A' ' 60' ' ' ASP . 28.0 m-70 64.74 45.43 3.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.076 -1.015 . . . . 0.0 109.274 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -114.32 -2.74 13.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 110.582 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.31 -0.94 34.97 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.546 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 2.4 mtt -129.35 155.94 44.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.323 -1.104 . . . . 0.0 110.312 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.991 HD12 HG11 ' A' ' 36' ' ' VAL . 11.0 mt -122.56 121.15 35.82 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.312 -0.867 . . . . 0.0 110.969 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 1.1 m-20 -80.47 155.81 26.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.151 -0.968 . . . . 0.0 108.932 178.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.546 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 11.1 ptt180 -40.14 -31.71 0.14 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 0.0 111.491 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.483 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 81.5 m-20 -85.71 -31.53 22.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.038 -1.039 . . . . 0.0 109.839 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 54.8 mt-10 -77.41 -42.39 36.39 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.767 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 43.5 t80 -57.68 -32.65 67.55 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.504 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -60.63 -53.69 54.43 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.584 0.707 . . . . 0.0 110.302 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.945 HG13 HD11 ' A' ' 94' ' ' LEU . 80.8 t -53.53 -26.74 13.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.525 -0.734 . . . . 0.0 110.242 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.965 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -87.68 -11.16 49.18 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.117 -0.989 . . . . 0.0 112.673 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.58 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 9.0 mmm -86.65 -43.42 12.64 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.342 -1.474 . . . . 0.0 111.036 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.645 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 2.0 p90 -76.83 -23.26 52.76 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.632 -1.227 . . . . 0.0 108.244 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.774 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.5 mt -76.0 -21.76 56.55 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.38 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.808 HG23 HG11 ' A' ' 53' ' ' VAL . 75.5 t -90.93 -26.46 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.373 -0.83 . . . . 0.0 109.766 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -89.49 -23.14 22.15 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.335 -0.853 . . . . 0.0 109.271 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 30.3 m -82.44 -13.31 56.98 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.39 -0.819 . . . . 0.0 108.9 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.622 ' C ' HD23 ' A' ' 81' ' ' LEU . . . -89.31 -11.14 44.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.393 -0.817 . . . . 0.0 108.974 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.814 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.6 mt -90.82 -43.51 10.01 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.677 0.751 . . . . 0.0 109.563 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 6.2 tp10 -69.22 -53.31 20.6 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.909 -0.717 . . . . 0.0 109.608 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 9.9 tttm 178.1 -26.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.286 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -63.29 113.1 8.43 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.001 -1.062 . . . . 0.0 111.08 -178.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.68 155.42 58.79 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.987 1.52 . . . . 0.0 110.019 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.642 HG11 ' CG2' ' A' ' 53' ' ' VAL . 69.5 t -109.83 119.76 46.7 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.998 -1.064 . . . . 0.0 110.717 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.593 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.3 Cg_endo -89.32 145.67 5.07 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.869 1.457 . . . . 0.0 109.394 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.905 ' C ' HD21 ' A' ' 56' ' ' LEU . 1.2 ptt? -75.33 5.08 6.08 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.029 -1.044 . . . . 0.0 111.526 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.56 ' N ' HD21 ' A' ' 56' ' ' LEU . 58.2 m -98.57 104.56 16.6 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 118.821 -1.152 . . . . 0.0 112.24 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.668 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -44.48 104.99 0.41 Allowed Pre-proline 0 C--N 1.299 -1.617 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.418 178.155 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.517 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 39.4 Cg_endo -67.0 139.9 52.74 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.774 1.407 . . . . 0.0 110.624 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.38 -6.44 19.17 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.066 1.561 . . . . 0.0 111.095 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -97.09 19.06 13.52 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.945 HD11 HG13 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -151.42 13.03 0.65 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.758 0.79 . . . . 0.0 110.142 -178.657 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.5 p -104.02 136.27 19.22 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 120.645 -1.284 . . . . 0.0 110.038 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.08 146.16 90.48 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.964 1.508 . . . . 0.0 109.803 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.565 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 42.0 Cg_endo -68.87 -3.4 11.31 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.899 1.473 . . . . 0.0 111.376 -178.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t -86.38 -21.93 26.91 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.004 -1.06 . . . . 0.0 109.403 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.449 ' HE3' HG21 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -89.99 2.86 54.65 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.391 -0.818 . . . . 0.0 109.687 179.242 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.565 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 10.9 ptp180 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 110.327 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.861 ' HE1' HD22 ' A' ' 94' ' ' LEU . 15.5 t90 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.254 0.55 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -44.94 -27.74 0.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 110.342 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.605 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 16.3 t -89.84 137.57 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.209 -0.932 . . . . 0.0 110.116 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 5.4 mttt -92.81 168.29 12.72 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.666 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 38.3 Cg_endo -65.9 -34.56 38.68 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.638 1.336 . . . . 0.0 109.763 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.67 -25.05 60.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.345 -0.847 . . . . 0.0 109.252 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -83.95 -38.36 21.12 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -67.78 -17.45 64.54 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.453 -0.78 . . . . 0.0 109.192 179.071 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.16 -40.43 27.34 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.64 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 3.7 ptmt -79.23 -24.1 43.29 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.64 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.0 m-30 -75.07 -35.68 61.83 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -76.68 -11.73 59.89 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.261 0.553 . . . . 0.0 110.182 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -94.82 -34.33 12.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.66 HG22 ' CE1' ' A' ' 70' ' ' PHE . 21.4 mt -75.78 -32.68 24.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.718 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -68.15 -37.98 81.63 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.498 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 13.6 t70 -89.75 1.72 55.75 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.546 -0.721 . . . . 0.0 109.966 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -92.81 0.13 57.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 108.65 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.056 HD22 HG21 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -113.85 -2.12 13.72 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER 82.69 89.81 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.8 Cg_endo -75.29 150.85 37.52 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 124.352 1.711 . . . . 0.0 110.721 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 98.8 t -117.59 96.9 4.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.561 -0.712 . . . . 0.0 109.505 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 10.4 t30 56.93 20.49 5.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.923 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.55 32.28 3.98 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 90.7 m-85 -149.98 158.6 44.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.194 -1.18 . . . . 0.0 111.378 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.988 HD13 HD12 ' A' ' 24' ' ' LEU . 40.5 mt -135.21 132.51 37.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.555 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 9.2 p -80.66 140.23 35.77 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.445 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.47 -26.38 0.38 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 32' ' ' SER . 8.4 t0 -62.77 -16.37 57.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -1.159 . . . . 0.0 110.378 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 17.5 mttm -107.58 -42.2 4.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.237 -0.914 . . . . 0.0 109.298 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.931 HG11 HD12 ' A' ' 65' ' ' LEU . 64.9 t -74.31 -35.66 40.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.835 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.581 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 14.3 tttp -49.4 -54.59 28.64 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 110.229 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 1.051 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.5 Cg_endo -65.09 -30.29 56.0 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.493 1.26 . . . . 0.0 108.997 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.056 HG21 HD22 ' A' ' 24' ' ' LEU . 4.3 t -76.4 -10.32 13.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.361 0.601 . . . . 0.0 109.741 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.783 ' HB3' HD22 ' A' ' 50' ' ' LEU . 68.5 mt -100.86 -16.09 17.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.051 HD12 ' HA ' ' A' ' 38' ' ' PRO . 7.7 mt -87.16 -40.69 14.37 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.51 -0.744 . . . . 0.0 109.575 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -52.34 -20.81 2.99 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.068 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.544 ' CA ' HD21 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -66.95 -6.15 15.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.579 -0.701 . . . . 0.0 110.085 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.3 OUTLIER 72.43 9.5 5.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.865 . . . . 0.0 109.96 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.026 HD13 HG21 ' A' ' 49' ' ' ILE . 14.9 mt -91.58 157.16 42.4 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 110.322 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.2 Cg_endo -74.47 164.35 34.15 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.138 1.599 . . . . 0.0 110.191 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.83 -8.75 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 110.159 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.84 -40.23 63.45 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.053 -1.029 . . . . 0.0 108.309 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.026 HG21 HD13 ' A' ' 45' ' ' LEU . 10.3 mm -68.34 -47.72 76.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.783 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.4 mt -62.62 -17.38 60.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -88.72 -33.67 9.82 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.504 ' HD2' ' O ' ' A' ' 87' ' ' PRO . 16.7 ttm-85 -91.77 -55.78 3.34 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.461 -1.023 . . . . 0.0 109.321 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.858 HG11 HG23 ' A' ' 77' ' ' VAL . 24.7 t -47.64 -58.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.37 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.489 ' HB3' ' O ' ' A' ' 50' ' ' LEU . 7.7 t-105 -47.35 -54.85 10.07 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.686 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 17.8 mm-40 -47.39 -51.9 18.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 110.02 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.687 HD21 ' C ' ' A' ' 88' ' ' MET . 2.6 mt -74.57 -7.65 53.81 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.317 -0.864 . . . . 0.0 109.642 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.893 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -100.53 -36.23 9.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.418 -0.801 . . . . 0.0 110.269 179.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.543 ' HA ' HD23 ' A' ' 65' ' ' LEU . 36.3 t0 -79.31 71.89 5.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.441 -0.787 . . . . 0.0 109.495 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.466 ' HB ' ' HG2' ' A' ' 69' ' ' GLU . 36.8 mm -40.16 -33.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.622 -0.674 . . . . 0.0 110.658 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -93.22 -27.59 16.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.946 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.546 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 14.4 m-70 64.67 45.2 3.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.21 -0.931 . . . . 0.0 110.762 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.495 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 2.6 p-10 -113.38 20.88 15.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 110.787 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.53 0.66 89.33 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.555 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 3.3 mtt -130.81 160.26 34.92 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.293 -1.122 . . . . 0.0 110.314 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.931 HD12 HG11 ' A' ' 36' ' ' VAL . 21.3 mt -126.97 114.27 17.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 110.542 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 8.9 t70 -69.74 172.96 6.74 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.142 -0.974 . . . . 0.0 109.395 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.573 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 5.2 ptt180 -55.42 -31.72 62.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 110.768 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.78 -32.54 19.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.089 -1.007 . . . . 0.0 109.778 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 28.0 mt-10 -78.16 -39.3 41.4 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.264 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.804 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 62.6 t80 -65.61 -27.56 68.49 Favored 'General case' 0 C--N 1.303 -1.457 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.865 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.38 -45.44 87.7 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.796 0.808 . . . . 0.0 109.685 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.893 HG13 HD21 ' A' ' 94' ' ' LEU . 48.1 t -61.64 -20.29 22.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.333 0.587 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.893 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.36 -11.12 41.56 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 111.65 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.569 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 5.7 mmm -89.1 -41.52 12.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.699 -1.251 . . . . 0.0 110.385 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.584 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 1.8 p90 -78.97 -23.29 44.63 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.046 -1.061 . . . . 0.0 108.55 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.799 ' HB3' HG13 ' A' ' 53' ' ' VAL . 6.1 mt -74.61 -23.64 58.75 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.858 HG23 HG11 ' A' ' 53' ' ' VAL . 55.6 t -91.03 -59.03 3.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.485 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.5 m-85 -47.85 -22.73 0.6 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.796 -0.565 . . . . 0.0 111.567 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -83.74 -16.85 43.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.882 -1.136 . . . . 0.0 110.048 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.953 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -86.8 -14.18 42.96 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.325 -0.859 . . . . 0.0 109.484 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.754 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.7 mp -86.65 -40.4 15.15 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 . . . . . 0 C--N 1.301 -1.517 0 CA-C-O 121.376 0.608 . . . . 0.0 109.858 179.495 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.757 HG13 HD22 ' A' ' 76' ' ' LEU . 76.5 t . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 120.629 0.252 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.618 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.8 Cg_endo -83.3 -167.52 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.999 1.526 . . . . 0.0 109.359 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.687 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -117.63 9.95 13.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.109 -0.994 . . . . 0.0 110.405 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.492 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 90.5 p -108.28 107.2 17.69 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.307 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.606 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -55.71 107.1 0.78 Allowed Pre-proline 0 C--N 1.294 -1.808 0 C-N-CA 120.061 -0.655 . . . . 0.0 109.811 178.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.547 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 41.6 Cg_endo -73.67 149.31 43.21 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.744 1.392 . . . . 0.0 110.606 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.537 ' HA ' ' CG1' ' A' ' 95' ' ' VAL . 48.3 Cg_endo -72.5 -3.98 14.44 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.224 1.644 . . . . 0.0 111.85 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -94.66 -23.37 17.62 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.072 -1.018 . . . . 0.0 109.225 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.969 HD22 ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -98.21 -14.38 20.36 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.786 0.803 . . . . 0.0 109.255 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.537 ' CG1' ' HA ' ' A' ' 92' ' ' PRO . 8.9 p . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.081 -1.012 . . . . 0.0 110.519 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.511 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.3 t90 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.157 0.503 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.907 ' HB3' HD12 ' A' ' 94' ' ' LEU . . . -41.66 -29.53 0.19 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.511 -0.743 . . . . 0.0 109.831 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.552 HG22 ' CD2' ' A' ' 75' ' ' PHE . 92.3 t -92.08 158.59 2.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.548 -0.72 . . . . 0.0 109.865 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.527 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 6.0 mttt -126.36 178.09 1.68 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.952 . . . . 0.0 110.13 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.657 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 40.0 Cg_endo -66.67 -36.48 24.82 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.913 1.481 . . . . 0.0 110.141 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -69.88 -36.23 75.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 109.101 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -83.54 -33.43 25.47 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 10' ' ' LYS . 16.4 tptp -78.64 -20.64 49.86 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -68.05 -41.9 81.34 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.626 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.7 ptpt -72.9 -31.81 64.92 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.626 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -66.59 -38.31 86.75 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 62.8 t0 -68.99 -11.1 60.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.672 -0.643 . . . . 0.0 110.331 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -96.39 -34.45 11.54 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.674 HG22 ' CE2' ' A' ' 70' ' ' PHE . 26.5 mt -78.35 -31.57 16.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.546 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -68.3 -37.98 81.16 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.529 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.1 t70 -90.41 0.99 57.05 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.625 -0.672 . . . . 0.0 109.916 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -92.72 2.71 56.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 108.77 178.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.055 HD22 HG21 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -115.6 -1.67 12.68 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER 79.52 87.0 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -73.87 147.46 39.31 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 124.446 1.761 . . . . 0.0 110.666 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 34.6 t -114.37 105.94 19.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 9.4 t30 55.49 23.71 6.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -0.983 . . . . 0.0 109.284 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.405 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 91.77 37.36 6.11 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 86.4 m-85 -149.92 158.03 43.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -1.098 . . . . 0.0 111.233 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.77 HD22 ' HB2' ' A' ' 24' ' ' LEU . 12.0 mt -136.4 133.15 36.41 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.555 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -79.63 140.74 37.0 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.414 -0.804 . . . . 0.0 110.408 -179.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.52 -25.54 0.85 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 32' ' ' SER . 4.8 t70 -68.37 -9.07 45.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -1.173 . . . . 0.0 110.237 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HD2' ' OG ' ' A' ' 32' ' ' SER . 4.6 mtpp -114.05 -43.35 3.25 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.886 0.851 . . . . 0.0 109.348 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.972 HG11 ' CD1' ' A' ' 65' ' ' LEU . 85.8 t -76.94 -46.21 29.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.78 -0.575 . . . . 0.0 110.266 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.6 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 39.0 tttt -46.19 -49.23 42.47 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 110.796 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.913 ' HA ' HD12 ' A' ' 41' ' ' LEU . 41.4 Cg_endo -68.58 -34.93 18.37 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 N-CA-C 108.918 -1.224 . . . . 0.0 108.918 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.055 HG21 HD22 ' A' ' 24' ' ' LEU . 2.4 t -62.72 -25.21 37.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.93 ' HB3' HD22 ' A' ' 50' ' ' LEU . 20.0 mt -84.02 -15.84 46.14 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.408 -0.807 . . . . 0.0 109.173 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.913 HD12 ' HA ' ' A' ' 38' ' ' PRO . 16.0 mt -76.44 -28.13 56.48 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.533 ' ND2' ' HA ' ' A' ' 39' ' ' VAL . 31.9 m-80 -63.51 -15.63 58.43 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.472 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.559 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -72.68 -1.54 16.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.504 -0.748 . . . . 0.0 110.155 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 43' ' ' SER . 7.8 ttpt 68.73 18.15 8.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -0.865 . . . . 0.0 109.925 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.024 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.8 mt -100.11 162.05 22.24 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.387 -0.821 . . . . 0.0 110.375 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.9 Cg_endo -74.14 166.18 30.18 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.106 1.582 . . . . 0.0 110.288 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 t -66.65 -7.52 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.404 -0.81 . . . . 0.0 110.22 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -40.93 59.6 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.958 HG21 HD13 ' A' ' 45' ' ' LEU . 21.5 mm -64.91 -44.87 96.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.93 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.8 mt -65.74 -17.88 64.93 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.335 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -87.92 -30.57 17.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.598 ' O ' HD12 ' A' ' 56' ' ' LEU . 4.1 ttm180 -92.73 -56.27 3.07 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.403 -1.057 . . . . 0.0 109.45 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.049 HG11 HG23 ' A' ' 77' ' ' VAL . 41.0 t -46.6 -39.82 4.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.281 -0.968 . . . . 0.0 109.058 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.517 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 18.5 t-105 -65.51 -60.35 3.03 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.814 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 4.1 mm-40 -44.25 -54.68 5.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 109.826 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 90' ' ' LEU . 1.7 mt -69.9 -9.94 56.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.393 -0.817 . . . . 0.0 109.662 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 1.097 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 3.1 t -100.52 -32.75 10.63 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.442 -0.786 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.583 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 22.7 t0 -80.07 76.43 6.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.305 -0.872 . . . . 0.0 110.21 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.51 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 41.6 mm -45.96 -32.56 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.482 -0.761 . . . . 0.0 109.833 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 22.7 m-20 -95.8 -21.73 17.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.539 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 88.5 m-70 57.38 48.47 14.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 109.563 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.455 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 1.7 p-10 -117.64 6.57 12.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.404 -0.81 . . . . 0.0 110.376 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.83 8.85 59.0 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.555 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 5.9 mtt -141.85 160.63 39.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -1.147 . . . . 0.0 110.89 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.972 ' CD1' HG11 ' A' ' 36' ' ' VAL . 35.9 mt -130.18 120.66 24.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.379 -0.826 . . . . 0.0 109.986 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.583 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 2.0 p30 -79.45 166.33 22.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.885 -1.135 . . . . 0.0 110.036 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.523 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 9.6 ptt180 -36.97 -46.83 0.67 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.456 -0.778 . . . . 0.0 111.596 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 63.1 m-20 -79.91 -33.9 39.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.139 -0.976 . . . . 0.0 110.381 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.567 ' HG2' HD23 ' A' ' 65' ' ' LEU . 13.1 tt0 -67.94 -50.75 54.12 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.346 -0.847 . . . . 0.0 109.785 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.71 ' CE1' HG13 ' A' ' 36' ' ' VAL . 62.5 t80 -56.0 -27.42 52.84 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.11 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -62.63 -47.33 84.2 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.564 0.697 . . . . 0.0 110.103 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.717 HG13 ' HG ' ' A' ' 94' ' ' LEU . 96.2 t -59.67 -24.48 29.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.501 -0.75 . . . . 0.0 109.875 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.097 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -88.39 -6.48 57.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.26 -0.9 . . . . 0.0 111.605 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.572 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 8.7 mmm -90.17 -42.77 10.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.383 -1.448 . . . . 0.0 110.332 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.7 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.0 p90 -76.44 -22.58 54.46 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.965 -1.094 . . . . 0.0 108.339 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 72' ' ' VAL . 14.9 mt -73.7 -28.36 61.69 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.049 HG23 HG11 ' A' ' 53' ' ' VAL . 41.2 t -92.09 -56.4 5.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.732 -0.605 . . . . 0.0 109.551 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.603 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -53.31 -18.85 2.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.416 -0.802 . . . . 0.0 110.812 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 75' ' ' PHE . 11.7 m -86.13 -16.94 36.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.933 . . . . 0.0 109.945 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.024 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.82 -11.91 52.21 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.191 -0.943 . . . . 0.0 109.564 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.624 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.2 mp -87.52 -43.78 11.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.377 -0.827 . . . . 0.0 109.222 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.459 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.23 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.621 HG21 ' CG2' ' A' ' 53' ' ' VAL . 53.3 t . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 120.636 0.255 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.575 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.4 Cg_endo -83.14 176.5 7.41 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.921 1.485 . . . . 0.0 109.724 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.653 ' C ' HD21 ' A' ' 56' ' ' LEU . 31.7 mtp -103.21 15.81 28.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.091 -1.006 . . . . 0.0 110.345 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.591 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 75.7 m -114.06 105.33 13.09 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.954 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.709 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -82.25 106.13 5.91 Favored Pre-proline 0 C--N 1.289 -2.046 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.592 ' HD2' HD22 ' A' ' 94' ' ' LEU . 40.5 Cg_endo -66.36 158.83 53.17 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.906 1.477 . . . . 0.0 110.244 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.19 -15.59 31.81 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.882 1.464 . . . . 0.0 110.312 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -72.47 -7.5 50.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.907 HD12 ' HB3' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -90.5 -28.36 18.61 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.62 -0.675 . . . . 0.0 110.122 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.481 -0.762 . . . . 0.0 111.098 -179.086 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.584 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 13.9 t90 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.236 0.541 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.885 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -41.43 -33.21 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.596 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.584 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 55.4 t -98.38 122.89 50.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.357 -0.839 . . . . 0.0 110.142 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.557 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 2.0 mtmt -91.26 -177.28 0.73 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 110.107 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.557 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 43.2 Cg_endo -71.24 -36.26 7.39 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.811 1.427 . . . . 0.0 110.242 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.78 -24.16 58.63 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.314 -0.866 . . . . 0.0 109.302 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -86.5 -37.04 18.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.309 -0.869 . . . . 0.0 108.914 179.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -18.42 59.38 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.31 -39.53 71.36 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.732 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -75.19 -19.02 60.03 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 13.0 m-30 -82.83 -30.25 28.86 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -76.6 -11.3 59.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.718 -0.614 . . . . 0.0 110.053 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.47 -33.66 15.12 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.732 HD12 ' O ' ' A' ' 16' ' ' LYS . 6.9 mt -80.38 -29.03 12.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.628 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -75.51 -35.46 60.76 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.002 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.56 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -89.48 -1.92 58.2 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.594 -0.691 . . . . 0.0 109.88 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.44 -6.02 56.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 109.206 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.646 ' HB2' HD22 ' A' ' 31' ' ' LEU . 1.9 mt -108.35 -9.82 15.41 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.5 m 83.16 92.21 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.8 Cg_endo -73.05 148.52 44.98 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.351 1.711 . . . . 0.0 110.577 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.473 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 28.3 t -111.94 113.14 43.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.441 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER 46.04 25.09 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.835 . . . . 0.0 109.719 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.46 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 96.8 34.58 5.67 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.634 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 85.0 m-85 -151.55 153.8 35.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.085 -1.244 . . . . 0.0 111.72 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.666 HD23 ' HD2' ' A' ' 35' ' ' LYS . 41.7 mt -123.15 127.95 49.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 35' ' ' LYS . 60.1 p -65.84 137.96 57.56 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.862 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.619 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -48.28 -26.97 5.18 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.66 -14.65 58.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -1.124 . . . . 0.0 109.633 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.666 ' HD2' HD23 ' A' ' 31' ' ' LEU . 21.0 ttmm -91.88 -39.55 11.66 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.944 HG11 HD12 ' A' ' 65' ' ' LEU . 89.7 t -83.1 -31.05 8.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.437 0.637 . . . . 0.0 110.098 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.639 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -39.86 -51.28 5.55 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.535 -0.728 . . . . 0.0 111.122 -179.282 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 36.7 Cg_endo -63.02 -31.05 76.74 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.425 1.223 . . . . 0.0 109.841 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.591 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 2.9 t -74.46 -14.92 16.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.628 -0.67 . . . . 0.0 109.866 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.938 ' HB3' HD22 ' A' ' 50' ' ' LEU . 66.9 mt -97.41 -23.93 15.85 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.295 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 38' ' ' PRO . 2.5 mt -87.74 -34.2 18.43 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.188 -0.945 . . . . 0.0 110.063 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.591 ' ND2' ' HA ' ' A' ' 39' ' ' VAL . 2.0 p30 -65.6 -9.95 31.39 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.579 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.468 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 2.3 m -79.77 7.72 8.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 110.475 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 64.75 16.76 10.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.125 -0.984 . . . . 0.0 110.489 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.997 HD13 HG21 ' A' ' 49' ' ' ILE . 14.5 mt -97.0 153.81 38.41 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 109.967 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.6 Cg_endo -74.79 163.64 35.25 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.998 1.525 . . . . 0.0 110.467 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.6 t -64.77 -8.43 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.718 . . . . 0.0 110.513 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -76.3 -41.18 49.48 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.997 HG21 HD13 ' A' ' 45' ' ' LEU . 23.0 mm -65.03 -44.93 95.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.938 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.9 mt -61.97 -18.42 60.35 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.35 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.67 -31.16 19.27 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.782 ' C ' HD12 ' A' ' 56' ' ' LEU . 1.2 mtm180 -94.95 -55.38 3.11 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.43 -1.041 . . . . 0.0 109.455 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.798 HG23 HG21 ' A' ' 86' ' ' VAL . 30.0 t -49.08 -42.69 14.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.246 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.619 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 14.6 t-105 -65.55 -58.57 5.46 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.138 -0.976 . . . . 0.0 109.513 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.583 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 5.2 mm-40 -51.43 -33.45 30.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.995 . . . . 0.0 109.142 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.917 ' O ' HD11 ' A' ' 90' ' ' LEU . 6.7 mt -86.01 -15.27 41.94 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.493 -0.754 . . . . 0.0 109.343 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.989 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 50.4 m -100.16 -29.54 12.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.484 -0.76 . . . . 0.0 110.396 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 42.1 t0 -85.45 66.62 9.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.275 -0.891 . . . . 0.0 109.842 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 58' ' ' ASP . 42.0 mm -40.36 -29.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.485 0.659 . . . . 0.0 110.22 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 6.3 t0 -89.33 -28.51 19.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.362 -0.836 . . . . 0.0 110.826 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.583 ' CE1' ' O ' ' A' ' 55' ' ' GLU . 87.7 m-70 56.32 50.59 12.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.084 -1.01 . . . . 0.0 110.083 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 63' ' ' GLY . 5.3 p-10 -118.79 -10.11 10.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 110.409 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.424 ' N ' ' OD1' ' A' ' 62' ' ' ASP . . . 116.61 8.69 12.07 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.586 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 15.4 mtp -142.7 160.87 39.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -1.148 . . . . 0.0 110.228 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.944 HD12 HG11 ' A' ' 36' ' ' VAL . 13.0 mt -120.77 105.6 10.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.286 -0.884 . . . . 0.0 109.767 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.634 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 1.8 t70 -72.58 171.66 12.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.879 -1.138 . . . . 0.0 110.258 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.486 ' N ' ' CG ' ' A' ' 66' ' ' ASP . 16.2 ptp180 -45.71 -39.84 8.58 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.771 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.446 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 30.8 t0 -81.77 -31.79 31.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.195 -0.94 . . . . 0.0 110.458 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.478 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 27.5 mt-10 -77.95 -42.06 34.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.215 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.72 ' CE1' HG22 ' A' ' 20' ' ' ILE . 44.0 t80 -66.72 -28.06 68.12 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.536 -0.727 . . . . 0.0 109.376 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.473 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -65.72 -51.98 54.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 110.018 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.894 ' O ' HD12 ' A' ' 76' ' ' LEU . 93.2 t -55.65 -21.79 10.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.537 -0.727 . . . . 0.0 110.281 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.989 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.49 -14.61 32.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.219 -0.925 . . . . 0.0 111.766 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.628 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 7.0 mmm -80.18 -41.8 24.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.744 -1.223 . . . . 0.0 109.924 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.6 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.7 p90 -77.74 -22.34 50.45 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.894 HD12 ' O ' ' A' ' 72' ' ' VAL . 6.6 mt -75.95 -30.76 58.78 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.673 0.749 . . . . 0.0 109.126 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.629 HG23 HG11 ' A' ' 53' ' ' VAL . 44.4 t -90.19 -20.19 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.6 -0.688 . . . . 0.0 109.867 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.4 OUTLIER -90.56 -23.0 21.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.453 -0.779 . . . . 0.0 109.655 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 1.6 m -86.25 -17.98 33.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.446 -0.784 . . . . 0.0 109.731 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.973 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -83.91 -9.36 58.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.434 -0.791 . . . . 0.0 109.177 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.791 HD23 ' N ' ' A' ' 81' ' ' LEU . 2.0 mt -89.59 -45.93 9.02 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.714 0.769 . . . . 0.0 109.227 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 C--N 1.3 -1.562 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.645 179.657 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.798 HG21 HG23 ' A' ' 53' ' ' VAL . 60.0 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.558 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 44.8 Cg_endo -80.19 -165.01 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.61 1.321 . . . . 0.0 110.063 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.07 3.16 17.17 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 111.114 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -177.74 29.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.745 -1.222 . . . . 0.0 111.674 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.917 HD11 ' O ' ' A' ' 56' ' ' LEU . 9.6 mt 57.65 120.49 0.01 OUTLIER Pre-proline 0 C--N 1.285 -2.226 0 O-C-N 121.96 -0.463 . . . . 0.0 110.509 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.07 ' HG2' HD23 ' A' ' 94' ' ' LEU . 40.0 Cg_endo -70.28 176.86 6.59 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 123.641 1.338 . . . . 0.0 109.15 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 40.2 Cg_endo -65.65 -9.72 23.78 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.558 1.294 . . . . 0.0 111.894 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.658 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -98.64 4.18 47.94 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.049 -1.032 . . . . 0.0 110.604 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.07 HD23 ' HG2' ' A' ' 91' ' ' PRO . 4.2 mm? -117.35 38.57 3.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.011 -1.056 . . . . 0.0 111.295 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.694 ' O ' HG13 ' A' ' 95' ' ' VAL . 8.8 p . . . . . 0 C--N 1.3 -1.583 0 O-C-N 120.91 -1.119 . . . . 0.0 110.603 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.787 ' HE1' HD22 ' A' ' 94' ' ' LEU . 11.1 t90 . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -41.14 -27.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.0 109.787 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.475 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 38.0 t -99.51 149.02 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.438 -0.789 . . . . 0.0 109.69 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.6 mttt -111.48 173.36 2.91 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 110.02 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.8 Cg_endo -68.94 -34.51 17.29 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.835 1.44 . . . . 0.0 109.404 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 10.5 pt-20 -80.21 -26.7 39.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.47 -0.768 . . . . 0.0 109.646 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 1.6 m-20 -83.34 -41.38 18.29 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -69.06 -16.99 63.83 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.11 -42.42 72.69 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.629 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -70.68 -27.63 64.17 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -69.38 -37.48 77.58 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.22 -10.37 57.43 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.426 0.631 . . . . 0.0 109.969 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -92.79 -34.55 13.83 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.726 HG22 ' CE1' ' A' ' 70' ' ' PHE . 15.8 mt -80.97 -28.46 11.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.85 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.68 -36.01 60.2 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.541 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.4 t70 -88.65 -2.17 58.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.667 -0.646 . . . . 0.0 109.712 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 29.5 t -91.3 0.91 57.44 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.053 HD22 HG21 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -113.12 -5.51 13.71 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.593 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 82.63 86.58 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.092 0 CA-C-O 121.131 0.491 . . . . 0.0 109.827 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.541 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -73.53 147.4 40.78 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 O-C-N 124.418 1.746 . . . . 0.0 110.903 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -115.89 111.83 37.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.633 -0.667 . . . . 0.0 109.242 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 54.52 20.52 2.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 109.468 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . 95.58 32.68 6.8 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.613 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 94.5 m-85 -146.32 158.96 43.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.432 -1.04 . . . . 0.0 110.643 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.95 HD22 ' HB2' ' A' ' 24' ' ' LEU . 16.5 mt -136.77 128.7 29.28 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.58 -0.7 . . . . 0.0 109.177 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.541 ' OG ' ' CE ' ' A' ' 64' ' ' MET . 0.7 OUTLIER -74.49 137.41 42.51 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.273 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.34 -32.38 1.16 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 38' ' ' PRO . 72.0 m-20 -53.38 -24.44 12.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -1.142 . . . . 0.0 110.027 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 12.1 mttm -103.3 -44.61 5.12 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.019 0.914 . . . . 0.0 109.072 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.086 HG11 HD12 ' A' ' 65' ' ' LEU . 40.2 t -76.63 -49.13 24.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 O-C-N 121.81 -0.556 . . . . 0.0 110.467 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.594 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 14.7 ttpt -43.17 -50.2 14.95 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.484 -0.887 . . . . 0.0 110.801 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.884 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.8 Cg_endo -67.05 -34.49 28.62 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 N-CA-C 109.108 -1.151 . . . . 0.0 109.108 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.053 HG21 HD22 ' A' ' 24' ' ' LEU . 2.3 t -65.15 -23.83 34.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.016 ' HB3' HD22 ' A' ' 50' ' ' LEU . 16.4 mt -86.33 -15.06 41.73 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.392 -0.817 . . . . 0.0 109.203 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.884 HD12 ' HA ' ' A' ' 38' ' ' PRO . 27.8 mt -77.97 -26.85 48.96 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 38.7 m-80 -62.55 -13.9 36.19 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.623 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.532 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -78.63 2.13 20.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.563 -0.711 . . . . 0.0 110.327 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 43' ' ' SER . 1.7 mtpt 63.53 15.6 8.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -0.902 . . . . 0.0 110.362 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.036 HD13 HG21 ' A' ' 49' ' ' ILE . 13.6 mt -94.82 162.54 24.99 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.143 -0.973 . . . . 0.0 109.915 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.519 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.1 Cg_endo -73.99 164.91 33.34 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.013 1.533 . . . . 0.0 110.957 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 t -64.96 -9.1 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.502 -0.749 . . . . 0.0 109.776 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -72.48 -41.31 66.17 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.036 HG21 HD13 ' A' ' 45' ' ' LEU . 20.3 mm -64.2 -47.49 89.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.016 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.3 mt -65.6 -23.11 66.75 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.632 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.498 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -86.03 -30.78 22.12 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HD3' ' HG2' ' A' ' 88' ' ' MET . 13.7 ttm180 -91.52 -54.95 3.68 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.506 -0.996 . . . . 0.0 109.667 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.851 ' CG2' HG21 ' A' ' 86' ' ' VAL . 26.7 t -49.67 -42.89 18.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.993 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.556 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 16.3 t-105 -61.86 -58.19 8.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.831 . . . . 0.0 111.05 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 17.0 mt-10 -51.6 -36.9 47.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.883 -1.136 . . . . 0.0 109.607 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.018 HD22 ' N ' ' A' ' 90' ' ' LEU . 18.5 mt -90.07 -8.44 51.45 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.516 0.674 . . . . 0.0 109.485 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 1.042 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 4.6 t -100.11 -30.29 12.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.448 -0.783 . . . . 0.0 108.916 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.597 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 13.3 t0 -84.65 68.25 10.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.485 -0.759 . . . . 0.0 109.631 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.558 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 35.5 mm -37.4 -29.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.266 0.555 . . . . 0.0 110.471 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.539 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 76.4 m-20 -90.68 -25.66 19.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 111.31 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 0.3 OUTLIER 59.71 26.46 15.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.883 -1.136 . . . . 0.0 108.913 -179.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.428 ' OD2' ' HG3' ' A' ' 64' ' ' MET . 3.9 p-10 -90.82 -24.25 20.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.524 -0.735 . . . . 0.0 110.665 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.38 4.35 4.48 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.7 mtp -145.2 161.16 40.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.002 -1.293 . . . . 0.0 110.313 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.086 HD12 HG11 ' A' ' 36' ' ' VAL . 33.5 mt -115.82 112.16 21.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -0.844 . . . . 0.0 109.984 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.613 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 4.9 p30 -76.08 165.05 25.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.799 -1.188 . . . . 0.0 110.019 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.618 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -39.41 -40.31 0.8 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.458 -0.776 . . . . 0.0 111.741 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 1.4 t0 -80.28 -36.28 34.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.979 -1.075 . . . . 0.0 110.563 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.519 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 44.0 mt-10 -76.17 -41.62 49.15 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.186 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.813 ' CE2' HG13 ' A' ' 36' ' ' VAL . 35.3 t80 -61.82 -25.46 67.52 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -66.56 -51.09 60.29 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.943 0.877 . . . . 0.0 109.648 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.926 HG22 HD21 ' A' ' 94' ' ' LEU . 60.5 t -55.12 -23.88 13.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.358 0.599 . . . . 0.0 110.382 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.042 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -89.86 -10.85 43.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 111.815 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.577 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 7.9 mmm -85.09 -48.06 9.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.639 -1.288 . . . . 0.0 110.121 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.574 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -72.65 -21.52 61.07 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 72' ' ' VAL . 9.6 mt -73.79 -32.79 63.94 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.723 HG21 HD22 ' A' ' 40' ' ' LEU . 70.5 t -91.42 -25.54 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.535 -0.728 . . . . 0.0 110.504 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.5 OUTLIER -86.81 -27.01 23.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.742 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 60.1 m -80.29 -19.05 47.54 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.421 -0.799 . . . . 0.0 108.857 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.843 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -82.15 -7.97 59.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.475 -0.766 . . . . 0.0 109.344 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.54 ' N ' HD23 ' A' ' 81' ' ' LEU . 6.4 mt -90.25 -47.6 7.67 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.566 0.698 . . . . 0.0 110.026 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? . . . . . 0 C--N 1.3 -1.544 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.924 -179.048 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.851 HG21 ' CG2' ' A' ' 53' ' ' VAL . 41.6 t . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.744 ' HD2' HG13 ' A' ' 86' ' ' VAL . 44.9 Cg_endo -85.93 -165.94 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.662 1.348 . . . . 0.0 109.791 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.48 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 5.7 mtt -129.68 18.87 5.68 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.623 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 33.3 t -161.14 23.74 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.268 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 1.018 ' N ' HD22 ' A' ' 56' ' ' LEU . 2.4 mt 61.7 118.48 0.02 OUTLIER Pre-proline 0 C--N 1.283 -2.324 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.54 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.624 ' O ' HG23 ' A' ' 95' ' ' VAL . 41.8 Cg_endo -76.08 146.35 28.85 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.792 1.417 . . . . 0.0 110.005 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.04 -1.03 8.03 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.736 1.624 . . . . 0.0 112.09 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -99.9 -20.53 16.1 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.05 -1.031 . . . . 0.0 109.854 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.975 HD22 ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -101.82 -13.9 17.5 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.588 0.709 . . . . 0.0 109.497 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.856 HG22 HD22 ' A' ' 90' ' ' LEU . 95.4 t . . . . . 0 N--CA 1.492 1.664 0 O-C-N 120.938 -1.101 . . . . 0.0 110.676 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.599 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 15.5 t90 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 121.061 0.458 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.733 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -41.11 -31.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.405 -0.809 . . . . 0.0 110.413 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.599 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 70.4 t -94.45 131.44 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.401 -0.812 . . . . 0.0 109.976 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.532 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 18.0 mttt -95.12 -179.43 0.95 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.846 . . . . 0.0 110.162 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.1 Cg_endo -69.79 -37.32 9.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.903 1.475 . . . . 0.0 110.187 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -71.18 -24.64 62.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 109.664 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.582 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -83.0 -41.8 18.28 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 2.4 tppt? -66.48 -20.17 65.97 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.68 -0.637 . . . . 0.0 109.363 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.7 -42.66 60.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.375 -0.828 . . . . 0.0 109.064 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.625 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -79.14 -26.15 42.83 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.5 m-30 -71.85 -34.47 69.27 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 8.0 m-20 -81.07 -10.6 59.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.717 -0.614 . . . . 0.0 109.88 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -93.58 -35.45 12.89 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.558 HG21 ' SD ' ' A' ' 74' ' ' MET . 51.3 mt -76.47 -36.9 29.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.582 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -64.13 -36.59 84.52 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.549 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -90.24 -0.11 57.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.749 -0.595 . . . . 0.0 109.991 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 22.8 t -91.33 0.51 57.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.215 -0.928 . . . . 0.0 109.046 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.968 HD22 HG21 ' A' ' 39' ' ' VAL . 1.2 mt -109.06 -6.61 15.57 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.578 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER 80.29 83.55 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.549 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 42.7 Cg_endo -69.11 149.98 71.63 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 O-C-N 124.65 1.868 . . . . 0.0 110.357 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.3 t -113.16 103.92 16.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.339 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 5.6 t30 59.19 21.9 10.04 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.479 -0.763 . . . . 0.0 109.374 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.493 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 93.01 39.2 5.24 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.493 ' CD2' ' C ' ' A' ' 29' ' ' GLY . 82.3 m-85 -150.12 159.56 44.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.428 -1.042 . . . . 0.0 111.302 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.679 HD13 HD12 ' A' ' 24' ' ' LEU . 46.1 mt -133.22 131.4 40.29 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.561 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 18.2 p -79.06 141.48 37.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.548 -0.72 . . . . 0.0 110.929 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.612 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -49.76 -24.44 6.0 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.26 -11.95 59.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.419 -1.048 . . . . 0.0 109.66 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.65 ' HD2' HD23 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -97.73 -46.28 6.04 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.316 1.055 . . . . 0.0 108.778 179.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.633 HG11 HD12 ' A' ' 65' ' ' LEU . 98.3 t -78.45 -33.07 16.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.069 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.575 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -40.68 -54.85 4.89 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.443 -0.786 . . . . 0.0 110.952 -178.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.995 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.2 Cg_endo -64.24 -31.05 64.19 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.557 1.293 . . . . 0.0 109.332 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.968 HG21 HD22 ' A' ' 24' ' ' LEU . 3.4 t -73.38 -8.41 11.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.721 -0.612 . . . . 0.0 109.363 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.871 ' HB3' HD22 ' A' ' 50' ' ' LEU . 42.3 mt -99.87 -16.42 18.04 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 108.541 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.995 HD12 ' HA ' ' A' ' 38' ' ' PRO . 4.7 mt -89.03 -41.56 12.26 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.501 -0.75 . . . . 0.0 109.785 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -49.82 -22.04 1.32 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.226 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.561 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -68.7 -5.31 19.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.362 -0.836 . . . . 0.0 110.085 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 73.68 8.89 4.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.378 -0.826 . . . . 0.0 110.378 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.054 HD13 HG21 ' A' ' 49' ' ' ILE . 14.3 mt -84.48 155.48 62.63 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 109.769 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.551 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.3 Cg_endo -74.38 162.83 37.57 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.789 1.415 . . . . 0.0 110.753 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.9 t -62.63 -10.58 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.57 -0.706 . . . . 0.0 110.816 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.41 -41.01 57.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.934 -1.104 . . . . 0.0 108.353 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.054 HG21 HD13 ' A' ' 45' ' ' LEU . 27.8 mm -64.11 -44.87 97.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.871 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.6 mt -60.23 -18.19 46.9 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.49 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -84.57 -31.74 23.77 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.479 ' CD ' ' O ' ' A' ' 87' ' ' PRO . 9.8 mtm180 -94.97 -55.26 3.15 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.494 -1.003 . . . . 0.0 109.844 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.646 HG23 HG21 ' A' ' 86' ' ' VAL . 17.2 t -44.83 -39.3 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.642 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.612 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 13.0 t-105 -74.38 -59.02 2.92 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.973 -1.08 . . . . 0.0 110.331 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 65.3 mm-40 -51.38 -30.13 17.96 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.086 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.844 HD22 ' N ' ' A' ' 90' ' ' LEU . 46.8 mt -90.41 -14.78 32.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.57 -0.706 . . . . 0.0 109.496 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.991 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 12.7 m -98.98 -27.81 13.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.476 -0.765 . . . . 0.0 109.642 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 59' ' ' ILE . 13.8 t0 -81.76 69.1 8.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.289 -0.882 . . . . 0.0 109.565 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 58' ' ' ASP . 39.3 mm -40.48 -30.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.511 0.672 . . . . 0.0 109.877 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.451 ' OD2' ' HB3' ' A' ' 62' ' ' ASP . 0.8 OUTLIER -96.15 -28.73 14.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.61 -0.681 . . . . 0.0 109.999 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ASP . 22.8 m-70 61.71 46.5 7.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.164 -0.96 . . . . 0.0 110.644 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.451 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 3.1 p-10 -112.66 16.85 19.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 110.265 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.37 5.0 76.4 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.561 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 5.0 mtt -140.4 157.02 46.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -1.145 . . . . 0.0 110.647 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.633 HD12 HG11 ' A' ' 36' ' ' VAL . 74.2 mt -118.63 113.79 21.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.381 -0.824 . . . . 0.0 109.842 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.9 OUTLIER -73.2 155.85 39.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.949 -1.094 . . . . 0.0 109.62 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.575 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -33.83 -44.07 0.15 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.761 -0.587 . . . . 0.0 111.372 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 3.2 p-10 -74.94 -45.26 43.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.36 -0.838 . . . . 0.0 109.897 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.482 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 19.3 mt-10 -62.32 -45.83 91.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.582 -0.698 . . . . 0.0 109.563 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.582 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 52.0 t80 -59.96 -24.07 64.1 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.616 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -68.15 -45.92 72.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.549 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.722 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.3 t -61.79 -23.91 32.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.535 -0.728 . . . . 0.0 109.963 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.991 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.96 -1.35 57.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -0.877 . . . . 0.0 110.832 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.621 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 13.1 mmt -89.09 -46.02 9.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.083 -1.011 . . . . 0.0 109.463 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.668 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 1.7 p90 -75.83 -30.0 58.82 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.722 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.8 mt -63.74 -30.94 71.98 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.616 ' O ' HD21 ' A' ' 81' ' ' LEU . 70.5 t -90.64 -23.84 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.878 -0.514 . . . . 0.0 109.936 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -26.55 20.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.365 -0.834 . . . . 0.0 109.31 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 51.6 m -84.4 -12.28 54.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.437 -0.789 . . . . 0.0 109.211 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.038 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -89.23 -8.87 52.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.465 -0.772 . . . . 0.0 109.065 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.814 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.5 mt -90.97 -45.34 8.79 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.614 0.721 . . . . 0.0 109.358 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 . . . . . 0 C--N 1.299 -1.621 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.705 179.821 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.646 HG21 HG23 ' A' ' 53' ' ' VAL . 59.2 t . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 46.1 Cg_endo -84.42 -163.42 0.2 Allowed 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.688 1.362 . . . . 0.0 110.092 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 2.4 ttt -122.19 10.0 9.93 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.371 -0.831 . . . . 0.0 111.106 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.89 23.88 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.719 -1.238 . . . . 0.0 111.432 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.868 HD23 ' HD2' ' A' ' 91' ' ' PRO . 1.6 mt 62.09 123.17 0.02 OUTLIER Pre-proline 0 C--N 1.284 -2.276 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.849 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.868 ' HD2' HD23 ' A' ' 90' ' ' LEU . 40.2 Cg_endo -68.42 174.5 8.19 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.007 1.53 . . . . 0.0 110.137 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 49.6 Cg_endo -75.29 -22.68 14.07 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.964 1.507 . . . . 0.0 111.97 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.746 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -90.79 7.88 37.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.923 -1.111 . . . . 0.0 110.483 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.746 HD22 ' C ' ' A' ' 93' ' ' ALA . 4.1 mm? -114.29 34.9 4.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.081 -1.012 . . . . 0.0 111.495 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.49 1.565 0 O-C-N 120.766 -1.209 . . . . 0.0 110.617 -179.849 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.515 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.6 t90 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.166 0.508 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -41.81 -28.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 0.0 110.138 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.515 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 45.5 t -94.76 156.48 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.826 . . . . 0.0 109.978 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.507 ' HD3' ' HD2' ' A' ' 11' ' ' PRO . 28.3 mmtt -111.5 171.55 4.25 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.507 ' HD2' ' HD3' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -66.9 -35.93 24.96 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.819 1.431 . . . . 0.0 110.431 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.13 -25.59 60.89 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.135 -0.978 . . . . 0.0 109.11 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.579 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 63.6 m-20 -85.57 -35.87 20.78 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.241 -0.912 . . . . 0.0 108.851 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.508 ' CD ' ' HB2' ' A' ' 71' ' ' ALA . 2.2 tptp -73.26 -17.77 61.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.29 -41.82 56.19 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.637 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.15 -24.73 51.52 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.637 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.4 m-30 -74.95 -35.98 62.12 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.469 ' OD1' ' NZ ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -71.07 -10.1 59.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.777 -0.577 . . . . 0.0 110.135 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.0 -38.97 10.41 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.827 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.257 27.9 mt -72.17 -29.19 31.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.987 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -69.26 -40.34 77.87 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.464 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.5 t70 -86.1 1.36 50.76 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.581 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.695 ' C ' HD23 ' A' ' 24' ' ' LEU . 37.8 m -93.37 -0.14 56.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.314 -0.866 . . . . 0.0 108.768 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.085 HD22 HG21 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -116.7 -1.21 12.16 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 80.35 97.59 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.95 0 CA-C-O 121.136 0.493 . . . . 0.0 110.246 -179.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 55.4 Cg_endo -77.26 147.69 26.26 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.502 1.791 . . . . 0.0 110.343 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.508 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 60.1 t -119.89 94.07 2.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.508 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER 68.94 24.51 6.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.428 -0.795 . . . . 0.0 109.061 -178.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 90.93 28.34 15.95 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 35.3 m-85 -143.41 143.28 31.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.394 -1.062 . . . . 0.0 111.133 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.987 HD11 ' O ' ' A' ' 21' ' ' PHE . 53.4 mt -117.57 131.87 56.61 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.572 ' OG ' ' HE2' ' A' ' 64' ' ' MET . 0.5 OUTLIER -89.48 147.5 23.96 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.578 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.15 -31.12 0.84 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -54.07 -22.7 11.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -1.097 . . . . 0.0 110.096 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 1.5 mttm -111.15 -43.36 3.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.935 . . . . 0.0 109.342 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.935 HG11 HD12 ' A' ' 65' ' ' LEU . 87.5 t -74.75 -53.73 16.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.029 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.588 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -40.75 -49.94 7.33 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.529 -0.732 . . . . 0.0 110.892 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.891 ' HA ' HD12 ' A' ' 41' ' ' LEU . 40.6 Cg_endo -69.84 -33.19 16.79 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 N-CA-C 108.961 -1.207 . . . . 0.0 108.961 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.085 HG21 HD22 ' A' ' 24' ' ' LEU . 2.4 t -67.29 -29.01 44.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.885 ' HB3' HD22 ' A' ' 50' ' ' LEU . 17.7 mt -81.4 -17.12 50.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.407 -0.808 . . . . 0.0 108.911 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.891 HD12 ' HA ' ' A' ' 38' ' ' PRO . 20.3 mt -73.88 -26.16 60.41 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.546 ' ND2' ' HA ' ' A' ' 39' ' ' VAL . 33.2 m-80 -61.4 -20.58 63.22 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.209 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 1.004 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.3 t -71.36 -3.44 20.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.536 -0.728 . . . . 0.0 109.864 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.538 ' CE ' ' HA ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER 70.79 4.59 5.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 110.028 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.028 HD13 HG21 ' A' ' 49' ' ' ILE . 15.7 mt -83.49 159.29 61.74 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.977 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.531 ' HG2' HG12 ' A' ' 49' ' ' ILE . 43.3 Cg_endo -73.05 162.35 41.11 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.985 1.519 . . . . 0.0 110.502 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.93 -10.17 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 110.21 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.18 -39.1 68.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.028 HG21 HD13 ' A' ' 45' ' ' LEU . 18.5 mm -67.18 -47.41 81.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.885 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.0 mt -64.64 -20.05 66.06 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.95 -33.2 12.65 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.577 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -90.38 -54.96 3.78 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.51 -0.994 . . . . 0.0 109.224 179.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.901 HG11 HG23 ' A' ' 77' ' ' VAL . 29.2 t -49.23 -42.71 15.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.01 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.522 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 12.3 t-105 -59.09 -59.28 5.72 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.461 -0.774 . . . . 0.0 109.673 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 54' ' ' TRP . 1.6 mm-40 -44.06 -50.03 8.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -0.878 . . . . 0.0 109.833 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.913 HD21 ' C ' ' A' ' 88' ' ' MET . 1.6 mt -75.04 -14.31 60.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.375 -0.828 . . . . 0.0 109.54 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 1.093 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -95.35 -25.84 16.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.484 -0.76 . . . . 0.0 110.384 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.53 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 4.1 t0 -86.31 76.83 9.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.323 -0.861 . . . . 0.0 110.329 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.479 ' CG1' ' HG3' ' A' ' 69' ' ' GLU . 42.5 mm -44.12 -35.29 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.368 -0.832 . . . . 0.0 110.32 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.487 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 2.8 m-20 -95.73 -28.41 14.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 110.427 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 18.7 m-70 62.28 37.44 14.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 109.686 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -97.67 -14.57 20.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.386 -0.821 . . . . 0.0 110.452 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.443 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 125.33 3.67 7.25 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.572 ' HE2' ' OG ' ' A' ' 32' ' ' SER . 1.5 mtp -149.27 161.73 41.44 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.022 -1.281 . . . . 0.0 110.438 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.935 HD12 HG11 ' A' ' 36' ' ' VAL . 46.8 mt -113.39 118.82 35.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.625 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.8 OUTLIER -69.36 154.12 42.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.174 -0.954 . . . . 0.0 109.617 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.623 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 7.4 ptp85 -34.3 -44.86 0.2 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.648 -0.658 . . . . 0.0 111.06 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.678 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -81.16 -34.41 32.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 109.499 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 57' ' ' SER . 6.8 tt0 -67.26 -51.71 49.71 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.6 -0.687 . . . . 0.0 109.415 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.827 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 87.8 t80 -52.78 -26.02 13.08 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -62.15 -45.21 94.45 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.67 0.748 . . . . 0.0 109.837 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 1.022 HG13 HD12 ' A' ' 94' ' ' LEU . 57.6 t -60.03 -25.72 33.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.59 -0.694 . . . . 0.0 110.071 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.093 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -87.42 -11.48 49.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.876 . . . . 0.0 111.952 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.763 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 7.4 mmm -85.78 -37.97 18.7 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.32 -1.487 . . . . 0.0 110.451 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.034 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 3.4 p90 -78.33 -23.43 47.01 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.966 -1.084 . . . . 0.0 108.525 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.847 ' HB3' HG13 ' A' ' 53' ' ' VAL . 6.7 mt -75.19 -28.38 60.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.477 -0.764 . . . . 0.0 108.98 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.901 HG23 HG11 ' A' ' 53' ' ' VAL . 43.3 t -90.61 -25.83 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.508 -0.745 . . . . 0.0 110.058 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.489 ' HA ' HD12 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -84.12 -25.95 29.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 110.056 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 57.9 m -85.62 -14.06 46.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 109.454 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.852 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -79.86 -15.87 56.52 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.182 -0.948 . . . . 0.0 109.242 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.004 HD21 ' O ' ' A' ' 43' ' ' SER . 2.4 mt -92.1 -47.95 6.98 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.604 -0.685 . . . . 0.0 111.304 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.489 1.491 0 C-N-CA 119.503 -0.879 . . . . 0.0 112.033 -178.031 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.512 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 55.5 t . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.601 0.239 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.53 ' O ' HD11 ' A' ' 56' ' ' LEU . 51.2 Cg_endo -83.66 160.36 14.4 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.892 1.47 . . . . 0.0 109.663 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.913 ' C ' HD21 ' A' ' 56' ' ' LEU . 68.6 mtp -82.79 11.24 6.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.998 -1.064 . . . . 0.0 110.237 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.585 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.6 m -99.92 112.81 25.07 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.873 -1.131 . . . . 0.0 110.66 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.743 HD12 ' C ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -100.72 85.67 0.58 Allowed Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 89' ' ' SER . 38.2 Cg_endo -62.31 173.74 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.427 1.418 . . . . 0.0 111.477 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.892 ' O ' HG22 ' A' ' 95' ' ' VAL . 44.1 Cg_endo -69.18 -10.15 28.23 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.339 1.705 . . . . 0.0 110.77 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.626 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -76.84 0.76 19.6 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 109.093 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.034 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 2.5 mm? -108.34 -13.59 14.85 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.412 -0.805 . . . . 0.0 110.116 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 92' ' ' PRO . 26.7 m . . . . . 0 N--CA 1.487 1.397 0 O-C-N 121.351 -0.843 . . . . 0.0 110.554 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.536 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.4 t90 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 121.293 0.568 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.645 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . . . -46.34 -25.81 0.71 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.283 -0.886 . . . . 0.0 110.182 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.536 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 50.6 t -111.49 140.06 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.414 -0.804 . . . . 0.0 110.009 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.498 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 7.4 mttt -106.33 177.7 1.28 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.363 -0.836 . . . . 0.0 110.38 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.547 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 40.7 Cg_endo -68.24 -37.32 14.33 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.96 1.505 . . . . 0.0 109.647 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.441 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 16.0 pt-20 -66.52 -35.64 80.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.0 109.08 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.441 ' N ' ' CG ' ' A' ' 12' ' ' GLU . 0.6 OUTLIER -81.59 -38.64 25.76 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 1.3 tmtp? -73.01 -15.47 61.53 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -74.36 -42.54 59.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.616 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.3 ptpt -74.33 -21.15 59.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.616 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.8 m-30 -79.7 -30.26 40.97 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -75.07 -11.51 60.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.704 -0.622 . . . . 0.0 110.19 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.16 -36.05 12.23 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.67 HG22 ' CE2' ' A' ' 70' ' ' PHE 0.253 18.5 mt -75.59 -29.79 21.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -72.65 -40.32 66.45 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.474 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.1 t70 -85.33 0.02 53.34 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.558 -0.714 . . . . 0.0 109.681 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.569 ' C ' HD23 ' A' ' 24' ' ' LEU . 13.2 t -91.8 -4.7 54.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.915 . . . . 0.0 108.599 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.947 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -108.92 -3.95 17.15 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 79.7 93.56 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.918 0 CA-C-O 121.409 0.623 . . . . 0.0 109.726 -179.087 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.2 Cg_endo -74.45 147.32 36.34 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 124.452 1.764 . . . . 0.0 110.789 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 86.7 t -119.31 105.14 16.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.714 -0.617 . . . . 0.0 109.354 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 2.7 t30 57.69 22.94 8.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 109.652 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.83 32.89 7.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.614 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 89.3 m-85 -150.78 154.77 37.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.332 -1.099 . . . . 0.0 111.105 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.947 HD22 ' HB2' ' A' ' 24' ' ' LEU . 22.0 mt -126.97 131.16 51.12 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.484 ' OG ' ' HE2' ' A' ' 35' ' ' LYS . 0.9 OUTLIER -76.86 140.53 40.63 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.272 -0.892 . . . . 0.0 110.392 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -41.99 -27.94 0.43 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' SER . 34.1 t0 -57.53 -28.84 63.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -1.188 . . . . 0.0 110.303 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.484 ' HE2' ' OG ' ' A' ' 32' ' ' SER . 25.4 mttm -98.91 -39.37 8.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.089 HG11 HD12 ' A' ' 65' ' ' LEU . 93.5 t -74.58 -32.44 29.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.076 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.56 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.2 ttpt -52.06 -56.88 17.78 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.233 -0.917 . . . . 0.0 110.347 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.89 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.2 Cg_endo -65.9 -31.45 47.34 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.631 1.332 . . . . 0.0 109.117 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.761 HG21 HD22 ' A' ' 24' ' ' LEU . 13.1 t -73.47 -16.68 17.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.164 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.986 ' HB3' HD22 ' A' ' 50' ' ' LEU . 63.3 mt -93.82 -18.45 22.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 108.67 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' A' ' 38' ' ' PRO . 23.6 mt -81.24 -33.84 32.54 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.399 0.619 . . . . 0.0 109.833 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.597 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -43.86 -25.35 0.19 Allowed 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.935 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.715 ' HB2' HD11 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -73.29 -4.98 36.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.326 -0.859 . . . . 0.0 110.213 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 72.47 7.88 5.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.522 -0.736 . . . . 0.0 110.153 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.045 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.8 mt -80.73 160.31 67.03 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.327 -0.858 . . . . 0.0 110.306 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.556 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.7 Cg_endo -74.33 164.69 33.53 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 124.034 1.544 . . . . 0.0 110.483 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 t -65.17 -8.44 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 110.339 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.92 -40.6 60.75 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.036 -1.04 . . . . 0.0 108.265 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.031 HG21 HD13 ' A' ' 45' ' ' LEU . 14.3 mm -65.15 -45.51 93.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.986 HD22 ' HB3' ' A' ' 40' ' ' LEU . 6.1 mt -62.28 -18.42 61.22 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.82 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.36 -33.7 11.41 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.628 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.4 ttm180 -90.13 -52.16 5.09 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.47 -1.018 . . . . 0.0 109.644 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.702 HG11 HG23 ' A' ' 77' ' ' VAL . 24.3 t -50.94 -42.25 23.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.166 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 57' ' ' SER . 7.7 t-105 -61.55 -57.01 13.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 110.093 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -47.33 -52.66 15.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.838 . . . . 0.0 110.103 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.822 HD11 ' HA ' ' A' ' 88' ' ' MET . 1.4 mt -74.94 -7.62 54.11 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.811 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.92 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 6.4 m -100.05 -29.07 12.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.43 -0.794 . . . . 0.0 110.676 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.466 ' OD2' ' HA ' ' A' ' 61' ' ' HIS . 16.8 t0 -87.29 73.77 9.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.962 . . . . 0.0 110.202 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.519 ' HB ' ' HG2' ' A' ' 69' ' ' GLU . 45.4 mm -44.0 -30.59 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.5 -0.75 . . . . 0.0 109.314 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 4.4 t0 -95.19 -22.32 17.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.523 -0.736 . . . . 0.0 109.931 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 34.2 p80 40.15 57.28 2.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.546 -0.721 . . . . 0.0 110.232 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' HB3' ' CG ' ' A' ' 60' ' ' ASP . 1.3 p-10 -117.12 7.04 12.94 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.581 -0.699 . . . . 0.0 109.732 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 109.56 5.87 29.38 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.1 mtp -150.41 161.0 43.34 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.157 -1.202 . . . . 0.0 110.792 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.089 HD12 HG11 ' A' ' 36' ' ' VAL . 11.9 mt -114.15 108.45 16.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.452 -0.78 . . . . 0.0 109.298 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.614 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -69.77 171.84 8.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.929 -1.107 . . . . 0.0 110.152 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 9.4 ptt180 -52.87 -37.53 60.47 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.695 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.6 OUTLIER -81.77 -35.72 29.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.189 -0.944 . . . . 0.0 109.713 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.519 ' HG2' ' HB ' ' A' ' 59' ' ' ILE . 27.1 mt-10 -74.24 -46.6 40.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 20' ' ' ILE . 68.3 t80 -57.73 -33.42 68.43 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.404 ' HA ' ' HG2' ' A' ' 74' ' ' MET . . . -57.18 -49.41 76.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.398 -0.814 . . . . 0.0 109.996 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.48 ' O ' HD12 ' A' ' 76' ' ' LEU . 55.6 t -59.29 -21.7 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.611 -0.68 . . . . 0.0 110.443 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.92 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -90.53 -9.79 45.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.07 -1.018 . . . . 0.0 111.602 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.669 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 7.1 mmm -85.41 -41.08 15.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.792 -1.192 . . . . 0.0 109.886 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.599 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.4 p90 -77.41 -26.17 51.47 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.599 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 7.6 mt -70.14 -30.85 68.12 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.702 HG23 HG11 ' A' ' 53' ' ' VAL . 57.0 t -90.98 -19.12 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.679 -0.638 . . . . 0.0 110.349 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.31 -20.18 23.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.34 -0.85 . . . . 0.0 109.75 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -87.73 -16.37 34.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.517 -0.739 . . . . 0.0 109.705 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.045 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -84.92 -12.3 53.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.518 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.779 ' N ' HD23 ' A' ' 81' ' ' LEU . 2.9 mt -88.17 -43.06 11.9 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.539 -0.725 . . . . 0.0 109.373 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.298 -1.655 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.29 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.666 HG21 ' CG2' ' A' ' 53' ' ' VAL . 56.1 t . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 120.597 0.237 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.62 ' O ' HD11 ' A' ' 56' ' ' LEU . 46.5 Cg_endo -88.32 -165.3 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.948 1.499 . . . . 0.0 109.233 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.822 ' HA ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -127.7 10.89 6.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.137 -0.977 . . . . 0.0 110.471 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.605 ' N ' HD21 ' A' ' 56' ' ' LEU . 58.0 m -115.75 93.83 4.43 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.494 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.732 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -56.88 107.2 0.83 Allowed Pre-proline 0 C--N 1.291 -1.943 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.568 178.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.617 ' HG2' HD12 ' A' ' 94' ' ' LEU . 42.8 Cg_endo -82.07 173.32 11.07 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.703 1.37 . . . . 0.0 110.613 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 44.6 Cg_endo -71.21 -5.41 16.94 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.232 1.648 . . . . 0.0 111.418 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.44 ' O ' ' HG ' ' A' ' 94' ' ' LEU . . . -84.01 0.17 49.2 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 109.731 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.645 ' HG ' ' HB2' ' A' ' 8' ' ' ALA . 1.4 mp -138.29 31.24 2.38 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.19 -0.944 . . . . 0.0 110.994 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 92' ' ' PRO . 3.7 t . . . . . 0 N--CA 1.491 1.583 0 O-C-N 120.865 -1.147 . . . . 0.0 110.702 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.851 ' HE1' HD22 ' A' ' 94' ' ' LEU . 13.4 t90 . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 121.389 0.614 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -47.7 -25.83 1.34 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.493 -0.754 . . . . 0.0 109.991 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.6 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 56.0 t -88.96 147.04 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.496 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 28.5 mttt -99.93 167.28 11.3 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.237 -0.915 . . . . 0.0 109.847 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.0 Cg_endo -67.74 -33.96 26.04 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.81 1.426 . . . . 0.0 109.709 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -76.64 -24.17 53.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.524 -0.735 . . . . 0.0 109.513 179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.576 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -80.83 -38.73 27.79 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.527 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 28.4 tptp -65.23 -19.8 66.13 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.58 -44.52 50.46 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.58 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 4.1 ptpt -77.21 -19.2 57.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.619 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 6.9 m-30 -80.15 -33.32 38.59 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -79.57 -10.16 59.75 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.242 0.544 . . . . 0.0 110.151 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 23' ' ' SER . . . -94.93 -31.77 13.51 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.639 ' O ' HD21 ' A' ' 24' ' ' LEU . 61.7 mt -80.46 -32.74 13.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.559 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -71.45 -39.0 71.28 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.528 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.8 t0 -88.93 1.13 55.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.645 -0.66 . . . . 0.0 109.688 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 1.1 m -93.49 0.26 56.65 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.061 HD22 HG21 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -110.49 -4.99 15.24 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 p 81.93 87.59 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.528 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 49.8 Cg_endo -71.7 147.25 50.49 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.16 1.611 . . . . 0.0 110.854 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 99.9 t -116.94 104.77 17.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 14.9 t30 57.03 24.4 9.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.529 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 90.26 39.1 6.12 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.571 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 87.4 m-85 -150.58 156.54 41.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -1.179 . . . . 0.0 111.601 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.913 HD13 HD12 ' A' ' 24' ' ' LEU . 75.3 mt -128.77 135.32 49.02 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.542 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 10.2 p -80.36 142.07 34.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.392 -0.817 . . . . 0.0 111.104 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.612 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -51.22 -22.84 7.4 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -84.58 -9.65 58.11 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.363 -1.081 . . . . 0.0 109.36 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.647 ' HD2' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -97.19 -43.94 7.15 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.333 1.063 . . . . 0.0 108.336 179.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.602 HG21 HD12 ' A' ' 65' ' ' LEU . 96.8 t -78.82 -32.52 15.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.334 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.932 ' O ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -39.99 -54.58 4.29 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.421 -0.799 . . . . 0.0 110.852 -179.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.2 Cg_endo -63.68 -28.86 69.07 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.644 1.339 . . . . 0.0 109.825 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.061 HG21 HD22 ' A' ' 24' ' ' LEU . 4.8 t -79.72 -12.77 13.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.444 0.64 . . . . 0.0 110.244 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.768 ' HB3' HD22 ' A' ' 50' ' ' LEU . 66.2 mt -98.69 -17.05 18.76 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.85 -1.156 . . . . 0.0 109.1 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.932 HD12 ' O ' ' A' ' 37' ' ' LYS . 1.9 mt -88.74 -32.3 18.0 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.421 -0.799 . . . . 0.0 110.036 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.583 ' ND2' ' HA ' ' A' ' 39' ' ' VAL . 6.1 p30 -67.23 -8.21 29.97 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.061 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 50.3 m -77.53 7.23 5.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.462 -0.774 . . . . 0.0 109.905 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 65.33 16.34 10.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -0.963 . . . . 0.0 109.565 -179.489 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.996 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.2 mt -100.28 151.55 37.57 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.444 -0.785 . . . . 0.0 110.625 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.565 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.1 Cg_endo -75.12 159.45 40.91 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.142 1.601 . . . . 0.0 110.085 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.1 t -60.72 -10.11 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.809 . . . . 0.0 110.933 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.08 -42.4 60.21 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.931 -1.106 . . . . 0.0 108.311 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.917 HG13 HD22 ' A' ' 45' ' ' LEU . 8.8 mm -64.61 -45.02 96.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.768 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.2 mt -63.14 -21.53 66.25 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.176 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.29 -30.62 24.6 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.537 ' HD3' ' CG ' ' A' ' 88' ' ' MET . 10.3 ttm180 -94.16 -54.0 3.74 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.495 -1.003 . . . . 0.0 109.547 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.811 HG11 HG23 ' A' ' 77' ' ' VAL . 37.7 t -52.75 -33.06 18.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.071 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.612 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 10.7 t-105 -71.26 -57.06 4.84 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.919 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -47.41 -47.74 26.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.9 . . . . 0.0 109.983 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.909 HD11 ' HA ' ' A' ' 88' ' ' MET . 4.5 mt -76.77 -10.3 59.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 0.0 109.523 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 1.029 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 2.8 t -98.66 -34.2 10.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.447 -0.783 . . . . 0.0 110.257 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.599 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 19.6 t0 -79.79 68.16 5.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.357 -0.84 . . . . 0.0 109.338 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.455 ' C ' ' O ' ' A' ' 58' ' ' ASP . 31.2 mm -34.57 -30.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.116 0.484 . . . . 0.0 111.36 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 58' ' ' ASP . 54.1 m-20 -100.48 -19.59 16.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.088 -1.007 . . . . 0.0 111.601 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.599 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 3.8 m170 63.71 35.13 11.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.859 -1.151 . . . . 0.0 109.448 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -102.19 12.13 37.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.92 . . . . 0.0 110.826 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.11 10.11 81.11 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.543 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.7 mtt -139.32 160.19 40.4 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.335 -1.097 . . . . 0.0 110.89 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.602 HD12 HG21 ' A' ' 36' ' ' VAL . 87.9 mt -125.33 112.1 15.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.302 -0.874 . . . . 0.0 110.405 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.571 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 16.5 t0 -68.93 169.86 10.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.838 -1.163 . . . . 0.0 109.48 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.559 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 11.4 ptm180 -48.03 -40.61 23.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.681 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.466 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -80.64 -31.31 36.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.328 -0.857 . . . . 0.0 110.407 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.512 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 31.3 mt-10 -75.69 -38.1 58.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.735 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.661 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 52.6 t80 -68.28 -19.51 64.71 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.367 -0.833 . . . . 0.0 109.439 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.38 -39.84 52.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.444 -0.785 . . . . 0.0 109.395 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.886 HG13 HD21 ' A' ' 94' ' ' LEU . 38.3 t -64.0 -23.49 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.555 0.693 . . . . 0.0 109.192 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.029 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.57 -8.2 50.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.624 -0.673 . . . . 0.0 110.854 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.619 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 14.8 mmt -83.03 -46.89 12.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.064 -1.022 . . . . 0.0 109.907 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.59 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 5.4 p90 -76.27 -25.57 55.06 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.738 ' HB3' HG13 ' A' ' 53' ' ' VAL . 11.0 mt -69.92 -25.83 63.85 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.863 HG13 HD12 ' A' ' 45' ' ' LEU . 51.9 t -91.39 -62.74 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.548 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.2 m-85 -47.61 -25.44 1.16 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.614 -0.679 . . . . 0.0 111.131 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 33.6 m -82.71 -12.31 57.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.986 -1.071 . . . . 0.0 109.843 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.996 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.13 -10.67 43.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.291 -0.881 . . . . 0.0 109.179 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.784 ' N ' HD12 ' A' ' 81' ' ' LEU . 7.0 mp -87.91 -43.46 11.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 109.348 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.302 -1.499 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.665 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.69 HG11 ' CG2' ' A' ' 53' ' ' VAL . 97.2 t . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.613 0.244 . . . . 0.0 110.665 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.5 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.7 Cg_endo -85.24 -169.31 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.979 1.515 . . . . 0.0 109.407 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.909 ' HA ' HD11 ' A' ' 56' ' ' LEU . 2.7 mtp -116.22 8.05 14.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 0.0 109.983 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.416 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 58.5 m -106.08 104.96 14.78 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.812 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.621 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -50.05 106.49 0.64 Allowed Pre-proline 0 C--N 1.292 -1.92 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.514 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 39.4 Cg_endo -68.68 142.99 54.71 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.926 1.487 . . . . 0.0 111.215 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.99 -7.56 21.29 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.422 1.748 . . . . 0.0 111.311 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.598 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -100.0 21.68 12.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.166 -0.959 . . . . 0.0 108.772 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.952 ' O ' HD22 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -141.52 -11.34 0.92 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.285 0.564 . . . . 0.0 110.426 -178.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.427 ' H ' HG23 ' A' ' 95' ' ' VAL . 2.0 t . . . . . 0 N--CA 1.492 1.651 0 O-C-N 120.439 -1.413 . . . . 0.0 110.133 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.564 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 9.5 t90 . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -39.39 -26.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.843 . . . . 0.0 110.43 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.564 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 12.3 t -99.04 127.76 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.586 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.522 ' CD ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -84.6 175.96 4.15 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 110.334 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' CD ' ' A' ' 10' ' ' LYS . 42.6 Cg_endo -70.4 -34.38 12.54 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.079 1.568 . . . . 0.0 109.515 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -78.72 -24.36 44.93 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.593 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 19.8 m-20 -82.97 -48.79 10.28 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.514 ' HE2' ' HB2' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -63.95 -19.23 64.98 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -80.63 -43.76 19.96 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.587 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.35 -28.04 60.95 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 8.1 m-30 -70.65 -36.78 73.57 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 66.5 t0 -72.66 -9.29 58.44 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.446 0.641 . . . . 0.0 109.74 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.19 -35.86 11.69 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.503 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 29.3 mt -77.73 -32.49 18.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.587 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -69.75 -43.82 71.5 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.345 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.554 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 47.5 t0 -83.49 2.62 35.98 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.41 0.624 . . . . 0.0 109.558 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.451 ' HB2' ' HA ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -90.56 -8.41 50.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.331 -0.855 . . . . 0.0 109.208 179.013 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.688 HD12 HD13 ' A' ' 31' ' ' LEU . 2.9 mt -104.65 -8.07 19.17 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m 83.14 93.77 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.995 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.5 Cg_endo -74.27 145.41 34.47 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.374 1.723 . . . . 0.0 110.533 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 21.1 t -113.15 102.56 14.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER 62.4 19.95 11.5 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.323 -0.861 . . . . 0.0 109.268 -179.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 92.28 34.05 7.31 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 77.9 m-85 -144.56 149.5 35.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.165 -1.197 . . . . 0.0 111.566 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.688 HD13 HD12 ' A' ' 24' ' ' LEU . 52.3 mt -125.7 131.87 52.49 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.549 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -77.42 138.46 39.28 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.443 -0.785 . . . . 0.0 110.029 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -43.01 -25.64 0.38 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 6.0 m-20 -65.52 -20.88 66.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -1.175 . . . . 0.0 110.337 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 9.1 mtpp -97.98 -39.78 8.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.176 -0.952 . . . . 0.0 109.073 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.955 HG11 HD12 ' A' ' 65' ' ' LEU . 60.4 t -78.15 -36.6 21.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 121.485 0.659 . . . . 0.0 109.769 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.5 tttt -48.08 -54.69 22.59 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.859 . . . . 0.0 110.171 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.923 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.0 Cg_endo -63.6 -29.24 70.01 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.58 1.305 . . . . 0.0 108.907 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.591 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 4.7 t -80.63 -11.27 12.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 121.659 0.742 . . . . 0.0 109.46 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.685 ' HB3' HD22 ' A' ' 50' ' ' LEU . 42.0 mt -99.94 -14.97 18.48 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.166 -0.959 . . . . 0.0 108.677 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.923 HD12 ' HA ' ' A' ' 38' ' ' PRO . 7.9 mt -89.42 -33.9 16.67 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.642 -0.661 . . . . 0.0 110.089 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 6.6 p30 -64.24 -9.85 19.9 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.735 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 1.4 m -72.35 -1.83 16.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 110.052 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 43' ' ' SER . 17.4 ttmt 69.55 14.62 8.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.307 -0.871 . . . . 0.0 110.455 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.044 HD13 HG21 ' A' ' 49' ' ' ILE . 14.9 mt -100.46 163.64 17.81 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.217 -0.927 . . . . 0.0 110.317 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HG2' HG12 ' A' ' 49' ' ' ILE . 44.1 Cg_endo -75.18 160.92 39.03 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.982 1.517 . . . . 0.0 110.047 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.6 t -64.96 -7.17 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.132 -0.98 . . . . 0.0 110.373 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.06 -40.31 62.9 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.044 HG21 HD13 ' A' ' 45' ' ' LEU . 15.3 mm -64.13 -43.62 97.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.685 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.1 mt -66.26 -21.19 66.28 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.735 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.14 -27.97 29.48 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.565 ' CD ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -94.54 -54.73 3.4 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.465 -1.021 . . . . 0.0 109.329 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.954 HG11 HG23 ' A' ' 77' ' ' VAL . 33.2 t -52.36 -41.01 33.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.517 -0.873 . . . . 0.0 108.685 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.539 ' CZ2' ' OD2' ' A' ' 58' ' ' ASP . 9.0 t-105 -62.6 -56.44 17.8 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.449 -0.782 . . . . 0.0 109.795 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.518 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 12.0 mm-40 -45.33 -56.48 4.87 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.389 -0.82 . . . . 0.0 110.104 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.724 HD21 ' C ' ' A' ' 88' ' ' MET . 1.4 mt -72.1 -10.94 60.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.687 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.971 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 8.0 m -96.8 -23.15 16.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.377 -0.827 . . . . 0.0 110.263 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.579 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 6.7 t0 -93.26 76.06 4.58 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.356 -0.84 . . . . 0.0 109.569 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.473 ' HB ' ' OE1' ' A' ' 69' ' ' GLU . 34.4 mm -41.23 -32.52 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.712 -0.618 . . . . 0.0 110.236 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 35.5 m-20 -93.48 -22.06 19.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.386 -0.821 . . . . 0.0 110.717 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 46.1 m-70 55.47 42.81 29.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 109.716 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -112.45 3.36 16.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.464 -0.773 . . . . 0.0 110.887 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.93 3.84 48.63 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.549 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 4.6 mtt -133.94 159.45 40.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -1.131 . . . . 0.0 110.82 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.955 HD12 HG11 ' A' ' 36' ' ' VAL . 10.5 mt -124.38 110.97 15.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.576 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -72.56 172.62 10.23 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.866 -1.146 . . . . 0.0 109.781 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.498 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -49.36 -38.07 26.96 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.603 -0.686 . . . . 0.0 111.313 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.15 -31.21 21.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.007 -1.058 . . . . 0.0 110.221 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.487 ' OE2' ' HB3' ' A' ' 66' ' ' ASP . 27.9 mt-10 -75.76 -42.35 50.61 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.285 -0.884 . . . . 0.0 109.593 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.656 ' HA ' HD13 ' A' ' 65' ' ' LEU . 61.4 t80 -62.66 -31.45 72.33 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.069 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.514 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . . . -60.36 -49.05 79.12 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.79 0.805 . . . . 0.0 109.89 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 1.057 HG13 HD21 ' A' ' 94' ' ' LEU . 85.6 t -57.73 -24.2 22.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 121.333 0.587 . . . . 0.0 110.427 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.971 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -90.46 -6.15 55.21 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.183 -0.948 . . . . 0.0 111.852 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.581 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 11.3 mmm -89.97 -43.15 10.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.648 -1.283 . . . . 0.0 110.121 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.586 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.6 p90 -76.84 -27.71 55.22 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.876 -1.13 . . . . 0.0 108.115 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.711 ' HB3' HG13 ' A' ' 53' ' ' VAL . 9.6 mt -69.47 -27.15 64.98 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.954 HG23 HG11 ' A' ' 53' ' ' VAL . 30.3 t -91.59 -32.79 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.501 -0.75 . . . . 0.0 110.431 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -81.83 -33.01 30.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.13 -0.981 . . . . 0.0 110.043 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 65.1 m -75.45 -20.09 59.04 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.698 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -71.64 -16.7 62.28 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 81' ' ' LEU . 5.6 mt -90.56 -44.4 9.58 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.542 0.687 . . . . 0.0 109.787 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.612 -0.68 . . . . 0.0 111.731 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.576 HG21 ' CG2' ' A' ' 53' ' ' VAL . 85.5 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.59 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.4 Cg_endo -84.44 169.86 10.8 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.87 1.458 . . . . 0.0 109.405 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.724 ' C ' HD21 ' A' ' 56' ' ' LEU . 4.2 mtm -98.85 12.76 34.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.917 -1.114 . . . . 0.0 110.261 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.468 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 72.2 m -108.63 103.83 13.01 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.715 -1.194 . . . . 0.0 112.044 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.594 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 2.2 mt -51.74 106.38 0.65 Allowed Pre-proline 0 C--N 1.292 -1.927 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.233 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.663 ' HD2' HD12 ' A' ' 94' ' ' LEU . 41.2 Cg_endo -72.07 150.36 54.09 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.759 1.4 . . . . 0.0 110.51 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.508 ' HA ' ' CG2' ' A' ' 95' ' ' VAL . 43.8 Cg_endo -70.16 -5.82 17.36 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.146 1.603 . . . . 0.0 111.068 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -100.62 24.59 8.83 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.057 HD21 HG13 ' A' ' 72' ' ' VAL 0.25 0.3 OUTLIER -158.19 34.36 0.24 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.338 1.066 . . . . 0.0 109.015 -178.128 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.508 ' CG2' ' HA ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 O-C-N 120.623 -1.298 . . . . 0.0 110.347 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.549 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.515 0.674 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.447 ' HB2' HD22 ' A' ' 94' ' ' LEU . . . -46.45 -24.56 0.52 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.447 -0.783 . . . . 0.0 110.652 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.549 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 73.3 t -103.6 130.99 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.793 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.639 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.5 mttt -93.64 174.47 3.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.476 -0.765 . . . . 0.0 109.007 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.639 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 38.2 Cg_endo -65.44 -37.48 30.01 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.287 1.151 . . . . 0.0 109.957 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 8.0 pt-20 -64.71 -25.94 68.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.215 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.596 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -84.0 -38.34 21.05 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 9.9 tptm -72.88 -17.03 61.57 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.576 0.703 . . . . 0.0 109.258 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.55 -37.84 65.43 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 2.3 mtmt -80.82 -39.18 27.05 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.596 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 5.3 m-30 -66.26 -22.69 66.32 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 6.3 t0 -85.81 -15.45 41.93 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.631 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -90.33 -28.14 18.93 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.739 HG22 ' CE1' ' A' ' 70' ' ' PHE . 15.7 mt -82.7 -31.85 9.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.605 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -74.31 -40.49 62.19 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.523 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.2 t0 -84.9 -0.57 54.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.643 -0.66 . . . . 0.0 109.839 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -89.34 -7.18 55.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.844 . . . . 0.0 109.04 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.856 ' HB2' HD22 ' A' ' 31' ' ' LEU . 2.5 mt -107.08 -8.66 16.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER 82.17 95.07 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.4 Cg_endo -74.49 150.17 40.41 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.994 1.523 . . . . 0.0 110.838 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 40.8 t -118.81 101.55 11.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER 65.22 26.58 12.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 108.891 -178.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . 85.14 35.72 12.03 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.604 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 93.8 m-85 -150.04 159.26 44.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.641 -0.917 . . . . 0.0 110.598 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.856 HD22 ' HB2' ' A' ' 24' ' ' LEU . 12.7 mt -135.02 128.95 33.34 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.471 ' OG ' ' CD ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -73.09 139.21 46.33 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.452 -0.78 . . . . 0.0 110.541 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -43.07 -32.87 1.64 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.43 -15.83 7.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -1.153 . . . . 0.0 110.016 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 9.6 mtpp -111.77 -35.39 5.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.277 -0.889 . . . . 0.0 108.95 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.999 HG11 HD12 ' A' ' 65' ' ' LEU . 84.8 t -91.32 -46.27 14.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.698 -0.626 . . . . 0.0 110.179 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.635 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 ttpt -45.22 -47.83 33.17 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 110.661 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.869 ' HA ' HD12 ' A' ' 41' ' ' LEU . 40.0 Cg_endo -69.01 -31.63 23.43 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.38 1.2 . . . . 0.0 109.377 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.532 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 1.9 t -65.71 -31.01 51.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.778 -0.576 . . . . 0.0 109.629 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.843 ' HB3' HD22 ' A' ' 50' ' ' LEU . 18.8 mt -80.59 -14.74 57.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.213 -0.93 . . . . 0.0 109.026 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.869 HD12 ' HA ' ' A' ' 38' ' ' PRO . 33.7 mt -76.25 -26.49 56.06 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 35.8 m-80 -63.32 -17.05 62.14 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.138 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.529 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -76.55 1.97 15.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.265 -0.897 . . . . 0.0 110.327 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 43' ' ' SER . 6.0 tttm 64.71 11.82 7.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 0.0 110.083 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.955 HD13 HG21 ' A' ' 49' ' ' ILE . 15.1 mt -86.89 158.41 53.38 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.864 . . . . 0.0 110.087 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.7 Cg_endo -73.61 159.11 46.53 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.068 1.562 . . . . 0.0 110.851 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -58.93 -10.74 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.984 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.27 -42.38 59.71 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.959 -1.088 . . . . 0.0 108.073 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.955 HG21 HD13 ' A' ' 45' ' ' LEU . 21.1 mm -61.84 -42.62 95.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.843 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.7 mt -66.77 -22.81 66.03 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.484 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . -82.65 -24.59 53.06 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.578 ' CD ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -99.01 -59.59 1.7 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.545 -0.974 . . . . 0.0 109.711 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.856 HG11 HG23 ' A' ' 77' ' ' VAL . 46.2 t -46.58 -36.44 2.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.012 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.554 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 9.3 t-105 -73.07 -59.33 2.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 110.211 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 52.5 mm-40 -44.16 -45.5 8.34 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.195 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.75 HD21 ' C ' ' A' ' 88' ' ' MET . 1.8 mt -81.52 -16.5 51.59 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.339 -0.944 . . . . 0.0 109.586 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.933 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 3.2 t -88.39 -25.9 22.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.455 -0.778 . . . . 0.0 109.457 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.562 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 15.7 t0 -85.0 81.38 8.93 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.505 -0.747 . . . . 0.0 109.745 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.531 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 33.2 mm -47.8 -30.94 2.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 120.134 -0.627 . . . . 0.0 110.504 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 4.4 p-10 -103.92 -16.28 15.4 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.039 -1.064 . . . . 0.0 111.309 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.562 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 34.8 m-70 54.73 41.51 31.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.894 -1.129 . . . . 0.0 109.948 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 64' ' ' MET . 1.1 p-10 -100.96 -10.76 20.29 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.357 -0.839 . . . . 0.0 110.171 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.433 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 117.9 8.93 10.29 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.572 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.0 mtp -145.55 161.36 39.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -1.174 . . . . 0.0 110.116 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.999 HD12 HG11 ' A' ' 36' ' ' VAL . 15.6 mt -117.4 106.0 12.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.172 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.604 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -69.59 172.91 6.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.779 -1.201 . . . . 0.0 110.297 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.494 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.5 ptm180 -47.73 -39.57 18.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.614 -0.679 . . . . 0.0 111.032 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.46 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 5.6 m-20 -84.87 -31.97 23.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 0.0 110.338 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.531 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 18.9 mt-10 -77.2 -44.16 31.08 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.392 -0.818 . . . . 0.0 109.091 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.788 ' CE2' HG13 ' A' ' 36' ' ' VAL . 62.0 t80 -64.46 -29.12 70.17 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -62.28 -50.4 71.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.42 -0.8 . . . . 0.0 110.226 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.992 HG13 HD12 ' A' ' 94' ' ' LEU . 41.8 t -56.31 -24.11 17.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.51 -0.744 . . . . 0.0 109.8 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.933 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -86.69 -9.88 54.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.195 -0.941 . . . . 0.0 111.831 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.59 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 9.1 mmm -87.85 -39.11 15.1 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.602 -1.312 . . . . 0.0 110.574 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.997 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 3.2 p90 -78.93 -20.23 49.84 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.834 -1.146 . . . . 0.0 108.212 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.748 HD12 ' O ' ' A' ' 72' ' ' VAL . 10.5 mt -79.83 -25.47 40.79 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.611 0.719 . . . . 0.0 109.217 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.856 HG23 HG11 ' A' ' 53' ' ' VAL . 78.5 t -91.49 -26.99 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.478 -0.764 . . . . 0.0 110.327 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.46 -29.96 21.02 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.267 -0.895 . . . . 0.0 110.039 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 3.0 t -81.19 -14.78 57.22 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.265 -0.897 . . . . 0.0 108.861 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.71 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.22 -7.68 58.92 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.4 -0.812 . . . . 0.0 109.12 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.749 HD23 ' N ' ' A' ' 81' ' ' LEU . 2.8 mt -90.46 -50.29 6.03 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.584 -0.698 . . . . 0.0 109.968 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.649 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.425 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.528 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 44.5 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.635 0.255 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.594 ' O ' HD11 ' A' ' 56' ' ' LEU . 51.7 Cg_endo -90.45 147.49 4.25 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.933 1.491 . . . . 0.0 109.72 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.75 ' C ' HD21 ' A' ' 56' ' ' LEU . 4.7 mtm -81.96 11.2 5.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.88 -1.138 . . . . 0.0 110.348 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.467 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 68.3 m -106.84 106.4 16.91 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.598 -178.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.604 ' HG ' ' HA ' ' A' ' 56' ' ' LEU . 2.1 mt -54.66 107.81 0.97 Allowed Pre-proline 0 C--N 1.294 -1.841 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.919 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.645 ' HG2' HD23 ' A' ' 94' ' ' LEU . 40.1 Cg_endo -67.93 161.03 45.87 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 124.076 1.566 . . . . 0.0 110.14 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.11 -20.59 16.5 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.002 1.527 . . . . 0.0 111.098 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.623 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -88.84 15.29 8.62 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.152 -0.968 . . . . 0.0 109.734 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.997 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 3.9 mm? -118.33 -23.03 7.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.205 -0.934 . . . . 0.0 110.611 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.4 t . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.341 -0.849 . . . . 0.0 110.855 -179.208 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.569 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.1 t90 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.2 0.524 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.721 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -42.4 -28.84 0.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 110.277 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.569 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 39.0 t -100.09 146.05 9.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.348 -0.845 . . . . 0.0 109.72 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.516 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.1 mtmt -119.47 178.07 1.2 Allowed Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.192 -0.942 . . . . 0.0 109.693 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 38.3 Cg_endo -64.9 -36.42 39.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.84 1.442 . . . . 0.0 110.252 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 18.3 pt-20 -65.35 -35.73 81.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.327 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 92.4 m-20 -81.95 -34.41 29.81 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.883 ' HE2' ' HB2' ' A' ' 71' ' ' ALA . 1.1 tppp? -70.91 -20.6 62.47 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.21 -40.02 78.26 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.655 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.7 ptmm? -79.79 -24.82 41.19 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.655 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.7 m-30 -72.18 -35.86 69.09 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 35.0 t0 -74.47 -8.75 57.32 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.238 0.542 . . . . 0.0 110.455 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.08 -41.22 9.22 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.644 HG22 ' CE2' ' A' ' 70' ' ' PHE 0.251 15.5 mt -72.51 -29.62 31.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -70.73 -39.72 73.19 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.517 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.2 t70 -88.6 2.99 52.05 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.572 -0.705 . . . . 0.0 109.816 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.5 m -91.01 -4.95 56.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 108.663 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.892 HD12 HD13 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -110.74 -6.02 14.87 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER 80.88 96.33 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.2 Cg_endo -72.9 147.63 44.27 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 O-C-N 124.611 1.848 . . . . 0.0 110.691 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.7 t -117.61 103.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 1.1 t30 62.2 21.9 12.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.942 . . . . 0.0 109.223 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.58 34.56 7.33 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CE1' ' CB ' ' A' ' 66' ' ' ASP . 96.9 m-85 -150.43 160.64 43.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -1.113 . . . . 0.0 111.134 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.892 HD13 HD12 ' A' ' 24' ' ' LEU . 42.8 mt -126.61 132.91 51.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.508 -0.745 . . . . 0.0 109.529 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.561 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.5 OUTLIER -80.54 138.9 36.55 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.358 -0.839 . . . . 0.0 110.458 -179.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -40.62 -25.68 0.11 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 32' ' ' SER . 8.7 m-20 -63.93 -17.94 63.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -1.141 . . . . 0.0 110.969 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -111.6 -36.42 5.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.937 -1.102 . . . . 0.0 109.942 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.015 HG11 HD12 ' A' ' 65' ' ' LEU . 82.2 t -79.09 -54.19 12.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.316 -0.865 . . . . 0.0 109.964 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.618 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -40.43 -49.88 6.74 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.581 -0.699 . . . . 0.0 110.459 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.858 ' HA ' HD12 ' A' ' 41' ' ' LEU . 41.2 Cg_endo -68.27 -31.97 27.59 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.376 1.198 . . . . 0.0 109.413 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.688 HG21 ' CD2' ' A' ' 24' ' ' LEU . 2.2 t -67.51 -31.65 53.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.576 -0.703 . . . . 0.0 109.572 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.959 ' CB ' HD22 ' A' ' 50' ' ' LEU . 11.4 mt -78.72 -15.66 58.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.049 -1.032 . . . . 0.0 108.636 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.858 HD12 ' HA ' ' A' ' 38' ' ' PRO . 14.8 mt -75.47 -24.29 56.94 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.423 -0.798 . . . . 0.0 108.901 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 32.6 m-80 -66.98 -19.03 65.65 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.001 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 1.039 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -74.07 0.08 14.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.273 -0.892 . . . . 0.0 110.252 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.3 OUTLIER 69.49 4.35 4.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.12 -0.987 . . . . 0.0 110.577 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.003 HD13 HG21 ' A' ' 49' ' ' ILE . 15.7 mt -79.2 160.37 70.89 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.011 . . . . 0.0 110.224 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HD2' HG13 ' A' ' 49' ' ' ILE . 41.7 Cg_endo -73.43 161.57 42.18 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.04 1.547 . . . . 0.0 110.287 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.78 -11.39 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.41 -0.806 . . . . 0.0 110.527 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.75 -40.07 66.32 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.003 HG21 HD13 ' A' ' 45' ' ' LEU . 28.3 mm -64.0 -44.82 97.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.959 HD22 ' CB ' ' A' ' 40' ' ' LEU . 13.5 mt -61.52 -17.78 56.28 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . -88.57 -27.4 24.8 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -96.34 -54.54 3.24 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.665 -0.903 . . . . 0.0 109.332 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.869 HG23 HG21 ' A' ' 86' ' ' VAL . 45.0 t -48.16 -33.42 4.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.901 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 10.4 t-105 -76.96 -59.59 2.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.315 -0.866 . . . . 0.0 110.32 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 64.8 mm-40 -45.65 -41.18 10.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.266 -0.896 . . . . 0.0 109.841 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.81 HD22 ' N ' ' A' ' 90' ' ' LEU . 20.9 mt -83.23 -17.61 42.13 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.557 -0.714 . . . . 0.0 109.454 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 1.032 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 8.3 t -92.33 -23.54 19.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.342 -0.849 . . . . 0.0 109.457 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.589 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 23.5 t0 -84.49 65.88 9.19 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.318 -0.864 . . . . 0.0 110.12 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.567 HG12 ' HG2' ' A' ' 69' ' ' GLU . 40.2 mm -39.28 -30.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.373 0.606 . . . . 0.0 110.013 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 21.8 m-20 -95.71 -25.76 15.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.436 -0.79 . . . . 0.0 110.507 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 75.2 m-70 59.62 48.9 8.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.919 . . . . 0.0 109.829 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -117.38 -10.69 10.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 110.434 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.25 8.87 16.37 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.561 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 2.8 mtt -143.55 160.8 39.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.381 -1.07 . . . . 0.0 110.323 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.015 HD12 HG11 ' A' ' 36' ' ' VAL . 69.7 mt -123.85 116.87 23.65 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.13 -0.981 . . . . 0.0 110.937 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.547 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -72.23 160.21 32.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.897 -1.127 . . . . 0.0 109.743 178.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.543 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 9.7 ptm180 -41.73 -37.76 1.29 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.345 -0.847 . . . . 0.0 111.479 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.474 ' OD1' ' NZ ' ' A' ' 14' ' ' LYS . 52.8 m-20 -81.1 -30.13 34.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.855 -1.153 . . . . 0.0 109.528 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.567 ' HG2' HG12 ' A' ' 59' ' ' ILE . 9.4 mt-10 -74.29 -46.37 41.63 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.609 0.718 . . . . 0.0 109.132 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.765 ' CE1' HG22 ' A' ' 36' ' ' VAL . 42.3 t80 -59.87 -18.01 41.11 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.742 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.883 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . . . -72.33 -49.81 31.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.425 -0.797 . . . . 0.0 109.809 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.645 ' O ' HD12 ' A' ' 76' ' ' LEU . 46.8 t -61.01 -22.0 25.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.91 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.032 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.12 -5.18 56.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.221 -0.924 . . . . 0.0 111.008 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.551 ' HG2' ' O ' ' A' ' 70' ' ' PHE . 2.1 mmt -87.84 -45.97 9.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.913 -1.117 . . . . 0.0 110.077 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.764 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.2 p90 -75.04 -33.8 61.79 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 72' ' ' VAL . 29.4 mt -59.02 -30.19 67.83 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.806 ' O ' HD12 ' A' ' 81' ' ' LEU . 98.0 t -91.55 -45.06 14.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.784 -0.572 . . . . 0.0 110.059 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.451 ' HA ' HD12 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -72.92 -25.91 61.22 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.397 -0.814 . . . . 0.0 111.045 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 74.5 m -84.79 -18.37 35.23 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.05 -1.031 . . . . 0.0 109.726 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.842 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -79.35 -12.65 59.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.889 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.039 HD21 ' O ' ' A' ' 43' ' ' SER . 1.2 mt -90.54 -47.13 7.88 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.742 0.782 . . . . 0.0 110.116 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 . . . . . 0 C--N 1.3 -1.579 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.656 -179.097 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.869 HG21 HG23 ' A' ' 53' ' ' VAL . 35.4 t . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.568 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 43.6 Cg_endo -86.35 -166.28 0.31 Allowed 'Trans proline' 0 C--N 1.302 -1.911 0 O-C-N 123.586 1.308 . . . . 0.0 109.897 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 73.3 mtp -123.63 11.32 9.15 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.292 -0.88 . . . . 0.0 111.03 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -168.43 23.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.552 -1.259 . . . . 0.0 111.926 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.81 ' N ' HD22 ' A' ' 56' ' ' LEU . 0.6 OUTLIER 53.81 119.35 0.0 OUTLIER Pre-proline 0 C--N 1.283 -2.32 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.788 178.343 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.735 ' HG2' HD23 ' A' ' 94' ' ' LEU . 43.8 Cg_endo -73.56 169.84 21.38 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.725 1.382 . . . . 0.0 109.883 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.37 -16.85 27.63 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.853 1.449 . . . . 0.0 111.919 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.633 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -92.09 12.23 22.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.787 -1.195 . . . . 0.0 110.853 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.764 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 3.4 mm? -113.75 -17.8 12.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.087 -1.008 . . . . 0.0 111.56 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.092 -1.005 . . . . 0.0 110.91 -179.074 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.521 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.4 t90 . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.444 0.64 . . . . 0.0 109.991 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.02 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -46.55 -27.5 1.14 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.42 -0.8 . . . . 0.0 110.151 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.521 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 37.4 t -93.04 129.71 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.395 -0.815 . . . . 0.0 110.332 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.516 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -93.94 179.13 1.31 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.755 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 39.5 Cg_endo -67.65 -35.49 22.11 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.795 1.418 . . . . 0.0 110.224 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -75.15 -26.37 59.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.842 . . . . 0.0 110.058 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.453 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 4.1 m-20 -86.08 -37.43 18.85 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HG3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -76.18 -13.55 60.18 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.588 -0.695 . . . . 0.0 109.175 178.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -73.81 -40.81 63.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 108.901 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.635 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.57 -26.46 50.87 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.36 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.635 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.5 m-30 -71.83 -27.6 63.02 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.14 -10.71 59.6 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.338 0.589 . . . . 0.0 109.937 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.02 -36.54 11.51 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.527 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 82.3 mt -74.81 -33.98 32.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.792 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -65.39 -39.09 91.79 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.529 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.2 t0 -89.31 2.65 54.06 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.694 -0.629 . . . . 0.0 109.706 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.527 ' HB2' ' HA ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -93.83 0.83 56.44 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.847 0.832 . . . . 0.0 108.978 178.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.079 HD22 HG21 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -116.63 -2.49 11.93 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 80.17 90.53 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.855 0 CA-C-O 121.368 0.604 . . . . 0.0 109.838 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.6 Cg_endo -75.27 148.59 34.48 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 124.558 1.82 . . . . 0.0 110.458 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 44.0 t -117.86 108.51 24.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.663 -0.648 . . . . 0.0 109.422 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 16.7 t30 55.44 21.49 4.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.07 -1.018 . . . . 0.0 109.741 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 97.03 33.58 5.98 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.624 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 66.2 m-85 -149.76 150.51 32.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -1.104 . . . . 0.0 111.41 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.911 HD13 HD12 ' A' ' 24' ' ' LEU . 30.7 mt -118.56 129.94 55.62 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.71 -0.796 . . . . 0.0 108.994 178.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.54 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -78.76 138.47 38.24 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.606 -0.684 . . . . 0.0 110.616 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -44.08 -25.33 0.67 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 32' ' ' SER . 10.3 t70 -62.27 -17.75 59.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.288 -1.125 . . . . 0.0 110.226 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -114.47 -33.98 5.4 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.325 -0.86 . . . . 0.0 109.377 179.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.918 HG11 HD12 ' A' ' 65' ' ' LEU . 98.6 t -79.19 -51.83 16.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 119.516 -0.873 . . . . 0.0 109.765 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 48.6 tttt -42.68 -49.88 13.04 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 110.338 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 1.027 ' HA ' HD12 ' A' ' 41' ' ' LEU . 39.6 Cg_endo -67.39 -31.09 35.49 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 N-CA-C 108.854 -1.248 . . . . 0.0 108.854 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.079 HG21 HD22 ' A' ' 24' ' ' LEU . 2.8 t -76.22 -10.43 13.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.523 0.677 . . . . 0.0 109.507 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.838 ' HB3' HD22 ' A' ' 50' ' ' LEU . 97.2 mt -99.21 -15.09 19.03 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.027 HD12 ' HA ' ' A' ' 38' ' ' PRO . 6.9 mt -84.63 -33.32 23.33 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.479 -0.763 . . . . 0.0 109.595 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.602 ' ND2' ' HA ' ' A' ' 39' ' ' VAL . 7.8 p30 -71.12 -2.97 17.47 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.865 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 9.4 m -80.37 5.5 14.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.31 -0.869 . . . . 0.0 110.033 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 43' ' ' SER . 27.8 tttt 65.54 12.61 8.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.09 HD13 HG21 ' A' ' 49' ' ' ILE . 15.5 mt -99.82 156.24 35.56 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 110.036 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.547 ' HG2' HG12 ' A' ' 49' ' ' ILE . 40.4 Cg_endo -73.09 162.44 40.8 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.952 1.501 . . . . 0.0 110.153 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.1 t -63.88 -7.93 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.432 -0.792 . . . . 0.0 110.725 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.23 -40.59 51.67 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.09 HG21 HD13 ' A' ' 45' ' ' LEU . 10.9 mm -65.59 -43.53 94.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.838 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.7 mt -66.03 -21.32 66.38 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.33 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.6 -28.11 22.73 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.56 ' O ' HD12 ' A' ' 56' ' ' LEU . 3.8 ttm180 -95.3 -47.42 6.32 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.519 -0.989 . . . . 0.0 109.606 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.939 HG11 HG23 ' A' ' 77' ' ' VAL . 45.7 t -57.45 -39.11 66.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.277 -0.89 . . . . 0.0 109.201 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.553 ' CE3' HD11 ' A' ' 65' ' ' LEU . 6.7 t-105 -68.69 -53.22 23.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.502 -0.749 . . . . 0.0 110.172 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.479 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 5.7 mm-40 -47.58 -50.02 25.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.381 -0.824 . . . . 0.0 109.906 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.688 HD11 ' O ' ' A' ' 87' ' ' PRO . 3.3 mt -76.38 -8.49 57.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.669 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 1.044 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.3 t -99.76 -27.62 13.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.475 -0.766 . . . . 0.0 110.422 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.487 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 11.8 t0 -83.82 90.01 7.28 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.387 -0.821 . . . . 0.0 109.384 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.466 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 46.1 mm -53.45 -32.71 20.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.496 -0.752 . . . . 0.0 110.549 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 24.8 p-10 -106.42 -13.75 15.27 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.185 -0.947 . . . . 0.0 111.021 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.536 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 78.0 m-70 56.45 43.69 25.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.076 -1.015 . . . . 0.0 110.358 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.461 ' OD1' ' OD2' ' A' ' 60' ' ' ASP . 1.1 p-10 -104.3 18.45 22.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.931 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.61 10.42 83.34 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.54 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 4.2 mtt -139.43 161.82 36.55 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.538 -0.977 . . . . 0.0 110.911 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.918 HD12 HG11 ' A' ' 36' ' ' VAL . 71.1 mt -130.76 119.48 22.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.346 -0.846 . . . . 0.0 110.387 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.624 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -79.59 166.59 21.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.896 -1.127 . . . . 0.0 109.484 179.026 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.447 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -43.26 -30.45 0.5 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.457 -0.777 . . . . 0.0 111.275 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.456 ' HB2' ' OD1' ' A' ' 66' ' ' ASP . 58.7 m-20 -90.06 -31.15 17.28 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.14 -0.975 . . . . 0.0 109.766 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.466 ' OE1' ' N ' ' A' ' 59' ' ' ILE . 10.0 mt-10 -76.93 -38.56 53.17 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.412 -0.805 . . . . 0.0 109.378 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.735 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 56.9 t80 -70.71 -24.56 62.67 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.705 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.27 -41.22 77.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 109.552 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.456 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.3 t -62.94 -29.66 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.639 -0.663 . . . . 0.0 110.043 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.044 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.33 -4.46 57.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.154 -0.966 . . . . 0.0 110.9 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.535 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 9.7 mmt -83.37 -46.49 12.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.003 -1.061 . . . . 0.0 109.76 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.687 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 4.3 p90 -77.2 -24.24 51.37 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.667 ' CB ' HG13 ' A' ' 53' ' ' VAL . 15.3 mt -72.89 -25.76 61.19 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.939 HG23 HG11 ' A' ' 53' ' ' VAL . 42.4 t -91.06 -34.46 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.639 -0.663 . . . . 0.0 109.663 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -80.12 -26.39 39.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -0.779 . . . . 0.0 110.034 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 65.1 m -82.11 -12.78 58.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.203 -0.935 . . . . 0.0 109.127 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.023 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.91 -13.73 46.91 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.333 -0.854 . . . . 0.0 108.923 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.681 HD23 ' N ' ' A' ' 81' ' ' LEU . 3.2 mt -89.58 -42.48 11.39 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.904 0.859 . . . . 0.0 109.014 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.298 -1.642 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.423 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.562 HG21 ' CG2' ' A' ' 53' ' ' VAL . 44.2 t . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 120.692 0.282 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.688 ' O ' HD11 ' A' ' 56' ' ' LEU . 52.1 Cg_endo -84.67 -170.69 0.84 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.958 1.504 . . . . 0.0 109.831 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.517 ' C ' HD21 ' A' ' 56' ' ' LEU . 4.8 mtt -115.2 13.89 16.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.069 -1.019 . . . . 0.0 110.634 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.485 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 5.3 m -113.13 103.05 10.97 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 118.729 -1.188 . . . . 0.0 111.688 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.627 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -57.07 108.26 1.18 Allowed Pre-proline 0 C--N 1.291 -1.94 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.824 179.21 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.051 ' HG2' HD23 ' A' ' 94' ' ' LEU . 49.6 Cg_endo -80.05 157.72 23.64 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 123.928 1.489 . . . . 0.0 110.328 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.26 -11.04 24.74 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.079 1.568 . . . . 0.0 110.828 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.597 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -84.15 -0.76 53.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.051 HD23 ' HG2' ' A' ' 91' ' ' PRO . 3.9 mm? -117.46 -9.69 10.81 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.313 -0.867 . . . . 0.0 110.164 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 95' ' ' VAL . 6.3 p . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.953 . . . . 0.0 110.748 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.462 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 12.8 t90 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.729 ' HB3' HD23 ' A' ' 94' ' ' LEU . . . -40.96 -32.42 0.23 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.298 -0.876 . . . . 0.0 109.931 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.462 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 64.9 t -89.71 153.23 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.481 -0.762 . . . . 0.0 109.565 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 11.5 mmtt -99.04 167.03 11.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.2 Cg_endo -66.5 -33.67 36.21 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.747 1.393 . . . . 0.0 109.755 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -76.53 -23.81 53.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.506 -0.746 . . . . 0.0 109.367 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.576 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 21.8 m-20 -82.79 -38.75 22.71 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 7.2 tptm -65.29 -20.33 66.36 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.39 -43.19 41.65 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.602 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.7 ptpt -79.15 -24.05 43.56 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 6.9 m-30 -74.96 -34.33 62.03 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.476 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 10.1 t70 -79.96 -8.4 59.31 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.381 0.61 . . . . 0.0 109.939 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.72 -37.23 10.88 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.681 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 28.0 mt -75.43 -26.66 18.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 1.014 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.2 -36.84 61.37 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.534 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.2 t70 -90.27 1.75 56.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.696 -0.627 . . . . 0.0 109.815 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.511 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.7 m -93.86 -1.38 54.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.35 -0.844 . . . . 0.0 108.821 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.018 HD12 HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -114.0 -1.77 13.7 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 81.71 91.1 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.107 0 CA-C-O 121.111 0.481 . . . . 0.0 109.707 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.4 Cg_endo -75.11 148.51 34.98 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.305 1.687 . . . . 0.0 110.746 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 99.2 t -120.03 109.44 25.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.625 -0.672 . . . . 0.0 109.561 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 9.3 t30 55.53 23.33 5.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.063 -1.023 . . . . 0.0 109.556 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 92.87 35.41 6.42 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.604 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 91.1 m-85 -151.42 152.55 33.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -1.153 . . . . 0.0 111.118 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.018 HD13 HD12 ' A' ' 24' ' ' LEU . 29.7 mt -122.23 127.87 50.47 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.485 ' OG ' ' HE2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -78.86 138.2 38.03 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.613 -179.069 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -38.53 -34.05 0.23 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 32' ' ' SER . 7.9 t0 -49.75 -21.6 1.14 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -1.212 . . . . 0.0 110.022 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 13.0 mttm -113.08 -39.71 4.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.42 -0.8 . . . . 0.0 109.443 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.019 HG11 HD12 ' A' ' 65' ' ' LEU . 96.1 t -79.35 -37.17 18.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.647 -0.658 . . . . 0.0 110.015 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.619 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.1 ttpt -49.34 -50.38 65.11 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.34 -0.85 . . . . 0.0 110.584 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.933 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.6 Cg_endo -66.93 -29.23 41.41 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 N-CA-C 108.812 -1.265 . . . . 0.0 108.812 178.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.571 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 3.2 t -73.97 -13.29 15.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.216 0.531 . . . . 0.0 110.303 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.651 ' HB3' HD22 ' A' ' 50' ' ' LEU . 77.9 mt -98.75 -14.0 19.95 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.967 -1.083 . . . . 0.0 108.568 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.933 HD12 ' HA ' ' A' ' 38' ' ' PRO . 20.3 mt -87.89 -41.72 13.01 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.707 -0.621 . . . . 0.0 110.073 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -52.78 -20.46 3.23 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.365 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -64.08 -9.45 16.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.467 -0.771 . . . . 0.0 110.431 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 71.24 7.91 6.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.142 -0.973 . . . . 0.0 109.72 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.937 HD13 HG21 ' A' ' 49' ' ' ILE . 15.7 mt -88.26 159.88 46.76 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 110.014 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.536 ' HG2' HG12 ' A' ' 49' ' ' ILE . 41.0 Cg_endo -72.41 151.9 54.22 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 123.941 1.495 . . . . 0.0 110.301 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.5 t -54.28 -14.07 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.268 -0.895 . . . . 0.0 110.991 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -39.85 75.08 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.801 -1.187 . . . . 0.0 108.354 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.937 HG21 HD13 ' A' ' 45' ' ' LEU . 4.9 mm -66.89 -47.18 83.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.5 mt -63.31 -21.14 66.07 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.05 -28.33 25.98 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.611 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.1 ttm180 -94.4 -55.71 3.07 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.473 -1.016 . . . . 0.0 109.272 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.978 HG11 HG23 ' A' ' 77' ' ' VAL . 55.3 t -47.64 -44.15 9.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.24 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.532 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 6.0 t-105 -64.62 -57.32 9.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.49 -0.756 . . . . 0.0 109.995 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.561 ' CG ' ' N ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER -47.54 -50.85 22.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.684 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.719 HD23 ' CB ' ' A' ' 90' ' ' LEU . 2.6 mt -70.69 -9.7 57.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.311 -0.868 . . . . 0.0 109.398 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.948 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -100.3 -36.24 9.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.607 -0.683 . . . . 0.0 110.258 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD2' ' CZ2' ' A' ' 54' ' ' TRP . 9.4 t0 -78.76 85.36 4.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.451 -0.78 . . . . 0.0 109.295 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.512 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 31.4 mm -52.47 -30.99 14.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.728 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 0.7 OUTLIER -99.52 -18.09 17.57 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.053 -1.029 . . . . 0.0 111.006 -179.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.475 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 7.5 m-70 56.85 31.78 20.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.975 -1.078 . . . . 0.0 108.895 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -90.99 -9.3 46.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.634 -0.666 . . . . 0.0 110.538 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 113.24 9.98 16.54 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.579 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 9.2 mtp -149.19 158.18 43.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -1.169 . . . . 0.0 110.732 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.019 HD12 HG11 ' A' ' 36' ' ' VAL . 41.5 mt -116.35 117.18 29.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.603 -0.685 . . . . 0.0 110.159 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.604 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 3.2 t70 -77.35 172.8 12.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.082 -1.011 . . . . 0.0 110.023 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.559 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.4 ptm180 -48.11 -43.18 30.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.519 -0.738 . . . . 0.0 111.36 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -80.4 -33.57 36.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.142 -0.974 . . . . 0.0 110.58 -179.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.516 ' CD ' ' HB3' ' A' ' 66' ' ' ASP . 66.7 mt-10 -73.74 -50.13 22.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 108.593 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.681 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 55.2 t80 -52.03 -33.24 37.78 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -56.47 -53.81 53.15 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.565 0.698 . . . . 0.0 109.96 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.613 HG11 ' O ' ' A' ' 56' ' ' LEU . 78.3 t -55.45 -25.14 17.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.548 -0.72 . . . . 0.0 110.334 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.948 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.28 -5.44 57.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.157 -0.964 . . . . 0.0 111.396 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.582 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 8.0 mmm -90.84 -35.32 14.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.515 -1.366 . . . . 0.0 110.284 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.64 ' CZ ' ' CD2' ' A' ' 94' ' ' LEU . 2.1 p90 -83.1 -24.47 32.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.135 -0.978 . . . . 0.0 108.596 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.77 ' HB3' HG13 ' A' ' 53' ' ' VAL . 3.8 mt -77.4 -23.72 50.62 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.644 -0.66 . . . . 0.0 109.316 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.978 HG23 HG11 ' A' ' 53' ' ' VAL . 48.7 t -89.93 -32.29 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.507 -0.746 . . . . 0.0 109.136 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.737 ' HA ' HD12 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -82.87 -25.46 32.53 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 109.786 179.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 64.4 m -86.15 -12.24 50.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.386 -0.821 . . . . 0.0 109.717 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.925 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -80.81 -19.13 45.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.916 -1.115 . . . . 0.0 108.456 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.737 HD12 ' HA ' ' A' ' 78' ' ' TYR . 3.3 mt -91.69 -40.71 11.12 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.149 0.5 . . . . 0.0 110.391 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 3.8 tt0 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 112.9 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.509 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 41.4 t . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.741 0.305 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.504 ' O ' HD11 ' A' ' 56' ' ' LEU . 52.4 Cg_endo -81.42 158.41 19.62 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.813 1.428 . . . . 0.0 109.404 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.706 ' C ' HD21 ' A' ' 56' ' ' LEU . 2.5 mtt -86.33 16.37 4.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.963 -1.086 . . . . 0.0 110.036 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.634 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 61.6 m -106.58 110.92 23.26 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.221 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.726 ' C ' HD12 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -91.25 98.57 1.77 Allowed Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.18 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.847 ' HG2' HD12 ' A' ' 94' ' ' LEU . 38.3 Cg_endo -63.9 167.61 13.63 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.673 1.354 . . . . 0.0 111.379 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.35 -9.23 24.94 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.208 1.636 . . . . 0.0 111.072 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.24 -7.76 55.59 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.318 -0.864 . . . . 0.0 109.095 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.847 HD12 ' HG2' ' A' ' 91' ' ' PRO . 2.6 mt -111.4 3.5 18.24 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.422 -0.799 . . . . 0.0 110.32 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.966 . . . . 0.0 110.615 -179.499 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.569 ' CZ2' ' HB ' ' A' ' 9' ' ' VAL . 19.1 t90 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.258 0.552 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.696 ' HB2' HD22 ' A' ' 94' ' ' LEU . . . -47.81 -27.69 2.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.486 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.569 ' HB ' ' CZ2' ' A' ' 7' ' ' TRP . 89.4 t -112.73 154.2 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.867 . . . . 0.0 110.453 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.558 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -113.65 -176.56 0.38 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.396 -0.815 . . . . 0.0 110.244 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.9 Cg_endo -69.75 -41.21 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.698 1.367 . . . . 0.0 110.305 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.455 ' HG2' ' OD1' ' A' ' 13' ' ' ASP . 15.3 pt-20 -65.15 -28.5 69.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 109.75 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.57 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 4.3 m-20 -84.25 -40.61 17.82 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 18' ' ' ASP . 1.5 tppp? -69.78 -14.14 62.63 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.79 -39.33 44.26 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 8.8 mtmt -81.61 -40.08 23.53 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CD1' ' HB3' ' A' ' 74' ' ' MET . 5.0 m-30 -64.04 -22.12 66.8 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 4.4 t70 -89.28 -16.84 30.23 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.799 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.05 -29.75 18.18 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.517 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 20.8 mt -80.08 -34.98 15.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -69.56 -38.02 77.26 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.003 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.566 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.1 t70 -88.11 -0.7 57.38 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.701 -0.624 . . . . 0.0 110.227 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.7 t -90.72 -3.84 57.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 109.206 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.02 HD22 HG21 ' A' ' 39' ' ' VAL . 2.2 mt -108.95 -8.09 15.3 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m 86.05 89.08 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.5 Cg_endo -73.55 145.03 36.86 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.455 1.766 . . . . 0.0 110.507 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.632 HG12 HD22 ' A' ' 28' ' ' ASN . 54.4 t -109.7 110.15 31.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.632 HD22 HG12 ' A' ' 27' ' ' VAL . 66.1 m-80 52.14 23.44 2.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.086 -1.009 . . . . 0.0 108.474 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 91.1 33.97 7.87 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.571 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 65.0 m-85 -144.52 148.61 34.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -1.124 . . . . 0.0 112.01 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.804 HD13 HD12 ' A' ' 24' ' ' LEU . 35.1 mt -122.63 134.26 54.51 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.572 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.3 OUTLIER -77.89 143.19 37.94 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.181 -0.949 . . . . 0.0 111.107 -178.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -50.4 -26.9 10.42 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.241 -1.943 . . . . 0.0 108.241 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -77.52 -9.67 59.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.35 -1.088 . . . . 0.0 109.466 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.582 ' HD2' ' CB ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -100.74 -46.56 5.12 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.593 HG22 ' HE2' ' A' ' 70' ' ' PHE . 72.4 t -77.67 -37.34 24.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.924 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.589 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -38.47 -51.88 3.46 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.423 -0.798 . . . . 0.0 111.176 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 1.095 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.6 Cg_endo -65.98 -30.61 47.9 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.311 1.163 . . . . 0.0 109.35 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.02 HG21 HD22 ' A' ' 24' ' ' LEU . 5.4 t -77.51 -10.19 12.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.427 0.632 . . . . 0.0 109.733 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.968 ' HB3' HD22 ' A' ' 50' ' ' LEU . 58.6 mt -100.31 -14.46 18.4 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.095 HD12 ' HA ' ' A' ' 38' ' ' PRO . 10.7 mt -87.0 -42.48 13.08 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.636 -0.665 . . . . 0.0 109.483 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -50.05 -22.87 1.78 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 118.75 -1.18 . . . . 0.0 108.556 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -60.94 -10.96 6.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 110.107 178.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.6 OUTLIER 74.02 18.96 3.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.326 -0.859 . . . . 0.0 109.982 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.022 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.3 mt -98.9 156.25 35.73 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.569 -0.707 . . . . 0.0 109.823 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.536 ' HG2' HG12 ' A' ' 49' ' ' ILE . 41.9 Cg_endo -74.65 156.11 44.59 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.973 1.512 . . . . 0.0 110.279 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.0 t -58.66 -12.38 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.483 -0.76 . . . . 0.0 110.714 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.28 -37.63 71.86 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.026 -1.046 . . . . 0.0 108.233 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.913 HG21 HD13 ' A' ' 45' ' ' LEU . 26.0 mm -68.23 -45.95 81.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.968 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.8 mt -61.61 -20.39 63.29 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.516 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -84.49 -29.98 28.55 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.048 -2.021 . . . . 0.0 108.048 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.6 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 1.1 ttm180 -94.76 -58.32 2.21 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.58 -0.953 . . . . 0.0 109.629 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.644 ' CG2' HG21 ' A' ' 86' ' ' VAL . 6.3 t -46.83 -49.95 6.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.209 -0.997 . . . . 0.0 108.756 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.553 ' HA ' ' HB2' ' A' ' 57' ' ' SER . 16.9 t-105 -56.81 -59.44 5.02 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.931 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 10.4 mm-40 -44.05 -58.39 2.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.158 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.77 HD11 ' HA ' ' A' ' 88' ' ' MET . 3.3 mt -70.25 -11.63 61.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.854 . . . . 0.0 109.803 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 1.008 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 19.3 m -96.2 -27.54 14.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 0.0 110.379 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 54' ' ' TRP . 19.0 t0 -87.14 81.59 7.96 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.241 -0.912 . . . . 0.0 109.455 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.532 HG12 ' HG3' ' A' ' 69' ' ' GLU . 32.1 mm -44.29 -32.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.616 -0.677 . . . . 0.0 110.449 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 9.5 p-10 -105.39 -14.98 15.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.126 -0.984 . . . . 0.0 111.034 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.536 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 29.7 m-70 56.27 41.71 28.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.046 -1.034 . . . . 0.0 110.113 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.473 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 2.2 p-10 -100.89 15.66 27.8 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 110.135 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.72 15.56 77.5 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.572 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 9.1 mtt -146.81 160.74 41.9 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.558 -0.966 . . . . 0.0 110.467 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 58' ' ' ASP . 43.5 mt -128.54 118.16 22.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.329 -0.857 . . . . 0.0 109.436 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.571 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 20.2 t0 -69.77 166.6 18.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.863 -1.148 . . . . 0.0 109.996 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.584 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 10.7 ttm180 -44.0 -46.33 8.28 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 110.142 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.5 m-20 -78.7 -26.72 44.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.383 -0.823 . . . . 0.0 109.66 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.532 ' HG3' HG12 ' A' ' 59' ' ' ILE . 4.7 tt0 -75.71 -39.57 57.16 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.59 0.709 . . . . 0.0 109.53 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.593 ' HE2' HG22 ' A' ' 36' ' ' VAL . 18.2 t80 -66.67 -17.75 65.01 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.691 0.758 . . . . 0.0 109.072 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.469 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -74.99 -43.61 52.97 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.469 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.935 HG13 HD12 ' A' ' 94' ' ' LEU . 59.2 t -60.57 -26.1 36.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.535 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.008 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -90.56 -4.35 56.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.52 -0.737 . . . . 0.0 111.074 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.579 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 11.1 mmt -86.27 -47.05 9.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.925 -1.109 . . . . 0.0 109.971 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.046 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 1.9 p90 -76.91 -24.57 52.47 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.533 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 8.4 mt -71.21 -24.53 62.23 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 73' ' ' ALA . 66.0 t -91.66 -61.92 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.557 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.2 m-85 -48.32 -21.66 0.56 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.721 -0.612 . . . . 0.0 111.597 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 2.1 m -86.21 -14.76 42.96 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.006 -1.059 . . . . 0.0 109.883 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.022 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -89.33 -10.19 47.65 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.282 -0.886 . . . . 0.0 109.302 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.702 ' N ' HD12 ' A' ' 81' ' ' LEU . 7.0 mp -87.04 -43.91 11.97 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.477 -0.765 . . . . 0.0 109.026 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 . . . . . 0 C--N 1.301 -1.523 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.777 179.649 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.644 HG21 ' CG2' ' A' ' 53' ' ' VAL . 77.9 t . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 120.608 0.242 . . . . 0.0 110.514 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.607 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.7 Cg_endo -81.27 -165.85 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.842 1.443 . . . . 0.0 110.097 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.77 ' HA ' HD11 ' A' ' 56' ' ' LEU . 67.0 mtm -120.48 17.11 12.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.267 -0.896 . . . . 0.0 110.609 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.523 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 42.0 m -117.04 95.47 5.01 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.039 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.611 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -57.12 106.71 0.72 Allowed Pre-proline 0 C--N 1.291 -1.962 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.491 178.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.048 ' HG2' HD23 ' A' ' 94' ' ' LEU . 50.9 Cg_endo -75.16 169.3 22.84 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.668 1.352 . . . . 0.0 109.826 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.64 -12.71 26.97 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.857 1.451 . . . . 0.0 111.012 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -86.67 8.44 22.41 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.086 -1.009 . . . . 0.0 109.477 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.048 HD23 ' HG2' ' A' ' 91' ' ' PRO . 1.4 mm? -113.75 6.18 16.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 110.597 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 95' ' ' VAL . 9.9 p . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.068 -1.02 . . . . 0.0 110.713 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.585 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 19.0 t90 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.276 0.56 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -40.97 -34.4 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.401 -0.812 . . . . 0.0 110.839 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.585 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 61.2 t -108.39 141.36 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 110.384 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.573 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -99.42 -177.13 0.55 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.385 -0.822 . . . . 0.0 109.909 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.573 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.6 Cg_endo -69.43 -35.99 12.55 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.662 1.349 . . . . 0.0 109.834 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 10' ' ' LYS . 20.3 pt-20 -68.46 -25.75 65.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 109.825 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.433 ' HB2' HG13 ' A' ' 9' ' ' VAL . 39.7 m-20 -86.13 -38.86 17.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.308 -0.87 . . . . 0.0 108.912 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.424 ' NZ ' ' OD1' ' A' ' 68' ' ' ASP . 3.8 ttmt -75.48 -17.25 60.18 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -74.88 -31.12 61.52 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.657 ' HG3' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -86.45 -21.28 27.16 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.657 ' CD1' ' HG3' ' A' ' 16' ' ' LYS . 17.7 m-30 -78.9 -33.39 45.63 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -13.84 62.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.859 -0.526 . . . . 0.0 110.009 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -89.31 -34.06 16.7 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.558 HG22 ' CE2' ' A' ' 70' ' ' PHE . 22.2 mt -80.72 -35.91 15.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.604 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -68.37 -35.39 77.65 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.55 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.3 t0 -89.1 -1.7 58.21 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.446 -0.784 . . . . 0.0 109.987 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -91.04 -1.51 57.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 0.0 108.648 178.442 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.864 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -109.38 -3.82 16.82 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 81.26 87.52 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 121.454 0.645 . . . . 0.0 109.265 -178.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -72.32 147.65 47.68 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 O-C-N 124.65 1.869 . . . . 0.0 110.896 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 61.3 t -116.26 106.59 20.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.576 -0.703 . . . . 0.0 109.186 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 9.1 t30 57.1 26.55 12.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.265 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 88.24 36.14 8.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.582 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 87.4 m-85 -150.31 160.14 43.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.433 -1.039 . . . . 0.0 111.142 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.864 HD22 ' HB2' ' A' ' 24' ' ' LEU . 12.3 mt -136.25 134.04 37.64 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.568 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -83.08 139.89 32.97 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.854 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -38.77 -28.52 0.07 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.6 OUTLIER -53.04 -35.58 59.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.347 -1.09 . . . . 0.0 111.064 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 1.3 mttm -97.41 -42.13 7.89 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.083 -1.01 . . . . 0.0 109.561 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.956 HG11 HD12 ' A' ' 65' ' ' LEU . 41.9 t -71.61 -47.45 57.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.62 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.572 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 40.9 tttp -45.99 -52.12 28.04 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 110.819 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.935 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.6 Cg_endo -66.48 -34.15 34.77 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.262 1.138 . . . . 0.0 109.164 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.846 HG21 HD22 ' A' ' 24' ' ' LEU . 2.2 t -62.77 -28.02 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.274 0.559 . . . . 0.0 109.606 178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.9 ' HB3' HD22 ' A' ' 50' ' ' LEU . 30.3 mt -83.62 -14.76 51.25 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.168 -0.958 . . . . 0.0 109.479 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.935 HD12 ' HA ' ' A' ' 38' ' ' PRO . 21.5 mt -78.8 -29.01 44.65 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.558 ' ND2' ' HA ' ' A' ' 39' ' ' VAL . 37.0 m-80 -58.13 -28.29 64.54 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.036 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.601 ' HB2' HD11 ' A' ' 81' ' ' LEU . 3.6 p -62.2 -13.01 23.25 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.638 -0.664 . . . . 0.0 109.648 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 75.6 13.63 2.93 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.445 0.64 . . . . 0.0 109.864 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.031 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.4 mt -85.92 158.59 55.92 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.498 -0.751 . . . . 0.0 109.834 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.558 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.5 Cg_endo -73.22 157.3 50.39 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 O-C-N 124.088 1.573 . . . . 0.0 110.265 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.0 t -58.28 -10.92 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.42 -0.8 . . . . 0.0 111.109 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -73.85 -41.96 61.49 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.83 -1.169 . . . . 0.0 108.213 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.983 HG21 HD13 ' A' ' 45' ' ' LEU . 12.9 mm -61.95 -44.55 99.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.9 HD22 ' HB3' ' A' ' 40' ' ' LEU . 11.1 mt -62.17 -20.79 64.51 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.2 -28.51 36.64 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.582 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 0.3 OUTLIER -97.68 -57.21 2.29 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.529 -0.983 . . . . 0.0 109.665 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.701 HG11 ' CG2' ' A' ' 77' ' ' VAL . 3.8 t -47.42 -34.92 3.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.204 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 7.5 t-105 -75.11 -58.98 2.95 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.979 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.572 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 2.9 pt-20 -47.21 -46.22 23.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.621 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.782 HD11 ' O ' ' A' ' 87' ' ' PRO . 7.6 mt -76.52 -12.31 60.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.46 -0.775 . . . . 0.0 109.456 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 1.075 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 2.6 t -96.55 -35.06 11.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.362 -0.836 . . . . 0.0 110.002 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.581 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 11.4 t0 -77.69 86.09 3.99 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.427 ' HB ' ' CD ' ' A' ' 69' ' ' GLU . 36.1 mm -50.35 -32.59 9.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.647 -0.658 . . . . 0.0 111.16 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 53.8 p30 -103.65 -15.1 15.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.933 -1.105 . . . . 0.0 111.256 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 1.4 m80 63.88 43.85 5.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.845 -1.159 . . . . 0.0 109.726 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 6.2 p-10 -107.17 15.69 24.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 110.588 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.91 8.35 87.74 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.568 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 3.6 mtt -142.07 160.82 39.46 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.362 -1.081 . . . . 0.0 110.478 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.956 HD12 HG11 ' A' ' 36' ' ' VAL . 47.4 mt -127.04 120.37 28.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 110.79 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.582 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 8.7 t0 -69.57 164.53 23.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.947 -1.095 . . . . 0.0 109.326 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.508 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 8.9 ptm180 -45.81 -34.46 3.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 110.468 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 10.2 m-20 -85.81 -32.57 21.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.102 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 16.1 mt-10 -71.13 -42.75 68.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.94 . . . . 0.0 108.819 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.682 ' CE1' HG13 ' A' ' 36' ' ' VAL . 42.3 t80 -59.22 -32.56 70.07 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -57.32 -48.37 79.14 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.768 0.794 . . . . 0.0 110.161 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 1.039 HG13 HD12 ' A' ' 94' ' ' LEU . 87.5 t -59.8 -26.61 35.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.645 -0.659 . . . . 0.0 110.739 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.075 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -86.97 -5.62 59.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.159 -0.963 . . . . 0.0 111.723 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.612 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 14.4 mmm -90.45 -41.24 11.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.604 -1.31 . . . . 0.0 110.096 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.978 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.3 p90 -79.38 -17.45 54.39 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.868 -1.133 . . . . 0.0 108.477 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 76' ' ' LEU . 6.8 mt -82.57 -20.88 35.65 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.772 HG21 HD22 ' A' ' 40' ' ' LEU . 77.7 t -90.89 -41.83 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.565 -0.709 . . . . 0.0 109.723 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -71.32 -21.0 62.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.385 -0.822 . . . . 0.0 110.126 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 7.6 t -80.82 -15.14 57.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.268 -0.895 . . . . 0.0 109.087 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.031 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.17 -13.61 35.26 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.52 -0.737 . . . . 0.0 109.38 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.83 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.7 mt -90.5 -33.78 15.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.0 109.222 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 . . . . . 0 C--N 1.301 -1.539 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.663 179.664 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.54 HG21 ' CG2' ' A' ' 53' ' ' VAL . 61.5 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.604 0.24 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.782 ' O ' HD11 ' A' ' 56' ' ' LEU . 51.4 Cg_endo -86.74 -168.66 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.979 1.515 . . . . 0.0 110.159 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.582 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 10.7 mtp -113.65 6.95 17.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.335 -0.853 . . . . 0.0 110.684 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.502 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.1 m -114.24 104.43 12.08 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.442 -1.303 . . . . 0.0 112.135 -177.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.653 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -60.24 107.94 1.23 Allowed Pre-proline 0 C--N 1.288 -2.071 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.379 178.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.032 ' HG2' HD23 ' A' ' 94' ' ' LEU . 41.1 Cg_endo -66.36 167.36 18.79 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.855 1.45 . . . . 0.0 109.946 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.67 -12.46 29.04 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.945 1.497 . . . . 0.0 111.628 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.632 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -87.07 2.53 49.42 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.073 -1.017 . . . . 0.0 110.113 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.039 HD12 HG13 ' A' ' 72' ' ' VAL . 3.0 mm? -107.69 -0.37 21.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.145 -0.972 . . . . 0.0 111.052 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 N--CA 1.493 1.7 0 O-C-N 120.964 -1.085 . . . . 0.0 110.695 -179.436 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.617 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.7 t90 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.079 0.466 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -47.21 -30.36 2.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.009 . . . . 0.0 110.16 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.617 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 72.5 t -102.3 149.69 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.397 -0.814 . . . . 0.0 109.857 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.531 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -126.74 171.91 7.34 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.422 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.684 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.8 Cg_endo -62.91 -34.18 72.47 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.741 1.39 . . . . 0.0 110.592 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -72.98 -35.64 66.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 109.62 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -83.19 -41.29 18.62 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.432 ' HG3' ' CB ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -70.03 -15.19 62.97 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -67.18 -40.82 86.63 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.638 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.9 ptpt -75.79 -25.87 56.79 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.638 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -72.61 -33.75 66.89 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.7 -10.9 60.16 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.41 0.624 . . . . 0.0 109.7 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.58 -35.91 14.74 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.647 HD13 ' SD ' ' A' ' 74' ' ' MET . 19.8 mt -76.73 -34.78 23.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.618 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -70.81 -33.56 70.82 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.554 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.9 t0 -88.97 -3.11 58.82 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.546 -0.721 . . . . 0.0 109.892 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.1 m -85.65 -13.73 47.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.084 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.617 HD12 HD13 ' A' ' 31' ' ' LEU . 4.4 mt -100.11 -11.7 20.27 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.607 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 t 85.6 99.41 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.152 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.3 Cg_endo -74.87 148.79 36.41 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 O-C-N 124.337 1.704 . . . . 0.0 110.807 -178.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 60.2 t -117.95 107.87 23.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 121.746 -0.596 . . . . 0.0 109.617 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 6.0 t30 56.9 17.5 3.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.359 -0.838 . . . . 0.0 109.421 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 96.96 36.0 5.14 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.605 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 94.7 m-85 -151.28 160.08 44.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -1.129 . . . . 0.0 110.877 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.627 HD12 ' CD2' ' A' ' 70' ' ' PHE . 37.8 mt -130.81 129.45 42.4 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.558 ' CA ' ' HE3' ' A' ' 64' ' ' MET . 12.2 p -78.23 139.97 38.91 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.854 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.04 -28.78 0.52 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 32' ' ' SER . 13.1 t70 -61.54 -11.23 10.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -1.142 . . . . 0.0 110.269 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' A' ' 24' ' ' LEU . 17.9 mtpp -116.27 -34.83 4.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -0.975 . . . . 0.0 109.02 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.872 HG22 ' HE2' ' A' ' 70' ' ' PHE . 98.0 t -84.34 -36.31 11.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.401 0.619 . . . . 0.0 109.694 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.65 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.3 tttt -48.37 -47.86 67.44 Favored Pre-proline 0 N--CA 1.487 1.384 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.158 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.995 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.7 Cg_endo -67.77 -30.74 33.5 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.407 1.214 . . . . 0.0 109.018 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.5 t -73.99 -9.43 12.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.798 -0.564 . . . . 0.0 109.584 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.001 ' HB3' HD22 ' A' ' 50' ' ' LEU . 82.4 mt -100.18 -15.92 17.96 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.139 -0.976 . . . . 0.0 108.515 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.995 HD12 ' HA ' ' A' ' 38' ' ' PRO . 7.0 mt -89.95 -37.31 14.45 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.549 -0.72 . . . . 0.0 110.16 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 6.6 p30 -58.68 -16.45 16.37 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.153 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.487 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.8 OUTLIER -73.71 -1.83 20.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.374 -0.829 . . . . 0.0 109.871 179.275 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 68.69 14.98 9.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.235 -0.916 . . . . 0.0 110.207 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.922 HD13 HG21 ' A' ' 49' ' ' ILE . 15.4 mt -91.79 155.94 43.09 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.07 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' HG13 ' A' ' 49' ' ' ILE . 40.8 Cg_endo -73.23 154.24 51.54 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.889 1.468 . . . . 0.0 110.466 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.0 t -58.53 -10.6 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.32 -0.863 . . . . 0.0 110.777 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -39.51 68.58 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.887 -1.133 . . . . 0.0 107.987 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.964 HG23 HG21 ' A' ' 86' ' ' VAL . 30.3 mm -64.96 -43.61 96.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.001 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.7 mt -63.89 -14.47 53.66 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.365 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 55' ' ' GLU . . . -83.37 -36.1 15.48 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.455 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 5.1 mtm-85 -94.23 -52.34 4.41 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.598 -0.942 . . . . 0.0 109.984 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.653 HG21 HG22 ' A' ' 49' ' ' ILE . 24.3 t -44.18 -50.29 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.59 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.547 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 7.2 t-105 -66.32 -57.68 6.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 0.0 110.174 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.533 ' HG2' ' HG ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER -53.84 -38.52 64.73 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.927 -1.108 . . . . 0.0 109.127 -179.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.868 HD22 ' N ' ' A' ' 90' ' ' LEU . 94.4 mt -81.33 -14.88 56.8 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.701 -0.624 . . . . 0.0 109.386 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.948 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 10.7 m -97.78 -35.34 10.57 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.365 -0.834 . . . . 0.0 110.159 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.605 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 16.9 t0 -75.32 69.39 2.13 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 58' ' ' ASP . 35.8 mm -35.2 -31.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.056 0.455 . . . . 0.0 111.0 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.541 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 14.7 p-10 -104.73 -16.66 14.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.055 -1.028 . . . . 0.0 111.333 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.605 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER 58.2 30.59 19.64 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.836 -1.165 . . . . 0.0 109.48 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.475 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 2.5 p-10 -84.32 -11.72 55.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.414 -0.804 . . . . 0.0 110.053 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 116.82 5.34 15.76 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.596 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 3.5 mtp -150.05 160.8 43.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -1.175 . . . . 0.0 110.164 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.833 ' CD1' HG11 ' A' ' 36' ' ' VAL . 16.8 mt -115.57 115.24 26.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.077 -1.015 . . . . 0.0 109.53 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.605 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 3.7 t70 -69.15 171.11 8.83 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.011 -1.055 . . . . 0.0 109.809 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 4.4 ptm180 -46.18 -42.43 14.05 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.63 -0.669 . . . . 0.0 110.658 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.468 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -78.71 -33.98 46.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.0 110.345 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.503 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 28.0 mt-10 -74.53 -43.18 57.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.973 . . . . 0.0 109.2 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.872 ' HE2' HG22 ' A' ' 36' ' ' VAL . 18.3 t80 -61.0 -21.58 63.71 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.483 -0.761 . . . . 0.0 109.327 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.432 ' CB ' ' HG3' ' A' ' 14' ' ' LYS . . . -73.08 -40.86 64.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.345 -0.847 . . . . 0.0 109.45 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.883 HG13 HD12 ' A' ' 94' ' ' LEU . 60.1 t -63.2 -27.04 42.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.513 0.673 . . . . 0.0 109.348 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.948 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.83 -4.84 56.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.528 -0.733 . . . . 0.0 110.862 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.647 ' SD ' HD13 ' A' ' 20' ' ' ILE . 11.3 mmt -84.59 -50.21 7.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.997 -1.065 . . . . 0.0 109.603 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.132 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 1.9 p90 -72.85 -31.62 64.89 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.577 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 9.9 mt -61.46 -31.22 71.17 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.716 HG21 ' CD2' ' A' ' 40' ' ' LEU . 46.0 t -92.16 -42.09 13.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.825 -0.547 . . . . 0.0 110.574 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.36 -40.42 62.12 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.821 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 69.5 m -76.46 -14.78 60.03 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.026 -1.047 . . . . 0.0 109.139 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.826 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -77.66 -11.44 59.87 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.635 HD23 ' N ' ' A' ' 81' ' ' LEU . 4.0 mt -91.12 -50.1 6.03 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.615 0.722 . . . . 0.0 109.949 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 N--CA 1.493 1.722 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.518 -178.225 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.964 HG21 HG23 ' A' ' 49' ' ' ILE . 13.4 t . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 86' ' ' VAL . 44.0 Cg_endo -87.52 -162.17 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.877 1.461 . . . . 0.0 109.73 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.6 mtt -129.31 12.4 6.0 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.26 -0.9 . . . . 0.0 110.945 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 90' ' ' LEU . 22.8 t -165.95 23.54 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.931 -1.106 . . . . 0.0 111.279 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.868 ' N ' HD22 ' A' ' 56' ' ' LEU . 2.1 mt 54.89 116.81 0.01 OUTLIER Pre-proline 0 C--N 1.284 -2.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.012 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.014 ' HG2' HD23 ' A' ' 94' ' ' LEU . 44.3 Cg_endo -72.77 175.02 10.88 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.597 1.314 . . . . 0.0 109.16 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 50.1 Cg_endo -74.34 -19.9 19.09 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.632 1.332 . . . . 0.0 111.67 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.604 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -90.29 28.44 1.44 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.97 -1.081 . . . . 0.0 109.479 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.132 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -127.06 -25.69 3.25 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.822 -178.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 95' ' ' VAL . 27.3 m . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.051 -1.03 . . . . 0.0 111.036 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.526 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.1 t90 . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.154 0.502 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -40.62 -27.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 110.525 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.526 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 91.1 t -102.9 138.74 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.87 . . . . 0.0 109.938 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -97.15 -179.91 0.98 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.314 -0.866 . . . . 0.0 110.434 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.3 Cg_endo -69.23 -35.51 14.06 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.934 1.492 . . . . 0.0 110.049 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -75.54 -28.41 59.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.375 -0.828 . . . . 0.0 109.835 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.569 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -83.29 -37.17 23.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.209 -0.932 . . . . 0.0 108.59 178.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 13.8 tptp -69.73 -20.16 63.52 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.08 -44.07 63.85 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.606 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 6.5 ptpt -74.51 -24.17 58.94 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.606 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.6 m-30 -74.25 -35.61 63.82 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -76.8 -9.73 58.88 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.302 0.572 . . . . 0.0 110.031 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.74 -34.97 13.01 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.734 HG22 ' CE1' ' A' ' 70' ' ' PHE . 37.6 mt -78.04 -30.18 15.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.823 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -74.44 -39.53 62.51 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.555 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.551 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 32.6 t70 -88.59 4.39 47.09 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.611 -0.681 . . . . 0.0 109.831 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.46 ' C ' HD23 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -90.54 -15.63 30.31 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.769 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.847 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -97.75 -8.0 29.5 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 84.48 98.21 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.4 Cg_endo -74.27 146.63 36.17 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.056 1.556 . . . . 0.0 110.762 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 27.3 t -116.33 98.57 6.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.505 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 64.97 22.44 12.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.359 -0.838 . . . . 0.0 109.393 -179.124 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 91.97 32.35 8.53 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.521 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 93.8 m-85 -150.23 152.76 35.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.407 -1.055 . . . . 0.0 111.145 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.847 HD22 ' HB2' ' A' ' 24' ' ' LEU . 32.5 mt -124.7 131.85 53.43 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 33' ' ' GLY . 93.9 p -78.19 137.39 38.13 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.272 -0.893 . . . . 0.0 110.43 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.57 -30.86 0.95 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -60.47 -16.24 34.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -1.082 . . . . 0.0 110.318 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.535 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 21.3 mtpp -108.38 -35.3 6.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 109.121 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.899 HG11 HD12 ' A' ' 65' ' ' LEU . 96.8 t -82.77 -31.12 9.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.618 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -50.17 -52.45 53.55 Favored Pre-proline 0 C--N 1.305 -1.363 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.897 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.942 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.6 Cg_endo -64.92 -31.44 56.52 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.581 1.306 . . . . 0.0 109.246 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.584 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 4.3 t -74.87 -10.66 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.447 0.642 . . . . 0.0 109.772 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.801 ' HB3' HD22 ' A' ' 50' ' ' LEU . 78.5 mt -100.24 -15.51 18.06 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 38' ' ' PRO . 8.4 mt -88.3 -44.58 10.71 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.569 -0.707 . . . . 0.0 109.486 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.584 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -47.83 -25.33 1.25 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.722 -1.191 . . . . 0.0 108.62 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.57 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 12.5 m -61.67 -12.15 14.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.508 -0.745 . . . . 0.0 110.032 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 43' ' ' SER . 3.5 tptp 74.1 18.84 3.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.231 -0.918 . . . . 0.0 109.956 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.835 HD13 HG21 ' A' ' 49' ' ' ILE . 15.4 mt -100.1 158.36 32.16 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 110.087 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.524 ' HG2' HG12 ' A' ' 49' ' ' ILE . 41.5 Cg_endo -73.08 156.54 51.7 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 123.934 1.491 . . . . 0.0 110.647 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 t -58.3 -10.85 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.662 -0.649 . . . . 0.0 110.88 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.58 -41.32 60.72 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.866 -1.146 . . . . 0.0 108.432 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.835 HG21 HD13 ' A' ' 45' ' ' LEU . 11.8 mm -64.24 -44.9 97.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.801 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.8 mt -66.98 -16.99 64.71 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.711 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.29 -32.84 15.56 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.374 -1.891 . . . . 0.0 108.374 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.623 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -92.5 -53.67 4.11 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.517 -0.99 . . . . 0.0 109.526 179.321 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.755 HG11 HG23 ' A' ' 77' ' ' VAL . 32.5 t -47.83 -32.08 2.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.25 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.529 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 8.2 t-105 -74.11 -59.29 2.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.841 . . . . 0.0 110.084 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.561 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 5.0 pt-20 -47.67 -45.62 28.34 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.501 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.926 HD21 ' C ' ' A' ' 88' ' ' MET . 2.7 mt -75.91 -11.74 60.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.579 -0.7 . . . . 0.0 109.57 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 1.025 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 2.8 t -99.28 -36.11 9.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.634 -0.666 . . . . 0.0 110.758 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.469 ' HA ' HD23 ' A' ' 65' ' ' LEU . 26.9 t0 -82.61 86.63 6.79 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.483 -0.76 . . . . 0.0 109.454 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.474 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 32.1 mm -51.55 -36.24 17.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.75 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 3.5 m-20 -90.33 -17.05 28.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.538 -0.726 . . . . 0.0 110.566 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 33.1 p80 40.25 39.77 0.71 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.816 0.817 . . . . 0.0 109.23 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -98.17 -9.65 25.39 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.754 -0.591 . . . . 0.0 110.192 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.479 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 126.57 4.39 6.29 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 6.0 mtp -149.54 160.72 43.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.093 -1.24 . . . . 0.0 110.491 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.899 HD12 HG11 ' A' ' 36' ' ' VAL . 34.1 mt -112.49 112.25 23.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.583 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.536 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 17.3 t0 -69.62 166.93 17.99 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.895 -1.128 . . . . 0.0 110.106 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.541 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -42.16 -44.45 3.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.528 -0.732 . . . . 0.0 111.012 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 8.7 p-10 -78.02 -43.01 30.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.368 -0.832 . . . . 0.0 110.162 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.536 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 33.7 mt-10 -61.64 -48.99 78.34 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.656 -0.653 . . . . 0.0 109.779 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.777 ' HE2' HG22 ' A' ' 36' ' ' VAL . 43.5 t80 -58.94 -26.22 64.21 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.395 -0.815 . . . . 0.0 109.373 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -67.22 -45.99 75.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.647 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 1.022 HG13 HD12 ' A' ' 94' ' ' LEU . 88.3 t -60.45 -23.04 27.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.542 -0.723 . . . . 0.0 110.018 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.025 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -89.73 -5.33 57.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.291 -0.88 . . . . 0.0 110.932 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.581 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 1.6 mmm -89.33 -44.86 9.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.999 -1.063 . . . . 0.0 110.038 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.091 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.5 p90 -76.24 -25.22 54.8 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.746 ' HB3' HG13 ' A' ' 53' ' ' VAL . 4.8 mt -69.99 -28.33 65.44 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.755 HG23 HG11 ' A' ' 53' ' ' VAL . 53.6 t -89.35 -29.59 5.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.658 ' HA ' HD12 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -79.53 -25.08 41.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.428 -0.795 . . . . 0.0 110.524 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -87.08 -10.65 52.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 110.172 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.767 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.54 -20.16 30.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.354 -0.841 . . . . 0.0 109.658 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.658 HD12 ' HA ' ' A' ' 78' ' ' TYR . 1.3 mt -92.35 -36.47 13.14 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.556 0.693 . . . . 0.0 110.694 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 . . . . . 0 C--N 1.299 -1.622 0 C-N-CA 119.525 -0.87 . . . . 0.0 108.792 -179.361 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.58 HG11 HG23 ' A' ' 53' ' ' VAL . 24.3 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.705 0.288 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.644 ' O ' HD11 ' A' ' 56' ' ' LEU . 47.0 Cg_endo -89.24 -164.94 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.935 1.492 . . . . 0.0 109.344 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.926 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -123.61 6.12 8.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.368 -0.833 . . . . 0.0 110.253 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.599 ' N ' HD21 ' A' ' 56' ' ' LEU . 55.1 m -105.65 98.44 8.13 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 119.114 -1.034 . . . . 0.0 111.294 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.731 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -54.96 107.14 0.78 Allowed Pre-proline 0 C--N 1.293 -1.866 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.753 179.256 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.057 ' HG2' HD23 ' A' ' 94' ' ' LEU . 42.5 Cg_endo -68.75 162.69 40.17 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.995 1.523 . . . . 0.0 109.984 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.435 ' O ' HG22 ' A' ' 95' ' ' VAL . 43.2 Cg_endo -69.97 -13.35 34.04 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.825 1.434 . . . . 0.0 111.149 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -89.04 19.92 3.92 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.011 -1.055 . . . . 0.0 109.308 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.091 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 1.9 mm? -121.03 -13.61 8.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.469 -0.769 . . . . 0.0 110.451 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 95' ' ' VAL . 30.6 m . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 0.0 111.119 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.605 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.8 t90 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 121.362 0.601 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -59.24 -25.72 64.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 110.285 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.605 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 18.8 t -95.07 160.35 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.575 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -108.32 171.32 4.63 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.069 -1.019 . . . . 0.0 110.491 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.11 -34.48 10.17 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.231 1.648 . . . . 0.0 109.53 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -78.76 -28.98 44.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.578 -0.702 . . . . 0.0 109.349 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.539 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 1.6 m-20 -81.11 -34.22 32.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.456 -0.777 . . . . 0.0 108.913 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 67' ' ' ARG . 16.2 tptt -72.35 -19.98 61.55 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.604 0.716 . . . . 0.0 109.225 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.87 -41.7 61.81 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.622 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.49 -26.09 60.75 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.622 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.3 m-30 -74.34 -38.34 63.28 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 3.1 t70 -73.17 -12.35 60.85 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.279 0.561 . . . . 0.0 110.207 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.61 -32.77 13.27 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.702 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.253 42.3 mt -78.34 -28.76 14.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.972 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.7 -37.77 65.08 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.6 t70 -90.29 1.65 56.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.697 -0.627 . . . . 0.0 109.926 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.427 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.4 t -91.89 -2.74 56.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 108.658 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.975 HD12 HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -112.7 -3.51 14.25 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.47 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.6 t 80.3 96.9 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.9 Cg_endo -71.29 147.31 52.94 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 O-C-N 124.427 1.751 . . . . 0.0 110.548 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 43.0 t -118.05 101.66 12.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 18.3 t30 57.98 30.78 19.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.859 . . . . 0.0 109.624 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.488 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 85.79 34.72 12.69 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.586 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 93.7 m-85 -151.11 153.83 35.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -1.162 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.975 HD13 HD12 ' A' ' 24' ' ' LEU . 24.2 mt -124.68 122.95 38.95 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.675 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.551 ' CA ' ' HE3' ' A' ' 64' ' ' MET . 0.7 OUTLIER -72.92 139.99 47.18 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.612 0.72 . . . . 0.0 111.108 -178.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -46.39 -25.3 1.94 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -58.55 -33.67 70.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -1.104 . . . . 0.0 110.281 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.562 ' HD3' ' CA ' ' A' ' 31' ' ' LEU . 5.1 ptmt -99.96 -28.19 13.21 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.874 0.845 . . . . 0.0 109.714 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.69 HG11 HD12 ' A' ' 65' ' ' LEU . 72.1 t -80.73 -48.37 19.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 CA-C-O 121.444 0.64 . . . . 0.0 109.629 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.61 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.25 -51.98 7.74 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.462 -0.774 . . . . 0.0 110.493 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.809 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.6 Cg_endo -66.28 -33.06 40.36 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 108.889 -1.235 . . . . 0.0 108.889 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.893 HG21 HD22 ' A' ' 24' ' ' LEU . 2.7 t -72.36 -12.23 15.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.949 ' HB3' HD22 ' A' ' 50' ' ' LEU . 90.4 mt -97.85 -16.87 19.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 38' ' ' PRO . 92.5 mt -78.92 -36.41 41.92 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.56 -0.713 . . . . 0.0 109.286 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -46.42 -23.87 0.43 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.552 179.119 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 1.034 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -73.93 6.34 3.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.566 -0.709 . . . . 0.0 111.091 -179.405 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.26 15.36 1.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.755 -1.215 . . . . 0.0 110.051 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.028 HD13 HG21 ' A' ' 49' ' ' ILE . 15.3 mt -93.59 158.76 36.18 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.117 -0.99 . . . . 0.0 109.856 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.556 ' HD2' HG13 ' A' ' 49' ' ' ILE . 41.4 Cg_endo -72.87 157.39 51.66 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.978 1.515 . . . . 0.0 110.294 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.6 t -59.66 -11.24 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 110.706 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.03 -36.49 69.67 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.915 -1.116 . . . . 0.0 108.18 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.028 HG21 HD13 ' A' ' 45' ' ' LEU . 32.6 mm -68.51 -45.2 82.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.949 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.6 mt -65.55 -20.39 66.31 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.486 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . -85.2 -30.02 26.43 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.527 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 16.0 ttm-85 -93.03 -55.43 3.35 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.467 -1.019 . . . . 0.0 109.562 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.826 HG11 HG23 ' A' ' 77' ' ' VAL . 39.4 t -49.76 -38.45 13.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.103 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.532 ' HA ' ' HB2' ' A' ' 57' ' ' SER . 8.6 t-105 -64.93 -56.67 11.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 109.3 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.595 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 68.5 mm-40 -44.52 -55.3 5.23 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.484 -0.76 . . . . 0.0 109.977 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.886 HD11 ' HA ' ' A' ' 88' ' ' MET . 4.7 mt -70.75 -10.5 59.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 0.0 109.913 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.856 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 17.4 m -96.15 -37.43 10.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 110.118 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.659 ' HA ' HD23 ' A' ' 65' ' ' LEU . 13.5 t0 -77.61 70.48 3.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.358 -0.839 . . . . 0.0 109.27 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 58' ' ' ASP . 45.2 mm -39.95 -31.73 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.637 -0.664 . . . . 0.0 110.789 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 62' ' ' ASP . 0.6 OUTLIER -98.79 -23.48 15.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.369 -0.832 . . . . 0.0 110.6 -178.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 55' ' ' GLU . 90.9 m-70 57.41 49.62 12.68 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.189 -0.944 . . . . 0.0 110.545 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.487 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 5.7 p-10 -111.97 0.99 16.22 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.041 -1.037 . . . . 0.0 110.286 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 112.43 2.43 26.04 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.551 ' HE3' ' CA ' ' A' ' 32' ' ' SER . 5.0 mtp -149.1 160.06 43.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.991 -1.299 . . . . 0.0 110.616 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.69 HD12 HG11 ' A' ' 36' ' ' VAL . 70.8 mt -111.69 115.24 28.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.551 -0.718 . . . . 0.0 109.948 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.586 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 7.0 t0 -69.18 164.18 23.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.892 -1.13 . . . . 0.0 109.733 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.54 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 1.7 ptt180 -37.76 -42.28 0.57 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.677 -0.64 . . . . 0.0 111.512 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.54 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -84.74 -33.02 23.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.211 -0.931 . . . . 0.0 110.888 -179.202 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 24.3 mt-10 -69.72 -42.65 73.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 109.368 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.702 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 50.5 t80 -64.14 -28.88 70.06 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.559 -0.713 . . . . 0.0 109.178 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -61.73 -48.95 78.41 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.774 0.797 . . . . 0.0 109.964 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 1.014 ' CG1' HD11 ' A' ' 94' ' ' LEU . 70.7 t -59.25 -24.03 26.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.685 -0.634 . . . . 0.0 110.424 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.856 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -86.71 -8.7 57.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.156 -0.965 . . . . 0.0 112.003 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.602 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 12.0 mmm -90.08 -40.5 12.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.639 -1.288 . . . . 0.0 110.489 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.519 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.6 p90 -78.19 -19.02 54.72 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.789 -1.165 . . . . 0.0 108.374 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.675 HD22 HG13 ' A' ' 86' ' ' VAL . 9.2 mt -80.91 -23.63 38.82 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.468 0.652 . . . . 0.0 109.48 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.826 HG23 HG11 ' A' ' 53' ' ' VAL . 70.1 t -91.65 -32.16 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.529 -0.732 . . . . 0.0 110.3 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.539 ' HA ' HD12 ' A' ' 81' ' ' LEU . 1.2 m-85 -80.04 -24.18 40.91 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.184 -0.947 . . . . 0.0 110.417 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 79.3 m -86.66 -13.76 44.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.256 -0.903 . . . . 0.0 109.395 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.841 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -76.69 -18.95 58.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.08 -1.012 . . . . 0.0 108.743 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.034 HD21 ' O ' ' A' ' 43' ' ' SER . 1.9 mt -92.41 -48.63 6.55 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.516 0.674 . . . . 0.0 111.471 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 82' ' ' GLU . 3.4 tp10 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 112.359 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.675 HG13 HD22 ' A' ' 76' ' ' LEU . 72.1 t . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.605 0.24 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.585 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.2 Cg_endo -80.43 -173.83 2.01 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.756 1.398 . . . . 0.0 109.617 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.886 ' HA ' HD11 ' A' ' 56' ' ' LEU . 20.1 mtm -114.68 20.98 14.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 0.0 110.347 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.496 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 69.0 m -111.18 103.89 12.36 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.696 -1.201 . . . . 0.0 111.434 -178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.8 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.1 mt -59.16 108.15 1.24 Allowed Pre-proline 0 C--N 1.293 -1.856 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.734 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 89' ' ' SER . 43.2 Cg_endo -68.77 141.9 50.85 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.948 1.499 . . . . 0.0 110.549 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.64 -4.54 14.83 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.027 1.54 . . . . 0.0 110.72 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -92.9 8.53 39.29 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.397 -0.814 . . . . 0.0 109.357 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.014 HD11 ' CG1' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -127.92 -7.8 5.5 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.589 0.709 . . . . 0.0 110.136 -178.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.491 1.58 0 O-C-N 120.888 -1.133 . . . . 0.0 110.721 -179.791 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.511 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.8 t90 . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.666 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -40.64 -27.49 0.05 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 0.0 109.889 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.511 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 10.0 t -103.73 128.26 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.424 -0.797 . . . . 0.0 109.534 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.517 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.0 mttt -82.2 178.98 2.11 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.933 . . . . 0.0 110.156 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.6 Cg_endo -71.24 -35.12 9.01 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.01 1.532 . . . . 0.0 109.908 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 2.0 pt-20 -81.07 -19.89 42.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.423 -0.798 . . . . 0.0 109.446 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.515 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 0.3 OUTLIER -81.91 -39.89 23.13 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.01 -14.85 59.36 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.82 -37.49 55.6 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.634 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -77.24 -22.82 51.63 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 13.3 m-30 -77.32 -33.71 55.53 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -70.78 -8.82 55.21 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.319 0.58 . . . . 0.0 110.004 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.57 -34.64 14.66 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.509 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 34.0 mt -81.78 -30.11 10.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.59 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -74.14 -34.76 63.97 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.56 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.6 t70 -89.18 -4.5 58.22 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.676 -0.64 . . . . 0.0 110.213 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.59 -2.69 58.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 108.986 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.668 ' HB2' HD22 ' A' ' 31' ' ' LEU . 3.2 mt -107.14 -12.15 15.46 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.2 t 83.89 87.94 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 44.9 Cg_endo -71.21 150.92 60.19 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 O-C-N 124.739 1.915 . . . . 0.0 110.331 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 28.7 t -116.05 107.48 22.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.65 -0.656 . . . . 0.0 109.802 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 14.9 t30 55.81 21.06 4.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.379 -0.825 . . . . 0.0 109.52 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 96.16 37.56 4.84 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 92.5 m-85 -150.89 159.94 44.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -1.141 . . . . 0.0 111.227 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.668 HD22 ' HB2' ' A' ' 24' ' ' LEU . 27.0 mt -137.77 129.68 28.68 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.591 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 2.7 p -75.01 137.88 41.83 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.421 -0.8 . . . . 0.0 110.871 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -43.91 -25.03 0.57 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' SER . 80.1 m-20 -65.15 -16.21 63.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.284 -1.127 . . . . 0.0 109.855 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 21.8 mtpp -105.12 -38.92 6.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.128 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.707 HG11 HD12 ' A' ' 65' ' ' LEU . 88.7 t -76.39 -33.18 22.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.544 0.688 . . . . 0.0 109.208 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.7 tttp -48.79 -56.04 17.05 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.724 -0.61 . . . . 0.0 110.228 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.711 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.5 Cg_endo -64.93 -28.4 58.22 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.73 1.384 . . . . 0.0 109.093 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.664 HG21 ' CD2' ' A' ' 24' ' ' LEU . 3.5 t -78.71 -11.01 13.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.3 0.571 . . . . 0.0 109.932 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.938 ' HB3' HD22 ' A' ' 50' ' ' LEU . 71.7 mt -101.08 -18.22 16.33 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.185 -0.947 . . . . 0.0 108.554 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.711 HD12 ' HA ' ' A' ' 38' ' ' PRO . 15.3 mt -85.14 -41.62 15.51 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.615 -0.678 . . . . 0.0 109.717 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -50.19 -22.72 1.82 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.694 -1.202 . . . . 0.0 108.807 179.317 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.541 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 35.1 m -64.15 -7.27 8.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.623 -0.673 . . . . 0.0 110.615 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.4 OUTLIER 72.82 10.07 5.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.219 -0.925 . . . . 0.0 109.932 -179.605 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.091 HD13 HG21 ' A' ' 49' ' ' ILE . 13.0 mt -90.41 158.82 42.76 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.401 -0.812 . . . . 0.0 110.14 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.558 ' HD2' HG13 ' A' ' 49' ' ' ILE . 41.8 Cg_endo -75.72 167.21 26.82 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.992 1.522 . . . . 0.0 109.908 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.416 ' O ' HG12 ' A' ' 47' ' ' VAL . 43.8 t -69.2 -5.81 5.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.419 -0.801 . . . . 0.0 110.508 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.89 -39.79 34.07 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.183 -0.948 . . . . 0.0 108.547 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.091 HG21 HD13 ' A' ' 45' ' ' LEU . 27.8 mm -66.96 -44.08 88.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.938 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.5 mt -66.32 -17.0 64.5 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.072 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 55' ' ' GLU . . . -87.5 -29.75 20.85 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.667 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -93.57 -55.61 3.21 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.509 -0.994 . . . . 0.0 109.374 179.493 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.755 HG11 HG23 ' A' ' 77' ' ' VAL . 36.5 t -49.94 -55.33 5.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.535 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 6.6 t-105 -50.37 -56.85 9.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.517 -0.74 . . . . 0.0 110.37 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.501 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -49.97 -45.96 52.0 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.415 -179.176 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.736 HD21 ' C ' ' A' ' 88' ' ' MET . 2.5 mt -76.81 -8.57 57.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.659 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.891 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -99.34 -39.86 8.2 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.397 -0.814 . . . . 0.0 109.663 179.194 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.571 ' HA ' HD23 ' A' ' 65' ' ' LEU . 30.4 t0 -75.52 86.02 2.62 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.494 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 30.6 mm -49.36 -34.23 7.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.128 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 35.9 p-10 -103.47 -9.97 18.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.998 -1.064 . . . . 0.0 111.354 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.531 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 51.3 m-70 55.63 41.62 30.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.953 -1.092 . . . . 0.0 109.517 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.46 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 3.4 p-10 -101.34 16.24 26.23 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.622 -0.674 . . . . 0.0 110.133 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.93 10.9 84.46 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.591 ' HG2' ' HA ' ' A' ' 32' ' ' SER . 5.0 mtt -142.31 160.3 40.53 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.389 -1.065 . . . . 0.0 110.638 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.707 HD12 HG11 ' A' ' 36' ' ' VAL . 44.0 mt -126.19 119.19 26.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.389 -0.82 . . . . 0.0 109.836 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 4.7 t0 -73.9 166.54 23.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.81 -1.181 . . . . 0.0 109.685 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.491 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -42.22 -46.07 4.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.227 -0.92 . . . . 0.0 110.229 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -73.46 -46.76 46.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.523 -0.736 . . . . 0.0 110.342 -179.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.516 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 14.4 mt-10 -60.56 -41.65 94.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.383 -0.823 . . . . 0.0 109.34 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.59 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 18.8 t80 -60.71 -30.13 69.77 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -64.12 -44.1 93.25 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.782 0.801 . . . . 0.0 110.046 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.999 HG13 HD11 ' A' ' 94' ' ' LEU . 63.4 t -61.11 -28.58 44.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.591 0.71 . . . . 0.0 110.289 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' A' ' 57' ' ' SER . . . -84.93 -6.93 59.34 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.478 -0.764 . . . . 0.0 111.559 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.594 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 9.4 mmm -90.23 -43.08 10.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.307 -1.496 . . . . 0.0 110.465 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.601 ' CZ ' HD13 ' A' ' 94' ' ' LEU . 2.9 p90 -76.92 -15.37 59.69 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.985 -1.086 . . . . 0.0 108.683 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.569 ' HB3' HG13 ' A' ' 53' ' ' VAL . 10.0 mt -85.3 -25.62 27.08 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.476 -0.765 . . . . 0.0 108.979 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.755 HG23 HG11 ' A' ' 53' ' ' VAL . 19.0 t -91.06 -28.51 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.006 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.88 -25.18 37.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.247 -0.908 . . . . 0.0 110.365 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -85.49 -13.04 50.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.956 . . . . 0.0 109.519 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.892 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.1 -9.54 52.94 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.384 -0.823 . . . . 0.0 109.119 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.803 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.5 mt -90.33 -45.26 9.14 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.825 0.822 . . . . 0.0 109.063 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.299 -1.608 0 C-N-CA 120.189 -0.605 . . . . 0.0 109.8 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.604 HG21 ' CG2' ' A' ' 53' ' ' VAL . 97.3 t . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.749 0.309 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.635 ' O ' HD11 ' A' ' 56' ' ' LEU . 45.9 Cg_endo -87.02 -171.89 0.83 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.021 1.537 . . . . 0.0 109.179 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.736 ' C ' HD21 ' A' ' 56' ' ' LEU . 18.5 mtm -114.64 7.11 15.92 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.992 -1.067 . . . . 0.0 110.162 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.2 m -111.94 100.64 9.05 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.791 -1.163 . . . . 0.0 111.861 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.756 HD23 HD23 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -46.54 108.53 0.85 Allowed Pre-proline 0 C--N 1.289 -2.032 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.492 178.576 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.455 ' HD2' ' CD2' ' A' ' 94' ' ' LEU . 38.3 Cg_endo -64.75 146.58 88.71 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.899 1.473 . . . . 0.0 110.676 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.82 -11.61 27.84 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.161 1.611 . . . . 0.0 111.565 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.666 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -93.89 24.25 4.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.03 -1.044 . . . . 0.0 108.651 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.999 HD11 HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -141.75 -3.33 1.14 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.797 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.492 1.655 0 O-C-N 120.803 -1.186 . . . . 0.0 110.665 -179.829 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.589 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 17.2 t90 . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.536 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -41.98 -26.97 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 110.089 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.589 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 79.1 t -109.99 124.74 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.0 109.913 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.467 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -86.15 174.36 5.67 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.322 -0.861 . . . . 0.0 110.36 -179.731 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.0 Cg_endo -66.19 -35.94 30.71 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.009 1.531 . . . . 0.0 109.787 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.39 -24.23 61.22 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.357 -0.84 . . . . 0.0 109.242 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -82.69 -42.08 18.54 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -72.27 -15.86 61.91 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.154 178.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.82 -33.34 70.59 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -82.33 -43.79 17.01 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.3 m-30 -61.68 -17.77 56.92 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -87.1 -18.1 31.29 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.802 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.404 ' O ' ' OG ' ' A' ' 23' ' ' SER . . . -90.77 -30.61 16.93 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.708 HG22 ' CE1' ' A' ' 70' ' ' PHE . 27.0 mt -79.62 -32.62 14.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.546 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -69.47 -41.33 76.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.51 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.526 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.8 t70 -86.75 2.69 47.88 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.332 0.587 . . . . 0.0 109.842 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.485 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.4 m -93.3 0.13 56.88 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.834 HD12 HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -113.65 -0.62 14.26 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.468 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 p 77.23 89.9 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 CA-C-O 121.568 0.699 . . . . 0.0 109.119 -178.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.526 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 53.4 Cg_endo -74.21 146.99 36.95 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.113 1.586 . . . . 0.0 110.314 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 98.1 t -114.49 103.55 15.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER 61.89 21.52 12.35 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.189 -0.944 . . . . 0.0 108.933 -178.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.552 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 91.78 33.05 8.09 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 37.9 m-85 -142.74 156.94 45.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -1.108 . . . . 0.0 111.606 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.834 HD13 HD12 ' A' ' 24' ' ' LEU . 37.6 mt -133.35 132.67 41.55 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.546 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.1 OUTLIER -84.49 149.5 25.9 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.342 -0.849 . . . . 0.0 111.22 -178.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -50.68 -21.99 5.32 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.03 -8.63 55.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.236 . . . . 0.0 110.136 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 5.0 mtpp -114.25 -42.1 3.39 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.925 0.869 . . . . 0.0 109.148 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.991 HG11 HD12 ' A' ' 65' ' ' LEU . 46.7 t -80.73 -47.44 20.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.528 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.626 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.7 tttp -43.37 -48.37 17.3 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.535 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.896 ' HA ' HD12 ' A' ' 41' ' ' LEU . 39.9 Cg_endo -68.07 -35.59 19.54 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.335 1.176 . . . . 0.0 109.155 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.649 HG21 HD22 ' A' ' 24' ' ' LEU . 2.3 t -64.06 -31.12 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.386 0.613 . . . . 0.0 109.414 178.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.897 ' HB3' HD22 ' A' ' 50' ' ' LEU . 20.9 mt -79.8 -16.95 54.51 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 109.016 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.896 HD12 ' HA ' ' A' ' 38' ' ' PRO . 75.9 mt -76.38 -24.69 54.14 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.562 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 33.0 m-80 -67.78 -15.98 63.9 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.452 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.43 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -72.55 -0.25 12.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.544 -0.722 . . . . 0.0 110.422 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.88 18.75 10.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.111 -0.993 . . . . 0.0 109.343 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.049 HD13 HG21 ' A' ' 49' ' ' ILE . 14.5 mt -96.34 160.58 29.39 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.631 -0.668 . . . . 0.0 110.009 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HG2' HG12 ' A' ' 49' ' ' ILE . 41.7 Cg_endo -74.29 161.94 39.46 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.878 1.462 . . . . 0.0 109.461 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 t -63.17 -9.24 4.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.379 -0.825 . . . . 0.0 110.177 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 3.0 t70 -73.52 -39.12 65.04 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.049 HG21 HD13 ' A' ' 45' ' ' LEU . 20.8 mm -70.41 -47.98 62.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.897 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.0 mt -66.07 -22.12 66.4 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.58 -28.34 29.94 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.538 ' HD3' ' N ' ' A' ' 88' ' ' MET . 3.8 ttm180 -95.72 -58.38 2.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.467 -1.02 . . . . 0.0 109.464 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.808 HG11 HG23 ' A' ' 77' ' ' VAL . 39.0 t -46.8 -29.19 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.785 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.5 ' O ' ' N ' ' A' ' 57' ' ' SER . 18.4 t-105 -74.19 -59.54 2.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.744 -0.598 . . . . 0.0 110.058 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -46.01 -42.18 12.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 109.722 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.905 HD21 ' C ' ' A' ' 88' ' ' MET . 1.5 mt -78.9 -17.23 55.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.385 -0.822 . . . . 0.0 109.276 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.965 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.3 t -92.41 -35.71 13.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.543 -0.723 . . . . 0.0 110.076 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.469 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 24.7 t0 -78.71 77.16 5.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.467 -0.771 . . . . 0.0 109.291 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.528 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 35.6 mm -40.72 -31.82 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.362 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 2.9 m-20 -96.24 -27.03 15.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.335 -0.853 . . . . 0.0 110.557 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.444 ' CB ' ' O ' ' A' ' 60' ' ' ASP . 28.0 m-70 64.74 45.43 3.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.076 -1.015 . . . . 0.0 109.274 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -114.32 -2.74 13.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 110.582 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.31 -0.94 34.97 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.546 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 2.4 mtt -129.35 155.94 44.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.323 -1.104 . . . . 0.0 110.312 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.991 HD12 HG11 ' A' ' 36' ' ' VAL . 11.0 mt -122.56 121.15 35.82 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.312 -0.867 . . . . 0.0 110.969 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 1.1 m-20 -80.47 155.81 26.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.151 -0.968 . . . . 0.0 108.932 178.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.546 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 11.1 ptt180 -40.14 -31.71 0.14 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 0.0 111.491 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.483 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 81.5 m-20 -85.71 -31.53 22.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.038 -1.039 . . . . 0.0 109.839 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.528 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 54.8 mt-10 -77.41 -42.39 36.39 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.767 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 43.5 t80 -57.68 -32.65 67.55 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.504 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -60.63 -53.69 54.43 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.584 0.707 . . . . 0.0 110.302 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.945 HG13 HD11 ' A' ' 94' ' ' LEU . 80.8 t -53.53 -26.74 13.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.525 -0.734 . . . . 0.0 110.242 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.965 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -87.68 -11.16 49.18 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.117 -0.989 . . . . 0.0 112.673 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.58 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 9.0 mmm -86.65 -43.42 12.64 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.342 -1.474 . . . . 0.0 111.036 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.645 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 2.0 p90 -76.83 -23.26 52.76 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.632 -1.227 . . . . 0.0 108.244 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.774 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.5 mt -76.0 -21.76 56.55 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.38 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.808 HG23 HG11 ' A' ' 53' ' ' VAL . 75.5 t -90.93 -26.46 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.373 -0.83 . . . . 0.0 109.766 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -89.49 -23.14 22.15 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.335 -0.853 . . . . 0.0 109.271 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 30.3 m -82.44 -13.31 56.98 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.39 -0.819 . . . . 0.0 108.9 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.622 ' C ' HD23 ' A' ' 81' ' ' LEU . . . -89.31 -11.14 44.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.393 -0.817 . . . . 0.0 108.974 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.814 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.6 mt -90.82 -43.51 10.01 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.677 0.751 . . . . 0.0 109.563 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 C--N 1.299 -1.595 0 C-N-CA 119.909 -0.717 . . . . 0.0 109.608 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.642 HG11 ' CG2' ' A' ' 53' ' ' VAL . 69.5 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.623 0.249 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.593 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.3 Cg_endo -89.32 145.67 5.07 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.869 1.457 . . . . 0.0 109.394 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.905 ' C ' HD21 ' A' ' 56' ' ' LEU . 1.2 ptt? -75.33 5.08 6.08 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.029 -1.044 . . . . 0.0 111.526 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.56 ' N ' HD21 ' A' ' 56' ' ' LEU . 58.2 m -98.57 104.56 16.6 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 118.821 -1.152 . . . . 0.0 112.24 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.668 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -44.48 104.99 0.41 Allowed Pre-proline 0 C--N 1.299 -1.617 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.418 178.155 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.517 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 39.4 Cg_endo -67.0 139.9 52.74 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.774 1.407 . . . . 0.0 110.624 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.38 -6.44 19.17 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.066 1.561 . . . . 0.0 111.095 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -97.09 19.06 13.52 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.945 HD11 HG13 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -151.42 13.03 0.65 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.758 0.79 . . . . 0.0 110.142 -178.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.5 p . . . . . 0 C--N 1.299 -1.63 0 O-C-N 120.645 -1.284 . . . . 0.0 110.038 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.483 0.864 0 CA-C-O 121.513 0.547 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.861 ' HE1' HD22 ' A' ' 94' ' ' LEU . 15.5 t90 -73.96 130.94 40.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.519 -0.738 . . . . 0.0 110.04 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -44.94 -27.74 0.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 110.342 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.605 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 16.3 t -89.84 137.57 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.209 -0.932 . . . . 0.0 110.116 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 5.4 mttt -92.81 168.29 12.72 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.666 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 38.3 Cg_endo -65.9 -34.56 38.68 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.638 1.336 . . . . 0.0 109.763 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.67 -25.05 60.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.345 -0.847 . . . . 0.0 109.252 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -83.95 -38.36 21.12 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -67.78 -17.45 64.54 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.453 -0.78 . . . . 0.0 109.192 179.071 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.16 -40.43 27.34 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.64 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 3.7 ptmt -79.23 -24.1 43.29 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.64 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.0 m-30 -75.07 -35.68 61.83 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -76.68 -11.73 59.89 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.261 0.553 . . . . 0.0 110.182 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -94.82 -34.33 12.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.66 HG22 ' CE1' ' A' ' 70' ' ' PHE . 21.4 mt -75.78 -32.68 24.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.718 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -68.15 -37.98 81.63 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.498 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 13.6 t70 -89.75 1.72 55.75 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.546 -0.721 . . . . 0.0 109.966 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -92.81 0.13 57.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 108.65 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.056 HD22 HG21 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -113.85 -2.12 13.72 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER 82.69 89.81 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.8 Cg_endo -75.29 150.85 37.52 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 124.352 1.711 . . . . 0.0 110.721 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 98.8 t -117.59 96.9 4.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.561 -0.712 . . . . 0.0 109.505 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 10.4 t30 56.93 20.49 5.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.923 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.55 32.28 3.98 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 90.7 m-85 -149.98 158.6 44.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.194 -1.18 . . . . 0.0 111.378 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.988 HD13 HD12 ' A' ' 24' ' ' LEU . 40.5 mt -135.21 132.51 37.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.555 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 9.2 p -80.66 140.23 35.77 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.445 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.47 -26.38 0.38 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 32' ' ' SER . 8.4 t0 -62.77 -16.37 57.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -1.159 . . . . 0.0 110.378 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 17.5 mttm -107.58 -42.2 4.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.237 -0.914 . . . . 0.0 109.298 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.931 HG11 HD12 ' A' ' 65' ' ' LEU . 64.9 t -74.31 -35.66 40.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.835 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.581 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 14.3 tttp -49.4 -54.59 28.64 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 110.229 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 1.051 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.5 Cg_endo -65.09 -30.29 56.0 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.493 1.26 . . . . 0.0 108.997 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.056 HG21 HD22 ' A' ' 24' ' ' LEU . 4.3 t -76.4 -10.32 13.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.361 0.601 . . . . 0.0 109.741 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.783 ' HB3' HD22 ' A' ' 50' ' ' LEU . 68.5 mt -100.86 -16.09 17.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.051 HD12 ' HA ' ' A' ' 38' ' ' PRO . 7.7 mt -87.16 -40.69 14.37 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.51 -0.744 . . . . 0.0 109.575 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -52.34 -20.81 2.99 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.068 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.544 ' CA ' HD21 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -66.95 -6.15 15.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.579 -0.701 . . . . 0.0 110.085 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.3 OUTLIER 72.43 9.5 5.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.865 . . . . 0.0 109.96 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.026 HD13 HG21 ' A' ' 49' ' ' ILE . 14.9 mt -91.58 157.16 42.4 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 110.322 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.2 Cg_endo -74.47 164.35 34.15 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.138 1.599 . . . . 0.0 110.191 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.83 -8.75 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 110.159 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.84 -40.23 63.45 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.053 -1.029 . . . . 0.0 108.309 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.026 HG21 HD13 ' A' ' 45' ' ' LEU . 10.3 mm -68.34 -47.72 76.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.783 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.4 mt -62.62 -17.38 60.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -88.72 -33.67 9.82 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.504 ' HD2' ' O ' ' A' ' 87' ' ' PRO . 16.7 ttm-85 -91.77 -55.78 3.34 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.461 -1.023 . . . . 0.0 109.321 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.858 HG11 HG23 ' A' ' 77' ' ' VAL . 24.7 t -47.64 -58.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.37 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.489 ' HB3' ' O ' ' A' ' 50' ' ' LEU . 7.7 t-105 -47.35 -54.85 10.07 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.686 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 17.8 mm-40 -47.39 -51.9 18.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 110.02 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.687 HD21 ' C ' ' A' ' 88' ' ' MET . 2.6 mt -74.57 -7.65 53.81 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.317 -0.864 . . . . 0.0 109.642 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.893 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -100.53 -36.23 9.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.418 -0.801 . . . . 0.0 110.269 179.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.543 ' HA ' HD23 ' A' ' 65' ' ' LEU . 36.3 t0 -79.31 71.89 5.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.441 -0.787 . . . . 0.0 109.495 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.689 HG23 ' HD3' ' A' ' 99' ' ' LYS . 36.8 mm -40.16 -33.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.622 -0.674 . . . . 0.0 110.658 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -93.22 -27.59 16.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.946 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.546 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 14.4 m-70 64.67 45.2 3.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.21 -0.931 . . . . 0.0 110.762 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.495 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 2.6 p-10 -113.38 20.88 15.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 110.787 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.53 0.66 89.33 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.555 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 3.3 mtt -130.81 160.26 34.92 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.293 -1.122 . . . . 0.0 110.314 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.931 HD12 HG11 ' A' ' 36' ' ' VAL . 21.3 mt -126.97 114.27 17.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 110.542 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 8.9 t70 -69.74 172.96 6.74 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.142 -0.974 . . . . 0.0 109.395 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.573 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 5.2 ptt180 -55.42 -31.72 62.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 110.768 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.78 -32.54 19.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.089 -1.007 . . . . 0.0 109.778 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 28.0 mt-10 -78.16 -39.3 41.4 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.264 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.804 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 62.6 t80 -65.61 -27.56 68.49 Favored 'General case' 0 C--N 1.303 -1.457 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.865 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.38 -45.44 87.7 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.796 0.808 . . . . 0.0 109.685 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.893 HG13 HD21 ' A' ' 94' ' ' LEU . 48.1 t -61.64 -20.29 22.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.333 0.587 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.893 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.36 -11.12 41.56 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 111.65 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.569 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 5.7 mmm -89.1 -41.52 12.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.699 -1.251 . . . . 0.0 110.385 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.584 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 1.8 p90 -78.97 -23.29 44.63 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.046 -1.061 . . . . 0.0 108.55 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.799 ' HB3' HG13 ' A' ' 53' ' ' VAL . 6.1 mt -74.61 -23.64 58.75 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.858 HG23 HG11 ' A' ' 53' ' ' VAL . 55.6 t -91.03 -59.03 3.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.485 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.5 m-85 -47.85 -22.73 0.6 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.796 -0.565 . . . . 0.0 111.567 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -83.74 -16.85 43.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.882 -1.136 . . . . 0.0 110.048 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.953 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -86.8 -14.18 42.96 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.325 -0.859 . . . . 0.0 109.484 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.754 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.7 mp -86.65 -40.4 15.15 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 7.6 tt0 -72.93 -54.51 8.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.376 0.608 . . . . 0.0 109.858 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 13.2 tttt 177.95 -23.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.342 -0.849 . . . . 0.0 111.598 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -78.69 113.79 37.94 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 120.977 -1.077 . . . . 0.0 111.318 -178.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.31 -170.6 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.794 1.418 . . . . 0.0 109.597 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.757 HG13 HD22 ' A' ' 76' ' ' LEU . 76.5 t -136.98 127.83 16.31 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.972 -1.08 . . . . 0.0 110.699 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.618 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.8 Cg_endo -83.3 -167.52 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.999 1.526 . . . . 0.0 109.359 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.687 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -117.63 9.95 13.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.109 -0.994 . . . . 0.0 110.405 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.492 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 90.5 p -108.28 107.2 17.69 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.307 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.606 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -55.71 107.1 0.78 Allowed Pre-proline 0 C--N 1.294 -1.808 0 C-N-CA 120.061 -0.655 . . . . 0.0 109.811 178.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.547 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 41.6 Cg_endo -73.67 149.31 43.21 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.744 1.392 . . . . 0.0 110.606 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.537 ' HA ' ' CG1' ' A' ' 95' ' ' VAL . 48.3 Cg_endo -72.5 -3.98 14.44 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.224 1.644 . . . . 0.0 111.85 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -94.66 -23.37 17.62 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.072 -1.018 . . . . 0.0 109.225 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.969 HD22 ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -98.21 -14.38 20.36 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.786 0.803 . . . . 0.0 109.255 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.539 ' CG2' ' HB3' ' A' ' 99' ' ' LYS . 8.9 p -87.95 136.51 32.28 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.081 -1.012 . . . . 0.0 110.519 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.446 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 44.3 Cg_endo -72.47 173.28 13.45 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.016 1.535 . . . . 0.0 110.133 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.572 ' HA ' ' CD ' ' A' ' 100' ' ' ARG . 47.4 Cg_endo -72.62 -2.64 12.13 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.972 1.512 . . . . 0.0 110.575 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.58 -18.23 36.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.197 -0.939 . . . . 0.0 109.834 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.689 ' HD3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -89.71 -0.81 57.77 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.3 -0.875 . . . . 0.0 109.498 179.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.572 ' CD ' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.355 -0.841 . . . . 0.0 109.909 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 N--CA 1.483 0.876 0 N-CA-C 110.293 -0.695 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.511 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.3 t90 -87.1 119.04 26.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 110.103 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.907 ' HB3' HD12 ' A' ' 94' ' ' LEU . . . -41.66 -29.53 0.19 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.511 -0.743 . . . . 0.0 109.831 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.552 HG22 ' CD2' ' A' ' 75' ' ' PHE . 92.3 t -92.08 158.59 2.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.548 -0.72 . . . . 0.0 109.865 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.527 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 6.0 mttt -126.36 178.09 1.68 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.952 . . . . 0.0 110.13 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.657 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 40.0 Cg_endo -66.67 -36.48 24.82 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.913 1.481 . . . . 0.0 110.141 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -69.88 -36.23 75.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 109.101 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -83.54 -33.43 25.47 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 10' ' ' LYS . 16.4 tptp -78.64 -20.64 49.86 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -68.05 -41.9 81.34 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.626 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.7 ptpt -72.9 -31.81 64.92 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.626 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -66.59 -38.31 86.75 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 62.8 t0 -68.99 -11.1 60.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.672 -0.643 . . . . 0.0 110.331 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -96.39 -34.45 11.54 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.674 HG22 ' CE2' ' A' ' 70' ' ' PHE . 26.5 mt -78.35 -31.57 16.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.546 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -68.3 -37.98 81.16 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.529 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.1 t70 -90.41 0.99 57.05 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.625 -0.672 . . . . 0.0 109.916 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -92.72 2.71 56.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 108.77 178.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.055 HD22 HG21 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -115.6 -1.67 12.68 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER 79.52 87.0 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -73.87 147.46 39.31 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 124.446 1.761 . . . . 0.0 110.666 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 34.6 t -114.37 105.94 19.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 9.4 t30 55.49 23.71 6.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -0.983 . . . . 0.0 109.284 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 91.77 37.36 6.11 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 86.4 m-85 -149.92 158.03 43.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -1.098 . . . . 0.0 111.233 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.77 HD22 ' HB2' ' A' ' 24' ' ' LEU . 12.0 mt -136.4 133.15 36.41 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.555 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -79.63 140.74 37.0 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.414 -0.804 . . . . 0.0 110.408 -179.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.52 -25.54 0.85 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 32' ' ' SER . 4.8 t70 -68.37 -9.07 45.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -1.173 . . . . 0.0 110.237 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HD2' ' OG ' ' A' ' 32' ' ' SER . 4.6 mtpp -114.05 -43.35 3.25 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.886 0.851 . . . . 0.0 109.348 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.972 HG11 ' CD1' ' A' ' 65' ' ' LEU . 85.8 t -76.94 -46.21 29.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.78 -0.575 . . . . 0.0 110.266 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.6 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 39.0 tttt -46.19 -49.23 42.47 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 110.796 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.913 ' HA ' HD12 ' A' ' 41' ' ' LEU . 41.4 Cg_endo -68.58 -34.93 18.37 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 N-CA-C 108.918 -1.224 . . . . 0.0 108.918 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.055 HG21 HD22 ' A' ' 24' ' ' LEU . 2.4 t -62.72 -25.21 37.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.93 ' HB3' HD22 ' A' ' 50' ' ' LEU . 20.0 mt -84.02 -15.84 46.14 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.408 -0.807 . . . . 0.0 109.173 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.913 HD12 ' HA ' ' A' ' 38' ' ' PRO . 16.0 mt -76.44 -28.13 56.48 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.533 ' ND2' ' HA ' ' A' ' 39' ' ' VAL . 31.9 m-80 -63.51 -15.63 58.43 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.472 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.559 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -72.68 -1.54 16.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.504 -0.748 . . . . 0.0 110.155 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 43' ' ' SER . 7.8 ttpt 68.73 18.15 8.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -0.865 . . . . 0.0 109.925 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.024 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.8 mt -100.11 162.05 22.24 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.387 -0.821 . . . . 0.0 110.375 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.9 Cg_endo -74.14 166.18 30.18 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.106 1.582 . . . . 0.0 110.288 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 t -66.65 -7.52 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.404 -0.81 . . . . 0.0 110.22 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -40.93 59.6 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.958 HG21 HD13 ' A' ' 45' ' ' LEU . 21.5 mm -64.91 -44.87 96.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.93 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.8 mt -65.74 -17.88 64.93 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.335 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -87.92 -30.57 17.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.598 ' O ' HD12 ' A' ' 56' ' ' LEU . 4.1 ttm180 -92.73 -56.27 3.07 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.403 -1.057 . . . . 0.0 109.45 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.049 HG11 HG23 ' A' ' 77' ' ' VAL . 41.0 t -46.6 -39.82 4.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.281 -0.968 . . . . 0.0 109.058 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.517 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 18.5 t-105 -65.51 -60.35 3.03 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.814 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 4.1 mm-40 -44.25 -54.68 5.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 109.826 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 90' ' ' LEU . 1.7 mt -69.9 -9.94 56.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.393 -0.817 . . . . 0.0 109.662 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 1.097 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 3.1 t -100.52 -32.75 10.63 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.442 -0.786 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.583 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 22.7 t0 -80.07 76.43 6.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.305 -0.872 . . . . 0.0 110.21 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.51 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 41.6 mm -45.96 -32.56 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.482 -0.761 . . . . 0.0 109.833 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 22.7 m-20 -95.8 -21.73 17.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.539 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 88.5 m-70 57.38 48.47 14.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 109.563 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.455 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 1.7 p-10 -117.64 6.57 12.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.404 -0.81 . . . . 0.0 110.376 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.83 8.85 59.0 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.555 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 5.9 mtt -141.85 160.63 39.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -1.147 . . . . 0.0 110.89 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.972 ' CD1' HG11 ' A' ' 36' ' ' VAL . 35.9 mt -130.18 120.66 24.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.379 -0.826 . . . . 0.0 109.986 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 2.0 p30 -79.45 166.33 22.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.885 -1.135 . . . . 0.0 110.036 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.523 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 9.6 ptt180 -36.97 -46.83 0.67 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.456 -0.778 . . . . 0.0 111.596 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 63.1 m-20 -79.91 -33.9 39.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.139 -0.976 . . . . 0.0 110.381 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.567 ' HG2' HD23 ' A' ' 65' ' ' LEU . 13.1 tt0 -67.94 -50.75 54.12 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.346 -0.847 . . . . 0.0 109.785 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.71 ' CE1' HG13 ' A' ' 36' ' ' VAL . 62.5 t80 -56.0 -27.42 52.84 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.11 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -62.63 -47.33 84.2 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.564 0.697 . . . . 0.0 110.103 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.717 HG13 ' HG ' ' A' ' 94' ' ' LEU . 96.2 t -59.67 -24.48 29.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.501 -0.75 . . . . 0.0 109.875 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.097 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -88.39 -6.48 57.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.26 -0.9 . . . . 0.0 111.605 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.572 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 8.7 mmm -90.17 -42.77 10.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.383 -1.448 . . . . 0.0 110.332 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.7 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.0 p90 -76.44 -22.58 54.46 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.965 -1.094 . . . . 0.0 108.339 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 72' ' ' VAL . 14.9 mt -73.7 -28.36 61.69 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.049 HG23 HG11 ' A' ' 53' ' ' VAL . 41.2 t -92.09 -56.4 5.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.732 -0.605 . . . . 0.0 109.551 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.603 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -53.31 -18.85 2.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.416 -0.802 . . . . 0.0 110.812 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 84' ' ' GLU . 11.7 m -86.13 -16.94 36.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.933 . . . . 0.0 109.945 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.024 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.82 -11.91 52.21 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.191 -0.943 . . . . 0.0 109.564 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.624 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.2 mp -87.52 -43.78 11.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.377 -0.827 . . . . 0.0 109.222 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.6 OUTLIER -69.78 -51.63 32.2 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.23 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 3.9 tttm 177.41 -25.53 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.018 . . . . 0.0 111.613 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 79' ' ' CYS . 2.4 mm-40 -76.89 112.3 21.69 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.045 -1.034 . . . . 0.0 111.124 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 84' ' ' GLU . 42.6 Cg_endo -69.59 -171.69 0.48 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.854 1.449 . . . . 0.0 110.191 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.621 HG21 ' CG2' ' A' ' 53' ' ' VAL . 53.3 t -126.81 119.41 22.6 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.114 -0.991 . . . . 0.0 110.981 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.575 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.4 Cg_endo -83.14 176.5 7.41 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.921 1.485 . . . . 0.0 109.724 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.653 ' C ' HD21 ' A' ' 56' ' ' LEU . 31.7 mtp -103.21 15.81 28.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.091 -1.006 . . . . 0.0 110.345 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.591 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 75.7 m -114.06 105.33 13.09 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.954 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.709 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -82.25 106.13 5.91 Favored Pre-proline 0 C--N 1.289 -2.046 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.592 ' HD2' HD22 ' A' ' 94' ' ' LEU . 40.5 Cg_endo -66.36 158.83 53.17 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.906 1.477 . . . . 0.0 110.244 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.19 -15.59 31.81 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.882 1.464 . . . . 0.0 110.312 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -72.47 -7.5 50.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.907 HD12 ' HB3' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -90.5 -28.36 18.61 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.62 -0.675 . . . . 0.0 110.122 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.557 ' CG1' ' HB2' ' A' ' 99' ' ' LYS . 46.3 t -68.83 136.53 89.99 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.481 -0.762 . . . . 0.0 111.098 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.477 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 45.3 Cg_endo -72.09 174.77 10.82 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.112 1.585 . . . . 0.0 110.152 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.564 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 44.4 Cg_endo -72.4 -9.87 24.76 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.817 1.43 . . . . 0.0 110.762 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.7 p -74.61 -26.0 59.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.114 -0.991 . . . . 0.0 109.912 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.557 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -89.42 7.53 35.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.418 -0.801 . . . . 0.0 109.539 179.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.274 -0.891 . . . . 0.0 110.45 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.483 0.858 0 N-CA-C 110.54 -0.6 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.584 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 13.9 t90 -90.76 131.43 36.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 0.0 109.843 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.885 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -41.43 -33.21 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.596 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.584 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 55.4 t -98.38 122.89 50.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.357 -0.839 . . . . 0.0 110.142 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.557 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 2.0 mtmt -91.26 -177.28 0.73 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 110.107 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.557 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 43.2 Cg_endo -71.24 -36.26 7.39 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.811 1.427 . . . . 0.0 110.242 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.78 -24.16 58.63 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.314 -0.866 . . . . 0.0 109.302 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -86.5 -37.04 18.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.309 -0.869 . . . . 0.0 108.914 179.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -18.42 59.38 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.31 -39.53 71.36 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.732 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -75.19 -19.02 60.03 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 13.0 m-30 -82.83 -30.25 28.86 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -76.6 -11.3 59.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.718 -0.614 . . . . 0.0 110.053 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.47 -33.66 15.12 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.732 HD12 ' O ' ' A' ' 16' ' ' LYS . 6.9 mt -80.38 -29.03 12.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.628 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -75.51 -35.46 60.76 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.002 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.56 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -89.48 -1.92 58.2 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.594 -0.691 . . . . 0.0 109.88 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.44 -6.02 56.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 109.206 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.646 ' HB2' HD22 ' A' ' 31' ' ' LEU . 1.9 mt -108.35 -9.82 15.41 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.5 m 83.16 92.21 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.8 Cg_endo -73.05 148.52 44.98 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.351 1.711 . . . . 0.0 110.577 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.473 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 28.3 t -111.94 113.14 43.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.441 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER 46.04 25.09 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.835 . . . . 0.0 109.719 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.46 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 96.8 34.58 5.67 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.634 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 85.0 m-85 -151.55 153.8 35.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.085 -1.244 . . . . 0.0 111.72 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.666 HD23 ' HD2' ' A' ' 35' ' ' LYS . 41.7 mt -123.15 127.95 49.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 35' ' ' LYS . 60.1 p -65.84 137.96 57.56 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.862 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.619 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -48.28 -26.97 5.18 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.66 -14.65 58.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -1.124 . . . . 0.0 109.633 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.666 ' HD2' HD23 ' A' ' 31' ' ' LEU . 21.0 ttmm -91.88 -39.55 11.66 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.944 HG11 HD12 ' A' ' 65' ' ' LEU . 89.7 t -83.1 -31.05 8.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.437 0.637 . . . . 0.0 110.098 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.639 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -39.86 -51.28 5.55 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.535 -0.728 . . . . 0.0 111.122 -179.282 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 36.7 Cg_endo -63.02 -31.05 76.74 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.425 1.223 . . . . 0.0 109.841 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.591 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 2.9 t -74.46 -14.92 16.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.628 -0.67 . . . . 0.0 109.866 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.938 ' HB3' HD22 ' A' ' 50' ' ' LEU . 66.9 mt -97.41 -23.93 15.85 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.295 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 38' ' ' PRO . 2.5 mt -87.74 -34.2 18.43 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.188 -0.945 . . . . 0.0 110.063 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.591 ' ND2' ' HA ' ' A' ' 39' ' ' VAL . 2.0 p30 -65.6 -9.95 31.39 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.579 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.468 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 2.3 m -79.77 7.72 8.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 110.475 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 64.75 16.76 10.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.125 -0.984 . . . . 0.0 110.489 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.997 HD13 HG21 ' A' ' 49' ' ' ILE . 14.5 mt -97.0 153.81 38.41 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 109.967 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.6 Cg_endo -74.79 163.64 35.25 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.998 1.525 . . . . 0.0 110.467 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.6 t -64.77 -8.43 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.718 . . . . 0.0 110.513 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -76.3 -41.18 49.48 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.997 HG21 HD13 ' A' ' 45' ' ' LEU . 23.0 mm -65.03 -44.93 95.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.938 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.9 mt -61.97 -18.42 60.35 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.35 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.67 -31.16 19.27 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.782 ' C ' HD12 ' A' ' 56' ' ' LEU . 1.2 mtm180 -94.95 -55.38 3.11 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.43 -1.041 . . . . 0.0 109.455 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.798 HG23 HG21 ' A' ' 86' ' ' VAL . 30.0 t -49.08 -42.69 14.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.246 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.619 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 14.6 t-105 -65.55 -58.57 5.46 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.138 -0.976 . . . . 0.0 109.513 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.583 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 5.2 mm-40 -51.43 -33.45 30.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.995 . . . . 0.0 109.142 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.917 ' O ' HD11 ' A' ' 90' ' ' LEU . 6.7 mt -86.01 -15.27 41.94 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.493 -0.754 . . . . 0.0 109.343 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.989 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 50.4 m -100.16 -29.54 12.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.484 -0.76 . . . . 0.0 110.396 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 42.1 t0 -85.45 66.62 9.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.275 -0.891 . . . . 0.0 109.842 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 58' ' ' ASP . 42.0 mm -40.36 -29.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.485 0.659 . . . . 0.0 110.22 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 6.3 t0 -89.33 -28.51 19.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.362 -0.836 . . . . 0.0 110.826 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.583 ' CE1' ' O ' ' A' ' 55' ' ' GLU . 87.7 m-70 56.32 50.59 12.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.084 -1.01 . . . . 0.0 110.083 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 63' ' ' GLY . 5.3 p-10 -118.79 -10.11 10.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 110.409 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' N ' ' OD1' ' A' ' 62' ' ' ASP . . . 116.61 8.69 12.07 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.586 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 15.4 mtp -142.7 160.87 39.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -1.148 . . . . 0.0 110.228 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.944 HD12 HG11 ' A' ' 36' ' ' VAL . 13.0 mt -120.77 105.6 10.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.286 -0.884 . . . . 0.0 109.767 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.634 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 1.8 t70 -72.58 171.66 12.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.879 -1.138 . . . . 0.0 110.258 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.486 ' N ' ' CG ' ' A' ' 66' ' ' ASP . 16.2 ptp180 -45.71 -39.84 8.58 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.771 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.446 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 30.8 t0 -81.77 -31.79 31.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.195 -0.94 . . . . 0.0 110.458 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.478 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 27.5 mt-10 -77.95 -42.06 34.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.215 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.72 ' CE1' HG22 ' A' ' 20' ' ' ILE . 44.0 t80 -66.72 -28.06 68.12 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.536 -0.727 . . . . 0.0 109.376 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.473 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -65.72 -51.98 54.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 110.018 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.894 ' O ' HD12 ' A' ' 76' ' ' LEU . 93.2 t -55.65 -21.79 10.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.537 -0.727 . . . . 0.0 110.281 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.989 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.49 -14.61 32.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.219 -0.925 . . . . 0.0 111.766 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.628 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 7.0 mmm -80.18 -41.8 24.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.744 -1.223 . . . . 0.0 109.924 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.6 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.7 p90 -77.74 -22.34 50.45 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.894 HD12 ' O ' ' A' ' 72' ' ' VAL . 6.6 mt -75.95 -30.76 58.78 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.673 0.749 . . . . 0.0 109.126 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.629 HG23 HG11 ' A' ' 53' ' ' VAL . 44.4 t -90.19 -20.19 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.6 -0.688 . . . . 0.0 109.867 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.4 OUTLIER -90.56 -23.0 21.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.453 -0.779 . . . . 0.0 109.655 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.479 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.6 m -86.25 -17.98 33.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.446 -0.784 . . . . 0.0 109.731 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.973 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -83.91 -9.36 58.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.434 -0.791 . . . . 0.0 109.177 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.791 ' N ' HD23 ' A' ' 81' ' ' LEU . 2.0 mt -89.59 -45.93 9.02 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.714 0.769 . . . . 0.0 109.227 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 46.8 mt-10 -70.02 -52.91 20.27 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.645 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 1.2 tttt 178.44 -28.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.809 -0.756 . . . . 0.0 111.115 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 79' ' ' CYS . 14.0 mt-10 -68.59 111.84 9.39 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.168 -0.958 . . . . 0.0 111.106 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 46.7 Cg_endo -75.38 -165.47 0.29 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.895 1.471 . . . . 0.0 110.224 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.798 HG21 HG23 ' A' ' 53' ' ' VAL . 60.0 t -114.65 149.85 42.99 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.359 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.558 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 44.8 Cg_endo -80.19 -165.01 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.61 1.321 . . . . 0.0 110.063 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.07 3.16 17.17 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 111.114 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -177.74 29.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.745 -1.222 . . . . 0.0 111.674 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.917 HD11 ' O ' ' A' ' 56' ' ' LEU . 9.6 mt 57.65 120.49 0.01 OUTLIER Pre-proline 0 C--N 1.285 -2.226 0 O-C-N 121.96 -0.463 . . . . 0.0 110.509 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.07 ' HG2' HD23 ' A' ' 94' ' ' LEU . 40.0 Cg_endo -70.28 176.86 6.59 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 123.641 1.338 . . . . 0.0 109.15 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 40.2 Cg_endo -65.65 -9.72 23.78 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.558 1.294 . . . . 0.0 111.894 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.658 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -98.64 4.18 47.94 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.049 -1.032 . . . . 0.0 110.604 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.07 HD23 ' HG2' ' A' ' 91' ' ' PRO . 4.2 mm? -117.35 38.57 3.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.011 -1.056 . . . . 0.0 111.295 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.694 ' O ' HG13 ' A' ' 95' ' ' VAL . 8.8 p -146.85 115.74 4.43 Favored Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 120.91 -1.119 . . . . 0.0 110.603 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.451 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 44.7 Cg_endo -72.48 174.18 12.02 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.827 1.435 . . . . 0.0 110.038 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.577 ' O ' ' CB ' ' A' ' 98' ' ' SER . 44.3 Cg_endo -71.88 173.47 12.71 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.952 1.501 . . . . 0.0 110.33 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.577 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 1.3 m 80.7 -32.45 0.12 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.951 -0.468 . . . . 0.0 110.123 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 48.2 tptt -89.0 -0.0 57.04 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.073 -1.017 . . . . 0.0 108.537 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.411 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.483 0.875 0 N-CA-C 110.039 -0.793 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.787 ' HE1' HD22 ' A' ' 94' ' ' LEU . 11.1 t90 -71.21 115.68 10.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.001 -1.062 . . . . 0.0 109.486 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -41.14 -27.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.0 109.787 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.475 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 38.0 t -99.51 149.02 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.438 -0.789 . . . . 0.0 109.69 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.6 mttt -111.48 173.36 2.91 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 110.02 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.8 Cg_endo -68.94 -34.51 17.29 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.835 1.44 . . . . 0.0 109.404 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 10.5 pt-20 -80.21 -26.7 39.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.47 -0.768 . . . . 0.0 109.646 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 1.6 m-20 -83.34 -41.38 18.29 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -69.06 -16.99 63.83 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.11 -42.42 72.69 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.629 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -70.68 -27.63 64.17 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -69.38 -37.48 77.58 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.22 -10.37 57.43 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.426 0.631 . . . . 0.0 109.969 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -92.79 -34.55 13.83 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.726 HG22 ' CE1' ' A' ' 70' ' ' PHE . 15.8 mt -80.97 -28.46 11.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.85 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.68 -36.01 60.2 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.541 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.4 t70 -88.65 -2.17 58.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.667 -0.646 . . . . 0.0 109.712 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 29.5 t -91.3 0.91 57.44 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.053 HD22 HG21 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -113.12 -5.51 13.71 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.593 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 82.63 86.58 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.092 0 CA-C-O 121.131 0.491 . . . . 0.0 109.827 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.541 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -73.53 147.4 40.78 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 O-C-N 124.418 1.746 . . . . 0.0 110.903 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -115.89 111.83 37.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.633 -0.667 . . . . 0.0 109.242 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 54.52 20.52 2.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 109.468 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . 95.58 32.68 6.8 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.613 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 94.5 m-85 -146.32 158.96 43.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.432 -1.04 . . . . 0.0 110.643 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.95 HD22 ' HB2' ' A' ' 24' ' ' LEU . 16.5 mt -136.77 128.7 29.28 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.58 -0.7 . . . . 0.0 109.177 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.541 ' OG ' ' CE ' ' A' ' 64' ' ' MET . 0.7 OUTLIER -74.49 137.41 42.51 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.273 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.34 -32.38 1.16 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 38' ' ' PRO . 72.0 m-20 -53.38 -24.44 12.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -1.142 . . . . 0.0 110.027 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 12.1 mttm -103.3 -44.61 5.12 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.019 0.914 . . . . 0.0 109.072 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.086 HG11 HD12 ' A' ' 65' ' ' LEU . 40.2 t -76.63 -49.13 24.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 O-C-N 121.81 -0.556 . . . . 0.0 110.467 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.594 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 14.7 ttpt -43.17 -50.2 14.95 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.484 -0.887 . . . . 0.0 110.801 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.884 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.8 Cg_endo -67.05 -34.49 28.62 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 N-CA-C 109.108 -1.151 . . . . 0.0 109.108 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.053 HG21 HD22 ' A' ' 24' ' ' LEU . 2.3 t -65.15 -23.83 34.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.016 ' HB3' HD22 ' A' ' 50' ' ' LEU . 16.4 mt -86.33 -15.06 41.73 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.392 -0.817 . . . . 0.0 109.203 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.884 HD12 ' HA ' ' A' ' 38' ' ' PRO . 27.8 mt -77.97 -26.85 48.96 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 38.7 m-80 -62.55 -13.9 36.19 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.623 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.532 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -78.63 2.13 20.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.563 -0.711 . . . . 0.0 110.327 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 43' ' ' SER . 1.7 mtpt 63.53 15.6 8.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -0.902 . . . . 0.0 110.362 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.036 HD13 HG21 ' A' ' 49' ' ' ILE . 13.6 mt -94.82 162.54 24.99 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.143 -0.973 . . . . 0.0 109.915 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.519 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.1 Cg_endo -73.99 164.91 33.34 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.013 1.533 . . . . 0.0 110.957 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 t -64.96 -9.1 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.502 -0.749 . . . . 0.0 109.776 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -72.48 -41.31 66.17 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.036 HG21 HD13 ' A' ' 45' ' ' LEU . 20.3 mm -64.2 -47.49 89.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.016 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.3 mt -65.6 -23.11 66.75 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.632 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.498 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -86.03 -30.78 22.12 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HD3' ' HG2' ' A' ' 88' ' ' MET . 13.7 ttm180 -91.52 -54.95 3.68 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.506 -0.996 . . . . 0.0 109.667 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.851 ' CG2' HG21 ' A' ' 86' ' ' VAL . 26.7 t -49.67 -42.89 18.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.993 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.556 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 16.3 t-105 -61.86 -58.19 8.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.831 . . . . 0.0 111.05 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 17.0 mt-10 -51.6 -36.9 47.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.883 -1.136 . . . . 0.0 109.607 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.018 HD22 ' N ' ' A' ' 90' ' ' LEU . 18.5 mt -90.07 -8.44 51.45 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.516 0.674 . . . . 0.0 109.485 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 1.042 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 4.6 t -100.11 -30.29 12.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.448 -0.783 . . . . 0.0 108.916 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.597 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 13.3 t0 -84.65 68.25 10.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.485 -0.759 . . . . 0.0 109.631 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.558 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 35.5 mm -37.4 -29.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.266 0.555 . . . . 0.0 110.471 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.539 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 76.4 m-20 -90.68 -25.66 19.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 111.31 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 0.3 OUTLIER 59.71 26.46 15.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.883 -1.136 . . . . 0.0 108.913 -179.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.428 ' OD2' ' HG3' ' A' ' 64' ' ' MET . 3.9 p-10 -90.82 -24.25 20.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.524 -0.735 . . . . 0.0 110.665 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.38 4.35 4.48 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.7 mtp -145.2 161.16 40.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.002 -1.293 . . . . 0.0 110.313 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.086 HD12 HG11 ' A' ' 36' ' ' VAL . 33.5 mt -115.82 112.16 21.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -0.844 . . . . 0.0 109.984 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.613 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 4.9 p30 -76.08 165.05 25.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.799 -1.188 . . . . 0.0 110.019 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.618 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -39.41 -40.31 0.8 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.458 -0.776 . . . . 0.0 111.741 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 1.4 t0 -80.28 -36.28 34.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.979 -1.075 . . . . 0.0 110.563 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.519 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 44.0 mt-10 -76.17 -41.62 49.15 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.186 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.813 ' CE2' HG13 ' A' ' 36' ' ' VAL . 35.3 t80 -61.82 -25.46 67.52 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -66.56 -51.09 60.29 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.943 0.877 . . . . 0.0 109.648 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.926 HG22 HD21 ' A' ' 94' ' ' LEU . 60.5 t -55.12 -23.88 13.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.358 0.599 . . . . 0.0 110.382 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.042 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -89.86 -10.85 43.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 111.815 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.577 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 7.9 mmm -85.09 -48.06 9.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.639 -1.288 . . . . 0.0 110.121 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.574 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -72.65 -21.52 61.07 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 72' ' ' VAL . 9.6 mt -73.79 -32.79 63.94 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.723 HG21 HD22 ' A' ' 40' ' ' LEU . 70.5 t -91.42 -25.54 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.535 -0.728 . . . . 0.0 110.504 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.5 OUTLIER -86.81 -27.01 23.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.742 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 60.1 m -80.29 -19.05 47.54 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.421 -0.799 . . . . 0.0 108.857 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.843 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -82.15 -7.97 59.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.475 -0.766 . . . . 0.0 109.344 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.54 ' N ' HD23 ' A' ' 81' ' ' LEU . 6.4 mt -90.25 -47.6 7.67 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.566 0.698 . . . . 0.0 110.026 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 2.7 pp20? -77.44 -40.44 43.31 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.924 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.488 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 0.2 OUTLIER 177.94 -37.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.594 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.2 OUTLIER -72.79 111.15 10.16 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 120.98 -1.075 . . . . 0.0 111.333 -178.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 48.8 Cg_endo -74.77 -169.64 0.65 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.76 1.4 . . . . 0.0 110.101 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.851 HG21 ' CG2' ' A' ' 53' ' ' VAL . 41.6 t -112.87 152.15 44.62 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.264 -0.898 . . . . 0.0 109.017 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.744 ' HD2' HG13 ' A' ' 86' ' ' VAL . 44.9 Cg_endo -85.93 -165.94 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.662 1.348 . . . . 0.0 109.791 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.48 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 5.7 mtt -129.68 18.87 5.68 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.623 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 33.3 t -161.14 23.74 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.268 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 1.018 ' N ' HD22 ' A' ' 56' ' ' LEU . 2.4 mt 61.7 118.48 0.02 OUTLIER Pre-proline 0 C--N 1.283 -2.324 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.54 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.624 ' O ' HG23 ' A' ' 95' ' ' VAL . 41.8 Cg_endo -76.08 146.35 28.85 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.792 1.417 . . . . 0.0 110.005 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.04 -1.03 8.03 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.736 1.624 . . . . 0.0 112.09 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -99.9 -20.53 16.1 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.05 -1.031 . . . . 0.0 109.854 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.975 HD22 ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -101.82 -13.9 17.5 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.588 0.709 . . . . 0.0 109.497 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.856 HG22 HD22 ' A' ' 90' ' ' LEU . 95.4 t -86.22 124.14 70.6 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.938 -1.101 . . . . 0.0 110.676 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 46.3 Cg_endo -73.99 172.14 16.51 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.892 1.469 . . . . 0.0 110.449 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.42 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 46.1 Cg_endo -73.23 -11.35 24.95 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.068 1.562 . . . . 0.0 110.381 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -25.49 67.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.917 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -90.4 9.32 29.51 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.347 -0.846 . . . . 0.0 109.591 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.42 -0.8 . . . . 0.0 110.133 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 N--CA 1.482 0.802 0 N-CA-C 110.339 -0.677 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.599 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 15.5 t90 -65.79 133.7 51.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.878 . . . . 0.0 109.811 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.733 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -41.11 -31.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.405 -0.809 . . . . 0.0 110.413 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.599 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 70.4 t -94.45 131.44 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.401 -0.812 . . . . 0.0 109.976 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.532 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 18.0 mttt -95.12 -179.43 0.95 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.846 . . . . 0.0 110.162 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.1 Cg_endo -69.79 -37.32 9.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.903 1.475 . . . . 0.0 110.187 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -71.18 -24.64 62.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 109.664 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.582 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -83.0 -41.8 18.28 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 2.4 tppt? -66.48 -20.17 65.97 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.68 -0.637 . . . . 0.0 109.363 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.7 -42.66 60.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.375 -0.828 . . . . 0.0 109.064 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.625 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -79.14 -26.15 42.83 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.5 m-30 -71.85 -34.47 69.27 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 8.0 m-20 -81.07 -10.6 59.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.717 -0.614 . . . . 0.0 109.88 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -93.58 -35.45 12.89 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.558 HG21 ' SD ' ' A' ' 74' ' ' MET . 51.3 mt -76.47 -36.9 29.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.582 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -64.13 -36.59 84.52 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.549 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -90.24 -0.11 57.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.749 -0.595 . . . . 0.0 109.991 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 22.8 t -91.33 0.51 57.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.215 -0.928 . . . . 0.0 109.046 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.968 HD22 HG21 ' A' ' 39' ' ' VAL . 1.2 mt -109.06 -6.61 15.57 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.578 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER 80.29 83.55 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.549 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 42.7 Cg_endo -69.11 149.98 71.63 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 O-C-N 124.65 1.868 . . . . 0.0 110.357 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.3 t -113.16 103.92 16.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.339 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 5.6 t30 59.19 21.9 10.04 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.479 -0.763 . . . . 0.0 109.374 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.493 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 93.01 39.2 5.24 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.493 ' CD2' ' C ' ' A' ' 29' ' ' GLY . 82.3 m-85 -150.12 159.56 44.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.428 -1.042 . . . . 0.0 111.302 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.679 HD13 HD12 ' A' ' 24' ' ' LEU . 46.1 mt -133.22 131.4 40.29 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.561 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 18.2 p -79.06 141.48 37.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.548 -0.72 . . . . 0.0 110.929 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.612 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -49.76 -24.44 6.0 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.26 -11.95 59.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.419 -1.048 . . . . 0.0 109.66 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.65 ' HD2' HD23 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -97.73 -46.28 6.04 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.316 1.055 . . . . 0.0 108.778 179.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.633 HG11 HD12 ' A' ' 65' ' ' LEU . 98.3 t -78.45 -33.07 16.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.069 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.575 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -40.68 -54.85 4.89 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.443 -0.786 . . . . 0.0 110.952 -178.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.995 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.2 Cg_endo -64.24 -31.05 64.19 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.557 1.293 . . . . 0.0 109.332 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.968 HG21 HD22 ' A' ' 24' ' ' LEU . 3.4 t -73.38 -8.41 11.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.721 -0.612 . . . . 0.0 109.363 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.871 ' HB3' HD22 ' A' ' 50' ' ' LEU . 42.3 mt -99.87 -16.42 18.04 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 108.541 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.995 HD12 ' HA ' ' A' ' 38' ' ' PRO . 4.7 mt -89.03 -41.56 12.26 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.501 -0.75 . . . . 0.0 109.785 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -49.82 -22.04 1.32 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.226 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.561 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -68.7 -5.31 19.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.362 -0.836 . . . . 0.0 110.085 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 73.68 8.89 4.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.378 -0.826 . . . . 0.0 110.378 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.054 HD13 HG21 ' A' ' 49' ' ' ILE . 14.3 mt -84.48 155.48 62.63 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 109.769 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.551 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.3 Cg_endo -74.38 162.83 37.57 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.789 1.415 . . . . 0.0 110.753 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.9 t -62.63 -10.58 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.57 -0.706 . . . . 0.0 110.816 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.41 -41.01 57.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.934 -1.104 . . . . 0.0 108.353 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.054 HG21 HD13 ' A' ' 45' ' ' LEU . 27.8 mm -64.11 -44.87 97.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.871 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.6 mt -60.23 -18.19 46.9 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.49 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -84.57 -31.74 23.77 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.479 ' CD ' ' O ' ' A' ' 87' ' ' PRO . 9.8 mtm180 -94.97 -55.26 3.15 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.494 -1.003 . . . . 0.0 109.844 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.646 HG23 HG21 ' A' ' 86' ' ' VAL . 17.2 t -44.83 -39.3 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.642 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.612 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 13.0 t-105 -74.38 -59.02 2.92 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.973 -1.08 . . . . 0.0 110.331 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 65.3 mm-40 -51.38 -30.13 17.96 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.086 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.844 HD22 ' N ' ' A' ' 90' ' ' LEU . 46.8 mt -90.41 -14.78 32.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.57 -0.706 . . . . 0.0 109.496 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.991 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 12.7 m -98.98 -27.81 13.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.476 -0.765 . . . . 0.0 109.642 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 59' ' ' ILE . 13.8 t0 -81.76 69.1 8.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.289 -0.882 . . . . 0.0 109.565 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.689 HG23 ' HD2' ' A' ' 99' ' ' LYS . 39.3 mm -40.48 -30.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.511 0.672 . . . . 0.0 109.877 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.451 ' OD2' ' HB3' ' A' ' 62' ' ' ASP . 0.8 OUTLIER -96.15 -28.73 14.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.61 -0.681 . . . . 0.0 109.999 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ASP . 22.8 m-70 61.71 46.5 7.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.164 -0.96 . . . . 0.0 110.644 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.451 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 3.1 p-10 -112.66 16.85 19.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 110.265 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.37 5.0 76.4 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.561 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 5.0 mtt -140.4 157.02 46.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -1.145 . . . . 0.0 110.647 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.633 HD12 HG11 ' A' ' 36' ' ' VAL . 74.2 mt -118.63 113.79 21.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.381 -0.824 . . . . 0.0 109.842 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.9 OUTLIER -73.2 155.85 39.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.949 -1.094 . . . . 0.0 109.62 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.575 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -33.83 -44.07 0.15 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.761 -0.587 . . . . 0.0 111.372 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 3.2 p-10 -74.94 -45.26 43.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.36 -0.838 . . . . 0.0 109.897 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.482 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 19.3 mt-10 -62.32 -45.83 91.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.582 -0.698 . . . . 0.0 109.563 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.582 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 52.0 t80 -59.96 -24.07 64.1 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.616 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -68.15 -45.92 72.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.549 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.722 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.3 t -61.79 -23.91 32.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.535 -0.728 . . . . 0.0 109.963 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.991 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.96 -1.35 57.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -0.877 . . . . 0.0 110.832 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.621 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 13.1 mmt -89.09 -46.02 9.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.083 -1.011 . . . . 0.0 109.463 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.668 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 1.7 p90 -75.83 -30.0 58.82 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.722 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.8 mt -63.74 -30.94 71.98 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.616 ' O ' HD21 ' A' ' 81' ' ' LEU . 70.5 t -90.64 -23.84 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.878 -0.514 . . . . 0.0 109.936 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -26.55 20.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.365 -0.834 . . . . 0.0 109.31 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 51.6 m -84.4 -12.28 54.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.437 -0.789 . . . . 0.0 109.211 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.038 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -89.23 -8.87 52.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.465 -0.772 . . . . 0.0 109.065 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.814 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.5 mt -90.97 -45.34 8.79 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.614 0.721 . . . . 0.0 109.358 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 40.2 mm-40 -69.45 -52.98 21.62 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.705 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 3.5 ttpt 178.9 -28.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.466 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.3 OUTLIER -63.76 111.84 6.08 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.986 -1.071 . . . . 0.0 111.291 -178.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 48.3 Cg_endo -74.86 -177.65 3.58 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.94 1.495 . . . . 0.0 110.098 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.646 HG21 HG23 ' A' ' 53' ' ' VAL . 59.2 t -112.34 149.61 41.29 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.142 -0.974 . . . . 0.0 109.191 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 46.1 Cg_endo -84.42 -163.42 0.2 Allowed 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.688 1.362 . . . . 0.0 110.092 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 2.4 ttt -122.19 10.0 9.93 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.371 -0.831 . . . . 0.0 111.106 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.89 23.88 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.719 -1.238 . . . . 0.0 111.432 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.868 HD23 ' HD2' ' A' ' 91' ' ' PRO . 1.6 mt 62.09 123.17 0.02 OUTLIER Pre-proline 0 C--N 1.284 -2.276 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.849 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.868 ' HD2' HD23 ' A' ' 90' ' ' LEU . 40.2 Cg_endo -68.42 174.5 8.19 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.007 1.53 . . . . 0.0 110.137 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 49.6 Cg_endo -75.29 -22.68 14.07 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.964 1.507 . . . . 0.0 111.97 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.746 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -90.79 7.88 37.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.923 -1.111 . . . . 0.0 110.483 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.746 HD22 ' C ' ' A' ' 93' ' ' ALA . 4.1 mm? -114.29 34.9 4.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.081 -1.012 . . . . 0.0 111.495 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -125.58 129.31 24.42 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.766 -1.209 . . . . 0.0 110.617 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.473 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 47.1 Cg_endo -72.77 175.19 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.993 1.523 . . . . 0.0 109.964 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.54 ' O ' ' CB ' ' A' ' 98' ' ' SER . 45.7 Cg_endo -71.44 163.31 39.48 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.877 1.462 . . . . 0.0 110.215 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER 76.47 -45.2 0.5 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.626 -0.672 . . . . 0.0 110.344 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.689 ' HD2' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -88.1 6.73 34.93 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.09 -1.006 . . . . 0.0 108.562 178.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.452 ' HD3' ' O ' ' A' ' 96' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.02 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.482 0.803 0 N-CA-C 110.167 -0.744 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.515 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.6 t90 -78.6 126.99 31.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 110.053 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -41.81 -28.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 0.0 110.138 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.515 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 45.5 t -94.76 156.48 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.826 . . . . 0.0 109.978 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.507 ' HD3' ' HD2' ' A' ' 11' ' ' PRO . 28.3 mmtt -111.5 171.55 4.25 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.507 ' HD2' ' HD3' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -66.9 -35.93 24.96 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.819 1.431 . . . . 0.0 110.431 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.13 -25.59 60.89 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.135 -0.978 . . . . 0.0 109.11 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.579 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 63.6 m-20 -85.57 -35.87 20.78 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.241 -0.912 . . . . 0.0 108.851 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.508 ' CD ' ' HB2' ' A' ' 71' ' ' ALA . 2.2 tptp -73.26 -17.77 61.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.29 -41.82 56.19 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.637 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.15 -24.73 51.52 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.637 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.4 m-30 -74.95 -35.98 62.12 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.469 ' OD1' ' NZ ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -71.07 -10.1 59.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.777 -0.577 . . . . 0.0 110.135 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.0 -38.97 10.41 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.827 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.257 27.9 mt -72.17 -29.19 31.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.987 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -69.26 -40.34 77.87 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.464 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.5 t70 -86.1 1.36 50.76 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.581 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.695 ' C ' HD23 ' A' ' 24' ' ' LEU . 37.8 m -93.37 -0.14 56.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.314 -0.866 . . . . 0.0 108.768 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.085 HD22 HG21 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -116.7 -1.21 12.16 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 80.35 97.59 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.95 0 CA-C-O 121.136 0.493 . . . . 0.0 110.246 -179.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 55.4 Cg_endo -77.26 147.69 26.26 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.502 1.791 . . . . 0.0 110.343 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.508 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 60.1 t -119.89 94.07 2.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.508 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER 68.94 24.51 6.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.428 -0.795 . . . . 0.0 109.061 -178.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 90.93 28.34 15.95 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 35.3 m-85 -143.41 143.28 31.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.394 -1.062 . . . . 0.0 111.133 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.987 HD11 ' O ' ' A' ' 21' ' ' PHE . 53.4 mt -117.57 131.87 56.61 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.572 ' OG ' ' HE2' ' A' ' 64' ' ' MET . 0.5 OUTLIER -89.48 147.5 23.96 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.578 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.15 -31.12 0.84 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -54.07 -22.7 11.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -1.097 . . . . 0.0 110.096 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 1.5 mttm -111.15 -43.36 3.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.935 . . . . 0.0 109.342 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.935 HG11 HD12 ' A' ' 65' ' ' LEU . 87.5 t -74.75 -53.73 16.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.029 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.588 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -40.75 -49.94 7.33 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.529 -0.732 . . . . 0.0 110.892 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.891 ' HA ' HD12 ' A' ' 41' ' ' LEU . 40.6 Cg_endo -69.84 -33.19 16.79 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 N-CA-C 108.961 -1.207 . . . . 0.0 108.961 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.085 HG21 HD22 ' A' ' 24' ' ' LEU . 2.4 t -67.29 -29.01 44.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.885 ' HB3' HD22 ' A' ' 50' ' ' LEU . 17.7 mt -81.4 -17.12 50.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.407 -0.808 . . . . 0.0 108.911 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.891 HD12 ' HA ' ' A' ' 38' ' ' PRO . 20.3 mt -73.88 -26.16 60.41 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.546 ' ND2' ' HA ' ' A' ' 39' ' ' VAL . 33.2 m-80 -61.4 -20.58 63.22 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.209 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 1.004 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.3 t -71.36 -3.44 20.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.536 -0.728 . . . . 0.0 109.864 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.538 ' CE ' ' HA ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER 70.79 4.59 5.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 110.028 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.028 HD13 HG21 ' A' ' 49' ' ' ILE . 15.7 mt -83.49 159.29 61.74 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.977 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.531 ' HG2' HG12 ' A' ' 49' ' ' ILE . 43.3 Cg_endo -73.05 162.35 41.11 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.985 1.519 . . . . 0.0 110.502 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.93 -10.17 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 110.21 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.18 -39.1 68.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.028 HG21 HD13 ' A' ' 45' ' ' LEU . 18.5 mm -67.18 -47.41 81.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.885 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.0 mt -64.64 -20.05 66.06 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.95 -33.2 12.65 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.577 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -90.38 -54.96 3.78 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.51 -0.994 . . . . 0.0 109.224 179.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.901 HG11 HG23 ' A' ' 77' ' ' VAL . 29.2 t -49.23 -42.71 15.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.01 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.522 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 12.3 t-105 -59.09 -59.28 5.72 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.461 -0.774 . . . . 0.0 109.673 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 54' ' ' TRP . 1.6 mm-40 -44.06 -50.03 8.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -0.878 . . . . 0.0 109.833 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.913 HD21 ' C ' ' A' ' 88' ' ' MET . 1.6 mt -75.04 -14.31 60.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.375 -0.828 . . . . 0.0 109.54 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 1.093 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -95.35 -25.84 16.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.484 -0.76 . . . . 0.0 110.384 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.53 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 4.1 t0 -86.31 76.83 9.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.323 -0.861 . . . . 0.0 110.329 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.479 ' CG1' ' HG3' ' A' ' 69' ' ' GLU . 42.5 mm -44.12 -35.29 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.368 -0.832 . . . . 0.0 110.32 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.487 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 2.8 m-20 -95.73 -28.41 14.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 110.427 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 18.7 m-70 62.28 37.44 14.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 109.686 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -97.67 -14.57 20.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.386 -0.821 . . . . 0.0 110.452 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.443 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 125.33 3.67 7.25 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.572 ' HE2' ' OG ' ' A' ' 32' ' ' SER . 1.5 mtp -149.27 161.73 41.44 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.022 -1.281 . . . . 0.0 110.438 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.935 HD12 HG11 ' A' ' 36' ' ' VAL . 46.8 mt -113.39 118.82 35.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.625 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.8 OUTLIER -69.36 154.12 42.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.174 -0.954 . . . . 0.0 109.617 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.623 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 7.4 ptp85 -34.3 -44.86 0.2 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.648 -0.658 . . . . 0.0 111.06 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.678 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -81.16 -34.41 32.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 109.499 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 57' ' ' SER . 6.8 tt0 -67.26 -51.71 49.71 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.6 -0.687 . . . . 0.0 109.415 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.827 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 87.8 t80 -52.78 -26.02 13.08 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -62.15 -45.21 94.45 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.67 0.748 . . . . 0.0 109.837 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.022 HG13 HD12 ' A' ' 94' ' ' LEU . 57.6 t -60.03 -25.72 33.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.59 -0.694 . . . . 0.0 110.071 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.093 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -87.42 -11.48 49.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.876 . . . . 0.0 111.952 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.763 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 7.4 mmm -85.78 -37.97 18.7 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.32 -1.487 . . . . 0.0 110.451 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.034 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 3.4 p90 -78.33 -23.43 47.01 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.966 -1.084 . . . . 0.0 108.525 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.847 ' HB3' HG13 ' A' ' 53' ' ' VAL . 6.7 mt -75.19 -28.38 60.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.477 -0.764 . . . . 0.0 108.98 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.901 HG23 HG11 ' A' ' 53' ' ' VAL . 43.3 t -90.61 -25.83 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.508 -0.745 . . . . 0.0 110.058 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.489 ' HA ' HD12 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -84.12 -25.95 29.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 110.056 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.534 ' CA ' ' HB3' ' A' ' 83' ' ' LYS . 57.9 m -85.62 -14.06 46.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 109.454 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.852 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -79.86 -15.87 56.52 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.182 -0.948 . . . . 0.0 109.242 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.004 HD21 ' O ' ' A' ' 43' ' ' SER . 2.4 mt -92.1 -47.95 6.98 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.604 -0.685 . . . . 0.0 111.304 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -116.68 -23.65 8.08 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.503 -0.879 . . . . 0.0 112.033 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.534 ' HB3' ' CA ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -88.04 -89.38 0.13 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.612 -1.305 . . . . 0.0 110.903 -179.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.551 ' CG ' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -149.18 176.21 2.37 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.971 -1.08 . . . . 0.0 110.177 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.551 ' HD2' ' CG ' ' A' ' 84' ' ' GLU . 40.8 Cg_endo -66.81 -179.19 1.54 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.934 1.492 . . . . 0.0 110.582 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.512 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 55.5 t -122.41 122.16 27.48 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.864 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.53 ' O ' HD11 ' A' ' 56' ' ' LEU . 51.2 Cg_endo -83.66 160.36 14.4 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.892 1.47 . . . . 0.0 109.663 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.913 ' C ' HD21 ' A' ' 56' ' ' LEU . 68.6 mtp -82.79 11.24 6.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.998 -1.064 . . . . 0.0 110.237 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.585 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.6 m -99.92 112.81 25.07 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.873 -1.131 . . . . 0.0 110.66 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.743 HD12 ' C ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -100.72 85.67 0.58 Allowed Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 89' ' ' SER . 38.2 Cg_endo -62.31 173.74 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.427 1.418 . . . . 0.0 111.477 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.892 ' O ' HG22 ' A' ' 95' ' ' VAL . 44.1 Cg_endo -69.18 -10.15 28.23 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.339 1.705 . . . . 0.0 110.77 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.626 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -76.84 0.76 19.6 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 109.093 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.034 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 2.5 mm? -108.34 -13.59 14.85 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.412 -0.805 . . . . 0.0 110.116 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 92' ' ' PRO . 26.7 m -85.13 126.93 66.24 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.351 -0.843 . . . . 0.0 110.554 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.557 ' CG ' ' HD3' ' A' ' 99' ' ' LYS . 43.6 Cg_endo -71.23 175.17 9.65 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.886 1.466 . . . . 0.0 109.86 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 44.0 Cg_endo -71.39 -16.17 31.1 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.742 1.391 . . . . 0.0 110.611 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.1 t -85.83 -36.13 20.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.113 -0.992 . . . . 0.0 109.588 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.557 ' HD3' ' CG ' ' A' ' 96' ' ' PRO . 4.0 mttp -90.02 9.19 28.96 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.383 -0.823 . . . . 0.0 109.083 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.7 ttm-85 . . . . . 0 N--CA 1.487 1.404 0 O-C-N 121.281 -0.887 . . . . 0.0 109.404 179.889 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.485 0.99 0 N-CA-C 110.742 -0.522 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.536 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.4 t90 -55.94 131.99 48.64 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.474 -0.766 . . . . 0.0 109.957 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.645 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . . . -46.34 -25.81 0.71 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.283 -0.886 . . . . 0.0 110.182 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.536 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 50.6 t -111.49 140.06 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.414 -0.804 . . . . 0.0 110.009 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.498 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 7.4 mttt -106.33 177.7 1.28 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.363 -0.836 . . . . 0.0 110.38 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.547 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 40.7 Cg_endo -68.24 -37.32 14.33 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.96 1.505 . . . . 0.0 109.647 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.441 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 16.0 pt-20 -66.52 -35.64 80.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.0 109.08 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.441 ' N ' ' CG ' ' A' ' 12' ' ' GLU . 0.6 OUTLIER -81.59 -38.64 25.76 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 1.3 tmtp? -73.01 -15.47 61.53 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -74.36 -42.54 59.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.616 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.3 ptpt -74.33 -21.15 59.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.616 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.8 m-30 -79.7 -30.26 40.97 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -75.07 -11.51 60.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.704 -0.622 . . . . 0.0 110.19 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.16 -36.05 12.23 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.67 HG22 ' CE2' ' A' ' 70' ' ' PHE 0.253 18.5 mt -75.59 -29.79 21.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -72.65 -40.32 66.45 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.474 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.1 t70 -85.33 0.02 53.34 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.558 -0.714 . . . . 0.0 109.681 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.569 ' C ' HD23 ' A' ' 24' ' ' LEU . 13.2 t -91.8 -4.7 54.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.915 . . . . 0.0 108.599 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.947 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -108.92 -3.95 17.15 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 79.7 93.56 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.918 0 CA-C-O 121.409 0.623 . . . . 0.0 109.726 -179.087 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.2 Cg_endo -74.45 147.32 36.34 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 124.452 1.764 . . . . 0.0 110.789 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 86.7 t -119.31 105.14 16.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.714 -0.617 . . . . 0.0 109.354 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 2.7 t30 57.69 22.94 8.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 109.652 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.83 32.89 7.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.614 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 89.3 m-85 -150.78 154.77 37.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.332 -1.099 . . . . 0.0 111.105 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.947 HD22 ' HB2' ' A' ' 24' ' ' LEU . 22.0 mt -126.97 131.16 51.12 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.484 ' OG ' ' HE2' ' A' ' 35' ' ' LYS . 0.9 OUTLIER -76.86 140.53 40.63 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.272 -0.892 . . . . 0.0 110.392 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -41.99 -27.94 0.43 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' SER . 34.1 t0 -57.53 -28.84 63.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -1.188 . . . . 0.0 110.303 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.484 ' HE2' ' OG ' ' A' ' 32' ' ' SER . 25.4 mttm -98.91 -39.37 8.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.089 HG11 HD12 ' A' ' 65' ' ' LEU . 93.5 t -74.58 -32.44 29.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.076 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.56 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.2 ttpt -52.06 -56.88 17.78 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.233 -0.917 . . . . 0.0 110.347 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.89 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.2 Cg_endo -65.9 -31.45 47.34 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.631 1.332 . . . . 0.0 109.117 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.761 HG21 HD22 ' A' ' 24' ' ' LEU . 13.1 t -73.47 -16.68 17.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.164 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.986 ' HB3' HD22 ' A' ' 50' ' ' LEU . 63.3 mt -93.82 -18.45 22.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 108.67 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' A' ' 38' ' ' PRO . 23.6 mt -81.24 -33.84 32.54 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.399 0.619 . . . . 0.0 109.833 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.597 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -43.86 -25.35 0.19 Allowed 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.935 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.715 ' HB2' HD11 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -73.29 -4.98 36.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.326 -0.859 . . . . 0.0 110.213 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 72.47 7.88 5.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.522 -0.736 . . . . 0.0 110.153 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.045 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.8 mt -80.73 160.31 67.03 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.327 -0.858 . . . . 0.0 110.306 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.556 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.7 Cg_endo -74.33 164.69 33.53 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 124.034 1.544 . . . . 0.0 110.483 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 t -65.17 -8.44 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 110.339 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.92 -40.6 60.75 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.036 -1.04 . . . . 0.0 108.265 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.031 HG21 HD13 ' A' ' 45' ' ' LEU . 14.3 mm -65.15 -45.51 93.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.986 HD22 ' HB3' ' A' ' 40' ' ' LEU . 6.1 mt -62.28 -18.42 61.22 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.82 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.36 -33.7 11.41 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.628 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.4 ttm180 -90.13 -52.16 5.09 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.47 -1.018 . . . . 0.0 109.644 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.702 HG11 HG23 ' A' ' 77' ' ' VAL . 24.3 t -50.94 -42.25 23.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.166 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 57' ' ' SER . 7.7 t-105 -61.55 -57.01 13.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 110.093 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -47.33 -52.66 15.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.838 . . . . 0.0 110.103 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.822 HD11 ' HA ' ' A' ' 88' ' ' MET . 1.4 mt -74.94 -7.62 54.11 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.811 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.92 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 6.4 m -100.05 -29.07 12.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.43 -0.794 . . . . 0.0 110.676 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.466 ' OD2' ' HA ' ' A' ' 61' ' ' HIS . 16.8 t0 -87.29 73.77 9.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.962 . . . . 0.0 110.202 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.526 HG21 ' HG2' ' A' ' 96' ' ' PRO . 45.4 mm -44.0 -30.59 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.5 -0.75 . . . . 0.0 109.314 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 4.4 t0 -95.19 -22.32 17.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.523 -0.736 . . . . 0.0 109.931 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 34.2 p80 40.15 57.28 2.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.546 -0.721 . . . . 0.0 110.232 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' HB3' ' CG ' ' A' ' 60' ' ' ASP . 1.3 p-10 -117.12 7.04 12.94 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.581 -0.699 . . . . 0.0 109.732 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 109.56 5.87 29.38 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.1 mtp -150.41 161.0 43.34 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.157 -1.202 . . . . 0.0 110.792 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.089 HD12 HG11 ' A' ' 36' ' ' VAL . 11.9 mt -114.15 108.45 16.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.452 -0.78 . . . . 0.0 109.298 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.614 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -69.77 171.84 8.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.929 -1.107 . . . . 0.0 110.152 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 9.4 ptt180 -52.87 -37.53 60.47 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.695 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.6 OUTLIER -81.77 -35.72 29.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.189 -0.944 . . . . 0.0 109.713 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.519 ' HG2' ' HB ' ' A' ' 59' ' ' ILE . 27.1 mt-10 -74.24 -46.6 40.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 20' ' ' ILE . 68.3 t80 -57.73 -33.42 68.43 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.404 ' HA ' ' HG2' ' A' ' 74' ' ' MET . . . -57.18 -49.41 76.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.398 -0.814 . . . . 0.0 109.996 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.48 ' O ' HD12 ' A' ' 76' ' ' LEU . 55.6 t -59.29 -21.7 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.611 -0.68 . . . . 0.0 110.443 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.92 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -90.53 -9.79 45.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.07 -1.018 . . . . 0.0 111.602 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.669 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 7.1 mmm -85.41 -41.08 15.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.792 -1.192 . . . . 0.0 109.886 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.599 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.4 p90 -77.41 -26.17 51.47 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.599 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 7.6 mt -70.14 -30.85 68.12 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.702 HG23 HG11 ' A' ' 53' ' ' VAL . 57.0 t -90.98 -19.12 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.679 -0.638 . . . . 0.0 110.349 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.31 -20.18 23.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.34 -0.85 . . . . 0.0 109.75 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -87.73 -16.37 34.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.517 -0.739 . . . . 0.0 109.705 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.045 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -84.92 -12.3 53.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.518 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.779 ' N ' HD23 ' A' ' 81' ' ' LEU . 2.9 mt -88.17 -43.06 11.9 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.539 -0.725 . . . . 0.0 109.373 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.4 OUTLIER -69.41 -52.25 28.7 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.29 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.477 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 2.2 tttp 177.69 -26.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.568 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 79' ' ' CYS . 10.4 mm-40 -77.91 111.37 17.59 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.039 -1.038 . . . . 0.0 111.243 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 43.8 Cg_endo -71.32 -167.44 0.29 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.974 1.513 . . . . 0.0 110.126 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.666 HG21 ' CG2' ' A' ' 53' ' ' VAL . 56.1 t -130.08 135.07 26.89 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.325 -0.859 . . . . 0.0 110.53 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.62 ' O ' HD11 ' A' ' 56' ' ' LEU . 46.5 Cg_endo -88.32 -165.3 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.948 1.499 . . . . 0.0 109.233 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.822 ' HA ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -127.7 10.89 6.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.137 -0.977 . . . . 0.0 110.471 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.605 ' N ' HD21 ' A' ' 56' ' ' LEU . 58.0 m -115.75 93.83 4.43 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.494 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.732 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -56.88 107.2 0.83 Allowed Pre-proline 0 C--N 1.291 -1.943 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.568 178.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.617 ' HG2' HD12 ' A' ' 94' ' ' LEU . 42.8 Cg_endo -82.07 173.32 11.07 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.703 1.37 . . . . 0.0 110.613 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 44.6 Cg_endo -71.21 -5.41 16.94 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.232 1.648 . . . . 0.0 111.418 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.44 ' O ' ' HG ' ' A' ' 94' ' ' LEU . . . -84.01 0.17 49.2 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 109.731 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.645 ' HG ' ' HB2' ' A' ' 8' ' ' ALA . 1.4 mp -138.29 31.24 2.38 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.19 -0.944 . . . . 0.0 110.994 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.489 HG12 ' HB3' ' A' ' 99' ' ' LYS . 3.7 t -109.05 114.92 57.68 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.865 -1.147 . . . . 0.0 110.702 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.526 ' HG2' HG21 ' A' ' 59' ' ' ILE . 43.6 Cg_endo -69.71 175.5 7.98 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.988 1.52 . . . . 0.0 110.059 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.528 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 45.3 Cg_endo -71.81 -2.44 11.45 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.903 1.475 . . . . 0.0 110.852 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.4 t -79.33 -24.4 42.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 109.704 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.489 ' HB3' HG12 ' A' ' 95' ' ' VAL . 5.8 tptt -89.86 5.23 47.15 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.433 -0.792 . . . . 0.0 109.557 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.528 ' CG ' ' HA ' ' A' ' 97' ' ' PRO . 2.9 mmp_? . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.267 -0.896 . . . . 0.0 110.24 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 N--CA 1.483 0.905 0 N-CA-C 110.514 -0.61 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.851 ' HE1' HD22 ' A' ' 94' ' ' LEU . 13.4 t90 -73.17 126.44 30.05 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.33 -0.856 . . . . 0.0 109.979 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -47.7 -25.83 1.34 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.493 -0.754 . . . . 0.0 109.991 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.6 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 56.0 t -88.96 147.04 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.496 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 28.5 mttt -99.93 167.28 11.3 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.237 -0.915 . . . . 0.0 109.847 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.0 Cg_endo -67.74 -33.96 26.04 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.81 1.426 . . . . 0.0 109.709 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -76.64 -24.17 53.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.524 -0.735 . . . . 0.0 109.513 179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.576 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -80.83 -38.73 27.79 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.527 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 28.4 tptp -65.23 -19.8 66.13 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.58 -44.52 50.46 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.58 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 4.1 ptpt -77.21 -19.2 57.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.619 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 6.9 m-30 -80.15 -33.32 38.59 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -79.57 -10.16 59.75 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.242 0.544 . . . . 0.0 110.151 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 23' ' ' SER . . . -94.93 -31.77 13.51 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.639 ' O ' HD21 ' A' ' 24' ' ' LEU . 61.7 mt -80.46 -32.74 13.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.559 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -71.45 -39.0 71.28 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.528 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.8 t0 -88.93 1.13 55.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.645 -0.66 . . . . 0.0 109.688 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 1.1 m -93.49 0.26 56.65 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.061 HD22 HG21 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -110.49 -4.99 15.24 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 p 81.93 87.59 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.528 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 49.8 Cg_endo -71.7 147.25 50.49 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.16 1.611 . . . . 0.0 110.854 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 99.9 t -116.94 104.77 17.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 14.9 t30 57.03 24.4 9.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.529 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 90.26 39.1 6.12 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.571 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 87.4 m-85 -150.58 156.54 41.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -1.179 . . . . 0.0 111.601 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.913 HD13 HD12 ' A' ' 24' ' ' LEU . 75.3 mt -128.77 135.32 49.02 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.542 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 10.2 p -80.36 142.07 34.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.392 -0.817 . . . . 0.0 111.104 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.612 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -51.22 -22.84 7.4 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -84.58 -9.65 58.11 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.363 -1.081 . . . . 0.0 109.36 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.647 ' HD2' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -97.19 -43.94 7.15 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.333 1.063 . . . . 0.0 108.336 179.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.602 HG21 HD12 ' A' ' 65' ' ' LEU . 96.8 t -78.82 -32.52 15.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.334 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.932 ' O ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -39.99 -54.58 4.29 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.421 -0.799 . . . . 0.0 110.852 -179.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.2 Cg_endo -63.68 -28.86 69.07 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.644 1.339 . . . . 0.0 109.825 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.061 HG21 HD22 ' A' ' 24' ' ' LEU . 4.8 t -79.72 -12.77 13.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.444 0.64 . . . . 0.0 110.244 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.768 ' HB3' HD22 ' A' ' 50' ' ' LEU . 66.2 mt -98.69 -17.05 18.76 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.85 -1.156 . . . . 0.0 109.1 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.932 HD12 ' O ' ' A' ' 37' ' ' LYS . 1.9 mt -88.74 -32.3 18.0 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.421 -0.799 . . . . 0.0 110.036 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.583 ' ND2' ' HA ' ' A' ' 39' ' ' VAL . 6.1 p30 -67.23 -8.21 29.97 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.061 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 50.3 m -77.53 7.23 5.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.462 -0.774 . . . . 0.0 109.905 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 65.33 16.34 10.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -0.963 . . . . 0.0 109.565 -179.489 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.996 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.2 mt -100.28 151.55 37.57 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.444 -0.785 . . . . 0.0 110.625 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.565 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.1 Cg_endo -75.12 159.45 40.91 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.142 1.601 . . . . 0.0 110.085 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.1 t -60.72 -10.11 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.809 . . . . 0.0 110.933 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.08 -42.4 60.21 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.931 -1.106 . . . . 0.0 108.311 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.917 HG13 HD22 ' A' ' 45' ' ' LEU . 8.8 mm -64.61 -45.02 96.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.768 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.2 mt -63.14 -21.53 66.25 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.176 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.29 -30.62 24.6 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.537 ' HD3' ' CG ' ' A' ' 88' ' ' MET . 10.3 ttm180 -94.16 -54.0 3.74 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.495 -1.003 . . . . 0.0 109.547 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.811 HG11 HG23 ' A' ' 77' ' ' VAL . 37.7 t -52.75 -33.06 18.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.071 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.612 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 10.7 t-105 -71.26 -57.06 4.84 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.919 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -47.41 -47.74 26.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.9 . . . . 0.0 109.983 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.909 HD11 ' HA ' ' A' ' 88' ' ' MET . 4.5 mt -76.77 -10.3 59.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 0.0 109.523 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 1.029 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 2.8 t -98.66 -34.2 10.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.447 -0.783 . . . . 0.0 110.257 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.599 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 19.6 t0 -79.79 68.16 5.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.357 -0.84 . . . . 0.0 109.338 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.455 ' C ' ' O ' ' A' ' 58' ' ' ASP . 31.2 mm -34.57 -30.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.116 0.484 . . . . 0.0 111.36 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 58' ' ' ASP . 54.1 m-20 -100.48 -19.59 16.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.088 -1.007 . . . . 0.0 111.601 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.599 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 3.8 m170 63.71 35.13 11.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.859 -1.151 . . . . 0.0 109.448 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -102.19 12.13 37.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.92 . . . . 0.0 110.826 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.11 10.11 81.11 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.543 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.7 mtt -139.32 160.19 40.4 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.335 -1.097 . . . . 0.0 110.89 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.602 HD12 HG21 ' A' ' 36' ' ' VAL . 87.9 mt -125.33 112.1 15.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.302 -0.874 . . . . 0.0 110.405 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.571 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 16.5 t0 -68.93 169.86 10.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.838 -1.163 . . . . 0.0 109.48 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.559 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 11.4 ptm180 -48.03 -40.61 23.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.681 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.466 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -80.64 -31.31 36.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.328 -0.857 . . . . 0.0 110.407 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.512 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 31.3 mt-10 -75.69 -38.1 58.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.735 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.661 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 52.6 t80 -68.28 -19.51 64.71 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.367 -0.833 . . . . 0.0 109.439 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.38 -39.84 52.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.444 -0.785 . . . . 0.0 109.395 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.886 HG13 HD21 ' A' ' 94' ' ' LEU . 38.3 t -64.0 -23.49 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.555 0.693 . . . . 0.0 109.192 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.029 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.57 -8.2 50.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.624 -0.673 . . . . 0.0 110.854 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.619 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 14.8 mmt -83.03 -46.89 12.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.064 -1.022 . . . . 0.0 109.907 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.59 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 5.4 p90 -76.27 -25.57 55.06 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.738 ' HB3' HG13 ' A' ' 53' ' ' VAL . 11.0 mt -69.92 -25.83 63.85 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.863 HG13 HD12 ' A' ' 45' ' ' LEU . 51.9 t -91.39 -62.74 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.548 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.2 m-85 -47.61 -25.44 1.16 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.614 -0.679 . . . . 0.0 111.131 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 84' ' ' GLU . 33.6 m -82.71 -12.31 57.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.986 -1.071 . . . . 0.0 109.843 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.996 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.13 -10.67 43.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.291 -0.881 . . . . 0.0 109.179 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.784 HD12 ' N ' ' A' ' 81' ' ' LEU . 7.0 mp -87.91 -43.46 11.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 109.348 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.7 OUTLIER -69.88 -55.88 8.56 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.665 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 14.7 ttmt 177.92 -23.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 111.229 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 79' ' ' CYS . 11.1 mm-40 -67.82 112.05 9.4 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.963 -1.086 . . . . 0.0 111.198 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 45.3 Cg_endo -73.14 172.1 16.23 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.829 1.436 . . . . 0.0 109.758 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.69 HG11 ' CG2' ' A' ' 53' ' ' VAL . 97.2 t -121.02 125.77 26.88 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.028 -1.045 . . . . 0.0 110.665 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.5 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.7 Cg_endo -85.24 -169.31 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.979 1.515 . . . . 0.0 109.407 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.909 ' HA ' HD11 ' A' ' 56' ' ' LEU . 2.7 mtp -116.22 8.05 14.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 0.0 109.983 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.416 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 58.5 m -106.08 104.96 14.78 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.812 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.621 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -50.05 106.49 0.64 Allowed Pre-proline 0 C--N 1.292 -1.92 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.514 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 39.4 Cg_endo -68.68 142.99 54.71 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.926 1.487 . . . . 0.0 111.215 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.99 -7.56 21.29 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.422 1.748 . . . . 0.0 111.311 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.598 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -100.0 21.68 12.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.166 -0.959 . . . . 0.0 108.772 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.952 HD22 ' O ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -141.52 -11.34 0.92 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.285 0.564 . . . . 0.0 110.426 -178.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.525 HG11 ' HB3' ' A' ' 99' ' ' LYS . 2.0 t -78.69 143.73 63.51 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.439 -1.413 . . . . 0.0 110.133 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.509 ' HD2' HG12 ' A' ' 95' ' ' VAL . 43.8 Cg_endo -71.32 162.93 40.81 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.872 1.459 . . . . 0.0 109.274 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.669 ' HA ' ' NE ' ' A' ' 100' ' ' ARG . 44.4 Cg_endo -71.5 57.1 2.3 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.636 1.335 . . . . 0.0 110.711 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.8 t -143.18 -38.68 0.33 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.549 ' O ' ' C ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -92.48 11.49 26.11 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.592 178.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.669 ' NE ' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.225 0 O-C-N 121.923 -0.486 . . . . 0.0 111.629 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 7' ' ' TRP . 49.3 Cg_endo . . . . . 0 N--CA 1.485 0.978 0 N-CA-C 110.567 -0.59 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.564 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 9.5 t90 -41.58 128.13 3.16 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.555 -0.715 . . . . 0.0 109.461 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -39.39 -26.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.843 . . . . 0.0 110.43 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.564 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 12.3 t -99.04 127.76 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.586 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.522 ' CD ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -84.6 175.96 4.15 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 110.334 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' CD ' ' A' ' 10' ' ' LYS . 42.6 Cg_endo -70.4 -34.38 12.54 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.079 1.568 . . . . 0.0 109.515 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -78.72 -24.36 44.93 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.593 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 19.8 m-20 -82.97 -48.79 10.28 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.514 ' HE2' ' HB2' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -63.95 -19.23 64.98 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -80.63 -43.76 19.96 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.587 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.35 -28.04 60.95 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 8.1 m-30 -70.65 -36.78 73.57 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 66.5 t0 -72.66 -9.29 58.44 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.446 0.641 . . . . 0.0 109.74 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.19 -35.86 11.69 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.503 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 29.3 mt -77.73 -32.49 18.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.587 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -69.75 -43.82 71.5 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.345 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.554 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 47.5 t0 -83.49 2.62 35.98 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.41 0.624 . . . . 0.0 109.558 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.451 ' HB2' ' HA ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -90.56 -8.41 50.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.331 -0.855 . . . . 0.0 109.208 179.013 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.688 HD12 HD13 ' A' ' 31' ' ' LEU . 2.9 mt -104.65 -8.07 19.17 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m 83.14 93.77 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.995 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.5 Cg_endo -74.27 145.41 34.47 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.374 1.723 . . . . 0.0 110.533 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 21.1 t -113.15 102.56 14.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER 62.4 19.95 11.5 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.323 -0.861 . . . . 0.0 109.268 -179.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 92.28 34.05 7.31 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 77.9 m-85 -144.56 149.5 35.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.165 -1.197 . . . . 0.0 111.566 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.688 HD13 HD12 ' A' ' 24' ' ' LEU . 52.3 mt -125.7 131.87 52.49 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.549 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -77.42 138.46 39.28 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.443 -0.785 . . . . 0.0 110.029 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -43.01 -25.64 0.38 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 6.0 m-20 -65.52 -20.88 66.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -1.175 . . . . 0.0 110.337 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 9.1 mtpp -97.98 -39.78 8.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.176 -0.952 . . . . 0.0 109.073 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.955 HG11 HD12 ' A' ' 65' ' ' LEU . 60.4 t -78.15 -36.6 21.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 121.485 0.659 . . . . 0.0 109.769 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.5 tttt -48.08 -54.69 22.59 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.859 . . . . 0.0 110.171 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.923 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.0 Cg_endo -63.6 -29.24 70.01 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.58 1.305 . . . . 0.0 108.907 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.591 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 4.7 t -80.63 -11.27 12.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 121.659 0.742 . . . . 0.0 109.46 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.685 ' HB3' HD22 ' A' ' 50' ' ' LEU . 42.0 mt -99.94 -14.97 18.48 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.166 -0.959 . . . . 0.0 108.677 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.923 HD12 ' HA ' ' A' ' 38' ' ' PRO . 7.9 mt -89.42 -33.9 16.67 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.642 -0.661 . . . . 0.0 110.089 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 6.6 p30 -64.24 -9.85 19.9 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.735 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 1.4 m -72.35 -1.83 16.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 110.052 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 43' ' ' SER . 17.4 ttmt 69.55 14.62 8.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.307 -0.871 . . . . 0.0 110.455 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.044 HD13 HG21 ' A' ' 49' ' ' ILE . 14.9 mt -100.46 163.64 17.81 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.217 -0.927 . . . . 0.0 110.317 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HG2' HG12 ' A' ' 49' ' ' ILE . 44.1 Cg_endo -75.18 160.92 39.03 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.982 1.517 . . . . 0.0 110.047 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.6 t -64.96 -7.17 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.132 -0.98 . . . . 0.0 110.373 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.06 -40.31 62.9 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.044 HG21 HD13 ' A' ' 45' ' ' LEU . 15.3 mm -64.13 -43.62 97.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.685 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.1 mt -66.26 -21.19 66.28 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.735 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.14 -27.97 29.48 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.565 ' CD ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -94.54 -54.73 3.4 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.465 -1.021 . . . . 0.0 109.329 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.954 HG11 HG23 ' A' ' 77' ' ' VAL . 33.2 t -52.36 -41.01 33.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.517 -0.873 . . . . 0.0 108.685 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.539 ' CZ2' ' OD2' ' A' ' 58' ' ' ASP . 9.0 t-105 -62.6 -56.44 17.8 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.449 -0.782 . . . . 0.0 109.795 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.518 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 12.0 mm-40 -45.33 -56.48 4.87 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.389 -0.82 . . . . 0.0 110.104 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.724 HD21 ' C ' ' A' ' 88' ' ' MET . 1.4 mt -72.1 -10.94 60.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.687 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.971 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 8.0 m -96.8 -23.15 16.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.377 -0.827 . . . . 0.0 110.263 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.579 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 6.7 t0 -93.26 76.06 4.58 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.356 -0.84 . . . . 0.0 109.569 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.512 HG23 ' HE3' ' A' ' 99' ' ' LYS . 34.4 mm -41.23 -32.52 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.712 -0.618 . . . . 0.0 110.236 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 35.5 m-20 -93.48 -22.06 19.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.386 -0.821 . . . . 0.0 110.717 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 46.1 m-70 55.47 42.81 29.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 109.716 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -112.45 3.36 16.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.464 -0.773 . . . . 0.0 110.887 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.93 3.84 48.63 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.549 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 4.6 mtt -133.94 159.45 40.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -1.131 . . . . 0.0 110.82 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.955 HD12 HG11 ' A' ' 36' ' ' VAL . 10.5 mt -124.38 110.97 15.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.576 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -72.56 172.62 10.23 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.866 -1.146 . . . . 0.0 109.781 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.498 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -49.36 -38.07 26.96 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.603 -0.686 . . . . 0.0 111.313 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.15 -31.21 21.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.007 -1.058 . . . . 0.0 110.221 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.487 ' OE2' ' HB3' ' A' ' 66' ' ' ASP . 27.9 mt-10 -75.76 -42.35 50.61 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.285 -0.884 . . . . 0.0 109.593 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.656 ' HA ' HD13 ' A' ' 65' ' ' LEU . 61.4 t80 -62.66 -31.45 72.33 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.069 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.514 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . . . -60.36 -49.05 79.12 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.79 0.805 . . . . 0.0 109.89 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.057 HG13 HD21 ' A' ' 94' ' ' LEU . 85.6 t -57.73 -24.2 22.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 121.333 0.587 . . . . 0.0 110.427 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.971 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -90.46 -6.15 55.21 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.183 -0.948 . . . . 0.0 111.852 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.581 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 11.3 mmm -89.97 -43.15 10.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.648 -1.283 . . . . 0.0 110.121 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.586 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.6 p90 -76.84 -27.71 55.22 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.876 -1.13 . . . . 0.0 108.115 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.711 ' HB3' HG13 ' A' ' 53' ' ' VAL . 9.6 mt -69.47 -27.15 64.98 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.954 HG23 HG11 ' A' ' 53' ' ' VAL . 30.3 t -91.59 -32.79 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.501 -0.75 . . . . 0.0 110.431 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -81.83 -33.01 30.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.13 -0.981 . . . . 0.0 110.043 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 65.1 m -75.45 -20.09 59.04 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.698 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -71.64 -16.7 62.28 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.561 ' N ' HD23 ' A' ' 81' ' ' LEU . 5.6 mt -90.56 -44.4 9.58 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.542 0.687 . . . . 0.0 109.787 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.54 35.91 4.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.612 -0.68 . . . . 0.0 111.731 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 79' ' ' CYS . 0.9 OUTLIER -146.24 -69.46 0.26 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.655 -1.278 . . . . 0.0 110.822 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -176.54 177.68 0.48 Allowed Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 110.212 -179.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 42.9 Cg_endo -70.12 170.92 15.86 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.875 1.461 . . . . 0.0 109.575 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.576 HG21 ' CG2' ' A' ' 53' ' ' VAL . 85.5 t -112.47 131.06 22.8 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 110.2 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.59 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.4 Cg_endo -84.44 169.86 10.8 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.87 1.458 . . . . 0.0 109.405 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.724 ' C ' HD21 ' A' ' 56' ' ' LEU . 4.2 mtm -98.85 12.76 34.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.917 -1.114 . . . . 0.0 110.261 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.468 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 72.2 m -108.63 103.83 13.01 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.715 -1.194 . . . . 0.0 112.044 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.594 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 2.2 mt -51.74 106.38 0.65 Allowed Pre-proline 0 C--N 1.292 -1.927 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.233 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.663 ' HD2' HD12 ' A' ' 94' ' ' LEU . 41.2 Cg_endo -72.07 150.36 54.09 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.759 1.4 . . . . 0.0 110.51 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.508 ' HA ' ' CG2' ' A' ' 95' ' ' VAL . 43.8 Cg_endo -70.16 -5.82 17.36 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.146 1.603 . . . . 0.0 111.068 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -100.62 24.59 8.83 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.057 HD21 HG13 ' A' ' 72' ' ' VAL 0.25 0.3 OUTLIER -158.19 34.36 0.24 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.338 1.066 . . . . 0.0 109.015 -178.128 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.751 HG12 ' HE2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -132.07 130.97 22.26 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.623 -1.298 . . . . 0.0 110.347 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.503 ' O ' ' NZ ' ' A' ' 99' ' ' LYS . 40.2 Cg_endo -68.04 174.66 7.56 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.784 1.413 . . . . 0.0 109.053 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 98' ' ' SER . 45.7 Cg_endo -72.34 179.27 5.2 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.54 1.284 . . . . 0.0 111.351 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.1 OUTLIER 75.09 -52.01 0.67 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.776 -0.578 . . . . 0.0 110.99 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.751 ' HE2' HG12 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -88.27 8.97 24.76 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.031 -1.043 . . . . 0.0 108.578 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.525 -0.734 . . . . 0.0 109.265 179.263 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 N--CA 1.482 0.816 0 N-CA-C 110.628 -0.566 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.549 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 -76.69 124.03 27.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.875 . . . . 0.0 110.113 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.447 ' HB2' HD22 ' A' ' 94' ' ' LEU . . . -46.45 -24.56 0.52 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.447 -0.783 . . . . 0.0 110.652 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.549 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 73.3 t -103.6 130.99 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.793 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.639 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.5 mttt -93.64 174.47 3.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.476 -0.765 . . . . 0.0 109.007 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.639 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 38.2 Cg_endo -65.44 -37.48 30.01 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.287 1.151 . . . . 0.0 109.957 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 8.0 pt-20 -64.71 -25.94 68.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.215 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.596 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -84.0 -38.34 21.05 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 9.9 tptm -72.88 -17.03 61.57 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.576 0.703 . . . . 0.0 109.258 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.55 -37.84 65.43 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 2.3 mtmt -80.82 -39.18 27.05 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.596 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 5.3 m-30 -66.26 -22.69 66.32 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 6.3 t0 -85.81 -15.45 41.93 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.631 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -90.33 -28.14 18.93 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.739 HG22 ' CE1' ' A' ' 70' ' ' PHE . 15.7 mt -82.7 -31.85 9.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.605 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -74.31 -40.49 62.19 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.523 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.2 t0 -84.9 -0.57 54.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.643 -0.66 . . . . 0.0 109.839 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -89.34 -7.18 55.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.844 . . . . 0.0 109.04 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.856 ' HB2' HD22 ' A' ' 31' ' ' LEU . 2.5 mt -107.08 -8.66 16.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER 82.17 95.07 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.4 Cg_endo -74.49 150.17 40.41 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.994 1.523 . . . . 0.0 110.838 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 40.8 t -118.81 101.55 11.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER 65.22 26.58 12.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 108.891 -178.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . 85.14 35.72 12.03 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.604 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 93.8 m-85 -150.04 159.26 44.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.641 -0.917 . . . . 0.0 110.598 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.856 HD22 ' HB2' ' A' ' 24' ' ' LEU . 12.7 mt -135.02 128.95 33.34 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.471 ' OG ' ' CD ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -73.09 139.21 46.33 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.452 -0.78 . . . . 0.0 110.541 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -43.07 -32.87 1.64 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.43 -15.83 7.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -1.153 . . . . 0.0 110.016 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 9.6 mtpp -111.77 -35.39 5.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.277 -0.889 . . . . 0.0 108.95 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.999 HG11 HD12 ' A' ' 65' ' ' LEU . 84.8 t -91.32 -46.27 14.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.698 -0.626 . . . . 0.0 110.179 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.635 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 ttpt -45.22 -47.83 33.17 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 110.661 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.869 ' HA ' HD12 ' A' ' 41' ' ' LEU . 40.0 Cg_endo -69.01 -31.63 23.43 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.38 1.2 . . . . 0.0 109.377 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.532 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 1.9 t -65.71 -31.01 51.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.778 -0.576 . . . . 0.0 109.629 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.843 ' HB3' HD22 ' A' ' 50' ' ' LEU . 18.8 mt -80.59 -14.74 57.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.213 -0.93 . . . . 0.0 109.026 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.869 HD12 ' HA ' ' A' ' 38' ' ' PRO . 33.7 mt -76.25 -26.49 56.06 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 35.8 m-80 -63.32 -17.05 62.14 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.138 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.529 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -76.55 1.97 15.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.265 -0.897 . . . . 0.0 110.327 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 43' ' ' SER . 6.0 tttm 64.71 11.82 7.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 0.0 110.083 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.955 HD13 HG21 ' A' ' 49' ' ' ILE . 15.1 mt -86.89 158.41 53.38 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.864 . . . . 0.0 110.087 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.7 Cg_endo -73.61 159.11 46.53 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.068 1.562 . . . . 0.0 110.851 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -58.93 -10.74 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.984 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.27 -42.38 59.71 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.959 -1.088 . . . . 0.0 108.073 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.955 HG21 HD13 ' A' ' 45' ' ' LEU . 21.1 mm -61.84 -42.62 95.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.843 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.7 mt -66.77 -22.81 66.03 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.484 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . -82.65 -24.59 53.06 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.578 ' CD ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -99.01 -59.59 1.7 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.545 -0.974 . . . . 0.0 109.711 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.856 HG11 HG23 ' A' ' 77' ' ' VAL . 46.2 t -46.58 -36.44 2.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.012 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.554 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 9.3 t-105 -73.07 -59.33 2.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 110.211 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 52.5 mm-40 -44.16 -45.5 8.34 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.195 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.75 HD21 ' C ' ' A' ' 88' ' ' MET . 1.8 mt -81.52 -16.5 51.59 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.339 -0.944 . . . . 0.0 109.586 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.933 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 3.2 t -88.39 -25.9 22.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.455 -0.778 . . . . 0.0 109.457 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.562 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 15.7 t0 -85.0 81.38 8.93 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.505 -0.747 . . . . 0.0 109.745 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.622 ' CG2' ' HG2' ' A' ' 99' ' ' LYS . 33.2 mm -47.8 -30.94 2.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 120.134 -0.627 . . . . 0.0 110.504 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 4.4 p-10 -103.92 -16.28 15.4 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.039 -1.064 . . . . 0.0 111.309 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.562 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 34.8 m-70 54.73 41.51 31.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.894 -1.129 . . . . 0.0 109.948 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 64' ' ' MET . 1.1 p-10 -100.96 -10.76 20.29 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.357 -0.839 . . . . 0.0 110.171 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.433 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 117.9 8.93 10.29 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.572 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.0 mtp -145.55 161.36 39.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -1.174 . . . . 0.0 110.116 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.999 HD12 HG11 ' A' ' 36' ' ' VAL . 15.6 mt -117.4 106.0 12.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.172 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.604 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -69.59 172.91 6.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.779 -1.201 . . . . 0.0 110.297 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.494 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.5 ptm180 -47.73 -39.57 18.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.614 -0.679 . . . . 0.0 111.032 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.46 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 5.6 m-20 -84.87 -31.97 23.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 0.0 110.338 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.531 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 18.9 mt-10 -77.2 -44.16 31.08 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.392 -0.818 . . . . 0.0 109.091 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.788 ' CE2' HG13 ' A' ' 36' ' ' VAL . 62.0 t80 -64.46 -29.12 70.17 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -62.28 -50.4 71.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.42 -0.8 . . . . 0.0 110.226 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.992 HG13 HD12 ' A' ' 94' ' ' LEU . 41.8 t -56.31 -24.11 17.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.51 -0.744 . . . . 0.0 109.8 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.933 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -86.69 -9.88 54.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.195 -0.941 . . . . 0.0 111.831 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.59 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 9.1 mmm -87.85 -39.11 15.1 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.602 -1.312 . . . . 0.0 110.574 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.997 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 3.2 p90 -78.93 -20.23 49.84 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.834 -1.146 . . . . 0.0 108.212 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.748 HD12 ' O ' ' A' ' 72' ' ' VAL . 10.5 mt -79.83 -25.47 40.79 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.611 0.719 . . . . 0.0 109.217 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.856 HG23 HG11 ' A' ' 53' ' ' VAL . 78.5 t -91.49 -26.99 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.478 -0.764 . . . . 0.0 110.327 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.46 -29.96 21.02 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.267 -0.895 . . . . 0.0 110.039 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 3.0 t -81.19 -14.78 57.22 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.265 -0.897 . . . . 0.0 108.861 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.71 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.22 -7.68 58.92 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.4 -0.812 . . . . 0.0 109.12 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.749 ' N ' HD23 ' A' ' 81' ' ' LEU . 2.8 mt -90.46 -50.29 6.03 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.584 -0.698 . . . . 0.0 109.968 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -71.08 -51.26 26.19 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.425 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 2.8 tptt 176.89 79.51 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.98 -1.075 . . . . 0.0 111.376 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.537 ' CB ' ' O ' ' A' ' 79' ' ' CYS . 5.3 tp10 -166.71 116.36 0.74 Allowed Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.61 -1.306 . . . . 0.0 111.439 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.57 160.97 40.64 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.878 1.462 . . . . 0.0 109.662 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.528 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 44.5 t -118.25 126.92 26.91 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.855 -1.153 . . . . 0.0 110.833 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.594 ' O ' HD11 ' A' ' 56' ' ' LEU . 51.7 Cg_endo -90.45 147.49 4.25 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.933 1.491 . . . . 0.0 109.72 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.75 ' C ' HD21 ' A' ' 56' ' ' LEU . 4.7 mtm -81.96 11.2 5.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.88 -1.138 . . . . 0.0 110.348 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.467 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 68.3 m -106.84 106.4 16.91 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.598 -178.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.604 ' HG ' ' HA ' ' A' ' 56' ' ' LEU . 2.1 mt -54.66 107.81 0.97 Allowed Pre-proline 0 C--N 1.294 -1.841 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.919 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.645 ' HG2' HD23 ' A' ' 94' ' ' LEU . 40.1 Cg_endo -67.93 161.03 45.87 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 124.076 1.566 . . . . 0.0 110.14 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.11 -20.59 16.5 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.002 1.527 . . . . 0.0 111.098 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.623 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -88.84 15.29 8.62 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.152 -0.968 . . . . 0.0 109.734 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.997 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 3.9 mm? -118.33 -23.03 7.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.205 -0.934 . . . . 0.0 110.611 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.414 HG11 ' HA ' ' A' ' 100' ' ' ARG . 53.4 t -76.56 132.02 73.15 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.341 -0.849 . . . . 0.0 110.855 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.424 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 41.0 Cg_endo -69.28 173.05 11.1 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.992 1.522 . . . . 0.0 109.479 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 98' ' ' SER . 44.6 Cg_endo -72.07 166.03 30.84 Favored 'Trans proline' 0 C--N 1.301 -1.961 0 O-C-N 123.823 1.433 . . . . 0.0 111.093 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 1.0 OUTLIER 73.99 -52.74 0.69 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.459 -0.775 . . . . 0.0 110.606 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.622 ' HG2' ' CG2' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -88.07 9.91 20.94 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.113 -0.992 . . . . 0.0 108.498 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.414 ' HA ' HG11 ' A' ' 95' ' ' VAL . 3.8 ptm180 . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 110.156 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 N--CA 1.483 0.9 0 N-CA-C 110.592 -0.58 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.569 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.1 t90 -83.05 122.06 27.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.339 -0.85 . . . . 0.0 109.887 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.721 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -42.4 -28.84 0.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 110.277 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.569 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 39.0 t -100.09 146.05 9.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.348 -0.845 . . . . 0.0 109.72 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.516 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.1 mtmt -119.47 178.07 1.2 Allowed Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.192 -0.942 . . . . 0.0 109.693 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 38.3 Cg_endo -64.9 -36.42 39.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.84 1.442 . . . . 0.0 110.252 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 18.3 pt-20 -65.35 -35.73 81.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.327 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 92.4 m-20 -81.95 -34.41 29.81 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.883 ' HE2' ' HB2' ' A' ' 71' ' ' ALA . 1.1 tppp? -70.91 -20.6 62.47 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.21 -40.02 78.26 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.655 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.7 ptmm? -79.79 -24.82 41.19 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.655 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.7 m-30 -72.18 -35.86 69.09 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 35.0 t0 -74.47 -8.75 57.32 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.238 0.542 . . . . 0.0 110.455 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.08 -41.22 9.22 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.644 HG22 ' CE2' ' A' ' 70' ' ' PHE 0.251 15.5 mt -72.51 -29.62 31.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -70.73 -39.72 73.19 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.517 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.2 t70 -88.6 2.99 52.05 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.572 -0.705 . . . . 0.0 109.816 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.5 m -91.01 -4.95 56.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 108.663 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.892 HD12 HD13 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -110.74 -6.02 14.87 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER 80.88 96.33 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.2 Cg_endo -72.9 147.63 44.27 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 O-C-N 124.611 1.848 . . . . 0.0 110.691 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.7 t -117.61 103.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 1.1 t30 62.2 21.9 12.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.942 . . . . 0.0 109.223 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.58 34.56 7.33 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CE1' ' CB ' ' A' ' 66' ' ' ASP . 96.9 m-85 -150.43 160.64 43.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -1.113 . . . . 0.0 111.134 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.892 HD13 HD12 ' A' ' 24' ' ' LEU . 42.8 mt -126.61 132.91 51.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.508 -0.745 . . . . 0.0 109.529 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.561 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.5 OUTLIER -80.54 138.9 36.55 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.358 -0.839 . . . . 0.0 110.458 -179.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -40.62 -25.68 0.11 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 32' ' ' SER . 8.7 m-20 -63.93 -17.94 63.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -1.141 . . . . 0.0 110.969 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -111.6 -36.42 5.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.937 -1.102 . . . . 0.0 109.942 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.015 HG11 HD12 ' A' ' 65' ' ' LEU . 82.2 t -79.09 -54.19 12.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.316 -0.865 . . . . 0.0 109.964 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.618 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -40.43 -49.88 6.74 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.581 -0.699 . . . . 0.0 110.459 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.858 ' HA ' HD12 ' A' ' 41' ' ' LEU . 41.2 Cg_endo -68.27 -31.97 27.59 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.376 1.198 . . . . 0.0 109.413 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.688 HG21 ' CD2' ' A' ' 24' ' ' LEU . 2.2 t -67.51 -31.65 53.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.576 -0.703 . . . . 0.0 109.572 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.959 ' CB ' HD22 ' A' ' 50' ' ' LEU . 11.4 mt -78.72 -15.66 58.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.049 -1.032 . . . . 0.0 108.636 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.858 HD12 ' HA ' ' A' ' 38' ' ' PRO . 14.8 mt -75.47 -24.29 56.94 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.423 -0.798 . . . . 0.0 108.901 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 32.6 m-80 -66.98 -19.03 65.65 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.001 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 1.039 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -74.07 0.08 14.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.273 -0.892 . . . . 0.0 110.252 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.3 OUTLIER 69.49 4.35 4.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.12 -0.987 . . . . 0.0 110.577 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.003 HD13 HG21 ' A' ' 49' ' ' ILE . 15.7 mt -79.2 160.37 70.89 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.011 . . . . 0.0 110.224 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HD2' HG13 ' A' ' 49' ' ' ILE . 41.7 Cg_endo -73.43 161.57 42.18 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.04 1.547 . . . . 0.0 110.287 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.78 -11.39 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.41 -0.806 . . . . 0.0 110.527 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.75 -40.07 66.32 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.003 HG21 HD13 ' A' ' 45' ' ' LEU . 28.3 mm -64.0 -44.82 97.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.959 HD22 ' CB ' ' A' ' 40' ' ' LEU . 13.5 mt -61.52 -17.78 56.28 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . -88.57 -27.4 24.8 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -96.34 -54.54 3.24 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.665 -0.903 . . . . 0.0 109.332 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.869 HG23 HG21 ' A' ' 86' ' ' VAL . 45.0 t -48.16 -33.42 4.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.901 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 10.4 t-105 -76.96 -59.59 2.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.315 -0.866 . . . . 0.0 110.32 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 64.8 mm-40 -45.65 -41.18 10.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.266 -0.896 . . . . 0.0 109.841 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.81 HD22 ' N ' ' A' ' 90' ' ' LEU . 20.9 mt -83.23 -17.61 42.13 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.557 -0.714 . . . . 0.0 109.454 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 1.032 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 8.3 t -92.33 -23.54 19.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.342 -0.849 . . . . 0.0 109.457 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.589 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 23.5 t0 -84.49 65.88 9.19 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.318 -0.864 . . . . 0.0 110.12 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.567 HG12 ' HG2' ' A' ' 69' ' ' GLU . 40.2 mm -39.28 -30.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.373 0.606 . . . . 0.0 110.013 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 21.8 m-20 -95.71 -25.76 15.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.436 -0.79 . . . . 0.0 110.507 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 75.2 m-70 59.62 48.9 8.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.919 . . . . 0.0 109.829 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -117.38 -10.69 10.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 110.434 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.25 8.87 16.37 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.561 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 2.8 mtt -143.55 160.8 39.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.381 -1.07 . . . . 0.0 110.323 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.015 HD12 HG11 ' A' ' 36' ' ' VAL . 69.7 mt -123.85 116.87 23.65 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.13 -0.981 . . . . 0.0 110.937 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.547 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -72.23 160.21 32.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.897 -1.127 . . . . 0.0 109.743 178.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.543 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 9.7 ptm180 -41.73 -37.76 1.29 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.345 -0.847 . . . . 0.0 111.479 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.474 ' OD1' ' NZ ' ' A' ' 14' ' ' LYS . 52.8 m-20 -81.1 -30.13 34.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.855 -1.153 . . . . 0.0 109.528 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.567 ' HG2' HG12 ' A' ' 59' ' ' ILE . 9.4 mt-10 -74.29 -46.37 41.63 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.609 0.718 . . . . 0.0 109.132 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.765 ' CE1' HG22 ' A' ' 36' ' ' VAL . 42.3 t80 -59.87 -18.01 41.11 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.742 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.883 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . . . -72.33 -49.81 31.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.425 -0.797 . . . . 0.0 109.809 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.645 ' O ' HD12 ' A' ' 76' ' ' LEU . 46.8 t -61.01 -22.0 25.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.91 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.032 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.12 -5.18 56.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.221 -0.924 . . . . 0.0 111.008 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.551 ' HG2' ' O ' ' A' ' 70' ' ' PHE . 2.1 mmt -87.84 -45.97 9.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.913 -1.117 . . . . 0.0 110.077 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.764 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.2 p90 -75.04 -33.8 61.79 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 72' ' ' VAL . 29.4 mt -59.02 -30.19 67.83 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.806 ' O ' HD12 ' A' ' 81' ' ' LEU . 98.0 t -91.55 -45.06 14.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.784 -0.572 . . . . 0.0 110.059 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.451 ' HA ' HD12 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -72.92 -25.91 61.22 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.397 -0.814 . . . . 0.0 111.045 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' GLU . 74.5 m -84.79 -18.37 35.23 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.05 -1.031 . . . . 0.0 109.726 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.842 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -79.35 -12.65 59.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.889 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.039 HD21 ' O ' ' A' ' 43' ' ' SER . 1.2 mt -90.54 -47.13 7.88 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.742 0.782 . . . . 0.0 110.116 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.507 ' HG3' ' N ' ' A' ' 83' ' ' LYS . 26.4 pt-20 -68.3 -43.73 77.0 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.656 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.523 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 0.0 OUTLIER 177.71 -34.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.633 -1.227 . . . . 0.0 112.64 179.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 79' ' ' CYS . 14.0 mt-10 -84.19 108.56 14.67 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.866 -1.146 . . . . 0.0 111.729 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 46.2 Cg_endo -71.66 -162.01 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.905 1.476 . . . . 0.0 110.68 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.869 HG21 HG23 ' A' ' 53' ' ' VAL . 35.4 t -106.87 153.24 40.95 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.568 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 43.6 Cg_endo -86.35 -166.28 0.31 Allowed 'Trans proline' 0 C--N 1.302 -1.911 0 O-C-N 123.586 1.308 . . . . 0.0 109.897 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 73.3 mtp -123.63 11.32 9.15 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.292 -0.88 . . . . 0.0 111.03 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -168.43 23.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.552 -1.259 . . . . 0.0 111.926 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.81 ' N ' HD22 ' A' ' 56' ' ' LEU . 0.6 OUTLIER 53.81 119.35 0.0 OUTLIER Pre-proline 0 C--N 1.283 -2.32 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.788 178.343 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.735 ' HG2' HD23 ' A' ' 94' ' ' LEU . 43.8 Cg_endo -73.56 169.84 21.38 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.725 1.382 . . . . 0.0 109.883 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.37 -16.85 27.63 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.853 1.449 . . . . 0.0 111.919 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.633 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -92.09 12.23 22.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.787 -1.195 . . . . 0.0 110.853 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.764 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 3.4 mm? -113.75 -17.8 12.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.087 -1.008 . . . . 0.0 111.56 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 t -80.15 127.23 77.39 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.092 -1.005 . . . . 0.0 110.91 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.528 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 43.1 Cg_endo -71.21 177.27 6.76 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.101 1.579 . . . . 0.0 109.628 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 41.2 Cg_endo -66.89 169.19 15.28 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.549 1.289 . . . . 0.0 110.643 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.1 OUTLIER 72.43 -55.18 0.68 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.674 -179.211 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.3 mmtm -88.93 15.53 8.38 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.534 -0.729 . . . . 0.0 110.389 -179.689 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.485 0.997 0 N-CA-C 110.121 -0.761 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.521 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.4 t90 -86.98 120.59 28.41 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.105 -0.997 . . . . 0.0 109.991 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.02 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -46.55 -27.5 1.14 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.42 -0.8 . . . . 0.0 110.151 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.521 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 37.4 t -93.04 129.71 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.395 -0.815 . . . . 0.0 110.332 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.516 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -93.94 179.13 1.31 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.755 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 39.5 Cg_endo -67.65 -35.49 22.11 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.795 1.418 . . . . 0.0 110.224 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -75.15 -26.37 59.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.842 . . . . 0.0 110.058 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.453 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 4.1 m-20 -86.08 -37.43 18.85 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HG3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -76.18 -13.55 60.18 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.588 -0.695 . . . . 0.0 109.175 178.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -73.81 -40.81 63.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 108.901 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.635 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.57 -26.46 50.87 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.36 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.635 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.5 m-30 -71.83 -27.6 63.02 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.14 -10.71 59.6 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.338 0.589 . . . . 0.0 109.937 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.02 -36.54 11.51 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.527 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 82.3 mt -74.81 -33.98 32.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.792 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -65.39 -39.09 91.79 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.529 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.2 t0 -89.31 2.65 54.06 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.694 -0.629 . . . . 0.0 109.706 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.527 ' HB2' ' HA ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -93.83 0.83 56.44 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.847 0.832 . . . . 0.0 108.978 178.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.079 HD22 HG21 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -116.63 -2.49 11.93 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 80.17 90.53 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.855 0 CA-C-O 121.368 0.604 . . . . 0.0 109.838 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.6 Cg_endo -75.27 148.59 34.48 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 124.558 1.82 . . . . 0.0 110.458 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 44.0 t -117.86 108.51 24.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.663 -0.648 . . . . 0.0 109.422 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 16.7 t30 55.44 21.49 4.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.07 -1.018 . . . . 0.0 109.741 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 97.03 33.58 5.98 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.624 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 66.2 m-85 -149.76 150.51 32.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -1.104 . . . . 0.0 111.41 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.911 HD13 HD12 ' A' ' 24' ' ' LEU . 30.7 mt -118.56 129.94 55.62 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.71 -0.796 . . . . 0.0 108.994 178.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.54 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -78.76 138.47 38.24 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.606 -0.684 . . . . 0.0 110.616 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -44.08 -25.33 0.67 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 32' ' ' SER . 10.3 t70 -62.27 -17.75 59.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.288 -1.125 . . . . 0.0 110.226 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -114.47 -33.98 5.4 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.325 -0.86 . . . . 0.0 109.377 179.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.918 HG11 HD12 ' A' ' 65' ' ' LEU . 98.6 t -79.19 -51.83 16.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 119.516 -0.873 . . . . 0.0 109.765 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 48.6 tttt -42.68 -49.88 13.04 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 110.338 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 1.027 ' HA ' HD12 ' A' ' 41' ' ' LEU . 39.6 Cg_endo -67.39 -31.09 35.49 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 N-CA-C 108.854 -1.248 . . . . 0.0 108.854 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.079 HG21 HD22 ' A' ' 24' ' ' LEU . 2.8 t -76.22 -10.43 13.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.523 0.677 . . . . 0.0 109.507 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.838 ' HB3' HD22 ' A' ' 50' ' ' LEU . 97.2 mt -99.21 -15.09 19.03 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.027 HD12 ' HA ' ' A' ' 38' ' ' PRO . 6.9 mt -84.63 -33.32 23.33 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.479 -0.763 . . . . 0.0 109.595 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.602 ' ND2' ' HA ' ' A' ' 39' ' ' VAL . 7.8 p30 -71.12 -2.97 17.47 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.865 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 9.4 m -80.37 5.5 14.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.31 -0.869 . . . . 0.0 110.033 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 43' ' ' SER . 27.8 tttt 65.54 12.61 8.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.09 HD13 HG21 ' A' ' 49' ' ' ILE . 15.5 mt -99.82 156.24 35.56 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 110.036 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.547 ' HG2' HG12 ' A' ' 49' ' ' ILE . 40.4 Cg_endo -73.09 162.44 40.8 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.952 1.501 . . . . 0.0 110.153 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.1 t -63.88 -7.93 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.432 -0.792 . . . . 0.0 110.725 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.23 -40.59 51.67 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.09 HG21 HD13 ' A' ' 45' ' ' LEU . 10.9 mm -65.59 -43.53 94.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.838 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.7 mt -66.03 -21.32 66.38 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.33 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.6 -28.11 22.73 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.56 ' O ' HD12 ' A' ' 56' ' ' LEU . 3.8 ttm180 -95.3 -47.42 6.32 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.519 -0.989 . . . . 0.0 109.606 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.939 HG11 HG23 ' A' ' 77' ' ' VAL . 45.7 t -57.45 -39.11 66.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.277 -0.89 . . . . 0.0 109.201 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.553 ' CE3' HD11 ' A' ' 65' ' ' LEU . 6.7 t-105 -68.69 -53.22 23.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.502 -0.749 . . . . 0.0 110.172 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.479 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 5.7 mm-40 -47.58 -50.02 25.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.381 -0.824 . . . . 0.0 109.906 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.688 HD11 ' O ' ' A' ' 87' ' ' PRO . 3.3 mt -76.38 -8.49 57.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.669 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 1.044 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.3 t -99.76 -27.62 13.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.475 -0.766 . . . . 0.0 110.422 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.487 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 11.8 t0 -83.82 90.01 7.28 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.387 -0.821 . . . . 0.0 109.384 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.896 HG21 ' HD3' ' A' ' 99' ' ' LYS . 46.1 mm -53.45 -32.71 20.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.496 -0.752 . . . . 0.0 110.549 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 24.8 p-10 -106.42 -13.75 15.27 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.185 -0.947 . . . . 0.0 111.021 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.536 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 78.0 m-70 56.45 43.69 25.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.076 -1.015 . . . . 0.0 110.358 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.461 ' OD1' ' OD2' ' A' ' 60' ' ' ASP . 1.1 p-10 -104.3 18.45 22.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.931 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.61 10.42 83.34 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.54 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 4.2 mtt -139.43 161.82 36.55 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.538 -0.977 . . . . 0.0 110.911 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.918 HD12 HG11 ' A' ' 36' ' ' VAL . 71.1 mt -130.76 119.48 22.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.346 -0.846 . . . . 0.0 110.387 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.624 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -79.59 166.59 21.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.896 -1.127 . . . . 0.0 109.484 179.026 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.447 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -43.26 -30.45 0.5 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.457 -0.777 . . . . 0.0 111.275 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.456 ' HB2' ' OD1' ' A' ' 66' ' ' ASP . 58.7 m-20 -90.06 -31.15 17.28 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.14 -0.975 . . . . 0.0 109.766 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.466 ' OE1' ' N ' ' A' ' 59' ' ' ILE . 10.0 mt-10 -76.93 -38.56 53.17 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.412 -0.805 . . . . 0.0 109.378 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.735 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 56.9 t80 -70.71 -24.56 62.67 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.705 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.27 -41.22 77.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 109.552 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.456 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.3 t -62.94 -29.66 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.639 -0.663 . . . . 0.0 110.043 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.044 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.33 -4.46 57.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.154 -0.966 . . . . 0.0 110.9 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.535 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 9.7 mmt -83.37 -46.49 12.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.003 -1.061 . . . . 0.0 109.76 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.687 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 4.3 p90 -77.2 -24.24 51.37 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.667 ' CB ' HG13 ' A' ' 53' ' ' VAL . 15.3 mt -72.89 -25.76 61.19 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.939 HG23 HG11 ' A' ' 53' ' ' VAL . 42.4 t -91.06 -34.46 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.639 -0.663 . . . . 0.0 109.663 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -80.12 -26.39 39.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -0.779 . . . . 0.0 110.034 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.525 ' HB3' ' CB ' ' A' ' 84' ' ' GLU . 65.1 m -82.11 -12.78 58.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.203 -0.935 . . . . 0.0 109.127 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.023 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.91 -13.73 46.91 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.333 -0.854 . . . . 0.0 108.923 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.681 HD23 ' N ' ' A' ' 81' ' ' LEU . 3.2 mt -89.58 -42.48 11.39 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.904 0.859 . . . . 0.0 109.014 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -68.86 -54.83 13.42 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.423 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 23.1 tttt 177.87 -24.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.617 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.525 ' CB ' ' HB3' ' A' ' 79' ' ' CYS . 0.2 OUTLIER -72.65 112.95 17.08 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.959 -1.088 . . . . 0.0 111.406 -178.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 48.4 Cg_endo -75.67 -174.57 2.07 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.987 1.519 . . . . 0.0 109.789 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.562 HG21 ' CG2' ' A' ' 53' ' ' VAL . 44.2 t -132.49 128.14 20.93 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.941 -1.1 . . . . 0.0 110.702 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.688 ' O ' HD11 ' A' ' 56' ' ' LEU . 52.1 Cg_endo -84.67 -170.69 0.84 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.958 1.504 . . . . 0.0 109.831 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.517 ' C ' HD21 ' A' ' 56' ' ' LEU . 4.8 mtt -115.2 13.89 16.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.069 -1.019 . . . . 0.0 110.634 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.485 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 5.3 m -113.13 103.05 10.97 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 118.729 -1.188 . . . . 0.0 111.688 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.627 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -57.07 108.26 1.18 Allowed Pre-proline 0 C--N 1.291 -1.94 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.824 179.21 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.051 ' HG2' HD23 ' A' ' 94' ' ' LEU . 49.6 Cg_endo -80.05 157.72 23.64 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 123.928 1.489 . . . . 0.0 110.328 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.26 -11.04 24.74 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.079 1.568 . . . . 0.0 110.828 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.597 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -84.15 -0.76 53.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.051 HD23 ' HG2' ' A' ' 91' ' ' PRO . 3.9 mm? -117.46 -9.69 10.81 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.313 -0.867 . . . . 0.0 110.164 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 95' ' ' VAL . 6.3 p -103.29 124.49 38.08 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.953 . . . . 0.0 110.748 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.484 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 43.6 Cg_endo -71.49 151.56 59.21 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.78 1.411 . . . . 0.0 109.801 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.565 ' HA ' ' HG3' ' A' ' 100' ' ' ARG . 45.7 Cg_endo -72.04 -20.34 25.43 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.945 1.497 . . . . 0.0 111.244 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.1 -11.41 60.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.963 -1.086 . . . . 0.0 110.135 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.896 ' HD3' HG21 ' A' ' 59' ' ' ILE . 9.6 mttm -102.58 8.58 39.77 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.372 -0.83 . . . . 0.0 109.62 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.565 ' HG3' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.094 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.483 0.868 0 N-CA-C 110.632 -0.565 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.462 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 12.8 t90 -83.75 129.49 34.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.389 -0.82 . . . . 0.0 109.875 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.729 ' HB3' HD23 ' A' ' 94' ' ' LEU . . . -40.96 -32.42 0.23 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.298 -0.876 . . . . 0.0 109.931 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.462 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 64.9 t -89.71 153.23 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.481 -0.762 . . . . 0.0 109.565 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 11.5 mmtt -99.04 167.03 11.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.2 Cg_endo -66.5 -33.67 36.21 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.747 1.393 . . . . 0.0 109.755 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -76.53 -23.81 53.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.506 -0.746 . . . . 0.0 109.367 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.576 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 21.8 m-20 -82.79 -38.75 22.71 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 7.2 tptm -65.29 -20.33 66.36 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.39 -43.19 41.65 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.602 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.7 ptpt -79.15 -24.05 43.56 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 6.9 m-30 -74.96 -34.33 62.03 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.476 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 10.1 t70 -79.96 -8.4 59.31 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.381 0.61 . . . . 0.0 109.939 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.72 -37.23 10.88 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.681 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 28.0 mt -75.43 -26.66 18.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 1.014 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.2 -36.84 61.37 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.534 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.2 t70 -90.27 1.75 56.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.696 -0.627 . . . . 0.0 109.815 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.511 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.7 m -93.86 -1.38 54.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.35 -0.844 . . . . 0.0 108.821 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.018 HD12 HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -114.0 -1.77 13.7 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 81.71 91.1 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.107 0 CA-C-O 121.111 0.481 . . . . 0.0 109.707 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.4 Cg_endo -75.11 148.51 34.98 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.305 1.687 . . . . 0.0 110.746 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 99.2 t -120.03 109.44 25.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.625 -0.672 . . . . 0.0 109.561 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 9.3 t30 55.53 23.33 5.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.063 -1.023 . . . . 0.0 109.556 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 92.87 35.41 6.42 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.604 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 91.1 m-85 -151.42 152.55 33.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -1.153 . . . . 0.0 111.118 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.018 HD13 HD12 ' A' ' 24' ' ' LEU . 29.7 mt -122.23 127.87 50.47 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.485 ' OG ' ' HE2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -78.86 138.2 38.03 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.613 -179.069 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -38.53 -34.05 0.23 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 32' ' ' SER . 7.9 t0 -49.75 -21.6 1.14 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -1.212 . . . . 0.0 110.022 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 13.0 mttm -113.08 -39.71 4.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.42 -0.8 . . . . 0.0 109.443 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.019 HG11 HD12 ' A' ' 65' ' ' LEU . 96.1 t -79.35 -37.17 18.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.647 -0.658 . . . . 0.0 110.015 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.619 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.1 ttpt -49.34 -50.38 65.11 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.34 -0.85 . . . . 0.0 110.584 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.933 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.6 Cg_endo -66.93 -29.23 41.41 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 N-CA-C 108.812 -1.265 . . . . 0.0 108.812 178.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.571 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 3.2 t -73.97 -13.29 15.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.216 0.531 . . . . 0.0 110.303 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.651 ' HB3' HD22 ' A' ' 50' ' ' LEU . 77.9 mt -98.75 -14.0 19.95 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.967 -1.083 . . . . 0.0 108.568 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.933 HD12 ' HA ' ' A' ' 38' ' ' PRO . 20.3 mt -87.89 -41.72 13.01 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.707 -0.621 . . . . 0.0 110.073 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -52.78 -20.46 3.23 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.365 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -64.08 -9.45 16.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.467 -0.771 . . . . 0.0 110.431 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 71.24 7.91 6.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.142 -0.973 . . . . 0.0 109.72 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.937 HD13 HG21 ' A' ' 49' ' ' ILE . 15.7 mt -88.26 159.88 46.76 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 110.014 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.536 ' HG2' HG12 ' A' ' 49' ' ' ILE . 41.0 Cg_endo -72.41 151.9 54.22 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 123.941 1.495 . . . . 0.0 110.301 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.5 t -54.28 -14.07 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.268 -0.895 . . . . 0.0 110.991 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -39.85 75.08 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.801 -1.187 . . . . 0.0 108.354 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.937 HG21 HD13 ' A' ' 45' ' ' LEU . 4.9 mm -66.89 -47.18 83.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 40' ' ' LEU . 4.5 mt -63.31 -21.14 66.07 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.05 -28.33 25.98 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.611 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.1 ttm180 -94.4 -55.71 3.07 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.473 -1.016 . . . . 0.0 109.272 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.978 HG11 HG23 ' A' ' 77' ' ' VAL . 55.3 t -47.64 -44.15 9.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.24 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.532 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 6.0 t-105 -64.62 -57.32 9.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.49 -0.756 . . . . 0.0 109.995 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.561 ' CG ' ' N ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER -47.54 -50.85 22.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.684 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.719 HD23 ' CB ' ' A' ' 90' ' ' LEU . 2.6 mt -70.69 -9.7 57.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.311 -0.868 . . . . 0.0 109.398 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.948 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -100.3 -36.24 9.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.607 -0.683 . . . . 0.0 110.258 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD2' ' CZ2' ' A' ' 54' ' ' TRP . 9.4 t0 -78.76 85.36 4.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.451 -0.78 . . . . 0.0 109.295 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.512 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 31.4 mm -52.47 -30.99 14.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.728 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 0.7 OUTLIER -99.52 -18.09 17.57 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.053 -1.029 . . . . 0.0 111.006 -179.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.475 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 7.5 m-70 56.85 31.78 20.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.975 -1.078 . . . . 0.0 108.895 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -90.99 -9.3 46.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.634 -0.666 . . . . 0.0 110.538 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 113.24 9.98 16.54 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.579 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 9.2 mtp -149.19 158.18 43.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -1.169 . . . . 0.0 110.732 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.019 HD12 HG11 ' A' ' 36' ' ' VAL . 41.5 mt -116.35 117.18 29.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.603 -0.685 . . . . 0.0 110.159 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.604 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 3.2 t70 -77.35 172.8 12.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.082 -1.011 . . . . 0.0 110.023 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.559 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.4 ptm180 -48.11 -43.18 30.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.519 -0.738 . . . . 0.0 111.36 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -80.4 -33.57 36.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.142 -0.974 . . . . 0.0 110.58 -179.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.516 ' CD ' ' HB3' ' A' ' 66' ' ' ASP . 66.7 mt-10 -73.74 -50.13 22.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 108.593 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.681 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 55.2 t80 -52.03 -33.24 37.78 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -56.47 -53.81 53.15 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.565 0.698 . . . . 0.0 109.96 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.613 HG11 ' O ' ' A' ' 56' ' ' LEU . 78.3 t -55.45 -25.14 17.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.548 -0.72 . . . . 0.0 110.334 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.948 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.28 -5.44 57.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.157 -0.964 . . . . 0.0 111.396 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.582 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 8.0 mmm -90.84 -35.32 14.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.515 -1.366 . . . . 0.0 110.284 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.64 ' CZ ' ' CD2' ' A' ' 94' ' ' LEU . 2.1 p90 -83.1 -24.47 32.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.135 -0.978 . . . . 0.0 108.596 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.77 ' HB3' HG13 ' A' ' 53' ' ' VAL . 3.8 mt -77.4 -23.72 50.62 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.644 -0.66 . . . . 0.0 109.316 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.978 HG23 HG11 ' A' ' 53' ' ' VAL . 48.7 t -89.93 -32.29 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.507 -0.746 . . . . 0.0 109.136 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.737 ' HA ' HD12 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -82.87 -25.46 32.53 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 109.786 179.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 83' ' ' LYS . 64.4 m -86.15 -12.24 50.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.386 -0.821 . . . . 0.0 109.717 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.925 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -80.81 -19.13 45.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.916 -1.115 . . . . 0.0 108.456 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.737 HD12 ' HA ' ' A' ' 78' ' ' TYR . 3.3 mt -91.69 -40.71 11.12 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.149 0.5 . . . . 0.0 110.391 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 3.8 tt0 -123.38 -11.49 7.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 112.9 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -96.07 -73.33 0.6 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.31 -1.494 . . . . 0.0 111.477 -179.098 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.565 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . 2.0 mt-10 -171.3 -175.97 0.34 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.917 -1.115 . . . . 0.0 110.123 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 39.7 Cg_endo -67.72 163.94 33.28 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.544 1.286 . . . . 0.0 110.233 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.509 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 41.4 t -112.81 121.28 38.91 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 110.942 -179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.504 ' O ' HD11 ' A' ' 56' ' ' LEU . 52.4 Cg_endo -81.42 158.41 19.62 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.813 1.428 . . . . 0.0 109.404 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.706 ' C ' HD21 ' A' ' 56' ' ' LEU . 2.5 mtt -86.33 16.37 4.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.963 -1.086 . . . . 0.0 110.036 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.634 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 61.6 m -106.58 110.92 23.26 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.221 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.726 HD12 ' C ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -91.25 98.57 1.77 Allowed Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.18 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.847 ' HG2' HD12 ' A' ' 94' ' ' LEU . 38.3 Cg_endo -63.9 167.61 13.63 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.673 1.354 . . . . 0.0 111.379 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.35 -9.23 24.94 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.208 1.636 . . . . 0.0 111.072 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.24 -7.76 55.59 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.318 -0.864 . . . . 0.0 109.095 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.847 HD12 ' HG2' ' A' ' 91' ' ' PRO . 2.6 mt -111.4 3.5 18.24 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.422 -0.799 . . . . 0.0 110.32 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.452 HG12 ' CZ ' ' A' ' 100' ' ' ARG . 34.2 t -89.06 110.7 40.05 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.966 . . . . 0.0 110.615 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.471 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 43.8 Cg_endo -71.88 175.63 9.45 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.08 1.569 . . . . 0.0 109.519 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 44.1 Cg_endo -70.98 56.51 1.92 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.707 1.372 . . . . 0.0 110.536 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.9 m -134.49 -39.76 0.81 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.441 ' HE3' HG22 ' A' ' 95' ' ' VAL . 1.3 ttmm -89.21 6.06 41.89 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.454 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.327 -0.858 . . . . 0.0 110.429 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.483 0.858 0 N-CA-C 110.344 -0.675 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.569 ' CZ2' ' HB ' ' A' ' 9' ' ' VAL . 19.1 t90 -66.99 140.5 57.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.821 . . . . 0.0 110.159 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.696 ' HB2' HD22 ' A' ' 94' ' ' LEU . . . -47.81 -27.69 2.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.486 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.569 ' HB ' ' CZ2' ' A' ' 7' ' ' TRP . 89.4 t -112.73 154.2 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.867 . . . . 0.0 110.453 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.558 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -113.65 -176.56 0.38 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.396 -0.815 . . . . 0.0 110.244 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.9 Cg_endo -69.75 -41.21 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.698 1.367 . . . . 0.0 110.305 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.455 ' HG2' ' OD1' ' A' ' 13' ' ' ASP . 15.3 pt-20 -65.15 -28.5 69.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 109.75 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.57 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 4.3 m-20 -84.25 -40.61 17.82 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 18' ' ' ASP . 1.5 tppp? -69.78 -14.14 62.63 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.79 -39.33 44.26 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 8.8 mtmt -81.61 -40.08 23.53 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CD1' ' HB3' ' A' ' 74' ' ' MET . 5.0 m-30 -64.04 -22.12 66.8 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 4.4 t70 -89.28 -16.84 30.23 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.799 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.05 -29.75 18.18 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.517 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 20.8 mt -80.08 -34.98 15.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -69.56 -38.02 77.26 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.003 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.566 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.1 t70 -88.11 -0.7 57.38 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.701 -0.624 . . . . 0.0 110.227 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.7 t -90.72 -3.84 57.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 109.206 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.02 HD22 HG21 ' A' ' 39' ' ' VAL . 2.2 mt -108.95 -8.09 15.3 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m 86.05 89.08 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.5 Cg_endo -73.55 145.03 36.86 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.455 1.766 . . . . 0.0 110.507 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.632 HG12 HD22 ' A' ' 28' ' ' ASN . 54.4 t -109.7 110.15 31.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.632 HD22 HG12 ' A' ' 27' ' ' VAL . 66.1 m-80 52.14 23.44 2.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.086 -1.009 . . . . 0.0 108.474 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 91.1 33.97 7.87 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.571 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 65.0 m-85 -144.52 148.61 34.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -1.124 . . . . 0.0 112.01 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.804 HD13 HD12 ' A' ' 24' ' ' LEU . 35.1 mt -122.63 134.26 54.51 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.572 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.3 OUTLIER -77.89 143.19 37.94 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.181 -0.949 . . . . 0.0 111.107 -178.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -50.4 -26.9 10.42 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.241 -1.943 . . . . 0.0 108.241 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -77.52 -9.67 59.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.35 -1.088 . . . . 0.0 109.466 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.582 ' HD2' ' CB ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -100.74 -46.56 5.12 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.593 HG22 ' HE2' ' A' ' 70' ' ' PHE . 72.4 t -77.67 -37.34 24.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.924 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.589 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -38.47 -51.88 3.46 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.423 -0.798 . . . . 0.0 111.176 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 1.095 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.6 Cg_endo -65.98 -30.61 47.9 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.311 1.163 . . . . 0.0 109.35 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.02 HG21 HD22 ' A' ' 24' ' ' LEU . 5.4 t -77.51 -10.19 12.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.427 0.632 . . . . 0.0 109.733 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.968 ' HB3' HD22 ' A' ' 50' ' ' LEU . 58.6 mt -100.31 -14.46 18.4 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.095 HD12 ' HA ' ' A' ' 38' ' ' PRO . 10.7 mt -87.0 -42.48 13.08 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.636 -0.665 . . . . 0.0 109.483 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -50.05 -22.87 1.78 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 118.75 -1.18 . . . . 0.0 108.556 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -60.94 -10.96 6.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 110.107 178.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.6 OUTLIER 74.02 18.96 3.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.326 -0.859 . . . . 0.0 109.982 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.022 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.3 mt -98.9 156.25 35.73 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.569 -0.707 . . . . 0.0 109.823 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.536 ' HG2' HG12 ' A' ' 49' ' ' ILE . 41.9 Cg_endo -74.65 156.11 44.59 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.973 1.512 . . . . 0.0 110.279 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.0 t -58.66 -12.38 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.483 -0.76 . . . . 0.0 110.714 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.28 -37.63 71.86 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.026 -1.046 . . . . 0.0 108.233 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.913 HG21 HD13 ' A' ' 45' ' ' LEU . 26.0 mm -68.23 -45.95 81.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.968 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.8 mt -61.61 -20.39 63.29 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.516 ' O ' ' CG ' ' A' ' 55' ' ' GLU . . . -84.49 -29.98 28.55 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.048 -2.021 . . . . 0.0 108.048 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.6 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 1.1 ttm180 -94.76 -58.32 2.21 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.58 -0.953 . . . . 0.0 109.629 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.644 ' CG2' HG21 ' A' ' 86' ' ' VAL . 6.3 t -46.83 -49.95 6.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.209 -0.997 . . . . 0.0 108.756 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.553 ' HA ' ' HB2' ' A' ' 57' ' ' SER . 16.9 t-105 -56.81 -59.44 5.02 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.931 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 51' ' ' GLY . 10.4 mm-40 -44.05 -58.39 2.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.158 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.77 HD11 ' HA ' ' A' ' 88' ' ' MET . 3.3 mt -70.25 -11.63 61.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.854 . . . . 0.0 109.803 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 1.008 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 19.3 m -96.2 -27.54 14.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 0.0 110.379 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 54' ' ' TRP . 19.0 t0 -87.14 81.59 7.96 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.241 -0.912 . . . . 0.0 109.455 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.532 HG12 ' HG3' ' A' ' 69' ' ' GLU . 32.1 mm -44.29 -32.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.616 -0.677 . . . . 0.0 110.449 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 9.5 p-10 -105.39 -14.98 15.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.126 -0.984 . . . . 0.0 111.034 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.536 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 29.7 m-70 56.27 41.71 28.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.046 -1.034 . . . . 0.0 110.113 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.473 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 2.2 p-10 -100.89 15.66 27.8 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 110.135 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.72 15.56 77.5 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.572 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 9.1 mtt -146.81 160.74 41.9 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.558 -0.966 . . . . 0.0 110.467 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 58' ' ' ASP . 43.5 mt -128.54 118.16 22.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.329 -0.857 . . . . 0.0 109.436 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.571 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 20.2 t0 -69.77 166.6 18.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.863 -1.148 . . . . 0.0 109.996 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.584 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 10.7 ttm180 -44.0 -46.33 8.28 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 110.142 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.5 m-20 -78.7 -26.72 44.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.383 -0.823 . . . . 0.0 109.66 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.532 ' HG3' HG12 ' A' ' 59' ' ' ILE . 4.7 tt0 -75.71 -39.57 57.16 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.59 0.709 . . . . 0.0 109.53 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.593 ' HE2' HG22 ' A' ' 36' ' ' VAL . 18.2 t80 -66.67 -17.75 65.01 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.691 0.758 . . . . 0.0 109.072 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.469 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -74.99 -43.61 52.97 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.469 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.935 HG13 HD12 ' A' ' 94' ' ' LEU . 59.2 t -60.57 -26.1 36.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.535 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.008 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -90.56 -4.35 56.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.52 -0.737 . . . . 0.0 111.074 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.579 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 11.1 mmt -86.27 -47.05 9.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.925 -1.109 . . . . 0.0 109.971 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.046 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 1.9 p90 -76.91 -24.57 52.47 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.533 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 8.4 mt -71.21 -24.53 62.23 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 73' ' ' ALA . 66.0 t -91.66 -61.92 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.557 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.2 m-85 -48.32 -21.66 0.56 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.721 -0.612 . . . . 0.0 111.597 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.521 ' HB3' ' CB ' ' A' ' 84' ' ' GLU . 2.1 m -86.21 -14.76 42.96 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.006 -1.059 . . . . 0.0 109.883 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.022 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -89.33 -10.19 47.65 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.282 -0.886 . . . . 0.0 109.302 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.702 ' N ' HD12 ' A' ' 81' ' ' LEU . 7.0 mp -87.04 -43.91 11.97 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.477 -0.765 . . . . 0.0 109.026 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 74.4 mt-10 -72.17 -54.01 10.96 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.777 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 179.11 -26.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.479 -0.763 . . . . 0.0 111.422 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.521 ' CB ' ' HB3' ' A' ' 79' ' ' CYS . 1.8 mp0 -67.35 113.22 12.77 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.099 -1.001 . . . . 0.0 111.32 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 50.4 Cg_endo -75.46 -175.17 2.29 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.953 1.502 . . . . 0.0 110.312 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.644 HG21 ' CG2' ' A' ' 53' ' ' VAL . 77.9 t -131.84 122.53 18.6 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.186 -0.946 . . . . 0.0 110.514 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.607 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.7 Cg_endo -81.27 -165.85 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.842 1.443 . . . . 0.0 110.097 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.77 ' HA ' HD11 ' A' ' 56' ' ' LEU . 67.0 mtm -120.48 17.11 12.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.267 -0.896 . . . . 0.0 110.609 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.523 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 42.0 m -117.04 95.47 5.01 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.039 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.611 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -57.12 106.71 0.72 Allowed Pre-proline 0 C--N 1.291 -1.962 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.491 178.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.048 ' HG2' HD23 ' A' ' 94' ' ' LEU . 50.9 Cg_endo -75.16 169.3 22.84 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.668 1.352 . . . . 0.0 109.826 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.64 -12.71 26.97 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.857 1.451 . . . . 0.0 111.012 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -86.67 8.44 22.41 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.086 -1.009 . . . . 0.0 109.477 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.048 HD23 ' HG2' ' A' ' 91' ' ' PRO . 1.4 mm? -113.75 6.18 16.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 110.597 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 95' ' ' VAL . 9.9 p -120.48 124.27 27.73 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.068 -1.02 . . . . 0.0 110.713 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.08 159.81 51.16 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.077 1.567 . . . . 0.0 110.115 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.78 1.09 7.39 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.007 1.53 . . . . 0.0 110.644 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 p -76.79 -28.86 55.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.123 -0.986 . . . . 0.0 110.15 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -89.23 8.05 32.3 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.362 -0.836 . . . . 0.0 109.31 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.464 -0.772 . . . . 0.0 110.167 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.481 0.778 0 N-CA-C 110.435 -0.641 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.585 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 19.0 t90 -98.05 132.84 43.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.395 -0.816 . . . . 0.0 110.055 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -40.97 -34.4 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.401 -0.812 . . . . 0.0 110.839 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.585 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 61.2 t -108.39 141.36 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 110.384 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.573 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -99.42 -177.13 0.55 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.385 -0.822 . . . . 0.0 109.909 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.573 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.6 Cg_endo -69.43 -35.99 12.55 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.662 1.349 . . . . 0.0 109.834 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 10' ' ' LYS . 20.3 pt-20 -68.46 -25.75 65.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 109.825 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.433 ' HB2' HG13 ' A' ' 9' ' ' VAL . 39.7 m-20 -86.13 -38.86 17.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.308 -0.87 . . . . 0.0 108.912 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.424 ' NZ ' ' OD1' ' A' ' 68' ' ' ASP . 3.8 ttmt -75.48 -17.25 60.18 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -74.88 -31.12 61.52 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.657 ' HG3' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -86.45 -21.28 27.16 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.657 ' CD1' ' HG3' ' A' ' 16' ' ' LYS . 17.7 m-30 -78.9 -33.39 45.63 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -13.84 62.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.859 -0.526 . . . . 0.0 110.009 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -89.31 -34.06 16.7 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.558 HG22 ' CE2' ' A' ' 70' ' ' PHE . 22.2 mt -80.72 -35.91 15.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.604 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -68.37 -35.39 77.65 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.55 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.3 t0 -89.1 -1.7 58.21 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.446 -0.784 . . . . 0.0 109.987 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -91.04 -1.51 57.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 0.0 108.648 178.442 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.864 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -109.38 -3.82 16.82 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 81.26 87.52 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 121.454 0.645 . . . . 0.0 109.265 -178.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -72.32 147.65 47.68 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 O-C-N 124.65 1.869 . . . . 0.0 110.896 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 61.3 t -116.26 106.59 20.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.576 -0.703 . . . . 0.0 109.186 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 9.1 t30 57.1 26.55 12.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.265 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 88.24 36.14 8.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.582 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 87.4 m-85 -150.31 160.14 43.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.433 -1.039 . . . . 0.0 111.142 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.864 HD22 ' HB2' ' A' ' 24' ' ' LEU . 12.3 mt -136.25 134.04 37.64 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.568 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -83.08 139.89 32.97 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.854 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -38.77 -28.52 0.07 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.6 OUTLIER -53.04 -35.58 59.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.347 -1.09 . . . . 0.0 111.064 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 1.3 mttm -97.41 -42.13 7.89 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.083 -1.01 . . . . 0.0 109.561 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.956 HG11 HD12 ' A' ' 65' ' ' LEU . 41.9 t -71.61 -47.45 57.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.62 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.572 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 40.9 tttp -45.99 -52.12 28.04 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 110.819 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.935 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.6 Cg_endo -66.48 -34.15 34.77 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.262 1.138 . . . . 0.0 109.164 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.846 HG21 HD22 ' A' ' 24' ' ' LEU . 2.2 t -62.77 -28.02 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.274 0.559 . . . . 0.0 109.606 178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.9 ' HB3' HD22 ' A' ' 50' ' ' LEU . 30.3 mt -83.62 -14.76 51.25 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.168 -0.958 . . . . 0.0 109.479 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.935 HD12 ' HA ' ' A' ' 38' ' ' PRO . 21.5 mt -78.8 -29.01 44.65 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.558 ' ND2' ' HA ' ' A' ' 39' ' ' VAL . 37.0 m-80 -58.13 -28.29 64.54 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.036 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.601 ' HB2' HD11 ' A' ' 81' ' ' LEU . 3.6 p -62.2 -13.01 23.25 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.638 -0.664 . . . . 0.0 109.648 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 75.6 13.63 2.93 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.445 0.64 . . . . 0.0 109.864 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.031 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.4 mt -85.92 158.59 55.92 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.498 -0.751 . . . . 0.0 109.834 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.558 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 42.5 Cg_endo -73.22 157.3 50.39 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 O-C-N 124.088 1.573 . . . . 0.0 110.265 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.0 t -58.28 -10.92 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.42 -0.8 . . . . 0.0 111.109 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -73.85 -41.96 61.49 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.83 -1.169 . . . . 0.0 108.213 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.983 HG21 HD13 ' A' ' 45' ' ' LEU . 12.9 mm -61.95 -44.55 99.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.9 HD22 ' HB3' ' A' ' 40' ' ' LEU . 11.1 mt -62.17 -20.79 64.51 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.2 -28.51 36.64 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.582 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 0.3 OUTLIER -97.68 -57.21 2.29 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.529 -0.983 . . . . 0.0 109.665 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.701 HG11 ' CG2' ' A' ' 77' ' ' VAL . 3.8 t -47.42 -34.92 3.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.204 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 7.5 t-105 -75.11 -58.98 2.95 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.979 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.572 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 2.9 pt-20 -47.21 -46.22 23.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.621 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.782 HD11 ' O ' ' A' ' 87' ' ' PRO . 7.6 mt -76.52 -12.31 60.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.46 -0.775 . . . . 0.0 109.456 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 1.075 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 2.6 t -96.55 -35.06 11.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.362 -0.836 . . . . 0.0 110.002 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.581 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 11.4 t0 -77.69 86.09 3.99 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.456 HG22 ' HE2' ' A' ' 99' ' ' LYS . 36.1 mm -50.35 -32.59 9.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.647 -0.658 . . . . 0.0 111.16 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 53.8 p30 -103.65 -15.1 15.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.933 -1.105 . . . . 0.0 111.256 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 1.4 m80 63.88 43.85 5.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.845 -1.159 . . . . 0.0 109.726 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 6.2 p-10 -107.17 15.69 24.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 110.588 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.91 8.35 87.74 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.568 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 3.6 mtt -142.07 160.82 39.46 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.362 -1.081 . . . . 0.0 110.478 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.956 HD12 HG11 ' A' ' 36' ' ' VAL . 47.4 mt -127.04 120.37 28.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 110.79 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.582 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 8.7 t0 -69.57 164.53 23.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.947 -1.095 . . . . 0.0 109.326 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.508 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 8.9 ptm180 -45.81 -34.46 3.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 110.468 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 10.2 m-20 -85.81 -32.57 21.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.102 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 16.1 mt-10 -71.13 -42.75 68.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.94 . . . . 0.0 108.819 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.682 ' CE1' HG13 ' A' ' 36' ' ' VAL . 42.3 t80 -59.22 -32.56 70.07 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -57.32 -48.37 79.14 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.768 0.794 . . . . 0.0 110.161 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.039 HG13 HD12 ' A' ' 94' ' ' LEU . 87.5 t -59.8 -26.61 35.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.645 -0.659 . . . . 0.0 110.739 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.075 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -86.97 -5.62 59.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.159 -0.963 . . . . 0.0 111.723 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.612 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 14.4 mmm -90.45 -41.24 11.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.604 -1.31 . . . . 0.0 110.096 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.978 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.3 p90 -79.38 -17.45 54.39 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.868 -1.133 . . . . 0.0 108.477 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 76' ' ' LEU . 6.8 mt -82.57 -20.88 35.65 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.772 HG21 HD22 ' A' ' 40' ' ' LEU . 77.7 t -90.89 -41.83 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.565 -0.709 . . . . 0.0 109.723 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -71.32 -21.0 62.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.385 -0.822 . . . . 0.0 110.126 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 7.6 t -80.82 -15.14 57.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.268 -0.895 . . . . 0.0 109.087 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.031 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.17 -13.61 35.26 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.52 -0.737 . . . . 0.0 109.38 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.83 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.7 mt -90.5 -33.78 15.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.0 109.222 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 42.8 tp10 -70.06 -53.64 16.6 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.663 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER 176.41 -18.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.126 -1.03 . . . . 0.0 112.723 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 67.5 mm-40 -98.56 122.45 53.36 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 120.543 -1.348 . . . . 0.0 111.465 -178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.17 -167.27 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.981 1.516 . . . . 0.0 110.249 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.54 HG21 ' CG2' ' A' ' 53' ' ' VAL . 61.5 t -130.4 140.38 38.47 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.0 110.435 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.782 ' O ' HD11 ' A' ' 56' ' ' LEU . 51.4 Cg_endo -86.74 -168.66 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.979 1.515 . . . . 0.0 110.159 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.582 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 10.7 mtp -113.65 6.95 17.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.335 -0.853 . . . . 0.0 110.684 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.502 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.1 m -114.24 104.43 12.08 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.442 -1.303 . . . . 0.0 112.135 -177.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.653 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -60.24 107.94 1.23 Allowed Pre-proline 0 C--N 1.288 -2.071 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.379 178.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.032 ' HG2' HD23 ' A' ' 94' ' ' LEU . 41.1 Cg_endo -66.36 167.36 18.79 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.855 1.45 . . . . 0.0 109.946 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.67 -12.46 29.04 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.945 1.497 . . . . 0.0 111.628 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.632 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -87.07 2.53 49.42 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.073 -1.017 . . . . 0.0 110.113 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.039 HD12 HG13 ' A' ' 72' ' ' VAL . 3.0 mm? -107.69 -0.37 21.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.145 -0.972 . . . . 0.0 111.052 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.2 t -103.42 117.34 60.34 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.964 -1.085 . . . . 0.0 110.695 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 42.4 Cg_endo -69.45 173.24 10.99 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.987 1.519 . . . . 0.0 110.142 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.554 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 46.0 Cg_endo -73.13 -19.33 22.88 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.913 1.481 . . . . 0.0 110.93 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -20.85 63.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.976 -1.077 . . . . 0.0 109.886 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.456 ' HE2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -95.46 11.9 31.26 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.864 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.554 ' CG ' ' HA ' ' A' ' 97' ' ' PRO . 5.5 mmt180 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.327 -0.858 . . . . 0.0 110.467 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.481 0.76 0 N-CA-C 110.632 -0.565 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.617 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.7 t90 -94.17 132.02 39.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.494 -0.754 . . . . 0.0 109.81 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -47.21 -30.36 2.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.009 . . . . 0.0 110.16 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.617 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 72.5 t -102.3 149.69 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.397 -0.814 . . . . 0.0 109.857 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.531 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -126.74 171.91 7.34 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.422 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.684 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.8 Cg_endo -62.91 -34.18 72.47 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.741 1.39 . . . . 0.0 110.592 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -72.98 -35.64 66.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 109.62 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -83.19 -41.29 18.62 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' HG3' ' CB ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -70.03 -15.19 62.97 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -67.18 -40.82 86.63 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.638 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 2.9 ptpt -75.79 -25.87 56.79 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.638 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -72.61 -33.75 66.89 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.7 -10.9 60.16 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.41 0.624 . . . . 0.0 109.7 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.58 -35.91 14.74 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.647 HD13 ' SD ' ' A' ' 74' ' ' MET . 19.8 mt -76.73 -34.78 23.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.618 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -70.81 -33.56 70.82 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.554 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.9 t0 -88.97 -3.11 58.82 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.546 -0.721 . . . . 0.0 109.892 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.1 m -85.65 -13.73 47.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.084 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.617 HD12 HD13 ' A' ' 31' ' ' LEU . 4.4 mt -100.11 -11.7 20.27 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.607 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 t 85.6 99.41 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.152 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.3 Cg_endo -74.87 148.79 36.41 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 O-C-N 124.337 1.704 . . . . 0.0 110.807 -178.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 60.2 t -117.95 107.87 23.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 121.746 -0.596 . . . . 0.0 109.617 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 6.0 t30 56.9 17.5 3.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.359 -0.838 . . . . 0.0 109.421 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 96.96 36.0 5.14 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.605 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 94.7 m-85 -151.28 160.08 44.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -1.129 . . . . 0.0 110.877 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.627 HD12 ' CD2' ' A' ' 70' ' ' PHE . 37.8 mt -130.81 129.45 42.4 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.558 ' CA ' ' HE3' ' A' ' 64' ' ' MET . 12.2 p -78.23 139.97 38.91 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.854 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.04 -28.78 0.52 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 32' ' ' SER . 13.1 t70 -61.54 -11.23 10.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -1.142 . . . . 0.0 110.269 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' A' ' 24' ' ' LEU . 17.9 mtpp -116.27 -34.83 4.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -0.975 . . . . 0.0 109.02 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.872 HG22 ' HE2' ' A' ' 70' ' ' PHE . 98.0 t -84.34 -36.31 11.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.401 0.619 . . . . 0.0 109.694 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.65 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.3 tttt -48.37 -47.86 67.44 Favored Pre-proline 0 N--CA 1.487 1.384 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.158 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.995 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.7 Cg_endo -67.77 -30.74 33.5 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.407 1.214 . . . . 0.0 109.018 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.5 t -73.99 -9.43 12.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.798 -0.564 . . . . 0.0 109.584 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.001 ' HB3' HD22 ' A' ' 50' ' ' LEU . 82.4 mt -100.18 -15.92 17.96 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.139 -0.976 . . . . 0.0 108.515 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.995 HD12 ' HA ' ' A' ' 38' ' ' PRO . 7.0 mt -89.95 -37.31 14.45 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.549 -0.72 . . . . 0.0 110.16 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 6.6 p30 -58.68 -16.45 16.37 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.153 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.487 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.8 OUTLIER -73.71 -1.83 20.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.374 -0.829 . . . . 0.0 109.871 179.275 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 68.69 14.98 9.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.235 -0.916 . . . . 0.0 110.207 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.922 HD13 HG21 ' A' ' 49' ' ' ILE . 15.4 mt -91.79 155.94 43.09 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.07 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' HG13 ' A' ' 49' ' ' ILE . 40.8 Cg_endo -73.23 154.24 51.54 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.889 1.468 . . . . 0.0 110.466 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.0 t -58.53 -10.6 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.32 -0.863 . . . . 0.0 110.777 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -39.51 68.58 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.887 -1.133 . . . . 0.0 107.987 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.964 HG23 HG21 ' A' ' 86' ' ' VAL . 30.3 mm -64.96 -43.61 96.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.001 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.7 mt -63.89 -14.47 53.66 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.365 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 55' ' ' GLU . . . -83.37 -36.1 15.48 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.455 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 5.1 mtm-85 -94.23 -52.34 4.41 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.598 -0.942 . . . . 0.0 109.984 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.653 HG21 HG22 ' A' ' 49' ' ' ILE . 24.3 t -44.18 -50.29 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.59 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.547 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 7.2 t-105 -66.32 -57.68 6.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 0.0 110.174 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.533 ' HG2' ' HG ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER -53.84 -38.52 64.73 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.927 -1.108 . . . . 0.0 109.127 -179.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.868 HD22 ' N ' ' A' ' 90' ' ' LEU . 94.4 mt -81.33 -14.88 56.8 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.701 -0.624 . . . . 0.0 109.386 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.948 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 10.7 m -97.78 -35.34 10.57 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.365 -0.834 . . . . 0.0 110.159 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.605 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 16.9 t0 -75.32 69.39 2.13 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.63 HG21 ' CD ' ' A' ' 99' ' ' LYS . 35.8 mm -35.2 -31.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.056 0.455 . . . . 0.0 111.0 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.541 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 14.7 p-10 -104.73 -16.66 14.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.055 -1.028 . . . . 0.0 111.333 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.605 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER 58.2 30.59 19.64 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.836 -1.165 . . . . 0.0 109.48 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.475 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 2.5 p-10 -84.32 -11.72 55.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.414 -0.804 . . . . 0.0 110.053 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 116.82 5.34 15.76 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.596 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 3.5 mtp -150.05 160.8 43.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -1.175 . . . . 0.0 110.164 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.833 ' CD1' HG11 ' A' ' 36' ' ' VAL . 16.8 mt -115.57 115.24 26.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.077 -1.015 . . . . 0.0 109.53 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.605 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 3.7 t70 -69.15 171.11 8.83 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.011 -1.055 . . . . 0.0 109.809 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 4.4 ptm180 -46.18 -42.43 14.05 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.63 -0.669 . . . . 0.0 110.658 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.468 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -78.71 -33.98 46.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.0 110.345 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.503 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 28.0 mt-10 -74.53 -43.18 57.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.973 . . . . 0.0 109.2 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.872 ' HE2' HG22 ' A' ' 36' ' ' VAL . 18.3 t80 -61.0 -21.58 63.71 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.483 -0.761 . . . . 0.0 109.327 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.432 ' CB ' ' HG3' ' A' ' 14' ' ' LYS . . . -73.08 -40.86 64.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.345 -0.847 . . . . 0.0 109.45 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.883 HG13 HD12 ' A' ' 94' ' ' LEU . 60.1 t -63.2 -27.04 42.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.513 0.673 . . . . 0.0 109.348 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.948 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.83 -4.84 56.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.528 -0.733 . . . . 0.0 110.862 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.647 ' SD ' HD13 ' A' ' 20' ' ' ILE . 11.3 mmt -84.59 -50.21 7.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.997 -1.065 . . . . 0.0 109.603 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.132 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 1.9 p90 -72.85 -31.62 64.89 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.577 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 9.9 mt -61.46 -31.22 71.17 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.716 HG21 ' CD2' ' A' ' 40' ' ' LEU . 46.0 t -92.16 -42.09 13.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.825 -0.547 . . . . 0.0 110.574 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.36 -40.42 62.12 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.821 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.566 ' CA ' ' HB3' ' A' ' 83' ' ' LYS . 69.5 m -76.46 -14.78 60.03 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.026 -1.047 . . . . 0.0 109.139 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.826 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -77.66 -11.44 59.87 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.635 HD23 ' N ' ' A' ' 81' ' ' LEU . 4.0 mt -91.12 -50.1 6.03 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.615 0.722 . . . . 0.0 109.949 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -134.13 38.94 3.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.518 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.566 ' HB3' ' CA ' ' A' ' 79' ' ' CYS . 7.7 ttmt -160.05 -91.61 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.303 -1.498 . . . . 0.0 112.342 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.414 ' N ' ' HG2' ' A' ' 83' ' ' LYS . 0.7 OUTLIER -117.63 148.63 43.42 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.104 -0.998 . . . . 0.0 111.146 -178.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -75.98 -162.39 0.16 Allowed 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 124.4 1.737 . . . . 0.0 110.316 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.964 HG21 HG23 ' A' ' 49' ' ' ILE . 13.4 t -115.62 145.04 33.67 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.517 -0.739 . . . . 0.0 109.583 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 86' ' ' VAL . 44.0 Cg_endo -87.52 -162.17 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.877 1.461 . . . . 0.0 109.73 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.6 mtt -129.31 12.4 6.0 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.26 -0.9 . . . . 0.0 110.945 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 90' ' ' LEU . 22.8 t -165.95 23.54 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.931 -1.106 . . . . 0.0 111.279 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.868 ' N ' HD22 ' A' ' 56' ' ' LEU . 2.1 mt 54.89 116.81 0.01 OUTLIER Pre-proline 0 C--N 1.284 -2.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.012 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.014 ' HG2' HD23 ' A' ' 94' ' ' LEU . 44.3 Cg_endo -72.77 175.02 10.88 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.597 1.314 . . . . 0.0 109.16 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 50.1 Cg_endo -74.34 -19.9 19.09 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.632 1.332 . . . . 0.0 111.67 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.604 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -90.29 28.44 1.44 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.97 -1.081 . . . . 0.0 109.479 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.132 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -127.06 -25.69 3.25 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.822 -178.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 95' ' ' VAL . 27.3 m -91.3 136.32 27.19 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.051 -1.03 . . . . 0.0 111.036 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.523 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 42.9 Cg_endo -70.91 161.69 45.22 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.955 1.503 . . . . 0.0 109.261 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.512 ' HA ' ' CD ' ' A' ' 100' ' ' ARG . 46.7 Cg_endo -71.35 -24.29 23.0 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 123.954 1.502 . . . . 0.0 111.537 -178.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.3 t -84.47 -0.01 51.34 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.804 -1.185 . . . . 0.0 110.195 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.63 ' CD ' HG21 ' A' ' 59' ' ' ILE . 8.6 mmtt -106.64 -1.1 23.18 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.389 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.539 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 O-C-N 121.111 -0.993 . . . . 0.0 110.812 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.483 0.906 0 N-CA-C 110.336 -0.679 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.526 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.1 t90 -48.69 130.92 17.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.648 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -40.62 -27.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 110.525 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.526 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 91.1 t -102.9 138.74 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.87 . . . . 0.0 109.938 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -97.15 -179.91 0.98 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.314 -0.866 . . . . 0.0 110.434 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.3 Cg_endo -69.23 -35.51 14.06 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.934 1.492 . . . . 0.0 110.049 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -75.54 -28.41 59.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.375 -0.828 . . . . 0.0 109.835 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.569 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -83.29 -37.17 23.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.209 -0.932 . . . . 0.0 108.59 178.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 13.8 tptp -69.73 -20.16 63.52 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.08 -44.07 63.85 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.606 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 6.5 ptpt -74.51 -24.17 58.94 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.606 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.6 m-30 -74.25 -35.61 63.82 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -76.8 -9.73 58.88 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.302 0.572 . . . . 0.0 110.031 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.74 -34.97 13.01 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.734 HG22 ' CE1' ' A' ' 70' ' ' PHE . 37.6 mt -78.04 -30.18 15.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.823 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -74.44 -39.53 62.51 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.555 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.551 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 32.6 t70 -88.59 4.39 47.09 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.611 -0.681 . . . . 0.0 109.831 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.46 ' C ' HD23 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -90.54 -15.63 30.31 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.769 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.847 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -97.75 -8.0 29.5 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 84.48 98.21 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.4 Cg_endo -74.27 146.63 36.17 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.056 1.556 . . . . 0.0 110.762 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 27.3 t -116.33 98.57 6.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.505 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 64.97 22.44 12.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.359 -0.838 . . . . 0.0 109.393 -179.124 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 91.97 32.35 8.53 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.521 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 93.8 m-85 -150.23 152.76 35.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.407 -1.055 . . . . 0.0 111.145 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.847 HD22 ' HB2' ' A' ' 24' ' ' LEU . 32.5 mt -124.7 131.85 53.43 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 33' ' ' GLY . 93.9 p -78.19 137.39 38.13 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.272 -0.893 . . . . 0.0 110.43 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.57 -30.86 0.95 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -60.47 -16.24 34.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -1.082 . . . . 0.0 110.318 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 21.3 mtpp -108.38 -35.3 6.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 109.121 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.899 HG11 HD12 ' A' ' 65' ' ' LEU . 96.8 t -82.77 -31.12 9.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.618 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -50.17 -52.45 53.55 Favored Pre-proline 0 C--N 1.305 -1.363 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.897 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.942 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.6 Cg_endo -64.92 -31.44 56.52 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.581 1.306 . . . . 0.0 109.246 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.584 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 4.3 t -74.87 -10.66 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.447 0.642 . . . . 0.0 109.772 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.801 ' HB3' HD22 ' A' ' 50' ' ' LEU . 78.5 mt -100.24 -15.51 18.06 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 38' ' ' PRO . 8.4 mt -88.3 -44.58 10.71 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.569 -0.707 . . . . 0.0 109.486 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.584 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -47.83 -25.33 1.25 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.722 -1.191 . . . . 0.0 108.62 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.57 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 12.5 m -61.67 -12.15 14.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.508 -0.745 . . . . 0.0 110.032 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 43' ' ' SER . 3.5 tptp 74.1 18.84 3.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.231 -0.918 . . . . 0.0 109.956 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.835 HD13 HG21 ' A' ' 49' ' ' ILE . 15.4 mt -100.1 158.36 32.16 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 110.087 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.524 ' HG2' HG12 ' A' ' 49' ' ' ILE . 41.5 Cg_endo -73.08 156.54 51.7 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 123.934 1.491 . . . . 0.0 110.647 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 t -58.3 -10.85 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.662 -0.649 . . . . 0.0 110.88 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.58 -41.32 60.72 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.866 -1.146 . . . . 0.0 108.432 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.835 HG21 HD13 ' A' ' 45' ' ' LEU . 11.8 mm -64.24 -44.9 97.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.801 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.8 mt -66.98 -16.99 64.71 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.711 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.29 -32.84 15.56 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.374 -1.891 . . . . 0.0 108.374 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.623 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -92.5 -53.67 4.11 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.517 -0.99 . . . . 0.0 109.526 179.321 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.755 HG11 HG23 ' A' ' 77' ' ' VAL . 32.5 t -47.83 -32.08 2.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.25 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.529 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 8.2 t-105 -74.11 -59.29 2.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.841 . . . . 0.0 110.084 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.561 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 5.0 pt-20 -47.67 -45.62 28.34 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.501 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.926 HD21 ' C ' ' A' ' 88' ' ' MET . 2.7 mt -75.91 -11.74 60.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.579 -0.7 . . . . 0.0 109.57 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 1.025 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 2.8 t -99.28 -36.11 9.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.634 -0.666 . . . . 0.0 110.758 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.469 ' HA ' HD23 ' A' ' 65' ' ' LEU . 26.9 t0 -82.61 86.63 6.79 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.483 -0.76 . . . . 0.0 109.454 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.474 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 32.1 mm -51.55 -36.24 17.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.75 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 3.5 m-20 -90.33 -17.05 28.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.538 -0.726 . . . . 0.0 110.566 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 33.1 p80 40.25 39.77 0.71 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.816 0.817 . . . . 0.0 109.23 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -98.17 -9.65 25.39 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.754 -0.591 . . . . 0.0 110.192 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.479 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 126.57 4.39 6.29 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 6.0 mtp -149.54 160.72 43.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.093 -1.24 . . . . 0.0 110.491 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.899 HD12 HG11 ' A' ' 36' ' ' VAL . 34.1 mt -112.49 112.25 23.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.583 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.536 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 17.3 t0 -69.62 166.93 17.99 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.895 -1.128 . . . . 0.0 110.106 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.541 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -42.16 -44.45 3.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.528 -0.732 . . . . 0.0 111.012 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 8.7 p-10 -78.02 -43.01 30.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.368 -0.832 . . . . 0.0 110.162 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.536 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 33.7 mt-10 -61.64 -48.99 78.34 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.656 -0.653 . . . . 0.0 109.779 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.777 ' HE2' HG22 ' A' ' 36' ' ' VAL . 43.5 t80 -58.94 -26.22 64.21 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.395 -0.815 . . . . 0.0 109.373 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -67.22 -45.99 75.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.647 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.022 HG13 HD12 ' A' ' 94' ' ' LEU . 88.3 t -60.45 -23.04 27.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.542 -0.723 . . . . 0.0 110.018 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.025 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -89.73 -5.33 57.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.291 -0.88 . . . . 0.0 110.932 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.581 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 1.6 mmm -89.33 -44.86 9.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.999 -1.063 . . . . 0.0 110.038 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.091 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.5 p90 -76.24 -25.22 54.8 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.746 ' HB3' HG13 ' A' ' 53' ' ' VAL . 4.8 mt -69.99 -28.33 65.44 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.755 HG23 HG11 ' A' ' 53' ' ' VAL . 53.6 t -89.35 -29.59 5.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.658 ' HA ' HD12 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -79.53 -25.08 41.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.428 -0.795 . . . . 0.0 110.524 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -87.08 -10.65 52.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 110.172 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.767 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.54 -20.16 30.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.354 -0.841 . . . . 0.0 109.658 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.658 HD12 ' HA ' ' A' ' 78' ' ' TYR . 1.3 mt -92.35 -36.47 13.14 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.556 0.693 . . . . 0.0 110.694 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.54 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 10.2 mt-10 -66.47 -50.51 63.05 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.525 -0.87 . . . . 0.0 108.792 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.54 ' CG ' ' O ' ' A' ' 82' ' ' GLU . 3.6 mttt 174.49 -20.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 118.852 -1.139 . . . . 0.0 112.638 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 57.3 mm-40 -85.1 124.24 72.46 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 120.705 -1.247 . . . . 0.0 111.426 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.98 -179.38 3.41 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.845 1.445 . . . . 0.0 109.862 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.58 HG11 HG23 ' A' ' 53' ' ' VAL . 24.3 t -128.62 127.97 23.55 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.036 -1.04 . . . . 0.0 110.757 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.644 ' O ' HD11 ' A' ' 56' ' ' LEU . 47.0 Cg_endo -89.24 -164.94 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.935 1.492 . . . . 0.0 109.344 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.926 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -123.61 6.12 8.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.368 -0.833 . . . . 0.0 110.253 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.599 ' N ' HD21 ' A' ' 56' ' ' LEU . 55.1 m -105.65 98.44 8.13 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 119.114 -1.034 . . . . 0.0 111.294 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.731 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -54.96 107.14 0.78 Allowed Pre-proline 0 C--N 1.293 -1.866 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.753 179.256 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.057 ' HG2' HD23 ' A' ' 94' ' ' LEU . 42.5 Cg_endo -68.75 162.69 40.17 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.995 1.523 . . . . 0.0 109.984 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.435 ' O ' HG22 ' A' ' 95' ' ' VAL . 43.2 Cg_endo -69.97 -13.35 34.04 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.825 1.434 . . . . 0.0 111.149 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -89.04 19.92 3.92 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.011 -1.055 . . . . 0.0 109.308 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.091 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 1.9 mm? -121.03 -13.61 8.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.469 -0.769 . . . . 0.0 110.451 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 95' ' ' VAL . 30.6 m -86.88 120.76 71.81 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 0.0 111.119 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.512 ' HG3' ' HB2' ' A' ' 68' ' ' ASP . 45.9 Cg_endo -74.36 176.7 9.3 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 124.039 1.547 . . . . 0.0 109.26 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.525 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 42.3 Cg_endo -69.04 62.84 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.52 1.274 . . . . 0.0 110.771 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.56 -56.58 0.52 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 5.2 tptt -89.59 11.9 18.31 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.525 ' CG ' ' HA ' ' A' ' 97' ' ' PRO . 44.4 mmm-85 . . . . . 0 N--CA 1.494 1.75 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.154 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 N--CA 1.484 0.921 0 CA-C-O 121.481 0.534 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.605 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.8 t90 -96.11 138.59 33.51 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.449 -0.782 . . . . 0.0 110.114 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -59.24 -25.72 64.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 110.285 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.605 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 18.8 t -95.07 160.35 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.575 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -108.32 171.32 4.63 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.069 -1.019 . . . . 0.0 110.491 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.11 -34.48 10.17 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.231 1.648 . . . . 0.0 109.53 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -78.76 -28.98 44.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.578 -0.702 . . . . 0.0 109.349 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.539 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 1.6 m-20 -81.11 -34.22 32.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.456 -0.777 . . . . 0.0 108.913 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 67' ' ' ARG . 16.2 tptt -72.35 -19.98 61.55 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.604 0.716 . . . . 0.0 109.225 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.87 -41.7 61.81 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.622 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.49 -26.09 60.75 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.622 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.3 m-30 -74.34 -38.34 63.28 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 3.1 t70 -73.17 -12.35 60.85 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.279 0.561 . . . . 0.0 110.207 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.61 -32.77 13.27 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.702 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.253 42.3 mt -78.34 -28.76 14.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.972 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.7 -37.77 65.08 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.6 t70 -90.29 1.65 56.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.697 -0.627 . . . . 0.0 109.926 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.427 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.4 t -91.89 -2.74 56.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 108.658 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.975 HD12 HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -112.7 -3.51 14.25 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.47 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.6 t 80.3 96.9 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.9 Cg_endo -71.29 147.31 52.94 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 O-C-N 124.427 1.751 . . . . 0.0 110.548 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 43.0 t -118.05 101.66 12.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 18.3 t30 57.98 30.78 19.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.859 . . . . 0.0 109.624 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.488 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 85.79 34.72 12.69 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.586 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 93.7 m-85 -151.11 153.83 35.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -1.162 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.975 HD13 HD12 ' A' ' 24' ' ' LEU . 24.2 mt -124.68 122.95 38.95 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.675 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.551 ' CA ' ' HE3' ' A' ' 64' ' ' MET . 0.7 OUTLIER -72.92 139.99 47.18 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.612 0.72 . . . . 0.0 111.108 -178.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -46.39 -25.3 1.94 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -58.55 -33.67 70.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -1.104 . . . . 0.0 110.281 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.562 ' HD3' ' CA ' ' A' ' 31' ' ' LEU . 5.1 ptmt -99.96 -28.19 13.21 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.874 0.845 . . . . 0.0 109.714 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.69 HG11 HD12 ' A' ' 65' ' ' LEU . 72.1 t -80.73 -48.37 19.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 CA-C-O 121.444 0.64 . . . . 0.0 109.629 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.61 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.25 -51.98 7.74 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.462 -0.774 . . . . 0.0 110.493 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.809 ' HA ' HD12 ' A' ' 41' ' ' LEU . 38.6 Cg_endo -66.28 -33.06 40.36 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 108.889 -1.235 . . . . 0.0 108.889 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.893 HG21 HD22 ' A' ' 24' ' ' LEU . 2.7 t -72.36 -12.23 15.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.949 ' HB3' HD22 ' A' ' 50' ' ' LEU . 90.4 mt -97.85 -16.87 19.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 38' ' ' PRO . 92.5 mt -78.92 -36.41 41.92 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.56 -0.713 . . . . 0.0 109.286 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -46.42 -23.87 0.43 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.552 179.119 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 1.034 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -73.93 6.34 3.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.566 -0.709 . . . . 0.0 111.091 -179.405 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.26 15.36 1.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.755 -1.215 . . . . 0.0 110.051 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.028 HD13 HG21 ' A' ' 49' ' ' ILE . 15.3 mt -93.59 158.76 36.18 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.117 -0.99 . . . . 0.0 109.856 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.556 ' HD2' HG13 ' A' ' 49' ' ' ILE . 41.4 Cg_endo -72.87 157.39 51.66 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.978 1.515 . . . . 0.0 110.294 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.6 t -59.66 -11.24 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 110.706 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.03 -36.49 69.67 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.915 -1.116 . . . . 0.0 108.18 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.028 HG21 HD13 ' A' ' 45' ' ' LEU . 32.6 mm -68.51 -45.2 82.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.949 HD22 ' HB3' ' A' ' 40' ' ' LEU . 3.6 mt -65.55 -20.39 66.31 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.486 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . -85.2 -30.02 26.43 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.527 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 16.0 ttm-85 -93.03 -55.43 3.35 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.467 -1.019 . . . . 0.0 109.562 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.826 HG11 HG23 ' A' ' 77' ' ' VAL . 39.4 t -49.76 -38.45 13.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.103 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.532 ' HA ' ' HB2' ' A' ' 57' ' ' SER . 8.6 t-105 -64.93 -56.67 11.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 109.3 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.595 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 68.5 mm-40 -44.52 -55.3 5.23 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.484 -0.76 . . . . 0.0 109.977 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.886 HD11 ' HA ' ' A' ' 88' ' ' MET . 4.7 mt -70.75 -10.5 59.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 0.0 109.913 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.856 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 17.4 m -96.15 -37.43 10.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 110.118 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.659 ' HA ' HD23 ' A' ' 65' ' ' LEU . 13.5 t0 -77.61 70.48 3.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.358 -0.839 . . . . 0.0 109.27 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.428 HG23 ' HD2' ' A' ' 99' ' ' LYS . 45.2 mm -39.95 -31.73 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.637 -0.664 . . . . 0.0 110.789 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 62' ' ' ASP . 0.6 OUTLIER -98.79 -23.48 15.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.369 -0.832 . . . . 0.0 110.6 -178.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 55' ' ' GLU . 90.9 m-70 57.41 49.62 12.68 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.189 -0.944 . . . . 0.0 110.545 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.487 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 5.7 p-10 -111.97 0.99 16.22 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.041 -1.037 . . . . 0.0 110.286 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 112.43 2.43 26.04 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.551 ' HE3' ' CA ' ' A' ' 32' ' ' SER . 5.0 mtp -149.1 160.06 43.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.991 -1.299 . . . . 0.0 110.616 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.69 HD12 HG11 ' A' ' 36' ' ' VAL . 70.8 mt -111.69 115.24 28.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.551 -0.718 . . . . 0.0 109.948 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.586 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 7.0 t0 -69.18 164.18 23.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.892 -1.13 . . . . 0.0 109.733 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.54 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 1.7 ptt180 -37.76 -42.28 0.57 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.677 -0.64 . . . . 0.0 111.512 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.54 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -84.74 -33.02 23.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.211 -0.931 . . . . 0.0 110.888 -179.202 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 24.3 mt-10 -69.72 -42.65 73.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 109.368 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.702 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 50.5 t80 -64.14 -28.88 70.06 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.559 -0.713 . . . . 0.0 109.178 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -61.73 -48.95 78.41 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.774 0.797 . . . . 0.0 109.964 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.014 ' CG1' HD11 ' A' ' 94' ' ' LEU . 70.7 t -59.25 -24.03 26.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.685 -0.634 . . . . 0.0 110.424 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.856 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -86.71 -8.7 57.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.156 -0.965 . . . . 0.0 112.003 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.602 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 12.0 mmm -90.08 -40.5 12.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.639 -1.288 . . . . 0.0 110.489 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.519 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.6 p90 -78.19 -19.02 54.72 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.789 -1.165 . . . . 0.0 108.374 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.675 HD22 HG13 ' A' ' 86' ' ' VAL . 9.2 mt -80.91 -23.63 38.82 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.468 0.652 . . . . 0.0 109.48 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.826 HG23 HG11 ' A' ' 53' ' ' VAL . 70.1 t -91.65 -32.16 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.529 -0.732 . . . . 0.0 110.3 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.539 ' HA ' HD12 ' A' ' 81' ' ' LEU . 1.2 m-85 -80.04 -24.18 40.91 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.184 -0.947 . . . . 0.0 110.417 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 79.3 m -86.66 -13.76 44.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.256 -0.903 . . . . 0.0 109.395 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.841 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -76.69 -18.95 58.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.08 -1.012 . . . . 0.0 108.743 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.034 HD21 ' O ' ' A' ' 43' ' ' SER . 1.9 mt -92.41 -48.63 6.55 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.516 0.674 . . . . 0.0 111.471 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 82' ' ' GLU . 3.4 tp10 -108.03 -28.0 9.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 112.359 -177.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 79' ' ' CYS . 5.8 mttt -88.86 -87.68 0.16 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.727 -1.233 . . . . 0.0 111.19 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.546 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -155.31 177.92 1.85 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.081 -1.012 . . . . 0.0 110.306 -179.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 40.4 Cg_endo -65.99 171.9 9.32 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.819 1.431 . . . . 0.0 110.501 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.675 HG13 HD22 ' A' ' 76' ' ' LEU . 72.1 t -116.68 127.77 26.5 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.234 -0.916 . . . . 0.0 110.477 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.585 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.2 Cg_endo -80.43 -173.83 2.01 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.756 1.398 . . . . 0.0 109.617 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.886 ' HA ' HD11 ' A' ' 56' ' ' LEU . 20.1 mtm -114.68 20.98 14.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 0.0 110.347 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.496 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 69.0 m -111.18 103.89 12.36 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.696 -1.201 . . . . 0.0 111.434 -178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.8 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.1 mt -59.16 108.15 1.24 Allowed Pre-proline 0 C--N 1.293 -1.856 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.734 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 89' ' ' SER . 43.2 Cg_endo -68.77 141.9 50.85 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.948 1.499 . . . . 0.0 110.549 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.64 -4.54 14.83 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.027 1.54 . . . . 0.0 110.72 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -92.9 8.53 39.29 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.397 -0.814 . . . . 0.0 109.357 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.014 HD11 ' CG1' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -127.92 -7.8 5.5 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.589 0.709 . . . . 0.0 110.136 -178.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.428 ' HA ' ' HD2' ' A' ' 96' ' ' PRO . 46.8 t -82.45 113.28 43.19 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 120.888 -1.133 . . . . 0.0 110.721 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.487 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 42.4 Cg_endo -69.63 175.19 8.32 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.05 1.552 . . . . 0.0 110.093 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 98' ' ' SER . 41.7 Cg_endo -68.56 -172.98 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.858 1.451 . . . . 0.0 110.51 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.9 OUTLIER 75.24 -49.86 0.65 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.53 -0.731 . . . . 0.0 110.073 -179.098 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.428 ' HD2' HG23 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -88.27 13.13 12.19 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.131 -0.981 . . . . 0.0 108.552 178.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.431 ' O ' ' CG ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.412 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 7' ' ' TRP . 45.4 Cg_endo . . . . . 0 N--CA 1.484 0.953 0 N-CA-C 110.265 -0.706 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.511 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.8 t90 -44.62 128.95 6.84 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.215 -0.928 . . . . 0.0 109.255 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.666 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -40.64 -27.49 0.05 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 0.0 109.889 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.511 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 10.0 t -103.73 128.26 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.424 -0.797 . . . . 0.0 109.534 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.517 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.0 mttt -82.2 178.98 2.11 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.933 . . . . 0.0 110.156 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.6 Cg_endo -71.24 -35.12 9.01 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.01 1.532 . . . . 0.0 109.908 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 2.0 pt-20 -81.07 -19.89 42.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.423 -0.798 . . . . 0.0 109.446 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.515 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 0.3 OUTLIER -81.91 -39.89 23.13 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.01 -14.85 59.36 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.82 -37.49 55.6 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.634 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -77.24 -22.82 51.63 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 13.3 m-30 -77.32 -33.71 55.53 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -70.78 -8.82 55.21 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.319 0.58 . . . . 0.0 110.004 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.57 -34.64 14.66 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.509 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 34.0 mt -81.78 -30.11 10.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.59 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -74.14 -34.76 63.97 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.56 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.6 t70 -89.18 -4.5 58.22 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.676 -0.64 . . . . 0.0 110.213 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.59 -2.69 58.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 108.986 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.668 ' HB2' HD22 ' A' ' 31' ' ' LEU . 3.2 mt -107.14 -12.15 15.46 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.2 t 83.89 87.94 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 44.9 Cg_endo -71.21 150.92 60.19 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 O-C-N 124.739 1.915 . . . . 0.0 110.331 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 28.7 t -116.05 107.48 22.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.65 -0.656 . . . . 0.0 109.802 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 14.9 t30 55.81 21.06 4.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.379 -0.825 . . . . 0.0 109.52 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 96.16 37.56 4.84 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 92.5 m-85 -150.89 159.94 44.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -1.141 . . . . 0.0 111.227 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.668 HD22 ' HB2' ' A' ' 24' ' ' LEU . 27.0 mt -137.77 129.68 28.68 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.591 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 2.7 p -75.01 137.88 41.83 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.421 -0.8 . . . . 0.0 110.871 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -43.91 -25.03 0.57 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' SER . 80.1 m-20 -65.15 -16.21 63.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.284 -1.127 . . . . 0.0 109.855 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 21.8 mtpp -105.12 -38.92 6.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.128 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.707 HG11 HD12 ' A' ' 65' ' ' LEU . 88.7 t -76.39 -33.18 22.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.544 0.688 . . . . 0.0 109.208 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.7 tttp -48.79 -56.04 17.05 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.724 -0.61 . . . . 0.0 110.228 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.711 ' HA ' HD12 ' A' ' 41' ' ' LEU . 37.5 Cg_endo -64.93 -28.4 58.22 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.73 1.384 . . . . 0.0 109.093 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.664 HG21 ' CD2' ' A' ' 24' ' ' LEU . 3.5 t -78.71 -11.01 13.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.3 0.571 . . . . 0.0 109.932 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.938 ' HB3' HD22 ' A' ' 50' ' ' LEU . 71.7 mt -101.08 -18.22 16.33 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.185 -0.947 . . . . 0.0 108.554 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.711 HD12 ' HA ' ' A' ' 38' ' ' PRO . 15.3 mt -85.14 -41.62 15.51 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.615 -0.678 . . . . 0.0 109.717 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -50.19 -22.72 1.82 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.694 -1.202 . . . . 0.0 108.807 179.317 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.541 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 35.1 m -64.15 -7.27 8.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.623 -0.673 . . . . 0.0 110.615 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.4 OUTLIER 72.82 10.07 5.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.219 -0.925 . . . . 0.0 109.932 -179.605 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.091 HD13 HG21 ' A' ' 49' ' ' ILE . 13.0 mt -90.41 158.82 42.76 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.401 -0.812 . . . . 0.0 110.14 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.558 ' HD2' HG13 ' A' ' 49' ' ' ILE . 41.8 Cg_endo -75.72 167.21 26.82 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.992 1.522 . . . . 0.0 109.908 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 47' ' ' VAL . 43.8 t -69.2 -5.81 5.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.419 -0.801 . . . . 0.0 110.508 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.89 -39.79 34.07 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.183 -0.948 . . . . 0.0 108.547 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.091 HG21 HD13 ' A' ' 45' ' ' LEU . 27.8 mm -66.96 -44.08 88.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.938 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.5 mt -66.32 -17.0 64.5 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.072 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 55' ' ' GLU . . . -87.5 -29.75 20.85 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.667 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -93.57 -55.61 3.21 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.509 -0.994 . . . . 0.0 109.374 179.493 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.755 HG11 HG23 ' A' ' 77' ' ' VAL . 36.5 t -49.94 -55.33 5.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.535 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 6.6 t-105 -50.37 -56.85 9.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.517 -0.74 . . . . 0.0 110.37 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.501 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -49.97 -45.96 52.0 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.415 -179.176 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.736 HD21 ' C ' ' A' ' 88' ' ' MET . 2.5 mt -76.81 -8.57 57.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.659 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.891 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -99.34 -39.86 8.2 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.397 -0.814 . . . . 0.0 109.663 179.194 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.571 ' HA ' HD23 ' A' ' 65' ' ' LEU . 30.4 t0 -75.52 86.02 2.62 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.914 HG21 ' CG ' ' A' ' 99' ' ' LYS . 30.6 mm -49.36 -34.23 7.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.128 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 35.9 p-10 -103.47 -9.97 18.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.998 -1.064 . . . . 0.0 111.354 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.531 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 51.3 m-70 55.63 41.62 30.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.953 -1.092 . . . . 0.0 109.517 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.46 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 3.4 p-10 -101.34 16.24 26.23 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.622 -0.674 . . . . 0.0 110.133 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.93 10.9 84.46 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.591 ' HG2' ' HA ' ' A' ' 32' ' ' SER . 5.0 mtt -142.31 160.3 40.53 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.389 -1.065 . . . . 0.0 110.638 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.707 HD12 HG11 ' A' ' 36' ' ' VAL . 44.0 mt -126.19 119.19 26.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.389 -0.82 . . . . 0.0 109.836 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 4.7 t0 -73.9 166.54 23.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.81 -1.181 . . . . 0.0 109.685 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.491 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -42.22 -46.07 4.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.227 -0.92 . . . . 0.0 110.229 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -73.46 -46.76 46.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.523 -0.736 . . . . 0.0 110.342 -179.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.516 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 14.4 mt-10 -60.56 -41.65 94.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.383 -0.823 . . . . 0.0 109.34 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.59 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 18.8 t80 -60.71 -30.13 69.77 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -64.12 -44.1 93.25 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.782 0.801 . . . . 0.0 110.046 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.999 HG13 HD11 ' A' ' 94' ' ' LEU . 63.4 t -61.11 -28.58 44.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.591 0.71 . . . . 0.0 110.289 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' A' ' 57' ' ' SER . . . -84.93 -6.93 59.34 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.478 -0.764 . . . . 0.0 111.559 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.594 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 9.4 mmm -90.23 -43.08 10.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.307 -1.496 . . . . 0.0 110.465 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.601 ' CZ ' HD13 ' A' ' 94' ' ' LEU . 2.9 p90 -76.92 -15.37 59.69 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.985 -1.086 . . . . 0.0 108.683 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.569 ' HB3' HG13 ' A' ' 53' ' ' VAL . 10.0 mt -85.3 -25.62 27.08 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.476 -0.765 . . . . 0.0 108.979 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.755 HG23 HG11 ' A' ' 53' ' ' VAL . 19.0 t -91.06 -28.51 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.006 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.88 -25.18 37.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.247 -0.908 . . . . 0.0 110.365 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -85.49 -13.04 50.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.956 . . . . 0.0 109.519 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.892 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.1 -9.54 52.94 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.384 -0.823 . . . . 0.0 109.119 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.803 ' N ' HD23 ' A' ' 81' ' ' LEU . 1.5 mt -90.33 -45.26 9.14 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.825 0.822 . . . . 0.0 109.063 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.8 OUTLIER -70.01 -53.08 19.23 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 120.189 -0.605 . . . . 0.0 109.8 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 179.13 -28.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.464 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 79' ' ' CYS . 20.6 mt-10 -66.4 110.74 5.24 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.177 -0.952 . . . . 0.0 111.203 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 47.9 Cg_endo -74.05 178.5 6.82 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.978 1.515 . . . . 0.0 110.157 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.604 HG21 ' CG2' ' A' ' 53' ' ' VAL . 97.3 t -125.45 132.89 24.43 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.007 . . . . 0.0 110.63 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.635 ' O ' HD11 ' A' ' 56' ' ' LEU . 45.9 Cg_endo -87.02 -171.89 0.83 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.021 1.537 . . . . 0.0 109.179 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.736 ' C ' HD21 ' A' ' 56' ' ' LEU . 18.5 mtm -114.64 7.11 15.92 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.992 -1.067 . . . . 0.0 110.162 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.2 m -111.94 100.64 9.05 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.791 -1.163 . . . . 0.0 111.861 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.756 HD23 HD23 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -46.54 108.53 0.85 Allowed Pre-proline 0 C--N 1.289 -2.032 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.492 178.576 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.455 ' HD2' ' CD2' ' A' ' 94' ' ' LEU . 38.3 Cg_endo -64.75 146.58 88.71 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.899 1.473 . . . . 0.0 110.676 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.82 -11.61 27.84 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.161 1.611 . . . . 0.0 111.565 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.666 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -93.89 24.25 4.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.03 -1.044 . . . . 0.0 108.651 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.999 HD11 HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -141.75 -3.33 1.14 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.797 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.8 t -88.96 125.73 61.52 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.803 -1.186 . . . . 0.0 110.665 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.419 ' HG2' ' HB3' ' A' ' 99' ' ' LYS . 49.6 Cg_endo -75.16 152.98 40.69 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.917 1.483 . . . . 0.0 110.539 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 98' ' ' SER . 47.6 Cg_endo -76.42 154.4 35.9 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.877 1.461 . . . . 0.0 110.328 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.7 OUTLIER 73.18 -2.52 2.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.519 -0.738 . . . . 0.0 109.759 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.914 ' CG ' HG21 ' A' ' 59' ' ' ILE . 2.0 tppt? -117.77 -0.7 11.71 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.631 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 N--CA 1.483 0.86 0 N-CA-C 110.121 -0.761 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.589 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 17.2 t90 -68.16 122.2 17.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.213 -0.93 . . . . 0.0 109.766 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.536 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -41.98 -26.97 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 110.089 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.589 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 79.1 t -109.99 124.74 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.0 109.913 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.467 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -86.15 174.36 5.67 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.322 -0.861 . . . . 0.0 110.36 -179.731 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.0 Cg_endo -66.19 -35.94 30.71 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.009 1.531 . . . . 0.0 109.787 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.39 -24.23 61.22 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.357 -0.84 . . . . 0.0 109.242 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -82.69 -42.08 18.54 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -72.27 -15.86 61.91 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.154 178.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.82 -33.34 70.59 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -82.33 -43.79 17.01 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.3 m-30 -61.68 -17.77 56.92 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -87.1 -18.1 31.29 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.802 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.404 ' O ' ' OG ' ' A' ' 23' ' ' SER . . . -90.77 -30.61 16.93 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.708 HG22 ' CE1' ' A' ' 70' ' ' PHE . 27.0 mt -79.62 -32.62 14.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.546 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -69.47 -41.33 76.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.51 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.526 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.8 t70 -86.75 2.69 47.88 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.332 0.587 . . . . 0.0 109.842 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.485 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.4 m -93.3 0.13 56.88 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.834 HD12 HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -113.65 -0.62 14.26 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.468 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 p 77.23 89.9 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 CA-C-O 121.568 0.699 . . . . 0.0 109.119 -178.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.526 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 53.4 Cg_endo -74.21 146.99 36.95 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.113 1.586 . . . . 0.0 110.314 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 98.1 t -114.49 103.55 15.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER 61.89 21.52 12.35 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.189 -0.944 . . . . 0.0 108.933 -178.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.552 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 91.78 33.05 8.09 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 37.9 m-85 -142.74 156.94 45.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -1.108 . . . . 0.0 111.606 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.834 HD13 HD12 ' A' ' 24' ' ' LEU . 37.6 mt -133.35 132.67 41.55 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.546 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.1 OUTLIER -84.49 149.5 25.9 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.342 -0.849 . . . . 0.0 111.22 -178.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -50.68 -21.99 5.32 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.03 -8.63 55.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.236 . . . . 0.0 110.136 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 24' ' ' LEU . 5.0 mtpp -114.25 -42.1 3.39 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.925 0.869 . . . . 0.0 109.148 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.991 HG11 HD12 ' A' ' 65' ' ' LEU . 46.7 t -80.73 -47.44 20.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.528 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.626 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.7 tttp -43.37 -48.37 17.3 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.535 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.896 ' HA ' HD12 ' A' ' 41' ' ' LEU . 39.9 Cg_endo -68.07 -35.59 19.54 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.335 1.176 . . . . 0.0 109.155 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.649 HG21 HD22 ' A' ' 24' ' ' LEU . 2.3 t -64.06 -31.12 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.386 0.613 . . . . 0.0 109.414 178.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.897 ' HB3' HD22 ' A' ' 50' ' ' LEU . 20.9 mt -79.8 -16.95 54.51 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 109.016 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.896 HD12 ' HA ' ' A' ' 38' ' ' PRO . 75.9 mt -76.38 -24.69 54.14 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.562 ' ND2' ' O ' ' A' ' 38' ' ' PRO . 33.0 m-80 -67.78 -15.98 63.9 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.452 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.43 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -72.55 -0.25 12.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.544 -0.722 . . . . 0.0 110.422 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.88 18.75 10.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.111 -0.993 . . . . 0.0 109.343 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.049 HD13 HG21 ' A' ' 49' ' ' ILE . 14.5 mt -96.34 160.58 29.39 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.631 -0.668 . . . . 0.0 110.009 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HG2' HG12 ' A' ' 49' ' ' ILE . 41.7 Cg_endo -74.29 161.94 39.46 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.878 1.462 . . . . 0.0 109.461 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 t -63.17 -9.24 4.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.379 -0.825 . . . . 0.0 110.177 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 3.0 t70 -73.52 -39.12 65.04 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.049 HG21 HD13 ' A' ' 45' ' ' LEU . 20.8 mm -70.41 -47.98 62.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.897 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.0 mt -66.07 -22.12 66.4 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.58 -28.34 29.94 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.538 ' HD3' ' N ' ' A' ' 88' ' ' MET . 3.8 ttm180 -95.72 -58.38 2.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.467 -1.02 . . . . 0.0 109.464 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.808 HG11 HG23 ' A' ' 77' ' ' VAL . 39.0 t -46.8 -29.19 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.785 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.5 ' O ' ' N ' ' A' ' 57' ' ' SER . 18.4 t-105 -74.19 -59.54 2.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.744 -0.598 . . . . 0.0 110.058 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -46.01 -42.18 12.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 109.722 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.905 HD21 ' C ' ' A' ' 88' ' ' MET . 1.5 mt -78.9 -17.23 55.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.385 -0.822 . . . . 0.0 109.276 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.965 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.3 t -92.41 -35.71 13.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.543 -0.723 . . . . 0.0 110.076 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.469 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 24.7 t0 -78.71 77.16 5.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.467 -0.771 . . . . 0.0 109.291 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.528 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 35.6 mm -40.72 -31.82 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.362 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 2.9 m-20 -96.24 -27.03 15.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.335 -0.853 . . . . 0.0 110.557 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.444 ' CB ' ' O ' ' A' ' 60' ' ' ASP . 28.0 m-70 64.74 45.43 3.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.076 -1.015 . . . . 0.0 109.274 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -114.32 -2.74 13.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 110.582 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.31 -0.94 34.97 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.546 ' CG ' ' HA ' ' A' ' 32' ' ' SER . 2.4 mtt -129.35 155.94 44.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.323 -1.104 . . . . 0.0 110.312 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.991 HD12 HG11 ' A' ' 36' ' ' VAL . 11.0 mt -122.56 121.15 35.82 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.312 -0.867 . . . . 0.0 110.969 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 1.1 m-20 -80.47 155.81 26.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.151 -0.968 . . . . 0.0 108.932 178.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.546 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 11.1 ptt180 -40.14 -31.71 0.14 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 0.0 111.491 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.483 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 81.5 m-20 -85.71 -31.53 22.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.038 -1.039 . . . . 0.0 109.839 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 54.8 mt-10 -77.41 -42.39 36.39 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.767 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 43.5 t80 -57.68 -32.65 67.55 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.504 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -60.63 -53.69 54.43 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.584 0.707 . . . . 0.0 110.302 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.945 HG13 HD11 ' A' ' 94' ' ' LEU . 80.8 t -53.53 -26.74 13.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.525 -0.734 . . . . 0.0 110.242 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.965 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -87.68 -11.16 49.18 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.117 -0.989 . . . . 0.0 112.673 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.58 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 9.0 mmm -86.65 -43.42 12.64 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.342 -1.474 . . . . 0.0 111.036 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.645 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 2.0 p90 -76.83 -23.26 52.76 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.632 -1.227 . . . . 0.0 108.244 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.774 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.5 mt -76.0 -21.76 56.55 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.38 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.808 HG23 HG11 ' A' ' 53' ' ' VAL . 75.5 t -90.93 -26.46 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.373 -0.83 . . . . 0.0 109.766 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -89.49 -23.14 22.15 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.335 -0.853 . . . . 0.0 109.271 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 30.3 m -82.44 -13.31 56.98 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.39 -0.819 . . . . 0.0 108.9 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.622 ' C ' HD23 ' A' ' 81' ' ' LEU . . . -89.31 -11.14 44.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.393 -0.817 . . . . 0.0 108.974 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.814 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.6 mt -90.82 -43.51 10.01 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.677 0.751 . . . . 0.0 109.563 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 6.2 tp10 -69.22 -53.31 20.6 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.909 -0.717 . . . . 0.0 109.608 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 9.9 tttm 178.1 -26.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.286 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -63.29 113.1 8.43 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.001 -1.062 . . . . 0.0 111.08 -178.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.68 155.42 58.79 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.987 1.52 . . . . 0.0 110.019 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.642 HG11 ' CG2' ' A' ' 53' ' ' VAL . 69.5 t -109.83 119.76 46.7 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.998 -1.064 . . . . 0.0 110.717 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.593 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.3 Cg_endo -89.32 145.67 5.07 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.869 1.457 . . . . 0.0 109.394 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.905 ' C ' HD21 ' A' ' 56' ' ' LEU . 1.2 ptt? -75.33 5.08 6.08 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.029 -1.044 . . . . 0.0 111.526 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.56 ' N ' HD21 ' A' ' 56' ' ' LEU . 58.2 m -98.57 104.56 16.6 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 118.821 -1.152 . . . . 0.0 112.24 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.668 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -44.48 104.99 0.41 Allowed Pre-proline 0 C--N 1.299 -1.617 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.418 178.155 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.517 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 39.4 Cg_endo -67.0 139.9 52.74 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.774 1.407 . . . . 0.0 110.624 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.38 -6.44 19.17 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.066 1.561 . . . . 0.0 111.095 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -97.09 19.06 13.52 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.945 HD11 HG13 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -151.42 13.03 0.65 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.758 0.79 . . . . 0.0 110.142 -178.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.5 p -104.02 136.27 19.22 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 120.645 -1.284 . . . . 0.0 110.038 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.08 146.16 90.48 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.964 1.508 . . . . 0.0 109.803 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.565 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 42.0 Cg_endo -68.87 -3.4 11.31 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.899 1.473 . . . . 0.0 111.376 -178.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t -86.38 -21.93 26.91 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.004 -1.06 . . . . 0.0 109.403 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.449 ' HE3' HG21 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -89.99 2.86 54.65 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.391 -0.818 . . . . 0.0 109.687 179.242 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.565 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 10.9 ptp180 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 110.327 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_